zidovudine has been researched along with HIV Coinfection in 4179 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (0.60) | 18.7374 |
| 1990's | 2319 (55.49) | 18.2507 |
| 2000's | 1210 (28.95) | 29.6817 |
| 2010's | 544 (13.02) | 24.3611 |
| 2020's | 81 (1.94) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; De Clercq, E; Inouye, N; Miyasaka, T; Sekiya, K; Shigeta, S; Takashima, H; Tanaka, H; Ubasawa, M; Walker, RT | 1 |
| Driscoll, JS; Ford, H; Kelley, JA; Marquez, VE; Mitsuya, H; Shirasaka, T; Siddiqui, MA | 1 |
| Bader, JP; Buckheit, RW; Clanton, DJ; Cushman, M; Golebiewski, WM; Graham, L; Haugwitz, RD; McMahon, JB; Rice, WG; Weislow, O | 1 |
| Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK; Vig, R | 1 |
| Armon-Omer, A; Britan, E; Friedler, A; Hayouka, Z; Hizi, A; Kotler, M; Levin, A; Loya, S; Loyter, A; Rosenbluh, J | 1 |
| Chen, JJ; Cheng, P; Huang, N; Jiang, ZY; Ma, YB; Zhang, Q; Zhang, XM; Zheng, YT | 1 |
| Colonno, R; Dicker, I; Fan, L; Gali, V; Higley, H; Krystal, M; Lin, PF; Nowicka-Sans, B; Parkin, N; Tenney, D; Terry, B; Wang, C; Zhang, S | 1 |
| Chen, FF; Hammarskjold, ML; Ptak, R; Raman, S; Rekosh, D; Shuck-Lee, D; Willard, R | 1 |
| Balzarini, J; Cecchetti, V; Daelemans, D; Fravolini, A; Manfroni, G; Massari, S; Pannecouque, C; Sabatini, S; Stevens, M; Tabarrini, O | 1 |
| Cao, Y; De Clercq, E; Liu, X; Pannecouque, C; Wang, Y; Zhan, P | 1 |
| Bachmann, MH; Fessel, WJ; Kagan, RM; Mitsuya, Y; Shafer, RW; Shahriar, R; Varghese, V | 1 |
| Hamatake, M; Huang, W; Komano, J; Kumakura, S; Murakami, T; Okuma, K; Tanaka, R; Tanaka, Y; Toma, J; Yamamoto, N; Yamazaki, T; Yanaka, M | 1 |
| Amano, F; Hamashima, Y; Hasegawa, J; Kajimoto, T; Katoh, K; Node, M; Takebe, Y; Tanaka, R; Tsujii, H; Yamada, T | 1 |
| Abreu, P; Barbosa, JE; Batalha, PN; Bou-Habib, DC; Castro, HC; Cirne-Santos, CC; Cunha, AC; de Souza, MC; Ferreira, VF; Garrido, V; Giongo, V; Nogueira, CM; Paixão, IC; Rodrigues, CR; Santos, Fda C; Silva, Dde O; Simonetti, BR; Souza, TM; Temerozo, JR | 1 |
| Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N | 1 |
| De Clercq, E; Fang, Z; Li, Z; Liu, X; Pannecouque, C; Zhan, P | 1 |
| Aubertin, AM; Laumond, G; Mourer, M; Psychogios, N; Regnouf-de-Vains, JB | 1 |
| Asif, G; Fromentin, E; Hurwitz, SJ; Schinazi, RF; Tharnish, PM | 1 |
| Bharate, SB; Bhutani, KK; Chauthe, SK; Mitra, D; Sabde, S; Singh, IP | 1 |
| Fransen, S; Gupta, S; Huang, W; Paxinos, EE; Petropoulos, CJ; Stawiski, E | 1 |
| Almond, MR; Buckheit, RW; Hartman, T; Keilholz, L; Lampert, BM; Lanier, ER; Mankowski, MK; Osterling, MC; Painter, GR; Ptak, RG | 1 |
| Barbault, F; Chen, CH; Huang, L; Huang, R; Jiang, S; Jiang, X; Lee, KH; Lu, H; Qian, K; Qin, B; Tian, X; Xie, L | 1 |
| Fukushima, D; Habashita, H; Hirai, K; Hisaichi, K; Maeda, K; Mitsuya, H; Nakai, H; Nishiyama, T; Nishizawa, R; Sagawa, K; Shibayama, S; Tada, H; Takaoka, Y; Toda, M | 1 |
| Azas, N; Casano, G; Dumètre, A; Hutter, S; Pannecouque, C; Robin, M | 1 |
| Cai, QQ; He, YP; Lai, CC; Li, C; Li, DX; Long, J; Wang, H; Zhang, CS; Zhang, DH; Zhang, SS; Zheng, YT | 1 |
| Chen, FE; Dai, HF; Gu, SX; He, QQ; Ma, XD; Yang, LM; Yang, SQ; Zhang, X; Zheng, YT | 1 |
| Chen, W; Chen, X; De Clercq, E; Li, D; Li, X; Liu, X; Pannecouque, C; Tian, Y; Zhan, P | 1 |
| An, H; Chang, J; Cui, Y; Dong, L; Ge, Z; Guo, X; Hu, W; Li, Y; Pan, Z; Song, C; Tao, L; Wang, Q; Wang, S; Yang, Q; Yu, X | 1 |
| Geng, Y; Li, Y; Liu, Y; Qiao, W; Wang, M; Wang, Q; Wang, Z; Yao, X | 1 |
| Carnovale, C; Chiacchio, U; Frezza, C; Giofrè, SV; Macchi, B; Marino-Merlo, F; Pistarà, V; Romeo, G; Romeo, R | 1 |
| Agarwal, HK; Buckheit, KW; Buckheit, RW; Parang, K | 1 |
| Aminake, MN; Chibale, K; de Kock, C; Grobler, A; Hans, R; Kirschner, M; Kumar, V; Mahajan, A; Pradel, G; Rethwilm, A; Smith, PJ; Taylor, D; Wiesner, L | 1 |
| Andronova, VL; Galegov, GA; Jasko, MV; Kochetkov, SN; Prassolov, VS; Prokofjeva, MM; Shipitsyn, AV; Zakirova, NF | 1 |
| Hu, G; Hu, L; Huang, J; Li, W; Li, X; Li, Y; Liu, G; Ma, L; Shen, X; Tang, Y; Yang, LM; Zhang, X; Zheng, YT | 1 |
| Detorio, MA; Fernández, S; Ferrero, M; Gotor, V; Martínez-Montero, S; McBrayer, TR; Sanghvi, YS; Schinazi, RF; Theodorakis, EA; Whitaker, T | 1 |
| Chen, W; Chen, X; Clercq, ED; Li, X; Li, Z; Liu, X; Pannecouque, C; Tian, Y; Zhan, P | 1 |
| Kaye, PT; Klein, R; Mautsa, N; Olomola, TO; Sayed, Y | 1 |
| Allenspach, K; Asquith, CR; Hilton, ST; Hofmann-Lehmann, R; Konstantinova, LS; Laitinen, T; Meli, ML; Peräkylä, M; Poso, A; Rakitin, OA | 1 |
| Chen, W; De Clercq, E; Liu, X; Liu, Z; Pannecouque, C; Zhan, P | 1 |
| Ahmad, N; Bashyal, BP; Faeth, SH; Gunatilaka, AA; Ramakrishnan, R; Wellensiek, BP | 1 |
| Costa, J; Delang, L; Leyssen, P; Litaudon, M; Neyts, J; Nothias-Scaglia, LF; Pannecouque, C; Paolini, J; Renucci, F; Roussi, F | 1 |
| Chen, W; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Li, X; Liu, X; Liu, Z; Lu, X; Pannecouque, C; Yang, J; Zhan, P | 1 |
| Chen, H; Hou, Y; Li, X; Shao, J; Wei, S; Yin, Z; Zhu, M | 1 |
| Casey, MC; Huber, AD; Ji, J; Kankanala, J; Sarafianos, SG; Tang, J; Wang, Z; Wilson, DJ; Wu, B; Xie, J | 1 |
| Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Kurkin, AV; Kwon, YD; Kwong, PD; Ramesh, RR | 1 |
| Gu, SX; Ju, XL; Liu, GY; Lu, HH; Pannecouque, C; Xue, P; Zhang, XL; Zheng, XJ; Zhu, YY | 1 |
| Agarwal, HK; Chhikara, BS; Doncel, GF; Parang, K | 1 |
| Daelemans, D; De Clercq, E; Ding, X; Fang, Z; Huang, B; Huo, Z; Kang, D; Liu, X; Lu, X; Meng, Q; Pannecouque, C; Tian, Y; Wu, G; Xu, H; Yu, Z; Zhan, P; Zhang, H; Zhou, Z | 1 |
| Chen, CH; Daelemans, D; De Clercq, E; Huang, B; Kang, D; Lee, KH; Liu, J; Liu, X; Liu, Z; Pannecouque, C; Tian, Y; Zhan, P; Zhang, H | 1 |
| Asada, Y; Chen, CH; Huang, L; Koike, K; Lee, KH; Li, W; Liu, Q; Morris-Natschke, SL | 1 |
| Byrareddy, SN; Kongsted, J; Kramer, VG; Kurup, S; Liu, X; Namasivayam, V; Vanangamudi, M; Zhan, P | 1 |
| Asquith, CRM; Baranovsky, IV; Hofmann-Lehmann, R; Konstantinova, LS; Laitinen, T; Meili, T; Poso, A; Rakitin, OA | 1 |
| Chen, CH; Chen, DF; Huang, YS; Lee, KH; Lu, Y | 1 |
| Asquith, CRM; Coles, SJ; Hilton, ST; Hofmann-Lehmann, R; Laitinen, T; Poso, A; Sil, BC; Tizzard, GJ | 1 |
| Alharbi, NS; Huang, YM; Qin, HL; Rakesh, KP; Shantharam, CS; Sun, B | 1 |
| Abebe, M; Chanie, B; Getaneh, Z; Lemma, M; Temesgen, E; Wale, W; Walie, M | 1 |
| Berteli, TS; Keefe, DL; Navarro, PA; Pimentel, R; Robinson, LG; Wang, F | 1 |
| Chen, S; Dou, L; Li, J; Mou, F; Zhou, H | 1 |
| Boyer, PL; Caplan, MR; Clark, P; Dewar, R; Ferris, AL; Hughes, SH; Johnson, A; Maldarelli, F; Mican, J; Rehm, CA; Sneller, MC | 1 |
| Aizire, J; Atuhaire, P; Boivin, MJ; Familiar, I; Fowler, MG; Katumbi, C; Maliwichi, L; Mutebe, A; Ogwang, LW; Sikorskii, A; Taha, T | 1 |
| Blanche, S; Brossard, M; Dollfus, C; Faye, A; Frange, P; Le Chenadec, J; Mandelbrot, L; Tubiana, R; Warszawski, J | 1 |
| Bhatt, N; Couto, A; Cuco, RM; Degomme, O; Juga, A; Loquiha, O; Meggi, B; Osman, N; Sevene, E; Sidat, M; Temermam, M; Vubil, A | 1 |
| Egger, M; Goldstein, F; Hauser, A; Kouyos, RD; Reichmuth, ML; Riou, J; Wandeler, G | 1 |
| Aina, M; Dakum, P; Ezeanolue, E; Mensah, C; Salisu, A; Yesufu, Z | 1 |
| Fridayantara, WD; Gedela, K; Irwanto, I; Luis, H; Rajus, N; Sukmaningrum, E; Wignall, FS | 1 |
| Ebrahim, E; Ebrahim, H; Fiseha, T; Gebreweld, A | 1 |
| Awadu, JE; Coventry, A; Ezeamama, AE; Giordani, B; Sikorskii, A; Zalwango, S | 1 |
| Avihingsanon, A; Azwa, I; Chaiwarith, R; Chan, YJ; Choi, JY; Ditangco, R; Do, CD; Gani, YM; Huy, BV; Jiamsakul, A; Khusuwan, S; Kiertiburanakul, S; Kim, JH; Kumarasamy, N; Lee, MP; Ly, PS; Merati, TP; Ng, OT; Pujari, S; Ross, J; Tanuma, J; Yunihastuti, E; Zhang, F | 1 |
| Asienzo, J; Ategeka, G; Balyegisawa, A; Borok, M; Castelnuovo, B; Hoppe, A; Kaimal, A; Kambugu, A; Kiragga, A; Kityo, C; Lugemwa, A; Mirembe, G; Mugerwa, H; Musaazi, J; Odongpiny, ELA; Paton, NI; Siika, A; Walimbwa, S | 1 |
| Brandon, Z; Hemelaar, J; Johnson, B; Kirtley, S; Kumarendran, M; Murray, C; Portwood, C; Sexton, H | 1 |
| Ahmed, FO; Aning, BD; Ansah, RO; Ayisi-Boateng, NK; Enimil, AK; Ojuang, DA; Okeke, CB; Opoku, S; Sakyi, SA; Sarfo, AD; Senu, E; Wekesa, DN | 1 |
| Bhattacharya, D; Butler, K; Chakhtoura, N; Currier, JS; Dula, D; Fowler, MG; George, K; Govender, V; Kiweewa, FM; Mohtashemi, N; Moodley, D; Musoke, P; Peters, MG; Ship, H; Tierney, C; Vhembo, T | 1 |
| Abongwa, LE; Bella, S; Charles, F; Domkam, I; Emmanuel, N; Eyongetah, M; Jude, B; Moungang, EC; Mua, FH; Ngum, V; Nyamache, AK; Okemo, P; Tamboh, TC; Torimiro, J | 1 |
| Bhardwaj, G; Kaur, N; Kaur, R; Singh, N | 1 |
| Baltrusaitis, K; Browning, R; Fairlie, L; Fowler, MG; George, K; Heckman, B; Knowles, K; Makanani, B; Moodley, D; Nyakudya, LH; Siberry, GK; Stranix-Chibanda, L; Taha, TE; Theron, G; Tierney, C; Tomu, M | 1 |
| Evans, D; Hans, L; Levin, L; Steegen, K; Technau, KG | 1 |
| Alba Alejandre, I; Eberle, J; Kaestner, R; Mahner, S; Rack-Hoch, A; Sollinger, F; von Both, U; Weiss, F | 1 |
| Fortuin, R; Sitole, L; Tugizimana, F | 1 |
| Allodi, A; Badolato, R; Banderali, G; Bassetti, M; Bernardi, S; Bossi, G; Bovis, F; Capasso, L; Carloni, I; Cellini, M; Chiappini, E; Consolini, R; De Martino, M; Dedoni, M; Di Biagio, A; Di Pietro, G; Dodi, I; Dotta, L; Erba, P; Gabiano, C; Galli, L; Genovese, O; Giacomet, V; Giaquinto, C; Lisi, C; Mazza, A; Mignone, F; Montagnani, C; Pruccoli, G; Rampon, O; Salomè, S; Tagliabue, C; Taramasso, L; Tovo, PA; Zallocco, F | 1 |
| Adebisi, SA; Adedeji, NO; Adedeji, TA; Ajeigbe, AK; Ajose, AO; Akande, AA; Fawale, MB; Jeje, OA; Okesina, BA; Smith, OS | 1 |
| Alves, D; Balaguez, RA; Collares, T; da Rocha, JBT; da Silva, FD; Dornelles, L; Kula-Pacurar, A; Lenardão, EJ; Lopes, EF; Omage, FB; Piccoli, BC; Pyrc, K; Rodrigues, OED; Sancineto, L; Sarturi, JM; Segatto, NV; Seixas, FK | 1 |
| Ali, S; Bayserkin, B; Dzissyuk, N; Issanov, A; Mukhatayev, Z; Mukhatayeva, A; Mustafa, A; Vermund, SH | 1 |
| Abrams, EJ; Bonner, LB; Geffner, ME; Gerschenson, M; Jao, J; Kgole, S; Kurland, IJ; Legbedze, J; Makhema, J; Masasa, G; Mmalane, M; Mmasa, KN; Mohammed, T; Moyo, S; Powis, KM; Sun, S | 1 |
| Charoenphak, S; Nanthatanti, N; Sungkanuparph, S | 1 |
| Aghokeng, A; Ateba Ndongo, F; Bilong, S; Djeuda, ABD; Eboumbou Moukoko, CE; Eyoum Bille, B; Fokam, J; Grace, N; Koki Ndombo, P; Moukoko Mbonjo, M; Ndjolo, A; Penda, CI | 1 |
| Begovac, J; Šoštarić Zadro, A; Višković, K | 1 |
| Gao, AW; Houtkooper, RH; Janssens, GE; Jongejan, A; Kamble, R; McIntyre, RL; Molenaars, M; Possemato, R; Schomakers, BV; van Kuilenburg, ABP; van Weeghel, M | 1 |
| Brummel, SS; Chamanga, R; Chi, BH; Dadabhai, S; DeMarrais, P; Fowler, MG; Owor, M; Price, JT; Sebikari, D; Stringer, J; Taha, T | 1 |
| Awadu, JE; Bovin, MJ; Ezeamama, AE; Giordani, B; Musoke, PM; Sikorskii, A; Zalwango, SK | 1 |
| An, Y; Coulter, SM; Cross, ER; Donnelly, RF; Laverty, G; McAulay, K; McCarthy, HO; Peng, K; Pentlavalli, S; Schweins, R; Vora, LK | 1 |
| Chen, H; Deng, Y; Gao, Y; Ge, X; Ge, Y; Lan, G; Li, B; Li, S; Liu, S; Luo, H; Luo, L; Meng, Q; Qin, G; Qin, H; Wang, Y; Wen, P; Wu, X; Yang, H; Zhu, J; Zhu, Q | 1 |
| Behl, S; Cardenas, MC; Chakraborty, R; Enninga, EAL; Farnan, S; Gray, CM; Hamel, BL; Johnson, E; Littlefield, DR; Mejia Plazas, MC; Punia, S; Sintim-Aboagye, E; Temesgen, Z; Theiler, R | 1 |
| Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA | 1 |
| Bukachi, FO; Makamu, BL; Mwangi, PW | 1 |
| Arshad, S; Arshed, SM; Ayub, AR; Ayub, K; Basharat, G; Hamid, H; Iqbal, J; Nazir, S; Zahid, MN | 1 |
| Ávila, DS; da Silva, RS; de Oliveira Pereira, FS; Leal, JG; Nogara, PA; Rodrigues, OED; Sarturi, JM; Teixeira da Rocha, JB; Viçozzi, GP | 1 |
| Aldrovandi, GM; Brummel, SS; Chipato, T; Currier, JS; Flynn, PM; Fowler, MG; Gadama, LA; Koos, BJ; Li, F; Mcintyre, JA; Murphy, A; Nakabiito, C; Saidi, F; Tobin, NH | 1 |
| Kathiravan, MK; Namasivayam, V; Palaniappan, S; Vanangamudi, M | 1 |
| Cassidy, AR; Jao, J; Kgathi, C; Kgole, SW; Lebanna, L; Lockman, S; Makhema, JM; Masasa, G; Mmalane, MO; Ngwaca, M; Powis, KM; Schenkel, S; Shapiro, RL; Slogrove, AL; Williams, PL | 1 |
| Althaus, T; Banchongkit, S; Halue, G; Harrison, L; Jourdain, G; Lallemant, M; Lertkoonalak, R; Liegeon, G; Mary, JY; Nechba, A; Nilmanat, A; Pathipvanich, P; Thongpaen, S; Yutthakasemsunt, N | 1 |
| Brown, K; Cotton, MF; Frigati, LJ; Githinji, L; Gray, D; Hoare, J; Mahtab, S; Myer, L; Nourse, P; Stein, DJ; Zar, HJ; Zühlke, L | 1 |
| Chen, IT; Chen, JK; Chen, YS; Lee, SS; Sy, CL; Tsai, HC; Tseng, YT; Weng, YW; Wu, KS | 1 |
| Cecka, F; Cerveny, L; Huliciak, M; Martinec, O; Staud, F; Vokral, I | 1 |
| Cabrera, NB; Cardoso, CAA; Cosme, EM; de Avelar, JG; de Morais Salviato, C; de Oliveira, GRT; de Oliveira, TRD; Guimarães, MF; Lovero, KL; Pires, LL | 1 |
| Baijnath, S; Govender, T; Kruger, HG; Mdanda, S; Naicker, T; Ntshangase, S; Singh, SD | 1 |
| Bela, B; Ibrahim, F; Kusumaningrum, A; Yunihastuti, E | 1 |
| Chadwick, EG; Correia, KF; Crowell, CS; DiPerna, A; Hazra, R; Seage, GR; Smith, R; Van Dyke, RB; Williams, PL; Yildirim, C | 1 |
| Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK | 1 |
| Barker, PCA; Birgen, E; Bloomfield, GS; Chakraborty, H; Daud, I; Ellis, AM; Kisslo, JA; Koech, MM; McCrary, AW; Muehlbauer, MJ; Nyandiko, WM; Thielman, NM | 1 |
| Fischer, A; Gumede, SB; Lalla-Edward, ST; Venter, WDF | 1 |
| Boucher, M; Kakkar, F; Karatzios, C; Lamarre, V; Metras, ME; Ransy, DG; Renaud, C; Trahan, MJ; Valois, S | 1 |
| Ajibola, G; Batlang, O; Bennett, K; Capparelli, EV; Hughes, MD; Jean-Philippe, P; Kuritzkes, DR; Lichterfeld, M; Lockman, S; Makhema, J; Maswabi, K; Mohammed, T; Moyo, S; Sakoi, M; Shapiro, RL | 1 |
| Teshale, AB; Tsegaye, AT; Wolde, HF | 1 |
| Ainembabazi, P; Ayitewala, A; Kato, CD; Kyeyune, F; Nabulime, E; Nankya, I | 1 |
| Arraes, LC; Brandão, LAC; Carvalho-Silva, WHV; Coelho, AVC; Crovella, S; Guimarães, RL; Moura, RR; Valeriano, JJLS | 1 |
| An, M; Ding, H; Han, X; Li, S; Ouyang, J; Wang, L; Zhang, M; Zhao, B | 1 |
| Alejandria, M; Arcangel, L; Arevalo, GM; Ching, PR; Destura, R; Dungca, NT; Leyritana, K; Lim, J; Mendoza, KAR; Palaypayon, NS; Peñalosa-Ramos, C; Salvana, EMT; Samonte, GMJ; Schwem, BE; Solante, R; Tactacan-Abrenica, RJ; Telan, E; Tonga, AD; Trinidad, LF | 1 |
| Dollfus, C; Lemoine, A; Michot, J; Tounian, P; Viala, J | 1 |
| Mega, TA; Negera, GZ; Usamo, FB | 1 |
| Amzal, B; Cressey, TR; Jarupanich, T; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Rawangban, B; Sabsanong, P; Siriwachirachai, T; Sripan, P; Urien, S; Wanasiri, P | 1 |
| Figg, WD; George, J; Goncalves, P; Lurain, K; Marshall, V; Peer, CJ; Ramaswami, R; Serquiña, A; Steinberg, SM; Uldrick, TS; Wang, V; Whitby, D; Widell, A; Yarchoan, R; Ziegelbauer, J | 1 |
| Azmi, M; Baber, ZU; Badlani, S; Dodani, SK; Nasim, A; Sheerani, M | 1 |
| Kammarabutr, J; Mahalapbutr, P; Okumura, H; Rungrotmongkol, T; Wolschann, P | 1 |
| Anthony, P; Best, BM; Cahn, P; Chakhtoura, N; Chokephaibulkit, K; Cressey, TR; de Lourdes B Teixeira, M; Essack, Z; Frenkel, LM; Fuller, TL; Gouvèa, MIS; Hennessy, R; João, EC; Laimon, L; Mathiba, R; Mirochnick, M; Mmbaga, BT; Moreira, LF; Morrison, RL; Ngocho, JS; Njau, BN; Pilotto, JHS; Prommas, S; Rolon, MJ; Shapiro, DE; Siberry, GK; Violari, A; Werarak, P | 1 |
| Betha, TP; Calcagno, A; Dravid, AN; Gawali, R; Kore, SD; Kulkarni, MM; Letendre, SL; Mahajan, US; Medisetty, M; Natrajan, K; Rathod, NM; Saraf, CK; Sharma, AK; Wadia, RS | 1 |
| Eggers, C; Hoetelmans, R; Läer, S | 1 |
| Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z | 1 |
| Cheng, CY; Cheng, SH; Hu, YC; Hung, TC; Lee, CY; Lin, MH; Lu, LC | 1 |
| Batra, H; Chawla, H; Das, BK; Hussain, AW; Kabra, SK; Katpara, S; Kumar, S; Lodha, R; Luthra, K; Singh, R; Singh, S | 1 |
| Dong, Y; Feng, L; Gui, X; Guo, W; Liang, K; Liu, Y; Yan, Y | 1 |
| Bae, J; Cook, RL; Delcher, C; Francois, K; Joseph, N; Pessoa-Brandão, L; Puttkammer, N; Rich, SN; Robin, E; Yaghjyan, L | 1 |
| Apalata, T; Bam, NE; Chitha, W; Mabunda, SA; Nomatshila, SC; Ntsaba, J | 1 |
| Aweeka, F; Bradford, S; Browning, R; Coletti, A; Costello, D; Graham, B; Hughes, E; Kamthunzi, P; Kawalazira, R; Mmbaga, BT; Moye, J; Musoke, P; Nathoo, K; Norman, J; Owor, M; Purdue, L; Reding, C; Tierney, C; Whalen, ME; Wiesner, L; Ziemba, L | 1 |
| da Silva, CH; da Silva, CLO; Friedrich, L; Magdaleno, AM; Menegotto, M | 1 |
| Fang, J; Iyer, SS; Jia, T; Liu, D; Luo, Y; Saikam, V; Sheng, X | 1 |
| Basu, A; Biswas, A; Das, BK; Nischal, N; Soneja, M; Sood, R; Wig, N | 1 |
| Beilstein-Wedel, E; Brown, DW; Brummel, SS; Chadwick, EG; Chanock, SJ; Engels, EA; Hartley, SW; Hazra, R; Kacanek, D; Karyadi, DM; Lee, OW; Lin, SH; Machiela, MJ; Marsit, CJ; Poirier, MC; Wang, Y; Zhou, W; Zhu, B | 1 |
| Boivin, MJ; Ezeamama, AE; Giordani, B; Musoke, PM; Sikorskii, A; Tuke, R; Zalwango, SK | 1 |
| Do, HQ; Kinai, E; Matsumoto, S; Nagai, M; Nguyen, HDT; Nguyen, KV; Oka, S; Pham, TN; Tanuma, J | 1 |
| Morales-Pérez, M | 1 |
| Araújo, PMM; Martins, J; Osório, NS; Poveda, E; Santos-Pereira, A; Soares, H; Souto, B; Triunfante, V | 1 |
| Yazie, TS | 1 |
| Asienzo, J; Ategeka, G; Balyegisawa, A; Castelnuovo, B; Hakim, J; Hoppe, A; Kaimal, A; Kambugu, A; Kiragga, A; Kityo, C; Mirembe, G; Mugerwa, H; Musaazi, J; Paton, NI; Siika, A; Tukamushabe, P; Walimbwa, S | 1 |
| Benamor Teixeira, ML; Chakhtoura, N; Coombs, RW; Frenkel, LM; Fuller, TL; Gouvêa, MI; Hennessey, R; João, EC; Mirochnick, M; Morrison, RL; Shapiro, DE; Whitson, K | 1 |
| Ajibola, G; Batlang, O; Bennett, K; Botebele, K; Chilisa, F; Holmes, LB; Lockman, S; Makhema, J; Powis, KM; Shapiro, RL; Widenfelt, EV; Zash, R | 1 |
| Ehmer, J; Hatz, C; Hobbins, MA; Labhardt, ND; Motlatsi, MM; Muhairwe, JA; Müller, UF; Muser, J; Pfeiffer, K; Ringera, I | 1 |
| Badia, R; Ballana, E; Clotet, B; Esté, JA; Martí, R; Menéndez-Arias, L; Pauls, E; Pujantell, M; Riveira-Muñoz, E; Ruzo, A; Torres-Torronteras, J | 1 |
| Burger, DM; Gisolf, JH; Swanink, CM; Ter Beest, G; van Luin, M; Wijnberger, LE | 1 |
| Callard, RE; Klein, NJ; Lewis, J; Majekodunmi, AO; Malyuta, R; Thorne, C; Volokha, A | 1 |
| Badal-Faesen, S; Brown, TT; Campbell, TB; Cardoso, SW; Erlandson, KM; Fiorillo, SP; Hakim, J; Kumarasamy, N; Kumwenda, J; Lalloo, U; Riviere, C; Sanchez, J | 1 |
| Conrad, F; Govender, M; Maartens, G; Manning, K; Papavarnavas, NS | 1 |
| Aarons, L; Borkird, T; Capparelli, EV; Cressey, TR; Jittayanun, K; Jourdain, G; Lallemant, M; Le Coeur, S; Luvira, A; Phanomcheong, S; Puangsombat, A; Punyawudho, B; Saenjum, C; Sukrakanchana, PO; Urien, S | 1 |
| Chow, SC; Yuan, M; Zheng, J | 1 |
| Bateman, BT; Hernandez-Diaz, S; Huybrechts, KF; Rough, K; Seage, GR; Sun, JW; Williams, PL | 1 |
| Abad-Carrillo, MA; Álvarez-Ríos, AI; Bernal-Morell, E; Genebat, M; González-García, J; Herrero-Fernández, I; Leal, M; Montero, M; Pacheco, YM; Pulido, F; Rosado-Sánchez, I; Ruiz-Mateos, E; Vidal, F | 1 |
| Iwata, K; Ogawa, W | 1 |
| Awoke, T; Birlie, B; Braekers, R; Kasim, A; Shkedy, Z | 1 |
| Abreu, TF; Araújo, LE; Carvalho, AW; Cordeiro, JR; Davies, MA; de Oliveira, RH; Egger, M; Frota, ACC; Hofer, CB; Keiser, O; Lima, GP; Witthlin, BB | 1 |
| Alexandrova, L; Andreevskaya, S; Chernousova, L; Khandazhinskaya, A; Kochetkov, S; Margolis, L; Matyugina, E; Smirnova, T; Vanpouille, C; Zicari, S | 1 |
| Andolina, A; Carbone, A; Castagna, A; Franzin, M; Galizzi, N; Galli, L; Gianotti, N; Lazzarin, A; Merli, M; Muccini, C; Oltolini, C; Poli, A; Spagnuolo, V; Tadini, P | 1 |
| Canals, F; Gutiérrez, F; Masiá, M | 1 |
| Bosire, R; Broliden, K; De Vincenzi, I; Farquhar, C; John-Stewart, G; Lohman-Payne, B; Luchters, S; Mbori-Ngacha, D; Merkel, M; Nduati, R; Reilly, M; Van de Perre, P; Wachuka, V | 1 |
| Brambilla, D; Ceffa, S; De Luca, A; Liotta, G; Luhanga, R; Magid, NA; Mancinelli, S; Marazzi, MC; Palombi, L; Sidumo, ZJ; Zanelli, G | 1 |
| He, C; Kan, W; Leng, X; Liang, S; Liao, L; Liu, P; Ma, Y; Marconi, VC; Ruan, Y; Shao, Y; Sun, G; Tang, H; Teng, T; Wall, KM; Xing, H; Zuohela, T | 1 |
| Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y | 1 |
| Abrams, EJ; Côté, HCF; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; Leroith, D; Nshom, E; Powis, KM; Sperling, RS; Yu, C | 1 |
| Joshy, KS; Laly, AP; Nandakumar, K; Sabu, T; Snigdha, S; Susan, MA | 1 |
| Calvez, V; Charpentier, C; Collin, G; Delelis, O; Descamps, D; Malet, I; Marcelin, AG; Subra, F | 1 |
| Ankrah, DNA; Lartey, M; Leufkens, HGM; Mantel-Teeuwisse, AK | 1 |
| Fitz Harris, LF; Lampe, MA; Nesheim, SR; Weidle, PJ; Wiener, J | 1 |
| Alzate Angel, JC; Duque Molina, MM; García García, HI | 1 |
| Chaisson, RE; Cohn, S; Dooley, KE; Hoffmann, C; Hoffmann, J; Lala, S; Martinson, N; Mashabela, F; Salazar-Austin, N; Waja, Z | 1 |
| Arudo, J; Barry, M; Hodgkinson, LM; Makori, J; Okwiri, J; Tsisiche, C | 1 |
| Agbaji, O; Audu, R; Chaplin, B; Ezechi, O; Idigbe, E; Imade, G; Kanki, PJ; Meloni, S; Muazu, M; Musa, AZ; Odaibo, G; Okpokwu, J; Olaleye, D; Onwuamah, C; Rawizza, H; Samuel, J | 1 |
| Chen, X; Fairley, CK; He, J; Jing, J; Mao, L; Sasadeusz, J; Su, S; Wei, X; Zeng, H; Zhang, L | 1 |
| Kimani, J; Ndakala, FN; Norbert Behrens, GM; Oluka, MN; Oyugi, JO | 1 |
| Akunuri, S; Kallampallil, J; Leong, S; Maweni, R | 1 |
| Aroke, D; Bechem, NN; Dimala, CA; Kadia, BM | 1 |
| Arts, EJ; Crawford, M; Gibson, RM; Kityo, C; Kyeyune, F; Mugyenyi, P; Nabulime, E; Nankya, I; Ndashimye, E; Nickel, G; Poon, AFY; Quiñones-Mateu, ME; Salata, RA; Venner, C | 1 |
| Blanche, S; Clavel, J; Dollfus, C; Faye, A; Goujon, S; Hleyhel, M; Mandelbrot, L; Sibiude, J; Tubiana, R; Warszawski, J | 1 |
| Cuong, DD; Dung, NT; Dung, NTH; Haneuse, S; Kinh, NV; Matsumoto, S; Oka, S; Tanuma, J; Thuy, PTT; Trung, NV; Vu, TV | 1 |
| Moodley, J; Sebitloane, HM | 1 |
| Ahmadi, NE; Ahsani-Nasab, S; Bayanolhagh, S; Esmaeilzadeh, A; Lolaie, M; Moallemi, S; Mohraz, M; Narouei, A; Sadeghi, L; SeyedAlinaghi, S; Tabatabai, RA | 1 |
| Broadhurst, R; Flick, R; Hosseinpour, MC; Lim, R; Ngongondo, M; Ongubo, D; Rosenberg, NE; Speight, C; Stanley, CC; Tembo, P | 1 |
| Domínguez-Castro, M; Figueroa-Damián, R; Flores-García, Z; Hernández-Pineda, J; Loaiza-Flores, G; López-Martínez, M; Plazola-Camacho, N; Ramírez-Ramírez, A; Rodríguez-Delgado, RG; Sánchez-Serrano, E | 1 |
| Balachandra, S; Dinh, TH; Kilmarx, PH; Mugurungi, O; Mushavi, A; Nyakura, J; Shambira, G; Shiraishi, RW; Tippett Barr, B; Tshimanga, M; Zinyowera, S | 1 |
| Domingues, RMSM; Leal, MDC; Saraceni, V | 1 |
| Awodele, O; Oshikoya, KA; Popoola, TD | 1 |
| Castelnuovo, B; Gonza, P; Kambugu, A; Kiragga, AN; Mbabazi, O; Mubiru, F; Musomba, R; Ratanshi, RP | 1 |
| Bourrel, R; Lapeyre-Mestre, M; Montastruc, JL; Rwagitinywa, J; Sommet, A | 1 |
| Chiappini, E; de Martino, M; Galli, L; Lumaca, A | 1 |
| Alemu, J; Tamir, Z; Tsegaye, A | 1 |
| Barr, E; Chadwick, EG; Currier, JS; Hernandez-Diaz, S; Hoffman, RM; Huo, Y; Patel, K; Rough, K; Seage, GR; Shapiro, DE; Williams, PL | 1 |
| Antony, J; Ashoor, HM; Blondal, E; Finkelstein, Y; Ghassemi, M; Gough, K; Hemmelgarn, BR; Hutton, B; Ivory, JD; Khan, PA; Lillie, E; Straus, SE; Tricco, AC; Vafaei, A; Veroniki, AA | 1 |
| Dai, Y; Jiang, S; Li, W; Lu, X; Wang, L; Wang, Q; Xie, L; Yu, F | 1 |
| Burger, D; Colbers, A; Emonts, M; Pickering, A; Waalewijn, H | 1 |
| Desai, M; Dinh, C; Gonzalez, R; Haaland, RE; Heneine, W; Katana, A; Martin, A; Menendez, C; Otieno, K; Slutsker, L; Williamson, J | 1 |
| Bhardwaj, N; Brown, JA; Chen, BK; Durham, ND; Gopal, R; Hoffman, KW; Lim, JK; O'Brien, M; Soare, AY; Swartz, TH; Tweel, B | 1 |
| Adeyeye, CM; Ali, I; Aliu, R; Awodele, O; Oni, Y | 1 |
| Mugusi, S; Ngaimisi, E; Sasi, P; Sungi, SS; Ulenga, N | 1 |
| Balakrishnan, P; Boobalan, J; Chitra, DA; Dinesha, TR; Mothi, SN; Poongulali, S; Saravanan, S; Solomon, S; Solomon, SS; Srirama, RB; Subashini, D | 1 |
| Alibés, R; Arnedo, M; Busqué, F; Escribà, T; García-Pardo, J; Lorenzo, J; Novio, F; Ruiz-Molina, D; Solórzano, R; Tort, O | 1 |
| de Oliveira, MA; Franco, JB; Martins E Martins, F; Maureira Pena, LJ; Ortega, KL | 1 |
| Kan, W; Leng, X; Liao, L; Liu, P; Ruan, Y; Shao, Y; Wang, J; Xing, H; Xu, W; Yan, J; You, Y; Zuo, Z | 1 |
| Chasela, CS; Corbett, A; Davis, NL; Hudgens, MG; Jamieson, DJ; Kaullen, J; Kourtis, AP; Miller, WC; Nelson, JAE; Sichali, D | 1 |
| Chendi, BH; Eyoh, A; Ikomey, GM; Jacobs, GB; Lyonga, E; Mesembe, M; Okomo Assoumou, MC; Yekwa, EL | 1 |
| Billong, SC; Cappelli, G; Ceccherini-Silberstein, F; Colizzi, V; Dambaya, B; Fokam, J; Fokunang, CN; Gori, C; Nanfack, AJ; Ndjolo, A; Perno, CF; Salpini, R; Santoro, MM; Sosso, SM; Takou, D; Teto, G | 1 |
| Di Rosa, Z; Falasca, K; Ucciferri, C; Vecchiet, J; Vignale, F | 1 |
| Huang, JP; Huang, WH; Luo, SD; Luo, XL; Mo, LD; Ni, ZY; Su, GS; Su, HZ; Wu, JY | 1 |
| Becker, C; Blohm, M; Hertling, S; Hollwitz, B; Kobbe, R; Kreuels, B; Laws, HJ; Martignoni, F; Neubert, J; Nguyen, TTT; Olah, K; Ole Jensen, BE; Oommen, PT; Schmidtke, S; Schulze-Sturm, U; Vasconcelos, MK | 1 |
| Aizire, J; Boivin, MJ; Familiar-Lopez, I; Fowler, MG; Kawalazira, R; Kuteesa, A; Maliwichi-Senganimalunje, L; Mallewa, M; Mutebe, A; Namukooli, JL; Nyakato, M; Ogwang, LW; Ruiseñor-Escudero, H; Sikorskii, A; Taha, TE | 1 |
| Aling, E; Bbosa, N; Kaleebu, P; Kapaata, A; Kateete, DP; Lunkuse, S; Nabirye, SE; Nannyonjo, M; Nassolo, F; Nsubuga, RN; Omooja, J; Sanyu, G; Segujja, F; Ssebaggala, E; Ssemwanga, D | 1 |
| Fekade, D; Gebre-Selassie, S; Grossmann, S; Kalu, AW; Marrone, G; Neogi, U; Sönnerborg, A; Tegbaru, B; Telele, NF | 1 |
| Beilstein-Wedel, E; Brummel, SS; Chadwick, EG; Chanock, SJ; Dagnall, CL; Engels, EA; Hazra, R; Kacanek, D; Machiela, MJ; Marsit, CJ; Poirier, MC; Savage, SA; Wang, Y | 1 |
| Anugulruengkitt, S; Chokephaibulkit, K; Cressey, TR; Jantarabenjakul, W; Ounchanum, P; Pancharoen, C; Punnahitanon, S; Puthanakit, T; Sophonphan, J; Srirompotong, U; Suntarattiwong, P | 1 |
| Bosire, R; Farquhar, C; John-Stewart, G; Mbori-Ngacha, D; Richardson, BA; Roxby, AC; Totten, PA; Yuhas, K | 1 |
| Adebisi, SA; Adedeji, NO; Adedeji, TA | 1 |
| Dugange, F; Harms, G; Hauser, A; Kirschner, W; Kunz, A; Lau, I; Sewangi, J; Theuring, S; Ziske, J | 1 |
| Fekade, D; Feleke, Y; Mezegebu, Y | 1 |
| Gabrielian, A; Holland, GN; Kukuyev, A; MacCumber, MM; Mitsuyasu, R; Sarraf, D | 1 |
| Frenkel, L; Ton, Q | 1 |
| Brady, JJ; Brinkman, K; Cotter, AG; Furrer, H; Fux, CA; Mallon, PW; Reiss, P; Sabin, CA; Vrouenraets, SM; Wit, FW | 1 |
| Darak, S; Darak, T; Hutter, I; Janssen, F; Kulkarni, S; Kulkarni, V; Parchure, R | 1 |
| Aebi-Popp, K; Gingelmaier, A; Hoesli, I; Lyons, F; Mulcahy, F; Rudin, C; Thorne, C | 1 |
| Benaboud, S; Blanche, S; Chappuy, H; Firtion, G; Giraud, C; Hirt, D; Lechenadec, J; Tréluyer, JM; Urien, S; Warszawski, J | 1 |
| Barr, CD; Essex, M; Makhema, J; Maruapula, D; Mongwato, D; Moyo, S; Novitsky, V; Pain, D; Wang, R; Weng, J | 1 |
| Alobwede, SM; Kongnyuy, EJ; Shey, MS; Wiysonge, CS | 1 |
| Lynen, L; Phe, T; Sok, S; Thai, S; van Griensven, J; Veng, C | 1 |
| Choo, HW; Davis, J; Fang, J; Hansson, AG; Langdon, G; Layton, G; Tawadrous, M; Vourvahis, M | 1 |
| André-Schmutz, I; Azria, E; Benachi, A; Blanche, S; Bouallag, N; Cagnard, N; Cavazzana, M; Cocchiarella, F; Cordier, AG; Dal-Cortivo, L; Kaltenbach, S; Le Chenadec, J; Leschi, C; Luce, S; Mandelbrot, L; Mavilio, F; Radford-Weiss, I; Recchia, A; Reimann, C; Revy, P; Six, E; Ternaux, B | 1 |
| Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF | 1 |
| Blanche, S; Warszawski, J | 1 |
| Anglaret, X; Bohoussou, F; Carrou, JL; Danel, C; Eholie, SP; Gabillard, D; Konan, R; Moh, R; Ouattara, E; Peytavin, G | 1 |
| Holmes, D | 1 |
| Davies, MA; Dickinson, D; Egger, M; Ehmer, J; Garone, D; Gsponer, T; Hoffmann, C; Keiser, O; Maskew, M; Mulenga, L; Prozesky, H; Wandeler, G; Wood, R | 1 |
| Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D | 1 |
| Delaporte, E; Desclaux, A; Koita Fall, MB; Ndoye, I; Taverne, B | 1 |
| Antinori, A; Bansi, L; Boumis, E; Callegaro, A; Ceccherini-Silberstein, F; Dunn, D; Fearnhill, E; Forbici, F; Francisci, D; Maggiolo, F; Mussini, C; Nicastri, E; Palamara, G; Perno, CF; Sabin, C; Santoro, MM; Zazzi, M; Zoncada, A | 1 |
| Aghokeng, A; Belec, L; Bertagnolio, S; Bunupuradah, T; Burda, S; Cane, P; Cappelli, G; Charpentier, C; Dagnra, AY; de Wit, TF; Deshpande, AK; El-Katib, Z; Eshleman, SH; Fleury, HJ; Fokam, J; Ford, N; Gody, JC; Hamers, RL; Hawkins, CA; Holmes, S; Hosseinipour, MC; Jordan, MR; Kanki, PJ; Katzenstein, D; Koyalta, DD; Kumwenda, JJ; Lallemant, M; Lynen, L; Manosuthi, W; Marconi, VC; Margot, NA; Moussa, S; Ndung'u, T; Ngo-Giang-Huong, N; Nyambi, PN; Orrell, C; Peeters, M; Rhee, SY; Ruxrungtham, K; Schapiro, JM; Schuurman, R; Shafer, RW; Sigaloff, KC; Sirivichayakul, S; Smith, D; Stevens, W; Tang, MW; van Zyl, GU; Wallis, CL; Zolfo, M | 1 |
| Charalambous, S; Churchyard, GJ; Grant, AD; Hoffmann, CJ; Lewis, JJ; Velen, K | 1 |
| Chamnanchanunt, S; Chierakul, W; Desakorn, V; Kiertiburanakul, S; Kyaw, NL; Manosuthi, W; Pitisuttithum, P; Sungkanuparph, S; Thanachartwet, V | 1 |
| Kanjanabuch, T; Suankratay, C; Woratanarat, K | 1 |
| Blanche, S; Briand, N; Cravello, L; Dollfus, C; Faye, A; Mandelbrot, L; Matheron, I; Nguyen, R; Pannier, E; Rouzioux, C; Tubiana, R; Warszawski, J; Winer, N | 1 |
| Boonsuk, S; Butchon, R; Chokephaibulkit, K; Kullert, N; Kulpeng, W; Phanuphak, N; Pilasant, S; Tantivess, S; Teerawattananon, Y; Tosanguan, K; Voramongkol, N; Werayingyong, P | 1 |
| Bosco, O; Cruciani, M; Malena, M; Mengoli, C; Parisi, SG; Serpelloni, G | 1 |
| Abrahamsson, B; Dressman, J; Groot, DW; Kopp, S; Langguth, P; Polli, JE; Rediguieri, CF; Serra, CH; Shah, VP; Soares, KC; Souza, J | 1 |
| Bunupuradah, T; Chan, KC; Chokephaibulkit, K; Fong, SM; Han, N; Hansudewechakul, R; Huy, BV; Kariminia, A; Kumarasamy, N; Kurniati, N; Lumbiganon, P; Nallusamy, R; Ramautarsing, R; Razali, K; Saphonn, V; Sirisanthana, V; Sohn, AH; Yusoff, NK | 1 |
| Massawe, A; Mghamba, FW; Minzi, OM; Sasi, P | 1 |
| Chin, BS; Kim, HS; Shin, HS | 1 |
| Chow, DC; Gangcuangco, LM; Kallianpur, KJ; Liang, CY; Nakamoto, BK; Shikuma, CM; Umaki, TM | 1 |
| Wilfert, CM | 3 |
| Bailey, H; Cortina-Borja, M; Malyuta, R; Semenenko, I; Thorne, C; Townsend, CL | 1 |
| Benaboud, S; Blanche, S; Bouazza, N; Fauchet, F; Foissac, F; Frange, P; Hirt, D; Treluyer, JM; Urien, S | 1 |
| An, JH; Jang, HC; Jang, MO; Jung, SI; Kang, SJ; Kim, J; Kim, SE; Park, KH | 1 |
| Baghfalaki, T; Berridge, D; Ganjali, M | 1 |
| Feucht, N; Hadeler, J; Lanzl, I; Loos, D; Schmid, RM; Schwerdtfeger, C; Spinner, CD | 1 |
| Ampofo, WK; Barnor, JS; Brandful, JA; Ibe, S; Ishikawa, K; Nii-Trebi, NI; Ofori, SB; Sugiura, W; Yamaoka, S | 1 |
| Gedefaw, L; Sahlemariam, Z; Yemane, T; Yilma, D | 1 |
| Arnoczy, G; Campbell, T; Fichtenbaum, CJ; Ha, B; Hicks, C; Koletar, S; Massengale, K; McComsey, GA; Sax, P; Stein, JH; Taiwo, B; Tebas, P; Walsh, K; Wohl, DA | 1 |
| de Oliveira, T; Lessells, RJ; Manasa, J; McGrath, N; Naidu, KK; Newell, ML; Skingsley, A | 1 |
| Douglas, M; Short, CE; Smith, JH; Taylor, GP | 1 |
| Blanco, J | 1 |
| Han, K; Jang, W; Kim, AH; Kim, Y; Oh, EJ; Park, YJ | 1 |
| Aka, E; Azondékon, A; Dicko, F; Eboua, TK; Ekouévi, D; Gueye, RD; Kouéta, F; Leroy, V; Malateste, K; Okomo, U; Renner, LA; Touré, P | 1 |
| Aliyu, MH; Blevins, M; Megazzini, KM; Mohammed, MY; Parrish, DD; Shepherd, BE; Vermund, SH; Wester, CW | 1 |
| Allen, M; Donnell, D; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, F; Musoke, P; Mwatha, A; Owor, M | 1 |
| Bentaleb, H; Cisse, VM; Dia Badiane, NM; Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fortes Déguénonvo, L; Ka, D; Lakhe, NA; Leye, MM; Manga, MN; Ndour, CT; Seydi, M; Soumaré, M; Sow, PS | 1 |
| Chersich, MF; Farley, TM; Luchters, S; Meda, N; Mwaura, M; Newell, ML; Sartorius, BK; Temmerman, M | 1 |
| Gisolf, EH; Langebeek, N; Legrand, J; Nieuwkerk, PT; Reiss, P; Richter, C; Sprangers, MA; Sprenger, HG | 1 |
| de Carvalho, LP; Kulay, L; Nakamura, MU; Oliveira-Filho, RM; Simões, RS; Tavella, JS; Wagner, A | 1 |
| Boulle, A; Chi, BH; Chimbetete, C; Egger, M; Fox, MP; Gerber, F; Gsponer, T; Hoffmann, CJ; Orrell, C; Prozesky, H; Rohr, J; Wandeler, G; Zwahlen, M | 1 |
| Lu, H; Qi, T; Shen, Y; Wang, J; Wang, Z | 1 |
| Bai, J; Gao, G; Guo, F; Han, Y; He, Y; Huang, A; Lei, J; Li, T; Li, Y; Lu, H; Luo, L; Lye, W; Sun, Y; Tang, X; Wang, H; Wu, X; Xie, J; Zhang, C; Zhang, T; Zhang, X | 1 |
| Doumbo, OK; Guirou, EA; Hendrix, CW; Kayentao, K; Nyunt, MM; Parsons, TL; Plowe, CV; Venkatesan, M | 1 |
| Adedeji, WA; Adewole, IF; Akinola, IT; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, FA; Lindegardh, N; Ma, Q; Morse, GD; Murphy, RL; Ojengbede, O; Parikh, S; Scarsi, KK; Taiwo, B; Tarning, J | 1 |
| Anino, E; Choge, JK; Khayeka-Wandabwa, C; Kweka, EJ; Ngemu, EK; Oyoo-Okoth, E | 1 |
| Ciampa, PJ; Gaveta, S; Howard, LM; Rothman, RL; Sidat, M; Tique, JA; Vermund, SH | 1 |
| Bharti, A; Chakravarty, J; Goel, R; Meena, LP; Rai, M; Sundar, S; Tiwary, NK | 1 |
| Aklillu, E; Gustafsson, LL; Kuteesa, RB; Mukonzo, JK; Nanzigu, S; Ogwal-Okeng, J; Owen, JS; Ross, C; Sewankambo, N; Thabane, L | 1 |
| Caprara, D; MacGillivray, SJ; Shah, R; Urquia, M; Yudin, MH | 1 |
| Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J | 1 |
| Boppana, SB; Chowdhury, N; Hsiao, NY; Hutto, C; Kroon, SM; Manicklal, S; Novak, Z; Pati, SK; van Niekerk, AM | 1 |
| Blackard, JT; Kong, L; Powell, EA; Welge, JA | 1 |
| Anderson, J; Hill, T; Huntington, S; Newell, ML; Pillay, D; Sabin, C; Taylor, GP; Thorne, C; Tookey, P | 1 |
| Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Kasirye, R; Kityo, C; Mambule, I; Mugyenyi, P; Pillay, D; Walker, AS | 1 |
| Awio, P; Dunn, DT; Gilks, CF; Goodall, RL; Kaleebu, P; Kityo, C; Munderi, P; Ndembi, N; Nkurunziza, P; Pattery, T; Pillay, D; van Cauwenberge, A | 1 |
| Betancor, G; Gómez-Puertas, P; Martínez, MA; Mendieta, J; Menéndez-Arias, L; Nevot, M | 1 |
| Adams, EJ; Ahmed, I; Carlin, E; Sadique, Z; Taylor, R | 1 |
| Abongomera, G; Arach, B; Asiimwe, AR; Cook, A; Gibb, DM; Kabamba, D; Kayiwa, J; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; Komunyena, J; Mirembe, G; Mulenga, V; Musiime, V; Nansubuga, C; Walker, SA; Wavamunno, P; Zangata, D | 1 |
| Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D | 1 |
| Abbas, SQ; Abro, AG; Baig-Ansari, N; Kazi, MA; Mir, F; Qamar, FN; Rizvi, A; Zaidi, AK | 1 |
| Arribas, J; Deckx, H; Duiculescu, D; Florence, E; Hung, CC; Sension, M; Stevens, M; Tebas, P; Vanveggel, S; Wilkin, T | 1 |
| Burger, D; Bwakura-Dangarembizi, M; Fillekes, Q; Gibb, DM; Kendall, L; Kitaka, S; Mugyenyi, P; Musoke, P; Ndigendawani, M; Walker, AS | 1 |
| Barchiesi, F; Cirioni, O; Fragola, V; Gabrielli, E; Giacometti, A; Marchionni, E; Massella, M; Weimer, LE | 1 |
| Brown, LA; Ferrell, D; Giunta, B; Jin, J; Obregon, D; Sadic, E; Smith, AJ; Tan, J | 1 |
| Lee, D; Nguyen, NH; Yee, BE | 1 |
| Guerrero-Sanchez, C; Melchjorsen, J; Postma, A; Ruiz-Sanchis, P; Smith, AA; Tolstrup, M; Zelikin, AN; Zuwala, K | 1 |
| Gui, T; Guo, W; Jia, L; Jiao, L; Li, H; Li, J; Li, L; Liu, S; Liu, Y; Zhuang, D | 1 |
| Bernardi, S; Buffolano, W; Calitri, C; Chiappini, E; De Martino, M; Esposito, S; Gabiano, C; Galli, L; Genovese, O; Giaquinto, C; Tovo, PA | 1 |
| Lertcheewakarn, P; Tongprasert, F | 1 |
| Barreto-de-Souza, V; Frolova, S; Karpenko, I; Khandazhinskaya, A; Kochetkov, S; Margolis, L; Vanpouille, C; Zicari, S | 1 |
| Oberdorfer, P; Pornprasert, S; Sirivatanapa, P; Wongnoi, R | 1 |
| Clumeck, N; Delforge, M; Ilunga, J; Kabeya, K; Kadiebwe, D; Kapend, L; Kasamba, E; Matanda, S; Milolo, C; Mwamba, C; Necsoi, C; Vaira, D | 1 |
| Benaboud, S; Bouazza, N; Fauchet, F; Firtion, G; Foissac, F; Hirt, D; Pannier, E; Treluyer, JM; Urien, S; Valade, E | 1 |
| Cai, J; Xiao, J; Zhang, Q | 1 |
| Farquhar, C; John-Stewart, GC; Otieno, PA; Richardson, BA; Unger, JA; Wamalwa, D | 1 |
| Fujita, J; Haranaga, S; Higa, F; Nakamura, K; Tamayose, M; Tasato, D; Tateyama, M; Yara, S | 1 |
| Bagratee, J; Grobler, A; Maharaj, NR; Moodley, D; Nandlal, V; Richardson, P | 1 |
| Bekolo, CE; Bekoule, PS; Djidjou, H; Kollo, B; Sonkoue, C | 1 |
| Dugas, TR; Glover, M; Hebert, VY; Nichols, K; Thibeaux, TM; Xue, SY; Zavecz, JA | 1 |
| Bouazza, N; Burger, D; Capparelli, EV; Fauchet, F; Foissac, F; Kiechel, JR; Lallemant, M; Treluyer, JM; Urien, S | 1 |
| Imai, Y; Kawamoto, M; Kohara, N; Sekiya, H; Togo, M; Yoshimura, H | 1 |
| Kock, A; Ruiz-Sanchis, P; Smith, AA; Tolstrup, M; Wohl, BM; Zelikin, AN; Zuwala, K | 1 |
| André, P; Cotte, L; Monneret, G; Ramière, C; Ronfort, C; Saison, J; Tardy, JC; Trabaud, MA; Venet, F | 1 |
| Blanche, S; Flynn, P; Giaquinto, C; Kakuda, TN; Komar, S; Lathouwers, E; Noguera-Julian, A; Opsomer, M; Van de Casteele, T; Welch, S | 1 |
| Barroso, LF; Johnson, JW; Kupiec, KE; Williamson, JC; Wrenn, RH | 1 |
| Beerenwinkel, N; Gopalakrishnan, S; Huisinga, W; Menz, S; Montazeri, H | 1 |
| Guo, F; Li, T; Lin, Q; Shao, H; Sun, P; Tian, J; Xu, Y; Yu, W; Zhou, X | 1 |
| Berendes, S; Campbell, TB; Cardoso, SW; Christian, P; Gupta, A; Gupte, N; Kanyama, C; Lama, JR; Mwelase, N; Pillay, S; Riviere, C; Samaneka, W; Semba, RD; Shivakoti, R; Sugandhavesa, P; Tang, AM; Yang, WT | 1 |
| Bierman, W; Bravenboer, B; Gisolf, E; Groeneveld, P; Hoepelman, AI; Koopmans, PP; Langebeek, N; Legrand, JC; Mulder, PG; Richter, C; Sprenger, HG; Ten Kate, RW; Ten Napel, CH; van der Werf, Ts; Vriesendorp, R | 1 |
| Alves, M; Guidet, B; Janneau-Magrino, L; Legendre, N; Pateron, D; Yordanov, Y | 1 |
| Álvarez, ML; Arterburn, S; Berenguer, J; Clotet, B; Curran, A; Estrada, V; Ferrer, P; Larrousse, M; Martínez, E; Negredo, E; Pulido, F; Ribera, E; Rubio, R; Sanz, J | 1 |
| André-Schmutz, I; Azria, E; Blanche, S; Cavazzana, M; Cordier, AG; Cuccuini, W; Lechenadec, J; Luce, S; Mandelbrot, L; Soheili, TS; Soulier, J; Vivanti, A | 1 |
| Gilks, CF; Kikaire, B; Kiwuwa-Muyingo, S; Levin, JB; Mambule, I; Musana, H; Musoro, G; Walker, AS | 1 |
| Webster, DP | 1 |
| Havens, PL; Hazra, R | 1 |
| Andre-Schmutz, I; Blanche, S; Gibbons, AT; Poirier, MC; Rugeles, MT | 1 |
| Goldenberg, MJ | 1 |
| Aoko, A; Bii, M; Close, N; Khamadi, S; Kiptoo, I; Langat, RC; Langat, RK; Maswai, J; Obiero, E; Sawe, FK; Shaffer, DN; Shikuku, KP; Sinei, S; Tarus, J; Yegon, P | 1 |
| Bekker, LG; Christensen, S; Ciaranello, AL; Daskilewicz, K; Doherty, K; Francke, JA; Freedberg, KA; Hou, T; Kelly, K; Myer, L; Walensky, RP; Wood, R; Wools-Kaloustian, K | 1 |
| Arterburn, S; Castaño, E; Cheng, AK; Chuck, SL; Church, J; Deville, J; Enejosa, JV; Estripeaut, D; Gaur, A; Rathore, M; Rhee, MS; Saez-Llorens, X; White, K | 1 |
| Daniels, MJ; Su, L | 1 |
| Clarance, P; Cohen, JT; George, L; Kang, G; Karthik, R; Muliyil, J; Mwamburi, M; Noubary, F; Ooriapdickal, AC; Peter, D; Pulimood, SA; Rupali, P; Sathasivam, R; Thuppal, SV; Varghese, GM; Wanke, CA | 1 |
| Bader, J; Glass, TR; Klimkait, T; Labhardt, ND; Lejone, TI; Puga, D; Ringera, I | 1 |
| Blanche, S; Bonnet, D; Delmas, S; Dollfus, C; Faye, A; Khoshnood, B; Le Chenadec, J; Lelong, N; Mandelbrot, L; Sibiude, J; Tubiana, R; Warszawski, J | 1 |
| Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
| Aris, E; Baernighausen, T; Chalamilla, G; Fawzi, W; Hertzmark, E; Jackson, E; Machumi, L; Muya, A; Mwanyika-Sando, M; Sando, D; Spiegelman, D | 1 |
| Clark, KF; Finocchario-Kessler, S; Gautney, BJ; Goggin, K; Khamadi, S; Okoth, V | 1 |
| Hemelaar, J; Montgomery-Taylor, S | 1 |
| Gordon, M; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
| Adeniyi, OV; Fuentes, YO; Sogbanmu, OO; Ter Goon, D | 1 |
| Barlow-Mosha, L; Cotton, M; Dominguez, K; Ford, N; Penazzato, M | 1 |
| Donnen, P; Koy, T; Malandala, GL; Mukumbi, H; Wilmet-Dramaix, M | 1 |
| Ananworanich, J; Bennett, K; Chomchey, N; DeGruttola, V; Ebenezer, G; Gerschenson, M; Hauer, P; Hongchookiat, P; Jadwattanakul, T; Mathajittiphun, P; McArthur, JC; Nakamoto, B; Phanuphak, N; Phanuphak, P; Praihirunkit, P; Shikuma, CM; Teeratakulpisarn, N | 1 |
| Antela, A; Esteban, H; Estébanez, M; Mariño, A; Moreno, S; Navarro, J; Pasquau, J; Perez-Molina, JA; Riera, M; Rivero, A; Rubio, R; Santos, J; Sanz-Moreno, J; Suárez-Lozano, I; Troya, J | 1 |
| Lennie, K; Meshack, N; Muhula, SO; Peter, M; Sibhatu, B | 1 |
| Dodoo, AN; Lartey, M; Leufkens, HG; Mantel-Teeuwisse, AK; Nartey, ET; Nortey, PA; Tetteh, RA | 1 |
| Bernatchez, JA; Damha, MJ; Deleavey, GF; Götte, M; Habibian, M; Ilina, T; Martínez-Montero, S; Parniak, MA; Wahba, AS; Yamada, K | 1 |
| Abrams, EJ; Epie, F; Geffner, ME; Jao, J; Kirmse, B; Kurland, IJ; LeRoith, D; Nshom, E; Powis, K; Qiu, Y; Sperling, RS; Tih, PM; Yu, C | 1 |
| Bhardwaj, S; Chopra, M; Dinh, TH; Doherty, T; Goga, A; Jackson, D; Lombard, C; Mogashoa, M; Pillay, Y; Puren, A; Ramokolo, V; Shaffer, N; Sherman, G; Woldesenbet, S | 1 |
| Bridges, AS; Cohen, MS; Dumond, JB; Fiscus, SA; Forrest, A; Kashuba, AD; Kendrick, R; Reddy, YS; Troiani, L; Yang, KH | 1 |
| Beck, I; Britto, P; Bumgarner, RE; Deng, W; Frenkel, LM; Jourdain, G; Mullins, JI; Ngo-Giang-Huong, N; Olson, SC; Shapiro, DE; Van Dyke, RB | 1 |
| Albano, J; Gee, C; Koram, N; Tilson, H; Vannappagari, V | 1 |
| Avi, R; Huik, K; Jõgeda, EL; Kallas, E; Karki, T; Lutsar, I; Margus, T; Pauskar, M | 1 |
| Bolton, MT; Puertolas, MV; Steele, RW | 1 |
| Antony, J; Arumugam, K; D'Souza, G; De Costa, A; Kumar, DS; Kumarasamy, N; Poongulali, S; Rewari, BB; Shastri, S; Shet, A | 1 |
| Bonnet, F; Calmy, A; Ciaffi, L; Delhumeau, C; Fampou, JC; Hill, A; Menga, G; Nchotu Ngang, P; Rougemont, M; Stoll, B | 1 |
| Cressey, TR; Jourdain, G; Kanjanavikai, P; Klinbuayaem, V; Koetsawang, S; Lallemant, M; Le Coeur, S; Mcintosh, K; Ngo-Giang-Huong, N; Sabsanong, P; Sirirungsi, W; Traisathit, P | 1 |
| Chirwa, M; Ishikawa, N; Jimba, M; Kapyata, H; Komada, K; Miyano, S; Msiska, CY; Okawa, S; Syakantu, G; Yasuoka, J | 1 |
| Abongomera, G; Asiimwe, A; Burger, D; Chabala, C; Chintu, C; Cook, AD; Gibb, DM; Kekitiinwa, A; Kenny, J; Kityo, C; Klein, N; McIlleron, H; Mirembe, G; Mulenga, V; Musiime, V; Owen-Powell, E; Thomason, MJ; Walker, AS | 1 |
| Ayudhaya, OP; Bouazza, N; Cressey, TR; Foissac, F; Ingsrisawang, L; Jittayanun, K; Jourdain, G; Jungpipun, J; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Puangsombat, A; Sripan, P; Srirompotong, U; Traisathit, P; Tréluyer, JM; Urien, S | 1 |
| Beach, MC; Callon, W; Cohn, J; Korthuis, PT; Moore, RD; Saha, S; Wilson, IB | 1 |
| Arends, J; Chene, G; Cosin, J; Dabis, F; Daikos, G; de Wit, S; Mallolas, J; Montforte, Ad; Mussini, C; Peters, L; Raben, D; Rockstroh, J; Smit, C; Zangerle, R; Zinkernagel, A | 1 |
| Boissonnault, M; Charest, L; Galanakis, C; Huchet, E; Longpré, D; Machouf, N; Murphy, D; Thomas, R; Trottier, B; Vézina, S | 1 |
| Agbaji, OO; Darin, KM; Eisen, G; Gashau, W; Kanki, PJ; Meloni, ST; Murphy, RL; Nkado, R; Okonkwo, P; Onwujekwe, DI; Rawizza, HE; Scarsi, KK; Tchetgen Tchetgen, EJ | 1 |
| Gorantla, S; Lu, Y; Makarov, E; Senanayake, TH; Vinogradov, SV; Warren, G | 1 |
| Cai, W; Caughey, B; Chung, C; Dai, Z; Hu, F; Lan, Y; Li, L; Tang, X; Zhang, K | 1 |
| Auge-Courtoi, C; Charpentier, C; Delory, T; Descamps, D; Matheron, S; Michard, F; Papot, E; Peytavin, G; Rioux, C; Yazdanpanah, Y | 1 |
| Cotton, MF; Holgate, S; Mirochnick, M; Nelson, A; Rabie, H; Wedderburn, C | 1 |
| Albano, JD; Koram, N; Napier, MD; Scheuerle, AE; Tilson, H; Vannappagari, V | 1 |
| Butler, L; Civitello, L; Crain, MJ; Ellis, A; Hazra, R; Rich, K; Seage, GR; Van Dyke, RB; Williams, PL; Yildirim, C | 1 |
| Balogun, K; Banko, N; Loutfy, M; MacGillivray, J; Mohammadi, H; Murphy, KE; Papp, E; Serghides, L; Shah, R; Silverman, M; Walmsley, SL; Yudin, MH | 1 |
| Abrahams, S; Hewer, R; Hoppe, HC; Isaacs, M; Kaye, PT; Klein, R; Majumder, S; Manyeruke, MH; Mautsa, N; Mnkandhla, D; Mosebi, S; Olomola, TO | 1 |
| Bodem, J; Buchholz, B; Corona, A; Di Santo, R; Jordan, M; Maccioni, E; Schneider, A; Spöring, I; Tramontano, E; Wöhrl, BM | 1 |
| Gatanaga, H; Ha, do Q; Hosokawa, S; Kato, S; Kikuchi, Y; Kinai, E; Kinh, NV; Lam, NV; Liem, NT; Oka, S; Sadatsuki, M | 1 |
| Maharaj, N; Moodley, D; Moodley, T; Sartorius, B; Sebitloane, M | 1 |
| Bennasar, M; Bijnens, B; Crispi, F; García-Otero, L; Gómez, O; Goncé, A; Gratacós, E; Loncà, M; López, M; Martínez, JM; Rodriguez-López, M; Sitges, M; Valenzuela-Alcaraz, B | 1 |
| Birnbaum, JM; Cha, A; Elsamadisi, P; Phipps, E; Su, CP | 1 |
| Aklillu, E; Bisaso, RK; Gustafsson, LL; Mukonzo, JK; Ogwal-Okeng, J; Owen, JS | 1 |
| Emanuel, EJ; Persad, GC | 1 |
| Biswas, A; Komaki, F | 1 |
| Goryaeva, MP; Gulyaeva, SS; Minaeva, SV; Moshkovich, GF; Tichonova, EV; Varlova, LW | 1 |
| Berrueco, R; Fortuny, C; Lahoz, R; Noguera-Julian, A; Rives, S; Rovira, N | 1 |
| Atashili, J; Dimala, CA; Mbuagbaw, JC; Monekosso, GL; Wilfred, A | 1 |
| Gunda, DW; Kilonzo, SB; Mpondo, BC | 1 |
| Amaral, E; Bahamondes, L; Bahamondes, MV; Brito, MB; Duarte, G; Ferriani, RA; Prandini, TR; Quintana, SM; Ragazini, CS; Vieira, CS | 1 |
| Sidibé, M; Singh, PK | 1 |
| Gordon, M; Julian, MN; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
| Belyhun, Y; Liebert, UG; Maier, M | 1 |
| Ananworanich, J; Chokephaibulkit, K; Do, VC; Kerr, SJ; Kosalaraksa, P; Kurniati, N; Nguyen, LV; Prasitsuebsai, W; Singtoroj, T; Sohn, AH; Sudjaritruk, T; Teeraananchai, S; Truong, KH | 1 |
| Dorrell, L; Sanderson, S; Simon, AK; Wallace, ZR | 1 |
| Essex, M; Hodinka, RL; Leidner, J; Lockman, S; Makhema, J; McAdam, AJ; McIntosh, K; Moffat, C; Shapiro, RL; Thior, I; Wester, C; Zash, RM | 1 |
| Bacha, T; Olana, T; Tadesse, BT; Worku, W | 1 |
| Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F | 1 |
| Abach, J; Abongomera, G; Chabala, C; Colebunders, R; Cook, A; Gibb, DM; Kekitiinwa, A; Kityo, C; Lamorde, M; Mulenga, V; Musiime, V; Thomason, M; Walker, AS | 1 |
| Banigbe, B; Chang, CA; Eisen, G; Jolayemi, T; Kanki, PJ; Meloni, ST; Okonkwo, PI | 1 |
| Bor, J; Boulle, A; Brennan, AT; Davies, MA; de Rekeneire, N; Fatti, G; Fox, MP; Leroy, V; Prozesky, H; Sikazwe, I; Stinson, K; Tanser, F; Wandeler, G; Wood, R; Wool-Kaloustian, K; Yuannoutsos, C | 1 |
| Basar, M; Bhosale, R; Bobat, R; Browning, R; Chi, BH; Chipato, T; Coletti, AS; Currier, JS; Fenton, T; Fiscus, SA; Flynn, PM; Fowler, MG; Gnanashanmugam, D; Klingman, KL; Loftis, AJ; Martinson, FE; McIntyre, J; Mlay, P; Mofenson, LM; Moodley, D; Owor, M; Purdue, L; Qin, M; Shapiro, DE; Siberry, GK; Strehlau, R; Taha, TE; Theron, GB; Violari, A | 1 |
| Brophy, JC; Chan, AK; Hawkes, MT; Mateyu, G; Mwinjiwa, E; Sodhi, SK | 1 |
| Asari, V; Baxter, C; Garrett, N; Grobler, A; Karim, QA; Karim, SSA; Majola, N; Naicker, N; Naidoo, A; Werner, L | 1 |
| Calkins, MJ; Chen, PC; Hsieh, HC; Hung, KM | 1 |
| Chen, Z; Huang, B; Kang, D; Li, W; Liu, X; Zhan, P; Zhou, Z | 1 |
| Kondapi, AK; Kumar, P; Lakshmi, YS | 1 |
| Barlow-Mosha, L; Borkowsky, W; Chen, J; Chi, BH; Deygoo, N; Duffy, PE; Gabriel, EE; Hobbs, CV; Ilmet, T; Jean Philippe, P; Kamthunzi, P; Kirmse, B; Li, Y; Mofenson, L; Musoke, P; Neal, J; Palumbo, P; Parikh, S; Petzold, E; Prescott, W; Tauzie, J; Tegha, G | 1 |
| Alteri, C; Bernardi, S; Bertoli, A; Liuzzi, G; Manno, EC; Palma, P; Perno, CF; Rossi, P; Tchidjou, HK; Zangari, P | 1 |
| Harrison, M; Matjila, M; Riemer, L; Tooke, L | 1 |
| Anglaret, X; Danel, C; Eholie, S; Ello, F; Girard, PM; Hoelscher, M; Kroidl, A; Lennemann, T; Maganga, L; Mgaya, J; Moh, R; Pruvost, A; Saathoff, E; von Massow, F; Zuhse, R | 1 |
| Binda, K; Essex, M; Hick, C; Leidner, J; Lockman, S; Makhema, J; Mmalane, M; Powis, K; Shapiro, RL; Souda, S; Zash, RM | 1 |
| Balestre, E; Dabis, F; Drabo, J; Jaquet, A; Leroi, C; Maiga, M; Messou, E; Minga, A; Sawadogo, A; Seydi, M; Zannou, M | 1 |
| Coelho, AV; Crovella, S; Decorti, G; Silva, SP; Stocco, G; Zandonà, L | 1 |
| Behrens, GM; Jablonka, A; Kimani, J; Ndakala, FN; Oluka, MN; Oyugi, JO | 1 |
| Dunn, DT; Gilks, C; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Mugarura, L; Munderi, P; Nkurunziza, P; Pattery, T; Pillay, D | 1 |
| Boulle, A; Cohen, K; Davies, MA; de Waal, R; Fortuin-de Smidt, M; Igumbor, EU; Maartens, G; Stinson, K; Technau, KG | 1 |
| Cardellach, F; Catalán-García, M; Coll, O; García-Otero, L; Garrabou, G; Gratacós, E; Guitart-Mampel, M; Hernández, S; López, M; Milisenda, J; Miró, Ò; Morén, C | 1 |
| Rawizza, H | 1 |
| Johnson, KA; Li, A; Ziehr, JL | 1 |
| Hamada, Y | 1 |
| Bulterys, M; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mebrahtu, T; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, MC | 1 |
| Gray, GE; Saloojee, H | 1 |
| Asavapiriyanont, S; Bollen, LJ; Chalermchockchareonkit, A; Chotpitayasunondh, T; Chuachoowong, R; Leelawiwat, W; McNicholl, JM; Mock, PA; Shaffer, N; Tappero, JW; Vanprapar, N; Whitehead, SJ | 1 |
| Basseila, GB; Bokilo, AD; Dokekias, AE; Galiba, FO; Malanda, F; Nsitou, MB; Ntsimba, P | 1 |
| Camacho, RJ; Clotet, B; Cozzi-Lepri, A; Deforche, K; Kjaer, J; Lundgren, JD; Moreau, Y; Phillips, A; Theys, K; Van Laethem, K; Vandamme, AM | 1 |
| Cohan, D; Rahangdale, L | 1 |
| Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Overbaugh, J; Richardson, BA | 1 |
| Balakrishnan, P; Kumarasamy, N; Murugavel, KG; Priya, B; Saghayam, S; Shankar, EM; Solomon, S; Sundaram, M; Venkatesh, KK | 1 |
| Aleyamma, TK; Buck, J; Chaguturu, S; Cu-Uvin, S; Gopalakrishnan, G; Lionel, J; Mayer, K; Varghese, L | 1 |
| Braude, J; Galambos, MR; Joelson, D; Johnson, M; Rubin, RA; Saifee, S; Sellers, M; Shrestha, R | 1 |
| Kisic, M; Martínez, MA; Martinez-Picado, J; Mendieta, J; Menéndez-Arias, L; Parera, M; Puertas, MC | 1 |
| Bentata, M; Chêne, G; Collin, F; Garré, M; Goujard, C; Lafaurie, M; Leport, C; Levy, Y; Molina, JM | 1 |
| Arnould, L; Isaakidis, P; Khem, S; Khim, SA; Kuoch, S; Phe, T; Raguenaud, ME; Reid, T | 1 |
| Bae, WH; Essex, M; Lockman, S; Onyait, K; Shapiro, RL; Smeaton, LM; Thior, I; Wester, C | 1 |
| Cortes, C; Domingo, P; Ferrer, E; Gatell, JM; Gutierrez, M; Leon, A; Niubo, J; Pedrol, E; Podzamczer, D; Puig, T; Sanchez, P; Veloso, S | 1 |
| Boue, F; Cohen-Codar, I; Delfraissy, JF; Dellamonica, P; Flandre, P; Marcellin, F; Norton, M; Raffi, F; Spire, B; Van Philippe, N | 1 |
| Elliott, EJ; Giles, ML; Hellard, ME; Kaldor, JM; Lewin, SR; McDonald, AM; Ziegler, JB | 1 |
| Abatemarco, DJ; Catov, JM; Cross, H; Delnevo, C; Hausman, A | 1 |
| Abdullah, F; Draper, B | 1 |
| Cotter, BR; Currier, JS; Dubé, MP; Fichtenbaum, CJ; Gerschenson, M; Komarow, L; Mitchell, CK; Murphy, RL; Parker, RA; Squires, K; Stein, JH; Torriani, FJ | 1 |
| Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J | 1 |
| Abrams, EJ; Becquet, R; Blanche, S; Coffie, PA; Dabis, F; Ekouevi, DK; Horo, A; Leroy, V; Thiebaut, R; Tonwe-Gold, B | 1 |
| Ajayi, SO; Akingbola, TS; Brown, BJ; Oladokun, R; Omigbodun, OO; Osinusi, K | 1 |
| Bélec, L; Charpentier, C; Karmochkine, M; Laureillard, D; Piketty, C; Si-Mohamed, A; Sodqi, M; Weiss, L | 1 |
| Bánhegyi, D; Bannister, WP; Chiesi, A; Friis-Møller, N; Gargalianos, P; Kirk, O; Lundgren, JD; Mocroft, A; van Lunzen, J; Viard, JP | 1 |
| Angels Ribas, M; Asensi, V; Berenguer, J; Domingo, P; Gimeno, JL; González, J; Miralles, P; Pedrol, E; Pérez-Molina, JA; Ribera, E; Santamaría, JM; Santos, J; Terrón, JA | 1 |
| Angel, JB; Fätkenheuer, G; Greaves, W; Hoffmann, C; Horst, H; Landovitz, RJ; Long, J; Opravil, M | 1 |
| Berrisford, AE; Boulle, AM; Jaspan, HB | 1 |
| Chen, SS; Cheng, AK; DeJesus, E; Enejosa, JV; Gallant, JE; Pozniak, AL; Winston, JA | 1 |
| Czauski, G; de Araújo Castro, GF; de Araújo Soares, RM; de Souza, IP; Kneipp, L; Pomarico, L; Portela, MB | 1 |
| Chung, MH; John-Stewart, GC; Kiarie, JN; Kinuthia, J; Lehman, DA; Njiri, F; Overbaugh, J; Richardson, BA | 1 |
| Gerstoft, J; Katzenstein, TL | 1 |
| Costelloe, S; de Ruiter, A; Hay, P; Larbalestier, N; Lyons, F; Mullen, J; O'Shea, S; Read, P; Taylor, G; Welch, J | 1 |
| Mills, J | 1 |
| Cohen, MS | 1 |
| Burty, C; Christian, B; Ghomari, K; May, T; Pavel, S; Pouaha, J; Rabaud, C; Vermersch, A; Yazdanpanah, Y | 1 |
| Storch, GA; Watson, ME | 1 |
| Hsu, CH; Taylor, JM | 1 |
| Boutté, P; Monpoux, F; Pitelet, G; Richelme, C | 1 |
| Babiker, AG; Cotton, MF; Gibb, DM; Jean-Philippe, P; Madhi, SA; McIntyre, JA; Steyn, J; Violari, A | 1 |
| Carter, MM; Cook, DL; Copeland, WC; Cordova, EM; McCash, CL; Ming, J; Pons, RM; Seilkop, SK; Torres, SM; Walker, DM; Walker, VE | 1 |
| Friese, K; Gingelmaier, A | 1 |
| Amrine-Madsen, H; Demarest, JF; Irlbeck, DM; Kitrinos, KM | 1 |
| Arimi, P; Asmelash, A; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Ndase, P; Novitsky, V; Rossenkhan, R; Shapiro, RL; Smeaton, L; Stevens, L; Thior, I; Wester, C | 1 |
| Capparelli, E; Fowler, MG; Holland, D; Masaba, R; Mirochnick, M; Odhiambo, P; Thigpen, MC; Thomas, T; Weidle, PJ; Zeh, C | 1 |
| George, C; Jayakumar, B; Lal, L; Yesoda, A | 1 |
| Patel, AK; Patel, JA; Patel, KK; Ranjan, RR; Sharma, R; Shukla, RK | 1 |
| Chen, XJ; Yu, K; Zhou, F | 1 |
| Portilla, J | 1 |
| de Ruiter, A; Mercey, D; O'Shea, S; Taylor, GP | 1 |
| Dickinson, JE; French, MA; Gilles, MT | 1 |
| Chang, SC; Chen, MY; Hsieh, SM; Hung, CC; Liu, WC; Lo, YC; Sheng, WH; Sun, HY; Wu, CH; Wu, PY | 1 |
| Casoli, V; Délia, G; Martin, D; Rousvoal, A | 1 |
| Baxter, L; Bryant, J; Hird, S | 1 |
| Allavena, C; Cahn, P; Clotet, B; Côté, H; Harris, M; Montaner, J; Negredo, E; Ochoa, C; Raffi, F; Singer, J; Thorne, A; Zala, C | 1 |
| van Delden, JJ; van der Graaf, R | 1 |
| Barré-Sinoussi, F; Faye, A; Gomuthbutra, V; Lallemant, M; Le Coeur, S; Leechanachai, P; Limtrakul, A; Mary, JY; Matanasaravoot, W; Menu, E; Ngo-Giang-Huong, N; Pornprasert, S; Rugpao, S; Sirivatanapa, P | 1 |
| Giles, M | 1 |
| Afonso, AO; Cunha, SM; Lemey, P; Machado, ES; Nissley, DV; Oliveira, RH; Soares, MA | 1 |
| Bussmann, H; Degruttola, V; Essex, M; Gaolathe, T; Makhema, J; Marlink, RG; Mawoko, N; Mine, M; Moffat, H; Moyo, S; Musonda, R; Muzenda, T; Ndwapi, N; Novitsky, V; Okezie, R; Thomas, A; Wester, CW; Widenfelt, E | 1 |
| Crowe, SM; Jaworowski, A; Kalionis, B; Lewin, SR; Muller, WA; Webster, NL; Westhorpe, CL; Zhou, J | 1 |
| Bernstein, BM; Campo, RE; Chiu, YL; Cotte, L; Da Silva, BA; Gathe, JC; Gazzard, B; Hicks, CB; King, MS; Klein, CE | 1 |
| Berzins, B; Evans, S; Forand, J; Hafner, R; Murphy, R; Owens, S; Shevitz, A; Tashima, K; Tebas, P; Yarasheski, K; Zhang, J | 1 |
| Fang, L; Han, J; Jiang, Y; Wang, L; Wang, Q; Yao, J; Zhang, Q | 1 |
| Buehring, GC; Hanson, CV; Jetsawang, B; Kittinunvorakoon, C; Morris, MK; Neeyapun, K | 1 |
| Briand, N; Galactéros, F; Jourdain, G; Lallemant, M; Le Coeur, S; Ngo-Giang-Huong, N; Pissard, S; Pornprasert, S; Sanguansermsri, T; Tatu, T | 1 |
| Feola, DJ; Rapp, RP; Romanelli, F; Steinke, DT; Thornton, AC; Venugopalan, V | 1 |
| Ambrose, P; Devaleenol, B; Kumarasamy, N; Manohar, D; Mayer, KH; Poongulali, S; Saghayam, S; Solomon, S; Venkatesh, KK; Yepthomi, T | 1 |
| Barr, EA; Davies, JK; Forster-Harwood, J; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, SM; Salbenblatt, CR; Soda, E; Vazquez, A; Weinberg, A | 1 |
| Malyuta, R; Pilipenko, T; Semenenko, I; Thorne, C | 1 |
| Anderson, DJ; Gottlieb, GS; Preston, BD; Pyrak, CL; Smith, RA | 1 |
| Black, V; Guidozzi, F | 1 |
| Alabi, A; Corrah, T; Cotten, M; Jallow, S; Janssens, W; Jaye, A; McConkey, SJ; Peterson, K; Rowland-Jones, S; Sarge-Njie, R; Vanham, G; Whittle, H | 1 |
| Brinkman, K; Danner, SA; Geerlings, SE; Hassink, EA; Lips, P; Reiss, P; Ristola, M; Sutinen, J; van Agtmael, MA; van Vonderen, MG | 1 |
| Dauer, B; Gute, P; Khaykin, P; Klauke, S; Staszewski, S; Stephan, C; Stuermer, M | 1 |
| Chaix, ML; Cohen-Codar, I; Delaugerre, C; Delfraissy, JF; Dellamonica, P; Flandre, P; Ghosn, J; Jaeger, H; Norton, M; Raffi, F; Rouzioux, C; Shürmann, D; Taburet, AM; Van, PN | 1 |
| Alcaro, S; Artese, A; Buzón, MJ; Ceccherini-Silberstein, F; Clotet, B; Martinez-Picado, J; Menendez-Arias, L; Perno, CF; Puertas, MC | 1 |
| Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S | 1 |
| Bosire, R; Farquhar, C; John-Stewart, G; Lohman-Payne, B; Mabuka, JM; Mackelprang, RD; Majiwa, M; Overbaugh, J; Rowland-Jones, S | 1 |
| Brinkman, K; Danner, SA; Geerlings, SE; Hassink, EA; Milinkovic, A; Reiss, P; Ristola, M; van Agtmael, MA; van Eeden, A; van Vonderen, MG | 1 |
| Benn, P; Cartledge, J; Edwards, SG; Linney, A; Moyle, G; Reilly, G; Ruff, C; Sabin, CA; Sauret-Jackson, V | 1 |
| Chung, MH; John-Stewart, GC; Kiarie, J; Kinuthia, J; Lehman, DA; Mabuka, JM; Overbaugh, J | 1 |
| Bernstein, BM; Brown, TT; da Silva, BA; King, MS; McComsey, GA; Qaqish, RB | 1 |
| Ammann, AJ | 2 |
| Asavapiriyanont, S; Chalermchockcharoenkit, A; Chotpitayasunondh, T; Culnane, M; Leelawiwat, W; McConnell, MS; McNicholl, JM; Mock, PA; Tappero, JW; Teeraratkul, A; Vanprapa, N | 1 |
| Flor-Parra, F; López-Cortés, LF; Mata, RC; Pérez-Romero, P; Viciana, P | 1 |
| Arasteh, K; Ebrahimi, R; Fenske, S; Freiwald, M; Gallo, L; Kuhlmann, B; Mertenskoetter, T; Ranneberg, R; Weitner, L | 1 |
| Agmon-Levin, N; Asher, I; Chowers, M; Cohen, Y; Elbirt, D; Gottesman, G; Gradestein, S; Levi, I; Maayan, S; Risenberg, K; Sthoeger, Z; Torten, D; Turner, D; Werner, B | 1 |
| Ebrahimi, R; Ewan, J; Fisher, M; Kingston, M; Liu, H; Moyle, GJ; Orkin, C; Reilly, G; Shahmanesh, M; Wilkins, E | 1 |
| Cohen, C; Dejesus, E; Elion, R; Gathe, JC; Ha, B; Hsu, RK; Lanier, R; Paulsen, D; Redfield, RR; Ross, L; Yau, L | 1 |
| Arribas López, JR | 1 |
| Adé, G; Azon-Kouanou, A; Bashi, BJ; Gougounon, A; Houngbè, F; Zannou, DM; Zinsou, R | 1 |
| Christie, CD; Evans-Gilbert, T; Moore, J; Palmer, P; Pierre, RB; Rodriguez, B; Steel-Duncan, J; White, YR | 1 |
| Christie, CD; Evans-Gilbert, T; Moore, J; Palmer, P; Pierre, RB; Pryce, C; Rodriguez, B; Steel-Duncan, J | 1 |
| Kongnyuy, EJ; Shang, J; Shey, M; Wiysonge, CS | 1 |
| Bruun, J; Clotet, B; Cozzi-Lepri, A; Eg Hansen, AB; Horban, A; Katlama, C; Lundgren, JD; Martinez-Picado, J; Monforte, Ad; Phillips, AN | 1 |
| Aizire, J; Donnell, D; Eshleman, SH; Fowler, MG; Guay, LA; Jackson, JB; Mmiro, FA; Musoke, PM; Mwatha, AK; Nakabiito, C | 1 |
| Andreotti, M; Antonelli, G; Ceccarelli, G; d'Ettorre, G; Massetti, P; Mastroianni, CM; Rizza, C; Turriziani, O; Vella, S; Vullo, V | 1 |
| Boamah, I; Court, MH; Kashuba, AD; Kenu, E; Kwara, A; Lartey, M; Oliver-Commey, J; Rezk, NL | 1 |
| Cheng, AK; Enejosa, J; Margot, NA; McColl, DJ; Miller, MD | 1 |
| Chaix, ML; Cohen-Codar, I; Delfraissy, JF; Dellamonica, P; Flandre, P; Ghosn, J; Girard, PM; Ngovan, P; Norton, M; Raffi, F | 1 |
| Alemayehu, YK; Bushen, OY; Muluneh, AT | 1 |
| Gomutbutra, V; Jungpichanvanich, S; Lallemant, M; Le Coeur, S; Mary, JY; Matanasarawut, W; Pornkitprasarn, W; Thantanarat, S; Traisathit, P; Wannapira, W | 1 |
| Ananworanich, J; Boonrak, P; Bunupuradah, T; Burger, D; Gorowara, M; Jupimai, T; Pancharoen, C; Phasomsap, C; Puthanakit, T; Ruxrungtham, K; van der Lugt, J | 1 |
| Inwani, IW; Musoke, RM; Nduati, RW | 1 |
| Wang, X; Yi, Y | 1 |
| Bisseye, C; Buelli, F; Castelli, F; Gnoula, C; Ilboudo, D; Karou, D; Nikiema, JB; Odolini, S; Ouermi, D; Pietra, V; Pignatelli, S; Sagna, T; Sanou, DS; Sia, DJ; Simpore, J | 1 |
| Biagetti, C; Bon, I; Borderi, M; De Crignis, E; Gibellini, D; Re, MC | 1 |
| Cole, SR; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, J; Kumwenda, NI; Li, Q; Mofenson, L; Taha, TE; Thigpen, MC | 1 |
| Batteux, F; Blanche, S; Chappuy, H; Chouzenoux, S; Declèves, X; Giraud, C; Goffinet, F; Manceau, S; Morini, JP; Scherrmann, JM; Tréluyer, JM; Yousif, S | 1 |
| Fox, MP; Ive, P; Long, L; Maskew, M; Sanne, I | 1 |
| Albrecht, H; Jorgensen, P; Marcus, U; Schürmann, D; Suttorp, N | 1 |
| Fisher, RG; Frasca, K; McGuire, E | 1 |
| Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Thigpen, M | 1 |
| Eklund, M; Gray, GE; Hall, DB; Hopley, M; Martinson, NA; Mayers, D; McIntyre, JA; Moodley, D; Robinson, P | 1 |
| John-Stewart, GC; Lehman, DA; Overbaugh, J | 1 |
| Cihlar, T; Ray, AS | 1 |
| Benfield, T; Kjaer, A; Kofoed, K; Kristoffersen, US; Kronborg, G; Lebech, AM | 1 |
| Diaz, C; Hanson, C; LaRussa, P; Lu, M; Mendez, H; Meyer, WA; Mofenson, LM; Rich, K; Thompson, B; Tuomala, RE; Watts, DH | 1 |
| Ackermans, MT; Blümer, RM; Danner, SA; Hassink, EA; Reiss, P; Sauerwein, HP; Serlie, MJ; Sutinen, J; van Agtmael, MA; van Vonderen, MG; Yki-Jarvinen, H | 1 |
| Libois, A | 1 |
| Cheng, I; Kuritzkes, DR; Paredes, R; Tuomala, RE | 1 |
| Louie, M; Marfatia, S; Mear, I; Meunier, J; Regnault, A; Viala-Danten, M | 1 |
| Aldrovandi, GM; Chu, C; Foca, M; Ha, BF; Li, D; McIntosh, K; Meyer, WA; Moye, J; Rich, KC; Shearer, WT; Thompson, B; Walter, J | 1 |
| Burke, A; Dunn, DT; Gibb, DM; Gilks, CF; Goodall, RL; Kaleebu, P; Katundu, P; Kityo, C; Lyagoba, F; McCormick, A; Munderi, P; Ndembi, N; Pillay, D; Robertson, V; Walker, AS; Yirrell, DL | 1 |
| Amuron, B; Birungi, J; Bunnell, R; Coutinho, A; Foster, S; Grosskurth, H; Jaffar, S; Kyomuhangi, R; Levin, J; Mermin, J; Nabiryo, C; Namara, G; Ndembi, N; Opio, A; Tappero, JW | 1 |
| Shah, I | 3 |
| Català, A; Fortuny, C; Jiménez, R; Lahoz, R; Noguera, A; Rovira, N; Sánchez, E | 1 |
| Asahchop, EL; Brenner, BG; Moisi, D; Ntemgwa, M; Toni, TA; Wainberg, MA | 1 |
| Eshleman, SH; Fowler, MG; Hoover, DR; Kafulafula, G; Kumwenda, N; Li, Q; Lidström, J; Mofenson, LM; Taha, TE; Thigpen, MC | 1 |
| Essex, M; Hagan, JE; Kim, S; Lockman, S; Makhema, J; Mitchell, R; Moyo, SM; Musonda, R; Ndung'u, T; Novitsky, V; Rossenkhan, R; Sebunya, TK; Shapiro, R; Thior, I; van Widenfelt, E | 1 |
| Bartlett, JA; Crump, JA; Kiwera, RA; Moon, AM; Ole-Nguyaine, S; Ramadhani, HO; Shao, HJ; Shao, JF; Thielman, NM; Uiso, LO; Woods, CW | 1 |
| Abaine, D; Aber, M; Ahimbisibwe, F; Akao, J; Akuma, S; Amuron, B; Amurwon, J; Angweng, E; Anywar, W; Atwiine, D; Atwiine, S; Awio, P; Babiker, A; Babiker, AG; Bafana, T; Bagaya, L; Bahendeka, S; Bakeinyaga, GT; Barungi, G; Bassett, M; Bohannon, J; Boocock, K; Borok, M; Bray, D; Breckenridge, A; Bulaya-Tembo, R; Buluma, E; Burke, A; Burke, C; Byakwaga, H; Byamukama, A; Byaruhanga, R; Chakonza, L; Chidziva, E; Chigwedere, E; Chimanzi, J; Chimbetete, C; Chirairo, H; Chirara, M; Chirema, O; Chitsungo, S; Chivhunga, T; Coutinho, A; Darbyshire, JH; Drasiku, A; Dunn, D; Enzama, R; Etukoit, B; Fadhiru, K; Ferrier, A; Florence, A; Foster, S; Gazzard, B; Generous, L; Gibb, DM; Gilks, C; Gilks, CF; Goodall, R; Grosskurth, H; Grundy, C; Haguma, W; Hakim, J; Hill, C; Hughes, P; Jamu, A; Jangano, M; Jones, S; Kabanda, J; Kabuye, G; Kagina, G; Kajungu, D; Kaleebu, P; Kambungu, A; Kankunda, R; Karungi, J; Kasirye, R; Katabira, E; Katabira, H; Katundu, P; Khauka, P; Kigozi, J; Kikaire, B; Kityo, C; Komugyena, J; Kulume, R; Kusiima, A; Kyomugisha, H; Labeja, O; Lara, AM; Latif, A; Levin, J; Lubwama, E; Lutwama, F; Lyagoba, F; Machingura, I; Machingura, J; Makota, S; Mambule, I; Mapinge, F; Mapuchere, C; Massa, R; Matenga, J; Matongo, M; Maweni, C; Mawora, A; McCormick, A; McLaren, A; Mdege, N; Moyo, K; Muchabaiwa, L; Mudzingwa, S; Mufuka-Kapuya, C; Muganzi, A; Mugisha, A; Mugurungi, O; Mugyenyi, P; Muhweezi, D; Muhwezi, A; Mukiibi, S; Mukose, A; Mulindwa, G; Mulindwa, M; Munderi, P; Murungi, S; Musana, H; Musoro, G; Mutowo, J; Mutsai, S; Muvirimi, C; Muyingo, S; Muzambi, M; Mwebesa, D; Mwesigwa, P; Nabankema, E; Nabongo, P; Naidoo, B; Nairuba, R; Nakahima, W; Nakazibwe, M; Nakiyingi, J; Nalumenya, R; Namale, L; Namara, W; Namata, I; Namazzi, A; Namuli, T; Namyalo, M; Nanfuka, A; Nanfuka, R; Nassuna, G; Ndembi, N; Newland, C; Ngorima, N; Nimwesiga, E; Nsibambi, D; Nyachwo, L; Nyiraguhirwa, D; Ochai, R; Ojiambo, H; Ojiambo, W; Oketta, F; Omony, W; Otim, T; Oyugi, J; Palfreeman, A; Pascoe, M; Pearce, G; Peto, L; Peto, T; Phiri, M; Pillay, D; Pozniak, A; Puddephatt, C; Rahim, S; Rauchenberger, M; Reid, A; Robertson, V; Ronald, A; Rooney, J; Ruberantwari, A; Rutikarayo, N; Sabiiti, J; Sadik, F; Sematala, F; Serwadda, D; Sheehan, S; Simango, M; Smith, M; Snowden, W; Spencer-Drake, C; Spyer, M; Ssali, F; Steens, JM; Svovanapasis, P; Takubwa, J; Taylor, K; Taziwa, F; Tinago, G; Todd, J; Tugume, S; Tukamushaba, J; Tumukunde, D; Tumusiime, C; Twijukye, C; Vere, L; Waita, R; Wakholi, BN; Walker, AS; Walusimbi, J; Wangati, K; Wanyama, J; Wapakhabulo, AC; Warambwa, C; Warara, R; Wavamunno, P; Weller, I; Whitworth, J; Wilkes, H; Winogron, D; Yirrell, D; Zalwango, A; Zalwango, E; Zawedde, C; Zengeza, E | 1 |
| Cohen, C; DeJesus, E; Elion, R; Gerondelis, P; Ha, B; Horton, J; Lanier, ER; Ross, LL; Rouse, E | 1 |
| Boothby, M; Gathercole, LL; McGee, KC; McTernan, PG; Nightingale, P; Shahmanesh, M; Shojaee-Moradie, F; Tomlinson, JW; Umpleby, AM | 1 |
| Bender, MA; Flanigan, T; Freedberg, KA; Kumarasamy, N; Lu, Z; Mayer, KH; Schackman, BR; Scott, CA; Walensky, RP; Wang, B | 1 |
| Koczor, C; Kohler, J; Lewis, W | 1 |
| Barin, F; Decker, L; Hemvuttiphan, J; Jourdain, G; Khamduang, W; Lallemant, M; Le Coeur, S; McIntosh, K; Ngo-Giang-Huong, N; Pagdi, K; Sirinontakan, S; Sirirungsi, W; Somsamai, R | 1 |
| Boer, K; England, K; Godfried, MH; Thorne, C | 1 |
| Battegay, M; Bernasconi, E; Cavassini, M; Elzi, L; Furrer, H; Hirschel, B; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R | 1 |
| Tan, DH; Walmsley, SL | 1 |
| Hou, T; Liu, JS; Wang, W; Zhang, J | 1 |
| Cooper, V; Fisher, M; Gellaitry, G; Horne, R; Lange, AC; Vrijens, B; White, D | 1 |
| Allison, J; Echevarria, J; Gotuzzo, E; Henostroza, G; Hernandez, F; Iglesias, D; Mugavero, MJ; Paz, J; Saag, MS; Seas, C; Tomatis, C; Westfall, AO; Willig, JH | 1 |
| Calvez, V; Grant, PM; Marcelin, AG; Nevins, AB; Taylor, J; Wirden, M; Zolopa, AR | 1 |
| Antonelli, G; Bernardi, S; Boni, A; Cursi, L; Falasca, F; Gattinara, GC; Maida, P; Rizzo, B; Turriziani, O | 1 |
| Babiker, AG; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Walker, AS | 1 |
| Clumeck, N; Coakley, E; Cooper, DA; Dejesus, E; Goodrich, J; Hackman, F; Heera, J; Horban, A; Ive, P; Mayer, H; Mingrone, H; Mohapi, L; Reeves, JD; Reyes-Teran, G; Saag, M; Sullivan, J; Tawadrous, M; Ting, N; Van Der Ryst, E; Walmsley, S; Westby, M | 1 |
| Cotton, MF; Rabie, H; van Zyl, GU | 1 |
| Achalapong, J; Ariyadej, S; Chotivanich, N; Collins, IJ; Cressey, TR; Frenkel, LM; Hemvuttiphan, J; Jarupanich, T; Jourdain, G; Kanchana, S; Kanjanasing, A; Kengsakul, K; Koetsawang, S; Lallemant, M; Le Coeur, S; Liampongsabuddhi, P; McIntosh, K; Ngo-Giang-Huong, N; Pornkitprasarn, W; Ratanakosol, J; Sabsanong, P; Sittipiyasakul, V; Sukhumanant, T; Traisaithit, P; Van Dyke, RB; Wannapira, W; Winiyakul, N | 1 |
| Radzio, J; Sluis-Cremer, N; Tachedjian, G; Yap, SH | 1 |
| Böni, J; Bürgisser, P; Demeter, LM; Ehteshami, M; Götte, M; Günthard, HF; Klimkait, T; Ledergerber, B; Nijhuis, M; Schuurman, R; Symons, J; von Wyl, V; Yerly, S | 1 |
| Tolle, MA | 1 |
| Davey, RT; Dewar, R; Follmann, DA; Herpin, B; Huang, CY; Kovacs, J; Lane, HC; Masur, H; Metcalf, JA; Polis, MA; Shah, A; Shen, J; Tavel, JA; Vasudevachari, MB | 1 |
| Aragón, SS; Awerkiew, S; Däumer, M; Kaiser, R; Kartashev, V; Klein, R; Lengauer, T; Pfister, H; Poplavskaja, T; Roomp, K; Sichtig, N; Thiele, B | 1 |
| Deshpande, A; Fleury, HJ; Jeannot, AC; Pinson, P; Schrive, MH; Wittkop, L | 1 |
| Brown, LB; Eron, JJ; Hosseinipour, MC; Kumwenda, JJ; Mhango, B; Mzinganjira, D; Phiri, S; van Oosterhout, JJ; Weigel, R | 1 |
| Khandazhinskaya, A; Matyugina, E; Shirokova, E | 1 |
| Kivel, NM; Mathew, J; Murphy, RL; Ochoa, C; Pascual, ML; Schinazi, RF; Tharnish, P; Zala, C | 1 |
| Camacho, RJ; Deforche, K; Libin, P; Theys, K; Van Laethem, K; Vandamme, AM | 1 |
| Butini, L; Cirioni, O; Costantini, A; Giacometti, A; Montroni, M; Scalise, G | 1 |
| Fay, M; Follmann, D | 1 |
| Bhowmik, BB; Chatterjee, A; Gupta, A; Kumar, L | 1 |
| Chirara, M; Gilks, CF; Goodall, RL; Joyce, A; Katundu, P; McCormick, AL; Ndembi, N; Pillay, D; Walker, S; Yirrell, D | 1 |
| Bravenboer, B; Gisolf, EH; Groeneveld, PH; Hoepelman, AI; Koopmans, PP; Langebeek, N; Legrand, JC; Mulder, PG; Richter, C; Sprenger, HG; Ten Kate, RW; Ten Napel, CH; van der Werf, TS; Van Kasteren, ME; Vriesendorp, R | 1 |
| Antinori, A; Ciccosanti, F; Corazzari, M; Fimia, GM; Iadevaia, V; Kroemer, G; Malorni, W; Matarrese, P; Pagliarini, V; Perfettini, JL; Piacentini, M; Soldani, F; Tinari, A; Zaccarelli, M | 1 |
| Bryan, G; Bweupe, M; Colebunders, R; Kabaso, M; Kasonde, P; Mukonka, V; Mwale, F; Torpey, K; Weaver, MA; Zimba, C | 1 |
| Farquhar, C; John-Stewart, GC; Katz, DA; Lohman-Payne, B; Mabuka, JM; Majiwa, M; Richardson, BA | 1 |
| Borum, PR; Brogly, SB; Chernoff, MC; Crain, MJ; Ford-Chatterton, HM; Malee, KM; Meyer, WA; Mitchell, WG; Moye, JH; Oleske, JM; Seage Iii, GR; Van Dyke, RB | 1 |
| Ahmed, YI; Chasela, CS; Chigwenembe, M; Ellington, SR; Fiscus, SA; Hoffman, IF; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; Kazembe, P; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, CM; Wiener, JB | 1 |
| Akhtar, M; Asmelash, A; Essex, M; Handelsman, E; Hughes, MD; Jayeoba, O; Kitch, D; Leidner, J; Lockman, S; Lubega, E; Makhema, J; Martinez-Tristani, M; Mazhani, L; Mburu, K; McIntosh, K; Moffat, C; Moko, E; Moyo, S; Ogwu, A; Powis, K; Shapiro, RL; Sharma, U; Snowden, W; Souda, S; Thior, I; Tumbare, E; Tuomola, R; van Widenfelt, E; Wester, C; Zwerski, S | 1 |
| Berger, A; Bickel, M; Dauer, B; Doerr, HW; Haberl, A; Klauke, S; Locher, L; Müller, A; Staszewski, S; Stephan, C; Stürmer, M | 1 |
| Deribew, A; Shurie, JS | 1 |
| Chirayus, S; Cressey, TR; Jourdain, G; Kongpanichkul, R; Lallemant, M; Ngo-Giang-Huong, N; Pattarakulwanich, S; Rawangban, B; Sabsanong, P; Varadisai, S; Voramongkol, N; Yuthavisuthi, P | 1 |
| Best, BM; Burchett, SK; Capparelli, EV; Hu, C; Li, H; Mirochnick, M; Read, JS; Rossi, SS; Smith, E; Stek, AM | 1 |
| Cisse, M; Doulougou, B; Kouanda, S; Ouedraogo, CM; Ouedraogo, G; Pietra, V; Simpore, J; Sondo, B; Soudre, R; Tougri, H | 1 |
| Avihingsanon, A; Duncombe, C; Kerr, SJ; Liddy, J; Phanuphak, P; Ruxrungtham, K | 1 |
| Charles, M; Colucci, N; Fitzgerald, DW; Koenig, SP; Lastimoso, C; Leger, P; Pape, JW; Riviere, C; Schackman, BR; Severe, P | 1 |
| Banda, HN; Chasela, C; Eron, JJ; Farr, SL; Fiscus, SA; Jamieson, DJ; Johnson, JA; Kashuba, AD; Kourtis, AP; Lipscomb, J; Matiki, C; Mpaso, M; Nelson, JA; Ng'ombe, TJ; Tegha, GL; van der Horst, C; Wiener, J | 1 |
| Abrams, EJ; Amani-Bosse, C; Chaix, ML; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; Tonwe-Gold, B | 1 |
| Rutherford, GW; Siegfried, N; Spaulding, A | 2 |
| Cortina-Borja, M; Newell, ML; Tookey, PA; Townsend, CL | 1 |
| Feng, Y; Huang, J; Huang, Y; Liao, L; Liu, S; Ma, L; Qu, S; Shao, Y; Sun, J; Xing, H; Yu, X; Yuan, L | 1 |
| Gerstoft, J; Hansen, AB; Nielsen, H; Obel, N; Pedersen, C | 1 |
| Betancor, G; Garriga, C; Martínez, MA; Martinez-Picado, J; Menéndez-Arias, L; Nevot, M; Puertas, MC | 1 |
| Avihingsanon, A; Belloso, WH; Boesecke, C; Cooper, DA; Duncombe, C; Emery, S; Gazzard, B; Li, L; Molina, JM; Petoumenos, K; Puls, RL; Srasuebkul, P | 1 |
| Bancheno, WM; Mareverwa, J; Mwanyumba, F | 1 |
| Balcarek, K; Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
| Araújo, AB; Bastos, FI; Bryson, YJ; Cunha, CB; Derrico, M; Fonseca, RC; Friedman, RK; Grinsztejn, B; João, EC; Kreitchmann, R; Morgado, MG; Pilotto, JH; Portela, MC; Saines, KN; Santos, BR; Veloso, VG | 1 |
| Cannon, K; Church, DL; Gill, MJ; Nunweiler, KD; van Marle, G; Wainberg, MA | 1 |
| Briand, N; Hinjiranandana, T; Hotrawarikarn, S; Jourdain, G; Kanjanavanit, S; Lallemant, M; Le Coeur, S; McIntosh, K; Sirinontakan, S; Traisathit, P | 1 |
| Castelnuovo, B; Kamya, MR; Kiragga, A; Manabe, Y | 1 |
| Bachani, D; Chan, PL; Deshpande, A; Rajasekaran, S; Rewari, BB; Srikantiah, P | 1 |
| Castejón-Morett, OC; Castejón-Sandoval, OC; López-González, AJ | 1 |
| Chang, Y; De Clercq, E; Li, W; Liu, X; Pannecouque, C; Zhan, P; Zhang, N | 1 |
| De Bruyn, G; Gray, GE; Harwell, JI; Lurie, MN; McGarvey, ST; Triche, EW; Venkatesh, KK | 1 |
| Arrivé, E; Avit, D; Benaboud, S; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; McIntyre, J; Nerrienet, E; Rey, E; Sim, KL; Tréluyer, JM; Urien, S | 1 |
| Mani, R; Rutland, E | 1 |
| Asensi, V; Miró, JM; Rodríguez-Guardado, A; Tuset, M | 1 |
| Bryson, YJ; Dickover, R; Dillon, M; Plaeger, SF; Sim, MS; Truong, HM; Uittenbogaart, CH | 1 |
| Williams, SD | 1 |
| Biwolé-Sida, M; Bork, K; Coudray, M; Cournil, A; Delaporte, E; Essomba, CN; Kouanfack, C; Laurent, C; Tonfack, CA | 1 |
| Castelnuovo, B; Kiragga, AN; Manabe, YC; Nakanjako, D | 1 |
| Delaporte, E; Diouf, A; Etard, JF; Girard, PM; Landman, R; Laurent, C; Molinari, N; Ndoye, I; Ngom Guèye, NF; Sow, PS; Tchatchueng Mbougua, JB | 1 |
| Bitarakwate, E; Byamugisha, J; Fowler, MG; Galla, M; Kayma, S; Kekitiinwa, A; Maganda, A; Matovu, J; Mubiru, M; Mudiope, P; Musoke, P; Namukwaya, Z; Salmond, W | 1 |
| Doerr, HW; Gürtler, L; Locher, L; Michels, I; Müller, A; Nisius, G; Staszewski, S; Stürmer, M | 1 |
| Banerjee, A; Banks, WA; Ercal, N; Manda, KR | 1 |
| Boué, F; Briot, K; Cohen-Codar, I; Delfraissy, JF; Flandre, P; Knysz, B; Kolta, S; Morlat, P; Norton, M; Pintado, C; Rode, R; Roux, C; Valantin, MA; Van, PN | 1 |
| Alvarez, SM; de Jesús Asencio Montiel, I; Flores, RA; Martínez, JG; Mata Marín, JA | 1 |
| Stanev, R | 1 |
| de Vincenzi, I | 1 |
| de Silva, T; Weiss, RA | 1 |
| Basu, S; Das, BK; Kumar, A | 1 |
| Baroncelli, S; Floridia, M; Genovese, O; Pinnetti, C; Tamburrini, E | 1 |
| Dryden-Peterson, S; Essex, M; Hughes, MD; Lockman, S; Makhema, J; Moffat, C; Moyo, S; Ogwu, A; Powis, K; Shapiro, RL | 1 |
| Alvarez, A; Azcoaga-Lorenzo, A; del Amo, J; Ferreyra, C; Palma, PP; Velilla, E | 1 |
| Zhang, XQ | 1 |
| Baumann, J; Delviks-Frankenberry, KA; Lengruber, RB; Nikolenko, GN; Pathak, VK; Santos, AF; Soares, MA | 1 |
| Albert, J; de Rivera, IL; Karlsson, AC; Largaespada, N; Murillo, W; Naver, L; Parham, L | 1 |
| Fowler, MG; Hoover, DR; Kumwenda, J; Kumwenda, NI; Li, Q; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC | 1 |
| Conway, K; Peters, BS | 1 |
| Cooper, V; Ewan, J; Fisher, M; Horne, R; Liu, HC; Moyle, GJ; Reilly, G | 1 |
| Aleman, K; Little, RF; Marshall, V; O'Mahony, D; Pittaluga, S; Polizzotto, MN; Steinberg, SM; Tosato, G; Uldrick, TS; Wang, V; Whitby, D; Wyvill, KM; Yarchoan, R | 1 |
| Eshleman, SH; Fogel, J; Fowler, MG; Hoover, DR; Kumwenda, N; Mofenson, LM; Sun, J; Taha, TE; Taylor, AW | 1 |
| Cortina-Borja, M; Duong, T; Elford, J; Tariq, S; Thorne, C; Tookey, PA; Townsend, CL | 1 |
| Andersen, JW; Butt, AA; Chung, RT; Sherman, KE; Umbleja, T | 1 |
| Blevins, M; Burlison, JR; Ciampa, PJ; Moon, TD; Rothman, RL; Sidat, M; Vermund, SH | 1 |
| Crane, J | 1 |
| Du, L; Jin, Y; Li, M; Tong, L; Xin, R | 1 |
| Anh, DT; Bang, ND; Chau, NV; Chau, TT; Chinh, NT; de Jong, M; Dong, DT; Dung, NH; Dung, NT; Farrar, JJ; Hai, NN; Hien, NQ; Hien, TT; Lan, NN; Lan, NT; Mai, NT; Mai, PP; Minh, NH; Phu, NH; Quy, HT; Simmons, CP; Thai, PV; Thoa, NT; Tien, NA; Török, ME; Wolbers, M; Yen, NT | 1 |
| Avancena, P; Hubbard, T; Kitchen, CM; Marsden, MD; Zack, JA | 1 |
| Chu, J; Ciaranello, AL; Dabis, F; Engelsmann, B; Freedberg, KA; Keatinge, J; Maruva, M; Mugwagwa, R; Mushavi, A; Perez, F; Walensky, RP | 1 |
| An, H; Koh, M; Park, J; Park, SB | 1 |
| Arendt, V; Gras, A; Henry, AP; Karasi, JC; Karasi-Omes, C; Sauvageot, N; Schmit, JC; Schneider, S; Seguin-Devaux, C; Ternes, AM | 1 |
| Antoni, AD; Baroncelli, S; Cavaliere, AF; Floridia, M; Genovese, O; Guaraldi, G; Molinari, A; Nardini, G; Pinnetti, C; Ricerca, BM; Tamburrini, E | 1 |
| Dugange, F; Harms, G; Jordan-Harder, B; Kirsten, I; Kunz, A; Sewangi, J; Theuring, S; Ziske, J | 1 |
| Giralt, E; Malakoutikhah, M; Teixidó, M | 1 |
| Bavoux, F; Benhammou, V; Blanche, S; Czernichow, P; Firtion, G; Foissac, F; Kariyawasam, D; Laborde, K; Layouni, I; Le Chenadec, J; Munzer, M; Polak, M; Simon, A; Tréluyer, JM; Warszawski, J | 1 |
| Hattori, T; Kodama, EN; Li, S | 1 |
| Brocklehurst, P; Siegfried, N; Sint, TT; van der Merwe, L | 1 |
| Azzoni, L; Firnhaber, C; Foulkes, AS; Fox, L; Glencross, DK; Gross, R; Hunt, G; Montaner, LJ; Morris, L; Sanne, I; Schulze, D; Stevens, W; Van Amsterdam, D; Yin, X | 1 |
| Atun, R; Ben-Smith, A; Chimbwandira, F; Chirwa, Z; Gilks, CF; Harries, AD; Jahn, A; Lynen, L; Makombe, SD; Meguid, T; Midiani, D; Mnthambala, A; Schouten, EJ; Shawa, M; Van Damme, W; van Oosterhout, JJ; Zachariah, R; Zolfo, M | 1 |
| Bygrave, H; Cleary, S; Ford, N; Gadot, L; Goemaere, E; Hilderbrand, K; Jouquet, G; Kranzer, K; Lee, J; Makakole, L; Trivino, L; Vlahakis, N | 1 |
| Bacheler, L; Dunn, DT; Gilks, C; Goodall, RL; Kaleebu, P; Kityo, C; Munderi, P; Pillay, D; Ranopa, M; Van Houtte, M | 1 |
| Asmelash, A; Dryden-Peterson, S; Essex, M; Hughes, MD; Jayeoba, O; Jibril, H; Keapoletswe, K; Lockman, S; Makhema, J; Modise, TA; Moyo, S; Shapiro, RL; Tlale, J; van Widenfelt, E | 1 |
| Ardonk, W; Borkird, T; Hinjiranandana, T; Hongsiriwon, S; Jourdain, G; Kanjanavanit, S; Khamduang, W; Krittigamas, P; Lallemant, M; Layangool, P; McIntosh, K; Nanta, S; Ngo-Giang-Huong, N; Pagdi, K; Sirinontakan, S; Sirirungsi, W; Somsamai, R | 1 |
| Chen, S; Fowler, MG; Hoover, DR; Kumwenda, NI; Mipando, L; Mofenson, LM; Nkanaunena, K; Taha, TE; Taylor, A; Thigpen, MC | 1 |
| Claassen, M; Preiser, W; van der Merwe, L; van Zyl, GU; Zeier, M | 1 |
| Moreno, V; Valencia, ME | 1 |
| Boom, WH; Charlebois, E; Havlir, DV; Lin, R; Mayanja-Kizza, H; Mugerwa, RD; Mugyenyi, P; Mupere, E; Nanteza, MW; Srikantiah, P; Whalen, CC | 1 |
| Bolton-Moore, C; Chi, BH; Chintu, NT; Giganti, MJ; Moyo, C; Mulenga, LB; Mwango, A; Schuttner, L; Sheneberger, R; Sikazwe, I; Stringer, EM; Stringer, JS | 1 |
| Brüll, L; Coulier, L; Gerritsen, H; Gruters, RA; Luider, TM; Osterhaus, AD; Reedijk, ML; van Kampen, JJ | 1 |
| Esteban-Cruciani, N; Hoffman, RS; Lee, S; Livshits, Z; Nelson, LS | 1 |
| Calis, JC; de Wit, TF; Geelen, SP; Sigaloff, KC; van Vugt, M | 1 |
| Amorelli-Chacel, ME; Brandão, RA; Brunetta, DM; Covas, DT; de Albernaz Muniz, RZ; de Lima, GM; De Santis, GC; Machado, AA; Vilar, FC | 1 |
| Bosire, R; Brown, ER; Choi, RY; Farquhar, C; Fowke, KR; John-Stewart, G; Juno, J; Lohman-Payne, B; Oyugi, JO | 1 |
| Dawson, L; Dixon, DO; Lie, RK; Shah, SK | 1 |
| Abraham, B; Bélec, L; Charpentier, C; Dandy, M; De Dieu Longo, J; Grésenguet, G; Matta, M; Mbelesso, P; Moussa, S; Péré, H | 1 |
| Brewster, D | 1 |
| Castejón, OC; López, AJ; Pérez Ybarra, LM | 1 |
| Corbell, C; Fuller, S; Kalemeera, F; Katjitae, I; Lates, J; Mabirizi, D; Mengistu, A; Nwokike, J; Sagwa, E; Stergachis, A | 1 |
| Mohiuddin, S; Rajesh, R; Varma, DM; Vidyasagar, S | 1 |
| Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kityo, C; Mambule, I; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS | 1 |
| Foisy, M; Hughes, C | 1 |
| Aurpibul, L; Puthanakit, T; Sirisanthana, T; Sirisanthana, V; Taejaroenkul, S | 1 |
| Amaral, E; Cecatti, JG; Delicio, AM; e Silva, JL; Lajos, GJ; Milanez, H; Morais, SS | 1 |
| Achalapong, J; Beck, IA; Britto, P; Chotivanich, N; Cressey, TR; Frenkel, L; Jourdain, G; Maupin, R; Mirochnick, M; Ngo-Giang-Huong, N; Prommas, S; Puthanakit, T; Rasri, W; Roongpisuthipong, A; Shapiro, DE; Van Dyke, RB; Yuthavisuthi, P | 1 |
| Henderson, DK | 2 |
| Drake, AL; Emery, S; Farquhar, C; Hitti, J; John-Stewart, G; Kiarie, J; Ongecha-Owuor, F; Overbaugh, J; Richardson, BA; Roxby, AC; Wald, A | 1 |
| Cooper, DA; Duncombe, C; Emery, S; Gill, JM; Kerr, SJ; Li, PC; Puls, R; Taylor-Robinson, SD; Winston, A | 1 |
| Back, DJ; Else, LJ; Khoo, SH; Taylor, S | 1 |
| Aurpibul, L; Capparelli, E; Chokephaibulkit, K; Cressey, TR; Eksaengsri, A; Hongsiriwon, S; Kabat, B; Limwongse, C; McIntosh, K; Muresan, P; Ngampiyaskul, C; Sirisanthana, V; Smith, ME; Toye, M; Wittawatmongkol, O; Yogev, R | 1 |
| Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G | 1 |
| Adkison, KK; Bakeera-Kitaka, S; Burger, DM; Gibb, DM; Kasirye, P; Kekitiinwa, A; Kendall, L; Mhute, T; Nahirya-Ntege, P; Snowden, W; Ssenyonga, M; Tumusiime, C; Walker, AS | 1 |
| Beck-Sagué, CM; Fernandez, AD; Leonardo-Guerrero, J; Nicholas, SW; Roman-Pouriet, J; Schmidt, NC | 1 |
| Ng, WP; Yip, WL | 1 |
| Borderi, M; Calza, L; Colangeli, V; Grossi, G; Manfredi, R; Motta, R; Salvadori, C; Trapani, F; Viale, P | 1 |
| Marquet, R; Metzner, P; Schütte, C; von Kleist, M | 1 |
| Boltz, VF; Chow, JY; Coffin, JM; Gray, GE; Hall, DB; Hopley, MJ; Maldarelli, F; Martinson, NA; Mayers, D; McIntyre, JA; Mellors, JW; Palmer, S; Robinson, P | 1 |
| Arenas-Pinto, A; Bolhaar, M; Bradman, N; Ekong, R; Grant, A; Ingram, C; Karstaedt, A; Reiss, P; Telisinghe, L; Weber, R; Weller, I | 1 |
| Arnaiz, JA; Clotet, B; Cruceta, A; Dalmau, D; Diaz-Brito, V; Domingo, P; García, F; Gatell, JM; Knobel, H; León, A; Peraire, J | 1 |
| Al-Daghri, NM; Boothby, M; Das, S; Gathercole, LL; Harte, AL; McGee, KC; McTernan, PG; Nightingale, P; Shahmanesh, M; Shojaee-Moradie, F; Tomlinson, JW; Tripathi, G; Umpleby, AM | 1 |
| Balzarini, J; Derudas, M; Grivel, JC; Introini, A; Lisco, A; Margolis, L; McGuigan, C; Merbah, M; Munawwar, A; Schinazi, RF; Vanpouille, C | 1 |
| Fessel, WJ; Israelski, D; Kagan, R; Kaufman, D; Melikian, GL; Rhee, SY; Robbins, GK; Shafer, RW; Taylor, J; Towner, W; Troia-Cancio, PV; Zolopa, A | 1 |
| Brehm, JH; Hammer, S; Katzenstein, D; Koontz, DL; Mellors, JW; Perry, S; Scott, Y; Sluis-Cremer, N | 1 |
| Anastos, K; Burger, H; Foley, B; Hamy, F; Kemal, KS; Klimkait, T; Mayers, D; Minin, VN; Petrovic, K; Ramirez, CM; Suchard, MA; Weiser, B | 1 |
| Agu, KA; Akpoigbe, KJ; Badru, T; Chabikuli, O; Eluwa, GI; Hamelmann, C | 1 |
| Dugange, F; Harms, G; Hauser, A; Kuecherer, C; Kunz, A; Lau, I; Mbezi, P; Sewangi, J; Theuring, S; Ziske, J | 1 |
| Anderson, PL; Bushman, LR; Gardner, EM; Klein, B; Lichtenstein, K; Mawhinney, S; Meditz, A; Predhomme, J; Rower, JE; Zheng, JH | 1 |
| Bhattacharya, R; Biswas, A | 1 |
| Boyer, PL; Clark, PK; Hughes, SH | 1 |
| Brinkman, K; Furrer, H; Fux, CA; Garcia, EF; Hoek, FJ; Krediet, RT; Reiss, P; van Straalen, JP; Vrouenraets, SM; Wit, FW | 1 |
| Blanche, S; Dollfus, C; Ekoukou, D; Faye, A; Mandelbrot, L; Rouzioux, C; Sibiude, J; Teglas, JP; Tubiana, R; Warszawski, J | 1 |
| Ascenzi, P; Ivanovic, J; Montesano, C; Narciso, P; Notari, S; Pucillo, LP; Sergi, M | 1 |
| Beck, IA; Blanco, AJ; Carlsson, J; Dross, S; Frenkel, LM; Gantt, S; Gloyd, S; Jamisse, L; Matediana, E; Matunha, L; Micek, MA; Montoya, P; Seidel, K | 1 |
| Ford, N | 1 |
| Chi, BH; Giganti, MJ; Levy, JW; Mulenga, L; Mulenga, P; Musonda, P; Mwango, AJ; Reid, SE; Saag, MS; Stringer, EM; Stringer, JS; Williams, FB | 1 |
| Benki-Nugent, SF; Chung, MH; Etyang, A; John-Stewart, GC; Kohler, PK; McGrath, CJ; Njoroge, J; Thiga, JW | 1 |
| Adair, LS; Chasela, CS; Ellington, SR; Fiscus, SA; Hoffman, I; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; King, CC; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, C; Wiener, JB | 1 |
| Chen, Z; Chu, Y; Qiu, M; Song, H; Wang, Q; Wu, Z; Yuan, Z | 1 |
| Clemente, SV; Floridia, M; Ghelardi, A; Lonardi, M; Lussiana, C; Pulido Tarquino, IA | 1 |
| Blaszczyk, AT; Vouri, SM | 1 |
| Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
| Deshpande, A; Fleury, H; Papuchon, J; Recordon-Pinson, P; Reigadas, S | 1 |
| Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A | 1 |
| Abrams, EJ; Barlow-Mosha, L; Bobat, R; Chi, BH; Cotton, MF; Eshleman, SH; Hughes, MD; Jean-Philippe, P; Kamthunzi, P; Khadse, S; Lindsey, JC; Millar, L; Mofenson, LM; Moultrie, H; Mujuru, HA; Palumbo, P; Petzold, E; Purdue, L; Schimana, W; Violari, A | 1 |
| Bastos, FI; Bethel, J; Bryson, YJ; Camarca, M; Ceriotto, M; Dickover, R; Fonseca, R; Gray, G; Grinsztejn, B; Joao, EC; Kreitchmann, R; Machado, D; Mirochnick, M; Mofenson, LM; Moreira, RI; Morgado, MG; Moye, J; Mussi-Pinhata, MM; Nielsen-Saines, K; Pilotto, JH; Pinto, J; Santos, B; Siberry, G; Theron, G; Veloso, VG; Watts, DH; Xu, J | 1 |
| Herman, BD; Radzio, J; Sluis-Cremer, N; Tachedjian, G; Yap, SH | 1 |
| Jaye, A; Oko, F; Okomo, U; Peterson, I; Peterson, K; Togun, T; Townend, J | 1 |
| Gibbs, C; Guyer, B; Haddad, M; McColl, DJ; Miller, MD; Su, C | 1 |
| Dugange, F; Harms, G; Hauser, A; Katerna, A; Kunz, A; Lau, I; Mbezi, P; Sewangi, J; Theuring, S; von Wurmb-Schwark, N; Ziske, J | 1 |
| Fu, Q; Han, Y; Li, TS; Liu, LF; Liu, ZY; Wang, L; Xie, J; Ye, M; Zhu, Z | 1 |
| Auerbach, B; Castelnuovo, B; Hermans, S; Kuznik, A; Lamorde, M; Manabe, YC; Semeere, A; Sempa, J; Ssennono, M; Ssewankambo, F | 1 |
| Bertagnolio, S; Cambiano, V; Jordan, MR; Lundgren, J; Miners, A; Phillips, AN; Pillay, D; von Wyl, V | 1 |
| Espiridião, S; Kulay, L; Moreira de Carvalho, A; Pereira Fontes, TM; Restum Antonio, E; Simões, RS; Uchiyama Nakamurau, M | 1 |
| Bauerfeind, R; Behrens, GM; Binz, A; Leverkus, M; Panayotova-Dimitrova, D; Stankov, MV; Vondran, FW | 1 |
| Brunet, C; Bui, E; De Saint Martin, L; Jovelin, T; Le Moal, G; Perfezou, P; Raffi, F; Reliquet, V; Venisse, N; Winer, N | 1 |
| Altman, RB; Anderson, PL; Ghodke, Y; Klein, TE; Lamba, J; Sangkuhl, K | 1 |
| Bonovas, S; Hatzakis, A; Nikolopoulos, G; Tsiodras, S | 1 |
| Chaiwarith, R; Kotarathitithum, W; Nuntachit, N; Praparattanapan, J; Sirisanthana, T; Supparatpinyo, K | 1 |
| Delviks-Frankenberry, KA; Kearney, MF; Lengruber, RB; Maldarelli, F; Pathak, VK; Santos, AF; Silveira, JM; Soares, MA | 1 |
| Flandre, P | 2 |
| Brumme, CJ; Chapman, D; Dong, W; Harrigan, PR; Heera, J; James, I; Lewis, M; McGovern, RA; Mo, T; Portsmouth, S; Thielen, A; Valdez, H; Woods, CK; Zhong, X | 1 |
| Bajunirwe, F; Kiwanuka, J; Nyesigire Ruhinda, E | 1 |
| Kemapunmanus, M; Nittayananta, W; Sriplung, H; Talungchit, S; Yangngam, S | 1 |
| Andriamanantena, D; Ficko, C; Flateau, C; Rapp, C; Reggad, A | 1 |
| Capparelli, E; Essex, M; Leidner, J; Lockman, S; Makhema, J; Moffat, C; Moss, M; Moyo, S; Ogwu, A; Rossi, S; Shapiro, RL | 1 |
| Agbaji, O; Ekong, E; Graham, C; Hawkins, C; Idoko, J; Kanki, P; Meloni, S; Muazu, M; Murphy, R; Nimzing, L; Sankalé, JL; Thio, CL | 1 |
| Ananworanich, J; Chomchey, N; Gerschenson, M; Hongchookiat, P; Jadwattanakul, T; Kerr, SJ; Kim, JH; Mathajittiphun, P; Phanuphak, N; Phanuphak, P; Pinyakorn, S; Praihirunyakit, P; Rungrojrat, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V | 1 |
| Adedokun, O; Badru, T; Chabikuli, O; Khamofu, H; Kuti, O; Odafe, S; Ogbanufe, O; Okechukwu, E; Oladele, EA; Torpey, K | 1 |
| Gutiérrez-Rivas, M; López-Galíndez, C; Olivares, I; Sánchez-Jiménez, C; Toledano, V; Vieira, CR | 1 |
| Han, Y; Li, TS; Li, YL; Qiu, ZF; Song, XJ; Su, YB; Xie, J; Yu, W | 1 |
| Armishaw, J; Cameron, PU; Chuah, J; Cooper, DA; Crowe, SM; Fairley, C; Gouillou, M; Hearps, A; Koelsch, KK; Leeansyah, E; Lewin, SR; Liu, JP; Pierce, AB; Smit, de V; Solomon, A; Spelman, T; Tennakoon, S; Velayudham, P | 1 |
| Adams, O; Bolten, M; Borkhardt, A; Laws, HJ; Neubert, J; Niehues, T; Pfeffer, M; Reuter, S; Stannigel, H | 1 |
| Bochot, A; Fattal, E; Giacalone, G; Hillaireau, H | 1 |
| Aweeka, FT; Huang, L; Levy, JA; Liu, L; Siu, V; Teque, F; Wang, L | 1 |
| Brumback, BA; Hernán, MA; Robins, JM | 1 |
| Bhana, N; Figgitt, DP; Ormrod, D; Perry, CM | 1 |
| Chaisilwatana, P; Chokephaibulkit, K; Piyasujabul, D; Roogpisuthipong, A; Sutthent, R; Vanprapa, N | 1 |
| Fernandez, MI; Fox-Tierney, R; Ickovics, JR; Koenig, LJ; Minkoff, HL; Royce, RA; Wilson, TE | 1 |
| Acosta, EP; Eron, JJ; Fiscus, SA; Gerber, JG; Gulick, RM; Murphy, RL; Pereira, AS; Smeaton, LM; Snyder, S; Tidwell, RR | 1 |
| Chantawuttinan, T; Dabtham, K; Hawkins, D; Hill, AM; Kanshana, S; Moyle, GJ; Sirichthaporn, P; Somburanasin, P; Supajatura, V; Vithayasai, V; Wattanatchariya, N | 1 |
| Akincigil, A; Crystal, S; McSpiritt, E; Sambamoorthi, U | 1 |
| Domínguez Castellanos, A; Justo Alpañés, E; Orbea Ríos, L | 1 |
| Aukrust, P; Frøland, SS; Kvale, D; Mellbye, OJ; Müller, F; Nordøy, I; Tjønnfjord, GE | 1 |
| Bednarsh, H; Jorge, J; McCarthy, GM; Page-Shafer, K; Ssali, CS; Wangrangsimakul, K | 1 |
| Piliero, PJ; Sax, PE | 1 |
| Ait-Khaled, M; Amphlett, G; Clotet, B; Katlama, C; Staszewski, S; Stone, C; Tisdale, M | 1 |
| Calvo, J; González-Macías, J; Hernández, JL; Ramos, C; Saiz, N; Salesa, R; Yánez, L | 1 |
| James, JS | 14 |
| Perronne, C | 1 |
| Anderson, JR | 3 |
| Gallant, JE | 2 |
| Sterling, TR | 1 |
| Allen, TM; Kelleher, AD; Walker, BD; Zaunders, J | 1 |
| Corral, A; de Mendoza, C; Gallego, O; Rodés, B; Soriano, V | 1 |
| Bamji, M; Demas, PA; Enriquez, E; Lambert, G; McWayne, J; Schoenbaum, EE; Thea, DM; Webber, MP; Weedon, J | 1 |
| Cotton, D | 2 |
| Brun-Vézinet, F; Delagnes, M; Descamps, D; Flandre, P; Meiffredy, V; Peytavin, G; Raffi, F; Saidi, Y | 1 |
| Heneine, W; Merigan, T; Qari, SH; Vandamme, AM; Winters, M | 1 |
| Aranda, M; Badía, X; Barrufet, P; Cahn, P; Casado, A; Casiró, A; Consiglio, E; Estela, J; Ferrer, E; Gatell, JM; González, A; Llibre, JM; Lozano, L; Luna, E; Lupo, S; Maños, M; Martínez-Lacasa, J; Miró, JM; Ocaña, I; Pedrol, E; Perez, JL; Perez, P; Podzamczer, D | 1 |
| Rollins, G | 1 |
| Alesse, E; Boschini, A; De Simone, C; Famularo, G; Lucci, L; Marcellini, S; Moretti, S; Santini, G; Trinchieri, V | 1 |
| Aldamiz-Etxebarría, M; Andonegui Navarro, J | 1 |
| Volmink, J | 2 |
| Likanonsakul, S; Moolasart, P | 1 |
| Prescott, LM | 2 |
| Chakraborty, B; Clotet, B; Domingo, E; Martínez, MA; Mas, A; Menéndez-Arias, L; Parera, M; Quiñones-Mateu, ME; Rangel, HR; Tadele, M; Weber, J | 1 |
| Nachega, J | 1 |
| Hurwitz, SJ; Schinazi, RF | 1 |
| Mandel, L; Surattanont, F | 1 |
| Aquaro, S; Bagnarelli, P; Balestra, E; Caliò, R; Clementi, M; De Luca, A; Guenci, T; Perno, CF | 1 |
| Lidman, K; Lindkvist, A; Sönnerborg, A; Svedhem, V | 1 |
| Pendergrass, S; Qazi, S; Richman, D; Uckun, FM; Venkatachalam, TK | 1 |
| Bates, M; Hellmann, NS; Hughes, MD; Katzenstein, DA; Shafer, RW; Shulman, NS; Whitcomb, JM; Winters, MA; Zolopa, AR | 1 |
| Chemlal, K; de Truchis, P; Devidas, A; Force, G; Mamet, JP; Mechali, D; Praindhui, D; Pulik, M; Rouveix, E; Welker, Y | 1 |
| Empey, K; Pomeroy, C; Romanelli, F | 1 |
| Dousman, L; Freund, YR; Mohagheghpour, N | 1 |
| Alcoba-Leza, M; Carro-Fernández, JA; Cuevas-González, MJ; Martín-Sánchez, V; Mostaza-Fernández, JL; Ortega-Valín, L; Ortiz de Urbina-González, JJ; Pérez-Simón, Mdel R; Rodríguez-María, M | 1 |
| Dierich, MP; El Attal, R; Falkensammer, B; Müllauer, B; Parson, W; Sarcletti, M; Stoiber, H | 1 |
| Duan, C; Kuritzkes, DR; Lu, J; MaWhinney, S; Shugarts, D; Stoeckli, TC; Uy, J | 1 |
| Fernando, SL; Keogh, GL; Quin, J; Steele, RH; Stojkova, V | 1 |
| Becker-Pergola, G; Eshleman, SH; Fleming, T; Guay, LA; Jackson, JB; Mmiro, F; Mracna, M; Musoke, P; Mwatha, A | 1 |
| Chaisilwattana, P; Chalermchockcharoenkit, A; Chearskul, S; Chokephaibulkit, K; Opartkiattikul, N; Sirimai, K; Sutthent, R; Vanprapar, N | 1 |
| Dabis, F; Leroy, V; Mandelbrot, L; Manigart, O; Meda, N; Montcho, C; Msellati, P; Viho, I; Yaro, S | 1 |
| Akintonwa, DA | 1 |
| Almond, LM; Back, DJ; De Vries, C; Gould, J; Hoggard, PG; Kewn, S; Khoo, SH; Lou, Y; Maherbe, A; Sales, SD; Wood, R | 1 |
| Aboulker, JP; Flandre, P; Harel, M; Joly, V; Leturque, N; Meiffredy, V; Yeni, P | 1 |
| Bruckner, T; Molitor, F; Ruiz, JD; Zukowski, D | 1 |
| Aboulker, JP; Brun-Vézinet, F; Descamps, D; Flandre, P; Harel, M; Izopet, J; Joly, V; Lastère, S; Meiffrédy, V; Peytavin, G; Tamalet, C; Yéni, P; Zeng, AF | 1 |
| John-Stewart, GC; Kiarie, JN; Kreiss, JK; Richardson, BA | 1 |
| Coll, O; Fiore, S; Floridia, M; Giaquinto, C; Grosch-Wörner, I; Guiliano, M; Lindgren, S; Lyall, H; Mandelbrot, L; Newell, ML; Peckham, C; Rudin, C; Semprini, AE; Taylor, G; Thorne, C; Tovo, PA | 1 |
| Brun-Vézinet, F; Calvez, V; Cécile, A; Collin, G; Costagliola, D; Damond, F; Delaugerre, C; Descamps, D; Katlama, C; Marcelin, AG; Matheron, S; Simon, A; Valantin, MA; Yvon, A | 1 |
| Atwine, D; Kebba, A; Kityo, C; Mwebaze, R; Nakityo, R; Peter, M | 1 |
| Wongvipat, N | 1 |
| Klosinski, L | 1 |
| Bhatta, MP; Lewis, J; Nichols, SA; Vermund, SH | 1 |
| Orentlicher, D | 1 |
| Blanchard, S; Capparelli, EV; Ciupak, G; Connor, JD; Dankner, WM; Gay, H; McSherry, GD; Mirochnick, M; Mofenson, L; Smith, B | 1 |
| Brody, BA | 1 |
| Aggarwal, V; Hakim, A; Pai-Dhungat, JV; Parikh, F; Satija, P; Sharma, B | 1 |
| Bardeguez, AD; Coombs, R; Cunningham, B; Fowler, MG; Frenkel, LM; Gandia, J; Huang, S; Jones, T; Maupin, R; Mofenson, LM; O'Sullivan, MJ; Shapiro, DE; Sperling, RS; Zorrilla, CD | 1 |
| Abrams, E; Bulterys, M; Lee, F; Nesheim, S; Palumbo, P; Sullivan, K; Vink, P | 1 |
| Diaz, RS; Filho, AC; Medeiros, R | 1 |
| Becher, F; Benech, HC; Créminon, CA; Delfraissy, JF; Goujard, CM; Grassi, JJ; Pruvost, AG; Schlemmer, DD | 1 |
| Boshoff, L; Coovadia, H; Gigliotti, M; Gray, G; Hall, D; Hofmyer, J; McIntyre, J; Moodley, D; Moodley, J; Nikodem, C; Robinson, P; Sullivan, JL | 1 |
| Arnedo, M; Barberá, MJ; Ferrer, E; Fumero, E; Gatell, JM; Gudiol, F; McKenna, P; Pérez, JL; Podzamczer, D; Pumarola, T; Rinehart, A | 1 |
| Veres, N | 1 |
| Baker, CJ; Capparelli, EV; Connor, JD; Englund, JA; McKinney, RE; Palumbo, P; Spector, SA | 1 |
| McLigeyo, SO | 1 |
| Paul, SM | 2 |
| Koduri, PR; Parekh, S | 1 |
| Cossarizza, A; Erdem, G; Gerschenson, M; Kamemoto, L; Pinti, M; Shikuma, C; Shikuma, KM; Shiramizu, B | 1 |
| Todres, J | 1 |
| Graziadei, IW; Koch, RO; Maier, H; Romani, N; Vogel, W; Zangerle, R | 1 |
| Ayers, L | 1 |
| Carr, A; Cooper, DA; Cunningham, PH; Duncombe, C; Grey, PA; Hecht, FM; Kahn, JO; Kaufmann, GR; Petersen, A; Quan, DC; Smith, DE; Zaunders, JJ | 1 |
| Beauvais, L; Clumeck, N; Fenske, S; Gazzard, B; Katlama, C; Lafeuillade, A; Lazzarin, A; Mallolas, J; Mamet, JP | 1 |
| Collier, AC; Coombs, RW; Lockhart, D; Marra, CM; Perrin, M; Zunt, JR | 1 |
| Campos, SB; de Araujo, M; Magaldi, AJ; Rienzo, M; Seguro, AC; Seguro, FS | 1 |
| Aboulker, JP; Brun-Vézinet, F; Descamps, D; Flandre, P; Izopet, J; Joly, V; Meiffrédy, V; Tamalet, C | 1 |
| Ayisi, NK; Nyadedzor, C | 1 |
| Bennett, D; García-Lerma, JG; Heneine, W; Kaplan, JE; MacInnes, H; Nidtha, S; Reid, P; Weinstock, H | 1 |
| Kahn, JG; Marseille, E | 1 |
| Aquilina, C; Boué, F; Brun-Vezinet, F; Descamps, D; Goetschel, A; Lafeuillade, A; Livrozet, JM; Mamet, JP; Matheron, S; Thiaux, C; Troisvallets, D | 1 |
| Ibbotson, T; Perry, CM | 1 |
| Brault, C; Chennebault, JM; Loison, J; Payan, C; Peigne, M | 1 |
| Chakraborty, R; Cross, A; D'Agostino, A; Musoke, R; Palakudy, T | 1 |
| Herrmann, SE; James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB; Nolan, DA; White, AJ | 1 |
| Cave, C; Kumar, A; St John, AM | 1 |
| Al-Harthi, L; Blattner, WA; Charurat, M; Divi, RL; Landay, AL; Nguyen, V; Olivero, OA; Poirier, MC; Walker, B; Walker, VE | 1 |
| Andron, L; Asmuth, DM; Grady, JJ; Green, S; McKinsey, DS; Pollard, RB; Rossero, R | 1 |
| Cane, P; Choudhury, B; Hellmann, N; Hué, S; Lie, Y; Petropoulos, C; Pillay, D; Ratcliffe, D; Taylor, S; Workman, J; Wrin, T; Xu, L | 1 |
| John-Stewart, G; Mbori-Ngacha, D; Nduati, R; Overbaugh, J; Panteleeff, DD; Richardson, BA; Steele, M | 1 |
| Bhatta, MP; Phanuphak, P; Stringer, JS; Vermund, SH | 1 |
| Gronowitz, JS; Källander, CF; Lennerstrand, J; Malmsten, A; Shao, XW; Sönnerborg, A; Unge, T | 1 |
| Alioum, A; Dabis, F; Ekpini, ER; Greenberg, AE; Hudgens, M; Karon, JM; Leroy, V; Msellati, P; van de Perre, P; Wiktor, SZ | 1 |
| Amici, R; Galluzzo, CM; Germinario, E; Giuliano, M; Kituuka, P; Magoni, M; Mmirro, F; Okong, P; Palmisano, L; Vella, S | 1 |
| Chabanenko, AI; Govorov, VT | 1 |
| Bachiller Luque, P; de Luis Román, DA; Eiros Bouza, JM; Ortega Lafont, M; Ortiz de Lejarazu, R | 1 |
| Meldrum, J | 1 |
| Korman, TM; Tapley, N; Woolley, I | 1 |
| Gomes, IM; Herdy, GV; Júnior Tavares, Pde A; Kurdian, B; Lopes, VG; Melo, R; Pinto, CA; Ribeiro, RP; Tchou, HY | 1 |
| Labelle, C; Moreno, A; Samet, JH | 1 |
| Boon, NA; Currie, PF | 2 |
| Barret, B; Blanche, S; Chabrol, B; Desguerre, I; Dollfus, C; Lacroix, C; Mayaux, MJ; Rustin, P; Tardieu, M | 1 |
| Bazin, GR; Braga, RC; Calvet, GA; Cruz, ML; d'Ippolito, MM; João, EC; Matos, HJ; Menezes, JA; Salgado, LT; Silva, SS | 1 |
| Antoun, Z; Demonty, N; Gazzard, B; Gordon, D; Katlama, C; Mallolas, J; Moroni, M; Schürmann, D | 1 |
| Das, P | 1 |
| Bethel, J; Fowler, MG; Harris, DR; Lambert, J; Mathieson, B; Meyer, WA; Mofenson, L; Nemo, G; Stiehm, ER; Watts, DH | 1 |
| Albert, J; Blaxhult, A; Brandin, E; Broström, C; Gisslen, M; Gyllensten, K; Hagberg, L; Lindborg, L; Tuvesson, B | 1 |
| Avila-Figueroa, C; Bertozzi, SM; Guijarro, MT; Rely, K | 1 |
| Domingo, P; Ordoñez, J; Pérez, A; Rodriguez, J; Sambeat, MA; Vázquez, G | 1 |
| Lin, DY; Ying, Z | 1 |
| Adungo, NO; Fujiyama, Y; Genga, IO; Ichimura, H; Kakimoto, K; Kiptoo, MK; Kobayashi, N; Mpoke, S; Songok, EM; Tukei, PM; Vulule, JM | 1 |
| Bruun, JN | 1 |
| Casals, A; González, R; Labbe, E; Northland, R; Ovalle, A; Vizueta, E | 1 |
| Cameron, DW | 1 |
| Amella, CA; Franchin, G; Gross, E; Pompucci, L; Schmidtmayerova, H; Sherry, B | 1 |
| Chuenyam, T; Cooper, D; Emery, S; Lange, J; Phanuphak, P; Ruxrungtham, K; Sirivichayakul, S; Techasathit, W; Ubolyam, S; Ungsedhapand, C | 1 |
| Tashima, K; Weiss, M | 1 |
| Gatanaga, H; Hiroe, M; Ishizaki, A; Kikuchi, Y; Kimura, S; Oka, S; Tanuma, J | 1 |
| Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Ducar, C; Duefield, C; Emel, L; Fleming, T; Fowler, MG; Gigliotti, M; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Mwatha, A; Nakabiito, C; Owor, M; Sherman, J | 1 |
| Blanche, S; Guihenneuc-Jouyaux, C; Le Chenadec, J; Mayaux, MJ | 1 |
| Bertolli, J; Hu, DJ; Macalalad, A; Nieburg, P; Simonds, RJ | 1 |
| Alimenti, A; Burdge, DR; Forbes, JC; Money, DM; Ogilvie, GS | 1 |
| Hammond, EL; Mallal, SA; Mamotte, CD; Martin, AM; Nolan, DA; Pace, CS | 1 |
| Bharucha, KE; Bollinger, RC; Brookmeyer, R; Bulakh, PM; Gadgil, B; Gupte, NA; Joshi, PL; Paranjape, RS; Phadke, MA; Pisal, H; Propper, L; Sastry, J; Shankar, AV; Shrotri, AN; Suryavanshi, N | 1 |
| Anderson, PL; Fletcher, CV; Kakuda, TN; Kawle, S | 1 |
| Chen, J; DiNubile, MJ; Fischl, MA; Harvey, CM; Hirsch, MS; Hirschel, B; Leavitt, RY; McMahon, D; Squires, K; Staszewski, S; Steigbigel, RT | 1 |
| Gazzard, BG; Gilleece, Y; Mandalia, S; Pillay, D; Pozniak, AL; Torti, C | 1 |
| Brown, LS; Crawford, KH; Farthing, CF; Goodwin, SD; Racine, J; Rawlings, MK; Scott, RC; Shaefer, MS; Thompson, MA; Tolson, JM; Williams, VC | 1 |
| Burr, CK; DiFerdinando, GT; Paul, SM | 1 |
| Broadhead, RL; Fiscus, S; Gibbons, A; Hoover, DR; Kumwenda, NI; Lema, V; Liomba, G; Miotti, PG; Nkhoma, C; Taha, TE | 1 |
| Chodakewitz, JA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; McMahon, D; Meibohm, A; Mellors, JW; Mosley, A; Richman, DD; Robertson, M | 1 |
| Clark, PA | 3 |
| Barber, RE; Lonergan, JT; Mathews, WC | 1 |
| Bonard, D; Dabis, F; Ekouévi, DK; Huet, C; Minga, A; Rouet, F; Rouzioux, C; Salamon, R; Toni, TA | 1 |
| Benson, C; Bosch, RJ; Connick, E; Haas, DW; Kessler, H; Kim, RB; Kuritzkes, D; Landay, A; Lederman, MM; Li, H; Wilkinson, GR; Wu, H | 1 |
| Bauer, GR; Colgrove, RR; Pitt, J; Welles, SL | 1 |
| Blanche, S; Mayaux, MJ; Teglas, JP | 1 |
| Boni-Ouattara, E; Ekpini, ER; Greenberg, AE; Jamieson, DJ; Karon, JM; Nkengasong, J; Roels, TH; Sadek, R; Sibailly, TS; Wiktor, SZ | 1 |
| Bellos, NC; Burnside, AE; Farthing, CE; Fischl, MA; Kauf, TL; Shaefer, MS; Thompson, MA; Wannamaker, PG; Williams, VC | 1 |
| Chen, Z; Phillips, DM; Wu, Z | 1 |
| Calvez, V; Delaugerre, C; Katlama, C; Marcelin, AG; Simon, A; Viegas, P; Wirden, M | 1 |
| Ajana, F; Alcaraz, I; Bocket, L; Gerard, Y; Goffard, A; Mouton, Y; Viget, N; Wattré, P; Yazdanpanah, Y | 1 |
| Maa, JF; McComsey, G | 1 |
| Bethel, J; Fowler, MG; Harris, DR; Lambert, JS; Meyer, WA; Mofenson, LM; Moye, J; Stiehm, ER | 1 |
| Coetzee, N; Etiebet, MA; Forsyth, B; Fransman, D; Hussey, G | 1 |
| Abreu, T; Andrade, M; Barbosa, R; Bondarovsky, M; Costa, TP; Halpern, M; Lambert, JS; Machado, ES; Nogueira, SA; Perez, M | 1 |
| Becker, MI; D'Aquila, RT; De Gruttola, V; Delapenha, R; Dubé, MP; Fischl, MA; Gedeon, L; Hirsch, MS; Merigan, TC; Murphy, RL; Pettinelli, C; Pollard, RB; Robbins, GK; Shafer, RW; Smeaton, LM; Snyder, SW; van der Horst, C; Vella, S | 1 |
| D'Aquila, RT; De Gruttola, V; Gripshover, BM; Haubrich, R; Hirsch, MS; Johnson, VA; Kaul, P; Martinez, AI; McCarty, SD; Merigan, TC; Morse, GD; Nokta, MA; Robbins, GK; Shafer, RW; Smeaton, LM; Snyder, SW; Swingle, M; Vella, S | 1 |
| Feinberg, J | 4 |
| Cotter, RL; Curthoys, NP; Erichsen, D; Herek, S; Lopez, AL; Zhao, J; Zheng, J | 1 |
| Koopmans, PP; ter Hofstede, HJ; Willems, HL | 1 |
| Bettiol, H; Duarte, G; Kato, CM; Mussi-Pinhata, MM; Paschoini, MC; Quintana, SM | 1 |
| Albert, J; Antonsson, L; Fenyö, EM; Karlsson, A; Karlsson, I; Leitner, T; Olde, B; Owman, C; Shi, Y | 1 |
| Danner, SA; Gruzdev, B; Jurriaans, S; Lange, JM; Peeters, M; Prins, JM; Rakhmanova, A; Sankatsing, SU; van't Klooster, G; Weverling, GJ | 1 |
| Chrystie, IL; Cottam, F; de Ruiter, A; Hay, P; Larbalestier, N; Mullen, J; O'Shea, S; Rice, P; Sabin, CA; Taylor, GP; Welch, J; Zuckerman, M | 1 |
| Choe, KW; Choi, YJ; Kim, HB; Kim, NJ; Oh, MD; Park, SW | 1 |
| Erbelding, EJ | 1 |
| Fisher, RL; Hernandez, JE; Hessenthaler, SM; Lonergan, JT; McComsey, GA; Sension, MG; Shalit, P; Ward, DJ; Williams, VC | 1 |
| Casula, M; de Ronde, A; Goudsmit, J; Lange, JM; Reiss, P; Weverling, GJ | 1 |
| Gazzard, BG; Gotch, F; Hand, J; Imami, N; Nelson, M; Pires, A; Portsmouth, S; Stebbing, J | 1 |
| Jackson, B; Mmiro, F | 1 |
| Hernández-Quero, J; Martínez-Ramírez, M; Muñoz-Medina, L; Parra-Ruiz, J; Serrano-Falcón, C | 1 |
| Baker, CJ; Colgrove, RC; Englund, JA; McKinney, R; Nikolic-Djokic, D; Palumbo, P; Raskino, C; Ross, LL; Vavro, C | 1 |
| Conway, B | 1 |
| Babiker, AG; Walker, AS; White, IR | 1 |
| Agher, R; Ait-Mohand, H; Bricaire, F; Calvez, V; Costagliola, D; Duvivier, C; Ghosn, J; Katlama, C; Marcelin, AG; Myrto, A; Peytavin, G; Schneider, L | 1 |
| Jourdain, G; Kanshana, S; Le Coeur, S | 1 |
| Angel, JB; Badley, AD; Cooper, CL; Hawley, N; Lum, JJ; Mbisa, G; Parato, K; Phenix, B | 1 |
| Boyle, BA | 1 |
| Hutton, N; Parsons, G; Siberry, GK | 1 |
| Gerntholtz, L | 1 |
| Pendergrass, S; Qazi, S; Uckun, FM; Venkatachalam, TK | 1 |
| Brumback, BA; Haneuse, SJ; Hernán, MA; Robins, JM | 1 |
| Cortina-Borja, M; Gray, L; Newell, ML | 1 |
| Brew, BJ; Pemberton, L; Ray, J | 1 |
| Antoniou, T; Arbess, G; Gough, K; Yoong, D | 1 |
| Needham, DM | 1 |
| Amin, J; Hill, A; Law, M; Moyle, G; Sawyer, W | 1 |
| Bassetti, D; Cargnel, A | 1 |
| Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
| do Lago, RF; Harrison, LH; Mendelsohn, AB; Moreira, RI; Moulton, LH; Schechter, M | 1 |
| Akinsete, O; Brundage, R; Henry, K; Shet, A; Weller, D | 1 |
| Mayss, A | 1 |
| Danehower, SC; DeJesus, E; Hill-Zabala, CE; Johnson, J; Liao, Q; Richmond, GJ; Ruane, PJ; Shaefer, MS | 1 |
| Chantratita, W; Panburana, P; Phuapradit, W; Sirinavin, S; Vibhagool, A | 1 |
| Fleming, RA; Furman, PA; Hes, J; Ishaq, KS; Iyer, N; Kucera, LS; Morris-Natschke, SL | 1 |
| Garry, RF; Jaspan, HB | 1 |
| Pendergrass, S; Qazi, S; Samuel, P; Uckun, FM; Venkatachalam, TK | 1 |
| Babiker, AG; Dunn, DT; Goodall, RL | 1 |
| Boffito, M; Bonora, S; Caci, AM; Conta, F; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Sinicco, A | 1 |
| Pezzotti, P; Phillips, A | 1 |
| Abrams, EJ; Adams, ME; Divi, RL; Nagashima, K; Nesel, CJ; O'Neill, JP; Poirier, MC; Seilkop, SK; Wade, NA; Walker, VE | 1 |
| Amin, J; Carr, A; Cooper, DA; Doong, N; Emery, S; Freund, J; Hoy, J; Martin, A; Ringland, C; Smith, DE; Workman, C | 1 |
| Barrett, H; Bassett, RL; Hazelwood, JD; Johnson, VA; Kuritzkes, DR; Rhodes, RA; Young, RK | 1 |
| Fletcher, CV; McIntosh, K; Nachman, SA; Pelton, S; Stanley, K; Wiznia, A; Yogev, R | 1 |
| Smart, T | 3 |
| Acosta, EP; Gulick, RM; Klingman, KL; Kuritzkes, DR; Lustgarten, S; Maher, WE; Meyer, WA; Murphy, RL; Pilcher, CD; Reichman, RC; Ribaudo, HJ; Schackman, BR; Shikuma, CM; Snyder, S; Squires, KE; Witt, MD | 1 |
| McComsey, GA; Piliero, PJ | 1 |
| Costagliola, D; Jourdain, G; Lallemant, M; Mary, JY; Prasitwattanaseree, S | 1 |
| Cardiello, P; Cooper, DA; Emery, S; Juengprasert, N; Kroon, ED; Lange, JM; Phanuphak, P; Ratanasuwan, W; Ruxrungtham, K; Siangphoe, U; Srasuebkul, P; Tongtalung, M; Ubolyam, S; Ungsedhapand, C | 1 |
| Becquet, R; Bequet, L; Dabis, F; Ekouevi, DK; Inwoley, A; Leroy, V; Rouet, F; Tonwe-Gold, B; Viho, I | 1 |
| Beliaeva, VV; Bogoslovskaia, EV; Kravchenko, AV; Miroshnichenko, AV; Serebrovskaia, LV; Sitdykova, IuR | 1 |
| Belfiori, B; Civljak, R; Deparis, P; Francisci, D; Ghinelli, F; Ippolito, G; Modestino, R; Puro, V; Roda, R; Sighinolfi, L | 1 |
| De Clercq, E; Fernández, S; Ferrero, M; Gotor, V; Lazrek, HB; Mohamed, LA; Pannecouque, C; Rochdi, A; Taourirte, M; Vasseur, JJ | 1 |
| Bennett, D; García-Lerma, JG; Heneine, W; MacInnes, H; Weinstock, H | 1 |
| File, TM; Fisher, RL; Hernandez, JE; Hessenthaler, SM; Lindsey, L; Lonergan, JT; McComsey, GA; Shalit, P; Ward, DJ; Williams, VC | 1 |
| Mukai, E | 1 |
| Feng, X; McDonald, JM; McKenna, MA; Nagy, TR; Pan, G; Wu, X | 1 |
| Coovadia, H | 1 |
| Jourdain, G; Kanshana, S; Koetsawang, S; Lallemant, M; Le Coeur, S; Mary, JY; McIntosh, K; Ngo-Giang-Huong, N; Thaineua, V | 1 |
| Ariyadej, S; Bowonwatanuwong, C; Hammer, S; Jourdain, G; Kantipong, P; Lallemant, M; Le Coeur, S; Leechanachai, P; Leenasirimakul, P; Ngo-Giang-Huong, N | 1 |
| Delfraissy, JF; Gatell, JM; Giordano, M; Jemsek, J; Lazzarin, A; Pokrovskiy, V; Powderly, WG; Rivero, A; Rozenbaum, W; Schrader, S; Sension, M; Squires, K; Thiry, A; Vibhagool, A | 1 |
| Ariyoshi, K; Auwanit, W; Matsuda, M; Myint, L; Pathipvanich, P; Rojanawiwat, A; Saeng-Aroon, S; Sawanpanyalert, P; Sugiura, W; Wichukchinda, N | 1 |
| Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Kafulafula, G; Kumwenda, NI; Liomba, G; Miotti, PG; Nkhoma, C; Nour, S; Taha, TE | 1 |
| Bozzi, A; Brisdelli, F; D'Alessandro, AM; D'Andrea, G; Lizzi, AR; Oratore, A; Rinaldi, AC | 1 |
| Brinkman, K; Casula, M; de Ronde, A; Hulsebosch, HJ; Lange, J; Nieuwkerk, P; Reiss, P; van der Valk, M; van Eck-Smit, B; van Eeden, A; van Kuijk, K; Weverlingz, GJ | 1 |
| Cahn, P; Carosi, G; Jordan, JC; Montroni, M; Pearce, G; Pharo, CE; Schechter, M; Smaill, F; Soto-Ramirez, L; Thomas, NE; Vibhagool, A | 1 |
| Cahn, P; Carosi, G; Jordan, JC; Pharo, CE; Schechter, M; Smaill, F; Soto-Ramirez, L; Steel, HM; Thomas, NE; Vibhagool, A | 1 |
| Cao, Y; McCoig, CC; Ramilo, O; Saavedra-Lozano, J; Vitetta, ES | 1 |
| Bates, M; Chappey, C; Clair, MS; Fisher, R; Lanier, ER; Parkin, N; Ross, L; Tisdale, M | 1 |
| De Luca, A; Di Giambenedetto, S | 1 |
| Castillo, SA; DeJesus, E; Farthing, CF; Gough, K; Grinsztejn, B; Madison, SJ; McCarty, D; Schrader, SR; Sension, MG; Shortino, DD; Thomas, DA | 1 |
| Carides, GW; Cook, JR; Coplan, PM; DiNubile, MJ; Hammer, SM; Heyse, JF; Meibohm, AR; Nguyen, BY; Wu, AW | 1 |
| Antonelli, G; Bambacioni, F; Gianotti, N; Lazzarin, A; Manconi, PE; Turriziani, O | 1 |
| Rosa, U; Sepkowitz, D; Smith, PR; Tripuraneni, NS; Weedon, J | 1 |
| Maida, I; Nuñez, M; Soriano, V | 1 |
| Li, DJ; Wu, X | 1 |
| Olivero, OA; Poirier, MC; Walker, DM; Walker, VE | 1 |
| Demeter, LM; Erice, A; Eshleman, SH; Fischl, MA; Hammer, SM; Hellmann, NS; Ribaudo, HJ | 1 |
| Anastos, K; Freeman, K; Huang, JM; Robison, E; Shi, R; Steinberg, JJ; Strickler, H | 1 |
| Abduch, R; Duarte, G; El Beitune, P; Figueiró-Filho, EA; Marcolin, AC; Quintana, SM | 1 |
| Crepin, M; Dabis, F; Dequae-Merchadoux, L; Janoff, EN; Leroy, V; Manigart, O; Meda, N; Rouet, F; Rouzioux, C; Valea, D; Van de Perre, P | 1 |
| Piscitelli, SC; Polis, MA | 1 |
| Bonny, T; Brand, JD; Brothers, CH; Buendia, CB; Castillo, SA; DeJesus, E; Gerstoft, J; Hernandez, J; Herrera, G; Lanier, ER; Scott, TR; Teofilo, E | 1 |
| Artuch, R; Fortuny, C; Jimenez, R; Muñoz-Almagro, C; Noguera, A; Pou, J; Sanchez, E; Vilaseca, MA | 1 |
| Herzmann, C; Karcher, H | 1 |
| Arthos, J; Barbaro, G; Buga, G; Byrns, RE; Cashman, J; Fiala, M; Iruela-Arispe, L; Luque, A; MacDougall, J; Murphy, T; Yang, W | 1 |
| Rudin, Ch | 1 |
| Hirschel, B | 5 |
| Bergshoeff, AS; Burger, DM; de Groot, R; Fraaij, PL; Hartwig, NG; van Rossum, AM; Verweel, G; Verweij, C | 1 |
| Ait-Khaled, M; Gibb, D; Givens, N; Griffin, P; Irlbeck, D; Lanier, ER; St Clair, M; Stone, C; Tisdale, M; Underwood, M; Walker, S | 1 |
| Cross, H; Martin, RM; Paul, S; Sia, J | 1 |
| Bartlett, JA; Bellos, NC; Eron, JJ; Johnson, J; Johnson, VA; Keller, A; Kuritzkes, DR; Santana, JL; St Clair, MH | 1 |
| Baumann, D; Bernasconi, E; Blasko, M; Calmy, A; Chave, JP; Furrer, H; Ledergerber, B; Opravil, M; Perrin, L; Vernazza, P | 1 |
| Fleming, PL; Lindegren, ML; Wortley, PM | 1 |
| Desai, A; Narang, VS; Purandare, S | 1 |
| Herman, B; Hogan, JW; Lin, X | 1 |
| Bower, M; Fisher, M; Gazzard, B; Johnson, M; Jones, R; Mandalia, S; Moyle, G; Nelson, M; Orkin, C; Stebbing, J | 1 |
| Gerber, JG; Wyles, DL | 1 |
| Cancio, R; Crespan, E; Hübscher, U; Locatelli, GA; Maga, G; Spadari, S | 1 |
| Byrne, CM; Coughlan, S; Hall, WW; Hopkins, SM; Lyons, FE; Mulcahy, FM | 1 |
| Berger, F; Gatell, J; Hoffmann, C; Holm, S; Kuhlmann, B; Martínez, E; Mauss, S; Milinkovic, A; Schmutz, G | 1 |
| Figueroa, L; Figueroa-Damián, R; Poblano, A; Schnaas, L | 1 |
| Ibarra Barrueta, O; Iglesias Lambarri, A; Illaro Uranga, A; Lertxundi Etxebarría, U; Martínez Bengoechea, MJ; Santos Ibáñez, A | 1 |
| Béguinot, I; Burty, C; Christian, B; Grandidier, M; Jeanmaire, H; May, T; Penalba, C; Rabaud, C | 1 |
| Aarnoutse, RE; Burger, DM; Verweij-van Wissen, CP | 1 |
| Ambu, S; Bartolozzi, D; Boddi, V; Farese, A; Giuntini, R; Leoncini, F; Martinelli, C | 1 |
| Asavapiriyanont, S; Chalermchokcharoenkit, A; Chotpitayasunondh, T; Culnane, M; Jetsawang, B; Mock, PA; Neeyapun, K; Simonds, RJ; Skunodum, N; Tappero, J; Teeraratkul, A; Vanprapa, N | 1 |
| Ahmed-Ouameur, A; Claveau, S; Neault, JF; Tajmir-Riahi, HA | 1 |
| Alexander, G; Christie, CD; Figueroa, JP; Harvey, KM; Johnson, N; McDonald, D; Mullings, AA; Palmer, P; Smikle, MF; Whorms, S; Williams, E | 1 |
| Christie, CD; Evans-Gilbert, T; Figueroa, JP; Hambleton, I; Palmer, P; Pierre, R; Rodriquez, B; Smikle, MF; Steel-Duncan, JC; Whorms, S | 1 |
| Christie, CD; Evans-Gilbert, T; Pierre, R; Rodriquez, B; Steel-Duncan, JC | 1 |
| Hudson, CP | 1 |
| Musoke, P | 1 |
| Arts, EJ; Asiimwe, S; Bajunirwe, F; Kamya, MR; Massaquoi, I; Whalen, CC | 1 |
| Evison, JM; Wunder, D | 1 |
| Coad, DS; Ivanova, A | 1 |
| Becquet, R; Bequet, L; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Fassinou, P; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Viho, I; Welffens-Ekra, C | 1 |
| Broadhead, R; Chen, S; Chitale, R; Hoover, D; Kafulafula, G; Katundu, P; Kumwenda, J; Kumwenda, N; Mukiibi, J; Nkhoma, C; Taha, TE | 1 |
| Back, N; Bakker, M; Berkhout, B; de Ronde, A; Jebbink, MF; Jurriaans, S; Parkin, N; Reiss, P; van der Hoek, L | 1 |
| Cherry, CL; Hernandez, J; Lal, L; McComsey, G; McLean, CA; Ross, LL; Thompson, KA; Wesselingh, SL | 1 |
| Capparelli, E; Cressey, TR; Jackson, JB; Jourdain, G; Kunkeaw, S; Lallemant, MJ; Mirochnick, M; Musoke, P | 1 |
| Fahey, JL; Grossberg, SE; Johnston, DM; Kagan, J; Mildvan, D; Schock, BR; Spritzler, J | 1 |
| Selgelid, MJ | 1 |
| Antonelli, G; Antonelli, L; Butera, O; Gianotti, N; Girardi, E; Iaiani, G; Lazzarin, A; Mazzi, R; Parisi, SG; Turriziani, O | 1 |
| Bedoni, AJ; Figueiredo, RM; Garcia, MT; Moretti, ML; Papaiordanou, PM; Resende, MR | 1 |
| Balakrishnan, P; Carpenter, CC; Cecelia, A; Flanigan, TP; Kumarasamy, N; Mayer, KH; Solomon, S; Vallabhaneni, S | 1 |
| Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
| Diaby, KL; Ekpini, ER; Kouassims, MK; Lin, LS; Matia, DM; Painter, TM; Roels, TH; Sibailly, TS; Wiktor, SZ | 1 |
| Chang, FM; Lin, HC; Liu, CC; Wang, SM; Wu, CS | 1 |
| Fleming, T; Jackson, B | 1 |
| Andrieux-Meyer, I; Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Lactuock, B; Laurent, C; Liégeois, F; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N; Zekeng, L | 1 |
| D'Agostino, C; d'Ettorre, G; Lichtner, M; Massetti, AP; Mastroianni, CM; Vullo, V | 1 |
| Amin, J; Carr, A; Cooper, DA; McAllister, J; Winston, A | 1 |
| Andreoli, A; Bandelier, C; Bianchi-Demicheli, F; Damsa, C; Lazignac, C; Maris, S; Vidailhet, P | 1 |
| Brabant, W; Daifuku, R; Gall, A; Harris, KS; Styrchak, S | 1 |
| Fernández-Guerrero, ML; Górgolas, M; Rivas, P | 1 |
| Pellegrin, JL | 1 |
| Eto, K; Kamihira, A; Kimura, T; Matsushita, S; Mitsuya, H; Oka, S; Shirasaka, T; Takano, M; Yoshimura, K | 1 |
| Goldring, DS | 1 |
| Britto, P; Capparelli, E; Cowles, MK; Fowler, MG; Husson, RN; Kovacs, A; McIntosh, K; Moye, J; Pitt, J; Rathore, MH | 1 |
| Clotet, B; Domingo, E; Fernàndez, G; Gómez-Mariano, G; Martínez, MA; Parera, M; Quiñones-Mateu, M; Tapia, N | 1 |
| Cunha, RV; Dal Fabbro, MM; Freitas, GM; Lindenberg, Ade S; Nogueira, SA; Paniago, AM | 1 |
| Abduch, R; Duarte, G; El Beitune, P; Figueiró-Filho, EA; Machado, AA; Quintana, SM | 1 |
| Götte, M; Kuritzkes, DR; Liang, F; Miranda, LR | 1 |
| Davis, EA; DeJesus, E; Hill-Zabala, C; Lang, J; Lanier, ER; Liao, Q; Markowitz, M; Shaefer, M | 1 |
| Bonjoch, A; Clotet, B; De la Torre, J; Galvez, J; Martínez, E; Miralles, C; Miranda, J; Muñoz-Moreno, JA; Paredes, R; Prieto, A; Videla, S; Vilades, C | 1 |
| Chaisilwattana, P; Chokephaibulkit, K; Phongsamart, W; Sutthent, R; Vanprapar, N | 1 |
| Ketter, A | 1 |
| Cohen, M; Garcia, P; Jerome, J; Lindau, ST; Miller, K; Monk, E | 1 |
| Chêuc, G; Cotte, L; Debord, T; Decazes, JM; Ferchal, F; Journot, V; Madelaine, I; Molina, JM; Pellegrin, I; Rancinan, C; Sombardier, MN | 1 |
| Amel, EB; Amel, LO; Amine, SM; Asma, J; Fethi, T; Mohamed, C; Mounira, G; Taoufik, BC | 1 |
| Barroso, PF; Boechat, LJ; Melo, MF; Schechter, M; Vettore, MV | 1 |
| Bolton, C; Chersich, MF; Gray, GE; McIntyre, JA; Stevens, W; Urban, M; van Niekerk, R; Violari, A | 1 |
| Young, SM | 1 |
| Campanini, A; Cancellieri, C; Marani, M; Mastroianni, A; Vicini, C | 1 |
| Capparelli, E; Connor, JD; Essex, M; Holland, DT; Lockman, S; Mirochnick, M; Peter, T; Shapiro, RL; Stevens, L; Thior, I; Wester, C | 1 |
| Chung, MH; John-Stewart, GC; Kiarie, JN; Lehman, DA; Overbaugh, J; Richardson, BA | 1 |
| Dettrairat, S; Klinbuayaem, V; Kunachiwa, W; Leechanachai, P; Leenasirimakul, P; Sangkitporn, S; Shide, L; Thamlikitkul, V; Wirayutwatthana, NA | 1 |
| Mahlat, U; Volmink, J | 1 |
| Fujita, S; Mastico, R; Suda, I; Terada, M | 1 |
| Abrams, EJ; Borkowsky, W; Britto, P; Chadwick, EG; Flynn, PM; Hughes, M; Luzuriaga, K; Palumbo, P; Powell, C; Rodman, JH; Yogev, R | 1 |
| Giacomet, V; Viganò, A | 1 |
| Anglaret, X; Anzian, A; Bissagnene, E; Danel, C; Gabillard, D; Gomis, OB; Inwoley, A; Konga, C; Minga, A; Moh, R; Salamon, R; Sauvageot, D; Sorho, S | 1 |
| Eley, B | 1 |
| Doyle, NM; Gardner, MO; Levison, JE | 1 |
| Abdullah, F; Boulle, A; Coetzee, D; Draper, B; Goemaere, E; Hilderbrand, K | 1 |
| Alston-Smith, BL; Dubé, MP; Kitch, DW; Mulligan, K; Parker, RA | 1 |
| Chernicoff, H; Gilmore, A; Jordan, J; Legorreta, A; Rosenzweig, JC; Yu, A | 1 |
| Back, D; Borucki, MJ; Dieterich, D; Gries, JM; Hoggard, PG; Lissen, E; Rodriguez-Torres, M; Soriano, V; Sulkowski, M; Torriani, FJ; Wang, K | 1 |
| Yearby, R | 1 |
| Alhassoon, OM; Brown, GG; Ellis, RJ; Gonzalez, R; Grant, I; Letendre, S; McCutchan, JA; Patterson, TL; Schweinsburg, BC; Taylor, MJ; Videen, JS | 1 |
| Chiapello, N; Gabiano, C; Spada, M; Tovo, PA; Zeviani, M | 1 |
| Bunn, JE; Kilonzo, SN; Klufio, A; Kuria, E; Mbugua, C; Speight, CG; Taegtmeyer, M | 1 |
| Biberfeld, G; Coovadia, H; Cortina-Borja, M; Dabis, F; Goudsmit, J; Gray, G; Grulich, A; Haverkamp, G; Kilewo, Ch; Kituuka, P; Lange, JM; Leroy, V; Massawe, A; McIntyre, J; Ndugwa, Ch; Newell, ML; Okong, P; Saba, J; Sakarovitch, C; von Briesen, H; Weverling, GJ | 1 |
| Engels, JW; Lazrek, HB; Rochdi, A; Taourirte, M; Vasseur, JJ | 1 |
| da Silva, MH; de Carvalho, HB; Gianna, MC; Gonçalves, A; Hearst, N; Matida, LH; Succi, RC; Tayra, A | 1 |
| Clark, PL; Hinthorn, D; Myers, SA; Torrente, S | 1 |
| Srinivasan, S | 1 |
| Billaud, E; Bugnon, F; Cua, E; Cuzin, L; Dellamonica, P; Delpierre, C; Massip, P; Pugliese, P; Raffi, F | 1 |
| Bhoopat, L; Bhoopat, T; Gomutbuthra, V; Kajanavanich, S; Khunamornpong, S; Lerdsrimongkol, P; Limtrakul, A; Sethavanich, S; Sirivatanapa, P; Thorner, PS | 1 |
| Back, DJ; Gazzard, BG; Jones, SP; Lebrecht, D; Morelese, J; Moyle, GJ; Pirmohamed, M; Qazi, N; Sutinen, J; Walker, UA; Yki-Jărvinen, H | 1 |
| Bester, R; Cotton, MF; de Waal, N; Rabie, H | 1 |
| Kanjanasing, A; Lallemant, M; Lamlertkittikul, S; Le Coeur, S; Mary, JY; Traisathit, P | 1 |
| Gochicoa Rangel, LG; Miranda Novales, MG; Palacios Saucedo, G; Solórzano Santos, F; Vázquez Rosales, G | 1 |
| Bautista-Arredondo, S; Bertozzi, SM; Mane, A | 1 |
| Moyle, GJ | 2 |
| Nolan, D | 1 |
| Girault, V | 1 |
| Galeano, V; Galli, A; Gutiérrez, S; Lioni, M; Maturo, M; Quian, J; Serra, M; Visconti, A | 1 |
| Arora, SK; Sachdeva, N; Sehgal, S | 1 |
| Kessler, HA | 1 |
| Chiu, SS; Jones, BM; Lau, YL; Lim, WW; Wong, WH | 1 |
| Grimm, T; Grubert, T; Guenzi, E; Jörg, A; Keller, U; Naschberger, E; Oostendorp, R; Samson, E; Stürzl, M | 1 |
| Balfour, HH; Brundage, RC; Cavert, W; Fox, K; Henry, K; Kurpad, AV; Raj, TD; Ravindran, GD; Vezina, HE; Weller, D | 1 |
| Bellón, JM; Berenguer, J; Camba, M; Flores, J; Gatell, JM; Hernández-Quero, J; Knobel, H; Miguélez, M; Pérez-Elías, MJ; Podzamczer, D; Resino, S; Rivas-González, P; Sala, M; Santos, I; Soriano, V | 1 |
| Abrams, EJ; Gvetadze, R; Kline, MW; Rivadeneira, E; Weidle, PJ | 1 |
| Borderi, M | 1 |
| Lin, DY; Pan, Z | 1 |
| Anderson, PL; Bushman, L; Delahunty, T; Fletcher, CV; King, T; Ray, M | 1 |
| Bamji, M; Demas, PA; Lambert, G; McWayne, J; Schoenbaum, EE; Thea, DM; Weedon, J | 1 |
| Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC | 1 |
| Arribas, JR; Campo, RE; Cheng, AK; Chuck, S; DeJesus, E; Enejosa, J; Gallant, JE; Gazzard, B; Lu, B; McColl, D; Pozniak, AL; Toole, JJ | 1 |
| Chen, S; Eshleman, SH; Fiscus, SA; Hoover, DR; Hudelson, SE; Jackson, JB; Kumwenda, NI; Piwowar-Manning, E; Taha, TE | 1 |
| Bequet, L; Chaix, ML; Dabis, F; Ekouevi, DK; Leroy, V; Menan, H; Peytavin, G; Rouet, F; Rouzioux, C; Tonwe-Gold, B; Toure, H; Viho, I | 1 |
| Aaron, E; Biondo, CP; Levine, AB; Monahan, K | 1 |
| Hodge, JG; Parini, MJ | 1 |
| McGovern, TM | 1 |
| Bernard, M; Bouhour, D; Boulliat, J; Fleury, J; Laurent-Coriat, C; Tilikete, C; Vighetto, A | 1 |
| Beq, S; Bugault, F; Colle, JH; Delfraissy, JF; Lambotte, O; Thèze, J | 1 |
| Greiner, T | 1 |
| Heitzmann, F; Keusch, G; Kis, L; Möddel, M | 1 |
| Blanco, R; Delgado, W; García, H; García, R; Meléndez, M; Rodríguez, JF; Rosario, O; Santana, J | 1 |
| Collier, AC; Lockhart, DW; Marra, CM; Rees, TS; Schouten, JT | 1 |
| Bienstock, RJ; Copeland, WC; Haase, CP; Hosseini, SH; Kohler, JJ; Lewis, W; Ludaway, T; McNaught, J; Russ, R; Santoianni, R; Stuart, T | 1 |
| Fisher, M; Gazzard, B; Higgs, C; Johnson, M; Mandalia, S; Moyle, G; Nelson, M; Teague, A | 1 |
| Barberá Farré, JR; Beato Pérez, JL; Cuadra García-Tenorio, F; Geijo Martínez, MP; Maciá Martínez, MA; Marcos Sánchez, F; Martínez Alfaro, E; Moreno Mendaña, JM; Rodríguez Zapata, M; Sanz Moreno, J; Sanz Sanz, J; Solera Santos, J | 1 |
| D'Avila, N; Hora, VP; Leal, RG; Martínez, AM; Mendoza-Sassi, R; Santos, AL; Silveira, J; Soares, EA; Soares, MA; Tanuri, A; Von Groll, A | 1 |
| Balestre, E; Boucher, S; Capdepont, S; Dabis, F; Dupon, M; Fleury, H; Masquelier, B; Thiébaut, R | 1 |
| Bhakeecheep, S; Briand, N; Hansudewechakul, R; Hongsiriwon, S; Ithisukanan, J; Karnchanamayul, V; Lallemant, M; Le Coeur, S; McIntosh, K; Ngampiyasakul, C; Traisathit, P | 1 |
| Allal, L; Batallan, A; Faucher, P; Legac, S; Madelenat, P; Matheron, S; Rodrigues, A | 1 |
| Koh, MT | 1 |
| Balestra, E; Casoli, C; Cassone, A; Conti, S; Magliani, W; Perno, CF; Pilotti, E; Polonelli, L; Polverini, E | 1 |
| Venhoff, N; Walker, UA | 1 |
| Chambon, JF; Coulibaly, M; Ekpini, R; Malkin, JE; Msellati, P; Noba, V; Rey, JL | 1 |
| Mahlati, U; Volmink, J | 1 |
| Gray, G; Jivkov, B; Ledeine, JM; McIntyre, J; Reynolds, L; Schnittman, S; Violari, A | 1 |
| Besser, M; Bulterys, M; Fowler, MG; Sansom, S; Soorapanth, S; Theron, G | 1 |
| Boyd, MA; Burger, DM; Cooper, DA; Duncombe, CJ; Hassink, EA; Khongphattanayothin, M; Lange, J; Phanuphak, P; Reiss, P; Ruxrungtham, K; Srasuebkul, P; Stek, M; Ubolyam, S | 1 |
| Antunes, F; Chiesi, A; Goebel, FD; Katlama, C; Knysz, B; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P | 1 |
| Hammerstrom, TS; Laessig, KA; Lewis, LL | 1 |
| Jenny-Avital, ER | 1 |
| Alabi, A; Aveika, A; Corrah, T; Jallow, S; Janssens, W; Kaye, S; McConkey, SJ; Rowland-Jones, S; Sabally, S; Sarge-Njie, R; Vanham, G; Whittle, H | 1 |
| Anderson, PL; Aquilante, CL; Fletcher, CV; Lamba, J; Schuetz, E | 1 |
| Brown, J; Heffernan-Vacca, S; Millery, M; Neu, N; Stimell, M | 1 |
| Cressey, TR; Jourdain, G; Lallemant, M; Leenasirimakul, P; Sukrakanchana, PO; Tawon, Y | 1 |
| Essex, M; Gaseitsiwe, S; Gilbert, PB; Heymann, SJ; Lagakos, S; Lockman, S; Makhema, J; Ndung'u, T; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; Wester, C | 1 |
| Lampe, MA | 1 |
| Bettiker, R; Samuel, R; Suh, B | 1 |
| Barcelos, N; Canti, I; Fuchs, SC; Gomes da Silva, MM; Kreitchmann, R | 1 |
| Burger, D; de Groot, R; van der Lee, M; Verweel, G | 1 |
| Bowornkitikajorn, P; Chearskul, S; Chokephaibulkit, K; Chotpitayasunondh, T; Phongsamart, W; Samkoset, R; Sutthent, R; Tarunothai, U; Vanprapar, N | 1 |
| Becher, F; Benech, H; Grassi, JJ; Pruvost, A | 1 |
| Baldeweg, T; Catalan, J; Chinn, RJ; Chong, WK; Hall-Craggs, MA; Harrison, MJ; Kendall, BE; Paley, M; Pugh, K; Riccio, M; Weller, IV; Wilkinson, ID; Williams, IG | 1 |
| Dabis, F; Nightingale, S | 1 |
| Fätkenheuer, G; Lehmann, C; Wyen, C | 1 |
| Acosta, EP; Bastow, B; Carlson, M; Gulick, RM; Klingman, KL; Koletar, SL; Kuritzkes, DR; Lalama, C; Meyer, WA; Murphy, RL; Pilcher, CD; Reichman, RC; Ribaudo, HJ; Schackman, BR; Schouten, J; Shikuma, CM; Squires, KE | 1 |
| Arimi, P; Essex, M; Gilbert, PB; Heymann, SJ; Kebaabetswe, P; Kim, S; Lagakos, S; Lee, TH; Lockman, S; Makhema, J; Marlink, R; Mazonde, P; McIntosh, K; Moffat, C; Ndase, P; Novitsky, V; Peter, T; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C | 1 |
| Benhammou, V; Blanche, S; Rustin, P; Tardieu, M; Warszawski, J | 1 |
| Anderson, J; De Ruiter, A; Fakoya, A; Hawkins, DA; Khan, W; Martin, F; Mercey, D; Navaratne, L; Noble, H; Sarner, L; Taylor, GP | 1 |
| Brothers, CH; Castillo, SA; Hernandez, JE | 1 |
| Alvarez, D; Ball, L; Brau, N; Dieterich, DT; Moorehead, L; Sulkowski, MS | 1 |
| Brindley, NM | 1 |
| Coombs, RW; Cooper, ER; Dinh, PV; Dragavon, J; Frenkel, LM; Goldman, D; Hitti, J; McKernan, J; Watts, DH | 1 |
| Lowry, D; Malcolm, K; Toner, C; Woolfson, D | 1 |
| Engchanil, C; Kosalaraksa, P; Lulitanond, V; Lumbiganon, P; Pongjunyakul, P; Suwan-apichon, O; Thuennadee, R; Tungsawad, S | 1 |
| Cartledge, J; Churchill, D; Fakoya, A; Hay, P; Johnson, M; Leen, C; Moyle, GJ; Murphy, M; Reilly, G; Sabin, CA; Scullard, G; Wilkins, E | 1 |
| Bernard-Henry, C; Cheneau, C; de Mautort, E; Hess, G; Krebs, M; Lang, JM; Partisani, M; Priester, M; Rey, D | 1 |
| Arribas, JR; Campo, RE; Chen, SS; Cheng, AK; DeJesus, E; Enejosa, J; Gallant, JE; Gazzard, B; McColl, D; Pozniak, AL; Toole, JJ | 1 |
| d'Ettorre, G; Mastroianni, CM; Vullo, V | 1 |
| Aubertin, AM; Boggetto, N; Condom, R; Di Giorgio, A; Liotard, JF; Mehiri, M; Patino, N; Reboud-Ravaux, M | 1 |
| Day, RB; Hage, CA; Knox, KS; Kohli, LM; Twigg, HL | 1 |
| Averbuch, D; Einhorn, M; Engelhard, D; Gottesman, G; Gradstein, S; Grisaru-Soen, G; Grossman, Z; Kedem, E; Lanier, ER; Ofir, M; Schapiro, JM | 1 |
| Berk, DR; Falkovitz-Halpern, MS; Maldonado, YA; Ruiz, J; Sullivan, B | 1 |
| Han, N; Lan, MD; Liu, ZY; Lu, LH; Wei, HS; Yao, J; Zhang, FJ; Zhao, HX | 1 |
| Arbess, G; Boyle, E; Chipato, T; Chitsike, I; Glazier, RH; Gottesman, M; Pilon, R; Silverman, M; Simor, A; Spitzer, RF; Thistle, P | 1 |
| Andreotti, M; Ceffa, S; Cusato, M; Germano, P; Giuliano, M; Guidotti, G; Liotta, G; Loureiro, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Regazzi, M; Vella, S; Villani, P | 1 |
| Gu, SM | 1 |
| Cecelia, AJ; Kumarasamy, N; Mayer, K; Saghayam, S; Solomon, S; Wanke, C | 1 |
| Angeletti, C; Boumis, E; Chinello, P; Lisena, FP; Papetti, F; Petrosillo, N | 1 |
| Bloom, BR | 1 |
| Neal, EF; Poston, PA; Robbins, BL; Rodman, JH; Slaughter, C | 1 |
| Fleckman, P; Williams, LH | 1 |
| Barreiro, P; Blanco, F; de Mendoza, C; García-Benayas, T; Gil, P; González-Lahoz, J; Maida, I; Martín-Carbonero, L; Soriano, V | 1 |
| Allers, K; Fischer, M; Günthard, HF; Knoepfel, SA; Metzner, KJ; Opravil, M; Rauch, P; Walter, H | 1 |
| Arimi, P; Asmelash, A; Chand, F; Essex, M; Lagakos, S; Lockman, S; Makhema, J; Mazhani, L; Moffat, C; Ndase, P; Novitsky, V; Shapiro, RL; Smeaton, LM; Stevens, L; Thior, I; van Widenfelt, E; Wester, C | 1 |
| Hawkins, JS | 1 |
| Becquet, R; Bedikou, G; Bequet, L; Dabis, F; Ekouevi, DK; Fassinou, P; Leroy, V; Sakarovitch, C; Timite-Konan, M; Viho, I | 1 |
| Borders, AE; Cohen, MH; Eary, RL; Garcia, PM; Handler, A | 1 |
| Bastow, B; Glesby, MJ; Gulick, RM; Kuritzkes, DR; Meyer, WA; Ribaudo, HJ; Shikuma, CM; Tashima, KT; Webb, N; Yang, Y | 1 |
| Brocklehurst, P; Siegfried, NL; van der Merwe, L; Volmink, J | 1 |
| Blauvelt, A; Hartley, O; Root, MJ; Sugaya, M | 1 |
| Bowers, P; Henry, DH; Lamarca, A; Leitz, G; Slim, J | 1 |
| Amellal, B; Calvez, V; Castro, ND; Chêne, G; Cotte, L; Gourlain, K; Journot, V; Molina, JM; Palmer, P; Pédrono, G; Rancinan, C | 1 |
| Samuels, DC | 1 |
| Dabis, F; Elenga, N; Fassinou, P; Msellati, P; Viho, I | 1 |
| Keiser, P; Nassar, N | 2 |
| Byakwaga, H; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Katabira, E; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Stöhr, W; Walker, AS | 1 |
| Boucher, S; Fleury, H; Lavignolle-Aurillac, V; Masquelier, B; Neau, D; Ragnaud, JM; Recordon-Pinson, P; Schrive, MH | 1 |
| Al-Sharqui, A; Manavi, K; McDonald, A | 1 |
| Cimerman, S; Diaz, RS; Lewi, DS; Sucupira, MC | 1 |
| Becker, S; Bernstein, B; Calhoun, D; Cameron, DW; da Silva, B; Foit, C; Hanna, GJ; King, MS; Klein, C; Tokimoto, D | 1 |
| Anso, E; Cruchaga, C; Font, M; Martinez-Irujo, JJ; Martino, VS; Rouzaut, A | 1 |
| Bührer, C; Casteleyn, S; Feiterna-Sperling, C; Loui, A; Obladen, M; Schmitz, T; Wahn, V; Weizsaecker, K | 1 |
| Gulick, RM; Klingman, KL; Koletar, SL; Kuritzkes, DR; Meyer, WA; Reichman, R; Ribaudo, HJ; Riddler, SA; Santana, J; Shikuma, C; Squires, KE | 1 |
| Bates, I; de José, MI; Madero, R; Orío, M; Peña, JM; Rives, MT; Sanz, M | 1 |
| Silver, E | 1 |
| López, G; Omiste, T; Ramos, C; Ruiz, M | 1 |
| Niamba, P; Taïeb, A; Traoré, A | 1 |
| Frankel, FA; Invernizzi, CF; Oliveira, M; Wainberg, MA | 1 |
| Gibb, DM; Grosskurth, H; Khoo, S; Kikaire, B; Mugyenyi, P; Munderi, P; Namale, L; Reid, A; Ssali, F; Walker, AS | 1 |
| Bharucha, KE; Bhosale, RA; Bollinger, RC; Bulakh, PM; Choi, TJ; Deshmukh, SD; Gupta, A; Gupte, N; Khandekar, MM; Kshirsagar, AS; Kulkarni, V; Nair, S; Nayak, U; Phadke, MA; Sastry, J; Sinha, G | 1 |
| Benech, H; Da Silva, D; Durand-Gasselin, L; Grassi, J; Pruvost, A | 1 |
| Al-Masoudi, NA; Al-Soud, YA; Ali, IA; De Clercq, E; Pannecouque, C; Schuppler, T | 1 |
| Abzug, MJ; Brady, M; Brogly, SB; Crain, MJ; Hughes, MD; Jean-Philippe, P; Mofenson, LM; Oleske, J; Seage, GR; Van Dyke, R; Ylitalo, N | 1 |
| Battegay, M; Huttner, AC; Kaufmann, GR; Opravil, M; Weber, R | 1 |
| Butler, K; Candeias, F; Castelli-Gattinara, G; Compagnucci, A; de Rossi, A; Della Negra, M; Feiterna-Sperling, C; Giaquinto, C; Gibb, DM; Green, H; Harper, L; Levy, J; Pillay, D; Saidi, Y; Walker, AS; Wintergerst, U | 1 |
| Chi, BH; Chintu, N; Lee, A; Sinkala, M; Stringer, EM; Stringer, JS | 1 |
| Ket-Aim, S; Poolsup, N; Suksomboon, N | 1 |
| Bain, BJ; Benzie, A; Phelan, L; Wilkinson, MJ | 1 |
| Blanche, S; Cibert, C; Costagliola, D; Firtion, G; Floch, C; Nigon, F; Parat, S; Senda, S; Viegas-Péquignot, E | 1 |
| Bernasconi, E; Bersinger, NA; Cavassini, M; Elzi, L; Furrer, H; Fux, CA; Hirschel, B; Mueller, B; Mueller, NJ; Schmid, P; Wunder, DM | 1 |
| Dauer, B; Doerr, HW; Haberl, A; Hanke, N; Knecht, G; Locher, L; Moesch, M; Mueller, A; Staszewski, S; Stürmer, M | 1 |
| Bryant Borders, AE; Cohen, MH; Eary, RL; Garcia, PM; Handler, A; Olszewski, Y; Statton, A | 1 |
| Antenozzi, S; Hulse, S; Luque, A; Shahzad, U; Smith, B; Tanzman, E; Wang, D | 1 |
| Bethel, J; Dharmarajan, S; Jacob, SM; Junankar, V; Parameshwari, S; Read, JS; Samuel, NM; Stoszek, SK; Van Hook, HM; Xu, J | 1 |
| Broadhead, RL; Chen, S; Fiscus, SA; Hoover, DR; Jackson, JB; Kafulafula, G; Kumwenda, NI; Miotti, PG; Nkhoma, C; Piwowar, E; Taha, TE | 1 |
| Dubé, MP; Grinspoon, SK; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Tebas, P | 1 |
| Hijikata, Y; Hirase, C; Kanamaru, A; Maeda, Y; Morita, Y; Takai, S; Tanaka, M; Tatsumi, Y; Yamaguchi, T | 1 |
| Alston, B; Aweeka, FT; Chung, RT; Kang, M; Lizak, P; Yu, JY | 1 |
| Johnston, E; Kassaye, SG; Katzenstein, DA; Shulman, NS; Winters, MA | 1 |
| Bhat, S; Brennan, TP; Chong, CR; Hale, B; Hegarty, R; Jilek, BL; Liu, JO; McMahon, MA; Shen, L; Siliciano, RF; Thio, CL; Wind-Rotolo, M; Xing, S; Zhou, Y | 1 |
| Abdoulaye, D; André, C; André, E; Bernard, L; Sandrine, PF; Sylvie, A | 1 |
| Dubé, MP; Grinspoon, SK; Komarow, L; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Tebas, P | 1 |
| Clavel, F; Dam, E; Gerstoft, J; Joergensen, LB; Laursen, AL; Mathiesen, S; Roge, B | 1 |
| Feola, DJ; Garvy, BA; Rapp, RP; Thornton, AC | 1 |
| Cascone, A; Colella, G; Di Martino, F; Filippini, A; Filippini, P; Lanza, A; Martini, S; Masiello, A; Pisapia, R | 1 |
| Campbell, O; de Morais, EN; Duarte, G; El-Beitune, P; Mauad-Filho, F; Quintana, SM; Rodrigues, LC; Spara-Gadelha, P | 1 |
| Amorim, AP; Campos, CP; Custódio, FL; Ferrão, SB; Fonseca, BA; Gaspar, GG; Golin, NA; Marangoni, AT; Melo, Ld; Morejón, KM; Ponzi, CC; Santana, RC; Vanni, T | 1 |
| Abdel-Megeed, MF; Kashuba, AD; Rezk, NL | 1 |
| Bussmann, H; DeGruttola, V; Essex, M; Gaseitsiwe, S; Marlink, RG; Moyo, S; Musonda, R; Novitsky, V; Thomas, A; Van Widenfelt, E; Wester, CW | 1 |
| Campbell, O; Duarte, G; El Beitune, P; Quintana, SM; Rodrigues, LC | 1 |
| Giry, C; Hebert, JC; Lartigau-Roussin, C; Malvy, D; Pettinelli, ME; Receveur, MC | 1 |
| Diquet, B; Goujard, C; Legrand, M; Mentré, F; Panhard, X; Taburet, AM | 1 |
| Bani-Sadr, F; Billaud, E; Cacoub, P; Carrat, F; Doll, J; Goderel, I; Penalba, C; Perronne, C; Pol, S; Welker, Y | 1 |
| Ansari, AW; Heiken, H; Schmidt, RE | 1 |
| Bagnis, CI; Bessette, C; Deray, G; Karie, S; Launay-Vacher, V; Tézenas Du Montcel, S; Tostivint, I; Tourret, J; Vigneau, C | 1 |
| Benmebarek, Y; Blanche, S; Dollfus, C; Douard, D; Faye, A; Firtion, G; Lechenadec, J; Meyer, L; Monpoux, F; Rouzioux, C; Tricoire, J; Warszawski, J | 1 |
| Doerr, HW; Staszewski, S; Stürmer, M | 1 |
| Abrams, EJ; Amani-Bosse, C; Becquet, R; Coffie, PA; Dabis, F; Ekouevi, DK; El-Sadr, WM; Leroy, V; Rouet, F; Tonwe-Gold, B; Toure, S; Viho, I | 1 |
| Bridges, AS; Cohen, MS; Corbett, AH; Dumond, JB; Jung, BH; Kashuba, AD; Patterson, KB; Rezk, NL; Stewart, PW; Yeh, RF | 1 |
| Boom, WH; Charlebois, ED; Havlir, DV; Kayanja, HK; Lin, R; Mayanja-Kizza, H; Mugerwa, RD; Srikantiah, P; Walusimbi, MN; Whalen, CC | 1 |
| Brenner, BG; Lalonde, R; Micheli, V; Moisi, D; Ntemgwa, M; Oliveira, M; Wainberg, MA | 1 |
| Bardeguez, A; Bryson, YJ; Cababasay, M; Dorenbaum, A; Fridland, A; Gandía, J; Gonzalez Garcia, A; Hitti, J; Mirochnick, M; Mofenson, L; Rathore, MH; Robbins, BL; Rodman, JH; Samson, P | 1 |
| Calmy, A; Ditangco, R; Huffam, SE; Kaldor, JM; Saphonn, V; Srasuebkul, P; Zhou, J | 1 |
| Amaral, E; Assis-Gomes, F; Cecatti, JG; Milanez, H; Pinto E Silva, JL; Vilela, MM | 1 |
| Dratwa, M; Guillaume, MP; Mesquita, M | 1 |
| Gulick, RM; Kuritzkes, DR; Ribaudo, HJ | 1 |
| Adile, SL; Chandrakar, AK; Garg, ML; Pandey, N; Patel, S | 1 |
| Fowler, MG; Harris, NS; Lampe, MA; Ruffo, N; Sansom, SL | 1 |
| Dzombo, D; Essajee, S; Jelagat, J; Mandaliya, K; Mwalimu, M; Shikely, K; Song, R | 1 |
| D'costa, GF; Khadke, K; Patil, YV | 1 |
| Arvold, ND; Changchit, T; Jourdain, G; Lallemant, M; McIntosh, K; Ngo-Giang-Huong, N; Piyaworawong, S; Suraseranivong, V; Warachit, B | 1 |
| Acosta, EP; Bassett, R; Eron, JJ; Fischl, MA; Johnson, VA; Kuritzkes, DR; Long, MC; Moore, JD; Sommadossi, JP | 1 |
| Bharucha, KE; Bhosale, R; Bollinger, RC; Gupta, A; Gupte, N; Kulkarni, P; Nayak, U; Phadke, M; Sastry, J; Tripathy, S | 1 |
| Altinbaş, A; Büyükaşik, Y; Ozkaya, G; Unal, S | 1 |
| Curkendall, SM; Emons, MF; Everhard, F; Fisher, AE; Richardson, JT | 1 |
| Dimarco, M; Dodard, C; Guilbaud, R; Marier, JF; Monif, T; Morelli, G; Singla, AK; Thudi, NR; Tippabhotla, SK | 1 |
| Kanouse, DE; Landovitz, RJ; Moe, A; Reback, C; Rotheram-Fuller, E; Shoptaw, S; Wang, J | 1 |
| Arribas, JR; Campo, RE; Chen, SS; Cheng, AK; Dejesus, E; Enejosa, J; Gallant, JE; Gazzard, B; Holmes, CB; McColl, D; Pozniak, AL; Toole, JJ | 1 |
| Bougnounou, R; Diallo, I; Drabo, J; Guiard-Schmid, JB; Nacoulma, EW; Ouédraogo, C; Some, Y; Tieno, H; Zoungrana, A | 1 |
| Easley, KA; Lennox, JL; Lu, C; Ofotokun, I; Smithson, SE | 1 |
| Coeur, SL; Jourdain, G; Lallemant, M; Limtrakul, A; Mary, JY; McIntosh, K; Ngo-Giang-Huong, N; Traisathit, P; Yuthavisuthi, P | 1 |
| Anderson, AM; Bartlett, JA; Kosinski, AS | 1 |
| Kimmelman, J | 1 |
| Allard, R; Boivin, JF | 1 |
| Fahey, J; Harrigan, PR; Kuiper, M; Lima, VD; Sheen, CW; Sluis-Cremer, N; Tachedjian, G; Tyssen, D; Wynhoven, B; Yap, SH; Zanin, M | 1 |
| Götte, M | 1 |
| Bain, S | 1 |
| Battegay, M; Bernasconi, E; Bucher, HC; Cavassini, M; Furrer, H; Günthard, H; Hirschel, B; Opravil, M; Vernazza, P; von Wyl, V; Wolbers, M; Yerly, S | 1 |
| Eron, JJ; Fiscus, SA; Foust, E; Kuruc, J; Leone, PA; McCoy, SI; Patterson, KB; Pilcher, CD; Williams, D; Wolf, L | 1 |
| Chaisson, RE; Charalambous, S; Churchyard, GJ; Fielding, KL; Grant, AD; Hoffmann, CJ; Innes, C; Sulkowski, MS; Thio, CL | 1 |
| Díaz-Curiel, M; Fernández-Guerrero, ML; García-Delgado, R; Górgolas, M; Goyenechea, A; Rivas, P | 1 |
| Ackermans, M; Blümer, RM; Danner, SA; Hassink, E; Reiss, P; Sauerwein, HP; Sutinen, J; van Agtmael, MA; van Vonderen, MG; Yki-Jarvinen, H | 1 |
| Chiappini, E; de Martino, M; Gabiano, C; Galli, L; Gattinara, GC; Martino, A; Scolfaro, C | 1 |
| Aguiar, RA; Aleixo, A; Cleto, S; Kakehasi, FM; Lin, E; Melo, VH; Pinto, JA; Tupinambás, U | 1 |
| Chhum, V; Fleury, HJ; Glaziou, P; Koum, K; Kruy, LS; Ly, N; Min, DC; Phoung, V; Reynes, JM; Srey, C | 1 |
| Berger, D; Elezović, I; Gotić, M; Marisavljević, D; Rolović, Z | 1 |
| Aguirrebengoa, K; Asensi, V; Barreiro, P; Cervantes, M; Echeverria, S; Garcia-Samaniego, J; Núñez, M; Ocampo, A; Pascual, A; Soriano, V | 1 |
| Asenjo, MA; Barrufet, P; Domingo, P; Gatell, JM; Gutiérrez, F; Knobel, H; Mallolas, J; Pedrol, E; Peñaranda, M; Peraire, J; Pich, J; Vidal, F | 1 |
| Chauvin, JP; Cohen-Codar, I; Delaugerre, C; Delfraissy, JF; Flandre, P; Ghosn, J; Girard, PM; Horban, A; Norton, M; Rouzioux, C; Taburet, AM; Van, PN | 1 |
| Dunn, D; Mihailidis, C; Pillay, D; Pozniak, A | 1 |
| Abrams, EJ; Becquet, R; Chaix, ML; Clarisse, AB; Coffie, PA; Dabis, F; Ekouevi, DK; Leroy, V; N'dri-Yoman, T; Rouzioux, C; Tonwe-Gold, B; Viho, I | 1 |
| Arizcorreta-Yarza, A; Collado, A; Fernández-Fuertes, E; Girón-González, JA; González-Serrano, M; López-Cortés, LF; Lozano, F; Macías, J; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Torres-Tortoso, M; Valera-Bestard, B | 1 |
| Berdasquera C, D; Díaz-Jidy, M; González N, I; Pérez A, J; Toledo R, ME | 1 |
| Arts, EJ; Bajunirwe, F; Demers, KR; Fraundorf, E; Kyeyune, F; Lalonde, MS; Mugyenyi, P; Syed, A; Troyer, RM; Whalen, CC | 1 |
| Brooks, JT; Hanson, DL; Sullivan, PS | 1 |
| Becquet, R; Dabis, F; Dequae-Merchadou, L; Ekouevi, DK; Horo, A; Leroy, V; Rouet, F; Rouzioux, C; Sakarovitch, C; Timité-Konan, M; Tonwe-Gold, B; Viho, I | 1 |
| Chan, C; Flexner, C; Lee, LS; Lietman, PS; Parsons, TL; Wise, SD | 1 |
| Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
| Aurpibul, L; Puthanakit, T; Sirisanthana, T; Sirisanthana, V | 1 |
| Abel, S; Muirhead, GJ; Ridgway, CE; Russell, D; Whitlock, LA | 1 |
| Herrera, L; Moreno, S; Sánchez-de la Rosa, R | 1 |
| Bresson, JL; Chaix, ML; Cohen-Codar, I; Delfraissy, JF; Galimand, J; Ghosn, J; Girard, PM; Peytavin, G; Raffi, F; Rouzioux, C | 1 |
| Antoniou, T; Balla, S; Du Mont, J; Husson, H; Loutfy, MR; Macdonald, S; Myhr, T; Rachlis, A | 1 |
| Gomutbutra, V | 1 |
| Barlow, P; Ciardelli, R; Gerard, M; Goetghebuer, T; Haelterman, E; Hainaut, M; Levy, J; Marvillet, I; Salameh, A | 1 |
| Bénech, H; Dehée, A; Dollfus, C; Durand-Gasselin, L; Garbarg-Chenon, A; Grassi, J; Leverger, G; Pruvost, A; Tabone, MD; Vaudre, G | 1 |
| Anglaret, X; Dabis, F; Dakoury-Dogbo, N; Diakite, N; Duvignac, J; Grundmann, C; Karcher, S; Kouadio, B; Marlink, R; Seyler, C; Toure, S; Traore, M | 1 |
| Claassen, M; Cotton, MF; Engelbrecht, S; Laten, JD; Preiser, W; Theron, GB; van Zyl, GU | 1 |
| Aweeka, F; Jayewardene, AL; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
| Cilleruelo Ortega, MJ; García-Hortelano, M; Martín-Fontelos, P; Mellado Peña, MJ; Núñez Cuadros, E; Penim Fernández, M; Piñeiro Pérez, R; Rivera Cuello, M; Villota Arrieta, J | 1 |
| Cortina-Borja, M; de Ruiter, A; Lyall, H; Peckham, CS; Tookey, PA; Townsend, CL | 1 |
| Fauci, AS | 2 |
| Bonjoch, A; Clotet, B; Domingo, P; Galindo, MJ; Iribarren, J; Llibre, JM; Martinez-Picado, J; Negredo, E; Pérez-Alvarez, N; Schapiro, J | 1 |
| Gibert, CL; Grunfeld, C; Peng, G; Sharma, S; Shlay, JC | 1 |
| Arenas-Pinto, A; Bhaskaran, K; Dunn, D; Weller, IV | 1 |
| Bonny, T; Clumeck, N; Currier, J; Kleim, JP; Lazzarin, A; McCarty, D; Millard, J; Slims, J; Sloan, L; Steel, H | 1 |
| González-Lahoz, J; Soriano, V | 1 |
| Brink, NS; Gibb, D; Howard, MR; Klein, N; Novelli, V; Shingadia, D; Tedder, R | 1 |
| Duesberg, PH | 1 |
| Benoit, SL; Eron, JJ; Fallon, MA; Jemsek, J; Kuritzkes, DR; MacArthur, RD; Quinn, JB; Rubin, M; Santana, J | 1 |
| Merigan, TC | 1 |
| Brennan, T; Essex, M; Gelber, R; Hammer, S; Lallemant, M; Le Coeur, S; Lee, TH; McIntosh, K; Sirivatanapa, P; Vithayasai, V | 1 |
| Alder, J; Clement, J; Hui, YH | 1 |
| Cooper, DA; Kaldor, JM; McNulty, AM | 1 |
| Castro, KG; Critchley, SE | 1 |
| Casabona, J; Rodés, A | 1 |
| Fessel, WJ | 1 |
| Schwartz, DH | 1 |
| Cates, W; Cohen, MS | 1 |
| Newell, ML; Scaravelli, G; Thorne, C | 1 |
| Davison, CF; Dunn, DT; Holland, FJ; Nicoll, A | 1 |
| Castello, G; Cerruti, A; Lerza, R; Mela, G; Mencoboni, M | 1 |
| Dolezal, J; Hraba, T | 2 |
| Gallo, N; Gezelter, S; Hoffman, L; Pope, M; Steinman, RM | 1 |
| Evans, JA; Levin, M; Marriage, SC; Walters, MD | 1 |
| Carbone, A; Errante, D; Fiorentini, G; Gastaldi, R; Milo, D; Monfardini, S; Nosari, AM; Rossi, G; Tirelli, U; Vaccher, E | 1 |
| Collier, AC | 2 |
| Conlon, CP; Edwards, A; Klenerman, P; Larder, BA; Phillips, RE | 1 |
| Barringer, K; Cheeseman, S; Corbeil, J; Havlir, D; Ignacio, C; Looney, D; Pauletti, D; Richman, DD; Spector, SA; Sullivan, J | 1 |
| Bozzette, SA; Hay, J; Parker, R | 1 |
| Balfour, HH; Erice, A | 1 |
| Neuzil, KM | 1 |
| Aguiniga, E; Halpern, J; Katzenstein, DA; Kozal, MJ; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Efron, B; Katzenstein, DA; Kozal, MJ; Kroodsma, K; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Caliendo, AM; Hirsch, MS | 1 |
| Auclair, C; Beaulieu, R; Boulerice, F; Gill, J; Montaner, JS; Phillips, P; Rachlis, A; Schindzielorz, A; Schlech, W; Smaldone, L | 1 |
| Britton, S; Julander, I | 1 |
| Arpadi, S; Chang, CJ; Dobroszycki, J; Hoberman, M; Lambert, G; Nozyce, M; St Louis, Y; Wiznia, A | 1 |
| De Pasquale, MP; Marchisio, P; Massironi, E; Principi, N; Tornaghi, R; Vago, T | 1 |
| Angarano, G; Appice, A; Fico, C; Giannelli, A; Monno, L; Pastore, G; Romanelli, C | 1 |
| Bakhtiari, M; Bell, S; Kuritzkes, DR | 1 |
| Bergmann, L; Nockher, WA; Scherberich, JE | 1 |
| Fuchs, D; Gisslén, M; Hagberg, L; Larsson, M; Norkrans, G; Wachter, H | 2 |
| Cheeseman, SH; Greenough, TC; Hall, D; Hattox, SE; Havlir, D; McLaughlin, MM; Myers, M; Spector, SA; Stein, DS; Sullivan, JL | 1 |
| Bassiakos, Y; Demeter, LM; Fischl, M; Greisberger, C; Leedom, J; Morse, GD; Para, M; Powderly, W; Reichman, RC; Resnick, L | 1 |
| Levantis, P; Oxford, JS; Stein, CA | 1 |
| Biteau, N; Doignon, F; Fleury, HJ; Masquelier, B; Michelet, C; Morlat, P; Pellegrin, I; Ragnaud, JM; Ruffault, A | 1 |
| Ayliffe, U; Kaye, S; Loveday, C; Semple, M; Tedder, RS; Tenant-Flowers, M; Weller, IV | 1 |
| Chiodi, F; Di Stefano, M; Hagberg, L; Leitner, T; Norkrans, G; Sabri, F; Svennerholm, B | 1 |
| Anderson, KW; Bakshi, KK; Durr, S; Göhler, R; Kober, A; Massari, FE; Schneider, CL; Staszewski, S; Taylor, VI; Waterbury, JA | 1 |
| Coombs, RW; Crumpacker, CS; D'Aquila, RT; Japour, AJ; Johnson, VA; Kahn, JO; Kuritzkes, DR; Reichelderfer, PS; Richman, DD; Welles, S | 1 |
| Besemer, D; Eastman, PS; Kolberg, J; Stempien, M; Urdea, M | 1 |
| Aguiniga, E; Iversen, AK; Katzenstein, DA; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Harrigan, PR; Kemp, SD; Larder, BA | 1 |
| Biasinutto, C; De Angelis, V; De Matteis, MC; Errante, D; Pradella, P; Spina, M; Steffan, A; Vettore, L | 1 |
| Britton, S; Eriksson, S; He, Q; Jacobsson, B; Karlsson, A | 1 |
| Hughes, MD; Lin, HM | 2 |
| Chen, S; Chopra, P; Emini, EA; Hahn, BH; Kappes, JC; McFarland, R; Piatak, M; Saag, MS; Shaw, GM; Yang, LC | 1 |
| Lee, L; MacRae, D; Saltzberg, AM | 1 |
| Farr, SS; Kammerman, LA; Kazempour, K | 1 |
| de la Iglesia, P; de Oña Navarro, M; Fernández Urgellés, M; Martinez Gutierrez, A; Melón Garcia, S; Mendez García, FJ; Rodriguez Pinto, C | 1 |
| Biedermann, K; Irion, O; Kind, C; Lauper, U; Rudin, C; Spoletini, G | 1 |
| Mitsuya, H; Shirasaka, T; Ueno, T | 1 |
| Brown, AE; Chung, RC; Hofheinz, D; Lane, JR; Mayers, DL; Ruiz, NM; Vahey, MT; Zhou, SY | 1 |
| Burt, BA; Kleinman, DV; Swango, PA; Tomar, SL | 1 |
| Minkoff, H; Willoughby, A | 1 |
| Choo, V | 2 |
| Ferrara, SD; Franchin, E; Giorgetti, R; Palù, G; Rassu, M; Tagliabracci, A | 1 |
| Dillner, L | 1 |
| LaCasse, RA; North, TW | 1 |
| Stretcher, BN | 2 |
| Caruso, A; De Santis, M; Mancuso, S; Noia, G | 1 |
| Bolde, M | 1 |
| Darville, T; Menard, J; Tucker, NC | 1 |
| Flexner, C; Ginsberg, R; Hamzeh, FM; Haubrich, RH; Hirsch, M; Lederman, MM; Lietman, P; Pettinelli, CP; Richman, DD; Spector, SA | 1 |
| Frank, JW; Leblanc, M; Major, C; McLaughlin, J; O'Shaughnessy, MV; Read, SE; Strathdee, SA | 1 |
| Gibb, D; Peckham, C | 1 |
| Klaus, BD | 2 |
| Bartlett, JA; Cohen, OJ; Graziosi, C; Holodniy, M; Lalezari, J; Niu, M; Pantaleo, G; Pavlakis, GN; Schnittman, S; Steigbigel, RT | 1 |
| Goldenberg, RL; Owen, J; Rouse, DJ; Vermund, SH | 1 |
| Darbyshire, J | 1 |
| Rouzioux, C | 1 |
| Volberding, P | 2 |
| Havlir, D; Richman, DD | 1 |
| Dalakas, MC; Frank, JA; Jay, C; McLaughlin, AC; Sinnwell, TM; Sivakumar, K; Soueidan, S | 1 |
| Collier, AC; Fischl, MA; Grimes, JM; Hirsch, MS; Lagakos, SW; Meng, TC; Phair, JP; Rooney, J; Stein, DS; Volberding, PA | 1 |
| Carr, A; Clumeck, N; Cooper, DA; Hirschel, BJ; Hoen, B; Kinloch-De Loës, S; Lazzarin, A; Mathiesen, L; Saurat, JH; Tindall, B | 1 |
| Ho, DD | 2 |
| Edmunds, J | 1 |
| Chaisson, RE; Gallant, JE; Keruly, J; Moore, RD; Richman, DD | 3 |
| Abrams, EJ; Bamji, M; Heagarty, M; Hernán, MA; Krasinski, K; Lambert, G; Matheson, PB; Rogers, MF; Thea, DM; Thomas, PA | 1 |
| Bryson, YJ; Deveikis, A; Frenkel, LM; Keller, M; Nielsen, K; Sim, MS; Stiehm, ER; Wei, LS | 1 |
| D'Silva, M; Flaherty, JP; Leibowitz, D | 1 |
| Cohen, J | 6 |
| Cao, G; Falguera, M; Perez-Mur, J; Puig, T | 1 |
| Church, JA; Dunkle, LM; Federici, ME; Goldsmith, JC; Harris, AT; Kaul, S; Kline, MW; Loewen, DF; Schultze, ME; Woods, L | 1 |
| Boogaard, J; Brok, M; Goudsmit, J; Jurriaans, S; Koot, M; Lange, J; Van Gemen, B; Van Strijp, D; Weverling, GJ | 1 |
| Gunnarsson, G; Hammer, SM | 1 |
| Berzofsky, JA; Clerici, M; Kessler, HA; Landay, AL; Pinto, LA; Shearer, GM; Sullivan, J | 1 |
| Hoernle, EH; Reid, TE | 1 |
| Elford, J; Kaldor, JM; MacDonald, MA | 1 |
| Gibb, DM; Newell, ML | 1 |
| Burmeister, G; Domschke, W; Kucharzik, T; Lügering, N; Sorg, C; Stoll, R | 1 |
| Klepser, ME; Nightingale, CH; Quintiliani, R | 1 |
| Agelink, MW; Diener, HC; Malessa, R | 1 |
| Abrams, EJ; Bamji, M; Grimm, K; Hutson, D; Krasinski, K; Lambert, G; Matheson, PB; Shaffer, N; Thea, DM; Thomas, PA | 1 |
| Côrte-Real, R; Da Cunha, S; Meliço-Silvestre, A; Pombo, V; Serra, JE | 1 |
| Goldschmidt, RH; Legg, JJ | 1 |
| Cherin, P; Coutellier, A; Herson, S | 1 |
| Bajpai, PK; Cannon, MR | 1 |
| Kwok, S; McKinney, N; Pratt, RD; Shapiro, JF; Spector, SA | 1 |
| Yoder, DK | 1 |
| Aperia, K; Cox, S; Palmer, S; Wahren, B | 1 |
| Damus, K; Drake, K; Youchah, J | 1 |
| Connor, EM; Mofenson, LM | 1 |
| Parra, E | 1 |
| Back, D; Barry, M; Giaquinto, C; Gibb, D; Nokes, L; Ormesher, S; Seefried, M | 1 |
| Beaulieu, R; Cameron, B; Dunkle, L; Gill, J; Montaner, JS; Raboud, J; Rachlis, A; Salomon, H; Schechter, MT; Smaldone, L; Tsoukas, C; Wainberg, MA | 1 |
| Katzenstein, DA; Kozal, MJ; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Kern, P; Schwander, S | 1 |
| Bird, AG; Froebel, KS; Watret, KC; Whitelaw, JA | 1 |
| Imai, M; Ito, A; Kondo, M; Oka, S; Saito, T; Takata, N | 1 |
| Kamali, F | 1 |
| Campbell, TB; D'Aquila, RT; Eron, JJ; Kuritzkes, DR; Tarpley, WG; Young, RK | 1 |
| Albert, J; Cox, SW; Ljungdahl-Ståhle, E; Wahren, B | 1 |
| Byrnes, VW; Douglas, J; Emini, EA; Hildebrand, C; Kappes, JC; Lapidus, WI; Laskin, OL; Saag, MS; Schleif, WA; Whitley, RJ | 1 |
| Bagnarelli, P; Clementi, M; Manzin, A; Menzo, S; Paolucci, S; Petroni, S; Sampaolesi, R; Scalise, G; Valenza, A; Varaldo, PE | 1 |
| Apolonio, EG; Detels, R; He, Y; Hoover, DR; Kaslow, RA; Lyter, DW; Phair, JP; Saah, AJ | 1 |
| Anderson, BD; Kojima, E; Mitsuya, H; Shirasaka, T; Yarchoan, R | 1 |
| Keystone, D | 1 |
| Atwood, SM; Cummins, TJ; Dewhurst, S; Frenkel, LM; Wagner, LE | 1 |
| Aboulker, JP; Darbyshire, JH; Debré, M; Giaquinto, C; Gibb, DM; Martinez, M; Tudor-Williams, G | 1 |
| Borella, M; Cargnel, A; Clerici, F; Grassi, MP; Mangoni, A; Perin, C; Zocchetti, C | 1 |
| Dabis, F; Mandelbrot, L; Msellati, P; Van de Perre, P | 1 |
| Biggar, RJ; Chiphangwi, J; Mtimavalye, L; Taha, TE | 1 |
| Galeano Jiménez, AH | 1 |
| Amato, DA; DeGruttola, V; Eyster, ME; Gjerset, GF; Ho, M; Kessler, CM; LoFaro, ML; Parenti, DM; Ragni, MV; Van Der Horst, C | 1 |
| Friedel, SD; Friedman, RF; Ganiban, GJ; Liss, RA | 1 |
| Carrera, J; Pinto, B; Porras, JA; Richart, C; Vidal, F | 1 |
| Aucott, JN; Gogate, P; Graham, RC; Granieri, J; Smith, H; Wisnieski, JJ | 1 |
| Lissen, E | 1 |
| Cappelleri, JC; Chalmers, TC; Ioannidis, JP; Lau, J; Melville, B; Sacks, HS; Skolnik, PR | 1 |
| Fahey, JL; Graham, NM; Mellors, J; Park, LP; Phair, JP; Piantadosi, S; Saah, AJ | 1 |
| Boyer, E; Dong, H; Eastman, S; Holodniy, M; Kolberg, J; Margolis, D; Mole, L; Moss, J; Urdea, M | 1 |
| Doyle, VB | 1 |
| Balfe, P; Bonhoeffer, S; Kaye, S; Loveday, C; Nowak, MA; Semple, M; Tedder, R; Tenant-Flowers, M | 1 |
| Barsanti, LA; Ceccherini Nelli, L; Chirianni, A; Conte, MC; Liuzzi, G; Piazza, M; Tullio Cataldo, P | 1 |
| Eldridge, RR | 1 |
| Guillonneau, M; Jacqz-Aigrain, E; Mandelbrot, L | 1 |
| Anderson, BD; Broder, S; Chokekijchai, S; Kojima, E; Mitsuya, H; Shirasaka, T; Steinberg, SM; Yarchoan, R | 1 |
| Broder, S; Mitsuya, H; Nguyen, BY; Pluda, JM; Venzon, DJ; Wyvill, KM; Yarchoan, R | 1 |
| Boer, K; Mulder-Kampinga, GA; Scherpbier, HJ | 1 |
| Lutwick, LI; Schaening, O; Smith, RM; Stahl, AJ | 1 |
| Faye, M; Michel, P; Sarthou, JL; Toure Balde, A | 1 |
| Khoo, SH; Wilkins, EG | 1 |
| Medina, D; Strair, R | 1 |
| Anedda, V; Piro, S; Piu, G; Rombi, G | 1 |
| Kitamura, T; Kunisada, T; Müller, WE; Ushijima, H | 1 |
| Hsieh, YH; Velasco-Hernandez, JX | 1 |
| Pinching, AJ | 3 |
| Bechtel, L; Larson, T | 1 |
| Davrinche, C; Farinotti, R; Nattouf, H; Sinet, M | 1 |
| Cao, Y; Chen, S; Hahn, BH; Ho, DD; Kokka, R; Lifson, JD; Piatak, M; Saag, MS; Todd, J; Urdea, M | 1 |
| Bariou, C; Cartier, F; Colimon, R; Genetet, N; Guist'hau, O; Jacquelinet, C; Michelet, C; Ruffault, A | 1 |
| French, MA; James, IR; Mallal, SA | 1 |
| Barton, SE; Schroeder, K | 1 |
| Authier, FJ; Bonne, G; Chariot, P; Gherardi, R; Marsac, C | 1 |
| Richman, DD | 9 |
| Johnson, VA | 3 |
| Carroll, R; Holodniy, M; Margolis, D; Mole, L; Todd, J | 1 |
| Fouchier, RA; Groenink, M; Klein, MR; Koot, M; Meyaard, L; Miedema, F; Roos, MT; Schellekens, PT; Tersmette, M; Van't Wout, AB | 1 |
| Sarkar, S | 1 |
| Elford, J; Janossy, G; Lee, C; Pasi, J; Phillips, A; Sabin, C | 1 |
| Steiner, JF | 1 |
| Wendel, TD | 1 |
| Boota, A; Cheeseman, SH; Fischl, MA; Meng, TC; Petrakis, T; Resnick, L; Richman, DD; Spector, SA; Wright, B | 1 |
| Koot, M; Miedema, F; Roos, MT; Schellekens, PT; Tersmette, M | 1 |
| Chandrasena, G; Ho, RJ; Qian, M; Unadkat, JD | 1 |
| Spector, SA | 1 |
| Lane, HC | 3 |
| Dormont, J | 2 |
| Cooper, DA | 1 |
| Chieco-Bianchi, L; Cogo, P; De Rossi, A; Gallo, P; Laverda, AM; Pagliaro, A; Sivieri, S; Tavolato, B | 1 |
| Coombs, RW; DeGruttola, V; Fiscus, SA; Gupta, P; Katzenstein, DA; Katzman, M; LoFaro, ML; Meyer, WA; Ragni, MV; Reichelderfer, PS | 1 |
| Bozzette, SA; Forthal, D; Kemper, C; Leedom, J; McCutchan, JA; Richman, DD; Sattler, FR; Tilles, JG | 1 |
| Hill, P | 1 |
| Walker, AR | 1 |
| Mulder, JW | 1 |
| Chiodi, F; Fuchs, D; Gisslén, M; Hagberg, L; Norkrans, G; Svennerholm, B; Wachter, H | 1 |
| Calis, KA; Paradis, J | 1 |
| Beall, G; Blick, G; Calabrese, LH; Conant, MA; Fisher, A; Galpin, JE; Goldstein, G; Grossman, HA; Hirsch, RL; Stampone, P | 1 |
| Dudley, MN | 1 |
| Rowe, PM | 3 |
| Blakemore, K; Perlman, EJ; Schwartz, DH; Sharma, UK | 1 |
| Campayo Ibáñez, A; de la Rubia Comos, J; Lacruz Rodrigo, J; López Chuelia, F; Perelló Roso, A; Valls Ferrer, JM | 1 |
| Colebunders, R; De Roo, A | 1 |
| Hoffman, CA; Munson, R | 1 |
| Thea, DM | 1 |
| Daiss, W; Lingenfelser, T; Overkamp, D; Weber, P | 1 |
| Mintz, M | 1 |
| Brouwers, P; Civitello, L; DeCarli, C; Moss, H; Pizzo, P; Tudor-Williams, G | 1 |
| Crumpacker, C; Freeman, W; Hardy, D; Heinemann, MH; Holland, G; Klystra, J; Polsky, B; Sharuk, G; Spector, S; van der Horst, C | 1 |
| Coll, O; Martínez de Tejada, B; Sánchez, E | 1 |
| Feldman, N; Mino, A | 1 |
| Baumberger, C; Hirschel, B; Kaiser, L; Perrin, LH; Yerly, S | 1 |
| Caruso, M; Klatzmann, D | 1 |
| Beijnen, JH; Bult, A; Burger, DM; Koks, CH; Meenhorst, PL; Mulder, JW; Neef, C; ten Napel, CH | 1 |
| Minkoff, H | 2 |
| Barcherini, S; Bucciardini, R; Chiesi, A; Floridia, M; Giuliano, M; Mariotti, S; Seeber, A; Tomino, C; Vella, S | 1 |
| Debaisieux, L; Delforge, ML; Farber, CM; Liesnard, C; Tchetcheroff, M; Van Vooren, JP | 1 |
| Albrecht, H; Fenske, S; Greten, H; Laufs, R; Plettenberg, A; Stellbrink, HJ; Stoehr, A | 1 |
| Fahey, JL; Graham, NM; Park, LP; Phair, JP; Piantadosi, S; Rinaldo, CR | 1 |
| Carpenter, CC; Cobbs, CG; Holmes, KK; Sande, MA; Sanford, JP | 1 |
| Gollapudi, S; Gupta, S | 1 |
| Berger, PB | 1 |
| Martinez, R | 1 |
| Alexius, B | 1 |
| Agresti, MG; Chiesi, A; Dally, LG; Floridia, M; Fragola, V; Giuliano, M; Moroni, M; Piazza, M; Tomino, C; Vella, S | 1 |
| Easterbrook, PJ; Emami, J; Gazzard, B | 1 |
| Gundacker, HM; Hughes, MD; Phair, JP; Stein, DS; Valentine, FT; Volberding, PA | 1 |
| Agbaria, R; Brawley, OW; Lietzau, JA; Mitsuya, H; Nguyen, BY; Pluda, JM; Saville, MW; Steinberg, SM; Wyvill, KM; Yarchoan, R | 1 |
| Lancaster, DJ; Lancaster, LL | 1 |
| Aylward, B; Craib, KJ; Hogg, RS; Le, TN; Montaner, JS; Schechter, MT | 1 |
| Blostein, J; Chu, SY; Farley, T; Kovacs, A; Morrison, L; Thompson, S; Wortley, P | 1 |
| Colford, JM; Ngo, L; Tager, I | 1 |
| Fischl, MA; Lai, S; Meng, TC; Resnick, L; Richman, DD; Spector, SA | 1 |
| Aspinall, RL; Collier, AC; Coombs, R; Fass, RJ; Fife, KH; Fischl, MA; Kremer, AB; Pottage, JC; Powderly, WG; Resnick, L | 1 |
| Baltimore, D; Rubinstein, P; Saksela, K; Stevens, C | 1 |
| Caruz, A; Larder, B; Leal, M; Luque, F; Pineda, JA; Torres, Y | 1 |
| Bubp, J; Israelski, D; Katzenstein, DA; Merigan, TC; Winger, E; Winters, M | 1 |
| Choremi-Papadopoulou, H; Gargalianos, P; Iniotaki-Theodoraki, A; Kordossis, T; Kosmidis, J; Viglis, V | 1 |
| Abrams, DI; Crane, LR; Goldman, AI; Grodesky, M; Kornegay, S; Korvick, JA; Launer, C; Muth, K; Neaton, JD; Wakefield, S | 1 |
| Cole, BF; Cotton, DJ; Gelber, RD; Goldhirsch, A; Lenderking, WR; Testa, MA; Volberding, PA | 1 |
| Dawson, JD; Lagakos, SW | 1 |
| Balis, FM; Brouwers, P; Farley, M; Goldsmith, JC; Husson, RN; Kovacs, A; Lewis, LL; Mueller, BU; Ono, J; Woods, L | 1 |
| Gordin, FM; Hamilton, JD; Hartigan, PM; Klimas, NG; Simberkoff, MS; Zolla-Pazner, SB | 1 |
| Bagnarelli, P; Clementi, M; Manzin, A; Menzo, S; Scalise, G; Valenza, A; Varaldo, PE | 1 |
| Lipsky, JJ | 1 |
| Dankner, WM; Ogino, MT; Spector, SA; Spencer, LT | 1 |
| Clark, SJ; Hahn, BH; Kappes, JC; Lifson, JD; Luk, KC; Piatak, M; Saag, MS; Shaw, GM; Yang, LC | 1 |
| de Biasi, R; Rocino, A | 1 |
| D'Agostini, C; Favalli, C; Garaci, E; Grelli, S; Mastino, A; Perroni, L; Rocchi, G; Soscia, F | 1 |
| Egger, M; Neaton, JD; Phillips, AN; Smith, GD | 1 |
| Graham, NM | 1 |
| Montaner, JS; O'Shaughnessy, M; Raboud, J | 1 |
| Bird, AG; Gore, SM | 1 |
| Laing, PA | 1 |
| de Boer, JB; Frissen, PH; Hoepelman, AI; Kauffmann, RH; Koopmans, PP; Schreij, GS; ten Napel, CH; van der Ende, ME; Weigel, HM; Weverling, GJ | 1 |
| McConnell, J | 1 |
| Barateau, V; Chevret, S; Ferchal, F; Modai, J; Molina, JM; Morinet, F; Poirot, C | 1 |
| Gatenby, P; Gringeri, A; Hessey, EW; Laurian, Y; Mannucci, PM; Martinez-Vazquez, JM; Pabinger-Fasching, I; Savidge, G; Steel, HM | 1 |
| Adams, O; Bartmann, P; Jablonowski, H; Sander, O; Wahn, V; Willers, R | 1 |
| Duiculescu, DC; Geffin, RB; Scott, GB; Scott, WA | 1 |
| Frost, SD; McLean, AR | 1 |
| Clumeck, N; Cooper, DA; Donovan, B; French, M; Gatell, JM; Gray, F; Mathiesen, L; Mulder, JW; Sandström, E; Yeo, JM | 1 |
| Balfour, HH; Bartlett, JA; Grimes, JM; Hirsch, MS; Lagakos, SW; Mitsuyasu, RT; Phair, JP; Reichman, RC; Stein, DS; Volberding, PA | 1 |
| Aukrust, P; Fagerhol, MK; Frøland, SS; Müller, F | 1 |
| Baldwin, RW; Byers, VS; Levin, AS; Malvino, A; Robins, RA; Waites, L | 1 |
| Ammann, A; Bryson, Y; Gottlieb, M; Landers, D; Pizzo, P; Stiehm, ER | 1 |
| Ashton, LJ; Kaldor, JM; Learmont, J; Luo, K; Stewart, G; Wylie, B | 1 |
| de Micco, P; Lafeuillade, A; Pellegrino, P; Quilichini, R; Tamalet, C; Vignoli, C | 1 |
| Bourut, C; Chenu, E; Mathé, G; Orbach-Arbouys, S; Pontiggia, P | 1 |
| Borkowsky, W; Bourinbaiar, AS; Krasinski, K; Lee-Huang, S | 1 |
| Matsumoto, Y; Ohashi, M; Sugihara, K | 1 |
| Bartlett, JG | 3 |
| Agrawal, KC; Akula, S; George, WJ; Greenspan, DL; Hyslop, NE; Lertora, JJ; Rege, AB | 1 |
| Flepp, M | 1 |
| Bareggi, SR; Cinque, P; D'Arminio, A; Lazzarin, A; Mazzei, M; Nicolin, A; Pirola, R; Ruggieri, A | 1 |
| Katzenstein, D; Merigan, TC; Ramachandran, RV | 1 |
| Craib, KJ; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Strathdee, SA | 1 |
| Bey, M; Connor, EM; Gelber, R; Jacobson, RL; Kiselev, P; O'Sullivan, MJ; Scott, G; Shearer, W; Sperling, RS; VanDyke, R | 1 |
| Jaffe, HW; Rogers, MF | 1 |
| Bayer, R | 1 |
| Gherardi, RK | 1 |
| Belda Mira, A; Díaz Sánchez, F; Michavila Gómez, J; Rovira Daudí, E | 1 |
| Ritzkowsky, A | 1 |
| Girolami, A; Mares, M; Sartori, MT; Stocco, D; Zerbinati, P | 1 |
| Davison, FD; Kaczmarski, RS; Mufti, GJ; Pozniak, A; Sutherland, S | 1 |
| Amadori, A; Barelli, A; Borri, A; Chieco-Bianchi, L; Del Mistro, A; Panozzo, M; Zamarchi, R | 1 |
| McKinney, RE; Wilfert, C | 1 |
| Bush, CE; Cohen, F; Donovan, RM; Moore, E; Saravolatz, LD; Smereck, SM | 1 |
| Graham, NM; Volberding, PS | 1 |
| Grange, JM; Hamedi-Sangsari, F; Malley, SD; Vila, JR | 1 |
| Koot, M; Miedema, F; Schuitemaker, H | 1 |
| Authier, J; Florea-Strat, A; Fromont, G; Gherardi, RK; Poron, F; Sabourin, JC | 1 |
| Frame, PT; Pesce, AJ; Stein, DS; Stretcher, BN | 1 |
| Kovelesky, RA; Minor, JR | 1 |
| Balis, FM; Drusano, GL; Gitterman, SR; Pizzo, PA | 1 |
| Back, D; Barry, M; Beeching, N; Breckenridge, A; Carey, P; Fox, R; Nye, F; Timmins, D; Veal, G; Wild, M | 1 |
| Egger, M; Neaton, JD; Phillips, AN; Sabin, CA; Smith, GD | 1 |
| Dal Maso, J; Grella, PV | 1 |
| Albert, J; Aperia, K; Fenyö, EM; Karlsson, A; Parsmyr, K; Sandström, E | 1 |
| Atoui, N; Bonardet, A; Conge, AM; Ducos, J; Huguet, MF; Reynes, J; Serre, A; Vendrell, JP | 1 |
| Mwatha, A; Nagelkerke, NJ | 1 |
| Goh, A; Ratnam, KV | 1 |
| Connor, EM; McSherry, G | 1 |
| Newell, ML; Peckham, C | 2 |
| Lüthy, R | 1 |
| Armstrong, JA; Gupta, P; Ho, M; Huang, XL; McMahon, DK; Pazin, GJ; Rinaldo, CR; Tripoli, C; Whiteside, TL | 1 |
| Gerstoft, J; Mathiesen, LR; Pedersen, C | 1 |
| Detels, R; Graham, NM; Ho, M; Hoover, DR; Park, LP; Phair, JP; Saah, AJ; Stein, DS | 1 |
| Fleckenstein, B; Stamminger, T | 1 |
| Brouwers, P; Church, JA; Farley, M; Goldsmith, J; Husson, RN; Kovacs, A; Mueller, BU; Ono, J; Pizzo, PA; Woods, L | 1 |
| Berman, DS; Wenglin, BD | 2 |
| Birks, E; Lin, TS; Pivazyan, A; Prusoff, W; Sun, AS | 1 |
| Henderson, EE; Schwartz, A; Yang, JY | 1 |
| Fonseca, VA; Martin, RE; Munshi, MN | 1 |
| Berrebi, A; Bongain, A; Ciraru-Vigneron, N; Delfraissy, JF; Gillet, JY; Mandelbrot, L; Pons, JC; Schlienger, I | 1 |
| Hostetler, KY; Kroneman, E; Kumar, R; Richman, DD; Sridhar, CN; van den Bosch, H; van Wijk, GM | 1 |
| Beekmann, SE; Henderson, DK | 1 |
| Antonelli, G; Arici, C; Del Poggio, P; Dianzani, F; Gregis, GP; Ippolito, G; Riva, E | 1 |
| Bélec, L; Dragon, MA; Grésenguet, G; Meillet, D; Pillot, J | 1 |
| Caquet, R; D'Oiron, R; Halfon, P; Le Bras, P; Quertainmont, Y | 1 |
| Bourut, C; Chenu, E; Mathé, G; Orbach-Arbouys, S | 1 |
| Figueroa Damián, R | 1 |
| Joos, B; Lüthy, R; Opravil, M | 1 |
| Brenner, BJ; Mercure, L; Phaneuf, D; Tsoukas, C; Wainberg, MA | 1 |
| Jacomet, C; Jupas, JJ; Lebrette, MG; Maslo, C; Rozenbaum, W | 1 |
| Erickson, J; Hoekzema, DT; Kageyama, S; Kempf, DJ; Kojima, E; Mitsuya, H; Murakawa, Y; Norbeck, DW; Shirasaka, T | 1 |
| Dierich, MP; Fuchs, D; Murr, C; Wachter, H; Zangerle, R | 1 |
| Bethel, J; Hirschhorn, R; Korelitz, J; Mofenson, LM; Moye, J; Nugent, R | 1 |
| Chirmule, N; Gurram, M; Pahwa, S; Ponugoti, N; Wang, XP | 1 |
| Elovaara, I; Hokkanen, L; Lähdevirta, J; Mattinen, S; Poutiainen, E; Raininko, R; Ranki, A; Suni, J; Virta, A | 1 |
| Hughes, PF; Khurranna, A; Kumar, RM | 1 |
| Gerberding, JL | 3 |
| Frame, PT; Greenberg, KA; Pesce, AJ; Stein, DS; Stretcher, BN | 1 |
| Cameron, DW; Gallicano, K; Garber, G; Ormsby, E; Sahai, J | 1 |
| Diehl, V; Rasokat, H; Scheding, S; Schmitz, SH; Schrappe, M; Voliotis, D | 1 |
| Kishimoto, T; Martínez-Maza, O; Miles, SA; van der Meyden, M; Widney, D; Yawetz, S | 1 |
| Volberding, PD | 1 |
| Cohen, P; Cohen, Y; Guillevin, L; Jarrousse, B; Lortholary, O; Zeller, V | 1 |
| Dobson, PM; Malcolm, JA; Sutherland, DC | 1 |
| Ehrhardt, AA; Gorman, JM; Marder, K; Mayeux, R; Richards, M; Sano, M; Stein, Z; Stern, Y; Tang, MX; Todak, G | 1 |
| Gazzard, BG; Moyle, GJ; Nelson, MR | 1 |
| Chandiok, S; Higgins, S; Woolley, PD | 1 |
| Bartlett, JG; Collins, D; Deykin, D; Feorino, P; Gail, M; Hamilton, JD; Hartigan, PM; Redfield, R; Roberts, R; Simberkoff, MS | 1 |
| Kundu, SK; Merigan, TC; Montoya, JG; Schwartz, DH; Wood, R | 1 |
| Holodniy, M; Katzenstein, D; Kozal, M; Merigan, TC; Montoya, J; Ragni, M; Shafer, R; Winters, M | 1 |
| Bush, CE; Donovan, RM; Markowitz, N; Saravolatz, LD; Smereck, SM; Strang, D | 1 |
| Choi, S; Lagakos, SW; Schooley, RT; Volberding, PA | 1 |
| Collins, R; Peto, R | 1 |
| Saah, AJ | 1 |
| Fischl, MA; Follansbee, SE; Frame, PT; Henry, DH; Lalezari, JP; Lieberman, J; Lin, AH; Nauss-Karol, C; Olson, RM; Remick, SC; Salgo, MP; Soo, W | 1 |
| Beaulieu, R; Thomas, R; Tsoukas, C; Wainberg, MA | 1 |
| Johnstone, IF; Katzenstein, DA; Kozal, MJ; Lipil, WH; Merigan, TC; Shafer, RW | 1 |
| Morse, GD; O'Donnell, AM; Shelton, MJ | 1 |
| Church, D; De Boer Visser, N; Gill, MJ; Macnab, KA; Sutherland, LR | 1 |
| Boswell, RN; Dolan, MJ; Hendrix, CW; Lucey, DR; Melcher, GP; Spencer, GA | 1 |
| Gazzard, BG | 2 |
| Danner, SA | 2 |
| Lagakos, S; Pettinelli, C; Stein, D | 1 |
| Green, G | 1 |
| Helbert, M; L'age Stehr, J; Mitchison, NA; Schwarz, S | 1 |
| Broder, S; Jaffe, ES; Karp, JE; Lietzau, J; Nelson, DL; Pluda, JM; Tosato, G; Venzon, DJ; Wyvill, K; Yarchoan, R | 1 |
| Cal, SX; Haslund, I; Jockusch, JD; Loss, SD; Nightingale, SD; Peterson, DM | 1 |
| Clarke, JR; Fleming, J; Mitchell, DM; Nukuna, A; Taylor, IK; Williamson, JD | 1 |
| Easterbrook, PJ; Emami, J; Gazzard, BG; Moyle, G | 1 |
| Bruun, JN; Clumeck, N; Cooper, DA; Gatell, JM; Goebel, FD; González-Lahoz, J; Kroon, S; Melville, RL; Millard, J; Stingl, G | 1 |
| Clark, WS; Karon, JM; Longini, IM | 1 |
| McCarthy, M | 1 |
| Fischl, MA; Lin, DY; Schoenfeld, DA | 1 |
| Clemens, J; Colman, N; Jacobson, JM; Marlin, L; Mills, JL; Ostrow, NA; Prince, AM; Rao, M; Simson, RW; Tomesch, D | 1 |
| Berkefeld, I; Fuchs, A; Wahn, V | 1 |
| Coutinho, RA; Koot, M; Lange, JM; Miedema, F; Mulder, JW; Roos, MT; Schellekens, PT; Tersmette, M | 1 |
| Finkelstein, DM; Richman, DD; Schoenfeld, DA | 1 |
| Bek, B; Burkowitz, J; Koch, J; Koch, MA; Schwartländer, B; Skarabis, H | 1 |
| Allendorf, A; Ehrenforth, S; Funk, M; Güngör, T; Hofmann, D; Kornhuber, B; Kreuz, W; Kynast, I; Linde, R; Lotz, C | 1 |
| Bethel, J; Flyer, P; Mofenson, LM; Moye, J; Nugent, R | 1 |
| Carausu, S; Coman, G; Cooper, D; Jipa, G; Lawrence, RM; Leibovitz, E; Orlow, SJ; Petrea, S | 1 |
| Saag, MS | 2 |
| Stoller, J | 1 |
| Chariot, P; Gherardi, R; Ruet, E | 1 |
| Cotton, P | 3 |
| Toeller, V | 1 |
| Craven, DE; Jarek, C; Steger, KA | 1 |
| Arduino, JM; Balfour, HH; Beckett, LA; Coombs, RW; DeGruttola, V; Fischl, MA; Hollinger, FB; Rasheed, S; Volberding, P | 1 |
| Bergé, P; Mildvan, D; Salgo, M; St Clair, M; Starrett, S | 1 |
| Fauci, AS; Schnittman, SM | 1 |
| Kellam, P; Larder, BA | 1 |
| Blanes, N; Coutellier, A; Fenouillet, E; Gluckman, JC | 1 |
| Maddox, J | 3 |
| Baumgarten, R | 2 |
| Chariot, P; Chousterman, M; Dubreuil-Lemaire, ML; Gherardi, R; Lefaucheur, JP; Monnet, I; Mouchet, M; Rohr, M | 1 |
| Back, DJ; Barry, M; Beeching, N; Breckenridge, AM; Howe, JL; Nye, F; Swart, AM; Weller, IV | 1 |
| Roberts, J | 1 |
| Brouwers, P; Hersh, S; Moss, HA; Pizzo, PA; Wiener, L; Wolters, PL | 1 |
| Brouwers, P; Moss, HA; Pizzo, PA; Wolters, PL | 1 |
| Phair, JP | 1 |
| Dalakas, MC | 1 |
| Albert, J; Angarano, G; Fiore, J; Uhlén, M; Wahlberg, J | 1 |
| Volberding, PA | 1 |
| Cameron, DW; Gallicano, K; Pakuts, A; Sahai, J | 1 |
| Alexander, D; Brandt, AM; Gostin, LO; Lazzarini, Z; Mayer, KH; Silverman, DC | 1 |
| Hall, ET; Kuchta, RD; Melançon, P; Yan, JP | 1 |
| Cinatl, J; Doerr, HW; Kornhuber, B; Mainke, M; Rabenau, H; Weber, B; Weissflog, A | 1 |
| Broers, B; Hirschel, B; Morabia, A | 1 |
| Gold, J; Jeffords, K; Ross, MW | 1 |
| Altman, DG; Cuzick, J; Peto, J | 1 |
| Newell, ML; Peckham, CS | 1 |
| Boucher, CA; de Jong, MD; Hall, D; Imrie, A; Kauffmann, RH; Koster, R; Loewenthal, M; Schipper, P; van der Ende, I; Weigel, HM | 1 |
| Armbrecht, C; Hengels, KJ; Jablonowski, H; Manegold, C; Mauss, S; Szelenyi, H | 1 |
| Allen, P; Cabanillas, F; Hagemeister, FB; Khetan, R; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F | 1 |
| Luzier, A; Morse, GD | 1 |
| Drusano, GL | 1 |
| Chaisson, RE; Glesby, MJ; Moore, RD | 1 |
| Kahn, JO; Liou, SH; Richardson, D | 1 |
| Adler-Storthz, K; Eversole, LR; Ficarra, G; Flaitz, CM; Gaglioti, D; Milo, D; Piluso, S | 1 |
| Niu, MT; Schnittman, SM; Stein, DS | 1 |
| Dubin, DT; Edlin, BR; Fitzgibbon, JE; Frenkel, LD; Gaur, S; Laraque, F | 1 |
| Phillips, AN; Sabin, CA | 1 |
| Fish, DN | 1 |
| Avramis, VI; Gomperts, E; Kwock, R; Solorzano, MM | 1 |
| Dawson, SC; Landsman, D; Lane, HC; Salzman, NP; Zhang, YM | 1 |
| Meyers, A; Rand, TH | 1 |
| Cowper, P; Feussner, JR; Hamilton, JD; Hartigan, P; Matchar, DB; Oddone, EZ; Samsa, G; Simberkoff, M | 1 |
| Becker, NG; Motika, M | 1 |
| Atwood, WJ; Berger, JR; Kaderman, R; Major, EO; Tornatore, CS | 1 |
| Hellinger, FJ | 1 |
| Yamada, K | 2 |
| Kageyama, S; Kurimura, T | 1 |
| Takamatsu, J | 2 |
| Mayaud, C | 1 |
| Alemán-Hoey, DD; Mercado-Díaz, L; Ruiz-Argüelles, GJ | 1 |
| Carruthers, A; Hsu, B; Kiene, K; Rowe, D | 1 |
| Lane, RJ; McLean, KA; Moss, J; Woodrow, DF | 1 |
| Beijnen, JH; Bult, A; Burger, DM; Koks, CH; Kraaijeveld, CL; Meenhorst, PL; Mulder, JW | 1 |
| Ayehunie, S; Johansson, B; Julander, I; Sönnerburg, A | 1 |
| Gøtzsche, P | 1 |
| Duesberg, P | 1 |
| Nusbaum, NJ | 2 |
| Felgenhauer, K; Gerhards, J; Lüer, W; Poser, S; Weber, T | 1 |
| Sacks, HS | 1 |
| Dalakas, M | 1 |
| Casademont, J; Grau, JM | 1 |
| Kieburtz, K | 1 |
| Chariot, P; Gherardi, R | 1 |
| Agut, H; Fillet, AM; Huraux, JM | 1 |
| Pocidalo, JJ; Sinet, M | 1 |
| Baranowski, E; Kaulen, P; Pham, DT; Wollensak, J | 1 |
| Alba, L; Grisetti, S; Guarascio, P; Narciso, P; Sette, P; Struglia, C; Tossini, G; Tozzi, V; Visco, G | 1 |
| Imai, M; Ito, A; Kondo, M; Nagao, T; Saito, T | 1 |
| Andrews, JC; Hamilton, JD; Hartigan, PM; Simberkoff, MS; St Clair, MH; Vavro, CL | 1 |
| Goldsmith, MF | 1 |
| Algra, PR; de Gans, J; Derix, MM; Enting, RH; Goudsmit, J; Lange, JM; Portegies, P | 1 |
| Elkins, MM; Hollander, H; Lifson, AR; O'Malley, PM | 1 |
| Berninger, T; Bogner, JR; Geier, SA; Goebel, FD; Held, M; Klauss, V; Kronawitter, U | 1 |
| Macilwain, C | 1 |
| Wong, RJ | 1 |
| Gøtzsche, PC | 2 |
| Berman, SM | 1 |
| Hirschel, B; Pechère, M; Samii, K | 1 |
| Pollack, S; Weaver, J | 1 |
| Bryson, YJ; Geffner, ME; Israele, V; Landaw, EM; Scott, ML; Stiehm, ER; Yeh, DY | 1 |
| Dong, BJ; Goldschmidt, RH | 1 |
| Kaldor, JM; Kopec-Schrader, E; Learmont, J; Tindall, B; Wylie, B | 1 |
| Bálint Gábor, S | 1 |
| Abramovici, M; Mattana, J; Singhal, PC | 1 |
| Cooper, DA; Sindhusake, D; Stewart, GJ; Yeung, SC | 1 |
| de Graeff-Meeder, ER; Prakken, AB; Scherpbier, HJ; van den Berg, H | 1 |
| Büyükbabani, N; Chauveau, D; Diouf, B; Droz, D; Durrbach, A; Trawalé, JM; Viard, JP; Vittecoq, D | 1 |
| Clumeck, N; Hermans, P; Sprecher, S | 1 |
| Douard, D; Fleury, HJ; Lemoigne, E; Masquelier, B; Pellegrin, I; Sandler, B | 1 |
| Back, D; Barry, M; Beeching, NJ; Breckenridge, A; Brettle, R; Howe, J; Mitchell, R; Nye, FJ | 1 |
| Roberts, JC | 1 |
| Chi, S; Fahy-Chandon, B; Singer, EJ; Syndulko, K; Tourtellotte, WW; Zorilla, C | 1 |
| Boutin, P; Collier, AC; Coombs, RW; Corey, L; Davis, LG; Fischl, MA; Henrard, DR; Hooper, CJ; Kaplan, LD; Northfelt, D; Skolnik, PR; Volberding, PA; Weller, S | 1 |
| Carr, A; Penny, R | 1 |
| Lang, W; Moss, A; Osmond, D; Page-Bodkin, K; Winkelstein, W | 1 |
| Bucher, GG | 1 |
| D'Aquila, RT; Hirsch, MS | 1 |
| Bandea, CI; Bell, DM; Culver, DH; Marcus, R; McKibben, PS; Schable, CA; Tokars, JI | 1 |
| Goebel, FD | 2 |
| Costigliola, P; Degrassi, A; Facchini, A; Lisignoli, G; Monaco, MC; Ricchi, E; Toneguzzi, S | 1 |
| Cameron, DW; Gallicano, K; McGilveray, I; Ormsby, E; Pakuts, A; Sahai, J | 1 |
| Cvetkovich, TA; Frenkel, LM | 1 |
| Blaschke, T; Bubp, J; Israelski, D; Merigan, T; Mole, L; O'Hanley, P | 1 |
| Coulaud, JP; Hénin, Y; Henrion, R; Mandelbrot, L; Montagnier, L; Pradinaud, R | 1 |
| Penny, R | 1 |
| Furtado, MR; Murphy, R; Wolinsky, SM | 1 |
| Boucher, FD; Crain, MJ; Elkins, MM; McKinney, R; Mirochnick, M; Modlin, JF; Pelton, S; Ruff, A; Weller, S; Wilfert, C | 1 |
| Cameron, P; Cohn, Z; Kaplan, G; Meyn, P; Montana, A; Smith, K; Teppler, H | 1 |
| Burrell, C; Kok, T; Li, P | 1 |
| Allan, JD; Beltangady, M; Cooley, TP; Dolin, R; McLaren, C; Nicaise, C; Rozencweig, M; Seidlin, M; Smaldone, LF; Yarchoan, R | 1 |
| Allan, JD; Canetta, R; Connolly, KJ; Fitch, H; Groopman, JE; Jackson-Pope, L; McLaren, C | 1 |
| Kaldor, J | 1 |
| Gross, ME; Kline, MW; Smith, EO | 1 |
| Confalonieri, F; Villa, A | 1 |
| Daniel, V; Opelz, G; Weimer, R; Zimmermann, R; Zipperle, S | 1 |
| Berod, T; Simon, P | 1 |
| Cremoni, L; D'Amico, P; Grassi, MG; Milazzo, F; Vaira, LL | 1 |
| Carr, A; Cooper, DA; Goldstein, D; Penny, R; Tindall, B | 1 |
| Demonty, J | 1 |
| Wray, L | 1 |
| Amenta, PS; Bharucha, N; Cappell, MS; Dadhania, J; Gaur, S; Lupski, D; Mascarhenas, M; Rosenthal, S | 1 |
| Robinson, EN | 1 |
| Pomeroy, C | 1 |
| Canessa, A; Ciravegna, B; Cirillo, C; De Maria, A; Ferrazin, A; Gotta, C; Mazzarello, G; Melica, F; Terragna, A | 1 |
| Balfour, HH; Erice, A; Henry, K; Mayers, DL; McCutchan, FE; Sannerud, KJ; Strike, DG | 1 |
| Soeiro, R | 1 |
| Halloran, J | 1 |
| Toltzis, P | 1 |
| Dickson, D; Macilwain, C | 1 |
| Montaner, JS; Nagai, K; O'Shaughnessy, M; Raboud, JM; Ruedy, J; Salomon, H; Schechter, MT; Singer, J; Spira, B; Tsoukas, C | 1 |
| Caggese, L; Cinque, P; Coen, M; di Luzio Paparatti, U; Gafa, S; Landonio, G; Lazzarin, A; Nosari, A; Rizzo, F; Tirelli, U | 1 |
| Dervenoulas, JG; Gogas, HJ; Lazanas, MC; Megalou, AA; Raptis, SA | 1 |
| Freiman, JP; Hamrell, MR; Helfert, KE; Stein, DS | 1 |
| Bartocci, C; Buffarini, F; Butini, L; Danieli, G; Montroni, M; Regnery, C; Silvestri, G | 1 |
| Arya, OP; Brown, R; Davis, A; Hind, CR; Saltissi, S; Valentine, C; Williams, O | 1 |
| Houweling, H | 1 |
| Abitbol, C; Montane, B; Pardo, V; Strauss, J; Zilleruelo, G | 1 |
| Boué, F; Bouvet, E; Certain, A; Gaudebout, C; Girard, PM; Jelazko, P; Landman, R; Olivares, R; Saimot, AG | 1 |
| Atkinson, JH; Bozzette, SA; Brysk, LM; Grant, I; Hardy, WD; Mathews, WC; McCutchan, JA; Rubin, HR; Spector, SA; Wu, AW | 1 |
| Sattler, L | 1 |
| Furrer, H; von Overbeck, J; Weiss, D | 1 |
| Gerberding, J | 1 |
| Cavagnolo, G; Deambrogio, V; Fruttaldo, L; Gatti, G; Mongiò, F; Schettino, G | 1 |
| Broyard, A; Brun-Vézinet, F; Jacqz-Aigrain, E; Rahimy, C; Vilmer, E | 1 |
| Ballester, OF; Edwards, TB; Lockey, RF; Nelson, RP; Saba, HI | 1 |
| Beijnen, JH; Burger, DM; Koks, CH; Meenhorst, PL | 1 |
| Dancis, J; Lee, JD; Liebes, L; Mendoza, S | 1 |
| Campbell, S; Chung, J; Colón, E; Melroe, NH; Reaney, S; Rhame, FS; Robiner, WN | 1 |
| Nicolosi, A | 1 |
| Marion, SA; Schechter, MT | 1 |
| Howard, EJ; Naides, SJ; Stapleton, JT; Swack, NS; True, CA | 1 |
| Alcaraz, JE; Atkinson, JH; Grant, I; Gulevich, S; Hsia, K; Lathey, J; McCutchan, JA; Pratt, D; Spector, SA; Wallace, M | 1 |
| Cosnes, J; Melchior, JC | 1 |
| Boucher, CA; Châteauvert, M; Dowd, P; Fernández-Cruz, E; Frissen, J; Furner, V; Lang, JM; Stevens, J | 1 |
| Boucher, CA; Cornelissen, M; Coutinho, RA; Goudsmit, J; Schuitemaker, H; Schuurman, R; van't Wout, AB; Veenstra, J | 1 |
| Fischl, M; Gundacker, H; Hughes, M; Jacobson, MA; Volberding, P | 1 |
| Dunn, D; Newell, ML; Peckham, C; Thorne, C | 1 |
| Benowitz, NB; Coleman, R; Delahunty, T; Harb, GE; Jacobson, MA; Mandema, JW; Sheiner, LB | 1 |
| Bartos, L; DeRemer, M; Ho, M; Morse, GD; Ragni, M; Shelton, MJ | 1 |
| Cooper, DA; Emery, S | 1 |
| Baldeweg, T; Burgess, A; Catalan, J; Catt, S; Gruzelier, J; Hawkins, D; Irving, G; Riccio, M; Stygall, J | 1 |
| Feinstein, R; Godfrey, E; Morgello, S; Simpson, DM; Tagliati, M; Wolfe, D | 1 |
| Asare, E; Dunn, G; Everall, I; Glass, J; Lantos, P; Luthert, P; McArthur, J | 1 |
| Muma, RD; Parcel, GS; Pollard, RB; Ross, MW | 1 |
| Endert, E; Godfried, MH; Lange, JM; Mulder, JW; Sauerwein, HP; van der Poll, T; Weverling, GJ | 1 |
| Avramis, VI; Kwock, R; Liu, X; Solorzano, MM; Wu, S | 1 |
| Buchbinder, SP; Chang, SW; Doll, LS; Hessol, NA; Katz, MH; O'Malley, P | 1 |
| Chambers, HF; Goldstein, D; Lee, BL; Sadler, B; Täuber, MG | 1 |
| Cooper, ER; Diaz, C; Handelsman, E; Kalish, LA; Moye, J; Pitt, J; Rich, KC; Sheon, AR | 1 |
| Chesebro, B; Iversen, AK; Merigan, TC; Mullins, JI; Shafer, RW; Wehrly, K; Winters, MA | 1 |
| Benoit, S; Esinhart, J; Hamilton, JD; Hartigan, PM; Hill, A; Martin, D; O'Brien, WA; Rubin, M; Simberkoff, MS | 1 |
| Bucher, HC; Griffith, L | 1 |
| Costagliola, D; Mary-Krause, M | 1 |
| Auten, J; Bonyhadi, ML; Kaneshima, H; McCune, JM; Su, L | 1 |
| Fotiades, J; Jiang, SB; Lim, HW; Moy, J; Sanchez, M; Soter, NA | 1 |
| Creus, L; Fuentes, CG; Salleras, M; Sánchez-Regaña, M; Umbert, P | 1 |
| Cañas, P; Casado, JL; Pérez-Molina, JA | 1 |
| Day, PL; Diamond, GR; Dickinson, GM; Drusano, GL; Egorin, MJ; George, WL; Gordin, FM; Hamilton, JD; Hartigan, PM; Hawkes, CA; Jensen, PC; Kilmas, NG; Labriola, AM; O'Brien, WA; Oster, CN; Pazner, SB; Simberkoff, MS; Weinhold, KJ; Wray, NP | 1 |
| Davis, S; Fleming, PL; Lindegren, ML; Sweeney, PA; Wortley, PM | 1 |
| Aloisi, MS; D'Ubaldo, C; De Santis, MT; Girardi, E; Ippolito, G; Puro, V; Romano, S | 1 |
| Bissuel, F; Cotte, L; Leriche, K; Rougier, P; Schlienger, I; Trabaud, MA; Trepo, C | 1 |
| Back, DJ; Barry, MG; Breckenridge, AM | 1 |
| Bradbeer, CS; Griffin, GE; Lau, R; O'Farrell, N; Pozniak, AL; Yoganathan, K | 1 |
| Boyer, E; Eastman, PS; Holodniy, M; Kolberg, J; Mole, L; Urdea, M | 1 |
| Graham, NM; Hoover, DR; Park, LP; Saah, AJ; Stein, DS | 1 |
| Ugen, KE | 1 |
| Andrews, W; Madhavankutty, K; Shyamasundar, K | 1 |
| Barker, E; Elbeik, T; Guthrie, J; Levy, JA; Ramachandran, B | 1 |
| Comber, E; Kaye, S; Loveday, C; Tenant-Flowers, M | 1 |
| Hui, F; Kavlick, MF; Kojima, E; Mitsuya, H; Pluda, JM; Shirasaka, T; Yarchoan, R | 1 |
| Caraballo, E; Cotton, DJ; Davis, RB; Makadon, HJ; Rind, DM; Rippel, K; Rury, C; Safran, C; Sands, DZ; Wang, Q | 1 |
| Brouwer, KL; Cheeseman, SH; Eyster, E; Lemon, SM; Moore, KH; Opheim, K; Raasch, RH; van der Horst, CM | 1 |
| Balfour, HH; Fletcher, CV; Henry, WK; Noormohamed, SE; Rhame, FS | 1 |
| Boyer, PJ; Bryson, YJ; Deveikis, A; Dickover, RE; Garratty, EM; Herman, SA; Keller, M; Plaeger, S; Sim, MS; Stiehm, ER | 1 |
| Larder, BA | 1 |
| Jablonowski, H | 1 |
| Staszewski, S | 2 |
| Lavelle, JP; Li, R; Narang, PK; Trapnell, CB | 1 |
| Baruch, A; Bassett, RL; Collier, AC; Coombs, RW; Corey, L; Facey, K; Friedman, HM; Hooper, C; Jones, M; McAuliffe, VJ; Merigan, TC; Reichman, RC; Schoenfeld, DA; Timpone, J; Whitacre, C | 1 |
| Katzenstein, DA; Kundu, SK; Merigan, TC; Ramachandran, R; Winters, MA | 1 |
| Bartlett, JA; Bilello, J; Cohen, OJ; Cohn, J; Fauci, AS; Fox, CH; Graziosi, C; Holodniy, M; Lalezari, J; McMahon, D; Niu, M; Novak, R; Orenstein, JM; Pantaleo, G; Pavlakis, GN; Schnittman, S; Steigbigel, RT | 1 |
| de Martino, M; Donati, MA; Filippi, L; Galli, L; Mannelli, F; Vierucci, A; Zammarchi, E | 1 |
| Bernard, N; Bonot, P; Fleury, HJ; Legrand, E; Masquelier, B; Neau, D; Pellegrin, I; Pellegrin, JL; Ragnaud, JM | 1 |
| Adams, O; Jablonowski, H; Mauss, S; Willers, R | 1 |
| Brew, BJ; Currie, JN; McArthur, JC; Wright, EJ | 1 |
| Acosta, EP; Henry, K; Jochimsen, E | 1 |
| Patil, P; Shenoy, V | 1 |
| Kocurek, K | 1 |
| Adimora, AA; Fiscus, SA; Kenny, J; Lim, W; McKinney, R; Rupar, D; Schoenbach, VJ; Wilfert, C; Woods, C | 1 |
| Crane, M; Harris, A; Lambert, G; Sansary, J; Solomon, L; Wiznia, AA | 1 |
| Rogers, M; Simonds, RJ | 1 |
| Ecker, JL | 1 |
| Montaner, JS; Raboud, JM; Schechter, MT; Singer, J; Thorne, A | 1 |
| Cotton, D; Dolin, R; Feinberg, J; Finkelstein, DM; Kahn, J; Molenberghs, G; Powderly, WG; Williams, PL | 1 |
| Brown, AJ; Cleland, A; Ludlam, CA; Robertson, P; Watson, HG | 1 |
| Ait-Cheik, L; Atoui, N; Berthier, A; Carrière, D; Fontaine, C; Gros, P; Huguet, M; Jansen, A; Pau, B; Reynes, J; Salhi, SL; Vendrell, J | 1 |
| Borkowsky, W; Brady, MT; Brouwers, P; Bryson, YJ; Elkins, MM; Fikrig, S; Fowler, MG; Gelber, R; Hutton, N; Jimenez, E; McGrath, N; McIntosh, K; McSherry, G; Mitchell, CD; Rubinstein, A; Weintrub, PS; Wilfert, CM; Yogev, R | 1 |
| Chee, Y; Dorman, K; Erickson, JW; Kaplan, AH; Lazzeroni, LC; Lech, WJ; McCrae, D; Sinsheimer, JS; Wang, G; Yang, YL | 1 |
| Chambers, DE; Cooper, DA; Crowe, S | 1 |
| Coombs, R; De Gruttola, V; Fleming, T | 1 |
| Scura, KW; Whipple, B | 1 |
| Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J | 1 |
| Brunet, C; Conciatori, M; Courcoul, M; Dhiver, C; George, F; Guillemain, C; Horschowski, N; Sampol, J; Spire, B | 1 |
| Chaisson, RE; Keruly, JC; Moore, RD | 3 |
| Arza, B; Barceló, MJ; Cadafalch, J; García-Die, F; Parellada, MM; Remacha, A | 1 |
| Younai, FS | 1 |
| Cameron, DW; Gallicano, K; Pakuts, A; Sahai, J; Seguin, I; Swick, L | 1 |
| Besley, D; Graham, NM; Jacobson, LP; Muñoz, A; Murphy, R; Park, LP; Zucconi, S | 1 |
| Cooper, DA; Harrigan, PR; Kinghorn, I; Lange, JM; Larder, BA; Lavelle, J; Lefkowitz, L; McKinnis, R; Moore, M; Mulder, JW; Pennington, KN; Ramirez-Ronda, C; Rooney, JF; Schooley, RT; St Clair, M; Steel, H | 1 |
| Auquier, P; Hairion, D; Macquart-Moulin, G; Manuel, C | 1 |
| Weller, IV; Williams, I | 1 |
| Danner, SA; Dellarnonica, P; Harrigan, PR; Hill, AM; Johnson, MA; Loveday, C; McDade, H; Picazo, JJ; Skinhøj, P; Staszewski, S; Verity, L | 1 |
| Clumeck, N; Hill, AM; Ingrand, D; Johnson, M; Katlama, C; Loveday, C; Mallolas, J; McDade, H; Pearce, G; Staszewski, S | 1 |
| Mauskopf, JA; Paul, JE; Tilson, HH; White, AD; Wichman, DS | 1 |
| Haddix, AC; Hu, DJ; Mansergh, G; Nieburg, PI; Rogers, M; Simonds, RJ; Steketee, RW | 1 |
| Detels, RR; Hoover, DR; Peng, Y; Phair, JP; Rinaldo, CR; Saah, A; Semba, R | 1 |
| Ballester Belda, E; de Lelis, FP; Gil Egea, M; Herrera Ballester, A; López de Medrano, V; Martín Herrera, A; Ortega González, E; Ronda Gasulla, FA | 1 |
| Belgado, BS; Hogan, TT | 1 |
| Galli, M; Gervasoni, C; Lovicu, GF; Lupo, A; Moroni, M; Musicco, M; Niero, F; Radice, D; Ridolfo, AL; Riva, A; Rusconi, S; Voltolin, L | 1 |
| Cleator, GM; Lucas, GS; Mani, GS; Stoddart, RW; Vallely, PJ | 1 |
| Coutinho, RA; de Ronde, A; de Rooij, ER; Goudsmit, J | 1 |
| Chou, TC; Polsky, B; Scarborough, A; Zhu, QY | 1 |
| Cabarcos, A; Martinez-Vazquez, JM | 1 |
| Arseneau, R; Gill, J; McLean, BD; Montaner, JS; Raboud, J; Ruedy, J; Schechter, MT; Singer, J | 1 |
| Chaisson, RE; Fortgang, I; Keruly, J; Moore, RD | 1 |
| Bartlett, JA; Benoit, SL; Ehmann, WC; Fallon, MA; Johnson, VA; Quinn, JB; Rubin, M; Self, PL; Sepulveda, GE; Tsoukas, C | 1 |
| Kimura, S | 2 |
| Ciraru-Vigneron, N | 1 |
| de Mendonça, JS | 1 |
| Rosenthal, C | 1 |
| Kovacs, A; Li, Z; Rasheed, S; Xu, D | 1 |
| Arredondo-Garcia, JL; Flores-Rivera, E; Gorbea-Robles, MC; Paredes-Vivas, Y; Villegas-Castrejon, H | 1 |
| Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C | 1 |
| Jellinger, RM; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Fernández González, F; Moreno García, M | 1 |
| Goldschmidt, RH; Moy, A | 1 |
| Cohn, SE; Klein, JD | 1 |
| Sherer, R | 1 |
| Kirschner, D; Webb, GF | 1 |
| Chaturachinda, K; Khupulsup, K; Kunakorn, M; Phuapradit, W; Raksakait, K; Taneepanichskul, S | 1 |
| Emini, EA | 1 |
| Childress, JF; DeMets, DL; Ellenberg, SS; Fleming, TR; Foulkes, M; Mayer, KH; O'Fallon, J; Pollard, RB; Rahal, JJ; Whitley, RJ | 1 |
| Andreoni, M; Duncan, I; Ercoli, L; Galluzzo, C; Giannini, G; Jacobsen, H; Pirillo, MF; Sarmati, L; Vella, S | 1 |
| Baruch, A; Bassett, R; Collier, AC; Coombs, RW; Corey, L; Schoenfeld, DA | 1 |
| Pollard, RB | 1 |
| Sneller, MC | 1 |
| De Lamballerie, X; Dhiver, C; Gallian, P; Lehucher, MP; Ravaux, I | 1 |
| Ahmed, PS; Brennan, TM; Bridges, CG; Casara, P; Hornsperger, JM; Navé, JF; Taylor, DL; Tyms, AS | 1 |
| Bilello, JA; Bilello, PA; Drusano, GL; Prichard, M | 1 |
| Andries, K; De Brabander, M; De Crée, J; De Raeymaeker, M; Miller, V; Moeremans, M; Pearce, G; Peeters, M; Rehmet, S; Stark, T; Staszewski, S; Stoffels, P; Van den Broeck, R; Verbiest, W | 1 |
| Davidian, M; Hafner, R; Jacobson, JM; Luft, BJ; Raasch, RH; Rainey, PM | 1 |
| Bird, AG; Brettle, RP; Burns, S; Gore, SM; Leen, CS; MacCallum, L; McNeil, AJ; Richardson, AM; Yap, PL | 1 |
| Mofenson, LM | 4 |
| Cundy, KC; Fisher, PE; Jaffe, HS; Lietman, PS; Pastelak, A; Petty, BG; Wachsman, M | 1 |
| Abraham, T; Nusbaum, NJ | 1 |
| Authier, FJ; Chariot, P; Gherardi, R; Labes, D; Le Maguet, F; Poron, F | 1 |
| Authier, FJ; Chariot, P; Gherardi, R | 2 |
| Blanc, B; Boubli, L; Bretelle, F; Cravello, L; d'Ercole, C; Piechon, L; Sperandeo, D | 1 |
| Endert, E; Frissen, PH; Jansen, J; Lange, JM; Sauerwein, HP; Weverling, GJ | 1 |
| Boulton, A | 2 |
| Aaronson, NK; De Boer, JB; Lange, JM; Sprangers, MA; van Dam, FS | 1 |
| De Ronde, A; Goudsmit, J; Ho, DD; Perelson, AS | 1 |
| Flynn, PM; Fridland, A; Robbins, B; Rodman, JH | 1 |
| Back, D; Barry, M; Hoggard, P; Khoo, S | 1 |
| Acosta, EP; Fletcher, CV; Henry, K; Schwebke, K | 1 |
| Ross, EL | 1 |
| Vella, S | 2 |
| Bruun, L; Gerstoft, J; Mathiesen, LR; Nielsen, C; Pedersen, C | 1 |
| Boucher, CA; Carr, A; Cooper, DA; de Jong, MD; Imrie, A; Sorice, F; Vella, S | 1 |
| Leal, M; Lissen, E; Medrano, FJ; Rey, C; Sánchez-Quijano, A; Torres, Y | 1 |
| Dimitrov, D; Erice, A; Frenkel, LM; Iversen, A; Japour, AJ; Kuritzkes, DR; Mayers, DL; Pena, F; Reichelderfer, PS; Sannerud, KJ; Shafer, RW; Weislow, OS; White, F; Winters, MA | 1 |
| André, E; Bez, G; Bourdillon, F; Delfraissy, JF; Nadal, JM | 1 |
| Amatea, MA; Bechtel, C; Kovacs, JA; Metcalf, JA; Piscitelli, SC; Vogel, S | 1 |
| Cañas, E; Castillo, JR; Cisneros, JM; Garcia-Pesquera, F; Jimenez-Mejias, ME; Pachon, J; Viciana, P | 1 |
| Bélec, L; Chrétien, F; de Truchis, P; Dubreuil-Lemaire, ML; Gray, F; Levy, Y | 1 |
| Lee, CA | 2 |
| Anderson, B; Farley, M; Fox, C; Luzuriaga, K; Mueller, BU; Pizzo, PA; Schwartzentruber, DJ; Sei, S; Sullivan, JL; Tudor-Williams, G; Venzon, DJ | 1 |
| Baba, M; Fujiwara, M; Ijichi, K; Konno, K; Shigeta, S; Yokota, T | 1 |
| Flynn, PM; Holden, WT; Srinivas, RV; Su, T | 1 |
| Costes, O; Djediouane, A; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C | 1 |
| Johnson, MA; Phillips, AN; Smith, GD | 1 |
| Willocks, L | 1 |
| Chatis, PA; Crumpacker, CS; Dogon, AL; Mayers, DL; McCutchan, FE; Page, C; Sharma, PL | 1 |
| Boyle, J; Chaitt, DG; Coleman, S; Cox, SR; Daenzer, CL; Davey, RT; Eastman, PS; Falloon, J; Freimuth, WW; Herpin, BR; Kovacs, JA; Lane, HC; Masur, H; Metcalf, JA; Polis, MA; Reed, GF; Walker, RE; Wathen, L | 1 |
| Gundacker, H; Hammer, SM; Haubrich, RH; Henry, WK; Hirsch, MS; Hughes, MD; Katzenstein, DA; Lederman, MM; Merigan, TC; Niu, M; Phair, JP; Schooley, RT | 1 |
| Elbeik, T; Fiscus, S; Gundacker, H; Hammer, SM; Hirsch, MS; Hughes, MD; Jackson, JB; Japour, A; Katzenstein, DA; Merigan, TC; Rasheed, S; Reichman, R | 1 |
| Corey, L; Holmes, KK | 1 |
| Gherardi, RK; Lefaucheur, JP; Verroust, J | 1 |
| Skowron, G | 2 |
| Lane, HC; Masur, H; Spooner, KM | 1 |
| Leal, M; Lissen, E; Luque, F; Pino, R; Relimpio, F; Rey, C; Sánchez-Quijano, A; Torres, Y | 1 |
| Coen, DM | 1 |
| Gambertoglio, JG; Peter, K | 2 |
| Baxa, D; Bush, CE; Cohen, F; Donovan, RM; Manzor, O; Moore, E; Saravolatz, LD | 1 |
| Bartlett, JA; Eron, JJ; Hill, AM; Johnson, J; Phillips, AN; Price, S; Rubin, M; Self, P | 1 |
| Crowley, VE; Olukogu, AO | 1 |
| Finelli, E; Perrella, A; Perrella, O; Scalera, G; Scognamiglio, P; Tartaglia, G | 1 |
| Antonelli, G; D'Offizi, G; Dianzani, F; Ferri, F; Narciso, P; Turriziani, O; Verri, A | 1 |
| Sommadossi, JP; Zhou, XJ | 1 |
| Esquivel-Pedraza, L; Ponce de León, S; Ramírez-Amador, VA | 1 |
| Kaiser, R; Matz, B; Rockstroh, J; Schneweis, KE; Wichers, M | 1 |
| Fisher, AC; Goldstein, G; Hirsch, RL; Merigan, TC; Meyerson, LA; Winters, MA | 1 |
| Boucher, C; de Ronde, A; Goudsmit, J; Schuurman, R; van den Hoek, A | 1 |
| Allegri, R; Cadeo, GP; Caruso, A; Comberti, E; Dima, F; Fallacara, F; Foresti, I; Gargiulo, F; Pollara, CP; Savio, ML; Turano, A | 1 |
| Agosti, JM; Bresnahan, J; Gere, J; Hammer, SM; McGrath, J; Pickus, O; Scadden, DT; Stretcher, B | 1 |
| Datema, R; Hincenbergs, M; Linquist, V; McCune, JM; Moreno, MB; Rabin, L; Rosenwirth, B; Seifert, J; Warren, S | 1 |
| Charpiot, B; Datema, R; Hincenbergs, M; Kaneshima, H; Linquist, V; McCune, JM; Moreno, MB; Rabin, L; Seifert, J; Warren, S | 1 |
| Giacchino, R; Lori, F; Maserati, R; Regazzi, MB; Villani, P | 1 |
| Marcus, U | 1 |
| Bakhtiari, M; Benoit, SL; Eron, JJ; Fallon, MA; Griffin, A; Kuritzkes, DR; Poticha, D; Quinn, JB; Rubin, M; Shugarts, DL | 1 |
| Slavkin, HC | 1 |
| Brown, M; Lorenzo, E; Matsuura, S; Scott, G; Scott, W; Smith, L; Unal, A | 1 |
| Carter, WA; Hamill, AK; Klimas, N; Molavi, A; Salvato, PD; Strayer, DR; Thompson, CE; Thompson, KA; Ventura, D; Zheng, Z | 1 |
| Barditch-Crovo, P; Lietman, PS; Trapnell, CB; Wachsman, M | 1 |
| Brown, AJ; Cleland, A | 1 |
| Berning, SE; Brudney, KF; Burman, WJ; Gerena, GT; McGuinness, ME; Miranda-Massari, JR; Nitta, AT; Peloquin, CA | 1 |
| Johnson, GM | 1 |
| Baumberger, C; Hirschel, B; Kinloch-de Loës, S; Pechère, M; Perrin, L; Rakik, A; Yerly, S | 1 |
| Carlo, DJ; Daigle, AE; Ferre, F; Jensen, FC; Levine, A; Moss, RB; Richieri, SP; Salk, J; Trauger, RJ; Truckenbrod, A; Turner, J | 1 |
| Faulds, D; Lea, AP | 1 |
| Anderson, JL; Arnold, E; Birch, C; Deacon, NJ; Gurusinghe, AD; Hooker, DJ; Land, S; Roy, BM; Solomon, AE; Tachedjian, G | 1 |
| Fuchs, D; Gisslen, M; Hagberg, L; Norkrans, G; Svennerholm, B; Wachter, H | 1 |
| Domachowske, JB | 1 |
| Zaretsky, MD | 2 |
| Scott, WF | 1 |
| Blackmore, T; Gordon, D | 1 |
| Cohen, LG; Noormohamed, SE | 1 |
| Hollingshead, MG; Shannon, WM; Westbrook, L; White, EL | 1 |
| Batki, SL; Ferrando, SJ; Sorensen, JL; Wall, TL | 1 |
| Newell, ML; Nicoll, A | 1 |
| Schattner, A | 1 |
| Mörike, EM | 1 |
| Brouwers, P; Farley, M; Lane, JR; Mueller, BU; Pizzo, PA; Robb, ML; Sei, S; Stewart, SK | 1 |
| Brichacek, B; Janoff, EN; Pirruccello, S; Stevenson, M; Swindells, S | 1 |
| Cooper, ER; Diaz, C; Fowler, MG; Hanson, C; Hershow, R; Kalish, LA; Mendez, H; Moye, J; Nugent, RP; Pitt, J; Smeriglio, V; Zorrilla, C | 1 |
| Boucher, CA; Brun-Vezinet, F; Descamps, D; Kaye, S; Loveday, C; Schuurman, R; Tedder, R; Tijnagel, J; van Leeuwen, R; Weverling, GJ; Williams, I | 1 |
| Hartigan, PM; Huang, IW; Rabeneck, L; Souchek, J; Wray, NP | 2 |
| Carr, A; Cooper, DA; Emery, S; Kelleher, A; Law, M | 1 |
| Costa, SJ; Morgan, D; Paul, SM; Ziskin, LZ | 1 |
| Barnes, L; Darby, C; Fogarty, J; Mulcahy, F; Murphy, GM; O'Connor, WJ; O'Moore, R | 1 |
| Coombs, RW; Flynn, PM; Herman, SA; Jimenez, E; McSherry, GD; O'Sullivan, MJ; Rouzioux, C; Shapiro, DE; Sperling, RS; Sullivan, JL; Todd, JA; Van Dyke, RB | 1 |
| Johnstone, FD | 1 |
| Barber, CG; Hogg, R; Montaner, JS; Murphy, C; O'Shaughnessy, M; Phillips, P; Schechter, MT; Srour, LF | 1 |
| Mayers, D | 1 |
| Balagué, M; Cabrera, C; Clotet, B; De Clercq, E; Martínez-Picado, J; Puig, T; Romeu, J; Ruiz, L; Schmit, JC; Segura, A; Sirera, G; Tural, C; Vandamme, AM | 1 |
| Epstein, J; González-Lahoz, J; Heredia, A; Hewlett, I; Mas, A; Soriano, V; Vallejo, A | 1 |
| Iezzi, A; Pizzigallo, E; Sisto, A | 1 |
| Meyer, CN; Nielsen, H | 1 |
| Aubertin, J; Bernard, N; Beylot, J; Chene, G; Grobost, F; Lacoste, D; Mercie, P; Morlat, P; Ragnaud, JM | 1 |
| Acosta, EP; Fletcher, CV; Page, LM | 1 |
| Beijnen, JH; Burger, DM; Hoetelmans, RM; Meenhorst, PL | 1 |
| Jablonowski, H; Philipp, T; Rave, K; Ross, B | 1 |
| Agut, H; Autran, B; Huraux, JM; Katlama, C; Magierowska-Jung, M | 1 |
| Mankertz, J; Matthes, E; Pauli, G; Riedel, E; Rokos, K; von Baeyer, H | 1 |
| Cicognani, M; De Vinci, C; Gritti, F; Guerra, L; Pizza, G; Raise, E; Rocaccio, L; Schiattone, ML; Viza, D | 1 |
| Abadi, J; Beenhouwer, DO; Dobroszycki, J; Lambert, G; Truong, TH; Wiznia, AA | 1 |
| Authier, FJ; Gherardi, RK; Lefaucheur, JP; Verroust, J | 1 |
| Berkhout, B; Boucher, C; Keulen, W; Nijhuis, M; Schuurman, R | 1 |
| Erb, P; Hirschel, B; Kinloch-de-Loes, S; Perrin, L; Rakik, A; Vernazza, P; Yerly, S | 1 |
| Schweiger, A | 1 |
| Carmichael, C | 1 |
| Patrick, DM | 1 |
| Elliott, FS; Linnville, SE | 1 |
| al-Jabri, AA; Levantis, P; Oxford, JS; Stein, CA | 1 |
| Bartlett, J; Eron, J; Gilbert, C; Hill, AM; Johnson, J; Johnson, VA; Keller, A; Kuritzkes, DR; Phillips, AN | 1 |
| Fornairon, S; Idatte, JM; Lesprit, P; Michaut, P; Modaï, J; Nochy, D | 1 |
| Lafeuillade, A; Pellegrino, P; Poggi, C; Profizi, N; Sayada, C | 1 |
| Back, D; Barry, M; Gibbons, S; Merry, C; Mulcahy, F | 1 |
| Eron, JJ | 1 |
| Stephenson, J | 1 |
| Millard, PS | 1 |
| Brambilla, D; Burns, D; Fowler, MG; Hillyer, GV; Landay, A; McIntosh, K; Mendez, H; Pitt, J; Reichelderfer, P | 1 |
| Erice, A; Japour, AJ; Johnson, VA; Marschner, IC; Mayers, DL; Reichelderfer, P; Richman, DD; Smeaton, L | 1 |
| Belohradsky, BH; Eberle, J; Gürtler, L; Notheis, G; Sölder, B; Wintergerst, U | 1 |
| Chirmule, N; Emiliani, S; Herbein, G; Lovett, J; McCloskey, T; Ott, M; Pahwa, S; Van Lint, C; Verdin, E | 1 |
| Mito, RS; Wahlers, M | 1 |
| Berrios, L; Cox, S; Demeter, LM; Dexter, A; Freimuth, W; Gerondelis, P; Meehan, PM; Morse, G; Reichman, RC | 1 |
| Andiman, WA; Shapiro, ED; Simpson, BJ | 1 |
| Antela, A; Parras, F; Podzamczer, D; Ruiz, I | 1 |
| Gatell, JM; Guerra, L; Pérez-Elías, MJ; Santamaría, JM | 1 |
| Aguirrebengoa, K; Mallolas, J; Torres Tortosa, M; Uriz, J | 1 |
| Bascuñana, A; Laguna, F; Ocaña, I; Pulido, F | 1 |
| Baraia, J; Díez, F; Iribarren, JA; Miralles, P | 1 |
| Bouza, E; Miró, JM; Pumarola, T; Soriano, V | 1 |
| Cross, A; Dellamonica, P; Dunkle, L; Gathe, J; Jemsek, JG; Mellors, JW; Murphy, R; Pavia, AT; Spruance, SL; Stool, E | 1 |
| Hagstrom, RM; Turner, DJ | 1 |
| Albrecht, H; Greten, H; Stellbrink, HJ | 1 |
| Bonhoeffer, S; Coffin, JM; Nowak, MA | 1 |
| Augenbraun, M; Minkoff, H | 1 |
| Phillips, AN; Smith, GD | 1 |
| Bartlett, J; Eron, JJ; Hill, AM; Johnson, J; Katlama, C; McDade, H; Sawyer, W; Staszewski, S | 1 |
| Feucht, HH; Helling-Giese, G; Laufs, R; Mattner, UM; Polywka, S; Schartl, W; Zöllner, B | 1 |
| Cohen, MS; Dyer, JR; Eron, JJ; Fiscus, SA; Gilliam, BL; Vernazza, PL | 1 |
| Back, D; Barry, M; Gibbons, S; Mulcahy, F | 1 |
| Gingeras, T; Jellinger, RA; Mamtora, G; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Agrofoglio, L; Bernhard, S; Duchin, KL; Kirk, M; Pan-Zhou, XR; Sommadossi, JP; Squires, K; Zhou, XJ | 1 |
| Wei, LJ; Zackin, R | 1 |
| Gerberding, JL; Katz, MH | 1 |
| Alp, NJ; Morrison, J | 1 |
| Chaudry, MN; Shepp, DH | 1 |
| Hirschel, B; Rutschmann, O | 1 |
| Schmidt, ME | 1 |
| Flum, DR; Wallack, MK | 1 |
| Aiuti, F; Angarano, G; Arlotti, M; d'Arminio Monforte, A; Galli, M; Gritti, F; La Regina, A; Lazzarin, A; Mazzotta, F; Milazzo, F; Moroni, M; Musicco, M; Paga, C; Visco, G | 1 |
| Gates, GA; Longstreth, WT; Marra, CM; Rees, TS; Syapin, CL; Wechkin, HA | 1 |
| Griffy, KG | 1 |
| Izopet, J; Lafeuillade, A; Pellegrino, P; Poggi, C; Tamalet, C; Tourres, C | 1 |
| Hirschel, B; Jenni, R; Joller-Jemelka, HI; Lüthy, R; Opravil, M; Pechère, M; Russi, EW; Speich, R | 1 |
| Burchett, SK; Coombs, RW; Frenkel, LM; Hitti, J; Hughes, JP; Johnson, EJ; King, PD; McLellan, CL; Melvin, AJ; Watts, DH; Williams, BL | 1 |
| Moreno García, M | 1 |
| Heins, JR | 1 |
| Bakshi, SS; Boone, G; Britto, P; Capparelli, E; Fowler, MG; Frank, Y; Jimenez, E; Mofenson, L; Pahwa, SG; Rasheed, S; Salgo, M; Schoenfeld, D; Yogev, R; Zimmer, B | 1 |
| Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C; Tourres, C | 1 |
| Almi, P; Catucci, M; De Milito, A; Gonnelli, A; Occhini, U; Romano, L; Rubino, M; Valensin, PE; Venturi, G; Zazzi, M | 1 |
| al-Mulla, W; Church, D; Gill, MJ | 1 |
| Bryson, Y; Cort, S; Krogstad, P; Lamson, M; Luzuriaga, K; Robinson, J; Stechenberg, B; Sullivan, JL | 1 |
| Agrawal, S; Ali, AN; Byrn, RA; Papp, B; Yamaguchi, K; Zhang, D | 1 |
| Andreoni, M; Ercoli, L; Galluzzo, C; Giannini, G; Nicastri, E; Pirillo, MF; Sarmati, L; Vella, S | 1 |
| Cavert, W; Danner, SA; Gebhard, K; Goudsmit, J; Haase, AT; Henry, K; McDade, H; Mills, R; Notermans, DW; Schuwirth, CM; Staskus, K; Wietgrefe, SW; Zhang, ZQ; Zupancic, M | 1 |
| Ammann, AJ; Cao, Y; Chen, IS; Clapp, S; Ho, DD; Jin, Z; Korber, BT; Koup, RA; Krogstad, P; Macken, C; Muldoon, M; Song, JL; Zhao, JQ | 1 |
| Knight, SC; Patterson, S | 1 |
| Cao, Y; Essunger, P; Ho, DD; Hurley, A; Markowitz, M; Perelson, AS; Saksela, K; Vesanen, M | 1 |
| Belohradsky, BH; Bogner, JR; Goebel, FD; Notheis, G; Rolinski, B; Roscher, AA; Wintergerst, U | 1 |
| Kane, D; Keating, S; McCann, S; Mulcahy, F | 1 |
| Costello, CE; Nelson, MR; Walsh, JC | 1 |
| de Boer, R; de Ronde, A; de Rooij, E; Goudsmit, J | 1 |
| Sherr, L | 1 |
| Ohta, Y; Shinkai, I | 1 |
| Aimi, N; Baba, M; Fujiwara, M; Hanasaki, Y; Ide, T; Ijichi, K; Katsuura, K; Konno, K; Shigeta, S; Takayama, H; Yokota, T | 1 |
| Gibb, D; Novelli, V; Sharland, M; Tudor-Williams, G; Walters, S | 1 |
| Brizzi, M; Ceccherini-Nelli, L; Forastieri, G; Iuliano, R; Mazzotta, F; Mecocci, L | 1 |
| Kurimura, T; Sakamoto, T; Tochikura, A; Tsuchie, H; Wakamiya, N | 1 |
| Bonsel, GJ; Danner, SA; Lange, JM; Reiss, P; van Leeuwen, R | 1 |
| Beveridge, A; Cooper, DA; Genn, W; Imrie, A; Vizzard, J | 1 |
| Delfraissy, JF | 1 |
| Berglund, O; Bruun, JN; Gerstoft, J; Głtzsche, PC; Mathiesen, L; Melander, H; Norrby, SR; Pedersen, C; Skinhłj, P | 1 |
| Abrams, EJ; Baker, CJ; Englund, JA; Fowler, MG; Gershon, A; McKinney, RE; McSherry, GD; Pearson, D; Petrie, B; Raskino, C; Schliozberg, J; Sullivan, JL | 1 |
| DeCherney, AH; Koos, B | 1 |
| Ades, AE; Duong, T; Gibb, DM; Goldberg, DJ; Hudson, CN; MacDonagh, SE; Nicoll, A; Peckham, CS; Tookey, PA | 1 |
| Fantini, J; Lafeuillade, A; Poggi, C; Tamalet, C; Yahi, N | 1 |
| Burrell, CJ; Fan, J; Kok, TW; Li, P | 1 |
| Blanchard, S; Dankner, WM; Hodes, D; McIntosh, K; McNamara, J; Oleske, JM; Salgo, M; Spector, SA; Wara, DW | 1 |
| Jarke, J; Juhl, K | 1 |
| Clifford, DB; Dafni, U; Hall, C; Kieburtz, K; Price, RW; Sidtis, JJ; Slasor, P; Tucker, T | 1 |
| Gorey, E; Siegel, K | 1 |
| Alberici, F; Bassetti, D; Cargnel, A; Carosi, G; Chiodo, F; Concia, E; Cremoni, L; Dianzani, F; Floridia, M; Fragola, V; Giannini, V; Gritti, FM; Mazzotta, F; Milazzo, F; Moroni, M; Ranieri, S; Ricciardulli, D; Seeber, AC; Sinicco, A; Tomino, C; Vella, S; Weimer, LE | 1 |
| Gisslén, M; Hagberg, L; Norkrans, G; Svennerholm, B | 2 |
| Harrison, LH; Quinn, TC; Schechter, M | 1 |
| Autran, B; Blanc, C; Carcelain, G; Debré, P; Katlama, C; Leibowitch, J; Li, TS; Mathez, D; Tubiana, R | 1 |
| Beck, T; Gerken, G; Ibe, M; Knolle, P; Meyer zum Büschenfelde, KH | 1 |
| Errante, D; Nasti, G; Tirelli, U | 1 |
| Wainberg, MA | 1 |
| Babiker, AG; Darbyshire, JH; Walker, S; White, IR | 2 |
| Ahle, D; Bushnell, S; Chang, C; Collins, ML; Detmer, J; Fine, E; Ho, DD; Horn, T; Irvine, B; Kolberg, J; Shen, LP; Tyner, D; Urdea, MS; Zayati, C | 1 |
| Böhler, T; Debatin, KM; Geiss, M; Haas, J; Herr, I | 1 |
| Fass, RJ; Mangino, JE | 1 |
| Caruz, A; Leal, M; Lissen, E; Luque, F; Pineda, JA; Rey, C; Rubio, A; Sanchez-Quijano, A | 1 |
| Biron, F; Peyramond, D; Verrier, B | 1 |
| Boucher, CA; Danner, S; de Groot, T; de Jong, D; Keulen, W; Lange, J; Nijhuis, M; Schuurman, R; van Leeuwen, R | 1 |
| Cotton, D; Davenny, K; Hanson, IC; Hershow, RC; Hillyer, GV; Landesman, S; Lew, J; Mofenson, LM; Quinn, TC; Riester, KA; Tang, HB; Thomas, DL | 1 |
| Rogers, MF | 1 |
| McIntosh, K | 2 |
| Andrews, E; Eldridge, R; White, A | 1 |
| Fowler, MG; Mofenson, L | 1 |
| Crowe, SM; Stent, G | 1 |
| Beijnen, JH; Burger, DM; Hoetelmans, RM; Koks, CH; Kraaijeveld, CL; Meenhorst, PL; Mulder, JW | 1 |
| Goldberg, B; Stricker, RB | 1 |
| Junghanss, BG | 1 |
| Collins, DO; Sakamoto, A | 1 |
| Teele, DW; Voss, LM | 1 |
| Leiner, S | 1 |
| Li, RW; Wong, JB | 1 |
| Andreoni, M; Ercoli, L; Galluzzo, C; Giannini, G; Nicastri, E; Sarmati, L; Vella, S | 1 |
| Comar, M; De Paoli, P; Giacca, M; Simonelli, C; Tirelli, U; Zanussi, S | 1 |
| Bogner, JR; Goebel, FD; Rolinski, B; Sadri, I; Wintergerst, U | 1 |
| Conville, PS; Craft, C; Davey, RT; Falloon, J; Kovacs, JA; Lane, HC; Masur, H; Metcalf, JA; Petty, B; Piscitelli, SC; Polis, MA; Vogel, S; Walker, RE; Witebsky, FG | 1 |
| Chien, SC; Chow, AT; Hendrix, CW; Rogge, MC; Williams, RR | 1 |
| Chenoweth, CE; Gobetti, JP | 1 |
| Diaz, C; Glenn Fowler, M; Rodriguez, EM | 1 |
| Firtion, G; Krivine, A; Le Bourdelles, S; Lebon, P | 1 |
| Gordin, FM; Horsburgh, CR; Schaier, S; Silver, R | 1 |
| Lillo, FB; Maillard, M; Saracco, A; Varnier, OE | 1 |
| Beaulieu, S; Bergeron, D; Cohen, EA; Courchesne, I; Lafontaine, M | 1 |
| Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE | 1 |
| Chodakewitz, JA; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT | 1 |
| Ahmad, N; Ampel, NM; Clark, DR; DeLuca, D; Hallett, CA; Yedavalli, VR | 1 |
| Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C | 1 |
| Harrer, E; Harrer, T; Kalden, JR; Löw, P; Rohwer, P; Weber, C | 1 |
| Dall, L; Frank, I; Gocke, DJ; Greenberg, SB; Kessler, H; McKinnis, R; Mertz, G; Moore, MD; Murphy, RL; Perez, G; Petersen, E; Pollard, RB; Ramirez-Ronda, C; Rooney, JF; Shepp, DH; Sherer, R | 1 |
| Lurie, P; Wolfe, SM | 6 |
| Delmas, B; Janbon, F; Montes, B; Reynes, J; Segondy, M; Vendrell, JP | 1 |
| Boucher, CA; de Boer, RJ; de Jong, MD; de Wolf, F; Foudraine, NA; Goudsmit, J; Lange, JM | 1 |
| Bettini, P; Boeri, E; Bucceri, AM; Farma, E; Lillo, FB; Mastrorilli, E; Rossi, G; Varnier, OE; Vignali, M | 1 |
| Escribano Hernández, A | 1 |
| Chusid, MJ; Cuene, BE; Gern, JE; Hand, JR; Havens, PL; Sullivan, BW | 1 |
| Satcher, D; Varmus, H | 1 |
| Laurence, J; Lee, AW; Mitra, D | 1 |
| Wilkinson, D | 1 |
| Chaturachinda, K; Phuapradit, W; Sirinavin, S; Taneepanichskul, S | 1 |
| Boucher, C; Brun-Vézinet, F; Descamps, D; Fauveau, V; Izopet, J; Jeffries, D; Kaye, S; Krzyanowski, C; Loveday, C; Nunn, A; Schuurman, R; Seigneurin, JM; Tamalet, C; Tedder, R; Weber, J; Weverling, GJ | 1 |
| Aiuti, F; Alario, C; Bernardi, ML; Carlesimo, M; Cassone, A; Guerra, EC; Leone, P; Mattiacci, G; Pirillo, MF; Pontesilli, O; Ricci, G; Varani, AR | 1 |
| Amado, RG; Chen, IS; Jamieson, BD; Kaplan, AH; Koka, PS; Withers-Ward, ES; Zack, JA | 1 |
| Schacker, T | 1 |
| Borleffs, JC; Boucher, CA; Esseveld, F; Hoepelman, IM | 1 |
| Feingold, A; Meislich, D; Rudy, B; Rutstein, RM; Word, B | 1 |
| Arendt, V; Chen, P; Fontaine, E; Hemmer, R; Kirpach, P; Lambert, C; Ninove, D; Plesseria, JM; Schmit, JC; Schneider, F | 1 |
| Legg, J | 1 |
| Bissuel, F; Cotte, L; Deruelle, E; Leriche-Guérin, K; Rougier, P; Trabaud, MA; Trépo, C | 1 |
| Kinloch-de Loës, S; Perneger, TV | 1 |
| Emini, E; Günthard, HF; Haase, AT; Havlir, DV; Ignacio, CC; Kwok, S; Richman, DD; Wong, JK; Zhang, ZQ | 1 |
| Günthard, HF; Havlir, DV; Hezareh, M; Ignacio, CC; Richman, DD; Spina, CA; Wong, JK | 1 |
| Reggy, AA; Rogers, MF; Simonds, RJ | 1 |
| Abiteboul, D; Bell, DM; Cardo, DM; Ciesielski, CA; Culver, DH; Heptonstall, J; Ippolito, G; Lot, F; Marcus, R; McKibben, PS; Srivastava, PU | 1 |
| Blaschke, TF; Collier, AC; Gries, JM; Kastrissios, H; Park, K; Sheiner, LB; Squires, K; Vanhove, GF; Verotta, D | 1 |
| Blaschke, TF; Collier, AC; Coombs, R; Gries, JM; Sheiner, LB; Vanhove, GF; Verotta, D | 1 |
| Pei, JC; Pike, IM; Van Harken, DR; Wagner, J | 1 |
| Einat, M; Fabian, I; Nagler, A; Toren, A | 1 |
| Bassett, R; Hughes, MD; Ioannidis, JP; Lau, J; Sacks, HS; Volberding, PA | 1 |
| Barreiro, G; Bernal, A; Cilleruelo, MJ; García, M; Martín-Fontelos, P; Mellado, MJ; Ortiz, M; Perez-Jurado, ML; Villota, J | 1 |
| DeCock, K; Rogers, M; Shaffer, N; Simonds, RJ; Wiktor, S | 1 |
| Battegay, M; Egger, M; Flepp, M; Francioli, P; Hirschel, B; Malinverni, R; Rickenbach, M; Sudre, P; Vernazza, P; Wirz, M | 1 |
| Kigotho, AW | 1 |
| Brambilla, D; Cooper, E; Fowler, MG; Hillyer, G; Landay, A; Mendez, H; Moye, J; Pitt, J; Rich, KC | 1 |
| Fischl, MA; Holden-Wiltse, J; Meehan, PM; Meng, TC; Richman, DD; Saag, M; Squires, KE | 1 |
| Fanning, TR; Hauck, WW; McKee-Nelsen, L; Turner, BJ | 1 |
| Andreoni, M; el-Sawaf, G; Ercoli, L; Nicastri, E; Salanitro, A; Sarmati, L; Vella, S; Ventura, L | 1 |
| Bravo, R; Garćia-Lerma, G; Gómez-Cano, M; González-Lahoz, J; Heredia, A; Laguna, F; Martínez, P; Mas, A; Moreno, V; Soriano, V; Valencia, E; Vallejo, A; Villalba, N | 1 |
| Bakker, M; Boucher, CA; Danner, SA; de Jong, MD; de Wolf, F; Lange, JM; Loeliger, AE; Notermans, DW; Ran, LJ; Reiss, P; Schuitemaker, H; van Leeuwen, R; van't Wout, AB | 1 |
| Kaiser, J | 1 |
| Becagli, P; Berto, V; Font, M; Martini, N; Messori, A; Tosolini, F; Trippoli, S; Venturini, F | 1 |
| Fowler, MG | 2 |
| Zion, D | 1 |
| Tuomala, RE | 1 |
| Anderson, VM | 1 |
| Weisser, M | 1 |
| Arranz Caso, JA | 1 |
| Belardelli, F; Fais, S; Lapenta, C; Logozzi, MA; Parlato, S; Pirillo, M; Proietti, E; Rizza, P; Santini, SM; Spada, M | 1 |
| Hauri, D; John, H; Müller, NJ; Opravil, M | 1 |
| Culnane, M; Gwynne, M; Hutcheon, N; Kline, MW; Lindsey, JC; McKinney, RE; Mitchell, WG; Nichols, S; Van Dyke, RB; Yogev, R | 1 |
| Mbidde, E | 1 |
| Easterbrook, PJ; Marshall, T; Yu, LM | 1 |
| Comar, M; De Paoli, P; Giacca, M; Simonelli, C; Tirelli, U; Vaccher, E; Zanussi, S | 1 |
| Bravo, R; Castro, A; García-Lerma, G; García-Samaniego, J; González, J; González-Lahoz, J; Soriano, V | 1 |
| Alaeus, A; Albert, J; Cox, S; Palmer, S | 1 |
| Goldstein, H; Katopodis, NF; Kim, A; Kollmann, TR; Pettoello-Mantovani, M; Raker, C; Wiltshire, H; Yurasov, S | 1 |
| Edelstein, RE; Frenkel, LM; Manns-Arcuino, LA; Nickerson, DA; Tobe, VO | 1 |
| Bratt, G; Cochaux, P; Gilljam, G; Hinkula, J; Leandersson, AC; Samson, M; Sandström, E; Wahren, B | 1 |
| Cavert, W; Danner, SA; de Jong, JJ; de Wolf, F; Foudraine, NA; Goodwin, C; Goudsmit, J; Jurriaans, S; Kauffmann, RH; Leonard, JM; McDade, H; Meenhorst, PL; Notermans, DW; Schuwirth, CM | 1 |
| Cooper, DA; Gow, I; Harris, J; Jaramillo, AB; Kelleher, AD; McMurchie, M; Patou, G; Roggensack, M; Smith, DE; Walker, A | 1 |
| Biedermann, K; Irion, O; Kind, C; Lauper, U; Nadal, D; Rudin, C; Schüpbach, J; Siegrist, CA; Wyler, CA | 1 |
| Feigley, CE; Gu, J; Khajotia, RR; Lee, E | 1 |
| Fätkenheuer, G; Reiser, M; Salzberger, B | 1 |
| Myers, ER; Simpson, K; Thompson, JW | 1 |
| Chapanduka, ZC; Matchaba, PT | 1 |
| Ait-Khaled, M; Bingham, S; Evans, JA; Lyall, EG; McClure, MO; Stainsby, C; Taylor, GP; Tudor-Williams, G; Walters, S; Weber, JN; Wright, A | 1 |
| Bell, CJ; Dobbs, TL; Gwinn, M; Hannon, WH; Mei, JV; Spruill, C | 1 |
| Le, TP; Tuazon, CU | 1 |
| Becker, W | 1 |
| Oka, S | 1 |
| Aker, D; Balis, FM; Brouwers, P; Edgerly, M; Heath-Chiozzi, M; Higham, C; Hsu, A; Jarosinski, P; Katz, TT; Mueller, BU; Nelson, RP; Pizzo, PA; Pizzuti, D; Saulis, R; Sei, S; Serchuck, L; Sleasman, J; Steinberg, SM; Whitcup, SM; Wood, LV; Zeichner, S; Zuckerman, J | 1 |
| Hanson, DL; Janssen, RS; Jones, JL; Qureshi, AI | 1 |
| Okada, H; Okada, N; Wu, X | 1 |
| Abbate, I; Antonelli, G; Capobianchi, MR; Dianzani, F; Dolei, A; Turriziani, O | 1 |
| Hughes, M; Katzenstein, DA; Merigan, TC; Pi, JT; Rey, D; Winters, M | 1 |
| Casserella, S; Cimoch, PJ; Griffy, KG; Jung, D; Lavelle, J; Pollard, R; Tarnowski, TL; Wong, R | 1 |
| Barton, S; Blaxhult, A; Clotet, B; Goebel, FD; Hirschel, B; Katlama, C; Lundgren, JD; Pedersen, C; Phillips, AN; Vella, S | 1 |
| Britto, P; Coombs, RW; Eastman, PS; Frenkel, LM; Herman, SA; McSherry, GD; Shapiro, DE; Sperling, RS | 1 |
| Byington, R; Elbeik, T; Fiscus, SA; Griffith, BP; Hammer, SM; Hughes, MD; Jackson, B; Japour, A; Katzenstein, DA; Lathey, JL; Pi, T; Rasheed, S; Reichman, R; Scott, W | 1 |
| Guatelli, JC; Günthard, HF; Havlir, DV; Ignacio, CC; Richman, DD; Riggs, NL; Wong, JK | 1 |
| Morris, K | 2 |
| Phanuphak, P | 1 |
| Spooner, KM | 1 |
| Brettle, RP; Gore, S; Hutchinson, S; Leen, CL; Lewis, S; Morgan, R; Morris, S; Povey, S; Wilson, A | 1 |
| Dondero, TJ; Rogers, MF; Simonds, RJ | 1 |
| Merson, MH | 1 |
| Francis, DP | 1 |
| Mbidde, EK | 1 |
| Blanche, S | 1 |
| Glantz, LH; Grodin, MA | 1 |
| Essex, M; Hammer, S; Jourdain, G; Lallemant, M; Le Coeur, S; Lee, TH; McIntosh, K; Prescott, N; Vithayasai, V | 1 |
| Khambaroong, C; Nelson, KE; Robb, ML | 1 |
| Gulgolgarn, V; Ketsararat, W; Sittisombut, N; Tovanabutra, S; Wera-arpachai, M; Wongchoosri, S | 1 |
| Marshall, E | 1 |
| Kalebic, T | 1 |
| Friedberg, DN; Heinemann, MH; Holland, GN; Rosberger, DF | 1 |
| Davis, JL; Friedberg, DN; Holland, GN; Levinson, RD; Lindley, JI; Terry, BT; Tufail, A; Vann, R | 1 |
| Conway, B; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Rhone, SA; Schechter, MT; Sherlock, C; Yip, B | 1 |
| Abrams, EJ; Alger, L; Bardeguez, AD; Byers, R; Lindsay, M; Matheson, P; Nesheim, S; Orloff, S; Palumbo, P; Rogers, M; Simonds, RJ; Steketee, R; Vink, P | 1 |
| Burdon, J | 1 |
| Jolly, DH; Lovvorn, AE; Quinn, SC | 1 |
| Leal, M; Lissen, E; Pineda, JA; Rey, C; Rubio, A; Sanchez-Quijano, A | 1 |
| Hester, EK; Peacock, JE | 1 |
| Flaxman, NA; Reed, HS | 1 |
| Rutter, T | 1 |
| Collier, AC; Coombs, RW; Corey, L; Panther, LA; Zeh, JE | 1 |
| Blatt, SP; Burke, DS; Chung, RC; Cohn, DL; Gardner, LI; Harris, RW; Harrison, SH; Hendrix, CW; Mayers, DL; Wagner, KF | 1 |
| Boucher, C; Danner, S; Heath-Chiozzi, ME; Japour, AJ; Kempf, DJ; Leonard, JM; Molla, A; Rode, RA; Sun, E; Valdes, J; Xu, Y | 1 |
| DeMasi, R; Hill, AM; Montaner, JS | 1 |
| Aiuti, F; Ammassari, A; Antinori, A; Carlesimo, M; Guerra, EC; Ortona, L; Pontesilli, O; Prozzo, A; Seeber, AC; Tamburrini, E; Tomino, C; Vella, S | 1 |
| Adams, O; Horneff, G; Wahn, V | 1 |
| Conway, B; Cooper, D; Hall, D; Harris, M; Lange, JM; Montaner, JS; Myers, M; Reiss, P; Robinson, P; Smith, D; Vella, S; Wainberg, MA | 1 |
| Blum, C; Fischer, C; Harewood, L; Rosenwald, V | 1 |
| Coutinho, RA; de Jong, JJ; de Wolf, F; Goudsmit, J; Jurriaans, S | 1 |
| Van Vooren, JP | 1 |
| Healton, C; Latta, RA; Longenecker, JC; Nakchbandi, IA; Ricksecker, MA; Smith, DG | 1 |
| Cabriallas, S; Carden, J; Feldstein, M; Gill, P; Levine, A; Marcus, S; Miles, S; Mitsuyasu, R | 1 |
| Capparelli, E; Dankner, W; Mirochnick, M; Spector, SA; Sperling, RS; van Dyke, R | 1 |
| Battegay, M; Egger, M; Kully, C; Pfluger, D; Rudin, C; Weisser, M | 1 |
| Costa Pérez-Herrero, JR; Crespo Garzón, AE; del Palacio Pérez-Medel, A; Esteban Fernández, FJ; Martín Fernández, J; Pulido Ortega, F; Rubio García, R | 1 |
| García-Lerma, G; Gómez-Cano, M; González-Lahoz, J; Soriano, V | 1 |
| Adrados, M; Calvo, F; Casas, E; García-Lerma, G; Gómez-Cano, M; Soriano, V | 1 |
| Martín Fernández, J; Pulido Ortega, F; Rubio García, R | 1 |
| Benito Blanco, AM; Castilla Castellano, V; Fraguas, C; Izquierdo, P; Martín Llorens, MM; Miquel Plaza, J; Moreno Collado, AM; Muñoz Jareño, MA; Nieto, MA; Pastor de Blas, M; Sáiz Hervas, E; Sierra, A | 1 |
| Beaulieu, R; Gelmon, K; Read, S; Sawka, C; Shepherd, FA; Singer, J; Thuot, CA | 1 |
| Aubertin, JM; Belair, MF; Bruneval, P; Charton-Bain, MC; Flamant, M; Gilquin, J; Kazatchkine, M | 1 |
| Gray, CM; Merigan, TC; Schapiro, JM; Winters, MA | 1 |
| Albano, F; Canani, RB; Castaldo, A; Guarino, A; Spagnuolo, MI | 1 |
| Berry, N; Bewley, S; Breuer, J; de Ruiter, A; du Mont, G; Kennedy, J; O'Shea, S; Smith, NA | 1 |
| Bai, J; Daar, ES; Giorgi, JV; Hausner, MA; Majchrowicz, M; Tamaddon, M | 1 |
| Burt, MS; Mills, RJ; Scott-Lennox, JA | 1 |
| Fox, CH; Hirschel, B; Marchal, F; Pantaleo, G; Perrin, L; Schockmel, GA; Yerly, S | 1 |
| Kavlick, MF; Mitsuya, H; Wyvill, K; Yarchoan, R | 1 |
| Bloor, S; de Béthune, MP; Harrigan, PR; Hertogs, K; Kemp, SD; Larder, BA; Miller, V; Pauwels, R; Phillips, A; Rottmann, C; Staszewski, S | 1 |
| Bethel, J; Mayers, D; Schnittman, S; Wainberg, MA; Weislow, O | 1 |
| Stevens, TP; Watson, WJ; Weinberg, GA | 1 |
| Pieper, B; Smitherman, HC | 1 |
| Conway, B; Cooper, D; Dohnanyi, C; Hall, DB; Lange, J; Montaner, JG; Myers, M; Reiss, P; Vella, S | 1 |
| Bloor, S; de Béthune, MP; Gröschel, B; Harrigan, PR; Hertogs, K; Kemp, SD; Larder, BA; Miller, V; Pauwels, R; Staszewski, S; Stürmer, M | 1 |
| Aboulker, JP; Batisse, D; Belec, L; Castiel, P; Gilquin, J; Gonzalez-Canali, G; Jayle, D; Karmochkine, M; Kazatchkine, MD; Piketty, C; Si Mohamed, A; Weiss, L | 1 |
| Batisse, D; Belec, L; Karmochkine, M; Kazatchkine, MD; Piketty, C; Si Mohamed, A | 1 |
| Dao, B; Meda, N; Ouangré, A | 1 |
| Minkoff, H; O'Sullivan, MJ | 1 |
| Diggle, PJ; Verbyla, AP | 1 |
| Bloch, J; Chavance, M | 1 |
| Abarca, K; Acuña, G; Gasep, J; Jiménez, G; Labarca, J; Noriega, M; Palacios, O; Pérez, C; Vial, C; Vial, PA | 1 |
| Kahn, JG; Marseille, E; Saba, J | 1 |
| Gómez-Cano, M; González-Lahoz, J; Gutiérrez, M; Machuca, A; Moreno, V; Pérez-Olmeda, M; Rodríguez-Rosado, R; Soriano, V; Valencia, E | 1 |
| Contopoulos-Ioannidis, DG; Ioannidis, JP | 2 |
| Hoar, ME | 1 |
| Malinverni, R; Rudin, C | 1 |
| Gompels, M; Knight, SC; Macatonia, SE; Patterson, S; Pinching, AJ; Roberts, MS | 1 |
| Balis, FM; Brouwers, P; Deutsch, PJ; Jarosinski, PF; Ju, W; Mistry, G; Mueller, BU; Nelson, RP; Pizzo, PA; Sei, S; Sleasman, J; Smith, S; Steinberg, SM; Winchell, G; Wood, LV; Zeichner, S; Zwerski, S | 1 |
| Dalod, M; Deschemin, JC; Dumon, B; Gomard, E; Harzic, M; Hoen, B; Levy, JP; Pellegrin, I; Sereni, D; Venet, A | 1 |
| Chiozzi, MH; Connick, E; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Roe, JD; Rousseau, F; Spritzler, J; St Clair, M; Wade, M | 1 |
| Bethel, J; Holodniy, M; Niu, MT; Schnittman, SM; Standiford, HC | 1 |
| Belohradsky, BH; Eberle, J; Gürtler, L; Hoffmann, F; Notheis, G; Petropoulou, T; Sölder, B; Wintergerst, U | 1 |
| Jürgens, H; Pollmann, H; Richter, H | 1 |
| Haddix, AC; Mansergh, G; Simonds, RJ; Steketee, RW | 1 |
| Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Holder, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Schleif, WA | 1 |
| Bénifla, JL; Berrebi, A; Blanche, S; Bongain, A; Delfraissy, JF; Le Chenadec, J; Mandelbrot, L; Mayaux, MJ | 1 |
| Clotet, B; Gómez-Cano, M; Leal, M; Pérez-Olmeda, M; Pineda, JA; Puig, T; Rubio, A; Ruiz, L; Soriano, V; Xaus, N; Zamora, L | 1 |
| Foli, A; Gallo, RC; Lisziewicz, J; Lori, F; Maserati, R; Minoli, L; Wainberg, MA | 1 |
| Frothingham, R | 1 |
| Jones, JL; Lansky, A; Lindegren, ML; Wan, PC; Wortley, P | 1 |
| Günthard, HF; Havlir, DV; Ignacio, CC; Richman, DD; Wong, JK | 1 |
| Berrey, MM; Chun, TW; Corey, L; Engel, D; Fauci, AS; Shea, T | 1 |
| Dabis, F; Mandelbrot, L; Msellati, P; Noba, V; Ramon, R; Viho, I; Welffens Ekra, C | 1 |
| Mirsattari, SM; Nath, A; Power, C | 1 |
| Baumgartner, EM; Feucht, HH; Laufs, R; Schröter, M; Stellbrink, HJ; Zöllner, B | 1 |
| Balotta, C; Moroni, M; Rusconi, S | 1 |
| Boeri, E; Carrera, P; Gianotti, N; Lazzarin, A; Tambussi, G | 1 |
| Jackson, RC | 1 |
| Bryson, YJ; Christopherson, C; Deveikis, A; Dickover, RE; Dillon, M; Keller, M; Krogstad, P; Kwok, S; Leung, KM; Plaeger, S; Stiehm, ER | 1 |
| Chopra, M | 1 |
| Moodley, K | 1 |
| Chiarelli, F; de Martino, M; Galli, L; Rossi, ME; Vierucci, A | 1 |
| Clotet, B; De Clercq, E; Desmyter, J; Puig, T; Rossau, R; Ruiz, L; Schmit, JC; Stuyver, L; Van Laethem, K; Vandamme, AM; Vanderlinden, I | 1 |
| Danner, SA; de Wolf, F; Goudsmit, J; Hoetelmans, RM; Jurriaans, S; Lange, JM; Lukashov, VV; Notermans, DW; Prins, JM; Roos, M; Schuitemaker, H; Weverling, GJ | 1 |
| Bouscarat, F; Brun-Vézinet, F; Girard, PM; Landman, R; Levacher, M; Muffat-Joly, M; Saimot, AG; Sinet, M | 1 |
| Bellman, PC | 1 |
| Ades, AE; Briggs, AH; Gibb, D; Ratcliffe, J; Sculpher, MJ | 1 |
| Harrigan, PR; Harris, M; Mo, T; Montaner, JS | 1 |
| Babiker, AG; Darbyshire, JH; Peto, TE; Walker, AS | 1 |
| Carpenter, WM; Cuny, E | 1 |
| Kibayashi, K; NG'walali, PM; Tsunenari, S | 1 |
| Friedland, G; Jatlow, P; McCance-Katz, EF; Rainey, PM | 1 |
| Boucher, CA; Bruisten, SM; Huisman, JG; Loeliger, AE; Reiss, P; Schuurman, R; van Swieten, P; Weverling, GJ | 1 |
| Berenguer, J; Cano, J; Fernández Alvarez, JM; Gimeno, M; Gonzalo Lafuente, JC; Vázquez-Piñeiro, T | 1 |
| Cammack, N; Dissanayeke, SR; Duncan, IB; Gilbert, SM; Moffatt, AR; Race, E; Rose, JS; Sheldon, JG; Sitbon, G | 1 |
| Danner, SA; de Wolf, F; Goudsmit, J; Mittler, J; Notermans, DW; Perelson, AS | 1 |
| de Jong, JJ; de Wolf, F; Foudraine, NA; Jan Weverling, G; Jurriaans, S; Keet, IP; Lange, JM; Maas, J; Roos, MT; van Benthem, BH; Vandermeulen, K | 1 |
| Clotet, B; Cruceta, A; García, F; Gatell, JM; Leal, M; Mallolas, J; Miró, JM; Pumarola, T; Ruiz, L; Tortajada, C; Vidal, C | 1 |
| Bouvet, E | 2 |
| Bachmeyer, C; Blum, L | 1 |
| Tashima, KT | 1 |
| Britton, S; Eriksson, S; Jacobsson, B; Törnevik, Y | 2 |
| Bowdler, N; Groginsky, E; Yankowitz, J | 1 |
| Howe, EG | 1 |
| Levine, RJ | 4 |
| Boelaert, M; Temmerman, M; Van der Stuyft, P | 1 |
| Britsch, P; Dettling, M; Müller-Oerlinghausen, B | 1 |
| Belec, L; Cotigny, S; Gilquin, J; Gutmann, L; Kazatchkine, M; Matta, M; Piketty, C; Si Mohamed, A; Weiss, L | 1 |
| Akeb, F; Fridland, A; Grassi, J; Guedj, R; Lancaster, D; Pinkerton, FH; Robbins, BL; Tran, TT | 1 |
| Asrat, T; Deveikis, A; Major, C; Nageotte, MP; Towers, CV | 1 |
| Chaovavanich, A; Phuapradit, W; Puchaiwatanon, O; Sirinavin, S; Sunthornkachit, R; Taneepanichskul, S; Wiratchai, A | 1 |
| Conway, B; Cooper, D; Hall, D; Harris, M; Lange, J; Montaner, JS; Myers, M; Raboud, JM; Rae, S; Reiss, P; Robinson, P; Vella, S; Wainberg, MA | 2 |
| Beveridge, A; Carr, A; Cooper, DA; Cunningham, P; Duncombe, C; French, M; Kaufmann, GR; Sayer, D | 1 |
| Heald, AE; Pieper, CF; Schiffman, SS | 1 |
| Floyd, K; Gilks, CF; Wilkinson, D | 2 |
| Gambertoglio, JG; Lalezari, JP; Pearl, JM; Peter, K; Thevanayagam, L | 1 |
| Schenk, M | 1 |
| Gaday, I; Senegas, F; Sleth, JC | 1 |
| Angel, JB; Cameron, DW; Garber, GE; Hawley-Foss, N; Houston, S; Kravcik, S; Sutherland, D; Victor, G | 1 |
| Caballero, B; Henderson, RA; Hutton, N; Talusan, K; Yolken, RH | 1 |
| Sewell, AC | 1 |
| Saag, MS; Schooley, RT | 1 |
| Dam Nielsen, S; Hansen, JE; Kjaer Ersboll, A; Mathiesen, L; Nielsen, JO | 1 |
| Coovadia, H; Goodwin, C; Harrigan, PR; Johnson, MA; Moodley, D; Moodley, J; Moore, KH; Pillay, K; Plumb, R; Saba, J; Stone, C; van Leeuwen, R | 1 |
| Volkert, R | 2 |
| Brouwers, P; Johnson, GM; Keller, A; McKinney, RE; McNamara, J; Mitchell, WG; Mofenson, L; O'Donnell, KJ; Spector, SA; Stanley, K; Wara, DW; Wiznia, A; Yogev, R; Yong, FH | 1 |
| Lindbloom, EJ; Stevermer, JJ | 1 |
| Bassett, RL; Boone, G; Collier, AC; Havlir, DV; Hirsch, MS; Holohan, MK; Ioannidis, JP; Leavitt, R; Marschner, IC; Richman, DD; Tebas, P | 1 |
| Aboulker, JP; Brun-Vezinet, F; Delfraissy, JF; Dellamonica, P; Flandre, P; Gastaut, JA; Meiffrédy, V; Pialoux, G; Raffi, F; Yeni, P | 1 |
| Allen, UD; Bowker, J; Forbes, JC; Gomez, MP; King, SM; Kirby, MA; Lapointe, N; Mukwaya, G; Raboud, J; Read, SE; Singer, J; Thorne, A; Tobin, J | 1 |
| Britto, P; Coombs, RW; Culnane, M; Cunningham, BE; Delfraissy, JF; Diaz, C; Harrison, DD; Jimenez, E; McSherry, GD; Scott, G; Shapiro, DE; Shearer, WT; Sperling, RS; Van Dyke, RB | 1 |
| Conly, J; Fletcher, D; Keystone, D; Salit, I; Tseng, A; Walmsley, S | 1 |
| Aquilina, C; Roueire, A; Viraben, R | 1 |
| González-Lahoz, J; Jiménez-Nacher, I; Moreno Celda, V; Rodríguez-Rosado Martínez-Echevarría, R; Soriano Vázquez, V; Valencia Ortega, E | 1 |
| Angelini, F; Cancrini, C; Cox, S; Gattinara, GC; Livadiotti, S; Orlandi, P; Romiti, ML; Rossi, P; Scaccia, S | 1 |
| Bartlett, JA; Berend, C; Ottinger, J; Petroni, GR; Pettinelli, C; Tyler, DL; Weinhold, KJ | 1 |
| Dresse, MF; Hoyoux, C; Jacquet, Y | 1 |
| Redondo, P; Vázquez-Doval, J | 1 |
| Baum, JB; Birkhead, GS; Charbonneau, TT; French, PT; Savicki, R; Tesoriero, JM; Wade, NA; Wang, L; Warren, BL | 1 |
| Dimitrov, DS; Heath-Chiozzi, M; Kuznetsov, VA; Mueller, BU; Pizzo, PA; Zeichner, SL | 1 |
| Chan, KC; Ho, TT; Lee, SS; Wong, KH | 1 |
| Arnedo, A; Mínguez, C; Olmos, P; Roca, B; Sáez-Royuela, A; Segarra, M; Simón, E; Teruel, C; Usó, J | 1 |
| Coolley, KL; Girard, YA; Hamdan, H; Katzenstein, DA; Levee, DJ; Merigan, TC; Shafer, RW; Winters, MA | 1 |
| Blaschke, TF; Girard, P; Kastrissios, H; Sheiner, LB | 1 |
| Darville, T; Matheney, R; Tucker, NC | 1 |
| Batki, SL; Chesney, M; DePhilippis, D; Mascovich, A; Sorensen, JL; Wall, TL | 1 |
| Andreoni, M; Ercoli, L; Galluzzo, C; Giannini, G; Nicastri, E; Parisi, SG; Sarmati, L; Vella, S; Ventura, L | 1 |
| Battegay, M; Bisset, LR; Cone, RW; Grob, PJ; Huber, W; Opravil, M; Vernazza, PL; Weber, R | 1 |
| Bonnez, W; Evans, TG; Fitzgerald, T; Gibbons, DC; Reichman, RC; Soucier, HR | 1 |
| Blaxhult, A; Lidman, K | 1 |
| Abrams, EJ; Bamji, M; Farley, J; Kuhn, L; Lambert, G; Nesheim, SR; Palumbo, P; Schoenbaum, E; Simonds, RJ; Steketee, RW; Thea, DM; Weedon, J | 1 |
| Anton, KE; Cherrington, JM; Lamy, PD; Miller, MD; Mulato, AS | 1 |
| Balsley, J | 1 |
| Jochimsen, EM | 1 |
| Ippolito, G; Puro, V | 2 |
| Beekmann, SE; Fahrner, R; Gerberding, JL; Henderson, DK | 1 |
| Gitterman, SR; Pratt, RD; Struble, KA | 1 |
| Alonso Arias, R; Fernández-Cruz, E; Gurbindo, MD; Miralles, P; Muñoz-Fernández, MA; Segovia, P | 1 |
| Moran, PJ; Welles, SL; Williams, MA | 1 |
| Mercey, D; Sculpher, M | 1 |
| Vittecocq, D | 1 |
| Blanquet, D; Hallard, M; Mathé, G; Morette, C; Pontiggia, P; Triana, K | 1 |
| Daniel, SS; Garland, M; Myers, MM; Stark, RI; Szeto, HH; Tropper, PJ | 1 |
| Boyer, P; Cooper, E; Goldfarb, J; Hammill, H; Hodes, D; Jenson, H; Kovacs, A; LaRussa, P; McIntosh, K; Peavy, H; Pitt, J; Schluchter, M; Shearer, W; Sperling, R; Tuomala, R | 1 |
| Izopet, J; Marchou, B; Massip, P; Pasquier, C; Puel, J; Salama, G; Sandres, K | 1 |
| Cherry, M | 2 |
| McNeill, PM | 1 |
| Brennan, TA; Studdert, DM | 1 |
| Brocklehurst, P; de Ruiter, A | 1 |
| Brew, BJ; Markus, R | 1 |
| Beckmann, A; Berger, A; Borchard, C; Dötterer, H; Eppner, MT; Esser, S; Exner, V; Fiedler, M; Goos, M; Hengge, UR; Müller, K; Wiehler, H | 1 |
| Chung, PH; Colgrove, RC; Japour, AJ; Pitt, J; Welles, SL | 1 |
| D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Myers, M; Sheiner, LB; Sommadossi, JP; Zhou, XJ | 1 |
| Esposito, S; Gabiano, C; Galli, L; Gattinara, GC; Marchisio, P; Orlandi, P; Principi, N; Rossi, P; Zuccotti, GV | 1 |
| Fleming, T; Wilfert, CM | 1 |
| Balter, M | 1 |
| Clark, NM; Dieng Sarr, A; Kanki, PJ; Kazanjian, P; Markovitz, DM; Sankalé, JL; Winfield, R | 1 |
| Fischer, T; Ramadori, G; Schwörer, H | 1 |
| Moyle, GJ; Sadler, M | 1 |
| Finkelstein, DM; Goggins, WB; Schoenfeld, DA; Zaslavsky, AM | 1 |
| Bersoff-Matcha, S; Horgan, M | 1 |
| Aquilina, C; Bonnet, E; Izopet, J; Marchou, B; Massip, P; Pasquier, C; Puel, J; Sailler, L; Sandres, K | 1 |
| Sperling, R | 1 |
| Clay, PG; Rathbun, RC; Slater, LN | 1 |
| Haubrich, R; Richman, D | 1 |
| Brady, M; Culnane, M; Cunningham, B; Diaz, C; Flynn, PM; Fowler, M; Gortmaker, SL; Jimenez, E; Lee, SS; McSherry, G; Mofenson, L; Moore, EC; O'Donnell, K; Oleske, J; Scott, G; Shapiro, DE | 1 |
| Fleury, S; Miedema, F; Otto, SA; Reiss, P; ten Kate, RW; van der Zee, AG; Wisman, GB; Wolthers, KC | 1 |
| Escolano, C; Gutiérrez, F; Maestre, A; Masiá, M; Mirete, G; Mora, A | 1 |
| Baleta, A | 1 |
| Baron, F; Daniel, C; Moutschen, M | 1 |
| Bortolin, MT; Comar, M; De Paoli, P; Giacca, M; Lucenti, A; Sandri, S; Simonelli, C; Talamini, R; Tirelli, U; Zanussi, S | 1 |
| Dickinson, BP; Flanigan, T; Mega, A; Mileno, MD; Mylonakis, E; Rich, JD; Schiffman, FJ | 1 |
| Cooper, DA; Kaufmann, G; Kelleher, AD; Murray, JM | 1 |
| Costa, SJ; Jorden, V; Paul, SM; Ziskin, LZ | 1 |
| Braner, HJ; Funk, M; Groeschel, B; Kornhuber, B; Kreuz, W; Linde, R | 1 |
| Diamant Berger, O; Questel, F; Ugo, V | 1 |
| Bethel, J; Gandia, J; Glenn Fowler, M; Hammill, H; Jimenez, E; Korelitz, J; Kovacs, A; Lambert, JS; Mathieson, BJ; Meyer, WA; Mofenson, LM; Moye, J; Nemo, GJ; Nugent, R; O'Sullivan, MJ; Reichelderfer, P; Sapan, CV; Scott, G; Shearer, WT; Stek, A; Stiehm, ER; Whitehouse, J | 1 |
| Baker, CJ; Englund, JA; Fiscus, S; Pahwa, S; Palumbo, PE; Raskino, C; Schutzbank, T; Spector, SA | 1 |
| Erb, P; Kind, C; Krautheim, A; Kully, C; Perrin, L; Rudin, C; Yerly, S | 1 |
| Balzarini, J; Dunkler, A; Kleim, JP; Merigan, TC; Oette, D; Riess, G; Suarez, JR; Winkler, I; Winters, M | 1 |
| Axelrod, J; DiVito, MM; Ernest, JM; Hitti, J; Livingston, E; Money, DM; Robbins, D; Silverman, NS; Watts, DH | 1 |
| Del Priore, G; Frenkel, LM; Hallmark, RJ; Lee, MJ | 1 |
| Flandre, P; Saidi, Y | 1 |
| Coovadia, HM; Karim, SS; Wilkinson, D | 1 |
| Borleffs, JC; Boucher, CA; Cohen Stuart, JW; Hamman, D; Miedema, F; Roos, M | 1 |
| Makadon, HJ | 1 |
| Caliendo, AM; Currier, JS; D'Aquila, RT; DeGruttola, V; Eron, JJ; Frank, I; Gerber, JG; Gulick, RM; Kuritzkes, DR; Murphy, RL; Smeaton, L; Sommadossi, JP; Tung, R | 1 |
| Samaranayake, LP; Tsang, PC | 1 |
| van der Linde, I | 2 |
| Been-Tiktak, AM; Borleffs, JC; Boucher, CA; Brun-Vezinet, F; Colebunders, R; Cooper, DA; Gatell, JM; Hawkins, DA; Hoy, JF; Johnson, MA; Joly, V; Jost, J; Kennedy, DH; Moroni, M; Mulder, JW; Parkin, JM; Staszewski, S; Stewart, GJ | 1 |
| Aeppli, D; Balfour, HH; Krown, SE | 1 |
| Chen, CL; D'Cruz, OJ; Jan, ST; Shih, MJ; Uckun, FM; Venkatachalam, TK | 1 |
| Barre-Sinoussi, F; Chaouat, G; Dubanchet, S; Fenyö, EM; Mauclere, P; Mbopi Keou, FX; Menu, E; Mognetti, B; Moussa, M; Nardese, V; Scarlatti, G; Tresoldi, L; Tscherning, C | 1 |
| Brackmann, HH; Hille, H; Oldenburg, J; Reichel, C; Rockstroh, JK | 1 |
| Andiman, W; Bryson, Y; de Martino, M; Fowler, M; Harris, D; Hutto, C; Korber, B; Kovacs, A; Landesman, S; Lapointe, N; Lindsay, M; Mandelbrot, L; Newell, M-L; Peavy, H; Read, J; Rudin, C; Semprini, A; Simonds, R; Tuomala, R | 1 |
| Dickinson, E; Stern, A | 1 |
| Benfield, P; Langtry, HD; Palmer, KJ | 1 |
| Eisenberg, JM; Lynn, LA; Schulman, KA | 1 |
| Chambers, ST | 1 |
| Phillips, L | 1 |
| De Graeve, D; Lescrauwaet, B; Nonneman, W | 1 |
| Larson, L | 1 |
| Chancellor, JV; Hill, AM; Sabin, CA; Simpson, KN; Youle, M | 1 |
| Kempel, A; Lacey, L; Mauskopf, J; Simpson, K | 1 |
| Brown, JW | 1 |
| Kalb, C | 1 |
| Costa, SJ; Paul, SM; Ziskin, LZ | 1 |
| Fiscus, SA; Schoenbach, VJ; Wilfert, C | 1 |
| Bornschlegel, K; Thomas, P | 1 |
| Bulterys, M; Shaffer, N; Simonds, RJ | 1 |
| Feiterna-Sperling, C; Grosch-Wörner, I; Maier, RF | 1 |
| Battegay, M; Zimmerli, W | 1 |
| Fagard, C; Hirschel, BJ; Perrin, L; San Millán Ruiz, D; Sudre, P | 1 |
| Schmied, B | 1 |
| Anthony, J; Burgess, J; Coetzee, E; Coetzee, N; Cotton, M; Eley, B; Fransman, D; Hussey, G; Jacobs, M; Maartens, G; McGillivray, G; Power, D; Reynolds, L; Schaaf, S; Theron, G; Woods, D | 1 |
| Beale, MW; Joubert, JR | 1 |
| Spenatto, N; Viraben, R | 1 |
| Lawrence, J; Merigan, TC; Schapiro, JM; Winters, MA | 1 |
| Delfraissy, JF; Goujard, C; Guillet, JG; Lantz, O; Lefebvre, P; Martinon, F; Michelet, C; Peguillet, I; Taoufik, Y | 1 |
| Claessen, FA; Hall, D; Hamann, D; Kauffmann, RH; Koopmans, PP; Kroon, ED; Kroon, FP; Lange, JM; Miedema, F; Montaner, JS; Otto, SA; Pakker, NG; Reiss, P; Roos, MT; Schellekens, PT; Sprenger, HG; ten Napel, CH; van der Ende, ME; Weigel, HM; Wit, FW | 1 |
| Chaisson, RE; Gallant, JE; Keruly, JC; Moore, RD | 1 |
| Fischer, T; Ramadori, G; Reich, K; Schwörer, H; Vente, C | 1 |
| Brunet, C; Chambost, H; Giraud, P; Michel, G; Perrimond, H; Tamalet, C; Thuret, I | 1 |
| Justesen, US; Mygind, LH; Pedersen, C; Pedersen, SS | 1 |
| Hosaka, H; Kubo, S; Nagai, K; Nakamura, N; Nonaka, H; Shinohara, M | 1 |
| Feinmann, J | 1 |
| Meadway, J | 1 |
| Acosta, BS; Grimsley, EW | 1 |
| Graham, MF; Li, L; Meng, G; Shaw, GM; Smith, PD | 1 |
| Coll, M; Montull, S; Pardo, MJ; Pedrol, E | 1 |
| Gürtler, L | 1 |
| Chodakewitz, J; Cook, J; Coplan, P; Dasbach, E; Markson, L; Meibohm, A; Mellors, J; Nguyen, BY; Yin, D | 1 |
| Cawthorne, P; Kasi-Sedapan, S; Kumphitak, A; Lakhonphol, S; Sanaeha, S; Unchit, N; Wilson, D | 1 |
| Colebunders, R; Coppieters, Y | 1 |
| Bubl, R; Di Gallo, A; Engelcke, G; Rinaldi, D; Rohrer, T; Rudin, C | 1 |
| Antonelli, TA; Cooper, E; Culnane, M; Fowler, MG; Hanson, IC; Kalish, LA; Lee, SS; McSherry, G; Mofenson, L; Oleske, JM; Shapiro, DE; Sperling, RS | 1 |
| Abramson, SL; Douglas, SD; Fenton, T; Kline, MW; Shearer, WT; Starr, SE | 1 |
| Cooper, DA; Gaines, H; Lindbäck, S; Vizzard, J | 1 |
| Baseler, M; Goodenow, MM; Hutson, A; Mueller, BU; Nelson, RP; Pizzo, PA; Sleasman, JW; Wilfret, D; Zuckerman, J | 1 |
| de Wolf, F; Foudraine, NA; Hoetelmans, RM; Keet, IP; Lange, JM; Maas, JJ; Portegies, P; van Benthem, BH | 1 |
| Bricaire, F | 1 |
| Dhillon, AP; Lee, CA; Mistry, PK; Nitu, IC | 1 |
| Adimora, AA; Fiscus, SA; Johnson, VA; Kenny, J; Lim, W; McKinney, R; Rupar, D; Schoenbach, VJ; Wilfert, C; Woods, C | 1 |
| Borleffs, JC; Boucher, CA; Bravenboer, B; Burger, DM; Cohen Stuart, JW; Hamann, D; Hoetelmans, RM; Juttmann, JR; Koopmans, PP; Kroon, FP; Meenhorst, PL; Richter, C; Schuurman, R; Sprenger, HG | 1 |
| Capiluppi, B; Ciuffreda, D; Lazzarin, A; Lillo, FB; Mastrorilli, E; Tambussi, G; Veglia, F; Vergani, B | 1 |
| Barker, C; Moyle, G; Revicki, DA; Stellbrink, HJ | 1 |
| Cassano, P; Clumeck, N; De Wit, S; Gerard, M; Hermans, P; Kabeya, K; O'Doherty, E | 1 |
| Axelrod, JH; Honigman, A | 1 |
| Beyers, N; Cotton, MF; Donald, PR; Gie, RP; Henning, PA; Hesseling, PB; Kirsten, GF; Kling, S; Nel, ED; Pieper, CH; Ravenscroft, A; Schaaf, HS; Schoeman, JF; Smith, J; van Buuren, AJ; van der Merwe, PL; van Schalkwyk, HJ; Wessels, G | 1 |
| Dabis, F; Leroy, V; Mandelbrot, L; Meda, N; Msellati, P; Van de Perre, P; Welffens-Ekra, C | 1 |
| Karchmer, S; Mayón González, J; Paredes Vivas, Y; Villegas Castrejón, H | 1 |
| Bérard, E; Bongain, A; Gillet, JY; Monpoux, F | 1 |
| Baker, R; Chougnet, CA; Kessler, HA; Khoury, MM; Kovacs, AA; Landay, AL; Olivero, OA; Poirier, MC; Proia, LA; Sha, BE; Shearer, GM; Stek, AM; Tarone, RE | 1 |
| Aboulker, JP; Boumsell, L; Capitant, C; Carriere, I; Delfraissy, JF; Gastaut, JA; Gomard, E; Goujard, C; Guillet, JG; Houhou, S; Levy, Y; Oksenhendler, E; Rabian, C; Seligmann, M; Viard, JP; Weiss, L | 1 |
| Beck, EJ; Houweling, H; Jager, JC; Mandalia, S; Postma, MJ; Sherr, L; Walters, MD | 1 |
| Petty, TL | 1 |
| Catucci, M; De Milito, A; Gonnelli, A; Riccio, ML; Romano, L; Rubino, M; Valensin, PE; Venturi, G; Zazzi, M | 1 |
| Rouse, DJ; Stringer, JS | 1 |
| Chittick, GE; McDowell, JA; Wang, LH | 1 |
| Skinner, J; Turner, MJ | 1 |
| Shields, JW | 1 |
| Berzofsky, JA; Clerici, M; D'Amico, R; Harris, AA; Kessler, HA; Landay, AL; Meyer, P; Pinto, LA; Shearer, GM | 1 |
| Carr, A; Cooper, DA; Cunningham, PH; Grey, P; Jaramillo, AB; Kaufmann, GR; Kelleher, AD; Smith, D; Vizzard, J; Wright, R; Zaunders, JJ | 1 |
| Chêne, G; Cotte, L; Debord, T; Decazes, JM; Ferchal, F; Journot, V; Madelaine, I; Molina, JM; Pellegrin, I; Rancinan, C; Sombardier, MN | 1 |
| Fine, N; Hurwitz, JJ; Rachlis, AR | 1 |
| Agut, H; Autran, B; Calvez, V; Katlama, C; Li, TS; Neumann, AU; Robert, C; Tubiana, R | 1 |
| Bassett, R; Bell, D; Eron, JJ; Fife, K; Fischl, MA; Johnson, VA; Kuritzkes, DR; Maenza, J; Marschner, I; Murphy, RL; Pettinelli, C; Rosandich, ME; Sommadossi, JP; Wood, K | 1 |
| Amado, RG; Cole, SW; Cortado, R; Jamieson, BD; Zack, JA | 1 |
| Goulder, PJ; Jones, NG; Kalams, SA; Ogg, GS; Shea, AK; Trocha, AK; Walker, BD | 1 |
| De Gruttola, V; Kim, S | 1 |
| Coombs, RW; Shapiro, DE; Sperling, RS | 1 |
| Wolffers, I | 1 |
| Cooper, E; Cundall, D; Golden, B; Moy, R | 1 |
| Connick, E; Fox, L; Kessler, H; Kuritzkes, DR; Landay, A; Lederman, MM; Patki, AH; Purvis, SF; Spritzler, J; St Clair, M; Valdez, H | 1 |
| Gutteberg, TJ; Lathey, JL; Spector, SA; Viani, RM | 1 |
| Cameron, DW; Foster, BC; Gallicano, KD; Kwok, D; Pakuts, A; Sahai, J; Seguin, I; Shukla, VK | 1 |
| Gómez-Cano, M; Holguín, A; Soriano, V; Villalba, N | 1 |
| Burger, H; Charbonneau, T; Frey, H; Grimson, R; Kovacs, A; Nachman, S; Philpott, S; Tropper, P; Vermund, SH; Visosky, A; Weiser, B | 1 |
| Funkhouser, EM; Jetwana, P; Phanuphak, P; Reinprayoon, D; Stringer, EM; Stringer, JS; Vermund, SH | 1 |
| Bertolli, J; Bohannon, B; Burkham, S; Jones, JL; Lansky, A; Reynolds, K | 1 |
| Bello, E; de Górgolas, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E; Moya, MJ | 1 |
| Bassett, R; Connick, E; Demeter, L; Fischl, M; Freimuth, W; Friedland, GH; Griffith, B; Hirsch, M; Hughes, M; Morse, G; Nevin, T; Pollard, R | 1 |
| Hogg, RS; Jahnke, N; Montaner, JS; O'Shaughnessy, M; Yip, B | 1 |
| Capparelli, E; Connor, J; Mirochnick, M | 1 |
| Kahn, J; Mastroianni, A | 1 |
| Bethel, J; Fowler, MG; Harris, DR; Lambert, JS; Mathieson, BJ; Meyer, WA; Mofenson, LM; Moye, J; Nemo, GJ; Reichelderfer, P; Stiehm, ER; Whitehouse, J | 1 |
| Burchett, SK; Garcia, PM; Hanson, C; Jackson, B; Kalish, LA; Kornegay, J; Lew, JF; Minkoff, H; Moye, J; Pitt, J; Quinn, TC; Zorrilla, C | 1 |
| Kidson, C | 1 |
| Lallemant, M; Lamboray, JL; Sirinirund, P; Soucat, A; Tanbanjong, A; Thaineua, V | 1 |
| Brouwers, P; Cox, JH; Jarosinski, P; Kumagai, M; Loomis-Price, LD; Moss, RB; Pizzo, PA; Ratto-Kim, S; Robb, ML; Sandelli, SL; Sei, S; Theofan, G; Venzon, DJ; Walsek, CM; Wood, LV; Xu, J | 1 |
| Hirsch, M; Hirschel, B; Lange, J; Leavitt, R; Meibohm, A; Mellors, J; Rawlins, S; Scerpella, E; Squires, K; Staszewski, S; Steigbigel, R | 1 |
| Ahmad, M; Brennan, JM; Caliendo, AM; Fiske, WD; Flanigan, TP; Gormley, JM; Tashima, KT | 1 |
| Brook, MG; Guha, I | 1 |
| Agostoni, C; D'Auria, E; Riva, E; Torcoletti, M; Zuccotti, GV | 1 |
| Byers, RH; Caldwell, B; Davis, SF; Fleming, PL; Gwinn, M; Lindegren, ML; Rogers, M; Thomas, P; Ward, JW | 1 |
| Contreras, G; De Jorge, R; Medrano, L; Menéndez-Arias, L; Moya, A; Nájera, R; Pérez-Alvarez, L; Villahermosa, ML | 1 |
| Bhadrakom, C; Chearskul, S; Chinayon, P; Chotpitayasunondh, T; Chuachoowong, R; Karon, J; Mastro, TD; Mock, PA; Roongpisuthipong, A; Shaffer, N; Simonds, RJ; Siriwasin, W; Young, NL | 1 |
| Coulibaly, IM; Ekpini, E; Greenberg, AE; Karon, JM; Kouassi, MK; Lackritz, EM; Maurice, C; Nkengasong, J; Roels, TH; Severin, ST; Wiktor, SZ | 1 |
| Cartoux, M; Combe, P; Dabis, F; Ky-Zerbo, O; Leroy, V; Mandelbrot, L; Manigart, O; Meda, N; Montcho, C; Msellati, P; Ouangré, A; Ramon, R; Rouzioux, C; Salamon, R; Simonon, A; Van de Perre, P; Welffens-Ekra, C; You, B | 1 |
| Battegay, M; Cone, RW; Hirschel, B; Ledergerber, B; Opravil, M; Vernazza, P; Zinkernagel, C | 1 |
| Baker, CJ; Brouwers, P; Englund, JA; Jimenez, E; Lifschitz, MH; McKinney, RE; Mintz, M; Nozyce, M; O'Donnell, K; Pearson, DA; Raskino, C | 1 |
| Van de Perre, P | 1 |
| Bindels, PJ; Mohrs, J; Reedijk, M; Wigersma, L | 1 |
| Bru, JP; Clavel, F; Kaiser, L; Perrin, L; Race, E; Yerly, S | 1 |
| Davey, RT; Detmer, J; Herpin, B; Hoofnagle, JH; Kolberg, J; Lau, DT; Metcalf, JA; Miller, KD | 1 |
| Beauvais, L; Bicart-See, A; Bourezane, Y; Dubeaux, B; Dumon, B; Fleury, H; Harzic, M; Hoen, B; Lascoux, C; Raffi, F; Ragnaud, JM; Séréni, D; Venet, A | 1 |
| Cauda, R; Gastaldi, R; La Verde, G; Lucia, MB; Marasca, G; Petrucci, MT; Rutella, S | 1 |
| Boyle, B; Corral, LG; Elbeik, T; Haslett, PA; Kaplan, G; Klausner, JD; Kunachiwa, W; Makonkawkeyoon, S; Maneekarn, N; Metatratip, P; Moreira, A; Shen, Z; Vongchan, P | 1 |
| Allen, M; Bagenda, D; Bakaki, P; Bray, D; Deseyve, M; Dransfield, K; Ducar, C; Emel, L; Fleming, T; Fowler, MG; Guay, LA; Jackson, JB; Miotti, P; Mirochnick, M; Mmiro, F; Mofenson, L; Musoke, P; Nakabiito, C; Sherman, J | 1 |
| Bloch, M; Carr, A; Cunningham, P; Smith, D; Vasak, E | 1 |
| Inui, K; Mano, T; Miyagawa, H; Miyoshi, H; Nishigaki, T; Okada, S; Ono, J; Sashihara, J; Tanaka-Taya, K; Teraoka, S | 1 |
| Bonner, E; Glied, S; Marin, MG; Van Lieu, J; Yee, A | 1 |
| Ait-Khaled, M; Braganza, R; Clarke, JR; Lyall, H; McClure, MO; Mirza, A; Parker, D; Stainsby, C; Taylor, GP; Weber, JN; Wright, A | 1 |
| Aleman, S; Loré, K; Sönnerborg, A; Visco-Comandini, U | 1 |
| Ross, L; St Clair, M; Vavro, C; Zimmermann, A | 1 |
| Burns, DN; Mofenson, LM | 1 |
| Barret, B; Blanche, S; Ciraru-Vigneron, N; Delfraissy, JF; Desguerre, I; Firtion, G; Lacroix, C; Mandelbrot, L; Mayaux, MJ; Rötig, A; Rouzioux, C; Rustin, P; Slama, A; Tardieu, M | 1 |
| Carlo, DJ; Kaplan, MH; Marecki, M; Moss, RB; Patterson, BK; Pawha, S | 1 |
| Ahrens, P; Funk, MB; Hoffmann, F; Kornhuber, B; Kreuz, W; Linde, R; Notheis, G; Schuster, T; Wintergerst, U | 1 |
| Bruno, F; Gastaut, JA; Lang, JM; Partisani, M; Poizot-Martin, I; Rouviere, O; Saint-Marc, T; Touraine, JL | 1 |
| Denayrolles, M; Fleury, H; Izopet, J; Massip, P; Montes, B; Pellegrin, I; Pellegrin, JL; Puel, J; Reynes, J; Segondy, M | 1 |
| Deray, G; Diquet, B; Izzedine, H; Jouan, M; Launay-Vacher, V; Theou, N | 1 |
| Mathew, J; Prabhakar, S; Pulvirenti, J; Roy, VP | 1 |
| Olivero, OA; Parikka, R; Poirier, MC; Vähäkangas, K | 1 |
| Arranz Caso, JA; Garcia Tena, J; Sanchez Mingo, C | 1 |
| Belfrage, E; Bohlin, AB; Christensson, B; Ehrnst, A; Lidin-Janson, G; Ljung, R; Navér, L; Sönnerborg, A | 1 |
| Adorni, F; Citterio, P; d'Arminio-Monforte, A; Galazzi, M; Galli, M; Gianotto, M; Grassini, A; Kurtagic, S; La Seta-Catamancio, S; Milazzo, L; Moroni, M; Rusconi, S; Testa, L | 1 |
| Bicart-See, A; Bonnet, E; Izopet, J; Marchou, B; Massip, P; Pasquier, C; Puel, J; Sandres, K | 1 |
| Gill, MJ; Lacey, L | 1 |
| Lacey, L; Lindrooth, R; Mauskopf, J; Pham, S; Saag, M; Sawyer, W | 1 |
| Behrens, M; Lacey, L; Schrappe, M; Staszewski, S; Trueman, P; Youle, M | 1 |
| Gill, MJ; Hopkinson, PK; Lacey, L; Leblanc, F; Montaner, J | 1 |
| Chatterton, ML; Scott, J; Scott-Lennox, J; Wu, AW | 1 |
| Simonds, RJ | 1 |
| Beltrami, JF; Cardo, DM; Jochimsen, EM; Luo, CC; Respess, RA; Schable, CA | 1 |
| Brown, R; Corbett, C; Thornton, CW | 1 |
| Bardeguez, AD; Blanchard, S; Flynn, PM; Fridland, A; Jimenez, E; Robbins, B; Rodman, JH; Rodriguez, JF | 1 |
| Cohen, MS; Dunn, JA; Eron, JJ; Fiscus, SA; Hall, JE; Kashuba, AD; Pereira, AS; Tidwell, RR; Troiani, L | 1 |
| Bardeguez, A; Borkowsky, W; Deutsch, L; Ho, DD; Huang, Y; Karanicolas, R; Korber, BT; Kostrikis, LG; Koup, RA; Lew, JF; Luzuriaga, K; McHardy, P; McIntosh, K; Moore, JP; Neumann, AU; Oleske, J; Palumbo, P; Pollack, H; Spiegel, HM; Sullivan, J; Thomson, B; Wolinsky, SM | 1 |
| Garcia, PM; Grobman, WA | 1 |
| Chaovavanich, A; Phuapradit, W; Puchaiwatananon, O; Sunthornkachit, R; Tantanathip, P; Wiratchai, A | 1 |
| Aranda, M; Dorca, E; Force, L; Tapiz, A | 1 |
| Albrecht, D; Lorenzen, T; Plettenberg, A; Stoehr, A; Weitzel, T | 1 |
| Martin, EM; Mullane, KM; Novak, RM; Pitrak, DL; Pursell, KJ | 1 |
| Black, FT; Blaxhult, A; Gerstoft, J; Jensen-Fangel, S; Kirk, O; Larsen, L; Lundgren, JD; Obel, N; Pedersen, C | 1 |
| Britto, P; Cunningham, BE; Mandelbrot, L; Shapiro, DE; Sperling, RS | 1 |
| Mandelbrot, L | 2 |
| Font, E; García, H; Rodriguez, JF; Rosario, O; Santana, J; Sommadossi, JP | 1 |
| Alesse, E; Boschini, A; Cifone, MG; De Simone, C; Di Marzio, L; Famularo, G; Marcellini, S; Moretti, S; Parroni, R; Zazzeroni, F | 1 |
| Agostoni, C; Bucceri, AM; Ferraris, G; Marini, A; Rancilio, L; Ravizza, M; Riva, E; Zuccotti, GV | 1 |
| Temesgen, Z; Wright, AJ | 1 |
| Arlotto, C; Bernard, A; Bernard-Pomier, G; Breittmayer, JP; Dellamonica, P; Pradier, C; Pugliese, P; Roger, PM | 1 |
| Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Voltersvik, P | 1 |
| Arrizabalaga, J; Clotet, BG; Cruceta, A; Dalmau, D; Gallart, T; García, F; Gatell, JM; Gomez-Sirvent, JL; Grau, I; Knobel, H; Miró, JM; O'Brien, WA; Podzamczer, D; Pumarola, T; Romeu, J; Sambeat, MA | 1 |
| Antunes, F; Brown, DJ; Clumeck, N; Fetter, A; Haubrich, R; Kahl, L; Lang, W; Pagano, G; Richman, D; Schooley, R; Sereni, D; Stein, A; Thompson, M; van der Ende, ME | 1 |
| Farina, D; Johnson, P; Labriola, DF; Manion, DJ; Morales-Ramirez, J; Rachlis, A; Ruiz, NM; Skiest, D; Stanford, J; Staszewski, S; Stryker, R; Tashima, KT | 1 |
| Mallolas, J | 1 |
| Flepp, M; Jost, J; Ledergerber, B; Opravil, M; Paris, D; Ruef, C; Weber, R; Zimmerli, S | 1 |
| Connick, E; Kessler, H; Kuritzkes, D; Landay, AL; Lederman, MM; Olinger, G; Spear, GT; Spritzler, J; St Clair, M; Sullivan, BL; Wu, H | 1 |
| Borleffs, JC; Boucher, CA; de Boer, RJ; Hamann, D; Hazenberg, MD; Miedema, F; Otto, SA; Stuart, JW | 1 |
| Chaisilwattana, P; Chaowanachan, T; Chearskul, S; Chuachoowong, R; Karon, J; Mastro, TD; Mock, PA; Shaffer, N; Simonds, RJ; Siriwasin, W; Waranawat, N; Young, NL | 1 |
| Ap, S; Berrey, MM; Brown, DJ; Corey, L; Huang, Y; Malhotra, U; Markee, J; McElrath, MJ; Musey, L; Schacker, T | 1 |
| Connick, E; Francis, I; Gross, B; Kessler, HA; Kuritzkes, D; Landay, A; Lederman, MM; McCune, JM; Smith, KY; Spritzler, J; Valdez, H | 1 |
| Chiozzi, MH; Connick, E; D'Arc Roe, J; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Rousseau, F; Sevin, AD; Spritzler, J; St Clair, M | 1 |
| Anderson, RM; Danner, SA; deWolf, F; Donnelly, CA; Ferguson, NM; Fraser, C; Garnett, GP; Ghani, AC; Goudsmit, J; Lange, JM; Reiss, P | 1 |
| Avrămescu, C; Balasoiu, M; Radu, E; Turculeanu, A; Voiculescu, C | 1 |
| Katlama, C | 1 |
| Falloon, J; Imamichi, H; Imamichi, T; Lane, HC; Metcalf, JA; Sinha, T; Zhang, YM | 1 |
| De Cabooter, N; Plum, J; Van Der Gucht, B; Verhofstede, C; Wanzeele, FV | 1 |
| Kottow, MH | 1 |
| Abel, S; Bera, O; Cabié, A; Césaire, R; Dos Santos, G; Sobesky, G | 1 |
| Aboulker, JP; Bazin, B; Brun-Vézinet, F; Calvez, V; Collin, G; Delaugerre, C; Descamps, D; Flandre, P; Meiffredy, V; Peytavin, G; Pialoux, G; Raffi, F; Robert-Delmas, S | 1 |
| Collier, AC; Havlir, DV; Hellmann, NS; Hirsch, MS; Petropoulos, CJ; Richman, DD; Sommadossi, JP; Tebas, P; Whitcomb, JM | 1 |
| Lyall, H; Poulton, J; Taylor, G; Williams, GT | 1 |
| Enting, RH; Foudraine, NA; Jurriaans, S; Lange, JM; Portegies, P; van der Poll, T; Weverling, GJ | 1 |
| Bartz-Schmidt, KU; Cornely, OA; Fricke, J; Lehrer, E; Lüke, C | 1 |
| Holtgrave, DR; Layde, PM; Pinkerton, SD | 1 |
| Evans, DW | 1 |
| Asjö, B; Baklien, K; Brantsaeter, AB; Bruun, JN; Dunlop, O; Dyrhol-Riise, AM; Røsok, BI; Skar, AG | 1 |
| Borkowsky, W; Fiscus, S; Jimenez, E; Lee, S; McIntosh, K; Mofenson, L; Nachman, SA; Pelton, S; Pitt, J; Rathore, M; Smith, ME; Stanley, K; Wells, B; Wiznia, A; Yogev, R | 1 |
| Cameron, S; Codere, G; Fletcher, C; Goldberg, D; Hutchinson, S; Johnston, J; McMenamin, J; Raeside, F; Stewart, M | 1 |
| Lucchesi, C; Simini, B | 1 |
| Cornelisse, PG; Craib, KJ; Hogg, RS; Montaner, JS; Montessori, V; O'Shaughnessy, MV; Yip, B | 1 |
| Bowen, A; Elwood, W; Freeman, R; Ross, M; Williams, M | 1 |
| Bakhtiari, M; Connick, E; Kessler, H; Kuritzkes, DR; Landay, A; Lederman, MM; Sevin, A; Spritzler, J; St Clair, M; Wu, H; Young, B | 1 |
| Copeland, KF; Fransen, S; Rosenthal, KL; Smaill, F; Smieja, M | 1 |
| Alexander, CS; Harrigan, PR; Mo, T; Montaner, JS; Raboud, JM; Rae, S; Rouleau, D; Zala, C | 1 |
| Simon-Meyer, J | 1 |
| Alcorn, T; Bloor, S; De Vroey, V; Dehertogh, P; Hertogs, K; Larder, BA; Miller, V; Stürmer, M; van Cauwenberge, A; van Den Eynde, C; van Houtte, M; Wegner, S | 1 |
| Gazzard, BG; Moyle, GJ | 2 |
| Albrecht, H; Hufert, FT; Lauer, J; Racz, P; Schneider, C; Stellbrink, HJ; Tenner-Racz, K; van Lunzen, J | 1 |
| Gartland, M; Gatell, J; Lange, J | 1 |
| Giorgi, JV; Killian, S; Kitchen, SG; Zack, JA | 1 |
| Campi, G; Casorati, G; Corey, L; Demarest, JF; Kaufmann, D; Lazzarin, A; Lenge, C; Pantaleo, G; Rizzardi, GP; Soudeyns, H; Tambussi, G | 1 |
| Byers, RH; Lindegren, ML; Steinberg, S | 1 |
| Murray, JD; Nelson, PW; Perelson, AS | 1 |
| Anderson, J; El-Gadi, S; Forster, G; Murphy, M; Parkin, JM; Pinching, AJ | 1 |
| Bassetti, S; Bisset, LR; Cone, RW; Fischer, M; Huber, W; Knuchel, MC; Lorenzi, P; Lüthy, R; Opravil, M; Ott, P; Roos, M; Vernazza, PL; Weber, R | 1 |
| Bakhtiari, M; Eron, JJ; Gingeras, TR; Johnson, J; Kennedy, M; Kuritzkes, DR; Poticha, D; Rubin, M; Shugarts, D | 1 |
| Coakley, EP; Gillis, JM; Hammer, SM | 1 |
| Ait-Khaled, M; Cutrell, A; Griffin, P; Harrigan, R; Katlama, C; Mesogiti, D; Miller, V; Pearce, G; Staszewski, S; Stone, C; Tisdale, M | 1 |
| Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Røsok, BI; Voltersvik, P | 1 |
| Currier, MM; Gay, H; Palmer, AL | 1 |
| Bamji, M; Healton, C; Messeri, P; Taylor, S; Weinberg, G | 1 |
| Albano, F; Berni Canani, R; Guarino, A; Spagnuolo, MI | 1 |
| Andreotti, M; Bricalli, D; Clerici, M; Dally, LG; Di Fabio, S; Ferrante, P; Pirillo, M; Principi, N; Saresella, M; Vanzulli, A; Vella, S; Vigano, A | 1 |
| Chung, PH; Colgrove, R; Colson, A; Fowler, MG; Hanson, C; Japour, AJ; Landesman, S; Lockman, S; McIntosh, K; Moye, J; Pitt, J; Rich, KC; Welles, SL; Zorrilla, C | 1 |
| Beguinot, I; Bernard, P; Derancourt, C; Drobacheff, C; Verraes, S | 1 |
| Clumeck, N | 1 |
| Bart, PA; Chapuis, A; De Boer, RJ; Fox, CH; Halkic, N; Hoover, S; Lange, JM; Lazzarin, A; Miller, V; Notermans, DW; Pantaleo, G; Perrin, L; Rizzardi, GP; Staszewski, S; Tambussi, G | 1 |
| Driscoll, M; Rahimian, A; Taylor, D | 1 |
| Molitor, F; Ruiz, JD | 1 |
| Arion, D; Götte, M; Parniak, MA; Wainberg, MA | 1 |
| Cartoux, M; Dabis, F; Fransen, L; Lepage, P; Leroy, V; Meda, N; Msellati, P; Nduati, R; Newell, ML; Peckham, C; Saba, J; van de Perre, P; Vincenzi, ID; Whynes, DK | 1 |
| Dong, BJ; Luber, AD | 1 |
| Aoki, M; Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamaguchi, M; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
| Aizawa, S; Aoki, M; Ida, S; Kikuchi, Y; Oka, S; Sakai-Hachiya, A; Tachikawa, N; Yasuoka, A | 1 |
| Delaney, JA; Fraser, VJ; Goergen, CA; Mundy, LM; Smits, AK; Williamson, C | 1 |
| Chadwick, KR; Finzi, D; Hutton, N; Margolick, JB; Persaud, D; Pierson, T; Ray, S; Ruff, A; Ruff, C; Siliciano, RF | 1 |
| Borowski, L; Day, RB; Fan, Z; Hildebrand, WH; Hoji, A; Huang, XL; Kalinyak, C; Margolick, JB; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR | 1 |
| Diaz, C; Febo, I; Font, E; Garcia, R; Rodriguez Orengo, JF; Rodriguez, JL; Rosario, O; Santana, J | 1 |
| Chow, KC; Lau, SM; Wang, JH; Yu, WL | 1 |
| Bucciardini, R; Fragola, V; Harrigan, PR; Montaner, JS; Raboud, JM; Rae, S; Ricciardulli, D; Vella, S | 1 |
| Bernstein, L; Golodner, M; Liu, GQ; Mizrachi, Y; Ochs, HD; Rubinstein, A; Shliozberg, J | 1 |
| Butler, KM; Clarke, SM; Condon, S; Healy, CM; Mulcahy, F | 1 |
| Barrio, C; Bastero, R; Contreras, JR; Delgado, R; Jiménez, J; Moreno, P; Muñoz, E; Ramos Amador, JT | 1 |
| Bassiakos, Y; Batts, D; Cox, S; Demeter, LM; Fischl, MA; Leedom, J; Morse, GD; Para, M; Powderly, W; Reichman, RC; Resnick, L; Timpone, J | 1 |
| Babiker, A; de Rossi, A; Gibb, DM; Grosch-Woerner, I; Klein, N; Newberry, A | 1 |
| Clotet, B; De Clercq, E; Desmyter, J; Evans, C; Hermans, P; Muyldermans, G; Ruiz, L; Schmit, JC; Schneider, F; Simons, P; Stuyver, L; Van Laethem, K; Van Vaerenbergh, K; Van Wanzeele, F; Van Wijngaerden, E; Vandamme, AM; Verhofstede, C | 1 |
| Angel, JB; Badley, AD; Cameron, DW; Cassol, S; Chambers, KA; Gallicano, K; Hawley-Foss, N; Kravcik, S; Mandy, F; Parato, K; Phenix, BN | 1 |
| Asavapiriyanont, S; Bhadrakom, C; Hannon, WH; Mastro, TD; Mei, JV; Moore, KH; Sangtaweesin, V; Shaffer, N; Simonds, RJ; Vanprapar, N; Young, NL | 1 |
| Boag, F; Easterbrook, PJ; Gazzard, B; Goetghebeur, E; McLean, K; Yu, LM | 1 |
| Currier, JS; D'Aquila, RT; Eron, JJ; Fiscus, SA; Gulick, RM; Lennox, JL; Murphy, RL; Rogers, MD; Smeaton, LM; Tung, R | 1 |
| Casado, JL; Moreno, S | 1 |
| Babiker, A; Collins, R; Darbyshire, J; Duncan, W; Foulkes, M; Hughes, M; Peto, R; Peto, T; Walker, A | 4 |
| Miyakuni, T; Sato, H; Shibamura, K; Shiino, T; Takebe, Y; Tomita, Y | 1 |
| Clezy, K; Emery, S | 1 |
| Grayson, ML; Hammer, SM; Hanvanich, M; Hughes, MD; Phanuphak, P; Ratanasuwan, W; Ruxrungtham, K; Sirivichayakul, S; Suwanagool, S; Ubolyam, S; Wanke, CA | 1 |
| Becker, S; Eron, JJ; Fisher, RL; Ruane, PJ; Sawyer, GA; Shaefer, MS; Tolson, JM; Yetzer, ES | 1 |
| Ganoczy, DA; Halpern, MT; Harris, DR; Read, JS | 1 |
| Tovo, PA | 1 |
| Fadnis, VP | 1 |
| Baker, R; Chougnet, C; Kovacs, A; Liewehr, DJ; Luban, NL; Mueller, BU; Shearer, GM; Steinberg, SM; Thomas, EK | 1 |
| Allende, MC; Belloso, WH; Benetucci, JA; Cahn, PE; Davey, RT; Emery, S; Lane, HC; Lasala, MC; Law, MG; Lopardo, G; Losso, MH; Nelson, E; Salomon, H; Saracco, M | 1 |
| Clewley, G; Devereux, HL; Emery, VC; Griffiths, PD; Lee, CA; Loveday, C; Phillips, AN; Sabin, CA | 1 |
| Marczyńska, M; Szczepańska-Putz, M | 1 |
| Albright, J; Mauskopf, JA; Pham, SV; Simpson, KN; Tolson, JM | 1 |
| Agnoli, M; Al-Harthi, L; Landay, A; Pottage, J; Siegel, J; Spritzler, J | 1 |
| Carrington, M; Havlir, DV; Ioannidis, JP; McDermott, DH; Murphy, PM; O'Brien, TR; Richman, DD | 1 |
| Martínez, E; Moreno, S | 1 |
| Bonard, D; Castetbon, K; Dabis, F; Dumon, MF; Malvy, D; Manigart, O; Thomas, MJ; Van de Perre, P | 1 |
| Anderson, R; Boerner, D; Diquet, B; Girard, PM; Pegram, PS; Raffi, F; Sereni, D; Tubiana, R | 1 |
| Beylot, J; Dabis, F; Dequae-Merchadou, L; Marimoutou, C; Mercié, P; Morlat, P; Neau, D; Pellegrin, I | 1 |
| Alvarez, A; Barreiro, P; Briones, C; de Mendoza, C; Gallego, O; González-Lahoz, J; Soriano, V | 1 |
| Burger, DM; de Graeff-Meeder, ER; De Groot, R; Geelen, SP; Hartwig, NG; Hop, WC; Niesters, HG; Osterhaus, AD; Scherpbier, HJ; Slieker, WA; Suur, MH; van Rossum, AM; Veerman, AJ; Weemaes, CM | 1 |
| Anwar, D; Geené, D; Goehring, C; Hirschel, B; Saaïdia, A; Sudre, P | 1 |
| Parazzini, F; Pardi, G; Ricci, E | 1 |
| Boschini, A; Calista, D | 1 |
| Balotta, C; Berlusconi, A; Colombo, MC; Corvasce, S; Facchi, G; Galli, M; Gori, A; Mazzucchelli, R; Moroni, M; Pan, A; Papagno, L; Riva, C; Rusconi, S; Saporetti, G; Velleca, R; Violin, M | 1 |
| Conway, B; Cooper, DA; Gaudet, R; Hirschel, B; Imrie, A; Perrin, L; Rouleau, D; Vanhems, P; Vizzard, J; Yerly, S | 1 |
| Murdaugh, C; Phillips, KD; Sowell, RL; Tavokali, A | 1 |
| Back, DJ; Gibbons, SE; Hoggard, PG; Karbwang, J; Khoo, SH; Na Bangchang, K; Phiboonbhanakit, D; Wattanagoon, Y | 1 |
| Bordes, I; Cotte, L; Detmer, J; Kolberg, J; Leriche-Guerin, K; Regis, C; Ritter, J; Trabaud, MA; Trépo, C | 1 |
| Grosch-Wörner, I; Seel, K | 1 |
| Bray, D; Clerici, M; Colombo, F; Dix, LP; Fusi, ML; Milazzo, F; Piconi, S; Rizzardini, G; Trabattoni, D | 1 |
| Bucceri, A; Fiore, S; Guerra, B; Muggiasca, ML; Pardi, G; Ravizza, M; Semprini, AE; Spinillo, A | 1 |
| Laird, NM; Pauler, DK | 1 |
| Fitzmaurice, GM; Ibrahim, J; Lipsitz, SR; Molenberghs, G | 1 |
| Blattner, W; Burns, DN; Charurat, M; Cooper, ER; Hoff, R | 1 |
| Aladdin, H; Dickmeiss, E; Gerstoft, J; Hede, A; Jørgensen, LB; Katzenstein, TL; Nielsen, C; Nielsen, H | 1 |
| Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT | 1 |
| Abrams, EJ; Bulterys, M; Kuhn, L; Lambert, G; Nesheim, SR; Palumbo, P; Schoenbaum, EE; Vink, PE; Weedon, J | 1 |
| Fife, KH; Fox, L; Friedland, GH; Havlir, DV; Kessler, H; Pollard, RB; Richman, DD; Smeaton, L; Sommadossi, JP; Tierney, C | 1 |
| Fowler, MG; Mofenson, LM | 1 |
| Cohen, MS; Dunn, JA; Eron, JJ; Hall, JE; Kenney, KB; Pereira, AS; Tidwell, RR | 1 |
| Carr, A; Chuah, J; Cooper, DA; Emery, S; French, M; Hoy, J; Hudson, J; Law, M; Sayer, D | 1 |
| Chieco-Bianchi, L; De Rossi, A; Del Mistro, A; Giaquinto, C; Zamarchi, R | 1 |
| Lou, Y; McDowell, JA; Stein, DS; Symonds, WS | 1 |
| Bavoux, F; Blanche, S; Loubeyre-Unique, C | 1 |
| Baker, CJ; Barroga, CF; Englund, JA; Fangon, MC; Palumbo, PE; Raskino, C; Spector, SA | 1 |
| Atkinson, B; Isaacson, J; Knowles, M; Mazabel, E; Patick, AK | 1 |
| Bethel, J; Fowler, MG; Lambert, JS; Read, J; Stiehm, ER; Watts, DH; Whitehouse, J | 1 |
| Bouvet, E; Casalino, E | 1 |
| Hang, A | 1 |
| James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB | 1 |
| Buranapraditkul, S; Chuenyam, M; Cooper, DA; Kroon, ED; Kunanusont, C; Lange, JM; Newell, ME; Phanuphak, P; Ruxrungtham, K; Sirivichayakul, S; Ubolyam, S; Ungsedhapand, C; van Leeuwen, R | 1 |
| Bethel, J; Fowler, MG; Gandia, J; Hammill, H; Harris, DR; Jimenez, E; Kovacs, A; Lambert, JS; Maupin, R; Mofenson, L; O'Sullivan, MJ; Scott, G; Shearer, WT; Silio, M; Stek, A; Stiehm, ER; van Dyke, R; Watts, DH; Whitehouse, J | 1 |
| Bulterys, M; de Maria, A; Denamur, E; Dunn, DT; Kalish, LA; Kind, C; Krivine, A; Loveday, C; Moye, J; Newell, ML; Rudin, C; Simonds, RJ | 1 |
| de Souza, RS; Gómez-Marín, O; Guasti, S; Mitchell, CD; O'Sullivan, MJ; Oliveira, RH; Scott, GB | 1 |
| Anderson, PL; Balfour, HH; Brundage, RC; Fletcher, CV; Henry, K; Noormohamed, SE | 1 |
| Dresse, MF; Hoyoux, C; Nkoghe, D; Schmitz, V | 1 |
| Ahmed, PS; Bedard, J; Bowlin, TL; Chambers, P; Clarke, J; Kelly, LA; Rando, RF; Taylor, DL; Tyms, AS; Wood, LJ | 1 |
| Bryson, YJ; Deville, J; Equils, O; Garratty, E; Krogstad, P; Nielsen, K; Plaeger, S; Sim, MS; Tapia, M; Wei, LS | 1 |
| Bergamini, A; Bolacchi, F; Bongiovanni, B; Capozzi, M; Cappelli, G; Cepparulo, M; Colizzi, V; Mancino, G; Rocchi, G; Uccella, I | 1 |
| Binley, JM; Clas, B; Hurley, A; Ketas, T; Little, S; Markowitz, M; Moore, JP; Richman, D; Schiller, D; Trkola, A | 1 |
| Berrey, MM; Burckhardt, B; Clumeck, N; Cooper, DA; Corey, L; Lazzarin, A; Markowitz, M; Mehrotra, D; Perrin, L; Robertson, M; Smith, D; Weber, R | 1 |
| Francke, S; Hayes, KA; Mathes, LE; Phipps, AJ | 1 |
| Fiore, S; Newell, ML | 1 |
| Barzilai, A; Soen-Grisaru, G | 1 |
| Brumback, B; Hernán, MA; Robins, JM | 2 |
| Coovadia, HM; Coutsoudis, A | 1 |
| Gathiram, V | 1 |
| Babiker, AG; Clarke, JR; Hooker, MH; Kaye, S; Tedder, R; Weber, JN | 1 |
| Angarano, G; Bagnarelli, P; Balotta, C; Berlusconi, A; Clementi, M; Facchi, G; Galli, M; Lippi, M; Monno, L; Moroni, M; Riva, C; Rusconi, S; Violin, M | 1 |
| Anderson, CE; Cocroft, J; Hauck, WW; Newschaffer, CJ; Turner, BJ | 1 |
| Degen, O; Stellbrink, HJ; van Lunzen, J | 1 |
| Andreotti, M; Binelli, A; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, MC; Giannini, G; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE | 1 |
| Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M | 1 |
| Collier, AC; Havlir, DV; Hirsch, MS; Ioannidis, JP; Richman, DD; Tebas, P | 1 |
| Clark, R; Cohen, C; Cooley, T; Grosso, R; Gulick, R; Marlowe, SI; Mauney, J; Mulanovich, V; Santana, J; Schoellkopf, N; Squires, KE; Stevens, M; Tebas, P; Uffelman, K; Wright, D; Yangco, B | 1 |
| Bellos, N; Eron, JJ; Esinhart, J; Grosso, R; Jemsek, J; Murphy, RL; Parenti, DM; Peterson, D; Pottage, J; Rashbaum, BC; Schoellkopf, N; Sepulveda, G; Stevens, M; Swindells, S | 1 |
| Akksilp, S; Amornwichet, P; Kanshana, S; Kullerk, N; Limpakarnjanarat, K; Mastro, TD; Sereesittipitak, V; Simonds, RJ; Teeraratkul, A; Thewanda, D | 1 |
| Belohradsky, BH; Rolinski, B; Stojanov, S; Wintergerst, U | 1 |
| Bricker, JT; Colan, SD; Easley, KA; Kaplan, S; Lai, WW; Lipshultz, SE; McIntosh, K; Moodie, DS; Orav, EJ; Sopko, G; Starc, TJ | 1 |
| Cooper, PA; Gray, GE; Jivkov, BI; Lala, SG; Schorn, MC | 1 |
| Kennedy, I; Williams, S | 1 |
| Bohlin, AB; Lidman, K; Lindgren, S; Sönnerborg, A | 1 |
| Casper, C; Ehrnst, A | 1 |
| Arathoon, E; Benetucci, L; Cahn, P; Chodakewitz, J; Chung, MO; Collier, AC; Currier, J; de Jesus Pedro, R; Gallant, JE; Haas, DW; Harvey, C; Lewi, DS; Mehrotra, D; Nguyen, BY; Noriega, LM; Paar, D; Ramirez-Ronda, CH; Thompson, MA; Uip, DE; Uribe, P; White, AC | 1 |
| Koranyi, K; Nahata, MC; Pai, VB | 1 |
| Bamberger, JD; Hirozawa, A; Katz, MH; Kimmerling, R; Myles, JE | 1 |
| Clavel, F; Mammano, F; Race, E | 1 |
| Bower, M; Gazzard, BG; Mandalia, S; Matthews, GV; Moyle, GJ; Nelson, M | 1 |
| Cotton, DJ; Currier, JS; Grimes, J; Hammer, SM; Hughes, MD; Katzenstein, DA; Spino, C; Wofsy, CB | 1 |
| Comeau, AM; Essex, M; Jourdain, G; Kim, S; Koetsawang, S; Lallemant, M; Le Coeur, S; McIntosh, K; Phoolcharoen, W; Vithayasai, V | 1 |
| Albrecht, MA; Balfour, HH; Hammer, SM; Hughes, MD; Katzenstein, DA; Liou, SH; Murphy, R; Para, MF; Valdez, H | 1 |
| Bajaj, K; Kavlick, MF; Marchand, C; Mitsuya, H; Owen, J; Pilon, AA; Pommier, Y | 1 |
| Kirby, H | 1 |
| Greenwood, MJ | 1 |
| Belec, L; Costagliola, D; Kazatchkine, MD; Ledeine, JM; Mohammed, AS; Troccaz, M; Van, PN | 1 |
| García, H; Rodriguez, JF; Rodriguez, JL; Rosario, O; Santana, J | 1 |
| Bentwich, Z; Chiodo, F; Concia, E; de Cian, W; Freimuth, WW; Gatell, AJ; Greenwald, C; Hawkins, DA; Hirschel, B; Joly, V; Jost, J; Lazzarin, A; Love, WC; Moroni, M; Vetter, N; Wilkins, EG | 1 |
| Barretto, OC; Ebner-Filho, W; Medeiros, TM; Miguita, K; Nonoyama, K; Oshiro, M; Poli-Neto, A; Watanabe, CI | 1 |
| Anderson, PL; Brundage, RC; Bushman, LR; Fletcher, CV; Kakuda, TN; Kawle, SP; Remmel, RP; Weller, D | 1 |
| Boers, PH; Gruters, RA; Guillon, C; Ly, TD; Osterhaus, AD; Schutten, M; van der Ende, ME | 1 |
| Alonso, MM; Arrizabalaga, J; Clotet, B; Cruceta, A; Dalmau, D; Ferrer, E; Frances, A; Gallart, T; García, F; Gatell, JM; Gomez-Sirvent, JL; Knobel, H; Miró, JM; O'Brien, WA; Pumarola, T; Romeu, J; Ruiz, I; Segura, F; Vidal, F | 1 |
| Cotton, MF; Pijnenburg, MW | 1 |
| Fleury, L; Lolom, I; Pellissier, G | 1 |
| Bonfanti, P; Carradori, S; Faggion, I; Gabbuti, A; Iemoli, E; Landonio, S; Niero, F; Pusterla, L; Quirino, T; Ricci, E | 1 |
| Bulgheroni, E; Chou, TC; Citterio, P; Croce, F; Galli, M; Herrmann, SH; Hirsch, MS; La Seta Catamancio, S; Merrill, DP; Rusconi, S; Yang, OO | 1 |
| Brothers, CH; Feinberg, J; Fischl, M; Goodgame, JC; Hardy, WD; Jablonowski, H; Morrow, P; Nacci, P; Pedneault, L; Pottage, JC; Stein, A; Vafidis, I; Yeo, J | 1 |
| Jackson, JH | 1 |
| Dyer, WB; Saksena, NK; Sullivan, JS; Wang, B; Wang, YM; Workman, C | 1 |
| Birch, C; Cunningham, AL; Dwyer, DE; Haddad, DN; Middleton, T; Saksena, NK | 1 |
| Moschovi, M; Papaevangelou, V; Theodoridou, M; Tzortzatou-Stathopoulou, F | 1 |
| La Seta Catamancio, S; Parker, D; Rusconi, S; Sheridan, F | 1 |
| Escolano, C; Gregori, J; Gutiérrez, F; Moltó, J; Mora, A; Nogueira, E; Pasquau, F | 1 |
| Giménez-Doménech, R; Kindelán, JM; Madueño, J; Vidal-Verdú, E | 1 |
| Guerra Romero, L; Parras Vázquez, F | 1 |
| Andreotti, M; Bucciardini, R; Floridia, M; Fragola, V; Galluzzo, CM; Giannini, G; Marzi, M; Massella, M; Mirra, M; Pirillo, MF; Ricciardulli, D; Tomino, C; Vella, S; Weimer, LE; Wu, AW | 1 |
| de Ronde, A; de Rooij, E; Goudsmit, J; Lange, J; van Dooren, M; van Gemen, B | 1 |
| Agy, M; Anderson, D; Bui, T; Finn, E; Herz, AM; Ho, RJ; Larsen, K; Morton, WR; Nosbisch, C; Schmidt, A; Sherbert, C; Unadkat, JD; Wang, XY | 1 |
| Allen, DY; Carlan, S; Cu-Uvin, S; Dobles, AR; Garb, J; Harwell, JI; Jones, TB; Morris, AB; Vajaranant, M; Zorrilla, C | 1 |
| Fiore, TC; Tashima, KT | 1 |
| Arnaiz, JA; Blanco, JL; Carné, X; Codina, C; Cruceta, A; García-Viejo, MA; Gatell, JM; Giner, V; Mallolas, J; Martínez, E; Pumarola, T; Sarasa, M; Soriano, A; Soy, D; Tuset, M | 1 |
| Gonzalez-Muñoz, M; Madrigal, P; Martinez-Rodriguez, S; Polo, R; Verdejo, J | 1 |
| Darque, A; Moore, JD; Sommadossi, JP; Valette, G; Zhou, XJ | 1 |
| Ceballos-Garcia, L; Ceballos-Salobreña, A; Gaitán-Cepeda, LA; Lezama-Del Valle, D | 1 |
| Acosta, EP; Anderson, PL; Brundage, RC; Fletcher, CV; Henry, K; Kakuda, TN; Page, LM; Rhame, FS; Schacker, TW | 1 |
| Fukuda, Y; Hayakawa, T; Hayashi, K; Katano, Y; Nakano, I; Takamatsu, J; Toyoda, H; Yokozaki, S | 1 |
| Alonso, R; Bellón, JM; Muñoz-Fernández, MA; Resino, S | 1 |
| Butera, ST; Heneine, W; Pau, CP; Roberts, BD; Weinstock, H | 1 |
| Rogers, MF; Stockton, PL | 1 |
| Eisinger, RW; Nathanson, N | 1 |
| Fleming, P; Gordon, L; Lindegren, ML; Rhodes, P | 1 |
| Haas, RH | 1 |
| Baker, R; Chougnet, CA; Khoury, MM; Kovacs, AA; Olivero, OA; Poirier, MC; Shearer, GM; Stek, AM | 1 |
| Mirochnick, M | 1 |
| Brenner, BG; Wainberg, MA | 1 |
| Bouwhuis, D; de Boer, R; de Ronde, A; de Rooij, E; Goudsmit, J; van Der Hoek, L; van Dooren, M; van Gemen, B | 1 |
| Lackey, DP | 1 |
| Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA | 1 |
| Murdaugh, C; Russell, RB; Sowell, R | 1 |
| Fleury, H; Garrigue, I; Izopet, J; Massip, P; Montes, B; Pellegrin, I; Pellegrin, JL; Puel, J; Reynes, J; Segondy, M | 1 |
| Fernandez, AD; McNeeley, DF | 1 |
| Acosta, EP; Collier, AC; Havlir, DV; Hirsch, M; Richman, DD; Sommadossi, JP; Tebas, P; Zhou, XJ | 1 |
| Feiterna-Sperling, C; Grosch-Wörner, I; Maier, RF; Obladen, M; Schäfer, A; Seel, K; Weigel, R | 1 |
| Bien, DD; Khongphatthanayothin, M; Kunanusont, C; Phanuphak, P; Poolcharoen, W; Rongkavilit, C; Sirivichayakul, S; Thisyakorn, U | 1 |
| Tamari, M | 1 |
| Brown, T; Feingold, AR; Meislich, D; Rudy, BJ; Rutstein, RM | 1 |
| Chen, KT; Sell, RL; Tuomala, RE | 1 |
| Alejo, A; García, ML; Palomares, JC; Perea, EJ; Romero, J; Terrero, E; Torres, MJ | 1 |
| French, MA; Price, P | 1 |
| Bellman, PC; Fisher, RL; Henry, K; Liao, Q; Norris, D; Ross, LL; Shaefer, MS; Wallace, RJ | 1 |
| Anastos, K; Augenbraun, M; Berhane, K; Cohen, M; Gange, SJ; Levine, AM; Masri-Lavine, L; Newman, M; Sanchez, M; Watts, H; Young, M | 1 |
| Becker, SL; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Igboko, EF; Raffanti, SR; Slatko, GH | 1 |
| Dworkin, MS; Wan, PT | 1 |
| Albrecht, M; Balfour, H; Hammer, S; Hughes, MD; Katzenstein, DA; Liou, SH; Murphy, R; Para, M | 1 |
| Atamasirikul, K; Hetrakul, P; Panburana, P; Phaupradit, W; Sirinavin S, S; Taneepanichskul, S; Thakkinstian, A | 1 |
| Bamberger, JD; Chambers, D; Chesney, M; Coates, TJ; Franses, K; Kahn, JO; Katz, MH; Martin, JN; Roland, ME | 1 |
| Collier, AC; Hirsch, MS; Hoering, A; Kuroda, MJ; Letvin, NL; Lifton, MA; Markee, J; McElrath, MJ; Sabath, DE; Schmitz, JE; Seth, A; Sevin, A | 1 |
| Carr, A; Cooper, DA; Cunningham, PH; Goh, LE; Grey, P; Kaufmann, GR; Smith, D; Suzuki, K; Zaunders, JJ | 1 |
| Back, DJ; Barry, MG; Dann, L; Gibbons, SE; Hoggard, PG; Khoo, SH; Lloyd, J; Loveday, C; Wilkins, EG | 1 |
| Bottasso, OA; Giovannoni, AG; Luraghi, MR; Montero, A; Sen, L | 1 |
| Halpern, SD | 1 |
| Thompson, CA | 1 |
| Hainaut, M; Lepage, P | 1 |
| Cotton, M; Mahumapelo, J; Pead, C; Regensberg, L | 1 |
| Amsden, G; Flaherty, J; Luke, D | 1 |
| Autran, B; Carcelain, G; Damond, F; Dehée, A; Delphin, N; Girard, PM; Jacomet, C; Mariot, P; Nicolas, JC; Rozenbaum, W; Saimot, AG; Schneider, V | 1 |
| Lewis, W | 1 |
| Bhagwat, RV; Changedia, S; Damania, K; Gilada, IS; Karkare, JS; Merchant, RH; Merchant, SR; Oswal, JS | 1 |
| Braun, S; Dippel, E; Ramaker, J; Zouboulis, CC | 1 |
| Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
| Babaki, P; Barré-Sinoussi, F; Charpak, N; de Thé, G; Dovie Akue, JP; Ferreira Rea, M; Huraux, C; Ndiaye, B; Pratomo, H; Samuel, NM; Wilfert, C; Zetterström, R | 1 |
| Back, DJ; Hart, CA; Hoggard, PG; Kewn, S; Khoo, SH; Sales, SD; Sunderland, D | 1 |
| Citterio, P; De Pasquale, MP; Galli, M; Kurtagic, S; La Seta Catamancio, S; Rusconi, S | 1 |
| Achilli, G; Bruno, R; Debiaggi, M; Filice, G; Patruno, SF; Pistorio, A; Romero, E; Sacchi, P; Zara, F | 1 |
| Brotas, V; Cooper, D; Cutrell, A; Gathe, J; Hammer, SM; Hetherington, S; Hicks, C; Isaacs, R; Johnson, M; Keiser, P; Montaner, J; Raffi, F; Spreen, W; Staszewski, S; Steel, H; Thorborn, D; Tortell, S | 1 |
| Jankelevich, S; Mackall, CL; Mueller, BU; Nelson, RP; Nguyen, BY; Pizzo, PA; Serchuck, L; Sleasman, JW; Smith, S; Steinberg, SM; Wood, LV; Yarchoan, R; Zeichner, SL; Zwerski, S | 1 |
| Arendt, G; Hefter, H; Theisen, A; von Giesen, HJ | 1 |
| Dabis, F; Leroy, V; Manigart, O; Meda, N; Montcho, C; Msellati, P; Rouzioux, C; Simonon, A; Van de Perre, P; You, B | 1 |
| Briones, C; del Romero, J; Hertogs, K; Pérez-Olmeda, M; Rodríguez, C; Soriano, V | 1 |
| Domagala, J; Gogliotti, R; Gracheck, S; Heldsinger, A; McQuade, T; Sharmeen, L | 1 |
| Arazo, P; Manero, FJ; Sesma, J | 1 |
| Loveday, C | 1 |
| Fournier, S; Maillard, A; Molina, JM | 1 |
| Kim, EY; Merigan, TC; Oberg, B; Vrang, L | 1 |
| Mendelow, BV; Sanne, I; Smego, RA | 1 |
| Bovolenta, C; Camorali, L; Ghezzi, S; Lazzarin, A; Mauri, M; Nozza, S; Poli, G; Tambussi, G | 1 |
| Brown, AJ; Emini, E; Eron, J; Fiscus, S; Frost, SD; Gamagami, R; Gulick, R; Günthard, HF; Haase, A; Havlir, DV; Ignacio, CC; Isaacs, R; Jonas, L; Meibohm, A; Mellors, J; Richman, DD; Schleif, W; Valentine, F; Wong, JK; Zhang, ZQ | 1 |
| Clerici, M; Gray, G; Kuhn, L; Meddows-Taylor, S; Shearer, GM; Tiemessen, C; Trabattoni, D | 1 |
| Bastian, H; Batallan, A; Benifla, JL; Faucher, P; Madelenat, P; Matheron, S; Morau, G | 1 |
| Achilli, G; Bruno, R; De Santolo, A; Debiaggi, M; Filice, G; Maserati, R; Pistorio, A; Romero, E; Sacchi, P; Spinillo, A; Zara, F | 1 |
| Crémieux, AC; Demarles, D; Gillotin, C; Katlama, C; Raffi, F; Yuen, GJ | 1 |
| Barret, B; Bénifla, JL; Berrebi, A; Blanche, S; Bongain, A; Burgard, M; Chaix, ML; Ciraru-Vigneron, N; Crenn-Hébert, C; Delfraissy, JF; Lachassine, E; Landreau-Mascaro, A; Mandelbrot, L; Mayaux, MJ; Rekacewicz, C; Rouzioux, C | 1 |
| Shaffer, N | 1 |
| Farthing, C; Graham, E; Pilson, RS; Sension, MG; Shaffer, AG; Siemon-Hryczyk, P | 1 |
| Caldwell, P; Furlan, S; Ho, D; Hurley, A; Johnson, J; Kost, RG; Markowitz, M; Smiley, L; Talal, A; Vesanen, M; Zhang, L | 1 |
| Beguinot, I; Bevilacqua, S; Canton, P; Dorvaux, V; May, T; Rabaud, C; Schuhmacher, H | 1 |
| Caruz, A; Falgueras, T; Gatell, JM; Jiménez de Anta, MT; Leal, M; Lissen, E; Mallolas, J; Padró, S; Parra, R; Pumarola, T; Rey, C; Sánchez-Quijano, A; Soriano, E; Torres, Y; Vidal, C | 1 |
| Bassiakos, Y; Bergé, P; Fessel, WJ; Fischl, MA; Grossberg, SE; Hyslop, N; Kasdan, P; Kim, J; Kramer, F; Krown, SE; Marshak, A; Mildvan, D; Paredes, J; Pettinelli, C; Poiesz, B; Rhame, F; Ruprecht, RM; Sacks, HS; Wood, K; Zachary, J; Zucker, ML | 1 |
| Andreoni, M; Angarano, G; Armignacco, O; Boudes, P; Bragman, K; Carosi, G; Chiodera, A; Duncan, I; Facey, K; Floridia, M; Lazzarin, A; Scaccabarozzi, S; Sinicco, A; Tambussi, G; Vella, S | 1 |
| Denereaz, N; Hirschel, B; Mermillod, B; Perrin, L; Yerly, S | 1 |
| Altisent, C; Bravo, R; García-Samaniego, J; Gómez-Cano, M; González-Lahoz, J; Ruiz, I; Soriano, V | 1 |
| Berry, S; Bozzette, SA; Duan, N; Kanouse, DE; Richman, DD | 1 |
| Hirsch, MS; Yeni, P | 1 |
| Foli, A; Lisziewicz, J; Lori, F; Maserati, R; Minoli, L; Tinelli, C | 1 |
| Caselli, D; Gabiano, C; Galli, L; Gattinara, GC; La Regina, A; Marchisio, P; Paga, C; Principi, N; Zuccotti, G | 1 |
| Chaisson, RE; Erbelding, EJ; Gallant, JE; Moore, RD | 1 |
| Boucher, CA; Danner, SA; Lange, JM; Nijhuis, M; Reiss, P; Schuurman, R; van Leeuwen, R | 1 |
| Kahn, MA | 1 |
| Beltangady, M; Cross, A; Dolin, R; Dunkle, L; Gatell, J; Hammer, SM; Hughes, MD; Kahn, J; Katzenstein, DA; Montaner, JS; Pavia, A; Raboud, JM; Rae, S; Smaldone, L | 1 |
| Boerner, D; Bogner, JR; Goebel, FD; Herrmann, DB; Hoegl, L; Jost, V; Mühlhöfer, A; Roecken, M; Thoma-Greber, E | 1 |
| Boerner, D; Bogner, JR; Goebel, FD; Gürtler, L; Herrmann, DB; Kaufmann, B; Plewig, G; Roecken, M | 1 |
| Berkhout, B; Boucher, C; Jeeninga, RE; Keulen, W; Sanders, RW | 1 |
| Kessler, HA; Nerad, JL | 1 |
| Fiscus, SA; Hamilton, CD; Hazelwood, JD; Johnson, VA; Parkin, NT; Petropoulos, CJ; Woods, CR | 1 |
| Figdor, E; Rosenfield, A | 1 |
| Khoury, M; Kovacs, A | 1 |
| Ahdieh, L; Greenblatt, RM; Minkoff, H; Schmidt, J; Schneider, M; Stek, A; Watts, H | 1 |
| Fernandez, MI; Ickovics, JR; Koenig, LJ; Walter, E; Wilson, TE | 1 |
| Gray, GE; Semba, RD | 1 |
| Carr, A; Mallon, P; Morey, A; Thorburn, DR; Williams, D | 1 |
| Apoola, A; Sriskandabalan, PS; Wade, AA | 1 |
| Johnson, S | 1 |
| Misener, TR; Phillips, KD; Rush, C; Seals, BF; Sowell, RL | 1 |
| Farley, J; Vink, P | 1 |
| Börner, C; Fernández-Cruz, E; Gurbindo, MD; Muñoz-Fernández, MA; Navarro, J; Obregón, E | 1 |
| Allen, UD; Goeree, R; Kirby, MA | 1 |
| Page, JB; Smith, PC | 1 |
| Phanuphak, P; Vermund, SH | 1 |
| Altare, F; Lala, R; Matarazzo, P; Palomba, E; Tovo, PA | 1 |
| Morrison, JC | 1 |
| Baker, RC; Brady, MT; Hunkler, JA; McOwen, NM; Nahata, MC; Sobol, BJ; Wintermeyer, SM | 1 |
| Harwell, T; Lancioni, C; Rutstein, RM | 1 |
| Mascolini, M | 7 |
| Gilden, D | 5 |
| Linnemeyer, PA | 1 |
| Parks, VE | 1 |
| Cheng, B | 3 |
| Glick, ME | 1 |
| Cotton, D; Watts, H | 1 |
| Kurth, A | 1 |
| Benson, M; Shannon, M | 1 |
| Poscher, M | 1 |
| Conant, M | 1 |
| Torres, G | 5 |
| Rubin, M | 1 |
| Japour, AJ | 1 |
| Levin, J | 1 |
| Romeyn, M | 1 |
| Baker, R | 3 |
| Darko, DF; Mitler, MM; White, JL | 1 |
| Chang, HE | 1 |
| Boucher, CA | 1 |
| Schouten, JT | 1 |
| Bray, JM | 1 |
| Huffbauer, SB | 1 |
| Hanna, L; Highleyman, L | 1 |
| Cockerell, CJ | 1 |
| Gilden, D; Smart, T | 1 |
| Grubman, S | 1 |
| MacDougall, DS | 4 |
| Cooper, EC | 1 |
| Smart, T; Torres, G | 1 |
| Bowersox, J | 4 |
| Randall, P | 2 |
| Elperin, A; Sax, P | 1 |
| Falkenberg, J; Gilden, D; Torres, G | 1 |
| Doepel, L; Folkers, G | 1 |
| Woodward, J | 1 |
| Boonprakong, L | 1 |
| Daily, JP | 1 |
| Hanna, L | 6 |
| Highleyman, L | 2 |
| Baker, R; Bowers, M | 2 |
| Landry, S | 1 |
| Wool, M | 1 |
| Flexner, C | 1 |
| Miller, G | 1 |
| Cadman, J | 5 |
| Farinas, CA | 1 |
| Saba, J | 1 |
| Maenza, JR | 1 |
| Eriksen, N | 1 |
| Arboleda, CH | 1 |
| Denison, R | 2 |
| del Rio, C; Soto-Ramirez, LE | 1 |
| Mirken, B | 1 |
| Kasper, T | 1 |
| Maldonado, M | 1 |
| Sax, PE | 2 |
| Lindsay, MK | 1 |
| Jackson, B | 1 |
| Gold, D; Loftus, R | 1 |
| Dabis, F; Dequae-Merchadou, L; Elenga, N; Leroy, V; Manigart, O; Meda, N; Msellati, P; Sombie, I; Viho, I | 1 |
| Asjö, B; Berg, OG; Dyrhol-Riise, AM; Kleivbo, S; Olofsson, J; Voltersvik, P | 1 |
| Gellett, LR; Haddon, L; Maskell, GF | 1 |
| Borkowsky , W; Essajee, S; Krasinski, K; Pollack, H; Rigaud, M; Rochford, G; Sitnitskaya, Y | 1 |
| Gazzard, BG; Gilleece, Y; Hertogs, K; Pozniak, AL; Torti, C | 1 |
| Khoshnood, K; Patchen, L | 1 |
| Tréluyer, JM | 1 |
| Bonot, P; Caumont, A; Fleury, H; Garrigue, I; Merel, P; Pellegrin, I; Pellegrin, JL; Schrive, MH | 1 |
| Burlina, A; D'Elia, R; De Romeo, A; De Rossi, A; Giacomet, V; Giaquinto, C; Rampon, O; Ruga, E; Sturkenboom, M | 1 |
| Funk, MB; Klingebiel, T; Kreuz, W; Linde, R; Notheis, G; Schuster, T; Wintergerst, U | 1 |
| Blanche, S; Burgard, M; Chaix, ML; Cottalorda, J; Douard, D; Doussin, A; Fleury, H; Izopet, J; Lechenadec, J; Masquelier, B; Mayaux, MJ; Rouzioux, C; Simon, F; Tamalet, C | 1 |
| Buranapraditkun, S; Cooper, DA; Kroon, ED; Kunanusont, C; Lange, JM; Pakker, N; Phanuphak, P; Ruxrungtham, K; Sonjai, A; Suwanagool, S; Tiengrim, S; Ubolyam, S; Ungsedhapand, C; Yimsuan, N | 1 |
| Beijnen, JH; Cooper, DA; Hall, D; Hoetelmans, RM; Lange, JM; Montaner, JS; Reiss, P; Veldkamp, AI; Vella, S; Weverling, GJ | 1 |
| Charbonneau, T; Kamkamidze, G; Sullivan, T | 1 |
| Arbona, SI; Dominguez, K; Doran, TI; Doyle, M; Handal, GA; Hanson, IC; Hauger, SB; Melville, SK; Murphey, DK; Patel, JA; Squires, JE | 1 |
| Avila, MM; Biglione, M; Ceballos, A; Liberatore, D; Pando, ML; Peralta, LM | 1 |
| Drummond, A; Forsberg, R; Rodrigo, AG | 1 |
| Bengalia, G; Bussolati, G; Cavatorta, E; Cocca, G; Degli Antoni, AM; Dodi, I; Fieni, S; Gambini, L; Grignaffini, A; Magnani, G; Ndongko, A; Pedicelli, A; Soncini, E; Verrotti, C; Zoncada, A | 1 |
| Conway, B; Cooper, D; Curry, R; Hall, D; Harris, M; Lange, JM; Montaner, JS; Reiss, P; Robinson, P; Vella, S; Wainberg, MA | 1 |
| Danner, SA; de Boer, RJ; Goudsmit, J; Huismans, R; Jebbink, MF; Lukashov, VV | 1 |
| Gray, L; Levy, J; Newell, ML; Peckham, C; Thorne, C | 1 |
| Antorn, MT; Carreras, R; Castellanos, E; Mur, A; Payá, A; Rovira, MT | 1 |
| Messori, A; Trippoli, S; Vaiani, M | 1 |
| Corzo, JE; Gómez-Mateos , J; Lozano, F; Ramayo, E | 1 |
| Kaye, D | 1 |
| Bassett, R; Collier, AC; Condra, J; Gilbert, P; Günthard, HF; Havlir, DV; Hirsch, MS; Ignacio, C; Levitan, D; Richman, DD; Tebas, P; Wong, JK | 1 |
| Benaglia, G; Cavatorta, E; Fieni, S; Grignaffini, A; Magnani, G; Pelicelli, A; Soncini, E; Verrotti, C | 1 |
| Johnson, MA; Moodley, D; Moodley, J; Moore, KH; Mudd, PN; Naidoo, K; Pakes, GE; Pillay, K | 1 |
| García-Díez, A; Jones-Caballero, M; Peñas, PF | 1 |
| Johnson, JK; Lekas, HM; Schrimshaw, EW; Siegel, K | 1 |
| Cho, GJ; Cho, YK; Joo, CH; Lee, HJ; Sung, H | 1 |
| Barbaro, G | 1 |
| Beckmann, RA; Bogner, JR; Goebel, FD; Michl, G; Salzberger, B; Vielhauer, V; Wille, L | 1 |
| Battegay, M; Bisset, LR; Cone, RW; Dubs, RW; Fischer, M; Grob, PJ; Opravil, M; Vernazza, PL; Weber, R | 1 |
| Das, BB; McNeeley, DF; Mendez, H; Rajegowda, BK; Rao, S | 1 |
| Hughes, M; Katzenstein, DA; Liou, SH; Machekano, RA; Shafer, RW; Shulman, NS; Winters, MA; Zolopa, AR | 1 |
| Dabis, F; Hingst, G; Kaba, F; Msellati, P; Viho, I; Welffens-Ekra, C | 1 |
| Beckerman, KP; Dorenbaum, A; Kilpatrick, SJ; Lo, B; Weintrub, PS; Wolf, LE | 1 |
| Bakker, M; Cremers, J; Danner, SA; de Jong, JJ; de Ronde, A; Goudsmit, J; Hellings, JA; Nijholt, L; Notermans, DW; Roos, MT | 1 |
| Allan, DA; Behrman, AJ | 1 |
| Coates, EA; Logan, RM; Pierce, AM; Wilson, DF | 1 |
| Margot, NA; Miller, MD; Naeger, LK | 1 |
| Gartland, M | 1 |
| Bentata, M; David, F; Delfraissy, JF; Katlama, C; Lanier, ER; Mamet, JP; Massip, P; Rozenbaum, W; Trepo, C; Vavro, C; Zucman, D | 1 |
| Abreu, T; Andrade, M; Araújo, L; Costa, T; Fernandes, I; Garcia Psic, MF; Lambert, JS; Mercadante, R; Nogueira, SA; Oliveira, R; Rodrigues, K; Sapia, MC | 1 |
| Frey, RL; Jones, JL; Lansky, A; Lindegren, ML | 1 |
| Rustin, P | 1 |
| Adams, EM; Bennett, K; Collier, AC; Gilbert, PB; Goodwin, D; Havlir, DV; Hirsch, MS; Holohan, MK; Richman, DD; Schnittman, S; Tebas, P; Wheat, LJ | 1 |
| Airoldi, M; Bertelli, D; Carosi, G; Moretti, F; Quiros-Roldan, E; Signorini, S; Torti, C | 1 |
| Angelini, E; Chêne, G; Clavel, F; Ferchal, F; Maillard, A; Molina, JM; Picard, V; Race, E | 1 |
| Allen, U; Cassol, S; Conway, B; Forbes, J; King, S; Lapointe, N; Marshall, C; Read, S; Stephens, D; Wells, G | 1 |
| Arduino, JM; Collier, AC; Fischl, MA; Spiegelman, D; Stanley, K | 1 |
| Becker, S; Fisher, R; Graham, N; Henry, K; Hernandez, J; Hirani, A; Liao, Q; Raffanti, S; Ross, L; Scarsella, A; St Clair, M | 1 |
| Buckheit, R; Gilbert, H; Margot, N; Miller, M; Palmer, S; Shaw, N | 1 |
| Cotton, MF; Pieper, CH; Rabie, H; Robson, B | 1 |
| Chaithongwongwatthana, S; Chantheptaewan, N; Chulasugondha, P; Hanwanich, M; Hawanon, P; Kongsin, P; Limpongsanurak, S; Phanuphak, P; Ruxrungtham, K; Tarounotai, U; Thaithumyanon, P; Thisyakorn, U; Triratwerapong, T; Ubolyam, S; Virutamasen, P | 1 |
| Abdullah, MF; Bitalo, L; Coetzee, N; Myers, JE; Young, T | 1 |
| Angarano, G; Bruno, F; Carbonara, S; Coppola, S; Fiorentino, G; Ingravallo, G; Maggi, P; Monno, L; Pastore, G; Serio, G | 1 |
| Bouchenafa, K; Burgard, M; Capitant, C; Delfraissy, JF; Gougeon, ML; Levy, Y; Liberman, I; Rouzioux, C; Taoufik, Y; Viard, JP | 1 |
| Bartlett, JG; del Rio, C | 1 |
| Solomon, R | 1 |
| Chaithongwongwatthana, S; Chantheptaewan, N; Kongsin, P; Limpongsanurak, S; Phanuphak, P; Ruxrungtham, K; Tarounotai, U; Thaithumyanon, P; Thisyakorn, U; Triratwerapong, T; Ubolyam, S | 1 |
| Chuachoowong, R; Fan, D; Lyles, RH | 1 |
| MacGowan, DJ; Scelsa, SN; Waldron, M | 1 |
| Clax, P; De Gruttola, VG; DeMets, DL; Downing, GJ; Ellenberg, SS; Friedman, L; Gail, MH; Prentice, R; Wittes, J; Zeger, SL | 1 |
| Dabis, F; Kottan, JB; Leroy, V; Montcho, C; Msellati, P; Rouet, F; Rouzioux, C; Viho, I; You, B | 1 |
| Abrams, EJ; Bulterys, M; Nesheim, S; Orloff, SL; Palumbo, P; Schoenbaum, E; Simonds, RJ; Steketee, RW; Vink, P | 1 |
| Chadapaud, S; Halfon, P; Hittinger, G; Khiri, H; Lafeuillade, A; Poggi, C | 1 |
| Beckerman, KP | 1 |
| Wolf, K | 1 |
| Alphonso, H; Causer, D; Miller, T; Papadimitriou, JM; Papadopulos-Eleopulos, E; Turner, VF | 1 |
| Anderson, R; Chapman, SK; Clendeninn, N; Conant, M; Myers, R; Saag, MS; Sension, M; Tebas, P | 1 |
| Duan, C; Kuritzkes, DR; McHenry, CS; Petropoulos, CJ; Poticha, D; Stoeckli, TC; Whitcomb, JM | 1 |
| Owens, MG | 1 |
| Crowe, DR | 1 |
| Bernasconi, E; Boggian, K; Boubaker, K; Chave, JP; Egger, M; Flepp, M; Francioli, P; Furrer, H; Haensel, A; Hirschel, B; Opravil, M; Rickenbach, M; Sudre, P; Telenti, A | 1 |
| Battegay, M; Tichelli, A; Wolf, K | 1 |
| Heimer, RR; Kyriakides, TC | 1 |
| de Zulueta, P | 1 |
| London, AJ | 1 |
| Blumoff, K; Garcia-Lerma, JG; Heneine, W; Nidtha, S; Weinstock, H | 1 |
| Boerlijst, MC; Coutinho, RA; de Ronde, A; Goudsmit, J; Lange, JM; Miedema, F; van der Hoek, L; Weverling, GJ | 1 |
| Blower, S | 1 |
| Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
| Kuritzkes, DR | 1 |
| Akanmu, AS; Akinsete, I; Davies, AO; Eshofonie, AO; Okany, CC | 1 |
| Bosch, RJ; Coombs, RW; Demeter, LM; Fischl, MA; Fiscus, SA; Grimes, JM; Hammer, SM; Hughes, MD; Jackson, JB; Spector, SA; Squires, KE | 1 |
| Bulterys, M; Clark, WS; Henderson, SL; Higgins, JE; Lindsay, MK; Nesheim, SR | 1 |
| Bickel, M; Jacobi, V; Rickerts, V; Staszewski, S; Tews, J | 1 |
| Chadapaud, S; Hittinger, G; Lafeuillade, A; Poggi, C | 1 |
| Amato, RJ; Beuzeboc, P; Bouhour, D; Chevreau, C; Droz, JP; Fizazi, K; Logothetis, CJ; Petit, N; Rebischung, C; Thiss, A | 1 |
| Abbadessa, V; Andreoni, M; D'Ettorre, G; Dalle, NE; Gallo, I; Mancino, G; Narciso, P; Nicastri, E; Parisi, SG; Sarmati, L; Traina, C; Vullo, V | 1 |
| Parizer, KL | 1 |
| Balasubramanian, R; Lagakos, SW | 1 |
| Friedland, G; Jatlow, P; Kosten, TR; McCance-Katz, EF; Rainey, PM | 1 |
| Fischl, MA; Gao, H; Gensler, T; Graham, NM; Hernandez, JE; Hessenthaler, SM; Kirkland, LR; McClernon, DR; Paar, D; Pittman, G; Rosenzweig, JR; Tashima, KT | 1 |
| Newell, ML | 1 |
| Chaithongwongwatthana, S; Limpongsanurak, S; Phanuphak, P; Punnahitanon, S; Ruxrungtham, K; Thaithumyanon, P; Thisyakorn, U; Ubolyam, S; Virutamasen, P | 1 |
| Rutstein, RM | 1 |
| Chaovaratna, P; Intarakamhaeng, S; Kiatchooskul, P; Kosalaraksa, P; Lueprasert, L; Patoomvivatana, P; Pinitsoontorn, P; Sakondhavat, C; Thamprisan, P; Thinkhamrop, J; Wongkham, J | 1 |
| Altisent, C; Briones, C; Domingo, E; Mas, A; Pérez-Olmeda, M; Soriano, V | 1 |
| Borchard, C; Esser, S; Goos, M; Hengge, UR; Mirmohammadsadegh, A; Schröder, M | 1 |
| Rothman, DJ | 1 |
| Anyiwo, CE; Ifeanyichukwu, M | 1 |
| Addy, C; Misener, T; Moneyham, L; Murdaugh, CL; Sowell, RL; Tavokoli, A | 1 |
| Boschini, A; Calista, D; Morri, M; Stagno, A | 1 |
| García-Tejedor, A; Maiques, V; Perales, A | 1 |
| Alfaro-Martínez, J; Mellor-Pita, S; Suárez, E; Yebra-Bango, M | 1 |
| Delaporte, E; Malonga-Mouellet, G; Mansaray, H; Mavoungou, R; Mistoul, I; Peeters, M; Vergne, L | 1 |
| Cox, P | 1 |
| Bruggeman, LA; Klotman, PE; Neumann, AU; Perelson, AS; Rappaport, J; Schwartz, EJ; Teixeira, AV | 1 |
| Kain, KC; Nathoo, S; Serghides, L; Walmsley, S | 1 |
| Jaccard, R; Jenni, R; Opravil, M; Speich, R | 1 |
| Elliott, R | 1 |
| Ameisen, JC; Benveniste, O; Estaquier, J; Lelièvre, JD; Leport, C; Vildé, JL | 1 |
| Bettendorf, D; Bucy, RP; Chan, E; Evans, T; Gonzalez, CJ; Landay, AL; Phair, JP; Schmitz, JL; Schnizlein-Bick, CT; Spritzler, J; Squires, KE | 1 |
| Arzumanov, AA; Aubertin, AM; Dyatkina, NB; Egron, D; Gosselin, G; Imbach, JL; Krayevsky, A; Périgaud, C | 1 |
| McLean, K; Winston, A | 1 |
| Meienberg, F | 1 |
| Goldenberg, RL; Rouse, DJ; Sinkala, M; Stringer, JS; Vermund, SH | 1 |
| Brocklehurst, P; Volmink, J | 2 |
| Anderson, PL; Brundage, RC; Fletcher, CV; Gross, CR; Henry, K; Kakuda, TN; Schacker, TW | 1 |
| Aboulker, JP; Brun Vezinet, F; Calvez, V; Descamps, D; Flandre, P; Harel, M; Hazebrouck, S; Meiffredy, V; Peytavin, G; Pialoux, G; Raffi, F | 1 |
| Andersson, J; Cooper, D; Goh, LE; Hoen, B; Janossy, G; Kinloch, S; Lampe, F; Perrin, L; Tilling, R; Tsoukas, C; Zaunders, J | 1 |
| Adjé, C; Ekpini, RA; Greenberg, AE; Maurice, C; Monga, BB; Nkengasong, JN; Roels, TH; Sibailly, T; Wiktor, SZ | 1 |
| Alioum, A; Dabis, F; Ekpini, ER; Greenberg, AE; Hudgens, M; Karon, JM; Leroy, V; Meda, N; Msellati, P; Wiktor, SZ | 1 |
| Burger, DM; de Groot, R; Geelen, SP; Hartwig, NG; Hop, WC; Osterhaus, AD; Scherpbier, HJ; Schutten, M; van Lochem, EG; van Rossum, AM; Weemaes, CM; Wolfs, TF | 1 |
| Hudson, CP; Moodley, J; Smith, AN | 1 |
| Antiochos, BB; Fernandez, JJ; Olivero, OA; Poirier, MC; St Claire, ME; Wagner, JL | 1 |
| Broadhead, R; Fiscus, S; Gibbons, A; Hoover, D; Kumwenda, N; Lema, V; Liomba, G; Mukiibi, J; Taha, TE | 1 |
| Delfraissy, JF; Glaziou, P; Kruy, LS; Leng, C; Min, DC; Rekacewicz, C; Saman, M | 1 |
| Cai, W; Cao, Y; Ding, Y; Gao, M; Li, L; Mei, S; Zhang, F | 1 |
| Ciria, L; de La Peña, A; Leyes, M; Ribas, A; Riera, M; Ruiz De Gopegui, R; Salas, A; Sánchez, E; Villalonga, C | 1 |
| Babiker, A; Darbyshire, J; Dunn, D; Hooker, M | 1 |
| Ginelli, R; Leoncini, F; Meli, M; Sbaragli, S; Trotta, M | 1 |
| Kanshana, S; Simonds, RJ | 1 |
| Barrios, A; Blanco, F; García-Benayas, T; Gómez-Viera, JM; González-Lahoz, J; Soriano, V | 1 |
| Stekelenburg, J | 1 |
| Bacheler, L; Bazmi, H; Diamond, S; Erickson-Viitanen, S; Gallagher, K; Garber, S; Geleziunas, R; Hammond, J; Klabe, R; Liotta, DC; Manion, DJ; Mellors, J; Otto, MJ; Pierce, M; Rayner, M; Schinazi, RF; Stuyver, L; Trainor, G; Wu, JT; Zhang, H | 1 |
| de Wolf, F; Jurriaans, S; Lange, JM; Prins, JM; van Praag, RM; Wit, FW | 1 |
| Chaix, ML; Delfraissy, JF; Deveau, C; Dubeaux, B; Garrigue, I; Goujard, C; Harzic, M; Hoen, B; Meyer, L; Ngo, N; Pellegrin, I; Rouzioux, C; Sereni, D | 1 |
| Schechter, M | 1 |
| Perrin, L | 1 |
| Klinowska-Skupniewska, J; Prandota-Schoepp, A | 1 |
| Ray, SC; Sulkowski, MS; Thomas, DL | 1 |
| Hasegawa, H; Hattori, T; Ishikawa, M; Kaku, M; Kikuchi, M; Ohno, I; Okada, S | 1 |
| Aboulker, JP; Brun-Vezinet, F; Certain, A; Descamps, D; Flandre, P; Gastaut, JA; Goujard, C; Joly, V; Meiffredy, V; Remy, G; Ruffault, A; Yeni, P | 1 |
| Nattrass, N; Skordis, J | 1 |
| Crawford-Faucher, A; Krist, AH | 1 |
| Blattner, W; Bremer, J; Hillyer, G; Hollinger, FB; Kufera, J; LaRussa, P; Lew, J; Magder, LS; McIntosh, K; Pitt, J; Sill, A | 1 |
| Easterbrook, PJ; Gazzard, BG; Hertogs, K; Larder, B; Waters, A; Wills, B | 1 |
| Clouse, KA; Fields, K; Grimm, TA; Kutza, J | 1 |
| Beltrami, EM; Cardo, DM; de la Torre, N; Luo, CC | 1 |
| Brůcková, M; Linka, M; Reinis, M; Stanková, M; Vandasová, J | 1 |
| Di Perri, G; Maiello, A; Quario, M; Racca, D; Sinicco, A; Zeme, DA | 1 |
| Amin, J; Carr, A; Cooper, DA; Doong, N; Freund, J; Hoy, J; Hudson, J; Law, M; Martin, A; Smith, DE; Workman, C | 1 |
| Butler, KM; Husson, RN; Jacobsen, F; Lewis, LL; Mueller, BU; Pizzo, PA | 1 |
| Aronson, JE; Bakshi, S; Boland, M; Borkowsky, W; Connor, E; Hoyt, L; Krasinski, K; McSherry, G; Oleske, J; Persaud, D | 1 |
| Dallenbach, F; Detmar, M; Garbe, C; Orfanos, CE; Reupke, H; Schröder, K; Waibel, M | 1 |
| Boucher, CA; Goudsmit, J; Kellam, P; Koot, M; Lange, JM; Larder, BA; Miedema, FF; Mulder, JW; Tersmette, M; Weverling, GJ | 1 |
| Koziel, MJ; Walker, BD | 1 |
| Fanning, M; Montaner, JS; O'Shaughnessy, M; Rooke, R; Ruedy, J; Tremblay, M; Tsoukas, C; Wainberg, MA | 1 |
| Bélec, L; Cotigny, S; Jacob, A; Longuet, MF; Matta, F; Mbopi Kéou, FX; Ripoll, L | 1 |
| Delzant, G; Grange, A; Marinho, E; Saiag, P; Winter, C | 1 |
| Reddy, MM; Sakai, K; Volsky, B; Volsky, DJ | 1 |
| Nightingale, SL | 1 |
| Balzarini, J; Bergamini, A; Calio, R; De Clercq, E; Milanese, G; Pauwels, R; Perno, CF; Rocchi, G; Yarchoan, R | 1 |
| Husson, RN; Pizzo, PA | 1 |
| Armany, RS; Koch, JA; Ruprecht, RM; Sharma, PL | 1 |
| Hammer, SM; McLeod, GX | 3 |
| Arai, M; Fujimaki, M; Fukutake, K; Koike, K; Matsumoto, K; Yorifuji, H | 1 |
| Garfunkel, AA; Glick, M | 1 |
| de Visser, M; Enting, RH; Portegies, P | 1 |
| Bird, AG; Boon, NA; Brettle, RP; Jacob, AJ; Ludlam, CA; McMillan, A; Sutherland, GR | 1 |
| Bawdon, RE; Dax, J; Sobhi, S | 1 |
| Bjornson, DC; Cortese, M | 1 |
| Bassiakos, Y; Bennett, D; Boota, AM; Fischl, MA; Lai, SH; Meng, TC; Richman, DD; Spector, SA; Wright, B | 1 |
| Day, PL; Diamond, GR; Dickinson, GM; Drusano, GL; Egorin, MJ; George, WL; Gordin, FM; Hamilton, JD; Hartigan, PM; Simberkoff, MS | 1 |
| Lynn, LA | 1 |
| Green, PJ | 1 |
| Grünewald, T; Habermehl, KO; Maxeiner, HG; Ruf, B | 1 |
| Detels, R; Graham, NM; Park, LP; Phair, JP; Rinaldo, CR; Vermund, SH; Zeger, SL | 1 |
| Chowdhury, MI; Kobayashi, S; Koyanagi, Y; Suzuki, M; Yamaguchi, K; Yamamoto, N | 1 |
| Bitran, JD; Connolly, PJ; Edlin, BR; Moore, JL; Ou, CY; Weinstein, RA; Whaling, SM | 1 |
| Anderson, DJ; Horsburgh, CR; Martinez, A; Mayer, KH; O'Brien, TR; Padian, N; Politch, JA; Seage, GR | 1 |
| Bailey, G; Denning, DW; Khoo, SH; Wilkins, EG | 1 |
| Kovacs, JA; Masur, H | 1 |
| Bloom, AL; Bowen, DJ; Dannatt, AH; Dasani, H; Goodwin, SJ; Peake, IR | 1 |
| Bindman, AB; Chan, AK; Katz, MH; Keane, D | 1 |
| Caswell, A | 1 |
| Beall, G; Brown, M; Cross, A; Crumpacker, CS; Kahn, JO; Lagakos, SW; Liou, SH; Pettinelli, C; Richman, DD; Volberding, PA | 1 |
| Berglund, O; Lidman, C; Lindbäck, S; Tynell, E | 1 |
| Barbuzano, C; Castro, A; Pedreira, J; Pereiro, C | 1 |
| Bandini, G; Bocchia, M; Conte, R; Coronado, O; Costigliola, P; Mazza, P; Raise, E; Ricchi, E; Tumietto, F; Vianelli, N | 1 |
| Bowdon, BJ; Buckheit, RW; Germany-Decker, J; Qualls-Goodwin, K; Shannon, WM | 1 |
| Barbier, M; Bayce, P; Debat, P; Dietlin, F; Fredj, G; Jasmin, C; Kalifa, D; Maurisson, G; Ratiney, R; Rudant, E | 1 |
| Bofill, M; Elford, J; Janossy, G; Lee, CA; Phillips, AN; Sabin, C | 1 |
| Alcabes, P; Buono, D; Davenny, K; Friedland, GH; Hartel, D; Klein, RS; Schoenbaum, EE; Selwyn, PA | 1 |
| Brůcková, M; Füst, G; Lackovicová, M; Mayer, V; Schmidtmayerová, H; Stanková, M; Surový, I; Ujhelyi, E | 1 |
| Aboulker, JP; Darbyshire, JH | 1 |
| Hirabayashi, Y; Kikuchi, Y; Kimura, S; Mitamura, K; Oka, S; Shimada, K; Toyoshima, T | 1 |
| Gerstoft, J; Gøtzsche, PC; Nielsen, C; Nielsen, CM; Vestergaard, BF | 1 |
| Ferchal, F; Marcel, P; Modai, J; Molina, JM; Morinet, F | 1 |
| Chiodo, F; Costigliola, P; Ricchi, E; Tumietto, F | 1 |
| Agut, H; Brun-Vézinet, F; Ferchal, F; Fleury, H; Masquelier, B; Puel, J; Rouzioux, C; Tamalet, C | 1 |
| Magallón Martínez, M; Ortega, F; Pinilla, J | 1 |
| Barsanti, L; Batoni, G; Ceccherini Nelli, L; Chirianni, A; Liuzzi, G; Piazza, M; Santoro, G; Tullio Cataldo, P | 1 |
| Burns, SM; Croft, N; Hague, RA; Mok, JY; Yap, PL | 1 |
| Borvák, J; Kasanická, J; Mayer, V | 1 |
| Chambost, H; de Boisse, P; Farnarier, C; Kaplanski, S; Leclaire, M; Michel, G; Perrimond, H; Tamalet, C; Thuret, I; Vallée, D | 1 |
| Hamilton, JD | 1 |
| Lumio, J | 1 |
| Boucher, CA; Darby, G; Goudsmit, J; Kellam, P; Lange, JM; Larder, BA; Mulder, JW; O'Sullivan, E; Ramautarsing, C | 1 |
| Broadhurst, K; Colvin, B; Forster, G; Goh, B; Gunkel, N; Jackson, GG; Levantis, P; Muckenthaler, M; Oxford, JS | 1 |
| Cooper, DA; Danner, SA; Lange, JM | 2 |
| Miles, SA | 1 |
| Dilworth, S; Fowler, AK; Marks, CA; Mayers, DL; McCutchan, FE; Merritt, LI; Richman, DD; Roberts, CR; Ruiz, NM; Sanders-Buell, EE | 1 |
| Kaye, S; Loveday, C; Tedder, RS | 1 |
| Bader, L; Bogner, JJ; Eberle, J; Geier, SA; Goebel, FD; Gürtler, L; Klauss, V; Kronawitter, U; Lund, OE; Mueller, A | 1 |
| Church, DL; Gill, MJ; Sutherland, LR | 1 |
| Cooper, DA; Cunningham, P; Evans, L; Hurren, L; McQueen, P; Mooney, J; Tindall, B; Vasak, E | 1 |
| Angarano, G; Arici, C; Cristini, G; Guzzanti, E; Ippolito, G; Pagano, G; Puro, V; Serafin, I; Soscia, F; Suter, F | 1 |
| Cameron, DW; Gallicano, K; Garber, G; Hawley-Foss, N; McGilveray, I; Sahai, J; Turgeon, N | 1 |
| Cosler, LE; Lambrinos, J | 1 |
| Birch, C; Land, S; Lucas, R; McGavin, C | 1 |
| Ascher, DP; Fowler, A; Roberts, C | 1 |
| Dawkins, RL; French, MA; Mallal, SA; Mallon, DF; Shearwood, W | 1 |
| Colan, SD; Hale, AR; Lipshultz, SE; McIntosh, K; Orav, EJ; Sanders, SP | 1 |
| Beattie, RM; Gibb, DM; Lyall, EG; Trounce, JQ | 1 |
| Cañas, E; Castillo, JR; Cisneros, JM; Garcia-Pesquera, F; Pachon, J; Viciana, P | 1 |
| Cameron, DW; Gallicano, K; Garber, G; Hawley-Foss, N; Huang, L; McGilveray, I; Pakuts, A; Sahai, J | 1 |
| Balfour, HH; Erice, A; Gekker, G; Peterson, PK; Verhoef, J | 1 |
| Blais, FX | 1 |
| Becker, B; Berger, TG; Maurer, TA; Obuch, ML | 1 |
| Behrman, RE; Feigal, DW; Kammerman, LA | 1 |
| Ballem, PJ; Belzberg, A; Chambers, H; Devine, DV; Doubroff, P; Lyster, D; Mikulash, K; Spruston, B | 1 |
| Bonnez, W; Marder, V; Morse, GD; Olson, J; Plank, C; Portmore, AC; Reichman, RC; Taylor, C | 1 |
| Butler, KM; Husson, RN; Lewis, LL; Patronas, N; Pizzo, PA; Saini, R | 1 |
| Bathgate, SL; Grossman, JH; Lopez-Zeno, J; Nies, BM; Parenti, DM | 1 |
| Chave, JP; Genné, D; Glauser, MP | 1 |
| Minkoff, H; Moreno, JD | 1 |
| Johnson, AM; Keenlyside, R; Phillips, AN | 1 |
| Cruciani, F; Mazzarino, R; Melino, G | 1 |
| Maayan, S; Rahav, G | 1 |
| Fast, PE; Mofenson, LM; Wright, PF | 1 |
| Camacho, J; García Rodríguez, MC; Gil, A; Lavilla, P; López Dupla, M; Pintado, V; Valencia, E; Zapico, RM | 1 |
| Gail, MH; Mark, SD | 1 |
| Dawkins, RL; French, MA; Mallal, SA | 1 |
| Holodniy, M; Katzenstein, DA; Merigan, TC; Winters, MA | 1 |
| Bodnar, J; Wright, EJ | 1 |
| Molina, JM | 1 |
| Artzrouni, M | 1 |
| Hamzeh, FM; Kornhauser, DM; Kuwahara, SK; Lewis, LD; Lietman, PS; Slusher, JT | 1 |
| Hewitt, RG; Morse, GD | 1 |
| Biollaz, J; Chatton, JY; Chave, JP; Glauser, MP; Munafo, A; Roch-Ramel, F; Steinhäuslin, F | 1 |
| Borderi, M; Chiodo, F; Costigliola, P; Guariento, A; Manfredi, R; Ricchi, E; Silvestri, MG | 1 |
| Abson, KG; Prose, NS; Scher, RK | 1 |
| Ellis-Pegler, RB; Kennedy, J; McDermott, J; Thomas, MG | 1 |
| Hamilton, JD; Hartigan, PM; Simberkoff, MS | 3 |
| Bitran, JD; Edlin, BR; King, DM; Pitha, PM; St Clair, MH; Weinstein, RA; Whaling, SM | 1 |
| Chaisson, RE; Creagh-Kirk, T; Keruly, J; Moore, RD; Richman, DD | 1 |
| Benson, CA; Kessler, HA; Pottage, JC; Sha, BE; Urbanski, P | 1 |
| Grieco, MH; Hargrove, D; McHugh, T; McKinley, GF; Reddy, MM; Winger, EE | 1 |
| Heinzl, S | 1 |
| Diener, HC | 1 |
| Bass, HZ; Cumberland, W; Fahey, JL; Hardy, WD; Mitsuyasu, RT; Wang, YX | 1 |
| Frame, PT; Hurtubise, PE; Pesce, AJ; Stretcher, BN | 1 |
| Fleming, J; Harris, JR; Mitchell, DM; Moss, FM; Pinching, AJ; Shaw, RJ; Veale, D | 1 |
| Boulberhane, A; Hellman, KB; Pierce, PF; Shepherd, LP; Ved Brat, SS | 1 |
| Bergeron, L; Sodroski, J | 1 |
| Lebret-Lerolle, D; Mahé, A; Pulik, M | 1 |
| Bongain, A; Fuzibet, JG; Gillet, JY; Pesce, A | 1 |
| Lessell, S; Newman, NJ | 1 |
| Coulaud, JP; Detruchis, P; Jaccard, A; Karam-Sarkis, D; Leport, C; Meyohas, MC; Rosenbaum, W; Salmon-Ceron, D; Vildé, JL | 1 |
| Berger, TG; Cockerell, CJ; Martin, AG; Weaver, CC | 1 |
| Andrews, JC; Bacchetti, P; Jacobson, MA; Moss, AR | 1 |
| Boyer, P; Gloeb, DJ; Hammill, H; Lambert, JS; Livingston, EG; Minkoff, H; O'Sullivan, MJ; Sperling, RS; Stratton, P; Watts, DH | 1 |
| McLean, AR; Nowak, MA | 1 |
| Asboe, D; Boag, FC; Daniels, D; Erskine, D | 1 |
| Constantinitis, I; Hudgins, P; Wallace, DC; Weissman, JD | 1 |
| Reichart, PA | 1 |
| Armbruster, C; Fuchs, D; Hutterer, J; Vetter, N; Wachter, H; Wallner, G | 1 |
| Chapnick, EK; Gradon, JD; Sepkowitz, DV | 1 |
| Angarano, G; Di Stefano, M; Fico, C; Fiore, JR; Fracasso, C; Grottola, A; Monno, L; Pastore, G | 1 |
| Hernandez, J; Mufson, MA; Zarraga, AL | 1 |
| Barr, MR; Lee, M; Lin, RY; Torres, RA | 1 |
| Gompels, M; Knight, SC; Macatonia, SE; Patterson, S; Pinching, AJ | 1 |
| Bazin, C; Régnier, B | 1 |
| Anderson, RM; May, RM | 1 |
| Bartocci, C; Butini, L; Danieli, G; Montroni, M; Regnery, C; Silvestri, G | 1 |
| Bergs, C; Heise, W; L'age, M; Riecken, EO; Ullrich, R; Zeitz, M | 1 |
| France, AJ; Maclean, VM; Phillip, G; Seaton, RA | 1 |
| Bartlett, JG; Bollinger, RC; Francis, HL; Kline, RL; Moss, MW; Quinn, TC | 1 |
| Scott, GM; Venning, GR | 1 |
| Allen, UD; Gafni, A; Read, S | 1 |
| Singer, EJ | 1 |
| Cole, BF; Cotton, DJ; Fischl, MA; Gelber, RD; Goldhirsch, A; Lenderking, WR; Testa, MA | 1 |
| Brechbühl, AB; Friedland, GH; Kahl, P; Miller, MA; Schwartz, EL; Selwyn, PA | 1 |
| Emminger, C; Holsboer, F; Krieg, JC; Moeller, AA; Oechsner, M; Wiegand, M | 1 |
| Hansen, JE; Mathiesen, LR; Nielsen, C; Svenningsen, A; Witzke, N | 1 |
| Goodwin, SD | 1 |
| Libman, H | 1 |
| DeHovitz, JA; Sadovsky, R | 1 |
| Cohen, C; Mayer, K; Shevitz, A | 1 |
| Batash, S; Falkenstein, D; Hollander, D; Katz, K; Ma, T; Raicht, R; Weinshel, E | 1 |
| Crittenden, JA; Handelsman, DJ; Stewart, GJ | 1 |
| Buchbinder, SP; Hessol, NA | 1 |
| Jeffries, DJ | 2 |
| Bassford, PJ; Keen, MG; Stamm, LV | 1 |
| Elkharrat, D | 1 |
| De Maria, A | 1 |
| Gerberding, JL; Henderson, DK | 1 |
| Dische, R; Holzman, I; Jew, E; Roboz, J; Silides, D; Sperling, RS | 1 |
| Groopman, JE; Molina, JM | 1 |
| Cohen, H; Kaplan, S | 1 |
| Barker, SM; Chen, SC; Cunningham, AL; Mitchell, DH; O'Neill, P; Stevens, SM | 1 |
| Devine, KG; Hay, AJ; Mahmood, N; McGuigan, C; Pathirana, RN | 1 |
| Rousseau, F; Sereni, D | 1 |
| Fischl, MA | 3 |
| Butler, K; Husson, R; Marshall, D; Pizzo, PA; Roilides, E; Venzon, D | 1 |
| Kaplan, LD; Northfelt, DW | 1 |
| Bedert, L; Chew, SL; Colebunders, RL; Verbraeken, H; Zachee, P | 1 |
| Simpson, DM; Wolfe, DE | 1 |
| Cao, W; Fuchs, BA; Germolec, DR; Luster, MI; Munson, AE; Prejean, JD; Rosenthal, GJ; Shopp, G; Thompson, MB; Tomaszewski, JE | 1 |
| Merigan, TC; Schwartz, DH; Skowron, G | 1 |
| Borkowsky, W; Connor, EM; Feinberg, J; Maha, MA; McIntosh, K; McKinney, RE; Modlin, JF; Scott, GB; Weintrub, P; Wulfsohn, M | 1 |
| Akerlund, B; Andersson, J; Berglund, O; Ehrnst, A; Engman, K; Lidman, K; Sönnerborg, A; Strannegård, O | 1 |
| Eisenberg, JM; Glick, HA; Lynn, LA; Schulman, KA | 1 |
| Bauermeister, CD; Biesert, L; Brede, HD; Gerte, S; Regeniter, A; Rübsamen-Waigmann, H; Schröder, B; Suhartono, H; von Briesen, H; Zimmermann, F | 1 |
| Chaisson, RE; Creagh-Kirk, T; Keruly, J; Link, G; Moore, RD; Richman, D; Wang, MC | 1 |
| Brettle, RP; Flegg, PJ | 1 |
| Ebert, S; Gockel, K; Graziano, F; Horowitz, S; Vogelman, B; Weber, P | 1 |
| Davey, RT; Davey, VJ; Falloon, J; Kovacs, JA; Lane, HC; Masur, H; Metcalf, JA; Polis, MA; Zunich, KM; Zurlo, JJ | 1 |
| Brown, WE; Campbell-Hill, S; Crain, MJ; Decker, WD; Hahn, BH; Leuther, M; Robinson, S; Saag, MS; Shaw, GM; Whitley, RJ | 1 |
| Broder, S; Lietzau, J; Pluda, JM; Steinberg, SM; Tsiatis, AA; Venzon, DJ; Wyvill, KM; Yarchoan, R | 1 |
| De Wolf, F; Gruters, RA; Harkema, T; Lange, JM; Miedema, F; Mulder, JW; Roos, MT; Schellekens, PT; Terpstra, FG | 1 |
| Knox, KA; Nye, KE; Pinching, AJ | 1 |
| Carlin, JB; Crowe, SM; Hoy, JF; Lucas, CR; Stewart, KI | 1 |
| Santangelo, J; Schnack, J | 1 |
| Emery, VC; Griffiths, PD; McLean, AR; Webster, A | 1 |
| Barlow, D; Bateman, NT; Cordery, M; Gill, S; Kelly, G; Spacey, B; Tang, A | 1 |
| Jones, PD | 1 |
| Albarello, V; Balotta, C; Cocchi, F; Galli, M; Moroni, M; Musicco, M; Ridolfo, AL; Riva, A | 1 |
| Carter, WA; Gillespie, DH; Hubbell, HR; Shapiro, DE; Strayer, DR; Ventura, D | 1 |
| Gazzard, B; Youle, M | 1 |
| Hirsch, MS | 1 |
| Ashorn, P; Berger, EA; Chaudhary, VK; FitzGerald, DJ; Moss, B; Pastan, I; Weinstein, JN | 1 |
| Ekert, H; Gatenby, PA; Jupe, DM; Keller, AJ; Kemp, AS; Palasanthiran, P; Smales, O; Ziegler, JB | 1 |
| Hoth, DF; Myers, MW | 1 |
| Kernoff, PB; Lee, CA; Lim, SG | 2 |
| Biglino, A; Busso, M; Forno, B; Gioannini, P; Pollono, AM; Pugliese, A | 1 |
| de Selys, A; Jonckheer, T; Moens, E; Pattijn, S; Pierre, C; Piot, P; Taelman, H; Vercauteren, G | 1 |
| Hirsch, MS; Johnson, VA | 1 |
| Krown, SE | 1 |
| Chalmers, AC; Greco, CM; Miller, RG | 1 |
| Broder, S; Mitsuya, H; Perno, CF; Pluda, JM; Yarchoan, R | 1 |
| Davis, C | 1 |
| Mito, RS; Standlee, JP | 1 |
| Gingeras, T; Grimes, J; Guatelli, JC; Richman, DD; Tsiatis, A | 1 |
| Hutlin, L; Lee, K; Miles, SA; Mitsuyasu, RT; Zsebo, KM | 1 |
| Fernández-Cruz, E | 1 |
| Cersosimo, RJ; Matthews, SJ; Spivack, ML | 1 |
| Plettenberg, A | 1 |
| Dalgleish, AG; Wilks, D | 1 |
| De Simone, C; Famularo, G; Jirillo, E; Moretti, S; Tzantzoglou, S | 1 |
| Livrozet, JM; Sanhadji, K; Touraine, JL; Zerhouni, B | 1 |
| Belfort, R; Butler, KM; Caruso, R; de Smet, MD; Husson, RN; Lopez, JS; Nussenblatt, RB; Pizzo, PA; Rubin, B; Whitcup, SM | 1 |
| Bubp, JL; Holodniy, M; Israelski, DM; Katzenstein, DA; Merigan, TC; Mole, LA; Sengupta, S | 1 |
| Kingsley, LA; Ragni, MV; Zhou, SJ | 1 |
| Corey, L; Fleming, TR | 1 |
| Bartlett, JD; Baughman, KL; Herskowitz, A; Schulman, SP; Willoughby, SB | 1 |
| Antoniskis, D; Barnes, PF; Davidson, PT; Easley, AC; Espina, BM | 1 |
| Clark, AG; Holodniy, M; Katzenstein, DA; Merigan, TC; Schwartz, DH | 1 |
| Sperling, RS; Stratton, P | 1 |
| Gibb, D; Newell, ML | 1 |
| Healy, B | 1 |
| de Jong, MD; Hulsebosch, HJ; Lange, JM | 1 |
| Callaham, ML | 1 |
| Dalakas, MC; Illa, I; Pezeshkpour, G | 1 |
| Arpadi, S; Lambert, G; Wiznia, A; Wong, M | 1 |
| Butala, A; Gounder, MP; Rabinowitz, M; Tongol, JM | 1 |
| Allegre, T; Arriodare, C; Blanc, AP; Chardon, H; Routy, JP | 1 |
| Aniz, E; Bañuls, J; Jorda, E; Ramon, D; Torres, V | 1 |
| De Wind, CM | 1 |
| Costantino, M | 2 |
| Allen, J; Easley, A; Espina, B; Levine, AM; Montgomery, T; Rarick, MU | 1 |
| Cameron, D; Conway, B; Garber, G; Sahai, J | 1 |
| White, A | 1 |
| Boudes, P | 1 |
| Belec, L; Bledin, M | 1 |
| Kouzan, S; Nebout, T | 1 |
| Cozzani, S; D'Elia, R; Giacomelli, A; Giaquinto, C; Laverda, AM; Mazza, A; Rubaltelli, F; Ruga, E; Zacchello, F | 1 |
| Frame, PT; Hurtubise, PE; Murray, JA; Pesce, AJ; Stretcher, BN; Vine, WH | 1 |
| Elford, J; Griffiths, P; Janossy, G; Kernoff, P; Lee, CA; Phillips, AN | 1 |
| Fauvelle, F; Guillevin, L; Leon, A; Petitjean, O | 1 |
| Benedetti, J; Collier, AC; Corey, L; Gianola, FG; Opheim, K; Tartaglione, TA | 1 |
| Barton, SE | 1 |
| Habets, L; Knechten, H; Knickmann, M; Wolters, D | 1 |
| Andersson, M; Chiodi, F; Fuchs, D; Hagberg, L; Norkrans, G; Svennerholm, B; Wachter, H | 1 |
| Henrion, R | 1 |
| Brew, BJ; Heyes, MP; Keilp, J; Martin, A; Mouradian, MM; Price, RW; Sadler, AE; Salazar, AM; Sidtis, JJ; Yergey, JA | 1 |
| Bogner, JR; Goebel, FD | 1 |
| Causey, DM; Dehlinger, M; Hafner, R; Jacobsen, MA; Mills, J; van der Horst, C | 1 |
| Amato, DA; Balsley, J; Benoit, S; Brettler, D; Brownstein, A; Kramer, AS; Merigan, TC; Perez-Michael, A; Power, M; Price, WA | 1 |
| Causey, D | 1 |
| Basham, T; Holdener, T; Merigan, T | 1 |
| Dalakas, M; Illa, I; Nath, A | 1 |
| Armstrong, JA; Hawk, H; Ho, M; McMahon, DK; Pazin, GJ; Winkelstein, A | 1 |
| David, O; Gabiano, C; Palomba, E; Pescarmona, GP; Tovo, PA | 1 |
| Bodsworth, N; Cooper, DA | 1 |
| Chaloupka, K; Collier, AC; Coombs, RW; Corey, L; Koehler, JK; Krieger, JN; Murphy, VL; Ross, SO | 1 |
| Nixon, D | 1 |
| Bonnet, N; Caulin, C; Elkharrat, D; Wautier, JL | 1 |
| Backmund, HC; Emminger, C; Holsboer, F; Moeller, AA; Oechsner, M; Popescu, M | 1 |
| Baudrimont, M; Bonne, G; Degoul, F; Geny, C; Gherardi, R; Marsac, C; Mhiri, C; Roullet, E | 1 |
| Belohradsky, BH; Füessl, H; Goebel, FD; Matuschke, A; Rolinski, B; Roscher, AA; Wintergerst, U | 1 |
| Amigoni, S; Bozza, M; Caprioli, S; Carosi, G; Maggiolo, F; Suter, P | 1 |
| Fleisher, D; Lu, HH; Sinko, PJ | 1 |
| Child, S; Fanning, M; Le, T; Montaner, J; Ruedy, J; Tsoukas, C; Wall, RA | 1 |
| Belardelli, F; Gresser, I; Locardi, C; Masuelli, L; Modesti, A; Petrini, C; Puddu, P; Sestili, P; Varano, F | 1 |
| Jones, P | 1 |
| Kaneshima, H; Machado, SG; McCune, JM; Namikawa, R; Outzen, H; Rabin, L; Shih, CC | 1 |
| Jost, J; Lüthy, R | 1 |
| Bartlett, JA; Bolognesi, DP; Stanley, SD; Stine, KC; Tyler, DS; Weinhold, KJ | 1 |
| Bakker, M; Coutinho, RA; Goudsmit, J; Krijnen, P; Lange, JM; Mulder, JW | 1 |
| Goldspiel, BR | 1 |
| Cooper, DA; Evans, L; Gaines, H; Imrie, A; Lindback, S; Strannegard, O; Tindall, B; Tsang, ML; von Sydow, MA | 1 |
| Bassetti, D; Concia, E; Cruciani, M; Di Perri, G; Garofano, T; Vento, S | 1 |
| Baumann, R; Chave, JP; Hirschel, B; Kinloch, S; Lüthy, R; Opravil, M; Pletscher, M; Täuber, MG | 1 |
| Armellino, D; Farber, BF; Kaplan, MH; Lesser, M; Napolitano, B; Woltmann, J | 1 |
| Corzo, JE; Leal, M | 1 |
| Bornkessel, B | 1 |
| Szebeni, J | 1 |
| Fife, D; Mode, CJ; Troy, SM | 1 |
| Régnier, B | 1 |
| Allen, UD; Detsky, AS; Guerriere, M; Read, SE | 1 |
| Bocchia, M; Chiodo, F; Coronado, O; Costigliola, P; Mazza, P; Ricchi, E; Tumietto, F; Tura, S | 1 |
| Mitsuyasu, RT | 1 |
| Rée, H | 1 |
| De Simone, C; Delia, S; di Orio, F; Jirillo, E; Leuter, C; Santini, G; Tzantzoglou, S; Vullo, V | 1 |
| Loveday, C; Semple, M; Tedder, R; Weller, I | 1 |
| Ammar, A; Bertoli, AM; Georgoulias, V; Jasmin, C; Meyer, P; Perraki, M; Rozenbaum, W; Sahraoui, Y; Tsilivakos, V | 1 |
| Baum, MK; Beach, RS; Feaster, D; Fletcher, MA; Javier, JJ; Mantero-Atienza, E; Sauberlich, HE; Shor-Posner, G | 1 |
| Fischl, MA; Lagakos, S; Lim, L; Stein, DS; Volberding, P | 1 |
| Chaisson, RE; Creagh-Kirk, T; Easterbrook, PJ; Keruly, JC; Moore, RD; Richman, DD | 1 |
| Smith, MD | 1 |
| Spechko, PL | 1 |
| Binder, LS; Chappell, JA | 1 |
| Laizure, SC; Lancaster, DJ; Palte, S; Stein, DS; Stevens, RC; Terry, D; Weems, JJ; Williams, CL | 1 |
| Hattori, T; Kannagi, M; Maeda, Y; Matsushita, S; Murakami, T; Sagawa, K; Takatsuki, K | 1 |
| Brown, EM; Caul, EO; Glover, SC; Harling, CC; Reeves, DS; Roome, AP | 1 |
| Barringer, KJ; Gingeras, TR; Guatelli, JC; Latimer, T; Prodanovich, P; Richman, DD | 1 |
| Chan, AK; Chernoff, D; Greenspan, D; Greenspan, JS; Heinic, GS; Hollander, H; Katz, MH | 1 |
| Friedland, GH | 1 |
| Balfour, HH; Bartlett, JA; Booth, DK; Hirsch, MS; Koch, MA; Lagakos, SW; Myers, MW; Pettinelli, C; Reichman, RC; Volberding, PA | 1 |
| Montaner, JS; Ruedy, J; Schechter, M | 1 |
| Allan, JD; Carey, JT; Collier, AC; Dolin, R; Fischl, MA; Hansen, N; Hardy, WD; Para, MF; Powderly, WG; Richman, DD | 1 |
| Adams, M; Busch, D; Corkery, K; Feigal, DW; Gordon, S; Jacobson, MA; Leoung, GS; Montgomery, AB; Volberding, PA; Wardlaw, L | 1 |
| MacDonell, KB; Till, M | 1 |
| Cefali, F; Easter, M; Klein, HG; Kovacs, JA; Lane, HC; Leitman, SF; Masur, H; Steis, RG; Wilson, W; Zunich, KM | 1 |
| Cory, JM; Eyster, ME; Kessler, HA; Landay, A; Ohlsson-Wilhelm, BM; Rapp, F | 1 |
| Daniels, DG; Davies, PT; Lane, RJ; McCormack, SM; McLean, KA | 1 |
| de Clercq, E; Jansen, RW; Meijer, DK; Molema, G; Pauwels, R | 1 |
| Eichinger, S; Hartl, H; Kier, P; Kyrle, PA; Lechner, K; Mayerhofer, S; Pabinger, I; Schwarzinger, I; Schweiger, C; Stain, C | 1 |
| Ewing, DJ; Piaggesi, A; Scott, G | 1 |
| Arcidiacono, I; Bedarida, G; Cambie, G; Cantaluppi, P; Crocchiolo, PR; D'Agostino, F; Filippi, C; Lizioli, A; Nardella, ML; Sobatti, D | 1 |
| Rhame, FS; Russell, AL | 1 |
| McKinney, RE | 1 |
| Deschênes, JG; Lalonde, RG; Seamone, C | 1 |
| Brown, ZA; Burchett, SK; Coombs, R; Corey, L; Opheim, K; Tartaglione, T; Watts, DH | 1 |
| Chaloupka, K; Collier, AC; Coombs, RW; Corey, L; Cummings, DK; Krieger, JN; Murphy, VL; Ross, SO | 1 |
| Boland, MG; Czarniecki, L | 1 |
| Kaneshima, H; McCune, JM; McGowan, J; Namikawa, R; Rabin, L; Sager, P; Shih, CC | 1 |
| Buskila, D; Gilmore, J; Gladman, DD; Salit, IE | 1 |
| Durand, E; Hugues, FC; Le Jeunne, C | 1 |
| Brunvand, L; Figenschou, KJ; Lindemann, R; Medbø, S; Ulstrup, J | 1 |
| Anderson, RM; Gupta, S; May, RM | 1 |
| Chaisson, RE; Flexner, C; Kessler, H; Moore, RD; Richman, DD | 1 |
| Stricker, RB | 1 |
| Golde, DW; Miles, SA; Mitsuyasu, RT | 1 |
| McKennett, MA | 1 |
| Gill, SK; Gilson, RJ; Hawkins, AE; Kelly, GK; Weller, IV | 1 |
| Israel, DS; Plaisance, KI | 1 |
| Petzoldt, D | 1 |
| Aguilar, JL; Espinoza, CG; Espinoza, LR; Gresh, J; Jara, J; Martinez-Osuna, P; Seleznick, M; Silveira, LH | 1 |
| Pavlatos, AM | 1 |
| Bryan, CS | 1 |
| Barrett, D; Cumming, W; Davis, J; Kalen, V; Kao, KJ; Lian, E; Mehta, P; Reiter, W; Saba, H; Sandler, E | 1 |
| Maha, M; McKinney, R | 1 |
| Borleffs, JC; Bosboom-Kalsbeek, KC; Gmelig-Meyling, FH; Hoepelman, AM; Schuurman, HJ; Vrehen, HM | 1 |
| Careddu, P; Cristina, S; D'Arminio Monforte, A; Marchisio, P; Massironi, E; Plebani, A; Principi, N | 1 |
| Weller, IV | 2 |
| Futterman, D; Hein, K | 1 |
| Nicholas, SW | 1 |
| Krasinski, K | 1 |
| Balson, PM; Coburn, M; Greenspan, D; Hyslop, N; Morse, EV; Simon, PM | 1 |
| Canet, C; Cigana, F; Da Costa Noble, R; Miquel, JL; Paille, C | 1 |
| Barnes, KE | 1 |
| Solomon, PJ; Wilson, SR | 1 |
| Curley, D; Devine, KG; Jeffries, DJ; Kinchington, D; McGuigan, C; O'Connor, TJ | 1 |
| Delia, S; Mastroianni, CM; Paoletti, F; Sorice, F; Vullo, V | 1 |
| Gil, A; Lavilla, P; López Dupla, JM; Pintado, V; Valencia, ME | 1 |
| Arnalich, F; Barbado, FJ; Dominguez, A; Mostaza, J; Peña, JM; Valencia, ME; Vazquez, JJ | 1 |
| Raub, W | 1 |
| Bakker, M; Coutinho, RA; de Wolf, F; Goudsmit, J; Houweling, JT; Lange, JM; Mulder, JW | 1 |
| Angarano, G; Barile, M; Fico, C; Fiore, JR; Fracasso, C; Lo Caputo, S; Pastore, G | 1 |
| Chadwick, EG; Millard, DD; Modlin, JF; Yogev, R | 1 |
| Oksenhendler, E; Seligmann, M | 1 |
| Bartlett, JA | 1 |
| Aldous, JA | 1 |
| Peto, TE | 1 |
| Eron, JJ; Hirsch, MS | 1 |
| Chen, IS; O'Brien, WA; Zack, JA | 1 |
| Burger, RA; Johnston, MI; Morrey, JD; Okleberry, KM; Sidwell, RW; Warren, RP | 1 |
| Broder, S | 1 |
| Pizzo, PA | 1 |
| Bozzette, SA; Richman, DD | 1 |
| Broder, S; Yarchoan, R | 1 |
| McGowan, J; Merigan, T; Sherwin, S | 1 |
| Broder, S; Mitsuya, H; Yarchoan, R | 1 |
| Adler-Storthz, K; Di Pietro, M; Ficarra, G; Forti, G; Gaglioti, D; Riccardi, R; Shillitoe, EJ | 1 |
| Pizzo, PA; Roilides, E; Rubin, M; Venzon, D | 1 |
| McCutchan, JA | 1 |
| Hardy, LM; Weiss, R | 1 |
| Eddy, J; Eppes, SC; Lane, BA; Lehrman, SN; Maha, MA; McKinney, RE; Parks, WP; Pizzo, PA; Riggs, M; Scott, GB | 1 |
| Falutz, J; Fanning, M; Gelmon, K; Le, T; Montaner, JS; O'Shaughnessy, M; Ruedy, J; Tsoukas, C; Wainberg, MA | 1 |
| Baudrimont, M; Cabane, J; Giral, P; Imbert, JC; Laraki, R; Lebas, J; Picard, O; Wattiaux, MJ | 2 |
| Broder, S; Hayashi, S; Mitsuya, H; Yarchoan, R | 1 |
| Polis, MA | 1 |
| Cardon, B; Gharakhanian, S; Navarette, MS; Rozenbaum, W | 1 |
| Hollak, CE; Kersten, MJ; Lange, JM; van der Lelie, J | 1 |
| Fletcher, C; Haus, E; Hrushesky, WJ; Rhame, F; Sackett-Lundeen, L; Sothern, RB; Suarez, C | 1 |
| Brooke, GL; Perez, JA; Perlmutter, BL; Safran, GF; Zatlin, GS | 1 |
| Shearer, WT | 1 |
| Andrzejewski, C; Benton, J; Boswell, RN; Lindquist, C; Lucey, D; Milum, S | 1 |
| Pincus, SH; Wehrly, K | 1 |
| Eigo, J; Itri, L; Johnson, MF; Richman, D | 1 |
| Jäger, H | 1 |
| Lam, M; Park, MC | 1 |
| Ramos Amador, JT; Ruiz Contreras, J | 1 |
| Chapel, HM; Dawson, SG; Eglin, RP | 1 |
| Angritt, P; Holland, TT; James, WD; Lupton, GP; Skelton, HG; Smith, KJ | 1 |
| Scoular, AB | 1 |
| Mahler, W | 1 |
| Goldstein, J | 1 |
| McWhinney, PH; Nathwani, D | 1 |
| Pluda, J; Yarchoan, R | 1 |
| Fritz, E; Grosch-Wörner, I; Koch, S; Vocks, M | 1 |
| Barzilai, A; Hodes, DS; Hyatt, AC; Reidenberg, BE; Sperling, RS; Wedgwood, JF | 1 |
| Hooker, M | 1 |
| Eitelberger, F; Tulzer, W | 1 |
| Elmslie, K; Mulligan, L; Ricketts, M | 1 |
| Cooper, DA; Edwards, P; Gold, J; Turner, J | 1 |
| Kaneshima, H; McCune, JM; Namikawa, R; Rabin, L; Shih, CC | 1 |
| Schumann, J | 1 |
| Gail, MH; Goedert, JJ; Rosenberg, PS | 1 |
| Bender, AN; Farraye, J; Mendelson, SG; Simpson, DM; Wolfe, DE | 1 |
| Amantea, MA | 1 |
| Anselmo, M; Canessa, A; Mazzarello, G; Rossi, E; Terragna, A | 1 |
| ten Kate, RW; Wijermans, PW | 1 |
| Abrar, D; Bongain, A; Garraffo, R; Gillet, JY; Lapalus, P | 1 |
| Boucher, CA; Danner, SA; Goudsmit, J; Hollak, CE; Lange, JM; Reiss, P; Roos, M; van Royen, EA; Wiltink, EH | 1 |
| Bernard, EM; Jules-Elysee, KM; Stover, DE; White, DA; Zaman, MB | 1 |
| Morse, GD; Olson, J; Plank, C; Portmore, A; Reichman, RC; Taylor, C | 1 |
| Biedermann-Hefner, M | 1 |
| Benet, LZ; Flynn, NF; Goldstein, E; Inciardi, JF; King, JH; Steffe, EM; Tonjes, TS | 1 |
| Bratzke, B; Orfanos, CE; Ruszczak, Z; Stadler, R | 1 |
| Albertini, F; D'Antuono, A; Fanti, PA; Gaddoni, G; Tosti, A | 1 |
| Dobloug, JH | 1 |
| Jost, J | 1 |
| Cadranel, J; Clauvel, JP; Ferchal, F; Oksenhendler, E; Sauvageon-Martre, H | 1 |
| Reichman, LB | 1 |
| Cannon, DL; Hahn, EF; Hart, GC; Saalmann, V; Schinazi, RF; Smith, GA; Sommadossi, JP; Xie, MY | 1 |
| Gingrich, MM | 1 |
| Johnson, MA; Squire, SB | 1 |
| Hamilton, JD; Hartigan, P; Simberkoff, MS | 1 |
| Danner, SA; Perenboom, R; Reiss, P; van 't Wout, JW | 1 |
| Beschorner, WE; Burns, WH; Donnenberg, AD; Farzadegan, H; Holland, HK; Jones, RJ; Quinnan, GV; Rossi, JJ; Saral, R; Vogelsang, GB | 1 |
| Falutz, J; Fanning, M; Gelmon, K; Gill, J; Montaner, JS; O'Shaughnessy, M; Smith, JR; Tsoukas, C; Wainberg, M; Wells, G | 1 |
| Jones, WN | 1 |
| Drees, N; Gerken, G; Hess, G; Meyer zum Büschenfelde, KH; Ramadori, G; Rossol, S; Voth, R | 1 |
| Blum, R; Hollander, H; Lifson, AR; Maha, M; Nusinoff-Lehrman, S; Rutherford, GW | 1 |
| Agur, Z | 1 |
| Hopewell, PC | 1 |
| Arrowsmith, JB | 1 |
| Benhamou, JP; Boyer, N; Dazza, MC; Girard, PM; Loriot, MA; Marcellin, P; Martinot-Peignoux, M; Pialoux, G | 1 |
| Van Demark, RE | 1 |
| Cochran, KD; Weatherburn, H | 1 |
| Civatte, J | 1 |
| Lewis, A | 1 |
| Gericke, D | 1 |
| Holdcroft, C; Lynn, MM | 1 |
| Colley, J; Feingold, AR; Iezza, A; Satyadeo, M; Selwyn, PA; Shaw, JF; Torres, R | 1 |
| Broder, S; Masur, H; Yarchoan, R | 1 |
430 review(s) available for zidovudine and HIV Coinfection
| Article | Year |
|---|---|
Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review.
Topics: Anti-HIV Agents; Chemistry Techniques, Synthetic; Drug Design; Drug Discovery; HIV Infections; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship | 2019 |
Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis.
Topics: Adult; Anti-Retroviral Agents; Bayes Theorem; Drug Resistance, Viral; Emtricitabine; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Tenofovir; Viral Load; Zidovudine | 2022 |
Adverse perinatal outcomes associated with HAART and monotherapy.
Topics: Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Zidovudine | 2022 |
Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
Topics: Adult; Anti-HIV Agents; Ghana; HIV Infections; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine | 2022 |
Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far.
Topics: Anti-HIV Agents; Child; Child, Preschool; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2023 |
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine | 2023 |
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2023 |
Review of the missed opportunities for the prevention of vertical transmission of HIV in Brazil.
Topics: Anti-HIV Agents; Brazil; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; Zidovudine | 2019 |
Zidovudine use in pregnancy and congenital malformations.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2017 |
Developments in early diagnosis and therapy of HIV infection in newborns.
Topics: Anti-HIV Agents; Early Diagnosis; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Ritonavir; Zidovudine | 2018 |
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2017 |
Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Lamivudine; Network Meta-Analysis; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 2017 |
Paediatric HIV-1 infection: updated strategies of prevention mother-to-child transmission.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2018 |
Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
Topics: Abnormalities, Drug-Induced; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Congenital Abnormalities; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Network Meta-Analysis; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Stavudine; Stillbirth; Zidovudine | 2018 |
Regression of human immunodeficiency virus-associated oral Kaposi sarcoma with combined antiretroviral therapy: A case report and literature review.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Mouth Neoplasms; Ritonavir; Sarcoma, Kaposi; Zidovudine | 2019 |
HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.
Topics: Alkynes; Anti-HIV Agents; Aptamers, Nucleotide; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Developing Countries; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mothers; Nevirapine; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sentinel Surveillance; Sequence Analysis, DNA; Viral Load; Zidovudine | 2013 |
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2013 |
[Tolerance of antiretroviral drugs during pregnancy].
Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutagens; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Zidovudine | 2013 |
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lipids; Maintenance Chemotherapy; Middle Aged; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2013 |
Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine).
Topics: Administration, Oral; Animals; Anti-HIV Agents; Caco-2 Cells; Cell Line; Dogs; Excipients; HIV Infections; Humans; Permeability; Solubility; Therapeutic Equivalency; Zidovudine | 2013 |
Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
Topics: Aneuploidy; Animals; Animals, Newborn; Disease Models, Animal; DNA, Mitochondrial; Erythrocebus patas; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2015 |
Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Ritonavir; Zidovudine | 2015 |
Recent progress in prodrug design strategies based on generally applicable modifications.
Topics: Amides; Animals; Anti-HIV Agents; Benzyl Compounds; Biological Availability; Carboxylic Acids; Drug Design; Esterification; HIV; HIV Infections; Humans; Prodrugs; Solubility; Zidovudine | 2017 |
[Tenofovir as a strategy to avoid or limit adverse effects].
Topics: Adenine; Anemia; Anti-HIV Agents; Antimetabolites; Clinical Trials as Topic; DNA, Mitochondrial; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Organophosphonates; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine | 2008 |
[Adipose tissue hypertrophy after Lipostructure in HIV patient with antiretroviral treatment. Case report and literature review].
Topics: Adipose Tissue; Adult; Anti-Retroviral Agents; Drug Combinations; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Lamivudine; Male; Postoperative Complications; Zidovudine | 2009 |
Non-occupational postexposure prophylaxis for HIV: a systematic review.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Databases, Bibliographic; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lopinavir; Premedication; Pyrimidinones; Ritonavir; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Unsafe Sex; Zidovudine | 2009 |
HIV and pregnancy: screening and management update.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cohort Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Obstetrics; Pregnancy; Pregnancy Complications, Infectious; Risk; Treatment Outcome; Zidovudine | 2009 |
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2009 |
Optimal versus suboptimal treatment for HIV-infected pregnant women and HIV-exposed infants in clinical research studies.
Topics: Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2009 |
[The "induction-maintenance" strategy].
Topics: Adipose Tissue; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Viral Load; Virus Replication; Zidovudine | 2008 |
A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2009 |
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.
Topics: Anti-HIV Agents; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Nucleosides; Nucleotides; Zidovudine | 2010 |
Transgenic mouse models of mitochondrial toxicity associated with HIV/AIDS and antiretrovirals.
Topics: Animals; Anti-HIV Agents; HIV Infections; Humans; Mice; Mice, Transgenic; Mitochondria, Heart; Models, Animal; Reverse Transcriptase Inhibitors; Zidovudine | 2010 |
Anti-HIV therapy with AZT prodrugs: AZT phosphonate derivatives, current state and prospects.
Topics: Animals; HIV Infections; Humans; Organophosphonates; Prodrugs; Zidovudine | 2010 |
Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Young Adult; Zidovudine | 2010 |
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2010 |
[The newest developments in anti-HIV-1 drugs].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Drug Resistance, Viral; Enfuvirtide; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Maraviroc; Molecular Structure; Peptide Fragments; Pyrrolidinones; Raltegravir Potassium; Saquinavir; Triazoles; Virus Replication; Zidovudine | 2010 |
Therapy for HIV: past, present, and future.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Developing Countries; Drug Combinations; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Zidovudine | 2011 |
Shuttle-mediated drug delivery to the brain.
Topics: Blood-Brain Barrier; Brain; Drug Carriers; HIV Infections; Humans; Liposomes; Nanoparticles; Peptides; Zidovudine | 2011 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.
Topics: Adolescent; Africa; Alkynes; Anti-HIV Agents; Asia; Benzoxazines; Child; Child, Preschool; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Drug Resistance, Viral; Female; Health Resources; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Latin America; Lopinavir; Male; Mutation; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Failure; Viral Load; Zidovudine | 2011 |
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine | 2011 |
Response-adaptive designs for continuous treatment responses in phase III clinical trials: A review.
Topics: Biostatistics; Clinical Trials, Phase III as Topic; Computer Simulation; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Models, Statistical; Neuralgia, Postherpetic; Pregabalin; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Statistics, Nonparametric; Zidovudine | 2016 |
Antiretrovirals for HIV Exposure Prophylaxis.
Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Emtricitabine; HIV; HIV Infections; Humans; Lamivudine; Occupational Exposure; Organophosphonates; Stavudine; Tenofovir; Zidovudine | 2012 |
Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
Topics: Adolescent; Anti-HIV Agents; Breast Feeding; Child; Child, Preschool; Drug Administration Schedule; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Transmission of HIV in the dental clinic and elsewhere.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Feeding; Cross Infection; Dental Clinics; Developed Countries; Developing Countries; Female; HIV Infections; Humans; Infant; Infection Control, Dental; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Occupational Diseases; Occupational Exposure; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Sexual Behavior; Tuberculosis; Zidovudine | 2002 |
[Treatment of chronic hepatitis C in patients coinfected with HIV: tolerability, drug interactions, therapeutic indications].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Didanosine; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Life Style; Mitochondria; Monitoring, Physiologic; Multicenter Studies as Topic; Patient Selection; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Ribavirin; Stavudine; Time Factors; Viral Load; Zidovudine | 2002 |
STI and beyond: the prospects of boosting anti-HIV immune responses.
Topics: Acute Disease; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chronic Disease; HIV; HIV Infections; Humans; Zidovudine | 2002 |
Mother to child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Zidovudine | 2002 |
Pregnancy and HIV infection: A european consensus on management.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cesarean Section; Child; Child Welfare; Contraception; Counseling; Drug Resistance; Drug Resistance, Viral; Female; Follow-Up Studies; Health Status; HIV Infections; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Compliance; Postnatal Care; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 2002 |
Mother to child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Curtailing maternal to child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Developing Countries; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kenya; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; Uganda; Viral Load; Zidovudine | 2002 |
Lamivudine/zidovudine/abacavir: triple combination tablet.
Topics: Administration, Oral; Anti-HIV Agents; Biological Availability; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 2003 |
Immunopathogenesis of HIV-related heart muscle disease: current perspectives.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Autoimmune Diseases; HIV Infections; Humans; Myocarditis; Nutrition Disorders; Ventricular Dysfunction; Zidovudine | 2003 |
Prevention of HIV transmission after health care worker occupational exposure.
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Risk Factors; Zidovudine | 2003 |
Recommendations for reducing the risk of occupational HIV transmission.
Topics: Anti-Retroviral Agents; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Practice Guidelines as Topic; Premedication; Referral and Consultation; Risk; United States; United States Public Health Service; Zidovudine | 2003 |
Updated recommendations for reducing vertical HIV transmission.
Topics: Anti-Retroviral Agents; Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; United States; United States Public Health Service; Zidovudine | 2003 |
Fozivudine: BM 211290, fozivudine tidoxil, FZT, HDP 990002, W 09726867.
Topics: Animals; Anti-HIV Agents; Drugs, Investigational; HIV Infections; Humans; Lipids; Zidovudine | 2004 |
[HIV-1 transmission from mother to child and its prevention].
Topics: Adult; Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Sanitation; Zidovudine | 2003 |
The continuing evolution of HIV therapy.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Cyclopropanes; Delayed-Action Preparations; Deoxycytidine; Didanosine; Dideoxynucleosides; Drug Monitoring; Emtricitabine; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Oxazines; Pyridines; Randomized Controlled Trials as Topic; Stavudine; Sulfonamides; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2003 |
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.
Topics: Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Hemoglobins; HIV Infections; Humans; Neutropenia; Randomized Controlled Trials as Topic; Stavudine; Viral Load; Zidovudine | 2004 |
Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Topics: Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk Factors; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2003 |
Preventing neonatal HIV: a review.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
[Neuromuscular diseases associated with HIV-1 infection].
Topics: Anti-HIV Agents; Cytomegalovirus Infections; HIV Infections; Humans; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Zalcitabine; Zidovudine | 2004 |
Effects of AZT on cellular iron homeostasis.
Topics: Animals; Cells; Gene Expression Regulation; HIV Infections; Homeostasis; Humans; Iron; Zidovudine | 2004 |
Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature.
Topics: Acidosis, Lactic; Adult; Didanosine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; New York; Reverse Transcriptase Inhibitors; Stavudine; Syndrome; Zidovudine | 2004 |
[Progress in the study of maternal-fetal vertical transmission of human immunodeficiency virus type-1].
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 2004 |
Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs.
Topics: Adult; Animals; Animals, Newborn; Anti-HIV Agents; Carcinogens; Female; HIV Infections; Humans; Infant, Newborn; Maternal-Fetal Exchange; Mutagens; Nucleosides; Placenta; Pregnancy; Zidovudine | 2004 |
Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Zidovudine | 2004 |
An update on drug interactions with zidovudine.
Topics: Anti-HIV Agents; Drug Interactions; HIV Infections; Humans; Zidovudine | 1998 |
[Antiretroviral therapy and pregnancy].
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Risk Assessment; Risk Factors; Treatment Outcome; Women's Health; Zidovudine | 2005 |
[Treatment strategies for human immunodeficiency virus infection or "return to the future"].
Topics: Clinical Protocols; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
HIV: mother to child transmission.
Topics: Administration, Intravaginal; Anti-HIV Agents; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Topics: Acidosis, Lactic; Anti-HIV Agents; Cardiomyopathies; Child; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Mitochondria; Nucleosides; Polyneuropathies; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape.
Topics: Adolescent; Adult; Anti-HIV Agents; Body Weight; Child; Child Abuse, Sexual; Child, Preschool; Feasibility Studies; Female; HIV Infections; Humans; Infant; Kenya; Lamivudine; Male; Pilot Projects; Practice Guidelines as Topic; Rape; Risk Factors; Rural Health; Sexually Transmitted Diseases; Zidovudine | 2006 |
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
Topics: Adult; Anti-HIV Agents; Breast Feeding; Drug Combinations; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Perinatal Care; Randomized Controlled Trials as Topic; Regression Analysis; Risk Factors; Treatment Outcome; Zidovudine | 2005 |
Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Metabolic Syndrome; Nevirapine; Oxazines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Zidovudine | 2005 |
[The treatment of HIV infection].
Topics: Adenine; Anti-Retroviral Agents; Carbamates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Furans; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Sulfonamides; Tenofovir; Zidovudine | 2005 |
Triple-nucleoside analog antiretroviral therapy: is there still a role in clinical practice? A review.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Treatment Outcome; Zidovudine | 2005 |
[Use of thymidine-sparing regimens in first-line therapy and in switches from thymidine analogues].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Stavudine; Thymidine; Treatment Outcome; Zidovudine | 2005 |
Mitochondrial disease in the offspring as a result of antiretroviral therapy.
Topics: Animals; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Mitochondrial Diseases; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine | 2006 |
HIV: mother to child transmission.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
Antiretroviral therapy 2006: pharmacology, applications, and special situations.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Enfuvirtide; Female; Genotype; Hepatitis B; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; Humans; Mutation; Peptide Fragments; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine | 2006 |
Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
Topics: Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; World Health Organization; Zidovudine | 2006 |
Vaginal microbicides for the prevention of HIV transmission.
Topics: Administration, Intravaginal; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Phospholipids; Zidovudine | 2004 |
Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple-nucleoside/nucleotide regimen of trizivir and tenofovir.
Topics: Adenine; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2006 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Computational models of antiviral toxicity.
Topics: Anti-HIV Agents; Computer Simulation; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Lamivudine; Molecular Structure; Stavudine; Zidovudine | 2007 |
Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Treatment Outcome; Zidovudine | 2007 |
Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Antimetabolites; Antiretroviral Therapy, Highly Active; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Zidovudine | 2007 |
Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Resistance, Multiple, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Organophosphonates; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Management of occupational exposure to HIV.
Topics: Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Zidovudine | 1995 |
What's new in treatment?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Drug Evaluation; HIV Infections; HIV Reverse Transcriptase; Humans; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Racial Groups; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 1993 |
Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review.
Topics: Antiviral Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1994 |
Pharmacologic therapy for human immunodeficiency virus infection: a review.
Topics: Antiviral Agents; Didanosine; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Zidovudine | 1994 |
Combination therapy for infection due to human immunodeficiency virus type 1.
Topics: Acyclovir; Antiviral Agents; CD4 Antigens; Clinical Trials as Topic; Combined Modality Therapy; Didanosine; Drug Therapy, Combination; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1994 |
Survival effects of ZDV, ddI, and ddC in patients with CD4 < or = 50 cells/mm3.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Didanosine; Double-Blind Method; HIV Infections; Humans; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Zalcitabine; Zidovudine | 1995 |
Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
Topics: Aging; Antineoplastic Agents; Antiviral Agents; Didanosine; Drug Interactions; Guidelines as Topic; HIV Infections; Humans; Phosphorylation; Racial Groups; Sex Characteristics; Stavudine; Zalcitabine; Zidovudine | 1995 |
Guidelines for the use of zidovudine in pregnant women with HIV infection.
Topics: Female; Guidelines as Topic; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Mother-to-child transmission of the human immunodeficiency virus.
Topics: Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pneumonia, Pneumocystis; Pregnancy; Prenatal Diagnosis; Risk Factors; Zidovudine | 1995 |
Prevention of maternal HIV transmission. Practical guidelines.
Topics: Drug Administration Schedule; Female; France; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Randomized Controlled Trials as Topic; United States; Zidovudine | 1995 |
The value of the CD4+ count of 500 cells/microliters.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; HIV Infections; Humans; Prognosis; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Infections; Humans; Survival Analysis; Time Factors; Virus Replication; Zidovudine | 1995 |
An approach to antiretroviral treatment of HIV disease. Nucleoside monotherapy.
Topics: Antiviral Agents; Didanosine; HIV Infections; HIV-1; Humans; Lamivudine; Nucleosides; Stavudine; Zalcitabine; Zidovudine | 1995 |
Human immunodeficiency virus infection in children.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Dapsone; Didanosine; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Stavudine; Trimethoprim, Sulfamethoxazole Drug Combination; Zalcitabine; Zidovudine | 1995 |
A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Resistance, Microbial; Female; Guidelines as Topic; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Risk Assessment; Zidovudine | 1995 |
Zidovudine for the reduction of perinatal transmission of human immunodeficiency virus.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Human immunodeficiency virus disease in pregnancy.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; United States; Zidovudine | 1995 |
Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.
Topics: Acquired Immunodeficiency Syndrome; Adult; Child; Didanosine; Dideoxynucleosides; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Interferons; Needlestick Injuries; Sarcoma, Kaposi; Zalcitabine; Zidovudine | 1993 |
Ocular syphilis and neurosyphilis in a patient with human immunodeficiency virus infection.
Topics: Adult; Angiography; Drug Therapy, Combination; Eye Diseases; HIV Infections; Humans; Male; Neurosyphilis; Penicillins; Prednisone; Syphilis Serodiagnosis; Zidovudine | 1995 |
[Anti-HIV therapy (1987-1994): from nothing to confusion].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Time Factors; Zalcitabine; Zidovudine | 1995 |
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness.
Topics: Acquired Immunodeficiency Syndrome; Disease Progression; HIV Infections; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Regression Analysis; Time Factors; Zidovudine | 1995 |
[HIV and pregnancy].
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Controversies in anti-retroviral therapy of adults.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Complex; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Drug Tolerance; HIV Infections; HIV-1; Humans; Zalcitabine; Zidovudine | 1995 |
Managing the child infected with HIV.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Child, Preschool; Family; HIV Infections; Humans; Infant; Infant, Newborn; Infection Control; Infectious Disease Transmission, Vertical; Social Support; Zidovudine | 1995 |
Early intervention in HIV infection: where are we?
Topics: CD4 Lymphocyte Count; Controlled Clinical Trials as Topic; Disease Progression; Follow-Up Studies; HIV Infections; Humans; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate; Zidovudine | 1994 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Combination therapy: more effective control of HIV type 1?
Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Virus Replication; Zalcitabine; Zidovudine | 1994 |
Changing virus-host interactions in the course of HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; CD4-Positive T-Lymphocytes; Disease Progression; HIV Infections; HIV-1; Humans; Immunity, Cellular; Lymphocyte Depletion; Zidovudine | 1994 |
Immunological and virological markers determining progression to AIDS.
Topics: Biomarkers; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Phenotype; Predictive Value of Tests; Prognosis; Zidovudine | 1994 |
HIV therapy advances. Pediatric antiretroviral choices.
Topics: Body Weight; Clinical Trials as Topic; Didanosine; Female; Growth; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Treatment Failure; Zalcitabine; Zidovudine | 1994 |
Interferons in HIV and related diseases.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clinical Trials as Topic; Combined Modality Therapy; Hepatitis B; HIV Infections; Humans; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Zidovudine | 1994 |
Future treatment strategies in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Forecasting; HIV Infections; Humans; Zalcitabine; Zidovudine | 1994 |
HIV therapy advances. Early antiretroviral therapy.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Multicenter Studies as Topic; Retroviridae; Time Factors; Zidovudine | 1994 |
HIV infections in children.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Fever; HIV Infections; Humans; Immunoglobulins, Intravenous; Immunotherapy, Active; Infant; Infant, Newborn; Lung Diseases; Respiratory Tract Infections; Zidovudine | 1995 |
Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1.
Topics: Clinical Trials as Topic; Didanosine; Dideoxynucleosides; Drug Resistance; HIV Infections; HIV-1; Humans; Zidovudine | 1995 |
Clinical pharmacokinetics of nucleoside antiretroviral agents.
Topics: Animals; Didanosine; Dideoxynucleosides; HIV Infections; Humans; Lamivudine; Stavudine; Zalcitabine; Zidovudine | 1995 |
Clinical comparison of adult and pediatric NeuroAIDS.
Topics: Adult; Age Factors; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Biomarkers; Central Nervous System; Child; HIV Infections; HIV-1; Humans; Peripheral Nervous System Diseases; Zidovudine | 1994 |
[The role of zidovudine and cesarean section in the prevention of vertical transmission of HIV].
Topics: Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.
Topics: Adult; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Didanosine; Dideoxynucleosides; Drug Resistance; Guidelines as Topic; HIV Infections; Humans; Leukocyte Count; Zalcitabine; Zidovudine | 1993 |
P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection.
Topics: Aging; Animals; Antigen-Presenting Cells; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Drug Resistance; Gene Expression; Genes; Hematopoietic Stem Cells; HIV Infections; HIV-1; Humans; Leukocytes; Lymphocyte Subsets; Macrophages; Membrane Glycoproteins; Mice; Models, Biological; Monocytes; Plasmodium falciparum; Protozoan Proteins; Rodentia; Zidovudine | 1993 |
The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Combined Modality Therapy; HIV Infections; Humans; Immunoglobulins, Intravenous; Leukocyte Count; Lymphocyte Activation; Pentamidine; Prospective Studies; Survival Rate; Treatment Failure; Zidovudine | 1994 |
Human immunodeficiency virus infection.
Topics: CD4-Positive T-Lymphocytes; Clinical Protocols; Critical Care; HIV Infections; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Leukocyte Count; Needlestick Injuries; Occupational Exposure; Personnel, Hospital; Risk Factors; United States; Zidovudine | 1993 |
Skeletal muscle involvement in HIV-infected patients.
Topics: HIV Infections; Humans; Muscle, Skeletal; Muscular Diseases; Zidovudine | 1994 |
Initiation of antiretroviral therapy in HIV infection: a review of interstudy consistencies.
Topics: Cohort Studies; Controlled Clinical Trials as Topic; Double-Blind Method; HIV Infections; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reproducibility of Results; Time Factors; Zidovudine | 1994 |
Recent development on research in AIDS pathogenesis.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Cytopathogenic Effect, Viral; Disease Progression; HIV Infections; HIV-1; Humans; Macrophages; Phenotype; Prognosis; Virulence; Zidovudine | 1994 |
Antiretroviral therapy during pregnancy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Current therapy of HIV associated infections and malignancies.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antineoplastic Agents; Dideoxynucleosides; HIV Infections; Humans; Lymphoma, AIDS-Related; Sarcoma, Kaposi; Zidovudine | 1994 |
Immune-based interventions in perinatal human immunodeficiency virus infection.
Topics: AIDS Vaccines; Cytokines; Female; HIV Infections; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
[Antiretroviral therapy. Current status and perspectives].
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Stavudine; Zalcitabine; Zidovudine | 1994 |
[Antiviral treatment of HIV infection].
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; Humans; Zidovudine | 1994 |
Empirical and rational approaches for development of inhibitors of the human immunodeficiency virus--HIV-1.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Drug Design; Gossypol; HIV Infections; HIV-1; Humans; Hydrocarbons, Halogenated; Molecular Sequence Data; Protease Inhibitors; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship; Virus Replication; Zidovudine | 1993 |
Managing occupational risks in the dental office: HIV and the dental professional.
Topics: Blood-Borne Pathogens; Dental Staff; Didanosine; HIV Infections; HIV Seropositivity; Humans; Needlestick Injuries; Occupational Exposure; Risk Factors; Universal Precautions; Zidovudine | 1994 |
Prevention of human immunodeficiency virus infection among hospital personnel.
Topics: Animals; HIV Infections; Humans; Infection Control; Occupational Diseases; Personnel, Hospital; Prospective Studies; Risk Factors; Zidovudine | 1994 |
Perspectives on the use of antiretroviral drugs in the treatment of HIV infection.
Topics: Didanosine; Dideoxynucleosides; Drug Administration Schedule; HIV Infections; Humans; Stavudine; Zalcitabine; Zidovudine | 1994 |
Zalcitabine.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; HIV Infections; Humans; Infant; Zalcitabine; Zidovudine | 1993 |
Human immunodeficiency virus infection in pregnancy: epidemiology and prevention of vertical transmission.
Topics: Adult; AIDS Serodiagnosis; Breast Feeding; Female; Fetal Diseases; HIV Infections; Humans; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Obstetric Labor Complications; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Puerperal Disorders; Risk Factors; Zidovudine | 1994 |
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Topics: Acquired Immunodeficiency Syndrome; AIDS Vaccines; AIDS-Related Opportunistic Infections; Female; Genetic Therapy; HIV Infections; HIV-1; Humans; Male; Viral Vaccines; Zidovudine | 1994 |
Retroviruses and inflammatory myopathies in humans and primates.
Topics: HIV Infections; HTLV-I Infections; Humans; Myositis; Retroviridae; Retroviridae Infections; Zidovudine | 1993 |
Working towards a European strategy for intervention to reduce vertical transmission of HIV.
Topics: Delivery, Obstetric; Female; HIV Infections; Humans; Immunity, Active; Immunization, Passive; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 1994 |
[Therapy of HIV infection with nucleoside analogs].
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nucleosides; Zalcitabine; Zidovudine | 1993 |
Pharmacodynamics of antiretroviral chemotherapy.
Topics: Antiviral Agents; Biological Availability; CD4 Antigens; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dextran Sulfate; Didanosine; HIV Core Protein p24; HIV Infections; Humans; T-Lymphocytes; Zidovudine | 1993 |
Prophylaxis of HIV infection following occupational exposure.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Drug Costs; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Risk Factors; Zidovudine | 1993 |
Human immunodeficiency virus type 1 infection of the brain.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Animals; Brain; Cerebrospinal Fluid; Child; Cytokines; HIV Infections; HIV-1; Humans; Infant; Male; Meningitis, Viral; Meningoencephalitis; Radiography; Rats; Zidovudine | 1993 |
Hepatitis, HIV, and the dermatologist: a risk review.
Topics: Canada; Dermatology; Health Personnel; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; HIV Infections; Humans; Occupational Diseases; Prevalence; Protective Clothing; Risk Factors; United States; Zidovudine | 1994 |
Infectious AIDS--stretching the germ theory beyond its limits.
Topics: Acquired Immunodeficiency Syndrome; AIDS Vaccines; Antibody Diversity; Female; HIV Infections; HIV-1; Humans; Male; Substance-Related Disorders; Zidovudine | 1994 |
[Antiviral chemotherapy: mechanisms of action, evaluation of activity, resistance and future developments].
Topics: Acyclovir; Animals; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; HIV Infections; Humans; Immune Tolerance; In Vitro Techniques; Thymidine Kinase; Viruses; Zidovudine | 1993 |
[Are immunomodulators capable to improve the activity of nucleoside antiretroviral agents?].
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Drug Combinations; Drug Synergism; Friend murine leukemia virus; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interferon-alpha; Mice; Poly A-U; Poly I-C; Poly U; Zidovudine | 1993 |
Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Zidovudine | 1993 |
[Azidothymidine in the management of immune deficiency complex].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Dose-Response Relationship, Drug; Female; HIV Infections; HIV Seropositivity; Humans; Male; Prognosis; Zidovudine | 1993 |
Roundtable discussion: management issues in didanosine therapy.
Topics: Didanosine; Dose-Response Relationship, Drug; Health Personnel; HIV Infections; Humans; Occupational Exposure; Pancreatitis; Peripheral Nervous System Diseases; Zidovudine | 1993 |
Therapy for human immunodeficiency virus infection.
Topics: Didanosine; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Protease Inhibitors; Zalcitabine; Zidovudine | 1993 |
[Prevention in the HIV-infected].
Topics: AIDS-Related Opportunistic Infections; Candidiasis; HIV Infections; HIV-1; Humans; Pneumonia, Pneumocystis; Retroviridae Infections; Toxoplasmosis; Tuberculosis, Pulmonary; Zidovudine | 1993 |
Current management of HIV infection in children.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Didanosine; Drug Monitoring; HIV Infections; Humans; Infant; Infant, Newborn; Zidovudine | 1993 |
Epidemiological pattern of HIV infection in Australia.
Topics: Australia; Female; HIV Infections; Homosexuality; Humans; Male; Prevalence; Substance Abuse, Intravenous; Zidovudine | 1993 |
Arguments against the chemoprophylactic use of zidovudine following occupational exposure to the human immunodeficiency virus.
Topics: Didanosine; Health Personnel; HIV Infections; Humans; Occupational Exposure; Zidovudine | 1993 |
Rationales for treating the human immunodeficiency virus-infected woman during pregnancy.
Topics: Animals; Female; HIV Envelope Protein gp120; HIV Infections; Humans; Immunotherapy; Infant, Newborn; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine | 1993 |
[AIDS and HIV infection as occupational disease].
Topics: Acquired Immunodeficiency Syndrome; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Occupational Diseases; Police; Risk Factors; Zidovudine | 1993 |
Human immunodeficiency virus nephropathy.
Topics: Acquired Immunodeficiency Syndrome; Child, Preschool; Glomerulosclerosis, Focal Segmental; HIV Infections; Humans; Infant; Peritoneal Dialysis; Proteinuria; Zidovudine | 1993 |
["Needlestick" accidents--procedures following potentially infectious exposure in medical personnel].
Topics: Health Personnel; Hepatitis B Vaccines; Hepatitis, Viral, Human; HIV Infections; Humans; Immunotherapy; Needlestick Injuries; Occupational Exposure; Risk Factors; Zidovudine | 1993 |
Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection.
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1995 |
Zidovudine therapy in HIV infection: which patients should be treated and when.
Topics: Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Phosphorylation; Pregnancy; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; World Health Organization; Zidovudine | 1995 |
Viral resistance and the selection of antiretroviral combinations.
Topics: Antiviral Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1995 |
Studies of zidovudine in combination with didanosine and zalcitabine.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Safety; Zalcitabine; Zidovudine | 1995 |
Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.
Topics: AIDS Dementia Complex; Antiviral Agents; Brain Diseases; HIV Infections; Humans; Nervous System Diseases; Peripheral Nervous System Diseases; Zidovudine | 1996 |
Primary care of the HIV patient: standard practice and new developments in the era of managed care.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cachexia; Female; HIV Infections; Humans; Male; Managed Care Programs; Physical Examination; Polymerase Chain Reaction; Primary Health Care; United States; Zidovudine | 1996 |
Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Multicenter Studies as Topic; Zalcitabine; Zidovudine | 1996 |
The overlooked epidemic: HIV in older adults.
Topics: Aged; AIDS Dementia Complex; Diagnosis, Differential; Female; HIV Infections; Humans; Male; Middle Aged; Patient Education as Topic; Sexual Behavior; United States; Zidovudine | 1996 |
Postexposure protocol.
Topics: Antibiotic Prophylaxis; Blood-Borne Pathogens; Clinical Protocols; Communicable Diseases; Dentistry; Gonorrhea; Hepatitis, Viral, Human; Herpes Simplex; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Professional Impairment; Risk Assessment; Syphilis; Zidovudine | 1996 |
Ups and downs--and ups in the antiviral therapy of HIV infection.
Topics: AIDS-Related Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; Didanosine; HIV Infections; Humans; Quality of Life; Randomized Controlled Trials as Topic; Zidovudine | 1996 |
[Clinical study of HIV infections].
Topics: AIDS-Related Opportunistic Infections; HIV Infections; Humans; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
[Pregnant women with HIV infection: medical decision].
Topics: Decision Making; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk Factors; Zidovudine | 1996 |
[Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Neoplasms; Neutropenia; Receptors, Granulocyte Colony-Stimulating Factor; Time Factors; Zidovudine | 1996 |
Resistance to anti-human immunodeficiency virus therapeutic agents.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Design; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Point Mutation; Zidovudine | 1995 |
The role of antiretroviral therapy in the management of HIV infection in women.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Treatment Outcome; Zidovudine | 1996 |
[Muscular involvement in HIV infection].
Topics: HIV Infections; Humans; Muscular Diseases; Reverse Transcriptase Inhibitors; Zidovudine | 1995 |
[Transmission of human immunodeficiency virus to the fetus during pregnancy].
Topics: Antimetabolites; Female; HIV Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Prognosis; Risk Factors; Zidovudine | 1996 |
Clinical experience with saquinavir.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; Zidovudine | 1995 |
Prophylaxis for occupational exposure to HIV.
Topics: Antiviral Agents; Health Personnel; HIV Infections; Humans; Lamivudine; Occupational Exposure; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
Transfusion-transmitted disease.
Topics: Blood; Blood Coagulation Factors; Carcinoma, Hepatocellular; Comorbidity; Creutzfeldt-Jakob Syndrome; Drug Contamination; Erythema Infectiosum; Hemophilia A; Hepatitis, Viral, Human; HIV Infections; Humans; Life Expectancy; Liver Neoplasms; Liver Transplantation; Lymphoma, AIDS-Related; Parvovirus B19, Human; Prognosis; Sexually Transmitted Diseases, Viral; Survival Analysis; Thrombocytopenia; Transfusion Reaction; Virus Diseases; Zidovudine | 1996 |
Will we ever know when to treat HIV infection?
Topics: Antiviral Agents; HIV Infections; Humans; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Zidovudine | 1996 |
Zidovudine: anno 1995.
Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; HIV Infections; Humans; Zidovudine | 1996 |
ddC (zalcitabine).
Topics: Antiviral Agents; Drug Therapy, Combination; HIV; HIV Infections; Humans; Zalcitabine; Zidovudine | 1996 |
Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Meta-Analysis as Topic; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1996 |
Wheel keeps turning for antiviral combination chemotherapy.
Topics: Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Lamivudine; Virus Diseases; Zidovudine | 1996 |
Prevention of perinatal transmission of human immunodeficiency virus: a progress report 2 years after completion of AIDS Clinical Trials Group trial 076.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Clinical Trials as Topic; Disease Notification; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Reporting; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1996 |
Ritonavir.
Topics: Administration, Oral; Anti-HIV Agents; Biological Availability; CD4-Positive T-Lymphocytes; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Leukocyte Count; Randomized Controlled Trials as Topic; Ritonavir; RNA, Messenger; Zalcitabine; Zidovudine | 1996 |
Pediatric human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Central Nervous System Diseases; Child; Child, Preschool; Cytomegalovirus Infections; Didanosine; Disease Transmission, Infectious; Eye Diseases; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Herpes Simplex; Herpes Zoster; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Neoplasms; Pregnancy; Prevalence; Risk Factors; Sexual Behavior; Skin Diseases; Transfusion Reaction; Zidovudine | 1996 |
Pediatric HIV infection: a primer for pharmacists.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Didanosine; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pharmacists; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
HIV and pregnancy.
Topics: Cesarean Section; Female; Global Health; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Zidovudine | 1996 |
Rational approaches to resistance: nucleoside analogues.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Clinical pharmacokinetics of zidovudine. An update.
Topics: Age Factors; Antiviral Agents; Biological Availability; Drug Interactions; HIV Infections; Humans; Tissue Distribution; Zidovudine | 1996 |
Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.
Topics: Antiviral Agents; HIV Infections; Prodrugs; Zidovudine | 1996 |
[Post-exposure drug prevention of HIV infection].
Topics: Animals; Anti-HIV Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Diseases; Randomized Controlled Trials as Topic; Risk Factors; Zidovudine | 1996 |
Preventing perinatal HIV transmission: zidovudine use during pregnancy.
Topics: Anti-HIV Agents; Counseling; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
Analysis of resistance mutants of viral polymerases.
Topics: Animals; Antiviral Agents; Cell Line; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Genetic Variation; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Simplexvirus; Thymidine Kinase; Zidovudine | 1996 |
[Anti-retroviral treatment. Approach to previously treated patients].
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1996 |
[Initial anti-retroviral treatment (therapeutic approach to patients without previous treatment)].
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1996 |
[Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
Topics: Adult; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1996 |
[Anti-retroviral treatment. Treatment modification: toxicity management].
Topics: Anti-HIV Agents; Didanosine; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hematologic Diseases; HIV Infections; Humans; Muscular Diseases; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
[Anti-retroviral treatment. Treatment in special situations: acute infection, pregnancy, central nervous system involvement, thrombocytopenia, accidental exposure].
Topics: Accidents, Occupational; Acute Disease; AIDS Dementia Complex; Animals; Anti-HIV Agents; Clinical Trials as Topic; Combined Modality Therapy; Disease Progression; Female; HIV Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Rats; Splenectomy; Thrombocytopenia; Zidovudine | 1996 |
[Monitoring anti-retroviral treatment].
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Evaluation; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Phenotype; RNA, Viral; Viremia; Zidovudine | 1996 |
Antiretroviral therapy for pregnant women.
Topics: Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Saquinavir; Zalcitabine; Zidovudine | 1997 |
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.
Topics: Adolescent; Adult; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Disease Progression; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; United States; Zidovudine | 1997 |
Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.
Topics: Anti-HIV Agents; Biological Availability; Blood Proteins; Half-Life; HIV Infections; Humans; Metabolic Clearance Rate; Protease Inhibitors; Zidovudine | 1997 |
[Anti-retrovirus agents in AIDS: therapeutic strategy and prospectives for the future].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; HIV Infections; Humans; Immunotherapy; Retroviridae; Zidovudine | 1997 |
Vertical transmission of human immunodeficiency virus.
Topics: Anti-HIV Agents; Breast Feeding; Delivery, Obstetric; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Welfare; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1997 |
Antiretroviral agents. Current usage.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Forecasting; HIV; HIV Infections; Humans; Research; Zidovudine | 1997 |
Antiretroviral therapy: a guide to the most important trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1997 |
The surgeon's database for AIDS: a collective review.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Databases, Factual; General Surgery; HIV; HIV Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Seroepidemiologic Studies; Universal Precautions; Zidovudine | 1997 |
[Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
Topics: Anemia; Anti-HIV Agents; Erythropoietin; HIV Infections; Humans; Recombinant Proteins; Time Factors; Zidovudine | 1997 |
Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology.
Topics: Animals; Anti-HIV Agents; Bone Marrow; CD4-Positive T-Lymphocytes; Dendritic Cells; HIV Infections; HIV-1; Humans; Interleukin-12; Lymphoid Tissue; Signal Transduction; Zidovudine | 1997 |
The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review.
Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cytarabine; Daunorubicin; Drug Therapy, Combination; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Thioguanine; Zidovudine | 1997 |
[HIV infection and acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Female; Health Occupations; HIV Antibodies; HIV Antigens; HIV Infections; HIV-1; Humans; Male; Occupational Exposure; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1997 |
[HIV and pregnancy: risks of transmission and therapeutic possibilities].
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1996 |
Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; CD4 Lymphocyte Count; Counseling; Female; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 1997 |
The clinical management of children perinatally exposed to HIV.
Topics: Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; United States; Zidovudine | 1997 |
Primary HIV infection. Early diagnosis and treatment are critical to outcome.
Topics: Animals; Anti-HIV Agents; HIV Infections; Humans; Zidovudine | 1997 |
[Muscular complications in HIV infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; HIV Infections; Humans; Muscular Diseases; Zidovudine | 1997 |
Update: transmission of HIV-1 from mother to child.
Topics: Breast Feeding; Europe; Female; Fetus; Guidelines as Topic; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Placenta; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; United States; United States Public Health Service; Zidovudine | 1997 |
Prevention of transmission. Pharmaceutical and obstetric approaches.
Topics: Anti-HIV Agents; Delivery, Obstetric; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
The placental barrier to maternal HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
ACOG committee opinion. Zidovudine for the prevention of vertical transmission of human immunodeficiency virus. Number 148--December 1994. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1995 |
[Infectious diseases that require world-wide control--HIV infections].
Topics: Anti-HIV Agents; Communicable Disease Control; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; International Cooperation; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Antiretroviral therapy in human immunodeficiency virus-infected individuals.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chemoprevention; Clinical Protocols; Decision Making; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Patient Care Planning; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine | 1998 |
Update on HIV chemoprophylaxis following exposure.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; Zidovudine | 1997 |
[Past, present and future of zidovudine, the first antiretroviral drug].
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Zidovudine | 1998 |
Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; ROC Curve; Viral Load; Viremia; Zidovudine | 1998 |
[Decision guides for antiretroviral treatment in pregnancy].
Topics: Adult; Anti-HIV Agents; Decision Support Techniques; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1998 |
Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection.
Topics: Anti-HIV Agents; HIV Infections; Humans; Phosphorylation; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors.
Topics: Adolescent; Adult; Anti-HIV Agents; Hemophilia A; Hemorrhage; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Overview on HIV-1-related drug resistance: from theory to clinical practice.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Virus Replication; Zidovudine | 1998 |
Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
Topics: Anti-HIV Agents; Follow-Up Studies; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1998 |
[Antiretroviral treatment in human immunodeficiency virus infection].
Topics: Antiviral Agents; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Ritonavir; Saquinavir; Stavudine; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1997 |
Update on vertical HIV transmission.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Obstetrics; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Resistance, Microbial; Evaluation Studies as Topic; HIV; HIV Infections; Humans; Risk; Risk-Taking; Sexual Behavior; Substance Abuse, Intravenous; Zidovudine | 1998 |
Antiretroviral chemotherapy.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1998 |
Failures of zidovudine postexposure prophylaxis.
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Occupational Exposure; Time Factors; Treatment Failure; Zidovudine | 1997 |
Toxicity of antiretroviral agents.
Topics: Anti-HIV Agents; Didanosine; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1997 |
How to assess an article on economic evaluation.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Data Interpretation, Statistical; Female; HIV Infections; Humans; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Treatment Outcome; Zidovudine | 1998 |
Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics.
Topics: Acriflavine; Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Ellipticines; HIV Infections; Humans; Treatment Outcome; Zidovudine | 1998 |
Clinical trials in developing countries: scientific and ethical issues.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Delivery of Health Care; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
HIV infection and pregnancy.
Topics: Anti-HIV Agents; Breast Feeding; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Viral Load; Zidovudine | 1998 |
Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1998 |
Zidovudine.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1998 |
Insights into the mechanisms of vertical transmission of HIV-1. BIOMED2 Working Group on the in utero transmission of HIV-1.
Topics: Anti-HIV Agents; Breast Feeding; Cameroon; Cohort Studies; Female; France; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Italy; Placenta; Pregnancy; Trophoblasts; Zidovudine | 1997 |
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
Topics: Anti-HIV Agents; Birth Weight; Cesarean Section; Cohort Studies; Delivery, Obstetric; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Male; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1999 |
Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Child, Preschool; Clinical Trials as Topic; Cost of Illness; Cost-Benefit Analysis; Drug Tolerance; Economics, Pharmaceutical; Evaluation Studies as Topic; Female; Formularies as Topic; Health Care Costs; HIV; HIV Infections; Humans; Infant, Newborn; Male; Models, Econometric; Occupational Exposure; Pregnancy; Quality of Life; Survival Rate; Zidovudine | 1993 |
[Reducing perinatal transmission by antiretroviral therapy].
Topics: Adult; Anti-HIV Agents; Clinical Trials as Topic; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1998 |
Combined treatment with zidovudine, lamivudine, nelfinavir and ganciclovir in an infant with human immunodeficiency virus type 1 infection and cytomegalovirus encephalitis: case report and review of the literature.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Infections; Diseases in Twins; Drug Therapy, Combination; Encephalitis, Viral; Female; Ganciclovir; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lamivudine; Nelfinavir; Zidovudine | 1999 |
[Response of fetal macrophages in the placenta of pregnant HIV-positive patients with and without antiretroviral treatment].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Macrophages; Pregnancy; Pregnancy Complications, Infectious; Retroviridae; Zidovudine | 1999 |
[Antiretroviral therapy and prevention of maternal-fetal transmission of HIV-1. Current and future strategies].
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Longitudinal Studies; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 1999 |
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Zalcitabine; Zidovudine | 1999 |
HIV and AIDS in Africa: impact on mother and child health.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Africa; Anti-HIV Agents; Breast Feeding; Child; Child Welfare; Child, Preschool; Chlorhexidine; Comorbidity; Delivery, Obstetric; Disease Outbreaks; Disinfectants; Double-Blind Method; Extraembryonic Membranes; Female; HIV Infections; Humans; Infant; Infant, Newborn; Labor, Obstetric; Maternal Age; Maternal Welfare; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Randomized Controlled Trials as Topic; Rupture, Spontaneous; Sexual Behavior; Sexually Transmitted Diseases; Substance Abuse, Intravenous; Therapeutic Irrigation; Zidovudine | 1999 |
Paediatric HIV-1 infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cesarean Section; Child; Clinical Trials as Topic; Drug Administration Schedule; Female; Global Health; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Zidovudine | 1999 |
[Rational therapy of HIV infections].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Diagnosis, Differential; Granulocyte Colony-Stimulating Factor; HIV; HIV Infections; Humans; Immune Tolerance; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Antiretrovirals.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Sulfonamides; Zalcitabine; Zidovudine | 1999 |
[Evaluation of the efficacy of anti-retroviral treatment. Publication of clinical trials].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; HIV Infections; HIV Protease Inhibitors; Humans; Information Services; Randomized Controlled Trials as Topic; Research Design; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 1999 |
Review of NNRTIs: 'today and tomorrow'.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Coming therapies: abacavir.
Topics: Anti-HIV Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Finding a role for zalcitabine in the HAART era.
Topics: Anti-HIV Agents; Drug Resistance; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Saquinavir; Zalcitabine; Zidovudine | 1998 |
Epidemiology of HIV/AIDS in children.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Child; Counseling; Female; HIV Infections; Humans; Prenatal Care; United States; Zidovudine | 2000 |
[Early treatment of sexual exposure to human immunodeficiency virus].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Probability; Risk Factors; Sexual Behavior; Sexual Partners; Time Factors; Zidovudine | 2000 |
Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy.
Topics: Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Retroviridae; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1998 |
Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review.
Topics: Adult; Aged; Anti-HIV Agents; Antimetabolites; Cells, Cultured; Child; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Female; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Phosphates; Phosphorylation; Polyphosphates; Radioimmunoassay; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2000 |
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine | 1999 |
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 2000 |
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
Topics: Anti-HIV Agents; Drug Administration Schedule; HIV Infections; Humans; Zidovudine | 2000 |
Interruption of materno-fetal transmission.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 2000 |
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; HIV Infections; Humans; Zidovudine | 2000 |
[Peripheral nerve diseases and myopathies associated with HIV infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; HIV Infections; Humans; Muscular Diseases; Peripheral Nervous System Diseases; Polyneuropathies; Polyradiculopathy; Zidovudine | 2000 |
[Anti-HIV chemoprophylaxis for blood-exposure accidents].
Topics: Anti-HIV Agents; Case-Control Studies; Drug Therapy, Combination; France; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Needlestick Injuries; Occupational Exposure; Patient Selection; Practice Guidelines as Topic; Risk Factors; Time Factors; Zidovudine | 2000 |
[Perinatal maternal-infant transmission of human immunodeficiency virus and its prevention].
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
Preventing perinatal transmission of HIV-1 infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, High-Risk; Zidovudine | 2000 |
HIV in pregnancy: strategies for management.
Topics: Africa; Antiviral Agents; Breast Feeding; Cesarean Section; Developing Countries; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 2000 |
Post-exposure prophylaxis for HIV.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Diseases; Risk Factors; Treatment Outcome; Zidovudine | 2000 |
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine | 2000 |
Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers.
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Reverse Transcriptase Inhibitors; United Kingdom; Zidovudine | 2000 |
HIV drug resistance and viral fitness.
Topics: Drug Resistance; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 2000 |
Prevention of perinatal HIV infection. What do we know? Where should future research go?
Topics: Anti-HIV Agents; Europe; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 2000 |
The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Management of the infant born to a mother infected with human immunodeficiency virus type 1 (HIV-1): current concepts.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Zidovudine | 2000 |
A decade in HIV treatment: what is the state of the art and how did we arrive.
Topics: Drug Therapy, Combination; HIV Infections; Humans; Patient Compliance; Patient Education as Topic; Practice Guidelines as Topic; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
[Reduction of perinatal transmission of HIV-1: antiretroviral prophylaxis and obstetrical interventions].
Topics: Anti-HIV Agents; Cesarean Section; Developed Countries; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
[Schonlein-Henoch purpura associated with hepatitis B in a patient with HIV infection].
Topics: Adult; Antiviral Agents; Bacterial Infections; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; HIV Infections; Humans; IgA Vasculitis; Interferon Type I; Male; Recombinant Proteins; Zidovudine | 2001 |
International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance.
Topics: Dideoxynucleosides; Disease Progression; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?
Topics: Africa; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; MEDLINE; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
Topics: AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; HIV Infections; Humans; Incidence; Randomized Controlled Trials as Topic; Zidovudine | 1997 |
Prevention of mother-to-child transmission of HIV.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Viral Load; Zidovudine | 2001 |
Pediatric HIV infection.
Topics: Age of Onset; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Prognosis; Zidovudine | 2001 |
Pathogenesis of anemia during human immunodeficiency virus infection.
Topics: Adult; Anemia; Anemia, Iron-Deficiency; Anti-HIV Agents; Chronic Disease; Female; Folic Acid Deficiency; Global Health; HIV Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Parvoviridae Infections; Pregnancy; Vitamin A Deficiency; Vitamin B 12 Deficiency; Zidovudine | 2001 |
Pediatric antiretroviral therapy: from research to practice.
Topics: Adolescent; Age Factors; Anti-HIV Agents; Child; Child, Preschool; Didanosine; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Viral Load; Virus Replication; Zidovudine | 1996 |
Cardiovascular manifestations of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathy, Dilated; Cardiovascular Diseases; Child; Coronary Disease; Endocarditis, Bacterial; HIV Infections; Humans; Hypertension; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Myocarditis; Myocardium; Nutrition Disorders; Pericardial Effusion; Ventricular Dysfunction, Right; Zidovudine | 2001 |
When parents reject interventions to reduce postnatal human immunodeficiency virus transmission.
Topics: Anti-HIV Agents; Attitude to Health; Disease Transmission, Infectious; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Liability, Legal; Male; Parent-Child Relations; Pregnancy; Prenatal Care; Risk Assessment; Treatment Refusal; United States; Zidovudine | 2001 |
Mitochondrial dysfunction in HIV infection: an overview of pathogenesis.
Topics: Anti-HIV Agents; Apoptosis; DNA, Mitochondrial; Drug-Related Side Effects and Adverse Reactions; Electron Transport; HIV Infections; Humans; Mitochondria; Permeability; Phosphorylation; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
A critical analysis of the pharmacology of AZT and its use in AIDS.
Topics: Anti-HIV Agents; HIV; HIV Core Protein p24; HIV Infections; Humans; In Vitro Techniques; Phosphorylation; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1999 |
A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Prevention of mother-to-child transmission of HIV: challenges for the current decade.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Drug Resistance, Microbial; Female; Health Resources; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Premedication; Reverse Transcriptase Inhibitors; Risk Factors; United Nations; Zidovudine | 2001 |
Prevention of perinatal HIV infection.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Delivery, Obstetric; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2001 |
The shame of medical research.
Topics: AIDS Vaccines; Control Groups; Developing Countries; Ethics, Research; Female; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Male; Placebos; Pregnancy; Research Design; Research Support as Topic; United States; Vulnerable Populations; Zidovudine | 2000 |
Anti-retroviral treatment in Nigeria: a review.
Topics: Anti-HIV Agents; Clinical Trials as Topic; HIV Infections; Humans; Lamivudine; Nigeria; Zidovudine | 2000 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Counseling; Diagnostic Tests, Routine; Efficiency, Organizational; Female; Forecasting; Health Policy; HIV Infections; Hospitals, Public; Humans; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Maternal-Child Health Centers; National Health Programs; Patient Education as Topic; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Program Development; Program Evaluation; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 2002 |
HIV vaccine evaluation center in Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; AIDS Vaccines; Anti-HIV Agents; Behavior Therapy; Bisexuality; Brazil; Clinical Trials, Phase II as Topic; Disease Transmission, Infectious; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Lamivudine; Male; Middle Aged; Safety; Sensitivity and Specificity; Zidovudine | 2002 |
Trizivir.
Topics: Antiretroviral Therapy, Highly Active; Biological Availability; Clinical Trials as Topic; Dideoxynucleosides; Drug Combinations; Drug Evaluation; HIV Infections; HIV-1; Humans; Intestinal Absorption; Lamivudine; Zidovudine | 2002 |
Management of newborns exposed to maternal HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Female; HIV Infections; Humans; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Tuberculosis, Pulmonary; Zidovudine | 2002 |
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Viruses, chemotherapy and immunity.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Ganciclovir; Herpesviridae Infections; HIV Infections; HIV-1; Humans; Immunity, Cellular; Interferons; Major Histocompatibility Complex; Virus Diseases; Zidovudine | 1992 |
Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Drug Resistance, Microbial; Genotype; HeLa Cells; HIV; HIV Infections; Humans; Molecular Sequence Data; Mutation; Phenotype; RNA-Directed DNA Polymerase; Time Factors; Zidovudine | 1992 |
[Estimated biological markers of progression in human immunodeficiency virus infection].
Topics: Antiviral Agents; Biomarkers; HIV Infections; Humans; Prognosis; Zidovudine | 1992 |
New developments in antiretroviral drug therapy for HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Combinations; Drug Therapy, Combination; Gene Products, tat; HIV Infections; HIV-1; Humans; Protease Inhibitors; tat Gene Products, Human Immunodeficiency Virus; Zalcitabine; Zidovudine | 1992 |
The use of nucleoside analogues in the treatment of HIV-infected children.
Topics: Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Infant, Newborn; Zalcitabine; Zidovudine | 1992 |
Development of antiviral treatment strategies in murine models.
Topics: Animals; Antiviral Agents; Drug Synergism; HIV Infections; HIV-1; Interferon-alpha; Leukemia Virus, Murine; Mice; Mice, SCID; Mice, Transgenic; Zidovudine | 1992 |
Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Zalcitabine; Zidovudine | 1992 |
Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Zalcitabine; Zidovudine | 1992 |
Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Time Factors; Zalcitabine; Zidovudine | 1992 |
HIV disease: therapy, related systemic and oral conditions--an update.
Topics: Acquired Immunodeficiency Syndrome; Bacterial Infections; Didanosine; HIV Infections; Humans; Mouth Diseases; Mycoses; Sarcoma, Kaposi; Virus Diseases; Zalcitabine; Zidovudine | 1992 |
[Myopathies in the course of HIV infection].
Topics: HIV Infections; Humans; Muscles; Muscular Diseases; Myositis; Succinate Cytochrome c Oxidoreductase; Zidovudine | 1992 |
Primary care for HIV infection.
Topics: CD4-Positive T-Lymphocytes; Clinical Protocols; Clinical Trials as Topic; Didanosine; Drug Monitoring; HIV Infections; HIV-1; Humans; Immunization; Leukocyte Count; Pneumonia, Pneumocystis; Primary Health Care; Sex Counseling; Zidovudine | 1992 |
Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Topics: Administration, Inhalation; Aerosols; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1992 |
Current status of therapy for human immunodeficiency virus type 1.
Topics: CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Didanosine; Drug Resistance; HIV Infections; HIV Seropositivity; HIV-1; Humans; T-Lymphocytes, Helper-Inducer; Zalcitabine; Zidovudine | 1992 |
AIDS and hemophilia: experience in the La Paz Hemophilia Center.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Blood Coagulation Factors; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Drug Contamination; Hemophilia A; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Infant; Leukocyte Count; Middle Aged; Prognosis; Spain; Survival Analysis; Transfusion Reaction; Zidovudine | 1992 |
Late treatment of HIV infection--is it better?
Topics: Clinical Trials as Topic; Drug Costs; Drug Resistance; HIV Infections; Humans; Time Factors; Zidovudine | 1992 |
[Treatment and prevention of HIV infection and related opportunistic infections].
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cytomegalovirus Infections; Female; Herpesviridae Infections; HIV Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Pneumocystis Infections; Toxoplasmosis; Tuberculosis; Zidovudine | 1992 |
[Anti-HIV treatment, today and in the near future].
Topics: Antiviral Agents; Didanosine; Dideoxynucleosides; DNA, Viral; Drug Therapy, Combination; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Stavudine; Transcription, Genetic; Zalcitabine; Zidovudine | 1992 |
Hematopoietic growth factors as adjuncts to antiretroviral therapy.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Leukopenia; Zidovudine | 1992 |
Nail pigmentation associated with zidovudine: a review and report of a case.
Topics: Adult; HIV Infections; Humans; Male; Nail Diseases; Pigmentation Disorders; Zidovudine | 1992 |
AZT: hope for many, help for few.
Topics: Acquired Immunodeficiency Syndrome; Drug Costs; Health Policy; Health Services Accessibility; HIV Infections; Humans; Research; Social Work; United States; Zidovudine | 1992 |
Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Drug Synergism; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; Humans; Leukocyte Count; Neutropenia; Zidovudine | 1992 |
Disorders of the nails and hair associated with human immunodeficiency virus infection.
Topics: Hair Diseases; HIV Infections; Humans; Nail Diseases; Pigmentation Disorders; Zidovudine | 1992 |
Zidovudine: five years later.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Zidovudine | 1992 |
HIV drug resistance.
Topics: Amino Acid Sequence; Base Sequence; Dideoxynucleosides; DNA, Viral; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Molecular Sequence Data; Zidovudine | 1992 |
[Pregnancy in HIV infected women. Current therapeutic indications].
Topics: Abortion, Therapeutic; Adult; CD4 Immunoadhesins; Female; HIV Infections; Humans; Immunization, Passive; Infant, Newborn; Interferon-alpha; Listeriosis; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Thrombocytopenia; Toxoplasmosis; Zidovudine | 1992 |
Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.
Topics: CD4 Antigens; Drug Resistance, Microbial; HIV; HIV Infections; Host-Parasite Interactions; Humans; Models, Biological; Zidovudine | 1992 |
Oral ulceration and iatrogenic disease in HIV infection.
Topics: Antifungal Agents; Antineoplastic Agents; Enterobacteriaceae Infections; HIV Infections; Humans; Iatrogenic Disease; Radiotherapy; Stomatitis, Aphthous; Zidovudine | 1992 |
[Antiretroviral treatments and their therapeutical trials].
Topics: Antiviral Agents; Clinical Trials as Topic; HIV; HIV Infections; Humans; Zidovudine | 1992 |
New drug treatments for HIV infection and AIDS. A review following the Seventh International Conference on AIDS, Florence 16-21 June 1991.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; HIV Infections; Humans; Placebos; Randomized Controlled Trials as Topic; Viral Vaccines; Zidovudine | 1992 |
Pathogenesis, natural history, and classification of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Cell Death; Chronic Disease; HIV Infections; Humans; Immunity, Cellular; Macrophages; Prognosis; T-Lymphocytes; Zidovudine | 1992 |
Initial clinical assessment and management of HIV infection.
Topics: Female; HIV Infections; Humans; Medical History Taking; Physical Examination; Physicians, Family; Risk Factors; Zidovudine | 1992 |
Expanding access to investigational new therapies.
Topics: Clinical Trials as Topic; Drug Evaluation; Drugs, Investigational; Health Services Accessibility; HIV Infections; Humans; Legislation, Drug; Physicians, Family; Research; United States; United States Food and Drug Administration; Zidovudine | 1992 |
Selection of zidovudine-resistant variants of human immunodeficiency virus by therapy.
Topics: Drug Resistance, Microbial; HIV; HIV Infections; Humans; Mutation; Zidovudine | 1992 |
Predictors of HIV disease progression in the era of prophylactic therapies.
Topics: Acquired Immunodeficiency Syndrome; Age Factors; Biomarkers; HIV Infections; Humans; Incidence; Predictive Value of Tests; Sex Factors; United States; Zidovudine | 1992 |
Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus.
Topics: Health Personnel; Hepatitis B; Hepatitis C; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1992 |
[Treatments of human immunodeficiency virus infection. Current developments].
Topics: Acquired Immunodeficiency Syndrome; Didanosine; HIV; HIV Infections; Humans; Zalcitabine; Zidovudine | 1991 |
New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Dideoxynucleosides; HIV Infections; Humans; Zalcitabine; Zidovudine | 1991 |
Clinical aspects of AIDS-related non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers, Tumor; Child; Child, Preschool; Cohort Studies; Disease Susceptibility; Female; Herpesvirus 4, Human; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Life Tables; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk; Risk Factors; Tumor Virus Infections; Zidovudine | 1991 |
The treatment of HIV disease.
Topics: Antiviral Agents; CD4 Antigens; Counseling; Drug Evaluation; HIV Infections; HIV Seropositivity; Humans; Immunotherapy; Opportunistic Infections; Receptors, Virus; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Zidovudine | 1990 |
Chemotherapy of human immunodeficiency virus infections: current practice and future prospects.
Topics: Animals; Antiviral Agents; Didanosine; DNA Nucleotidyltransferases; DNA Replication; Drug Therapy, Combination; Endopeptidases; HIV Infections; HIV-1; Humans; Integrases; RNA-Directed DNA Polymerase; Virus Replication; Zalcitabine; Zidovudine | 1990 |
New developments in antiretroviral drug therapy for human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Antigens; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Interferons; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1990 |
Interferon and other biologic agents for the treatment of Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; HIV Infections; Humans; Interferon Type I; Interferons; Recombinant Proteins; Sarcoma, Kaposi; Zidovudine | 1991 |
Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Resistance; HIV; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Retroviridae; Reverse Transcriptase Inhibitors; T-Lymphocytes, Helper-Inducer; Virus Replication; Zalcitabine; Zidovudine | 1991 |
HIV-specific treatment.
Topics: Adjuvants, Immunologic; Glycosylation; HIV Infections; Humans; Interferons; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1991 |
Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Child; Didanosine; Female; Foscarnet; HIV Infections; Humans; Phosphonoacetic Acid; Pregnancy; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1991 |
Chemotherapy against human immunodeficiency virus infection.
Topics: Antiviral Agents; Drug Evaluation, Preclinical; HIV Infections; Humans; In Vitro Techniques; Reverse Transcriptase Inhibitors; Zidovudine | 1991 |
Inosine pranobex in the treatment of HIV infection: a review.
Topics: Drug Therapy, Combination; HIV Infections; Humans; Inosine Pranobex; Zidovudine | 1991 |
Antiretroviral treatment: state of the art and future directions.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; Humans; Immunotherapy; Protein Biosynthesis; Reverse Transcriptase Inhibitors; Transcription, Genetic; Zidovudine | 1991 |
Antiretroviral drug resistance.
Topics: Antiviral Agents; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1991 |
Treatment options for human immunodeficiency virus-infected pregnant women. Obstetric-Gynecologic Working Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Topics: Female; HIV Infections; Humans; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1992 |
HIV infection in children.
Topics: Child; Child, Preschool; Female; HIV Infections; HIV Seroprevalence; Humans; Infant; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; United Kingdom; Zidovudine | 1992 |
Clinical, virological and immunological features of primary HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Diagnosis, Differential; HIV Infections; HIV-1; Humans; Risk Factors; Zidovudine | 1991 |
Recent advances in the diagnosis and treatment of infectious diseases.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Male; Opportunistic Infections; Zidovudine | 1991 |
HIV infection in the elderly.
Topics: Age Factors; Aged; Forecasting; HIV Infections; Humans; Transfusion Reaction; United States; Zidovudine | 1991 |
[Zidovudine (AZT). Current state of the development].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Animals; Child; Drug Administration Schedule; Drug Evaluation; HIV Infections; Humans; In Vitro Techniques; Zidovudine | 1991 |
Therapy of neonatal and pediatric HIV infection.
Topics: Antiviral Agents; Child; Child, Preschool; HIV Infections; Humans; Infant; Infant, Newborn; Opportunistic Infections; Zidovudine | 1991 |
The clinical management of patients with HIV infection and AIDS.
Topics: Female; HIV Infections; Humans; Male; Nervous System Diseases; Opportunistic Infections; United Kingdom; Zidovudine | 1991 |
Lymphocyte subsets as surrogate markers in antiretroviral therapy.
Topics: Evaluation Studies as Topic; HIV Infections; Humans; Immunity, Cellular; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Zidovudine | 1991 |
Concomitant ganciclovir and zidovudine treatment for cytomegalovirus retinitis in patients with HIV infection: an approach to treatment.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Retinitis; Zidovudine | 1991 |
Update on HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Australia; Female; HIV Infections; Humans; Male; Risk Factors; Zidovudine | 1991 |
[A new drug in a new role: dipyridamole in the treatment of HIV-1 infections?].
Topics: Acquired Immunodeficiency Syndrome; Dipyridamole; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Zidovudine | 1991 |
[Treatment of HIV infection with zidovudine. The good use of AZT].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Hematologic Diseases; HIV Infections; Humans; Time Factors; Zidovudine | 1991 |
Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Combined Modality Therapy; HIV Infections; Humans; Interferon-alpha; Male; Sarcoma, Kaposi; Zidovudine | 1991 |
Zidovudine in HIV infection.
Topics: HIV Infections; Humans; Needlestick Injuries; Zidovudine | 1991 |
The management of early human immunodeficiency virus infection.
Topics: HIV Infections; Humans; Pneumonia, Pneumocystis; Time Factors; Zidovudine | 1991 |
The role of alpha-interferon in patients with human immunodeficiency virus infection.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; HIV Infections; Humans; Interferon-alpha; Sarcoma, Kaposi; Zidovudine | 1991 |
Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Quality of Life; Zidovudine | 1990 |
Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
Topics: CD4-Positive T-Lymphocytes; Creatine Kinase; HIV Infections; HIV-1; Humans; Leukocyte Count; Muscular Diseases; Zidovudine | 1990 |
Antiviral therapy for human immunodeficiency virus infection in children.
Topics: Antiviral Agents; Child; HIV; HIV Infections; Humans; Virus Replication; Zidovudine | 1991 |
Starting life with HIV.
Topics: Child, Preschool; Education, Nursing, Continuing; HIV Infections; Humans; Infant; Infant, Newborn; Nursing Assessment; Zidovudine | 1991 |
State-of-the-art of zidovudine monitoring.
Topics: Adult; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; HIV Infections; Humans; Infant; Radioimmunoassay; Zidovudine | 1991 |
[Perinatal HIV-infection. Symptomatology, diagnosis and treatment].
Topics: Acquired Immunodeficiency Syndrome; Child; Child, Preschool; Female; HIV Infections; Humans; Immunoglobulins; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Norway; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1991 |
Hemostatic abnormalities in HIV disease.
Topics: Acquired Immunodeficiency Syndrome; Blood Coagulation Disorders; HIV Infections; Humans; Purpura, Thrombocytopenic; Purpura, Thrombotic Thrombocytopenic; Zidovudine | 1991 |
The use of hematopoietic hormones in HIV infection and AIDS-related malignancies.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Sarcoma, Kaposi; Zidovudine | 1991 |
Neutropenia in patients infected with human immunodeficiency virus.
Topics: Acyclovir; HIV Infections; Humans; Neutropenia; Sulfonamides; Zidovudine | 1991 |
Antiviral therapy of HIV infection.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Resistance; HIV Infections; Humans; Zidovudine | 1991 |
Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
Topics: Adult; Dermatomyositis; Diagnosis, Differential; Female; HIV Infections; Humans; Male; Middle Aged; Muscular Diseases; Myositis; Zidovudine | 1991 |
Management of the HIV-infected patient: a comprehensive approach. The SCMA AIDS Task Force.
Topics: HIV Infections; Humans; Male; Opportunistic Infections; South Carolina; Zidovudine | 1991 |
Early therapeutic intervention in HIV infection--stepping stones to success.
Topics: Drug Administration Schedule; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Pneumonia, Pneumocystis; Survival Rate; Zidovudine | 1991 |
AZT resistance in isolates of HIV.
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Zidovudine | 1991 |
Clinical overview of acquired immune deficiency syndrome (AIDS) and human immunodeficiency virus (HIV)-related disease.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1990 |
[Therapy of HIV infection with zidovudine (AZT)].
Topics: AIDS Dementia Complex; Dose-Response Relationship, Drug; HIV Infections; Humans; Zidovudine | 1990 |
[Drug surveillance for adverse reactions in patients with human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Product Surveillance, Postmarketing; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1990 |
HIV-related thrombocytopenia.
Topics: Adrenal Cortex Hormones; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Platelets; Cohort Studies; Combined Modality Therapy; Double-Blind Method; HIV Antibodies; HIV Infections; Humans; Immune Complex Diseases; Immunization, Passive; Prognosis; Prospective Studies; Purpura, Thrombocytopenic; Splenectomy; Zidovudine | 1990 |
Current and future treatment of HIV infection.
Topics: Adjuvants, Immunologic; Antiviral Agents; Forecasting; HIV Infections; Humans; Zidovudine | 1990 |
A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance; HIV Infections; Humans; Zidovudine | 1990 |
New anti-HIV-1 therapies and combinations: current data and prospects.
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Zidovudine | 1990 |
Molecular pathogenesis of HIV-1.
Topics: Animals; Disease Models, Animal; Genetic Variation; HIV Infections; HIV-1; Humans; Virus Replication; Zidovudine | 1990 |
Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Child; Child, Preschool; Dideoxynucleosides; Drug Tolerance; HIV; HIV Infections; Humans; Infant; Zalcitabine; Zidovudine | 1990 |
Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine.
Topics: Clinical Protocols; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Random Allocation; Zalcitabine; Zidovudine | 1990 |
Dideoxycytidine: current clinical experience and future prospects. A summary.
Topics: Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Forecasting; HIV Infections; Humans; Zalcitabine; Zidovudine | 1990 |
Virology, immunology, and clinical course of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; HIV-1; Humans; Opportunistic Infections; T-Lymphocytes; Zidovudine | 1990 |
HIV infection and health policy.
Topics: Delivery of Health Care; Federal Government; Health Policy; HIV Infections; Humans; Moral Obligations; Prejudice; United States; Viral Vaccines; Voluntary Programs; Zidovudine | 1990 |
Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
Topics: Antiviral Agents; Deoxyribonucleosides; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Microbial Sensitivity Tests; Zidovudine | 1990 |
[Muscular involvement in human immunodeficiency virus infection].
Topics: Creatine Kinase; Diagnosis, Differential; Electromyography; HIV Infections; Humans; Muscular Diseases; Zidovudine | 1990 |
Antiviral therapy against HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Dideoxynucleosides; HIV; HIV Infections; Humans; Zidovudine | 1990 |
Occupational transmission of human immunodeficiency virus.
Topics: Health Workforce; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1990 |
HIV disease: a review for the family physician. Part I. Evaluation and conventional therapy.
Topics: HIV Infections; Humans; Zidovudine | 1990 |
[Integrated management of the HIV positive patient--medical, psychological and psychosocial aspects].
Topics: Combined Modality Therapy; HIV Infections; HIV Seropositivity; Humans; Physician-Patient Relations; Sick Role; Social Adjustment; Zidovudine | 1990 |
[Treatment of HIV infection in childhood].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Child; Child, Preschool; HIV Infections; Humans; Immunization Schedule; Infant; Infant, Newborn; Opportunistic Infections; Vaccination; Viral Vaccines; Zidovudine | 1990 |
Living with AIDS--changes and challenges in the care of HIV disease.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Opportunistic Infections; Survival Rate; United States; Zidovudine | 1990 |
Headache and acquired immunodeficiency syndrome.
Topics: AIDS Dementia Complex; Headache; HIV Infections; HIV-1; Humans; Opportunistic Infections; Spinal Puncture; Zidovudine | 1990 |
Antiretroviral therapy and the use of zidovudine for HIV infection.
Topics: Clinical Trials as Topic; Drug Interactions; HIV Infections; HIV-1; Humans; Virus Replication; Zidovudine | 1990 |
Zidovudine: clinical experience in symptomatic HIV disease.
Topics: Acquired Immunodeficiency Syndrome; Drug Interactions; HIV Infections; Humans; Survival Rate; Zidovudine | 1989 |
State of antiretroviral therapy with zidovudine.
Topics: Drug Interactions; HIV; HIV Infections; Humans; Opportunistic Infections; Zidovudine | 1989 |
The treatment of asymptomatic HIV infection: lessons from the zidovudine experience.
Topics: HIV Infections; Humans; Zidovudine | 1989 |
AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Retroviridae Infections; Zidovudine | 1989 |
Prevention of lung infections associated with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Isoniazid; Lung Diseases; Pneumonia, Pneumocystis; Tuberculosis, Pulmonary; Zidovudine | 1989 |
[Causal therapy possibilities in HIV infections].
Topics: Antiviral Agents; HIV; HIV Infections; Humans; Virus Replication; Zidovudine | 1989 |
Current HIV therapy: an update on zidovudine.
Topics: HIV Infections; Humans; Quality of Life; Zidovudine | 1989 |
Therapy of acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antiviral Agents; Dideoxynucleosides; HIV Infections; Humans; Lymphoma; Opportunistic Infections; Sarcoma, Kaposi; Zidovudine | 1987 |
892 trial(s) available for zidovudine and HIV Coinfection
| Article | Year |
|---|---|
Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.
Topics: Adult; Anti-HIV Agents; Dioxolanes; Drug Administration Schedule; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Purine Nucleosides; Reverse Transcriptase Inhibitors; Treatment Outcome; Young Adult; Zidovudine | 2010 |
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non
Topics: Anti-HIV Agents; Darunavir; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Lamivudine; Oxazines; Piperazines; Prospective Studies; Pyridones; Ritonavir; RNA; Tenofovir; Viral Load; Zidovudine | 2022 |
Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B e Antigens; HIV Infections; Humans; Infant, Newborn; Lamivudine; Pregnancy; Pregnancy Outcome; Tenofovir; Zidovudine | 2022 |
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.
Topics: Anti-HIV Agents; Calcium; Female; HIV Infections; Humans; Infant; Infant, Newborn; Phosphates; Pregnancy; Tenofovir; Zidovudine | 2022 |
Lower Insulin Sensitivity in Newborns With In Utero HIV and Antiretroviral Exposure Who Are Uninfected in Botswana.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Botswana; Female; HIV Infections; Humans; Infant; Infant, Newborn; Insulin Resistance; Nevirapine; Pregnancy; Zidovudine | 2022 |
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine | 2019 |
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Integrase Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Raltegravir Potassium; Viral Load; Young Adult; Zidovudine | 2020 |
The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: A case-control study.
Topics: Adult; Diabetes Mellitus, Type 2; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Rural Population; South Africa; Stavudine; Time Factors; Zidovudine | 2020 |
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.
Topics: Africa South of the Sahara; Anti-HIV Agents; Area Under Curve; Child, Preschool; Chromatography, Liquid; Cohort Studies; Drug Combinations; Drug Elimination Routes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Lamivudine; Lopinavir; Male; Patient Safety; Ritonavir; Severe Acute Malnutrition; Tandem Mass Spectrometry; Zidovudine | 2021 |
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Darunavir; Drug Resistance; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Young Adult; Zidovudine | 2021 |
Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Raltegravir Potassium; Vigna; Viral Load; Virus Shedding; Zidovudine | 2021 |
Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Body Composition; Cyclopropanes; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Insulin-Like Growth Factor I; Lamivudine; Male; Prospective Studies; Tenofovir; Zidovudine | 2017 |
Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
Topics: Anti-HIV Agents; Breast Feeding; Chemoprevention; Clinical Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Thailand; World Health Organization; Zidovudine | 2017 |
Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Biological Variation, Population; Child; Child, Preschool; Cyclopropanes; Drug Monitoring; Female; HIV Infections; Humans; Lamivudine; Male; Tanzania; Zidovudine | 2018 |
Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.
Topics: Adenine; Adult; Anti-HIV Agents; Biomarkers; Bone and Bones; Bone Density; Cohort Studies; Down-Regulation; Drug Substitution; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Parathyroid Hormone; Tenofovir; Vitamin D; Zidovudine | 2013 |
Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoenzyme Techniques; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2013 |
Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Interactions; Emtricitabine; Female; Healthy Volunteers; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nitriles; Organophosphonates; Pyrazoles; Tenofovir; Young Adult; Zidovudine | 2013 |
Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.
Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Deoxycytidine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Emtricitabine; Female; Gastrointestinal Diseases; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Zidovudine | 2013 |
Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.
Topics: Anthropometry; Anti-HIV Agents; Body Height; Body Weight; Chemoprevention; Child, Preschool; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Survival Analysis; Zidovudine | 2013 |
Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
Topics: Adult; Africa South of the Sahara; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2013 |
A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial.
Topics: Adult; Antiretroviral Therapy, Highly Active; Belgium; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Netherlands; Odds Ratio; Patient Satisfaction; Quality of Life; Ritonavir; Zidovudine | 2014 |
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Kenya; Lamivudine; Medication Adherence; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Viral Load; Viremia; Young Adult; Zidovudine | 2014 |
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cross-Sectional Studies; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Probability; Retrospective Studies; RNA, Viral; Tenofovir; Uganda; Viral Load; Zidovudine | 2014 |
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Organophosphonates; Tenofovir; Uganda; Zidovudine | 2014 |
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
Topics: Anthropometry; Anti-HIV Agents; Child; Child, Preschool; Cross-Sectional Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lipid Metabolism; Lipodystrophy; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nevirapine; Stavudine; Triglycerides; Viral Load; Zidovudine | 2014 |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Aged, 80 and over; Alkynes; Anti-HIV Agents; Benzoxazines; Body Fat Distribution; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Young Adult; Zidovudine | 2014 |
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.
Topics: Anti-HIV Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Cross-Over Studies; Female; Guidelines as Topic; Hemoglobins; HIV Infections; Humans; Infant; Male; Plasma; Uganda; World Health Organization; Zidovudine | 2014 |
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.
Topics: Adenine; Adult; CD4 Lymphocyte Count; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE).
Topics: Adolescent; Anemia; CD4 Lymphocyte Count; Darunavir; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Nausea; Neutropenia; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides; Time Factors; Viral Load; Vomiting; Zidovudine | 2014 |
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Body Mass Index; C-Reactive Protein; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Didanosine; Disease Progression; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Multivariate Analysis; Oligopeptides; Prospective Studies; Pyridines; Risk Factors; Selenium; World Health Organization; Zidovudine | 2014 |
A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.
Topics: Adult; Aged; Anti-HIV Agents; Belgium; CD4 Lymphocyte Count; Clinical Protocols; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lipids; Male; Middle Aged; Netherlands; Prospective Studies; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2015 |
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Fat Distribution; Drug Combinations; Drug Substitution; Emtricitabine; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Regression Analysis; Tenofovir; Zidovudine | 2015 |
Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Didanosine; Female; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Peripheral Nervous System Diseases; Prevalence; Risk Factors; Stavudine; Uganda; Young Adult; Zidovudine; Zimbabwe | 2014 |
Kericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of Kenya.
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; HIV-1; Humans; Kenya; Male; Middle Aged; Nevirapine; Prospective Studies; Research Design; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2015 |
A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.
Topics: Adenine; Adolescent; Anti-HIV Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Organophosphonates; RNA, Viral; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2015 |
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Echocardiography; Female; Follow-Up Studies; France; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Sex Factors; Uterus; Young Adult; Zidovudine | 2015 |
Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Leg; Male; Peripheral Nervous System Diseases; Risk Factors; Sensory Receptor Cells; Skin; Stavudine; Tenofovir; Thailand; Zidovudine | 2015 |
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Substitution; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Viral Load; Zidovudine | 2015 |
Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.
Topics: Adult; Amino Acid Substitution; Anti-HIV Agents; Chemoprevention; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation, Missense; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Sequence Analysis, DNA; Young Adult; Zidovudine | 2015 |
Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Treatment Outcome; Zidovudine | 2016 |
Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
Topics: Adult; Anti-HIV Agents; Chemoprevention; DNA, Viral; Double-Blind Method; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placebos; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Thailand; Treatment Outcome; Young Adult; Zidovudine | 2015 |
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Stavudine; Tablets; Uganda; Zambia; Zidovudine | 2016 |
Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Thailand; Viral Load; Zidovudine | 2016 |
Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.
Topics: Adolescent; Adult; Alkynes; Amenorrhea; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Desogestrel; Drug Combinations; Drug Implants; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Metrorrhagia; Prospective Studies; Ritonavir; Young Adult; Zidovudine | 2016 |
The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding.
Topics: Adult; Anti-HIV Agents; Bacteria; Botswana; Breast Feeding; Diarrhea, Infantile; Feces; Female; HIV Infections; Humans; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia; Respiratory System; Zidovudine | 2016 |
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
Topics: Adult; Anti-Retroviral Agents; Black or African American; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; Humans; Infant; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Outcome; Tenofovir; Young Adult; Zidovudine | 2016 |
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Patient Safety; Pregnancy; Primary Prevention; RNA, Viral; South Africa; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Viral Load; Zidovudine | 2017 |
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Malaria, Falciparum; Malawi; Male; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2016 |
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lipids; Male; Middle Aged; Prospective Studies; Sustained Virologic Response; Tanzania; Treatment Outcome; Zidovudine | 2017 |
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Male; Milk, Human; Neutropenia; Nevirapine; Proportional Hazards Models; Risk Factors; Zidovudine | 2008 |
Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Topics: Adolescent; Adult; Anti-HIV Agents; Antibodies, Viral; Cervix Uteri; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Vagina; Viral Load; Virus Shedding; Zidovudine | 2008 |
HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cell-Free System; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
Topics: Adult; Albumins; Alkynes; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Drugs, Generic; Female; Glutathione Peroxidase; Glutathione Reductase; HIV Infections; Humans; India; Lamivudine; Male; Oxidative Stress; Reverse Transcriptase Inhibitors; Stavudine; Uric Acid; Young Adult; Zidovudine | 2008 |
Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Bacterial Infections; Benzoxazines; Blood Platelets; Cardiovascular Diseases; Cyclopropanes; Deoxycytidine; Didanosine; Emtricitabine; Female; Hemoglobins; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Pancytopenia; Platelet Count; Prevalence; Zidovudine | 2008 |
Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
Topics: Alanine Transaminase; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Biomarkers; Botswana; Breast Feeding; Cohort Studies; Female; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine | 2008 |
Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot study.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Endpoint Determination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pilot Projects; Prospective Studies; Spain; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Pyrimidinones; Quality of Life; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Brachial Artery; CD4 Lymphocyte Count; Cyclopropanes; Endothelium, Vascular; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Organophosphonates; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir; Time Factors; Zidovudine | 2008 |
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine | 2008 |
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; RNA, Viral; Severity of Illness Index; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Piperazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2008 |
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Phosphorus; Proteinuria; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Young Adult; Zidovudine | 2008 |
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Zidovudine | 2008 |
Early antiretroviral therapy and mortality among HIV-infected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; Treatment Failure; Zidovudine | 2008 |
Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism.
Topics: Anti-HIV Agents; Benzoates; Diketopiperazines; Drug Combinations; Drug Resistance, Viral; env Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Lamivudine; Phylogeny; Piperazines; Receptors, CCR5; Reverse Transcriptase Inhibitors; Spiro Compounds; Treatment Failure; Tropism; Zidovudine | 2009 |
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.
Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Zidovudine | 2009 |
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.
Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2009 |
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Botswana; CD4 Lymphocyte Count; Didanosine; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Male; Patient Compliance; RNA, Viral; Survival Analysis; Time Factors; Viremia; Zidovudine | 2009 |
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Medication Adherence; Plasma; Pyrimidinones; Ritonavir; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Intra-Abdominal Fat; Lopinavir; Male; Middle Aged; Nevirapine; Pyrimidinones; Radiography, Abdominal; Stavudine; Thigh; Viral Load; Zidovudine | 2009 |
Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
Topics: Adult; CD4 Lymphocyte Count; China; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2009 |
Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
Topics: Amino Acid Sequence; Anti-HIV Agents; Case-Control Studies; Female; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kinetics; Molecular Sequence Data; Peptide Fragments; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Virus Replication; Zidovudine | 2009 |
Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand.
Topics: Administration, Oral; alpha-Thalassemia; Anemia; Anti-HIV Agents; beta-Thalassemia; Blood Cell Count; DNA; Double-Blind Method; Drug Administration Schedule; Female; Hemoglobin E; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2009 |
Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
Topics: Adult; Anti-HIV Agents; Anti-Infective Agents; B-Lymphocytes; Cross-Over Studies; Cytokines; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunoglobulin G; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2009 |
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Osteoporosis; Pyrimidinones; Ritonavir; Young Adult; Zidovudine | 2009 |
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.
Topics: Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Pyrimidinones; Ritonavir; Treatment Outcome; Zidovudine | 2009 |
Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Biomarkers; Body Composition; Glucose; HIV Infections; HIV-1; Humans; Lamivudine; Lipids; Lipodystrophy; Lopinavir; Male; Middle Aged; Pyrimidinones; Zidovudine | 2009 |
Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors.
Topics: Absorptiometry, Photon; Adenine; Adult; Aged; Body Composition; Cheek; Dideoxynucleosides; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Organophosphonates; Quality of Life; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine | 2009 |
Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.
Topics: Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Mutation, Missense; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2009 |
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.
Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Bone Density; Cyclopropanes; Female; HIV Infections; Humans; Inflammation Mediators; Lamivudine; Lopinavir; Male; Middle Aged; Osteoporosis; Prospective Studies; Pyrimidinones; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk Factors; Ritonavir; Zidovudine | 2009 |
Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Emtricitabine; Female; Hemoglobins; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2009 |
A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals.
Topics: Adenine; Adipose Tissue; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Extremities; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lipids; Male; Middle Aged; Organophosphonates; Tenofovir; Young Adult; Zidovudine | 2009 |
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
Topics: Adenine; Adult; Amino Acid Substitution; Anti-HIV Agents; Dideoxynucleosides; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pilot Projects; RNA, Viral; Tenofovir; Treatment Failure; Zidovudine | 2009 |
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Uganda; Viral Load; Zidovudine | 2009 |
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation.
Topics: Adult; AIDS-Related Opportunistic Infections; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; Ghana; Glucuronides; Glucuronosyltransferase; Half-Life; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Stavudine; Tuberculosis; Zidovudine | 2009 |
Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934.
Topics: Adenine; Alkynes; Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Genome, Viral; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Mutation, Missense; Organophosphonates; Tenofovir; Treatment Failure; Zidovudine | 2009 |
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
Topics: Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Intention to Treat Analysis; Lamivudine; Lopinavir; Male; Medication Adherence; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Outcome; Zidovudine | 2010 |
96-Week MERIT ES analysis shows efficacy of Celsentri=Selzentry.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Maraviroc; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Triazoles; Zidovudine | 2009 |
Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Viral Load; Zidovudine | 2009 |
Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Plasma; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Chemoprevention; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Pregnancy; Young Adult; Zidovudine | 2009 |
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Insulin sensitivity in multiple pathways is differently affected during zidovudine/lamivudine-containing compared with NRTI-sparing combination antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Blood Glucose; Body Composition; Drug Therapy, Combination; HIV Infections; Humans; Insulin Resistance; Intra-Abdominal Fat; Lamivudine; Lipids; Lipolysis; Liver; Male; Middle Aged; Zidovudine | 2010 |
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Mutation; Nevirapine; RNA, Viral; Uganda; Viral Load; Zidovudine | 2010 |
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.
Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Community Health Services; Female; HIV; HIV Infections; Home Care Services; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Stavudine; Tenofovir; Uganda; Zidovudine | 2009 |
Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postpartum Period; Viral Load; Zidovudine | 2009 |
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Pilot Projects; Tanzania; Tuberculosis; Viral Load; Zidovudine | 2009 |
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Disease Progression; Drug Monitoring; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Neutrophils; Nevirapine; Organophosphonates; RNA, Viral; Tenofovir; Urea; Viral Load; Zidovudine | 2010 |
Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months.
Topics: Adenine; Adipocytes; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cell Differentiation; Cyclopropanes; Drug Therapy, Combination; Fatty Acids; Female; Gene Expression; Genes, Mitochondrial; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Up-Regulation; Zidovudine | 2009 |
Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Thailand; Viral Load; Young Adult; Zidovudine | 2010 |
The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Culture; Cyclopropanes; Didanosine; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Surveys and Questionnaires; Zidovudine | 2010 |
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Topics: Adult; Body Weight; CD4 Lymphocyte Count; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2010 |
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antiviral Agents; Benzoxazines; CCR5 Receptor Antagonists; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Maraviroc; Middle Aged; Receptors, CCR5; Treatment Outcome; Triazoles; Viral Load; Viral Tropism; Young Adult; Zidovudine | 2010 |
Interferon-alpha produces significant decreases in HIV load.
Topics: Adult; CD4-Positive T-Lymphocytes; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Immunophenotyping; Interferon-alpha; Male; Survival Analysis; Viral Load; Zidovudine | 2010 |
Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals.
Topics: Adult; Anti-HIV Agents; Dioxolanes; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Purine Nucleosides; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2010 |
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Viral Load; Zidovudine | 2010 |
Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2010 |
Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Burkina Faso; CD4 Lymphocyte Count; Chemoprevention; Cohort Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Male; Mothers; Nevirapine; Prospective Studies; South Africa; Viral Load; Zidovudine | 2010 |
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine | 2010 |
Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
Topics: Adult; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Nevirapine; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; RNA, Viral; Viral Load; Young Adult; Zidovudine | 2010 |
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy.
Topics: Adult; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Lopinavir; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Pyrimidinones; Ritonavir; RNA, Viral; Thailand; Viral Load; Young Adult; Zidovudine | 2010 |
Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.
Topics: Absorptiometry, Photon; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Density; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; Zidovudine | 2011 |
Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Pyridines; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2010 |
Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
Topics: Africa, Eastern; Africa, Southern; Africa, Western; Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Clinical Protocols; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Mothers; Nevirapine; Pregnancy; Pyrimidinones; Research Design; Ritonavir; Zidovudine | 2011 |
Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Topics: Adult; Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Growth Disorders; HIV Infections; Humans; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine | 2010 |
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Infant, Newborn; Nevirapine; Organophosphonates; Pregnancy; Tenofovir; Treatment Outcome; Young Adult; Zidovudine | 2011 |
Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
Topics: Adult; Anemia; Anti-HIV Agents; Female; Hemoglobins; HIV Infections; Humans; Male; Risk Factors; Uganda; Zidovudine | 2010 |
Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Treatment Outcome; Viral Load; Zidovudine | 2011 |
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Body Fat Distribution; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Zidovudine | 2011 |
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2011 |
Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
Topics: Adult; Anemia; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Zidovudine | 2011 |
Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Zidovudine | 2011 |
Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
Topics: Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Emtricitabine; Female; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Organophosphonates; Quality of Life; Tenofovir; Treatment Outcome; Young Adult; Zidovudine | 2011 |
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Topics: Adult; Anti-HIV Agents; Castleman Disease; Drug Therapy, Combination; Female; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Male; Middle Aged; Pilot Projects; Prodrugs; Protein Kinase Inhibitors; Protein Kinases; Survival Analysis; Valganciclovir; Viral Load; Viral Proteins; Virus Activation; Zidovudine | 2011 |
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
Topics: Adult; Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Benzoxazines; Cyclopropanes; Dexamethasone; Double-Blind Method; Female; HIV Infections; Humans; Lamivudine; Male; Placebos; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Meningeal; Zidovudine | 2011 |
Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; HIV Infections; Lamivudine; Lopinavir; Protease Inhibitors; Ritonavir; Stavudine; Zidovudine | 2011 |
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoring.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 2011 |
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary; Uganda; Young Adult; Zidovudine | 2011 |
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Central African Republic; DNA Fingerprinting; Drug Resistance, Viral; Female; Genetic Variation; Health Services Accessibility; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Medication Adherence; Oligopeptides; Organophosphonates; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Viral Load; Young Adult; Zidovudine | 2012 |
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
Topics: Adenine; Adult; Africa; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Glomerulus; Lamivudine; Male; Nevirapine; Organophosphonates; Risk Factors; Tenofovir; Time Factors; Zidovudine | 2011 |
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
Topics: Acyclovir; Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Nevirapine; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load; Young Adult; Zidovudine | 2012 |
Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cognition; Cognition Disorders; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Zidovudine | 2012 |
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
Topics: Anti-HIV Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Body Weight; Child; Child, Preschool; Cytochrome P-450 CYP2B6; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Oxidoreductases, N-Demethylating; Reverse Transcriptase Inhibitors; Tablets; Zidovudine | 2011 |
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women.
Topics: Anti-HIV Agents; Drug Combinations; Drug Resistance, Viral; Female; Genotype; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Zidovudine | 2012 |
Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Oligopeptides; Post-Exposure Prophylaxis; Pyridines; Ritonavir; Zidovudine | 2012 |
Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbones.
Topics: Adenine; Adipose Tissue; Adult; Alkynes; Anaerobiosis; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Electron Transport Complex IV; Female; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Ion Channels; Lipogenesis; Male; Middle Aged; Mitochondrial Proteins; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Uncoupling Protein 2; Zidovudine | 2012 |
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutant Proteins; Mutation; Phenotype; Protein Structure, Tertiary; Recombination, Genetic; Ribonuclease H; RNA, Viral; Zidovudine | 2012 |
A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; Deoxycytidine; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Lamivudine; Linear Models; Male; Middle Aged; Netherlands; Organophosphonates; Pilot Projects; Research Design; Statistics, Nonparametric; Tenofovir; Treatment Outcome; Zidovudine | 2012 |
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Topics: Adult; Anti-Retroviral Agents; Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Young Adult; Zidovudine | 2012 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine | 2012 |
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
Topics: Anti-Retroviral Agents; CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Ritonavir; RNA, Viral; Zidovudine | 2012 |
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Nelfinavir; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2012 |
Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; Gambia; HIV Infections; HIV-1; HIV-2; Humans; Infant; Kaplan-Meier Estimate; Lamivudine; Lopinavir; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Asian People; Female; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 2012 |
Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.
Topics: Adult; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Ritonavir; Saquinavir; Treatment Outcome; Viral Load; Viremia; Young Adult; Zidovudine | 2012 |
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Cyclohexanes; Drug Combinations; Drug Therapy, Combination; Female; Genotype; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Male; Maraviroc; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Viral Load; Viral Tropism; Young Adult; Zidovudine | 2012 |
Anaemia in HIV-infected children: severity, types and effect on response to HAART.
Topics: Adolescent; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Logistic Models; Male; Nevirapine; Prevalence; Prospective Studies; Severity of Illness Index; Treatment Outcome; Uganda; Zidovudine | 2012 |
Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Dideoxynucleosides; Female; HIV Infections; HIV-1; Humans; Infant; Lactation; Lamivudine; Lopinavir; Middle Aged; Milk, Human; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2013 |
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administration Schedule; Drug Substitution; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Peripheral Nervous System Diseases; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants.
Topics: Anti-HIV Agents; Base Sequence; Cells, Cultured; Cohort Studies; DNA, Viral; Female; Genome, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Perinatal Care; Phenotype; Phylogeny; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Sequence Analysis, DNA; Zidovudine | 2002 |
Anti-HIV agents. Indinavir--3 years and still going strong.
Topics: Adipose Tissue; Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Viral Load; Zidovudine | 2000 |
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).
Topics: Adult; Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Furans; Genitalia, Male; HIV Infections; HIV-1; Humans; Lamivudine; Male; RNA, Viral; Semen; Statistics, Nonparametric; Sulfonamides; Zidovudine | 2002 |
Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Safety; Saquinavir; Thailand; United Kingdom; Viremia; Zidovudine | 2002 |
Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Patient Compliance; RNA, Viral; Treatment Outcome; Zidovudine | 2002 |
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Treatment Outcome; Zidovudine | 2002 |
L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.
Topics: Anti-HIV Agents; Apoptosis; Carnitine; Didanosine; Drug Therapy, Combination; fas Receptor; Flow Cytometry; HIV Infections; HIV-1; Humans; Hydrogen Peroxide; Male; Membrane Potentials; Mitochondria; Oxidants; Oxidative Stress; Phenotype; Reverse Transcriptase Inhibitors; Superoxides; T-Lymphocytes; Zidovudine | 2002 |
The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
Topics: CD4 Lymphocyte Count; Child, Preschool; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Nelfinavir; Reverse Transcriptase Inhibitors; Thailand; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Topics: Adult; Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Phenotype; Predictive Value of Tests; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Efficacy and safety of a quadruple combination Combivir + abacavir + efavirenz regimen in antiretroviral treatment-naive HIV-1-infected adults: La Francilienne.
Topics: Administration, Oral; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; France; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Prospective Studies; Thailand; Zidovudine | 2002 |
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Interactions; Drug Resistance, Viral; Female; HIV Infections; Humans; Hydroxyurea; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Nevirapine; Nucleosides; Phosphorylation; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Constitution; Body Mass Index; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Risk Factors; Stavudine; Zidovudine | 2002 |
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mutation; Patient Compliance; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2002 |
Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya.
Topics: Adult; Anti-HIV Agents; Female; Focus Groups; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 2003 |
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; RNA, Viral; Survival Analysis; Viral Load; Zidovudine | 2003 |
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Topics: Adult; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2003 |
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Middle Aged; Mutation; Nelfinavir; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Spain; Treatment Failure; Zidovudine | 2003 |
Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.
Topics: Adolescent; Aging; Area Under Curve; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Male; Metabolic Clearance Rate; Zidovudine | 2003 |
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Prospective Studies; RNA, Viral; Viral Load; Zidovudine | 2003 |
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chi-Square Distribution; Cholesterol; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Protease Inhibitors; RNA, Viral; Statistics, Nonparametric; Triglycerides; Viral Load; Zidovudine | 2003 |
Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received.
Topics: Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Selection, Genetic; Thymidine; Zalcitabine; Zidovudine | 2003 |
Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Zidovudine | 2003 |
Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.
Topics: Adult; Body Composition; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Stavudine; Zidovudine | 2003 |
Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.
Topics: Adult; Child, Preschool; DNA, Mitochondrial; Female; Fetal Blood; Genetic Markers; HIV Infections; Humans; Infant; Infant, Newborn; Leukocytes, Mononuclear; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Ribosomal, 18S; Telomere; Zidovudine | 2003 |
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2003 |
Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Burkina Faso; CD4 Lymphocyte Count; Child, Preschool; Cote d'Ivoire; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Risk Factors; Treatment Failure; Zidovudine | 2003 |
Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued highly active antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; Cholesterol; Dideoxynucleosides; Drug Combinations; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Feeding risk cut for HIV-infected women.
Topics: Anti-HIV Agents; Breast Feeding; Didanosine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Rwanda; Uganda; Zidovudine | 2003 |
Progression of HIV disease among women following delivery.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Longitudinal Studies; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Zidovudine | 2003 |
The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant Mortality; Infectious Disease Transmission, Vertical; Kenya; Maternal Mortality; Pregnancy; Survival Rate; Treatment Refusal; Zidovudine | 2003 |
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Topics: Adult; Anti-HIV Agents; Disease Transmission, Infectious; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor Onset; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 2003 |
Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
Topics: Adipocytes; Adipose Tissue; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cell Differentiation; Dideoxynucleosides; DNA, Mitochondrial; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Mitochondria; Mitochondrial Proteins; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Messenger; Stavudine; Zidovudine | 2003 |
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Cytidine Triphosphate; Dideoxynucleotides; Female; Half-Life; HIV Infections; Humans; Immunoassay; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Severity of Illness Index; Sex Factors; Zidovudine | 2003 |
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Zidovudine | 2003 |
Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Patient Compliance; Patient Education as Topic; RNA, Viral; Zidovudine | 2003 |
Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
Topics: Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2003 |
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Drug Combinations; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Prospective Studies; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2003 |
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Female; Genes, MDR; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Polymorphism, Single Nucleotide; Retrospective Studies; Ritonavir; RNA, Viral; Zidovudine | 2003 |
Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease.
Topics: Adult; CD4 Lymphocyte Count; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Inhibitory Concentration 50; Phenotype; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2003 |
HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.
Topics: Breast Feeding; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; DNA, Viral; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.
Topics: Adolescent; Adult; Analysis of Variance; Anti-HIV Agents; Chemistry, Pharmaceutical; Confidence Intervals; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Zidovudine | 2003 |
Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Multiple, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mutation; Stavudine; Thymidine; Viral Load; Zidovudine | 2004 |
Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocytes; Nevirapine; Nucleic Acid Amplification Techniques; Predictive Value of Tests; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2003 |
A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2003 |
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Oxazines; RNA, Viral; Stavudine; Time Factors; Treatment Failure; Zidovudine | 2003 |
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nelfinavir; Oxazines; Stavudine; Time Factors; Treatment Failure; Zidovudine | 2003 |
Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Trizivir vs. efavirenz: results from ACTG 5095.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Oxazines; Placebos; Viral Load; Zidovudine | 2003 |
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2003 |
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Female; HIV; HIV Infections; HIV-1; Humans; Lipodystrophy; Male; Middle Aged; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2004 |
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
Topics: Case-Control Studies; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Male; Mutation; Pharmacogenetics; Phenotype; Polymerase Chain Reaction; Probability; Prospective Studies; Reference Values; Reverse Transcriptase Inhibitors; RNA, Viral; Statistics, Nonparametric; Viral Load; Zidovudine | 2004 |
Pharmacodynamic effects of zidovudine 600 mg once/day versus 300 mg twice/day in therapy-naïve patients infected with human immunodeficiency virus.
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zidovudine | 2004 |
Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
Topics: Adult; Anti-HIV Agents; Cesarean Section; Female; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Zidovudine | 2004 |
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
Topics: Absorptiometry, Photon; Adipose Tissue; Anti-HIV Agents; Body Composition; Bone Density; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens.
Topics: Drug Resistance, Multiple, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection.
Topics: Adolescent; Anti-HIV Agents; Area Under Curve; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Lamivudine; Male; Metabolic Clearance Rate; Ritonavir; Stavudine; Zidovudine | 2004 |
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.
Topics: Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2004 |
Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
Topics: Age of Onset; Anti-HIV Agents; Chemoprevention; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; RNA, Viral; Stavudine; Thailand; Time Factors; Zidovudine | 2004 |
Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.
Topics: Adult; Anti-HIV Agents; Dideoxynucleosides; Female; HIV Infections; HIV-1; Humans; Lactates; Male; Middle Aged; Recurrence; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2004 |
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gestational Age; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Thailand; Viral Load; Zidovudine | 2004 |
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Labor, Obstetric; Logistic Models; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2004 |
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Oligopeptides; Oxazines; Pyridines; RNA, Viral; Zidovudine | 2004 |
Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Viral Load; Zidovudine | 2004 |
Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
Topics: Adipose Tissue; Adult; Anti-HIV Agents; DNA, Mitochondrial; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Leukocytes, Mononuclear; Middle Aged; Muscle, Skeletal; Radiography; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014).
Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Reverse Transcriptase Inhibitors; RNA; Surveys and Questionnaires; Therapeutic Equivalency; Treatment Outcome; Zidovudine | 2004 |
Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Treatment Outcome; Zidovudine | 2004 |
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2004 |
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Quality of Life; Reverse Transcriptase Inhibitors; Sickness Impact Profile; Survival Analysis; Zidovudine | 2004 |
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Phenotype; Stavudine; Treatment Failure; Zidovudine | 2004 |
Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.
Topics: Africa; Anti-HIV Agents; Disease Transmission, Infectious; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Milk, Human; Perinatal Care; Pregnancy; RNA, Viral; Time Factors; Zidovudine | 2004 |
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Oxazines; RNA, Viral; Zidovudine | 2004 |
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.
Topics: Adolescent; Anti-HIV Agents; Area Under Curve; Child; Child, Preschool; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
New once-daily HIV combination better tolerated.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; HIV Infections; Humans; Lamivudine; Organophosphonates; Oxazines; Tenofovir; Zidovudine | 2004 |
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Zidovudine | 2004 |
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study).
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Lamivudine; Oxazines; Viral Load; Zidovudine | 2005 |
Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; Viral Load; Zidovudine | 2005 |
Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001.
Topics: Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Health Programs; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2005 |
Tenofovir regimen compared with Combivir.
Topics: Adenine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Europe; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Maximum Tolerated Dose; Organophosphonates; Risk Assessment; Severity of Illness Index; Single-Blind Method; Tenofovir; Treatment Outcome; United States; Viral Load; Zidovudine | 2005 |
Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.
Topics: Agranulocytosis; Anemia; Anti-HIV Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematocrit; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Nevirapine; Risk Factors; RNA, Viral; Zidovudine | 2004 |
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2005 |
Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2005 |
Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir containing regimen.
Topics: Adult; Aged; Anti-HIV Agents; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Japan; Lamivudine; Leukocyte Count; Male; Middle Aged; Neutrophils; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Zidovudine | 2005 |
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Male; Mutation; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Induction with abacavir/lamivudine/zidovudine plus efavirenz for 48 weeks followed by 48-week maintenance with abacavir/lamivudine/zidovudine alone in antiretroviral-naive HIV-1-infected patients.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Patient Compliance; RNA, Viral; Zidovudine | 2005 |
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Patient Compliance; Patient Satisfaction; Prospective Studies; Quality of Life; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2005 |
Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Topics: Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 1999 |
Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Retrospective Studies; Treatment Outcome; Tunisia; Viremia; Zidovudine | 2005 |
A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; Treatment Outcome; Zidovudine | 2005 |
Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; Botswana; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Milk, Human; Nevirapine; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Zidovudine | 2005 |
Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Nevirapine; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; RNA, Viral; Zidovudine | 2005 |
Efficacy and safety of zidovudine and zalcitabine combined with a combination of herbs in the treatment of HIV-infected Thai patients.
Topics: Adult; Anti-HIV Agents; Astragalus propinquus; Carthamus tinctorius; Double-Blind Method; Drug Therapy, Combination; Female; Glycyrrhiza; HIV Infections; Humans; Male; Middle Aged; Phytotherapy; Plant Preparations; Thailand; Treatment Outcome; Zalcitabine; Zidovudine | 2005 |
Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age.
Topics: Age Factors; Antiretroviral Therapy, Highly Active; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Male; Maximum Tolerated Dose; Prospective Studies; Risk Assessment; Ritonavir; Severity of Illness Index; Single-Blind Method; Survival Rate; Treatment Outcome; Zidovudine | 2005 |
Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
Topics: Adult; Anemia; Anti-HIV Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Blood Cell Count; Blood Platelets; Cohort Studies; Cote d'Ivoire; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Neutropenia; Prospective Studies; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2005 |
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study.
Topics: Adult; Area Under Curve; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin; Stavudine; Time Factors; Zidovudine | 2005 |
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.
Topics: Adult; Aspartic Acid; Brain; Cell Respiration; Didanosine; Female; HIV Infections; Humans; Lamivudine; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 2005 |
Gestational age determination and prevention of HIV perinatal transmission.
Topics: Anti-HIV Agents; Female; Gestational Age; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Outcome; Thailand; Time Factors; Zidovudine | 2006 |
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Cohort Studies; Confidence Intervals; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; HIV Infections; HIV Seronegativity; Humans; India; Lamivudine; Nevirapine; Tablets; Therapeutic Equivalency; Zidovudine | 2006 |
Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: the impact of social network factors, side effects, and perceived treatment efficacy.
Topics: Adult; Anti-HIV Agents; Attitude to Health; District of Columbia; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Logistic Models; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Complications, Infectious; Social Support; Zidovudine | 2005 |
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine | 2006 |
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
Topics: Adenine; Adolescent; Adult; Aged; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Oxazines; Prospective Studies; RNA, Viral; Tenofovir; Zidovudine | 2006 |
A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people.
Topics: Adult; Aging; Anti-HIV Agents; Didanosine; Female; Hearing Loss; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Zidovudine | 2006 |
An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Zidovudine | 2006 |
[Clinical trial comparing efficacy and safety of four highly active antiretroviral therapy (HAART) in antiretroviral-naive treatment with advanced HIV infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Ritonavir; Stavudine; Zidovudine | 2006 |
Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
Topics: Anti-HIV Agents; Body Height; Body Mass Index; Body Weight; Female; Growth; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 2006 |
Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: its role in preventing HIV infection in infants.
Topics: Acidosis, Lactic; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Fatty Liver; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; RNA, Viral; South Africa; Stavudine; Viral Load; Zidovudine | 2006 |
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Ritonavir; RNA, Viral; Time Factors; Viral Load; Zidovudine | 2006 |
Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Developing Countries; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; RNA, Viral; Tenofovir; Treatment Outcome; Uganda; Viral Load; Zidovudine; Zimbabwe | 2006 |
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Black People; Cytochrome P-450 CYP3A; DNA Primers; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Mitochondrial Proteins; Multidrug Resistance-Associated Proteins; Pharmacogenetics; Pilot Projects; Retrospective Studies; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Zidovudine | 2006 |
Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; New York City; Patient Compliance; Prospective Studies; Regression Analysis; Sex Offenses; Zidovudine | 2007 |
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Botswana; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Postpartum Period; Treatment Outcome; Zidovudine | 2006 |
Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Male; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Zidovudine | 2006 |
Initiation of antiretroviral treatment with dual nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected infants with less advanced disease in a resource-limited setting: a multi-center study in Thailand 1998-2000.
Topics: Developing Countries; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2005 |
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; RNA, Messenger; Viral Load; Zidovudine | 2006 |
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Breast Feeding; Disease-Free Survival; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2006 |
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.
Topics: Adult; Anemia; Antiviral Agents; Body Weight; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Zidovudine | 2006 |
Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children.
Topics: Anti-HIV Agents; Antimalarials; Child; Child, Preschool; Chloroquine; Didanosine; Female; HIV Infections; HIV-1; Humans; Male; Zidovudine | 2006 |
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Biomarkers; Body Fat Distribution; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lipids; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Zidovudine | 2006 |
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pilot Projects; Tenofovir; Viral Load; Zidovudine | 2006 |
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Oxazines; RNA, Viral; Tenofovir; Time Factors; Viral Load; Zidovudine | 2006 |
A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine; Zimbabwe | 2007 |
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV; HIV Infections; Humans; Lamivudine; Milk, Human; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; RNA, Viral; Stavudine; Zidovudine | 2007 |
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
Topics: Adult; Anti-Retroviral Agents; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Labor, Obstetric; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Proportional Hazards Models; Prospective Studies; Risk Factors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2007 |
Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cohort Studies; Cote d'Ivoire; Female; HIV Infections; Humans; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Morbidity; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Treatment Outcome; Zidovudine | 2007 |
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Glucose; Body Composition; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Insulin Resistance; Lactic Acid; Lamivudine; Lipids; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
Topics: Adult; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Leukocytes, Mononuclear; Logistic Models; Male; Reverse Transcriptase Inhibitors; Stavudine; Surveys and Questionnaires; Time Factors; Zidovudine | 2007 |
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Incidence; Male; Predictive Value of Tests; Prevalence; Reverse Transcriptase Inhibitors; Severity of Illness Index; Uganda; Zidovudine; Zimbabwe | 2006 |
Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Topics: Adenine; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Mutation; Organophosphonates; Pilot Projects; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Treatment Outcome; Zidovudine | 2006 |
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Saquinavir; Zidovudine | 2007 |
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Prospective Studies; Regression Analysis; RNA, Viral; Time Factors; Zidovudine | 2007 |
Clinically significant anemia in HIV-infected pregnant women in India is not a major barrier to zidovudine use for prevention of maternal-to-child transmission.
Topics: Adult; Anemia; Female; Folic Acid; HIV Infections; Humans; India; Infectious Disease Transmission, Vertical; Iron; Pregnancy; Zidovudine | 2007 |
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Topics: Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Reverse Transcriptase; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Maternal-Fetal Exchange; Mitochondrial Diseases; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Sex Factors; Zidovudine | 2007 |
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Dideoxynucleosides; Drug Resistance, Viral; Follow-Up Studies; Growth; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Late postnatal transmission of HIV-1 and associated factors.
Topics: Breast Feeding; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Milk, Human; Nevirapine; Risk Factors; RNA, Viral; Time Factors; Zidovudine | 2007 |
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Didanosine; Double-Blind Method; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Nelfinavir; Prospective Studies; Stavudine; Testosterone; Zidovudine | 2007 |
More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175.
Topics: Adult; Anti-Retroviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Middle Aged; Receptors, CCR5; Receptors, CXCR4; Zalcitabine; Zidovudine | 2007 |
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Time Factors; Treatment Outcome; United States; Zidovudine | 2007 |
Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
Topics: Adult; Anti-HIV Agents; Anti-Infective Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Influenza A virus; Influenza B virus; Influenza Vaccines; Male; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2007 |
Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Models, Biological; Nelfinavir; Reverse Transcriptase Inhibitors; Stavudine; Tissue Distribution; Zidovudine | 2007 |
Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
Topics: Adult; Anemia; Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Zidovudine | 2007 |
A comparison of three initial antiretroviral AIDS regimens.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; HIV; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2007 |
Pathology of placenta in HIV infection.
Topics: Anti-HIV Agents; Chorioamnionitis; Female; Fetal Death; HIV Infections; Humans; Hyperplasia; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Treatment Outcome; Trophoblasts; Zidovudine | 2007 |
144-week data released on Gilead's study 934.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Time Factors; Viral Load; Zidovudine | 2007 |
Maternal HIV-1 DNA load and mother-to-child transmission.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; RNA, Viral; Thailand; Viral Load; Zidovudine | 2007 |
Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.
Topics: Adult; Anti-HIV Agents; Bottle Feeding; Breast Feeding; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; India; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
Topics: Adolescent; Adult; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis.
Topics: Adenine; Adult; Alkynes; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2008 |
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Female; Fetal Diseases; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Male; Odds Ratio; Parturition; Pregnancy; Pregnancy Complications, Infectious; Risk Assessment; Risk Factors; Thailand; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
Topics: Adult; Alkynes; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Developing Countries; Dizziness; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; Neutropenia; Prospective Studies; South Africa; Treatment Outcome; Viral Load; Vomiting; Zidovudine | 2008 |
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.
Topics: Adiponectin; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Glucose; Glycerol; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperinsulinism; Insulin Resistance; Lamivudine; Lipid Metabolism; Lipids; Lopinavir; Male; Middle Aged; Pyrimidinones; Time Factors; Treatment Outcome; Zidovudine | 2008 |
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
Topics: Adult; Anemia; Anti-HIV Agents; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Multivariate Analysis; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Withholding Treatment; Zidovudine | 2008 |
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Failure; Treatment Outcome; Zidovudine | 2008 |
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease; HIV-1; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Outcome; Uganda; Zidovudine | 2008 |
Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Anti-HIV Agents; Antioxidants; Area Under Curve; Biomarkers, Pharmacological; Cells, Cultured; Chromatography, High Pressure Liquid; Deoxyguanosine; Dose-Response Relationship, Drug; Drug Interactions; F2-Isoprostanes; Female; Ginsenosides; HIV Infections; HIV Protease Inhibitors; Humans; Male; Metabolic Clearance Rate; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Panax; Phytotherapy; Plant Extracts; Zidovudine | 2008 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anti-HIV Agents; CCR5 Receptor Antagonists; Contraceptives, Oral; Cyclohexanes; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; HIV Infections; Humans; Lamivudine; Levonorgestrel; Male; Maraviroc; Midazolam; Middle Aged; Statistics as Topic; Triazoles; Zidovudine | 2008 |
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Genitalia, Male; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Lopinavir; Male; Plasma; Pyrimidinones; Ritonavir; RNA, Viral; Semen; Time Factors; Virus Shedding; Zidovudine | 2008 |
Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX.
Topics: Administration, Oral; Area Under Curve; Double-Blind Method; Female; HIV Infections; Humans; Lamivudine; Male; Placebos; Reverse Transcriptase Inhibitors; Uridine; Zidovudine | 2008 |
Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine.
Topics: Adult; Cohort Studies; Dideoxynucleosides; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Subcutaneous Fat; Zidovudine | 2008 |
The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial.
Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Zalcitabine; Zidovudine | 2008 |
Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
Topics: Adult; Aged; Anti-HIV Agents; Benzoates; Diketopiperazines; Double-Blind Method; Drug Therapy, Combination; Female; HIV Fusion Inhibitors; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Treatment Outcome; Zidovudine | 2008 |
Kaposi's sarcoma and KSHV.
Topics: Child, Preschool; DNA, Viral; Double-Blind Method; Female; HIV Infections; Humans; Sarcoma, Kaposi; Zidovudine | 1995 |
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zalcitabine; Zidovudine | 1995 |
Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Epirubicin; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prospective Studies; Vinblastine; Zidovudine | 1994 |
A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children.
Topics: Black or African American; Body Height; Body Weight; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cognition Disorders; Cohort Studies; Developmental Disabilities; Female; Hispanic or Latino; HIV Infections; Humans; Infant; Leukocyte Count; Male; Neuropsychological Tests; New York City; Poverty; Psychomotor Disorders; Socioeconomic Factors; Treatment Outcome; Urban Population; Zidovudine | 1994 |
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1995 |
Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Safety; Time Factors; Zidovudine | 1995 |
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor.
Topics: Adult; Antiviral Agents; Base Sequence; Benzoxazoles; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Zidovudine | 1995 |
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team.
Topics: Amino Acid Sequence; Base Sequence; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Codon; Didanosine; DNA Primers; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1995 |
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
Topics: Antiviral Agents; Base Sequence; CD4 Lymphocyte Count; Cell Line; Codon; Drug Resistance, Microbial; Drug Therapy, Combination; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Serial Passage; Zalcitabine; Zidovudine | 1995 |
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Topics: Antiviral Agents; Benzoxazoles; Biomarkers; CD4 Lymphocyte Count; Double-Blind Method; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoassay; Polymerase Chain Reaction; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viremia; Zidovudine | 1995 |
Diagnosis of HIV infection from bloodstains by PCR. A further marker for identification.
Topics: Antiviral Agents; Base Sequence; Biomarkers; Blood Stains; DNA, Viral; Forensic Medicine; HIV Infections; Humans; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Zidovudine | 1995 |
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team.
Topics: Adult; Antiviral Agents; Benzodiazepines; CD4 Lymphocyte Count; Didanosine; Dose-Response Relationship, Drug; Female; Gene Products, tat; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Time Factors; Zidovudine | 1995 |
Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue.
Topics: Adult; Didanosine; DNA, Viral; Female; HIV Infections; HIV-1; Humans; Lymph Nodes; Lymphocytes; Male; Time Factors; Viremia; Zidovudine | 1995 |
Prevention of maternal HIV transmission. Practical guidelines.
Topics: Drug Administration Schedule; Female; France; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Randomized Controlled Trials as Topic; United States; Zidovudine | 1995 |
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Double-Blind Method; Follow-Up Studies; HIV Infections; Humans; Male; Proportional Hazards Models; Survival Analysis; Time Factors; Zidovudine | 1995 |
A controlled trial of zidovudine in primary human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Time Factors; Zidovudine | 1995 |
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Complex; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Prospective Studies; Survival Rate; Zidovudine | 1995 |
Study of the role of vitamin B12 and folinic acid supplementation in preventing hematologic toxicity of zidovudine.
Topics: Adult; Anemia; Bone Marrow Diseases; CD4 Lymphocyte Count; Female; Folic Acid; Hematologic Diseases; HIV Infections; Humans; Leucovorin; Male; Neutropenia; Prospective Studies; Vitamin B 12; Zidovudine | 1995 |
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Female; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Stavudine; Survival Rate; Zidovudine | 1995 |
Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Base Sequence; DNA Primers; DNA, Viral; Double-Blind Method; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Molecular Sequence Data; Phenotype; Prognosis; RNA, Viral; Time Factors; Zidovudine | 1995 |
The use of zidovudine to prevent perinatal transmission of HIV.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1995 |
Dysfunction of visual pathways in HIV-1 infection.
Topics: Adult; Aged; Evoked Potentials, Visual; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Multivariate Analysis; Optic Neuritis; Photic Stimulation; Prospective Studies; Visual Pathways; Zidovudine | 1995 |
Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076--results and treatment recommendations.
Topics: Double-Blind Method; Drug Administration Schedule; Female; Guidelines as Topic; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; United States; United States Public Health Service; Zidovudine | 1995 |
Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Didanosine; Drug Interactions; Drug Therapy, Combination; Half-Life; HIV Infections; Humans; Male; Radioimmunoassay; Zidovudine | 1995 |
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Infections; Humans; Male; Prospective Studies; Zidovudine | 1995 |
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.
Topics: Adult; Antiviral Agents; Base Sequence; Benzoxazoles; CD4-Positive T-Lymphocytes; DNA, Viral; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Male; Molecular Sequence Data; Pyridones; Reverse Transcriptase Inhibitors; Zidovudine | 1993 |
Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups.
Topics: Adult; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Didanosine; Drug Therapy, Combination; Female; Hemophilia A; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Safety; Treatment Outcome; Viremia; Zidovudine | 1995 |
AZT in pregnant women with HIV: risks and benefits.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.
Topics: Adult; Base Sequence; CD4 Lymphocyte Count; Codon; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; RNA, Viral; Viremia; Zidovudine | 1995 |
Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infection.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Survival Rate; Zidovudine | 1995 |
High-performance liquid chromatographic assay for 3'-amino-3'-deoxythymidine in plasma, with 9-fluorenyl methyl chloroformate as the derivatization agent.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Dideoxynucleosides; Fluorenes; HIV Infections; Humans; Mice; Mice, Inbred DBA; Quality Control; Spectrometry, Fluorescence; Zidovudine | 1995 |
Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cohort Studies; HIV Infections; Humans; Hypersensitivity, Delayed; Longitudinal Studies; Mycobacterium avium-intracellulare Infection; Prospective Studies; Tuberculin Test; Zidovudine | 1994 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
Topics: Adult; CD4 Immunoadhesins; CD4 Lymphocyte Count; Drug Interactions; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Safety; United States; Viremia; Zidovudine | 1995 |
Interferons in HIV and related diseases.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clinical Trials as Topic; Combined Modality Therapy; Hepatitis B; HIV Infections; Humans; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Zidovudine | 1994 |
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial.
Topics: CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Treatment Outcome; Virus Cultivation; Zidovudine | 1995 |
The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Bone Marrow Diseases; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Leucovorin; Male; Pneumonia, Pneumocystis; Proportional Hazards Models; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
Topics: Adult; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Proportional Hazards Models; Thymopentin; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Something better than zidovudine for children.
Topics: Adolescent; Child; Child, Preschool; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Infant; Zidovudine | 1995 |
Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Ganciclovir; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; Humans; Male; Neutropenia; Prognosis; Zidovudine | 1994 |
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions.
Topics: Adult; Age Factors; Aged; Body Weight; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Kidney; Liver; Male; Middle Aged; Prospective Studies; Sex Characteristics; Zidovudine | 1994 |
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; CD4 Lymphocyte Count; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Regression Analysis; Risk Factors; Survival Rate; Treatment Outcome; Zidovudine | 1995 |
Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Pneumonia, Pneumocystis; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Zidovudine | 1994 |
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; CD8 Antigens; Cohort Studies; Female; Follow-Up Studies; Hemoglobins; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Monitoring, Immunologic; Platelet Count; Zidovudine | 1994 |
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; beta 2-Microglobulin; Body Weight; CD4-Positive T-Lymphocytes; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Pancreatitis; Pilot Projects; Zidovudine | 1994 |
Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
Topics: CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Drug Therapy, Combination; HeLa Cells; HIV; HIV Infections; Humans; Leukocyte Count; Time Factors; Zalcitabine; Zidovudine | 1994 |
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
Topics: 1-Deoxynojirimycin; Adult; Antiviral Agents; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hemoglobins; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Neutrophils; Paresthesia; RNA, Viral; Zidovudine | 1994 |
Provirus load changes in untreated and zidovudine-treated human immunodeficiency virus type 1-infected patients.
Topics: CD4-Positive T-Lymphocytes; DNA, Viral; HIV Infections; HIV-1; Humans; Leukocyte Count; Proviruses; Time Factors; Zidovudine | 1994 |
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Didanosine; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Risk; Zalcitabine; Zidovudine | 1994 |
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
Topics: CD4-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; Humans; Leukocyte Count; Quality of Life; Retrospective Studies; Survival Analysis; Zidovudine | 1994 |
Maternal transmission of HIV.
Topics: Female; Fetal Diseases; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leukocyte Count; Male; Treatment Outcome; Zidovudine | 1994 |
Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cohort Studies; Double-Blind Method; Female; HIV Infections; Humans; Hypersensitivity, Delayed; Leukocyte Count; Male; Prognosis; Proportional Hazards Models; Risk Factors; Skin Tests; Survival Rate; Treatment Outcome; Zidovudine | 1994 |
Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Leukocyte Count; Male; Patient Compliance; Survival Analysis; Treatment Outcome; Zidovudine | 1994 |
Hemofil-M study.
Topics: CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Drug Interactions; Factor VIII; Follow-Up Studies; Hemophilia A; HIV Infections; Humans; T-Lymphocyte Subsets; Time Factors; Zidovudine | 1994 |
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection.
Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cytotoxicity, Immunologic; Drug Synergism; Female; HIV; HIV Infections; Humans; Immunologic Factors; Interferon-alpha; Leukocyte Count; Male; Risk Factors; Thymalfasin; Thymosin; Virus Replication; Zidovudine | 1994 |
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.
Topics: Adult; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Polymerase Chain Reaction; Zidovudine | 1994 |
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; Hemophilia A; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Prospective Studies; Zidovudine | 1994 |
The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Combined Modality Therapy; HIV Infections; Humans; Immunoglobulins, Intravenous; Leukocyte Count; Lymphocyte Activation; Pentamidine; Prospective Studies; Survival Rate; Treatment Failure; Zidovudine | 1994 |
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Double-Blind Method; Europe; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Patient Compliance; Risk Factors; Safety; Time Factors; Zidovudine | 1994 |
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Clinical Protocols; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Proportional Hazards Models; Survival Analysis; Zidovudine | 1994 |
A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents.
Topics: Adolescent; Adult; Aged; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Leukocyte Count; Liver; Male; Middle Aged; Trichosanthin; Zidovudine | 1994 |
Reduction of HIV transmission from mother to infant.
Topics: Adolescent; Adult; Double-Blind Method; Female; France; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Treatment Outcome; Zidovudine | 1994 |
Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
Topics: Adult; Biological Availability; Drug Synergism; Half-Life; HIV Infections; Humans; Linear Models; Male; Middle Aged; Valproic Acid; Zidovudine | 1994 |
Pharmacokinetics of zidovudine in HIV-positive patients with liver disease.
Topics: Adult; Half-Life; HIV Infections; HIV Seropositivity; Humans; Liver Diseases; Metabolic Clearance Rate; Zidovudine | 1994 |
Long-term effects of interleukin-2 on CD4 cell counts in human immunodeficiency virus-infected patients.
Topics: CD4-Positive T-Lymphocytes; Follow-Up Studies; HIV Infections; Humans; Infusions, Intravenous; Interleukin-2; Polyethylene Glycols; Retrospective Studies; Time Factors; Zidovudine | 1994 |
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Topics: Adult; CD4 Lymphocyte Count; Confidence Intervals; Diseases in Twins; Double-Blind Method; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature, Diseases; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group.
Topics: Adolescent; Age Factors; Body Height; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Sensitivity and Specificity; Sex Factors; Survival Rate; Time Factors; Weight Gain; Zidovudine | 1994 |
Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients.
Topics: CD4 Lymphocyte Count; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Viremia; Zidovudine | 1994 |
Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
Topics: Adult; Dose-Response Relationship, Drug; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Monocytes; Phosphorylation; Zidovudine | 1994 |
Stavudine (Zerit). New antiretroviral joins arsenal against HIV.
Topics: Double-Blind Method; HIV Infections; Humans; Stavudine; Zidovudine | 1994 |
Quantitative relationships between zidovudine exposure and efficacy and toxicity.
Topics: CD4 Lymphocyte Count; Child; HIV Infections; Humans; Zidovudine | 1994 |
Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biotransformation; Dideoxynucleotides; HIV Infections; HIV Seronegativity; Humans; Leukocytes, Mononuclear; Middle Aged; Phosphorylation; Reference Values; Thymine Nucleotides; Zidovudine | 1994 |
The European-Australian Collaborative Group Study 017 of zidovudine versus placebo.
Topics: Acquired Immunodeficiency Syndrome; Australia; Europe; HIV Infections; Humans; Placebos; Research Design; Zidovudine | 1994 |
[Zidovudine in prevention of HIV transmission by the infected mother to her child].
Topics: Administration, Oral; Double-Blind Method; Drug Administration Schedule; Female; France; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Survival Rate; United States; Zidovudine | 1994 |
AZT reduces HIV transmission to newborns.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1994 |
A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine.
Topics: Adult; Drug Therapy, Combination; HIV Infections; Humans; Injections, Subcutaneous; Interleukin-2; Killer Cells, Natural; Leukocytes; Lymphocyte Activation; Male; Middle Aged; Receptors, Interleukin-2; Recombinant Proteins; Zidovudine | 1994 |
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; HIV Infections; Humans; Male; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome; Zidovudine | 1994 |
Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection.
Topics: Adolescent; Adult; Child; Child, Preschool; Didanosine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Male; Zidovudine | 1994 |
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Dev
Topics: AIDS-Related Opportunistic Infections; Bacterial Infections; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Hospitalization; Humans; Immunoglobulins, Intravenous; Male; Pneumonia, Pneumocystis; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1994 |
Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection.
Topics: Adult; beta 2-Microglobulin; CD4-CD8 Ratio; Central Nervous System Diseases; Cognition Disorders; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulin G; Male; Middle Aged; Zidovudine | 1994 |
Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.
Topics: Adolescent; Adult; beta 2-Microglobulin; Biomarkers; Biopterins; Female; HIV Infections; Humans; Male; Middle Aged; Neopterin; Phosphorylation; Zidovudine | 1994 |
Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
Topics: Adult; Body Surface Area; Body Weight; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1994 |
Effects of zidovudine on B lymphocyte activation.
Topics: Adult; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Cells, Cultured; Herpesvirus 4, Human; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Interleukin-6; Lymphocyte Activation; Lymphoma, AIDS-Related; Male; T-Lymphocytes; Time Factors; Zidovudine | 1994 |
Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Consent Forms; Double-Blind Method; Drug Administration Schedule; Ethics, Medical; Federal Government; HIV Infections; Humans; Informed Consent; Leukocyte Count; Risk Assessment; Therapeutic Human Experimentation; Zidovudine | 1993 |
Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study.
Topics: Adult; Analysis of Variance; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infusions, Intravenous; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocyte Count; Middle Aged; Polyethylene Glycols; T-Lymphocyte Subsets; Virus Replication; Zidovudine | 1993 |
CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Biomarkers; CD4-Positive T-Lymphocytes; Female; HIV Infections; Humans; Leukocyte Count; Male; Predictive Value of Tests; Proportional Hazards Models; Zidovudine | 1993 |
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
Topics: Adult; Body Weight; CD4-Positive T-Lymphocytes; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Regression Analysis; Severity of Illness Index; Survival Rate; Zalcitabine; Zidovudine | 1993 |
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Retrospective Studies; Zidovudine | 1993 |
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; HIV Infections; HIV-1; Humans; Leukocyte Count; Survival Rate; Zidovudine | 1993 |
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection.
Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Double-Blind Method; Female; HIV Antibodies; HIV Infections; Humans; Immunotherapy, Adoptive; Leukocyte Count; Male; Middle Aged; Zidovudine | 1993 |
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Double-Blind Method; Genetic Variation; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality; Humans; Male; Phenotype; Treatment Outcome; Zidovudine | 1993 |
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study
Topics: Age Factors; Analysis of Variance; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunoglobulins, Intravenous; Infant; Leukocyte Count; Linear Models; Longitudinal Studies; Male; Regression Analysis; Time Factors; Treatment Outcome; Zidovudine | 1993 |
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Double-Blind Method; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Pneumonia, Pneumocystis; Proportional Hazards Models; Risk Factors; Survival Analysis; Time Factors; Zidovudine | 1994 |
Zidovudine could cut transmission of HIV by mothers.
Topics: Clinical Trials as Topic; Female; HIV Infections; Humans; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Zidovudine for the prevention of HIV transmission from mother to infant.
Topics: Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
Topics: Adult; Analysis of Variance; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Male; Zidovudine | 1994 |
From the Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant.
Topics: Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Comprehension; Consent Forms; HIV Infections; Humans; Informed Consent; Male; Patient Acceptance of Health Care; Patient Education as Topic; Research Subjects; Risk Assessment; Sick Role; Therapeutic Human Experimentation; Zidovudine | 1994 |
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Topics: Adult; Clinical Protocols; Cohort Studies; Didanosine; Double-Blind Method; Female; HIV Infections; Humans; Male; Patient Compliance; Sensitivity and Specificity; Uric Acid; Zidovudine | 1993 |
Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.
Topics: Acquired Immunodeficiency Syndrome; Cost of Illness; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Schedule; Drug Costs; Follow-Up Studies; Health Care Costs; HIV Infections; Humans; Quality of Life; United States; Value of Life; Zidovudine | 1993 |
Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group.
Topics: Acquired Immunodeficiency Syndrome; Dose-Response Relationship, Drug; Follow-Up Studies; HIV Infections; Humans; Survival Rate; Zidovudine | 1993 |
Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4-CD8 Ratio; Cytomegalovirus Retinitis; Drug Therapy, Combination; HIV Infections; Humans; Incidence; Male; Prospective Studies; Zalcitabine; Zidovudine | 1993 |
Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Case-Control Studies; Drug Resistance, Microbial; Follow-Up Studies; Giant Cells; HIV; HIV Infections; Humans; Middle Aged; Phenotype; Retrospective Studies; Zidovudine | 1993 |
Three-year follow-up of asymptomatic HIV-infected men receiving combination zidovudine and acyclovir.
Topics: Acyclovir; Drug Therapy, Combination; Drug Tolerance; Follow-Up Studies; HIV Infections; Humans; Male; Zidovudine | 1993 |
Progression of periodontal disease in HIV seropositive patients.
Topics: Adult; Case-Control Studies; CD4-CD8 Ratio; Cohort Studies; Concanavalin A; Dental Plaque Index; HIV Infections; HIV Seropositivity; Humans; Lymphocyte Activation; Lymphocytes; Male; Periodontal Index; Periodontitis; Phytohemagglutinins; Regression Analysis; Time Factors; Zidovudine | 1993 |
The effects of indomethacin and naproxen on zidovudine pharmacokinetics.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Glucuronates; HIV Infections; Humans; Indomethacin; Male; Middle Aged; Naproxen; Zidovudine | 1993 |
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.
Topics: Adult; CD4 Antigens; Cell Count; Didanosine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; RNA, Viral; Zidovudine | 1993 |
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
Topics: Administration, Oral; Anemia; Drug Administration Schedule; Drug Tolerance; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1993 |
[Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
Topics: Acquired Immunodeficiency Syndrome; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; HIV Infections; Humans; Male; Scandinavian and Nordic Countries; Zidovudine | 1993 |
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus.
Topics: Administration, Oral; Adult; Blood Cell Count; Didanosine; Female; Hemoglobins; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Zidovudine | 1993 |
Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine.
Topics: Administration, Oral; Adult; Didanosine; Drug Administration Schedule; Female; Follow-Up Studies; Hematologic Diseases; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1993 |
Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT Trial.
Topics: Adult; DNA Mutational Analysis; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Male; Microbial Sensitivity Tests; Prospective Studies; Time Factors; Zidovudine | 1993 |
Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
Topics: Adult; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Middle Aged; Platelet Count; Thrombocytopenia; Zidovudine | 1993 |
Early AZT takes a pounding in French-British 'Concorde' trial.
Topics: Acquired Immunodeficiency Syndrome; France; HIV Infections; Humans; United Kingdom; United States; Zidovudine | 1993 |
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Topics: Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Dapsone; Drug Combinations; Encephalitis; Female; HIV Infections; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis, Cerebral; Zidovudine | 1993 |
Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.
Topics: Adult; Cognition; HIV Infections; Humans; Male; Outcome Assessment, Health Care; Quality of Life; Zidovudine | 1993 |
Is antiretroviral treatment after percutaneous HIV exposure justified?
Topics: Clinical Trials as Topic; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Occupational Diseases; Zidovudine | 1993 |
Psychological effects of participation and nonparticipation in a placebo-controlled zidovudine clinical trial with asymptomatic human immunodeficiency virus-infected individuals.
Topics: Adult; Analysis of Variance; Anxiety; Cohort Studies; Depression; Double-Blind Method; Female; HIV Infections; Humans; Male; Multivariate Analysis; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Stress, Psychological; Zidovudine | 1993 |
Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group.
Topics: Adolescent; Adult; Aged; CD4 Lymphocyte Count; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Interferon-alpha; Male; Middle Aged; Treatment Outcome; Zidovudine | 1995 |
Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Black People; CD4 Lymphocyte Count; Disease; Double-Blind Method; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Male; Risk Factors; Treatment Outcome; White People; Zidovudine | 1996 |
Pharmacokinetics of zidovudine and didanosine during combination therapy.
Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Zidovudine | 1995 |
Neurophysiological evaluation of zidovudine in asymptomatic HIV-1 infection: a longitudinal placebo-controlled study.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Evoked Potentials, Visual; HIV Infections; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Zidovudine | 1995 |
Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Biomarkers; Biopterins; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Neopterin; Receptors, Tumor Necrosis Factor; Solubility; Zidovudine | 1995 |
Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
Topics: Adult; Analysis of Variance; Antiviral Agents; Atovaquone; Cross-Over Studies; Glucuronates; HIV Infections; Humans; Male; Middle Aged; Naphthoquinones; Zidovudine | 1996 |
Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Longitudinal Studies; Male; Randomized Controlled Trials as Topic; Survival Rate; Veterans; Zidovudine | 1996 |
Tolerance of a triple combination therapy with zidovudine, didanosine and interferon-alpha in seven HIV-infected patients.
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Interferon-alpha; Zidovudine | 1995 |
Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Microbial; Genotype; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Phenotype; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1995 |
A clinical trial of a knowledge-based medical record.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Attitude of Health Personnel; CD4 Lymphocyte Count; Decision Making, Computer-Assisted; Expert Systems; HIV Infections; Hospital Information Systems; Humans; Medical Records Systems, Computerized; Physicians; Practice Guidelines as Topic; Quality of Health Care; Reminder Systems; Statistics, Nonparametric; Survival Rate; Zidovudine | 1995 |
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
Topics: Administration, Oral; Adult; Antiviral Agents; Biological Availability; Female; HIV Infections; Humans; Injections, Intravenous; Liver Diseases; Male; Middle Aged; Zidovudine | 1995 |
Strategies for control of zidovudine concentrations in serum.
Topics: Adolescent; Adult; Antiviral Agents; Bayes Theorem; HIV Infections; Humans; Middle Aged; Models, Biological; Zidovudine | 1995 |
Zidovudine and lamivudine: results of phase III studies.
Topics: Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1995 |
Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Male; Rifabutin; Zidovudine | 1996 |
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
Topics: Adult; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Male; Quinolines; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Treatment Outcome; Zalcitabine; Zidovudine | 1996 |
Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; Humans; Interleukin-2; Lymphocyte Activation; Male; Polyethylene Glycols; RNA, Viral; Thymosin; Zidovudine | 1996 |
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.
Topics: Adult; Antiviral Agents; Base Sequence; Biomarkers; CD4 Lymphocyte Count; DNA Primers; Female; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; In Situ Hybridization; Lymph Nodes; Male; Molecular Sequence Data; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Time Factors; Virus Replication; Zidovudine | 1996 |
Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Zalcitabine; Zidovudine | 1996 |
Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. Canadian HIV Trials Network A002 Study Group.
Topics: Antiviral Agents; Bias; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Data Interpretation, Statistical; Didanosine; Double-Blind Method; HIV Infections; Humans; Patient Dropouts; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Zidovudine | 1996 |
Patterns of opportunistic infections in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cytomegalovirus Infections; Didanosine; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Mycobacterium avium-intracellulare Infection; Mycoses; Pneumonia, Pneumocystis; Prospective Studies; Retrospective Studies; Risk Factors; Survival Rate; Zidovudine | 1996 |
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.
Topics: AIDS Dementia Complex; Antiviral Agents; Child; Child, Preschool; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; HIV Core Protein p24; HIV Infections; Humans; Infant; Liver; Male; Neuropsychological Tests; Zidovudine | 1996 |
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Erythema; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1996 |
Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Rifabutin; Zidovudine | 1995 |
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Phenotype; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lamivudine; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease.
Topics: Administration, Oral; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; HIV Infections; Humans; Male; Mannans; Pilot Projects; Safety; Zidovudine | 1996 |
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Biopterins; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Core Protein p24; HIV Infections; Humans; Lamivudine; Male; Neopterin; Polymerase Chain Reaction; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Zalcitabine; Zidovudine | 1996 |
[Comparative study of the placenta from HIV+ mothers. Ultrastructural analysis].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Microscopy, Electron; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
Topics: Adolescent; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Survival Analysis; Zalcitabine; Zidovudine | 1996 |
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; RNA, Viral; Saquinavir; Zidovudine | 1996 |
Combination therapy with zidovudine, didanosine and saquinavir.
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Saquinavir; Zidovudine | 1996 |
D4T nucleoside combinations for HIV.
Topics: Adult; Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Stavudine; Zidovudine | 1996 |
Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients.
Topics: Acetamides; Acetophenones; Adult; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Cross-Over Studies; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lamivudine; Middle Aged; Pilot Projects; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii.
Topics: AIDS-Related Opportunistic Infections; Drug Interactions; Half-Life; HIV Infections; Humans; Male; Pyrimethamine; Toxoplasmosis; Zidovudine | 1996 |
Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.
Topics: Adolescent; Adult; Antiviral Agents; Biological Availability; Cidofovir; Cytosine; Double-Blind Method; Drug Administration Routes; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Zidovudine | 1996 |
Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
Topics: Adult; Antigens, CD; Antiviral Agents; Biomarkers; Biopterins; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Neopterin; Predictive Value of Tests; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Risk; Zidovudine | 1996 |
A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Activities of Daily Living; Adaptation, Psychological; AIDS-Related Complex; Combined Modality Therapy; Feasibility Studies; HIV Infections; Humans; Interferon-alpha; Netherlands; Psychological Tests; Psychometrics; Quality of Life; Reproducibility of Results; Sick Role; Treatment Outcome; Zidovudine | 1996 |
Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Didanosine; Drug Resistance; HIV Infections; HIV-1; Humans; Mutation; Zidovudine | 1996 |
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Nevirapine; Pyridines; Zidovudine | 1996 |
Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines.
Topics: Adult; Antiviral Agents; Cytokines; Didanosine; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Interferon-alpha; Interleukin-2; Male; Reference Standards; Reference Values; Therapeutic Equivalency; Zidovudine | 1996 |
Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
Topics: Adult; Antifungal Agents; Antiviral Agents; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1996 |
Will we ever know when to treat HIV infection?
Topics: Antiviral Agents; HIV Infections; Humans; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Zidovudine | 1996 |
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.
Topics: Adult; Anti-HIV Agents; Biological Availability; Delavirdine; Didanosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indoles; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Proportional Hazards Models; Treatment Outcome; Zidovudine | 1996 |
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Phenotype; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Virus Replication; Zidovudine | 1996 |
Turns-amplitude analysis assessment of myopathies in HIV-infected patients.
Topics: Adult; Aged; Antiviral Agents; Electromyography; HIV Infections; Humans; Middle Aged; Mitochondrial Myopathies; Muscle Contraction; Muscle, Skeletal; Muscular Diseases; Zidovudine | 1996 |
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Predictive Value of Tests; Proportional Hazards Models; RNA, Viral; Zidovudine | 1996 |
The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. Alpha International Coordinating Committee.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Tolerance; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Pancreatitis; Zidovudine | 1996 |
Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV Seropositivity; Humans; Male; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
Topics: Adjuvants, Immunologic; Adult; Antigen-Antibody Complex; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Predictive Value of Tests; Prognosis; Retrospective Studies; RNA, Viral; Thymopentin; Viral Load; Zidovudine | 1996 |
Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1.
Topics: Adult; Antiviral Agents; Blood Cell Count; Cohort Studies; Granulocyte Colony-Stimulating Factor; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Zidovudine | 1996 |
Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evaluation Studies as Topic; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Male; Prospective Studies; Zidovudine | 1996 |
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Genes, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Virus Replication; Zidovudine | 1996 |
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Candida albicans; CD4 Lymphocyte Count; Cross-Over Studies; Disease Progression; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Mumps; Poly I-C; Poly U; RNA, Double-Stranded; Skin Tests; Tetanus; Trichophyton; Zidovudine | 1996 |
Lack of beta-oxidation defects in human immunodeficiency virus-positive subjects with and without chronic zidovudine exposure.
Topics: Acids; Adolescent; Adult; Antiviral Agents; Fatty Acids, Nonesterified; Fatty Liver; Female; HIV Infections; Humans; Liver Failure; Male; Mass Screening; Middle Aged; Mitochondria, Liver; Oxidation-Reduction; Pilot Projects; Risk; Zidovudine | 1996 |
Low antituberculosis drug concentrations in patients with AIDS.
Topics: Adult; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Drug Interactions; Female; Fluconazole; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Zidovudine | 1996 |
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapy.
Topics: AIDS Vaccines; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Envelope Protein gp120; HIV Infections; Hypersensitivity, Delayed; Immunotherapy, Active; Viral Load; Zidovudine | 1996 |
Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine.
Topics: Adult; Aged; Anti-HIV Agents; Biopterins; Didanosine; HIV Infections; HIV-1; Humans; Immunoglobulin G; Middle Aged; Neopterin; Zidovudine | 1996 |
Analysis of uncontrolled treatment changes in HIV clinical trails.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; Clinical Trials as Topic; Confidence Intervals; Cross-Over Studies; Female; HIV Infections; Humans; Likelihood Functions; Male; Models, Statistical; Placebos; Zidovudine | 1996 |
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
Topics: Biomarkers; Cross-Sectional Studies; HIV Infections; HIV-1; Humans; Laboratories; Longitudinal Studies; Reproducibility of Results; RNA, Viral; Viremia; Virology; Virus Replication; Zidovudine | 1996 |
Predicting progression to AIDS. An evaluation of two approaches.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Evaluation Studies as Topic; Female; HIV Infections; Humans; Male; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Zidovudine | 1996 |
CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
Topics: Acetamides; Acetophenones; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Lamivudine; Lymphocyte Count; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zalcitabine; Zidovudine | 1996 |
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Zidovudine | 1996 |
Should we embrace new drugs with open arms? Experience from a community-based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease.
Topics: Adult; Anti-HIV Agents; British Columbia; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Patient Selection; Practice Patterns, Physicians'; Prospective Studies; Zalcitabine; Zidovudine | 1996 |
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Viral Load; Zalcitabine; Zidovudine | 1996 |
Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV).
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Animals; Anti-HIV Agents; Cytokines; HIV Infections; HIV-1; Humans; Mice; Mice, Inbred BALB C; Sensitivity and Specificity; Th1 Cells; Th2 Cells; Transfer Factor; Zidovudine | 1996 |
Mismatch negativity: an index of subclinical neurological differences in HIV patients during rapid perceptual processing.
Topics: Adult; Anti-HIV Agents; Attention; Auditory Perception; Discriminant Analysis; Evoked Potentials, Auditory; HIV Infections; Humans; Male; Neuropsychological Tests; Zidovudine | 1997 |
The treatment of antiretroviral-naive subjects with the 3TC/zidovudine combination: a review of North American (NUCA 3001) and European (NUCB 3001) trials.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Europe; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; North America; Viral Load; Zidovudine | 1996 |
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Nausea; Neutropenia; Stavudine; Vomiting; Zidovudine | 1997 |
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.
Topics: Adolescent; Adult; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Disease Progression; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; United States; Zidovudine | 1997 |
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.
Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Resistance, Microbial; Genotype; HIV Infections; HIV Reverse Transcriptase; Humans; Mutation; Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1997 |
Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Biological Availability; Didanosine; Dideoxynucleotides; HIV Infections; Humans; Infusions, Intravenous; Male; Zidovudine | 1997 |
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Microbial; Female; HIV Infections; Humans; Immunocompromised Host; Italy; Male; Middle Aged; Multivariate Analysis; Pancreatitis; Treatment Outcome; Zidovudine | 1997 |
Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cause of Death; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Infant; Male; Neutropenia; Survival Rate; Time Factors; Zalcitabine; Zidovudine | 1997 |
Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-CD8 Ratio; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocytes; Male; Pilot Projects; Proviruses; RNA, Viral; Zidovudine | 1997 |
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.
Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pyridines; RNA, Viral; Viral Load; Zidovudine | 1997 |
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Plasma; Polymerase Chain Reaction; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 1997 |
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Dendritic Cells; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Image Processing, Computer-Assisted; In Situ Hybridization; Kinetics; Lamivudine; Leukocytes, Mononuclear; Macrophages; Palatine Tonsil; Proviruses; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Viral Load; Virus Replication; Zidovudine | 1997 |
Additive or sequential nucleoside analogue therapy compared with continued zidovudine monotherapy in human immunodeficiency virus-infected patients with advanced disease does not prolong survival: an observational study.
Topics: Adult; Age Factors; Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Treatment Outcome; Zalcitabine; Zidovudine | 1997 |
Alternating treatment with didanosine and zidovudine versus either drug alone for the treatment of advanced HIV infection. The Alter Study. Nordic HIV Therapy Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1997 |
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Disease Progression; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Treatment Outcome; Zidovudine | 1997 |
Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group.
Topics: Adolescent; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Zalcitabine; Zidovudine | 1997 |
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Didanosine; Disease Progression; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Risk; Zidovudine | 1997 |
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
Topics: Adult; Anti-HIV Agents; Antigens, Viral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Homeostasis; Humans; Immunologic Memory; Lymphocyte Activation; Lymphocyte Count; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Tuberculin; Viral Load; Viremia; Zalcitabine; Zidovudine | 1997 |
Impact of treatment changes on the interpretation of the Concorde trial.
Topics: Acquired Immunodeficiency Syndrome; Disease Progression; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Treatment Outcome; Zidovudine | 1997 |
No therapeutic advantage from didanosine (ddI) and hydroxyurea versus ddI alone in patients with HIV infection.
Topics: CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; RNA, Viral; Treatment Outcome; Viremia; Zidovudine | 1997 |
Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Topics: Adult; Anti-HIV Agents; Anti-Infective Agents; Double-Blind Method; Drug Interactions; HIV Infections; Humans; Levofloxacin; Male; Ofloxacin; Zidovudine | 1997 |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1997 |
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine | 1997 |
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.
Topics: Adult; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Zidovudine | 1997 |
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating Committee.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, pol; HIV Infections; HIV-1; Humans; Point Mutation; Prospective Studies; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 1997 |
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.
Topics: Adolescent; Adult; Anti-HIV Agents; Antibodies, Monoclonal; CD3 Complex; Cytotoxicity Tests, Immunologic; Double-Blind Method; Female; Flow Cytometry; HIV Antigens; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Immunity, Active; Immunity, Cellular; Immunologic Memory; Male; Middle Aged; Recombinant Proteins; RNA, Viral; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Vaccination; Vaccines, Synthetic; Viral Proteins; Viremia; Zidovudine | 1997 |
Primary HIV infection: follow-up of patients initially randomized to zidovudine or placebo.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Follow-Up Studies; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymph Nodes; RNA, Viral; Viral Load; Zidovudine | 1997 |
Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Male; Metabolic Clearance Rate; Middle Aged; Saquinavir; Zalcitabine; Zidovudine | 1997 |
Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; RNA, Viral; Saquinavir; Zalcitabine; Zidovudine | 1997 |
Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Appetite Stimulants; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Half-Life; HIV Infections; Humans; Male; Megestrol Acetate; Middle Aged; Radioimmunoassay; Zidovudine | 1997 |
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Patient Compliance; Patient Dropouts; Treatment Refusal; Zidovudine | 1997 |
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nucleosides; Prospective Studies; Protease Inhibitors; Risk Factors; Survival Analysis; Treatment Outcome; Zidovudine | 1997 |
Predicting outcomes in HIV-infected veterans: I. Progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Markov Chains; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; Veterans; Zidovudine | 1997 |
Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatment.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Neutralization Tests; RNA, Viral; Saquinavir; Time Factors; Viral Load; Zidovudine | 1997 |
A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.
Topics: Anti-HIV Agents; Bias; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Male; Neutropenia; Stavudine; Zidovudine | 1998 |
Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Interleukin-2; Leukocyte Common Antigens; Male; Pilot Projects; RNA, Viral; Viremia; Zidovudine | 1998 |
Induction of specific T-cell responses in HIV infection.
Topics: AIDS Vaccines; Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; HIV Antigens; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Receptors, Antigen, T-Cell, alpha-beta; Receptors, CCR5; T-Lymphocytes; Vaccination; Vaccines, Synthetic; Viral Load; Zidovudine | 1998 |
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphoid Tissue; Male; Palatine Tonsil; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 1998 |
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators.
Topics: Adult; AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Lymphocyte Count; Male; Middle Aged; Treatment Outcome; Vaccination; Viral Load; Zidovudine | 1998 |
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Male; Ritonavir; Viral Load; Zidovudine | 1998 |
Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Antiviral Agents; Area Under Curve; Didanosine; Drug Interactions; Female; Ganciclovir; Half-Life; HIV Infections; Humans; Male; Probenecid; Renal Agents; Zidovudine | 1998 |
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.
Topics: Clinical Protocols; Disease Susceptibility; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Pregnancy; Treatment Failure; Zidovudine | 1998 |
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
Topics: Adult; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Disease Progression; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Multivariate Analysis; Prognosis; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1998 |
Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy.
Topics: Amino Acid Sequence; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymph Nodes; Molecular Sequence Data; Mutation; RNA, Viral; Viral Load; Virus Replication; Zidovudine | 1998 |
Short course of AZT halves HIV-1 perinatal transmission.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1998 |
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
Topics: Aging; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Point Mutation; Quality Control; RNA, Viral; Viral Load; Viremia; Zidovudine | 1998 |
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mutation; Predictive Value of Tests; Retrospective Studies; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 1998 |
The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1998 |
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
Topics: Adolescent; Adult; AIDS Vaccines; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Double-Blind Method; Female; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Lymphocytes; Male; Middle Aged; RNA, Viral; Time Factors; Vaccines, Synthetic; Viremia; Zidovudine | 1998 |
Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pilot Projects; RNA, Viral; Viral Load; Zidovudine | 1998 |
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 1998 |
Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Topics: Anti-HIV Agents; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; Humans; Interferon-beta; Sarcoma, Kaposi; Zidovudine | 1998 |
Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus.
Topics: Aging; Antiviral Agents; Female; Gestational Age; Half-Life; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Male; Zidovudine | 1998 |
[Efficacy and safety of zidovudine in monotherapy in patients with HIV infection].
Topics: Adult; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; Male; Retrospective Studies; Survival Analysis; Treatment Outcome; Zidovudine | 1998 |
[Efficacy of combining zidovudine plus didanosine in patients with and without previous exposure to zidovudine].
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Viral Load; Zidovudine | 1998 |
Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Interferon-alpha; Male; Prospective Studies; Sarcoma, Kaposi; Zidovudine | 1998 |
Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life.
Topics: Adult; Anti-Bacterial Agents; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Quality of Life; Treatment Outcome; Zalcitabine; Zidovudine | 1998 |
Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cell Count; Cells, Cultured; Cross-Sectional Studies; Dendritic Cells; Flow Cytometry; HIV Infections; HIV-1; Humans; Viral Load; Zidovudine | 1998 |
A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
Topics: Adolescent; Adult; Biological Availability; Capsules; CD4 Lymphocyte Count; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Suspensions; Viral Load; Virus Replication; Zidovudine | 1998 |
Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy.
Topics: Anti-HIV Agents; Cell Line, Transformed; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Viral Load; Zidovudine | 1998 |
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
Topics: Adult; Anti-HIV Agents; Antigens; B-Lymphocytes; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypersensitivity, Delayed; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Time Factors; Zidovudine | 1998 |
Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative.
Topics: Adolescent; Adult; Anti-HIV Agents; Blotting, Western; CD4 Lymphocyte Count; Double-Blind Method; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Male; Patient Compliance; Phenotype; Placebos; Viral Load; Zidovudine | 1998 |
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Viral Load; Zidovudine | 1998 |
Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire.
Topics: Adult; Anti-HIV Agents; Cote d'Ivoire; Double-Blind Method; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Dropouts; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee.
Topics: Anti-HIV Agents; Follow-Up Studies; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1998 |
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
Topics: Administration, Oral; Adult; Anti-HIV Agents; Area Under Curve; Biological Availability; Female; Heroin Dependence; HIV Infections; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Methadone; Narcotics; Zidovudine | 1998 |
Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
Topics: Anti-HIV Agents; Base Sequence; Didanosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Proviruses; Reverse Transcriptase Inhibitors; Viral Load; Zalcitabine; Zidovudine | 1998 |
Correlation of response to treatment and HIV genotypic changes during phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy.
Topics: Amino Acid Sequence; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Treatment Outcome; Zalcitabine; Zidovudine | 1998 |
Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Models, Theoretical; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 1998 |
An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
Topics: Adult; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Homosexuality, Male; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 1998 |
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; Giant Cells; HIV Infections; HIV-1; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Phenotype; Probability; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Load; Zalcitabine; Zidovudine | 1998 |
A "bloodless cesarean section" and perinatal transmission of the human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Blood Loss, Surgical; Cesarean Section; Cohort Studies; Delivery, Obstetric; Female; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Prospective Studies; Zidovudine | 1998 |
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
Topics: Anti-HIV Agents; Australia; Canada; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Italy; Netherlands; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1998 |
Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals.
Topics: Adult; Anti-HIV Agents; CD4-CD8 Ratio; Cohort Studies; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Observation; Risk Factors; Ritonavir; Saquinavir; Treatment Failure; Viral Load; Zidovudine | 1998 |
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.
Topics: Administration, Oral; Adolescent; Adult; Amniotic Fluid; Anti-HIV Agents; Black People; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Pregnancy; Random Allocation; RNA, Viral; South Africa; Viral Load; Zidovudine | 1998 |
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
Topics: Adolescent; Anti-HIV Agents; CD4 Antigens; Child; Child, Preschool; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Neurodegenerative Diseases; Polymerase Chain Reaction; RNA, Viral; Survival Rate; Zidovudine | 1998 |
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Multivariate Analysis; Remission Induction; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 1998 |
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Remission Induction; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 1998 |
A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1998 |
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.
Topics: Anti-HIV Agents; Disease Progression; Double-Blind Method; Female; France; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnancy Outcome; United States; Zidovudine | 1998 |
[Efficacy and tolerance of a combination of AZT, DDC, and saquinavir in patients infected with the human immunodeficiency virus].
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Saquinavir; Zalcitabine; Zidovudine | 1998 |
Coadministration of zidovudine and interleukin-2 increases absolute CD4 cells in subjects with Walter Reed stage 2 human immunodeficiency virus infection: results of ACTG protocol 042.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Protocols; Drug Therapy, Combination; HIV Infections; Humans; Injections, Intravenous; Injections, Subcutaneous; Interleukin-2; Pilot Projects; Zidovudine | 1998 |
Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
Topics: Anti-HIV Agents; Clinical Protocols; Cohort Studies; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Male; Multivariate Analysis; New York; Polymerase Chain Reaction; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Retrospective Studies; Risk; Zidovudine | 1998 |
Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapy.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Prognosis; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Viral Load; Zidovudine | 1998 |
A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Treatment Outcome; Zalcitabine; Zidovudine | 1998 |
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; RNA, Viral; Saquinavir; Zidovudine | 1998 |
Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
Topics: Anti-HIV Agents; Antigens, CD; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Immunophenotyping; Indinavir; Lamivudine; Lymphocyte Activation; Statistics, Nonparametric; T-Lymphocyte Subsets; Viral Load; Zidovudine | 1998 |
Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro.
Topics: Adenine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Lamivudine; Organophosphonates; Point Mutation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1999 |
Efficacy of zidovudine in preventing HIV transmission from mother to infant.
Topics: Anti-HIV Agents; DNA, Viral; Female; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Treatment Outcome; Zidovudine | 1997 |
Zidovudine safety and tolerance among uninfected healthcare workers: a brief update.
Topics: Anti-HIV Agents; Confounding Factors, Epidemiologic; Health Personnel; HIV Infections; Humans; Occupational Exposure; Prospective Studies; Research Design; Zidovudine | 1997 |
Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Injections, Subcutaneous; Interleukin-2; Lamivudine; Male; Prospective Studies; Quality of Life; Reverse Transcriptase Inhibitors; Saquinavir; Viral Load; Zidovudine | 1998 |
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Models, Biological; Nevirapine; Zidovudine | 1999 |
Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
Topics: Anti-HIV Agents; Base Sequence; Child; Codon; Didanosine; DNA Primers; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.
Topics: Adult; Amino Acid Substitution; Anti-HIV Agents; CD4 Lymphocyte Count; DNA Mutational Analysis; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mutation; RNA, Viral; Zalcitabine; Zidovudine | 1999 |
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child Development; Child, Preschool; Echocardiography; Female; Growth; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Vision Tests; Zidovudine | 1999 |
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Topics: Adult; Anti-HIV Agents; Birth Weight; Cesarean Section; Delivery, Obstetric; Female; Gestational Age; HIV Antibodies; HIV Infections; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Puerto Rico; United States; Zidovudine | 1999 |
Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; Humans; Infant; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zidovudine | 1999 |
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Quinoxalines; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1999 |
Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy.
Topics: Adult; Anti-HIV Agents; Canada; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Statistics, Nonparametric; Treatment Outcome; United States; Zidovudine | 1998 |
[Increased serum level of naive CD8+-T-cells during intensive antiretroviral therapy].
Topics: Antiviral Agents; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Saquinavir; Zidovudine | 1998 |
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Furans; HIV Infections; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Sulfonamides; Zidovudine | 1999 |
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Delavirdine; Drug Therapy, Combination; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1999 |
Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Community Health Services; Consumer Product Safety; Drug Therapy, Combination; Female; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.
Topics: CD4 Lymphocyte Count; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 1999 |
An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 1999 |
HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Predictive Value of Tests; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zalcitabine; Zidovudine | 1999 |
[Experiences with antiretroviral combination therapy].
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; N-Glycosyl Hydrolases; Retrospective Studies; Ritonavir; RNA, Viral; Zidovudine | 1999 |
[Long-term observation on children. HIV-positive pregnant women: AZT therapy to be continued].
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1999 |
Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211).
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Interferon-gamma; Male; Neutrophils; Recombinant Proteins; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1999 |
Long-term prognosis following zidovudine monotherapy in primary human immunodeficiency virus type 1 infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; HIV Infections; HIV Long-Term Survivors; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Reverse Transcriptase Inhibitors; Sexual Behavior; Zidovudine | 1999 |
Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.
Topics: Adolescent; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Immunophenotyping; Infant; Leukocyte Common Antigens; Lymphocyte Subsets; Ritonavir; Viral Load; Zidovudine | 1999 |
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
Topics: Adult; AIDS Dementia Complex; Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Drug Combinations; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lamivudine; Middle Aged; RNA, Viral; Spinal Puncture; Stavudine; Zidovudine | 1998 |
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).
Topics: Adult; Anti-HIV Agents; Capsules; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Gelatin; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Treatment Outcome; Zidovudine | 1999 |
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 1999 |
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Quality of Life; Reverse Transcriptase Inhibitors; Saquinavir; Treatment Outcome; Zalcitabine; Zidovudine | 1999 |
Zidovudine and reduction of vertical transmission of HIV in Africa. ANRS 049 Trial Group.
Topics: Anti-HIV Agents; Breast Feeding; Burkina Faso; Cote d'Ivoire; Counseling; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Zidovudine | 1999 |
[Response of fetal macrophages in the placenta of pregnant HIV-positive patients with and without antiretroviral treatment].
Topics: Antiviral Agents; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Macrophages; Pregnancy; Pregnancy Complications, Infectious; Retroviridae; Zidovudine | 1999 |
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infusions, Intravenous; Injections, Subcutaneous; Interleukin-2; Male; Time Factors; Zidovudine | 1999 |
Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Cross-Over Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Zidovudine | 1999 |
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Prospective Studies; RNA, Viral; T-Lymphocyte Subsets; Viremia; Zidovudine | 1999 |
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viremia; Zidovudine | 1999 |
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1999 |
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Invest
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load; Zidovudine | 1999 |
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication.
Topics: Anti-HIV Agents; Apoptosis; Cell Cycle; Cross-Sectional Studies; DNA; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocytes; Ritonavir; RNA, Viral; Viral Load; Virus Replication; Zidovudine | 1999 |
Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.
Topics: Adult; Amines; Anti-HIV Agents; Antibiotics, Antitubercular; Area Under Curve; Biotransformation; Drug Interactions; Female; Glucuronates; Half-Life; HIV Infections; Humans; Male; Rifampin; Zidovudine | 1999 |
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Delavirdine; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Safety; Zidovudine | 1999 |
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Topics: Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; RNA, Viral; Viral Load; Zidovudine | 1999 |
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection.
Topics: Adolescent; AIDS Vaccines; Anti-HIV Agents; Child; Child, Preschool; Combined Modality Therapy; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Male; RNA, Viral; Safety; Time Factors; Zidovudine | 1999 |
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Survival Rate; Zidovudine | 1999 |
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Viral Load; Zidovudine | 1999 |
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1999 |
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Burkina Faso; Cote d'Ivoire; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Pregnancy; Treatment Outcome; Zidovudine | 1999 |
Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team.
Topics: Adolescent; Analysis of Variance; Anti-HIV Agents; Brain; Central Nervous System Diseases; Child; Child, Preschool; Cognition; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Intelligence Tests; Male; Motor Skills; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.
Topics: Adult; Alanine Transaminase; Comorbidity; Drug Therapy, Combination; Female; Flaviviridae; Hepatitis, Viral, Human; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Male; Middle Aged; Prevalence; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1999 |
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial.
Topics: Anti-HIV Agents; Confidence Intervals; Drug Therapy, Combination; Female; France; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Male; Ritonavir; RNA, Viral; Viral Load; Zidovudine | 1999 |
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Interleukin-2; Lamivudine; Lymphocyte Activation; Male; T-Lymphocytes; Thalidomide; Viral Load; Zidovudine | 1999 |
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 1999 |
Long-term effects of antiretroviral combination therapy on HIV type 1 DNA levels.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Data Interpretation, Statistical; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; RNA, Viral; Stavudine; Time Factors; Zidovudine | 1999 |
Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes.
Topics: Anti-HIV Agents; Child; Child, Preschool; Codon; Didanosine; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluorescent Dyes; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Zidovudine | 1999 |
Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen.
Topics: AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; DNA, Viral; Drug Therapy, Combination; Freund's Adjuvant; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Monocytes; Pilot Projects; RNA, Viral; T-Lymphocytes, Helper-Inducer; Viral Load; Zidovudine | 1999 |
Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Nelfinavir; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 1999 |
Long-term pattern of HIV-1 RNA load in perinatally infected children.
Topics: CD4 Lymphocyte Count; Child, Preschool; Disease Progression; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Male; Monitoring, Physiologic; Pregnancy; Prospective Studies; Risk Factors; RNA, Viral; Sensitivity and Specificity; Statistics, Nonparametric; Sweden; Viral Load; Viremia; Zidovudine | 1999 |
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Phenotype; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1999 |
Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1999 |
Lamivudine reduces healthcare resource use when added to zidovudine-containing regimens in patients with HIV infection.
Topics: Adult; Ambulatory Care; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; Health Resources; HIV Infections; Hospitalization; Humans; Lamivudine; Length of Stay; Male; Zidovudine | 1999 |
A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.
Topics: Adult; Ambulatory Care; Anti-HIV Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Health Resources; HIV Infections; Hospitalization; Humans; Lamivudine; Length of Stay; Male; Middle Aged; Prospective Studies; United States; Zidovudine | 1999 |
A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective.
Topics: Adult; Ambulatory Care; Anti-HIV Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Europe; Female; Health Care Costs; Health Resources; HIV Infections; Hospitalization; Humans; Lamivudine; Male; Prospective Studies; Zidovudine | 1999 |
An evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing regimens in HIV infection. Canadian perspective.
Topics: Adult; Ambulatory Care; Anti-HIV Agents; Canada; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Health Resources; HIV Infections; Hospitalization; Humans; Lamivudine; Male; Prospective Studies; Zidovudine | 1999 |
Quality of life and treatment satisfaction after the addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens in treatment-experienced patients with HIV infection.
Topics: Acetamides; Acetophenones; Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Patient Satisfaction; Quality of Life; Zidovudine | 1999 |
Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group.
Topics: Anti-HIV Agents; Body Weight; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Male; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk Factors; Treatment Failure; Zidovudine | 1999 |
Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry.
Topics: Adult; Aged; Anti-HIV Agents; Calibration; Cells, Cultured; Chromatography, High Pressure Liquid; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Mass Spectrometry; Middle Aged; Monocytes; Nucleotides; Reference Standards; Thymine Nucleotides; Zidovudine | 1999 |
Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis.
Topics: Adult; Anti-HIV Agents; Apoptosis; Caspase 1; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Ceramides; Didanosine; Drug Therapy, Combination; fas Receptor; HIV Infections; HIV-1; Humans; Male; Mitochondria; Viral Load; Viremia; Zidovudine | 1999 |
Zidovudine prophylaxis and perinatal HIV-1 transmission.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Female; Gestational Age; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Injections, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Treatment Outcome; Zidovudine | 1999 |
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Palatine Tonsil; Ritonavir; RNA, Viral; Spain; Stavudine; Viremia; Zalcitabine; Zidovudine | 1999 |
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; RNA, Viral; Safety; Sulfonamides; Time Factors; Viremia; Zidovudine | 1999 |
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1999 |
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons.
Topics: Anti-HIV Agents; Complement Pathway, Classical; Complement System Proteins; Drug Administration Schedule; Drug Therapy, Combination; HIV Antibodies; HIV Antigens; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 1999 |
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
Topics: Anti-HIV Agents; Antigens, CD; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV Seronegativity; HIV-1; Humans; Indinavir; Ki-67 Antigen; Lamivudine; Longitudinal Studies; Lymphocyte Activation; RNA, Viral; Saquinavir; T-Lymphocyte Subsets; T-Lymphocytes; Viral Load; Zidovudine | 2000 |
Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Topics: Cervix Uteri; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Trimester, Third; Risk Factors; RNA, Viral; Thailand; Vagina; Viral Load; Zidovudine | 2000 |
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
Topics: Anti-HIV Agents; Candida; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Immune System; Lamivudine; Mumps virus; Ritonavir; RNA, Viral; Zidovudine | 2000 |
Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.
Topics: Amino Acid Substitution; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Zidovudine | 1999 |
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
Topics: Anti-HIV Agents; Case-Control Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Patient Compliance; Treatment Failure; Viral Load; Zidovudine | 2000 |
15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.
Topics: Administration, Oral; Anti-HIV Agents; Breast Feeding; Burkina Faso; Cote d'Ivoire; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 1999 |
HIV-1 therapy and fetal mitochondrial dysfunction.
Topics: Anti-HIV Agents; Electron Transport; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mitochondrial Myopathies; Pregnancy; Zidovudine | 1999 |
Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.
Topics: Adult; Anti-HIV Agents; beta 2-Microglobulin; Chemokine CCL2; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Middle Aged; Receptors, Tumor Necrosis Factor; Solubility; Stavudine; Zidovudine | 2000 |
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2000 |
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Viral Load; Zidovudine | 2000 |
RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Chemokine CCL5; Gene Expression; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Single-Blind Method; T-Lymphocytes; Viral Load; Virus Replication; Zidovudine | 2000 |
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lamivudine; Logistic Models; Mutation; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 2000 |
AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients. AVANTI Study Group.
Topics: Acetamides; Acetophenones; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Zidovudine | 1999 |
Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphoid Tissue; Male; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Time Factors; Viral Load; Zidovudine | 2000 |
HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy.
Topics: Cohort Studies; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
Effects of ZDV-based patient education on intentions toward ZDV use, HIV testing and reproduction among a US cohort of women.
Topics: Anti-HIV Agents; Cohort Studies; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pamphlets; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1999 |
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Topics: Adult; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Viral Load; Zidovudine | 1999 |
Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients.
Topics: Adult; Anti-HIV Agents; Antigens, CD; Bacteriophage phi X 174; Flow Cytometry; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunophenotyping; Lymphocyte Activation; Reverse Transcriptase Inhibitors; Viral Vaccines; Zidovudine | 2000 |
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Patient Compliance; Placebos; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
[Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Zidovudine | 2000 |
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; Sex Characteristics; Zidovudine | 2000 |
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nausea; Pregnancy; Pregnancy Complications, Infectious; Radioimmunoassay; Thailand; Viral Load; Vomiting; Zidovudine | 2000 |
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
Topics: Adult; Carbamates; Double-Blind Method; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Regression Analysis; RNA, Viral; Semen; Sulfonamides; Virus Shedding; Zidovudine | 2000 |
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Female; HIV Infections; Humans; Male; Middle Aged; Thailand; Treatment Outcome; Zidovudine | 2000 |
Nevirapine and perinatal transmission.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; South Africa; Treatment Outcome; Zidovudine | 2000 |
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Patient Compliance; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2000 |
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Injections, Subcutaneous; Interleukin-2; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 2000 |
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine | 2000 |
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
Topics: Adult; Alleles; Anti-HIV Agents; Chemokine CXCL12; Chemokines, CXC; Drug Therapy, Combination; Female; Gene Frequency; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Linkage Disequilibrium; Male; Polymorphism, Genetic; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Receptors, Cytokine; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2000 |
Maternal vitamin A status and mother-to-child transmission of HIV in West Africa. DITRAME Study Group.
Topics: Adult; Africa, Western; Anti-HIV Agents; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Retinol-Binding Proteins; Reverse Transcriptase Inhibitors; Vitamin A; Vitamin A Deficiency; Zidovudine | 2000 |
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Multivariate Analysis; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Zalcitabine; Zidovudine | 2000 |
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Netherlands; Prospective Studies; Zidovudine | 2000 |
Caesarean section and antiretroviral treatment. Italian trial on mode of delivery in HIV-positive women study group.
Topics: Anti-HIV Agents; Cesarean Section; Delivery, Obstetric; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 2000 |
Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers.
Topics: Adult; Anti-HIV Agents; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Phosphorylation; Reverse Transcriptase Inhibitors; Thailand; Thymine Nucleotides; Zidovudine | 2000 |
Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection.
Topics: Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cytokines; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Prospective Studies; Reverse Transcriptase Inhibitors; Th1 Cells; Viremia; Zidovudine | 2000 |
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Indinavir; Kidney Calculi; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Viremia; Zidovudine | 2000 |
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Disease Progression; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Multivariate Analysis; Outcome Assessment, Health Care; Perinatal Care; Prenatal Care; RNA, Viral; Zidovudine | 2000 |
In vivo antagonism with zidovudine plus stavudine combination therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; RNA, Viral; Stavudine; Zidovudine | 2000 |
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Australia; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Stavudine; Viral Load; Zidovudine | 2000 |
Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults.
Topics: Adolescent; Adult; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Zidovudine | 2000 |
The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment.
Topics: Alleles; Anti-HIV Agents; Child, Preschool; Clinical Trials as Topic; Didanosine; Disease Progression; Disease-Free Survival; Ethnicity; Gene Frequency; HIV Infections; HIV-1; Humans; Racial Groups; Receptors, CCR5; Sequence Deletion; Zidovudine | 2000 |
Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL.
Topics: Adult; Blood Transfusion; CD4 Immunoadhesins; CD4 Lymphocyte Count; Cesarean Section; Chorioamnionitis; Cohort Studies; Delivery, Obstetric; Endometritis; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Immunoglobulins, Intravenous; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Infectious; Wound Infection; Zidovudine | 2000 |
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lymphocyte Count; Male; RNA, Viral; Thailand; Zalcitabine; Zidovudine | 2000 |
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Female; Fetal Growth Retardation; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2000 |
Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Area Under Curve; Glucuronides; HIV Infections; HIV-1; Humans; Male; Semen; Zidovudine | 2000 |
Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy.
Topics: Adolescent; CD4-Positive T-Lymphocytes; Cell Differentiation; Child; Coculture Techniques; Female; HIV Infections; HIV-1; Humans; Immunophenotyping; Infant; Lamivudine; Leukocytes, Mononuclear; Male; Nelfinavir; Prospective Studies; Receptors, CCR5; Receptors, CXCR4; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Virus Replication; Zidovudine | 2000 |
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Patient Compliance; Zidovudine | 2000 |
Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues.
Topics: Acetamides; Acetophenones; Anti-HIV Agents; Codon; DNA; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Nucleosides; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 2000 |
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Giant Cells; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 2000 |
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Zidovudine | 2000 |
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Viral Load; Zidovudine | 2000 |
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2000 |
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Female; HIV Infections; Humans; Liver; Male; Nucleosides; Prospective Studies; Sex Characteristics; Zalcitabine; Zidovudine | 2000 |
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Thailand; Zidovudine | 2000 |
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zalcitabine; Zidovudine | 2000 |
Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy. The AI454-147 Team.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Zidovudine | 2000 |
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group.
Topics: Anti-HIV Agents; Delavirdine; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Treatment Outcome; Zidovudine | 2000 |
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cytidine Triphosphate; Dideoxynucleotides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Middle Aged; Prospective Studies; Regression Analysis; Reverse Transcriptase Inhibitors; RNA, Viral; Thymine Nucleotides; Zidovudine | 2000 |
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early An
Topics: Adult; Blood; CD4 Lymphocyte Count; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Palatine Tonsil; Point Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Stavudine; Time Factors; Viral Load; Zidovudine | 2000 |
HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; Health Personnel; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.
Topics: Adolescent; Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Furans; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Sulfonamides; Zidovudine | 2000 |
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Nevirapine; Quality of Life; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2000 |
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients.
Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Pilot Projects; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2000 |
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.
Topics: Adult; Algorithms; Anti-HIV Agents; Area Under Curve; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Patient Compliance; Zidovudine | 2001 |
Antiretroviral treatment induces a shift to type-2 cytokine responses in HIV-1 infected pregnant women.
Topics: Anti-HIV Agents; Cross-Sectional Studies; Cytokines; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Phytohemagglutinins; Pregnancy; Pregnancy Complications, Infectious; T-Lymphocyte Subsets; Th2 Cells; Zidovudine | 2000 |
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection.
Topics: Adult; Anti-HIV Agents; Cesarean Section; Chemoprevention; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Logistic Models; Male; Pregnancy; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Homosexuality; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; White People; Zidovudine | 2001 |
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2001 |
Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1.
Topics: Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; Flow Cytometry; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Immunodominant Epitopes; Immunohistochemistry; Immunophenotyping; Indinavir; Lamivudine; Leukocyte Common Antigens; Prospective Studies; Protein Tyrosine Phosphatase, Non-Receptor Type 1; T-Lymphocytes, Cytotoxic; Viral Load; Zidovudine | 2001 |
Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.
Topics: Adolescent; Anti-HIV Agents; Area Under Curve; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Flow Cytometry; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Viral Load; Zidovudine | 2001 |
Lack of an effect of azithromycin on the disposition of zidovudine and dideoxyinosine in HIV-infected patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-HIV Agents; Azithromycin; Didanosine; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 2001 |
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Resistance, Microbial; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Survival Analysis; Therapeutic Equivalency; Viral Load; Zidovudine | 2001 |
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
Topics: Adolescent; Anti-HIV Agents; CD4 Antigens; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Leukocyte Common Antigens; Male; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA, Viral; Viral Load; Zidovudine | 2001 |
Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
Topics: Adult; Anti-HIV Agents; Central Nervous System Diseases; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Motor Skills; Stavudine; Zalcitabine; Zidovudine | 2001 |
Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
Topics: Africa; Breast Feeding; Case-Control Studies; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Viremia; Zidovudine | 2001 |
An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial.
Topics: Adult; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Ritonavir; Sample Size; Saquinavir; Stavudine; Zidovudine | 2001 |
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
Topics: Adult; Area Under Curve; Cross-Over Studies; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Half-Life; HIV Infections; HIV-1; Humans; Lamivudine; Male; Metabolic Clearance Rate; Reverse Transcriptase Inhibitors; Tablets; Zidovudine | 2001 |
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2001 |
Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Capsules; CD4 Lymphocyte Count; Chemistry, Pharmaceutical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Mental Disorders; Patient Compliance; Pilot Projects; Proportional Hazards Models; Reverse Transcriptase Inhibitors; Saquinavir; Substance Abuse, Intravenous; Transients and Migrants; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Chronic Disease; Dideoxynucleosides; Digestive System; Drug Synergism; Ethnicity; Female; Furans; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Subsets; Male; Pregnancy; Research Design; RNA, Viral; Sulfonamides; Treatment Refusal; Zidovudine | 2001 |
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Codon; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Multivariate Analysis; Mutation; Nausea; Neutropenia; Pilot Projects; RNA, Viral; Survival Analysis; Zidovudine | 1996 |
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Zidovudine | 1996 |
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; RNA, Viral; Saquinavir; Zidovudine | 1996 |
The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; Humans; Male; Severity of Illness Index; Sickness Impact Profile; Survival Analysis; Time Factors; Treatment Outcome; Zidovudine | 1996 |
Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Male; Middle Aged; Zidovudine | 1997 |
Once versus twice daily administration of didanosine in children with symptomatic HIV-associated disease who were intolerant to or clinically deteriorated on zidovudine. The Italian Pediatric Collaborative Study Group on Didanosine.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Male; Zidovudine | 1997 |
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290).
Topics: Adult; Anti-HIV Agents; Food; HIV Infections; Humans; Lipids; Male; Middle Aged; Zidovudine | 1997 |
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial.
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Lipids; Male; Middle Aged; RNA, Viral; Zidovudine | 1997 |
FDA Committee recommends clearance for HIVID combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
Phase II/III Trials of Viracept start.
Topics: Anti-HIV Agents; Blood; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Nelfinavir; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine; Sulfonic Acids; Time Factors; Zidovudine | 1996 |
Protease inhibitor combination.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Viral Load; Zidovudine | 1996 |
Medication therapy among intravenous drug users (IDUs) with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Attitude to Health; Female; HIV Infections; Humans; Interpersonal Relations; Life Style; Longitudinal Studies; Male; Middle Aged; Patient Compliance; Prospective Studies; Substance Abuse, Intravenous; Zidovudine | 1996 |
Final CESARE trial results show continued clinical and survival benefit.
Topics: Acetamides; Acetophenones; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Controlled Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Survival Rate; Zalcitabine; Zidovudine | 1997 |
Viramune triple combo reduces viral load below limit of detection.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine | 1997 |
Efavirenz shows promising results.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Oxazines; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Sustiva added to three-drug combination.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 1998 |
Indinavir gender study shows consistency.
Topics: Anti-HIV Agents; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Reverse Transcriptase Inhibitors; Sex Factors; Zidovudine | 1998 |
Phase III results presented on amprenavir triple combination.
Topics: Anti-HIV Agents; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Sulfonamides; Zidovudine | 1998 |
AZT: pediatric study changed after worse monotherapy survival.
Topics: Adolescent; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Survival Analysis; Zidovudine | 1995 |
Treatment for HIV-related inflammation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Hydroxychloroquine; Inflammation; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Reappraising d4T.
Topics: CD4 Lymphocyte Count; HIV; HIV Infections; Humans; Randomized Controlled Trials as Topic; Stavudine; Zidovudine | 1995 |
Major study shows AZT monotherapy inferior.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1995 |
A review of the Conference on HIV Infection in Women.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Female; Genital Diseases, Female; HIV Infections; Humans; Papanicolaou Test; Precancerous Conditions; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Sex Factors; United States; Uterine Cervical Neoplasms; Vaginal Smears; Zidovudine | 1995 |
Treatment for primary infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Chinese herb trial.
Topics: CD4 Lymphocyte Count; Drug Therapy, Combination; Drugs, Chinese Herbal; HIV Infections; Humans; RNA, Viral; Zidovudine | 1995 |
New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1995 |
Abbott laboratories files New Drug Application for ritonavir.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Double-Blind Method; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
CPCRA 007: preliminary results of combination antiretroviral study.
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1996 |
Protease inhibitors: major study stopped when 3-drug arm proves superior.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Treatment Outcome; Zidovudine | 1997 |
Major pediatric study stopped early: combination treatment better.
Topics: Anti-HIV Agents; Child; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zidovudine | 1997 |
Combination therapies improve outlook for children with HIV disease.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Lamivudine; Zidovudine | 1997 |
Acyclovir: no survival benefit seen in a large study.
Topics: Acyclovir; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cytomegalovirus Infections; HIV Infections; Humans; Placebos; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zidovudine | 1998 |
ACTG 343: (why) we can't relax our grip on viral suppression.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1998 |
Maintaining a low viral load with Nevirapine?
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
Virus sidesteps convergent therapy.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Zidovudine | 1995 |
18-Month mortality and perinatal exposure to zidovudine in West Africa.
Topics: Adult; Africa, Western; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Odds Ratio; Pregnancy; Proportional Hazards Models; Risk; Risk Factors; RNA, Viral; Zidovudine | 2001 |
Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2001 |
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
Topics: Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Lamivudine; Male; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Phenotype; Point Mutation; Reverse Transcriptase Inhibitors; Ritonavir; Time; Viral Load; Zidovudine | 2001 |
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Thailand; Treatment Outcome; Zidovudine | 2001 |
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.
Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Zidovudine | 2001 |
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.
Topics: Anti-HIV Agents; Didanosine; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours.
Topics: Adult; Area Under Curve; Breast Feeding; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Half-Life; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Metabolic Clearance Rate; Pregnancy; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2001 |
Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed.
Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Resistance, Microbial; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lymphocyte Count; Male; Molecular Sequence Data; Mutation; Panax; Phytotherapy; Reverse Transcriptase Polymerase Chain Reaction; Zidovudine | 2001 |
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Clinical Protocols; Diarrhea; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nausea; Nelfinavir; Patient Compliance; RNA, Viral; Zidovudine | 2001 |
Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.
Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Time Factors; Zidovudine | 2001 |
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.
Topics: Adolescent; Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; Humans; Hydroxyurea; Indinavir; Lamivudine; Male; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Prospective Studies; Survival Analysis; Treatment Failure; Viral Load; Zidovudine | 2001 |
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
Topics: Adult; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Phenotype; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Prognosis; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 2001 |
Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
Topics: Adolescent; Adult; Anti-HIV Agents; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prognosis; Statistics, Nonparametric; Treatment Outcome; Zidovudine | 2001 |
Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; RNA, Viral; Statistics, Nonparametric; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Can ginseng help suppress HIV?
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Male; Panax; Phytotherapy; Plants, Medicinal; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Triple nuke therapy--results after one year.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2001 |
Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay.
Topics: Africa; Anti-HIV Agents; Branched DNA Signal Amplification Assay; Breast Feeding; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2001 |
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Progression; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Morbidity; Prognosis; Ritonavir; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 2001 |
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2001 |
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Logistic Models; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine | 2001 |
Parents' attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. Paediatric European Network for Treatment of AIDS.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Caregivers; Female; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Male; Parents; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Third-Party Consent; Zidovudine | 1999 |
Evidence for prolonged clinical benefit from initial combination antiretroviral therapy: Delta extended follow-up.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; International Cooperation; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Zalcitabine; Zidovudine | 2001 |
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations.
Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Stavudine; Treatment Failure; Zidovudine | 2001 |
Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Therapy, Combination; Female; Health Care Costs; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome; Zidovudine | 2002 |
Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
Topics: Administration, Oral; Adult; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Primary Prevention; Thailand; Treatment Outcome; Zidovudine | 2001 |
CD36 deficiency induced by antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD36 Antigens; Cell Line; Cohort Studies; HIV Infections; HIV-1; Humans; In Vitro Techniques; Insulin Resistance; Lipodystrophy; Monocytes; Prospective Studies; Ritonavir; Zidovudine | 2002 |
Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cyclopropanes; Didanosine; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Feasibility Studies; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2002 |
Final analysis of the Trilège induction-maintenance trial: results at 18 months.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Multivariate Analysis; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa.
Topics: Africa, Western; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Zidovudine | 2002 |
Results of 2 years of treatment with protease-inhibitor--containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1.
Topics: Adolescent; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Netherlands; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2002 |
Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2002 |
Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.
Topics: Alanine Transaminase; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Liver Function Tests; Malawi; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
[A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection].
Topics: Adult; Aged; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; China; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Time Factors; Treatment Outcome; Viremia; Zidovudine | 2002 |
Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Multicenter Studies as Topic; Pregnancy; Risk Factors; South Africa; Tanzania; Treatment Outcome; Uganda; Zidovudine | 2002 |
Therapeutic vaccination in primary HIV infection, the Quest trial.
Topics: AIDS Vaccines; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Defective Viruses; Dideoxynucleosides; Furans; HIV Infections; Humans; Immunotherapy, Active; Lamivudine; Lymphocyte Count; Sulfonamides; T-Lymphocyte Subsets; Vaccination; Vaccinia virus; Viral Load; Viral Vaccines; Viremia; Zidovudine | 2002 |
Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir tria
Topics: Adult; Anti-HIV Agents; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Body Composition; Dideoxynucleosides; Female; HIV Infections; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Quality of Life; Reverse Transcriptase Inhibitors; Stavudine; Tomography, X-Ray Computed; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Characterization of zidovudine resistant variants of HIV-1 isolated from patients on prolonged therapy.
Topics: Blotting, Southern; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Time Factors; Zidovudine | 1992 |
Pitt tests new HIV/AIDS drug.
Topics: Antiviral Agents; Dideoxynucleosides; HIV Infections; Humans; Stavudine; Zidovudine | 1992 |
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Topics: Adult; CD4-Positive T-Lymphocytes; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Zalcitabine; Zidovudine | 1992 |
A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Patient Compliance; Survival Rate; Time Factors; Zidovudine | 1992 |
Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Zidovudine | 1992 |
The effects on survival of early treatment of human immunodeficiency virus infection.
Topics: CD4-Positive T-Lymphocytes; Cohort Studies; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Pneumonia, Pneumocystis; Time Factors; Zidovudine | 1992 |
Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Chemotherapy, Adjuvant; DNA, Viral; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Homosexuality; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Polymerase Chain Reaction; Recombinant Proteins; Treatment Outcome; Zidovudine | 1992 |
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Didanosine; Double-Blind Method; Female; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Patient Compliance; Survival Rate; Zidovudine | 1992 |
Open trial of tacrine therapy in 70 HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Tacrine; Zidovudine | 1992 |
Didanosine for zidovudine-intolerant patients with HIV disease.
Topics: Didanosine; Europe; HIV Infections; HIV-1; Humans; Survival Rate; Zidovudine | 1992 |
A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection.
Topics: Adolescent; Adult; Anorexia; CD4-Positive T-Lymphocytes; Central Nervous System Diseases; HIV Infections; HIV-1; Humans; Japan; Leukocyte Count; Leukopenia; Male; Nausea; Risk Factors; Zidovudine | 1992 |
Trend towards decreased survival in patients infected with HIV resistant to zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Infections; Humans; Leukocyte Count; Male; Survival Rate; Zidovudine | 1992 |
Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected children.
Topics: CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Infant; Leukocyte Count; Survival Rate; Treatment Outcome; Zidovudine | 1992 |
The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients.
Topics: Dietary Proteins; Half-Life; HIV Infections; Humans; Kidney; Male; Zidovudine | 1992 |
Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
Topics: Adult; Analysis of Variance; Chromatography, High Pressure Liquid; Drug Interactions; HIV Infections; Humans; Male; Middle Aged; Naproxen; Radioimmunoassay; Zidovudine | 1992 |
The effect of antiviral therapy on the natural history of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Time Factors; Zidovudine | 1992 |
[Azidothymidine in the treatment of patients with human immunodeficiency virus infection and persistent generalized adenopathies].
Topics: AIDS-Related Complex; Chi-Square Distribution; Dose-Response Relationship, Drug; HIV Infections; HIV-1; Humans; Lymphocyte Subsets; Prospective Studies; Time Factors; Zidovudine | 1992 |
Early zidovudine and survival in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Research Design; Zidovudine | 1992 |
Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.
Topics: Adult; Drug Interactions; Female; HIV Infections; Humans; Infusions, Intravenous; Male; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1992 |
Early zidovudine and survival in HIV infection.
Topics: HIV Infections; Humans; Time Factors; Zidovudine | 1992 |
Early zidovudine and survival in HIV infection. The Veterans Affairs AIDS Cooperative Studies Group.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1992 |
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Female; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; United States; Zidovudine | 1992 |
Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment.
Topics: Biomarkers; HIV Infections; Humans; Kinetics; Phenotype; T-Lymphocyte Subsets; Zidovudine | 1992 |
[Antiretroviral treatments and their therapeutical trials].
Topics: Antiviral Agents; Clinical Trials as Topic; HIV; HIV Infections; Humans; Zidovudine | 1992 |
Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons.
Topics: Cohort Studies; Double-Blind Method; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Hydrochloric Acid; Hydrogen-Ion Concentration; Predictive Value of Tests; Sensitivity and Specificity; Zidovudine | 1992 |
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.
Topics: Double-Blind Method; HIV Infections; Humans; Quality of Life; Statistics as Topic; Survival Analysis; Time Factors; Zidovudine | 1992 |
Nucleoside therapy for HIV infection--some answers, many questions.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Didanosine; HIV Infections; Humans; Zidovudine | 1992 |
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Eosinophilia; Female; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Hypersensitivity, Delayed; Interleukin-2; Intradermal Tests; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Male; Receptors, Interleukin-2; T-Lymphocytes, Regulatory; Viral Core Proteins; Zidovudine | 1991 |
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.
Topics: Adult; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Hematocrit; Hematologic Diseases; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Rate; Zidovudine | 1991 |
Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cohort Studies; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Zidovudine | 1991 |
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Topics: Administration, Oral; Adult; CD4-Positive T-Lymphocytes; Drug Evaluation; Drug Therapy, Combination; Erythema; Follow-Up Studies; Gene Products, gag; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Recombinant Proteins; Sarcoma, Kaposi; Viral Core Proteins; Zidovudine | 1991 |
CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.
Topics: CD4-Positive T-Lymphocytes; Confidence Intervals; Drug Evaluation; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Pilot Projects; Proportional Hazards Models; Risk Factors; Survival Analysis; Time Factors; Zidovudine | 1991 |
The effects of twice and four times daily zidovudine on p24 antigenaemia in CDC stage II/III patients.
Topics: Adult; Analysis of Variance; CD4-Positive T-Lymphocytes; Double-Blind Method; Drug Administration Schedule; Female; Hemoglobins; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Placebos; Zidovudine | 1991 |
Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
Topics: Adjuvants, Immunologic; Antiviral Agents; CD4-Positive T-Lymphocytes; HIV; HIV Infections; Humans; Leukocyte Count; Poly I-C; Poly U; RNA, Double-Stranded; Zidovudine | 1991 |
Chemotherapy of human immunodeficiency virus infections: current practice and future prospects.
Topics: Animals; Antiviral Agents; Didanosine; DNA Nucleotidyltransferases; DNA Replication; Drug Therapy, Combination; Endopeptidases; HIV Infections; HIV-1; Humans; Integrases; RNA-Directed DNA Polymerase; Virus Replication; Zalcitabine; Zidovudine | 1990 |
New developments in antiretroviral drug therapy for human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Antigens; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Interferons; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1990 |
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine.
Topics: Atrophy; Child; Child, Preschool; Didanosine; Drug Evaluation; Electrooculography; Electroretinography; Female; Follow-Up Studies; Fundus Oculi; HIV Infections; HIV-1; Humans; Male; Pigment Epithelium of Eye; Prospective Studies; Retina; Retinal Diseases; Zidovudine | 1992 |
Treatment of HIV infection--progress in perspective.
Topics: Drug Administration Schedule; HIV Infections; Humans; Zidovudine | 1992 |
[Zidovudine (AZT). Current state of the development].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Animals; Child; Drug Administration Schedule; Drug Evaluation; HIV Infections; Humans; In Vitro Techniques; Zidovudine | 1991 |
Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; London; Longitudinal Studies; Lymphocytes; Middle Aged; Risk Factors; Treatment Outcome; Zidovudine | 1991 |
Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
Topics: Acyclovir; Administration, Oral; Adult; Biological Availability; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Injections, Intravenous; Male; Middle Aged; Zidovudine | 1991 |
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Female; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Male; Placebos; Sexual Partners; T-Lymphocytes, Helper-Inducer; Zidovudine | 1991 |
Canadian multicenter azidothymidine trial: AZT pharmacokinetics.
Topics: Adult; Canada; HIV Infections; Homosexuality; Humans; Liver; Liver Function Tests; Male; Smoking; Zidovudine | 1991 |
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Topics: Administration, Oral; Adult; CD4 Antigens; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Gene Products, gag; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Interferon Type I; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Viral Core Proteins; Zidovudine | 1991 |
[Zidovudine in asymptomatic HIV infection].
Topics: Dose-Response Relationship, Drug; HIV Infections; Humans; Zidovudine | 1991 |
Clinical and immunologic effects of combination therapy with intravenous immunoglobulins and AZT in HIV-infected patients.
Topics: Adult; Female; HIV Infections; Humans; Immunoglobulins, Intravenous; Leukocyte Count; Male; Platelet Count; Tumor Necrosis Factor-alpha; Zidovudine | 1991 |
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Black People; Clinical Protocols; Female; Hispanic or Latino; HIV Infections; Humans; Male; Minority Groups; Substance Abuse, Intravenous; Treatment Outcome; Zidovudine | 1991 |
Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Topics: Adult; Chromatography, High Pressure Liquid; Complement C4; Drug Administration Schedule; Female; HIV Infections; Humans; Leucovorin; Male; Pneumonia, Pneumocystis; Prospective Studies; Sulfamethoxazole; Trimethoprim; Zidovudine | 1991 |
Resolution of hairy leukoplakia: an observational trial of zidovudine versus no treatment.
Topics: HIV Infections; Humans; Leukoplakia; Male; Recurrence; Zidovudine | 1991 |
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Double-Blind Method; Female; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Viral Core Proteins; Zidovudine | 1990 |
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Data Interpretation, Statistical; Double-Blind Method; Female; Hematologic Diseases; HIV Antigens; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Multicenter Studies as Topic; Opportunistic Infections; Randomized Controlled Trials as Topic; Zidovudine | 1990 |
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.
Topics: Adult; Aerosols; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Evaluation; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Pentamidine; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Survival Rate; Zidovudine | 1990 |
Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection.
Topics: Adult; Blood Transfusion; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Follow-Up Studies; HIV Infections; Humans; Immunization, Passive; Leukocyte Count; Lymphocyte Transfusion; Male; Middle Aged; Randomized Controlled Trials as Topic; Skin Tests; Zidovudine | 1990 |
Determinants of subject compliance within an experimental anti-HIV drug protocol.
Topics: Adult; Appointments and Schedules; Communication; Confidentiality; Consumer Behavior; Double-Blind Method; Epidemiologic Factors; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Patient Compliance; Physician-Patient Relations; Surveys and Questionnaires; Zidovudine | 1991 |
Zidovudine treatment for anti-HIV positive haemophiliacs.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Evaluation; Hematologic Diseases; Hemophilia A; HIV Infections; Humans; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Transfusion Reaction; Zidovudine | 1990 |
HIV-related thrombocytopenia.
Topics: Adrenal Cortex Hormones; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Platelets; Cohort Studies; Combined Modality Therapy; Double-Blind Method; HIV Antibodies; HIV Infections; Humans; Immune Complex Diseases; Immunization, Passive; Prognosis; Prospective Studies; Purpura, Thrombocytopenic; Splenectomy; Zidovudine | 1990 |
Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introduction.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; Humans; Zalcitabine; Zidovudine | 1990 |
Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine.
Topics: Clinical Protocols; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Random Allocation; Zalcitabine; Zidovudine | 1990 |
Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function.
Topics: Cell Survival; Chemotaxis, Leukocyte; Didanosine; HIV Infections; HIV-1; Humans; Neutrophils; Phagocytosis; Superoxides; Zalcitabine; Zidovudine | 1990 |
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; AIDS-Related Complex; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Follow-Up Studies; HIV Infections; Humans; Infant; Infusions, Intravenous; Multicenter Studies as Topic; Safety; Zidovudine | 1990 |
The effect of zidovudine on platelet count in HIV-infected individuals.
Topics: Canada; HIV Infections; Humans; Male; Multicenter Studies as Topic; Platelet Count; Thrombocytopenia; Zidovudine | 1990 |
Vitamin B12 injections in patients treated with zidovudine.
Topics: Anemia; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Vitamin B 12; Zidovudine | 1990 |
[Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Hematologic Diseases; HIV Infections; Humans; Male; Middle Aged; Multicenter Studies as Topic; Netherlands; Retrospective Studies; Time Factors; Zidovudine | 1990 |
Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial.
Topics: Adult; Canada; Dose-Response Relationship, Drug; Drug Eruptions; Fatigue; Headache; Hematologic Diseases; HIV Infections; Homosexuality; Humans; Male; Mood Disorders; Multicenter Studies as Topic; Nausea; Pruritus; Random Allocation; Time Factors; Zidovudine | 1989 |
AIDS in Arkansas. AMS Special Committee on AIDS. Update December 1989: results of controlled clinical trials of zidovudine in early HIV infection.
Topics: AIDS-Related Complex; Clinical Trials as Topic; HIV Infections; HIV Seropositivity; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1989 |
Clinical trials of zidovudine in HIV infection.
Topics: Animals; Cell Cycle; Clinical Trials as Topic; Drug Evaluation, Preclinical; HIV Infections; Humans; Mice; Mice, Inbred BALB C; Zidovudine | 1989 |
[HIV infection: when should zidovudine be administered?].
Topics: Clinical Trials as Topic; Drug Administration Schedule; HIV Infections; Humans; Zidovudine | 1989 |
2872 other study(ies) available for zidovudine and HIV Coinfection
| Article | Year |
|---|---|
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Thymine | 1995 |
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
Topics: Adenosine Deaminase; Antiviral Agents; Cells, Cultured; Didanosine; HIV Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Prodrugs; Solubility | 1995 |
Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Topics: Antiviral Agents; Aurintricarboxylic Acid; B-Lymphocytes; Cell Fusion; Cells, Cultured; DNA, Viral; HeLa Cells; HIV Infections; HIV-1; Humans; Macrophages; Phenotype; T-Lymphocytes; Virion; Virus Replication; Zidovudine | 1994 |
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Antiviral Agents; Binding Sites; Computer Simulation; Drug Design; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Models, Molecular; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiourea; Virus Replication | 1998 |
Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
Topics: Anti-HIV Agents; Drug Design; Gene Products, rev; HeLa Cells; HIV Infections; HIV Integrase; HIV-1; Humans; Lymphocytes; Peptide Mapping; Peptides; Protein Binding; rev Gene Products, Human Immunodeficiency Virus; Virus Integration; Virus Replication | 2007 |
1-Aryl-tetrahydroisoquinoline analogs as active anti-HIV agents in vitro.
Topics: Anti-HIV Agents; Cells, Cultured; Cyclization; HIV Infections; HIV-1; Microbial Sensitivity Tests; Models, Chemical; Structure-Activity Relationship; Tetrahydroisoquinolines; Toxicity Tests | 2008 |
Entecavir exhibits inhibitory activity against human immunodeficiency virus under conditions of reduced viral challenge.
Topics: Antiviral Agents; Cell Line; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans | 2008 |
Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.
Topics: Animals; Anti-HIV Agents; Cell Line; Chlorocebus aethiops; COS Cells; Gene Products, rev; Genes, env; Heterocyclic Compounds; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Virus Replication | 2008 |
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
Topics: Anti-HIV Agents; Cells, Cultured; HIV Infections; HIV-1; Humans; Quinolines; Quinolones; Structure-Activity Relationship | 2008 |
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Biological Assay; Cell Line; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Chemical; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiadiazoles; Virus Replication | 2008 |
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
Topics: Amino Acid Sequence; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors | 2009 |
The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.
Topics: Animals; Anti-HIV Agents; Calcium Signaling; Cell Line; Cells, Cultured; Chemokine CXCL12; CHO Cells; Cricetinae; Cricetulus; Fluorescent Antibody Technique; HIV Infections; HIV-1; Humans; Mice; Mice, SCID; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, CXCR4 | 2009 |
Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents.
Topics: Antiviral Agents; Cell Line; Cell Survival; Curcumin; Flavanones; HIV Infections; HIV-1; Humans; Molecular Structure; Pyrones; Quercetin; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; T-Lymphocytes; Triterpenes; Viral Proteins | 2009 |
Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives.
Topics: Animals; Anti-HIV Agents; Cell Survival; Chlorocebus aethiops; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Models, Molecular; Molecular Structure; Quinolones; Structure-Activity Relationship; Vero Cells | 2009 |
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2009 |
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Protein Binding; Structure-Activity Relationship | 2009 |
Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands.
Topics: Anti-HIV Agents; Calixarenes; Cell Line; Cell Survival; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Molecular Structure; Thiazoles; Water | 2010 |
Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols.
Topics: Anti-HIV Agents; Biomimetic Materials; Dimerization; HIV Infections; HIV Reverse Transcriptase; Humans; Phloroglucinol; Structure-Activity Relationship; Virus Replication | 2010 |
Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistance.
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutation; Nucleosides; Phenotype; pol Gene Products, Human Immunodeficiency Virus; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Virus Replication | 2010 |
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
Topics: Adenine; Anti-HIV Agents; Cell Survival; Cells, Cultured; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Macrophages; Nucleosides; Nucleotides; Organophosphonates; Tenofovir | 2010 |
Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Aniline Compounds; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |
Discovery of orally available spirodiketopiperazine-based CCR5 antagonists.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Biological Availability; Caco-2 Cells; CCR5 Receptor Antagonists; HIV Infections; HIV-1; Humans; Piperazines; Rats; Receptors, CCR5 | 2010 |
Anti-HIV and antiplasmodial activity of original flavonoid derivatives.
Topics: Anti-HIV Agents; Antimalarials; Cell Line; Cell Survival; Flavonoids; HIV; HIV Infections; Humans; Malaria, Falciparum; Plasmodium falciparum | 2010 |
Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents.
Topics: Anti-HIV Agents; Cell Line; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Nevirapine; Pyrimidines; Structure-Activity Relationship; Zidovudine | 2011 |
Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzophenones; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2011 |
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
Topics: Acetamides; Anti-HIV Agents; Cell Line; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Triazoles; Virus Replication | 2011 |
Synthesis and anti-HIV-1 activity of 4-substituted-7-(2'-deoxy-2'-fluoro-4'-azido-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine analogues.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Pyrimidines; Pyrroles; Ribonucleosides | 2011 |
Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.
Topics: Anti-HIV Agents; Benzoates; Cell Proliferation; Cells, Cultured; Drug Design; HIV Infections; HIV-1; Humans; Molecular Structure; Oxadiazoles; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2012 |
Truncated phosphonated C-1'-branched N,O-nucleosides: a new class of antiviral agents.
Topics: Anti-HIV Agents; Antiviral Agents; Cells, Cultured; Drug Evaluation, Preclinical; HIV Infections; Human T-lymphotropic virus 1; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Molecular Structure; Nitrogen Oxides; Nucleosides; Organic Chemistry Phenomena; Organophosphonates; Structure-Activity Relationship; Zidovudine | 2012 |
Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Dicarboxylic Acids; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2012 |
Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antimalarials; Dose-Response Relationship, Drug; Drug Therapy, Combination; HeLa Cells; HIV Infections; HIV-1; Humans; Malaria; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2012 |
Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; HEK293 Cells; Herpes Simplex; Herpesvirus 1, Human; HIV Infections; HIV-1; Humans; Vero Cells; Virus Replication | 2012 |
Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays.
Topics: Adaptor Proteins, Signal Transducing; Anti-HIV Agents; Biological Assay; Cell Death; Chalcones; Green Fluorescent Proteins; High-Throughput Screening Assays; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Transcription Factors | 2012 |
Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides.
Topics: Antiviral Agents; Aza Compounds; Halogenation; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Nucleosides | 2012 |
Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Structure-Activity Relationship; Thioacetamide | 2012 |
Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors.
Topics: Coumarins; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Zidovudine | 2013 |
Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infection.
Topics: Animals; Capsid Proteins; Cats; Cell Line; Cell Survival; Disease Models, Animal; HIV Infections; Humans; Immunodeficiency Virus, Feline; Molecular Structure; Pyrroles; Small Molecule Libraries; Thiazines | 2014 |
Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
Topics: Anti-HIV Agents; Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Structure; Niacinamide; Protein Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Altertoxins with potent anti-HIV activity from Alternaria tenuissima QUE1Se, a fungal endophyte of Quercus emoryi.
Topics: Alternaria; Anti-HIV Agents; Benz(a)Anthracenes; Endophytes; HIV Infections; HIV-1; Humans; Perylene; Quercus; T-Lymphocytes | 2014 |
Antiviral Activity of Diterpene Esters on Chikungunya Virus and HIV Replication.
Topics: Anti-HIV Agents; Antiviral Agents; Chikungunya virus; Diterpenes; DNA Replication; Esters; Euphorbiaceae; HIV Infections; HIV-1; HIV-2; Molecular Structure; Phorbol Esters; Tetradecanoylphorbol Acetate; Virus Replication | 2015 |
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Topics: Anti-HIV Agents; Binding Sites; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Point Mutation; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2016 |
Synthesis of tetracyclic iminosugars fused benzo[e][1,3]thiazin-4-one and their HIV-RT inhibitory activity.
Topics: Anti-HIV Agents; Crystallography, X-Ray; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazines | 2016 |
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
Topics: Cell Line; Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Oxazines; Piperazines; Pyridones; Pyrimidinones; Raltegravir Potassium; Ribonuclease H | 2016 |
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
Topics: Anti-HIV Agents; Biomimetic Materials; CD4 Antigens; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Pyrroles; Structure-Activity Relationship; Thiazoles; Virus Internalization | 2017 |
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Topics: Anti-HIV Agents; Cell Line; Drug Design; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Keto Acids; Molecular Docking Simulation; Pyrimidines; Reverse Transcriptase Inhibitors | 2017 |
Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Dicarboxylic Acids; Esters; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Reverse Transcriptase Inhibitors | 2017 |
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
Topics: Animals; Anti-HIV Agents; Drug Resistance, Viral; HEK293 Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Pyrimidines; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiophenes | 2017 |
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Niacinamide; Point Mutation; Structure-Activity Relationship; Triazoles | 2018 |
Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui.
Topics: Antiviral Agents; Cell Line; Diterpenes; Esters; Euphorbia; HIV Infections; HIV-1; Humans; Plant Extracts; Virus Replication | 2018 |
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Drug Discovery; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors | 2019 |
Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection.
Topics: Animals; Antiviral Agents; Cats; HIV Infections; Immunodeficiency Virus, Feline; Nucleocapsid Proteins; Structure-Activity Relationship | 2019 |
Potent Anti-HIV Ingenane Diterpenoids from Euphorbia ebracteolata.
Topics: Anti-HIV Agents; Chromatography, Liquid; Diterpenes; Euphorbia; HIV Infections; Humans; Plant Roots; Structure-Activity Relationship | 2019 |
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
Topics: Animals; Cats; Disease Models, Animal; HIV Infections; Humans; Immunodeficiency Virus, Feline; Nucleocapsid Proteins; Piperazines | 2019 |
Magnitude and associated factors of anemia among AZT based HAART experienced adult HIV patients at University of Gondar Comprehensive Specialized Referral Hospital, Northwest, Ethiopia, 2019: a retrospective cohort study.
Topics: Adult; Anemia; Antiretroviral Therapy, Highly Active; Ethiopia; Female; HIV Infections; Hospitals, Special; Humans; Middle Aged; Referral and Consultation; Retrospective Studies; Zidovudine | 2021 |
Zidovudine inhibits telomere elongation, increases the transposable element LINE-1 copy number and compromises mouse embryo development.
Topics: Animals; Anti-HIV Agents; Blastocyst; DNA Transposable Elements; Embryonic Development; Female; HIV Infections; Long Interspersed Nucleotide Elements; Mice; Models, Animal; Oocytes; Pregnancy; Reverse Transcriptase Inhibitors; RNA-Binding Proteins; Telomere; Zidovudine; Zygote | 2021 |
Neochlorogenic acid: an anti-HIV active compound identified by screening of Cortex Mori [
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Chlorogenic Acid; Dose-Response Relationship, Drug; HEK293 Cells; HIV Infections; HIV-1; Humans; Morus; Plant Extracts; Quinic Acid; Zidovudine | 2021 |
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and C.
Topics: Amino Acids; Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 2022 |
Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age.
Topics: Child; Female; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Longitudinal Studies; Malawi; Uganda; Zidovudine | 2022 |
Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal Prophylaxis in a High Resource Setting.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2022 |
Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Drug Combinations; Female; Hair; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Medication Adherence; Mozambique; Nevirapine; Postpartum Period; Pregnancy; Prospective Studies; Viral Load; Young Adult; Zidovudine | 2022 |
Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Health Facilities; HIV Infections; Humans; Male; Nigeria; Private Facilities; Retrospective Studies; Zidovudine | 2022 |
Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Communicable Disease Control; COVID-19; Female; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Indonesia; Male; Pandemics; Retrospective Studies; Sexual and Gender Minorities; Viral Load; Zidovudine | 2022 |
CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Ethiopia; HIV Infections; Humans; Male; Retrospective Studies; Zidovudine | 2022 |
Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
Topics: Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Autism Spectrum Disorder; Child; Developmental Disabilities; Female; HIV Infections; Humans; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Uganda; Zidovudine | 2022 |
Patterns and prognosis of holding regimens for people living with HIV in Asian countries.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Prognosis; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2022 |
Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cameroon; Chemical and Drug Induced Liver Injury; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Risk Factors; Young Adult; Zidovudine | 2022 |
Gold nanoparticles capped DHPMs for meliorate detection of antiretroviral drug: Azidothymidine.
Topics: Antiviral Agents; Gold; HIV Infections; Humans; Metal Nanoparticles; Zidovudine | 2022 |
Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment.
Topics: Adolescent; Anti-HIV Agents; Child; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Oxazines; Piperazines; Protease Inhibitors; Pyridones; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2022 |
Brief Report: HIV-Positive and Breastfeeding in High-Income Settings: 5-Year Experience From a Perinatal Center in Germany.
Topics: Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Retrospective Studies; Zidovudine | 2022 |
Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Arginine; Biomarkers; Disease Progression; Glucose; Glutamates; Glutamine; Glutathione; HIV Infections; Humans; Oxidative Stress; Reproducibility of Results; Zidovudine | 2022 |
Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Zidovudine | 2022 |
Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Emtricitabine; HIV Infections; Humans; Interleukin-6; Lamivudine; Middle Aged; Nevirapine; Tenofovir; Weight Loss; Zidovudine | 2022 |
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties.
Topics: Animals; Anti-HIV Agents; Antioxidants; Azides; HIV Infections; Mice; Oxidative Stress; Zidovudine | 2023 |
Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan.
Topics: Anti-HIV Agents; Darunavir; Drug Resistance, Viral; Emtricitabine; HIV Infections; HIV-1; Humans; Kazakhstan; Mutation; Nevirapine; Viral Load; Zidovudine | 2022 |
Progression of non-anemic macrocytosis to anemia in HIV-positive persons receiving zidovudine-containing regimens in a resource-limited setting.
Topics: Adult; Anemia; Anti-HIV Agents; Female; HIV Infections; HIV Seropositivity; Humans; Male; Retrospective Studies; Zidovudine | 2022 |
Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
Topics: Adolescent; Anti-HIV Agents; Cameroon; Drug Resistance, Viral; Follow-Up Studies; Health Facilities; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nevirapine; Retrospective Studies; Viral Load; Zidovudine | 2022 |
REVERSIBILITY OF LIPOATROPHY IN HIV-INFECTED PATIENTS TAKING ANTIRETROVIRAL THERAPY: A COHORT STUDY WITH ULTRASOUND ASSESSMENT.
Topics: Cohort Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Longitudinal Studies; Prospective Studies; Stavudine; Zidovudine | 2022 |
Anti-retroviral treatment with zidovudine alters pyrimidine metabolism, reduces translation, and extends healthy longevity via ATF-4.
Topics: Activating Transcription Factor 4; Animals; Caenorhabditis elegans; HIV Infections; Humans; Longevity; Retroviridae; Reverse Transcriptase Inhibitors; Zidovudine | 2023 |
Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study.
Topics: Anti-Retroviral Agents; Birth Weight; Case-Control Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Premature Birth; Progesterone; Prolactin; Zidovudine | 2023 |
Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
Topics: Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Child; Cohort Studies; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Uganda; Zidovudine | 2023 |
Enzyme-Triggered l-α/d-Peptide Hydrogels as a Long-Acting Injectable Platform for Systemic Delivery of HIV/AIDS Drugs.
Topics: Animals; Anti-HIV Agents; Esters; HIV Infections; Hydrogels; Peptides; Rats; Rats, Sprague-Dawley; Zidovudine | 2023 |
Short-term toxicity assessment of combined use of zidovudine, lamivudine and lopinavir/ritonavir in vitro and in vivo.
Topics: Animals; Anti-HIV Agents; Female; HIV Infections; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Mammals; Mice; Rats; Ritonavir; Zidovudine | 2023 |
Co-administration of rimonabant prevents glucose intolerance in Sprague-Dawley rats treated chronically with lopinavir/ritonavir and zidovudine: an experimental study design.
Topics: Adult; Animals; Anti-HIV Agents; Cannabinoids; Glucose Intolerance; HIV Infections; Humans; Lopinavir; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Rimonabant; Ritonavir; Zidovudine | 2023 |
A quantum mechanical investigation of nanocone oxide as a drug carrier for zidovudine: AIDS drug.
Topics: Anti-HIV Agents; Drug Carriers; HIV Infections; Humans; Oxides; Zidovudine | 2023 |
In silico evidences of Mpro inhibition by a series of organochalcogen-AZT derivatives and their safety in Caenorhabditis elegans.
Topics: Animals; Antioxidants; Caenorhabditis elegans; HIV Infections; Humans; SARS-CoV-2; Selenium; Vaccines; Zidovudine | 2023 |
Metabolomic profiling of preterm birth in pregnant women living with HIV.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Metabolomics; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Premature Birth; Protease Inhibitors; Zidovudine | 2023 |
Lower academic performance among children with perinatal HIV exposure in Botswana.
Topics: Academic Performance; Adolescent; Botswana; Breast Feeding; Child; Female; HIV Infections; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2023 |
Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors.
Topics: Adult; Anti-HIV Agents; Asian People; Body Weight; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Renal Insufficiency; Tenofovir; Thailand; Zidovudine | 2019 |
Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).
Topics: Adolescent; Anti-Retroviral Agents; Cardiovascular Diseases; CD4 Lymphocyte Count; Child; Cognition Disorders; Cross-Sectional Studies; Dideoxynucleosides; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Respiratory Tract Diseases; South Africa; Viral Load; Zidovudine | 2019 |
Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Taiwan; Zidovudine | 2019 |
Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.
Topics: Aged; Animals; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Caco-2 Cells; Carbamates; Drug Interactions; Female; Fluorenes; Hepatitis C; HIV Infections; Humans; Imidazoles; Intestines; Lopinavir; Male; Maraviroc; Middle Aged; Pyrrolidines; Rats; Rats, Wistar; Ritonavir; Saquinavir; Valine; Zidovudine | 2019 |
Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder.
Topics: Animals; Anti-HIV Agents; Chromatography, Liquid; Female; HIV Infections; Injections, Intraperitoneal; Lamivudine; Neurocognitive Disorders; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution; Zidovudine | 2019 |
HIV Drug Resistance after Failure of 6 Month First-line Therapy in a Hospital: A Case Series.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2019 |
Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Microcephaly; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Puerto Rico; Tenofovir; Young Adult; Zidovudine | 2020 |
Early cardiac dysfunction in children and young adults with perinatally acquired HIV.
Topics: Adolescent; Anti-HIV Agents; Child; Cross-Sectional Studies; Echocardiography, Doppler, Color; Female; Heart Diseases; HIV Infections; Humans; Interleukin-6; Kenya; Male; Multivariate Analysis; Regression Analysis; Stroke Volume; Ventricular Function, Left; Young Adult; Zidovudine | 2020 |
Descriptive analysis of World Health Organization-recommended second-line antiretroviral treatment: A retrospective cohort data analysis.
Topics: Adult; Age Factors; CD4 Lymphocyte Count; Databases, Factual; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Lost to Follow-Up; Male; Medication Adherence; Middle Aged; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Sex Factors; Tenofovir; Treatment Failure; Viral Load; World Health Organization; Zidovudine | 2019 |
Pregnancies Among the First Generation of Survivors of Perinatal HIV Infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Canada; Female; HIV Infections; HIV Long-Term Survivors; Humans; Infant; Infectious Disease Transmission, Vertical; Medication Adherence; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Unplanned; Quebec; Retrospective Studies; Viral Load; Young Adult; Zidovudine | 2020 |
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
Topics: Anti-HIV Agents; Botswana; Child; Child, Preschool; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine | 2021 |
Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling.
Topics: Adolescent; Adult; Ambulatory Care; Anti-Retroviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Hospitals, Special; Humans; Incidence; Lamivudine; Lost to Follow-Up; Male; Nevirapine; Regression Analysis; Retrospective Studies; Risk Factors; Young Adult; Zidovudine | 2020 |
Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Male; Mutation; Retrospective Studies; Tenofovir; Treatment Failure; Uganda; Young Adult; Zidovudine | 2020 |
Increased risk of dizziness in human immunodeficiency virus-infected patients taking zidovudine and efavirenz combination: a Brazilian cohort study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Brazil; Cyclopropanes; Depression; Dizziness; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Sleep Initiation and Maintenance Disorders; Survival Analysis; Time Factors; Zidovudine | 2020 |
The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Mutation Rate; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Virus Replication; Zidovudine | 2020 |
High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Epidemics; Female; HIV; HIV Infections; Humans; Male; Philippines; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2020 |
Antiretroviral Prophylaxis: A Digestive Complication to Know.
Topics: Anti-HIV Agents; Child; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Lamivudine; Zidovudine | 2021 |
Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Developing Countries; Dideoxynucleosides; Ethiopia; Female; HIV Infections; Humans; Male; Retrospective Studies; Zidovudine | 2020 |
Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
Topics: Adult; Anti-HIV Agents; Bayes Theorem; Drug Combinations; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Thailand; Viral Load; Young Adult; Zidovudine | 2020 |
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Topics: Adult; Anti-HIV Agents; Antibodies, Monoclonal, Humanized; Castleman Disease; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Interleukin-10; Interleukin-1beta; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome; Valganciclovir; Viral Load; Zidovudine | 2020 |
Movement disorder in a patient with Human Immunodeficiency Virus on an anti-retroviral therapy: A Case Report.
Topics: AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Benzoxazines; Blood-Brain Barrier; Brain Stem; Cerebellar Ataxia; Cerebellum; Cyclopropanes; Drug Substitution; Female; Gait Ataxia; HIV Infections; Humans; Lamivudine; Magnetic Resonance Imaging; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Nystagmus, Pathologic; Panic Disorder; Pons; Postural Balance; Sensation Disorders; Tenofovir; Zidovudine | 2020 |
Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase.
Topics: Anti-HIV Agents; Hepatitis B virus; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2021 |
Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; India; Male; Middle Aged; Retrospective Studies; Zidovudine | 2020 |
Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Male; RNA, Viral; Spinal Puncture; Stavudine; Viral Load; Zidovudine | 2020 |
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4
Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine | 2020 |
Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Female; Fetal Development; HIV Infections; Humans; Infant, Small for Gestational Age; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Taiwan; Zidovudine | 2020 |
Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
Topics: Anti-HIV Agents; Antibodies, Neutralizing; Antibody-Dependent Cell Cytotoxicity; Antiretroviral Therapy, Highly Active; Child, Preschool; Cohort Studies; Dideoxynucleosides; Drug Combinations; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Ritonavir; Viral Load; Zidovudine | 2020 |
Preventing mother to child transmission of HIV: lessons learned from China.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; China; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Young Adult; Zidovudine | 2020 |
Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; Haiti; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Risk Factors; Viral Load; Young Adult; Zidovudine | 2020 |
Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
Topics: Brazil; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Retrospective Studies; Syphilis; Zidovudine | 2022 |
Rapid, user-friendly, and inexpensive detection of azidothymidine.
Topics: Anti-HIV Agents; Antibodies; Antiretroviral Therapy, Highly Active; Azides; Calibration; Enzyme-Linked Immunosorbent Assay; Fluorescent Dyes; HIV Infections; Humans; Limit of Detection; Magnetic Resonance Spectroscopy; Microscopy, Fluorescence; Point-of-Care Testing; Quality of Life; Reproducibility of Results; Urine; Zidovudine | 2021 |
Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; HIV; HIV Infections; Humans; India; Lamivudine; Male; Prevalence; Risk Factors; Viral Load; Zidovudine | 2021 |
In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
Topics: Anti-HIV Agents; Child; Clonal Hematopoiesis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2021 |
In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.
Topics: Anti-HIV Agents; Child; Cognition; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Uganda; Zidovudine | 2021 |
Influence of maternal use of tenofovir disoproxil fumarate or zidovudine in Vietnamese pregnant women with HIV on infant growth, renal function, and bone health.
Topics: beta 2-Microglobulin; Body Height; Endopeptidases; Female; HIV Infections; Humans; Infant; Male; Maternal Exposure; Multivariate Analysis; Pregnancy; Pregnant Women; Prospective Studies; Tenofovir; Vietnam; Zidovudine | 2021 |
Adverse Reactions to Antiretrovirals in Cuban Patients Living with HIV/AIDS.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Cuba; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Middle Aged; Nevirapine; Young Adult; Zidovudine | 2021 |
Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Brazil; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2021 |
Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study.
Topics: Adult; Anemia; Anti-HIV Agents; Blood Glucose; Ethiopia; Female; HIV Infections; Humans; Hyperglycemia; Liver; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Regression Analysis; Surveys and Questionnaires; Tenofovir; Zidovudine | 2021 |
Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana.
Topics: Abnormalities, Drug-Induced; Anti-HIV Agents; Botswana; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Neonatal Screening; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2017 |
Metabolic syndrome in patients on first-line antiretroviral therapy containing zidovudine or tenofovir in rural Lesotho, Southern Africa.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Lesotho; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Rural Population; Sex Factors; Tenofovir; Zidovudine | 2017 |
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
Topics: Cell Line; Clustered Regularly Interspaced Short Palindromic Repeats; DNA Replication; Gene Editing; Gene Expression; Gene Knockdown Techniques; HEK293 Cells; HIV Infections; HIV-1; HIV-2; Host-Pathogen Interactions; Humans; Phosphorylation; Reverse Transcription; SAM Domain and HD Domain-Containing Protein 1; Viral Regulatory and Accessory Proteins; Virus Replication; Zidovudine | 2017 |
Zidovudine continuous infusion in an HIV-infected pregnant woman with a phobia of swallowing pills.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Phobic Disorders; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 2017 |
Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cohort Studies; Coinfection; Drug Combinations; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Lamivudine; Lopinavir; Male; Models, Immunological; Polyethylene Glycols; Recombinant Proteins; Recovery of Function; Ribavirin; Ritonavir; Time-to-Treatment; Zidovudine | 2017 |
Factors associated with loss to follow-up after occupational HIV exposure in Cape Town, South Africa: a retrospective cohort study.
Topics: Adult; Anti-HIV Agents; Emtricitabine; Female; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Lost to Follow-Up; Male; Occupational Exposure; Post-Exposure Prophylaxis; Retrospective Studies; South Africa; Stavudine; Tenofovir; Young Adult; Zidovudine | 2017 |
On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
Topics: Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Computer Simulation; Confidence Intervals; Drugs, Generic; Ethanolamines; Fluorenes; HIV Infections; Humans; Lamivudine; Lumefantrine; Malaria; Models, Statistical; Therapeutic Equivalency; Zidovudine | 2017 |
A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Cell Survival; Didanosine; Female; HIV Infections; Humans; Male; Middle Aged; Receptors, CXCR4; Stavudine; T-Lymphocytes, Regulatory; Viral Load; Zalcitabine; Zidovudine | 2017 |
Reversible diabetes mellitus induced by use of, and improved after discontinuation of, the antiretroviral medication zidovudine: a case report.
Topics: Adult; Anti-HIV Agents; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; HIV Infections; Humans; Hyperglycemia; Male; Remission Induction; Zidovudine | 2017 |
Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Lamivudine; Male; Models, Theoretical; Nevirapine; Pregnancy; Retrospective Studies; Stavudine; Tenofovir; Time-to-Treatment; Treatment Failure; Zidovudine | 2017 |
The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to go.
Topics: Adult; Anti-HIV Agents; Brazil; Breast Feeding; Contraindications; Female; HIV Infections; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Young Adult; Zidovudine | 2017 |
Dual-targeted anti-TB/anti-HIV heterodimers.
Topics: Antitubercular Agents; Cell Culture Techniques; Cells, Cultured; Drug Design; Drug Resistance, Multiple, Bacterial; HIV Infections; HIV-1; Humans; Lymphocytes; Mycobacterium tuberculosis; Tuberculosis; Virus Replication; Zidovudine | 2017 |
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Patient Safety; Poisson Distribution; RNA, Viral; Treatment Outcome; Zidovudine | 2017 |
Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunity, Maternally-Acquired; Immunoglobulin G; Kenya; Medication Adherence; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2018 |
Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Male; Mozambique; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2017 |
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; China; Drug Resistance, Viral; Female; HIV Infections; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Mutation; Prospective Studies; Risk Factors; Sentinel Surveillance; Stavudine; Sustained Virologic Response; Treatment Failure; Viral Load; Zidovudine | 2017 |
Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV-exposed uninfected infants in Cameroon.
Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Carnitine; DNA, Mitochondrial; Energy Metabolism; HIV Infections; Humans; Infant; Mitochondria; Nevirapine; Real-Time Polymerase Chain Reaction; Tandem Mass Spectrometry; Zidovudine | 2017 |
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery.
Topics: Alginates; Amides; Anti-HIV Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HIV; HIV Infections; Humans; Nanoparticles; Zidovudine | 2018 |
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
Topics: Amino Acid Substitution; Cell Line; Drug Resistance, Viral; Genes, nef; Heterocyclic Compounds, 3-Ring; High-Throughput Nucleotide Sequencing; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Mutation; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Virus Integration; Virus Replication; Zidovudine | 2017 |
Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Ghana; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Stavudine; Tenofovir; Young Adult; Zidovudine | 2017 |
Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978-2013.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2017 |
Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study.
Topics: Adolescent; Adult; Anti-HIV Agents; Antitubercular Agents; Female; Gestational Age; HIV Infections; HIV-1; Hospitalization; Humans; Infant; Infant Mortality; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; South Africa; Tuberculosis; Young Adult; Zidovudine | 2018 |
Community outreach programs and major adherence lapses with antiretroviral therapy in rural Kakamega, Kenya.
Topics: Adolescent; Adult; Anti-HIV Agents; Community Health Workers; Community-Institutional Relations; Female; HIV Infections; House Calls; Humans; Kenya; Male; Medication Adherence; Middle Aged; Rural Population; Stavudine; Survival Analysis; Tenofovir; Young Adult; Zidovudine | 2018 |
Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy.
Topics: Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nigeria; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2018 |
HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Treatment Outcome; Viral Load; Zidovudine | 2018 |
The incidence of first-line antiretroviral treatment changes and related factors among HIV-infected sex workers in Nairobi, Kenya.
Topics: Adult; Anti-HIV Agents; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Kenya; Male; Middle Aged; Retrospective Studies; Sex Workers; Stavudine; Tenofovir; Time Factors; Zidovudine | 2017 |
Concomitant AIDS cholangiopathy and Fanconi syndrome as complications of HIV in a single patient.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cholangitis; Fanconi Syndrome; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Tenofovir; Zidovudine | 2017 |
Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; Cohort Studies; Cross-Sectional Studies; Drug Combinations; Drug Substitution; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Referral and Consultation; Stavudine; Zidovudine | 2017 |
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome; Uganda; Viral Load; Young Adult; Zidovudine | 2017 |
Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Didanosine; Female; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Male; Maternal Exposure; Maternal-Fetal Exchange; Neoplasms; Nucleosides; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies; Reverse Transcriptase Inhibitors; Risk; Surveys and Questionnaires; Zidovudine | 2019 |
Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Female; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Nevirapine; Stavudine; Time Factors; Vietnam; Viral Load; Young Adult; Zidovudine | 2017 |
Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prenatal Care; Retrospective Studies; South Africa; Urinary Tract Infections; Zidovudine | 2017 |
Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Immunity, Cellular; Iran; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Sex Factors; Time Factors; Zidovudine | 2018 |
Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections; Humans; Malawi; Male; Middle Aged; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Zidovudine | 2018 |
Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Calibration; Chromatography, High Pressure Liquid; Colostrum; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Reference Standards; Reproducibility of Results; Ritonavir; Tandem Mass Spectrometry; Young Adult; Zidovudine | 2018 |
Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition Fro
Topics: Adolescent; Adult; Anti-HIV Agents; Birth Weight; Breast Feeding; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Time Factors; Zidovudine; Zimbabwe | 2018 |
Mother to child transmission of HIV in Brazil: Data from the "Birth in Brazil study", a national hospital-based study.
Topics: Adolescent; Adult; Anti-HIV Agents; Brazil; Breast Feeding; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Young Adult; Zidovudine | 2018 |
A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
Topics: Abdominal Pain; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Substitution; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nausea; Nevirapine; Nigeria; Prospective Studies; Sleep Initiation and Maintenance Disorders; Tenofovir; Young Adult; Zidovudine | 2016 |
Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Time; Uganda; Viral Load; Zidovudine | 2018 |
Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drugs, Generic; Female; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Tablets; Viral Load; Zidovudine | 2018 |
Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Ethiopia; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Young Adult; Zidovudine | 2018 |
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Disease Transmission, Infectious; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Zidovudine | 2018 |
Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Interactions; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2018 |
First reported use of zidovudine for prevention of perinatal HIV transmission in a premature neonate on extra corporal membrane oxygenation.
Topics: Administration, Intravenous; Anti-HIV Agents; Chemoprevention; Disease Transmission, Infectious; Extracorporeal Membrane Oxygenation; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Plasma; Zidovudine | 2018 |
Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
Topics: Adult; Anti-HIV Agents; Antimalarials; Cross-Sectional Studies; Drug Interactions; Female; Fetal Blood; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kenya; Lamivudine; Malaria; Mefloquine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2018 |
P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.
Topics: Benzenesulfonates; Down-Regulation; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Interleukin-10; Interleukin-1beta; Models, Biological; Palatine Tonsil; Purinergic P2X Receptor Antagonists; Pyridines; Tetrazoles; Tissue Culture Techniques; Virulence; Zidovudine | 2019 |
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Pharmacovigilance; Sex Factors; Young Adult; Zidovudine | 2018 |
Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2018 |
Versatile iron-catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy.
Topics: Anti-HIV Agents; Catechols; Cell Line; Drug Carriers; Drug Liberation; Drug Stability; HIV Infections; HIV-1; Humans; Ligands; Nanoparticles; Polymers; Zidovudine | 2018 |
Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015.
Topics: Adult; Anti-HIV Agents; China; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Retrospective Studies; Stavudine; Sustained Virologic Response; Tenofovir; Zidovudine | 2018 |
Antiretroviral Drug Concentrations in Breastmilk, Maternal HIV Viral Load, and HIV Transmission to the Infant: Results From the BAN Study.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Middle Aged; Milk, Human; Pregnancy; Ritonavir; RNA, Viral; Viral Load; Young Adult; Zidovudine | 2019 |
Zidovudine, tenofovir or abacavir? Different adverse effect profiles.
Topics: Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2016 |
Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cameroon; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2019 |
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
Topics: Adolescent; Adult; Anti-HIV Agents; Cameroon; Child; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir; Young Adult; Zidovudine | 2019 |
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient.
Topics: Aged; Anti-HIV Agents; Diabetes Mellitus; Drug Substitution; Glycated Hemoglobin; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Rilpivirine; Zidovudine | 2019 |
Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Stavudine; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2019 |
Reducing Hematologic Toxicity With Short Course Postexposure Prophylaxis With Zidovudine for HIV-1 Exposed Infants With Low Transmission Risk.
Topics: Anti-HIV Agents; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Diseases; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Retrospective Studies; Zidovudine | 2019 |
Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Topics: Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Cohort Studies; Drug Combinations; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Malawi; Male; Post-Exposure Prophylaxis; Postpartum Period; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Ritonavir; Uganda; Zidovudine | 2019 |
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2019 |
A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Ethiopia; Female; Genome-Wide Association Study; Genotype; HIV Infections; HIV Integrase; HIV-1; Humans; Male; Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Zidovudine | 2019 |
Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Leukocytes, Mononuclear; Male; Maternal-Fetal Exchange; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Telomere; United States; Young Adult; Zidovudine | 2019 |
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
Topics: Anti-Retroviral Agents; Chemoprevention; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Post-Exposure Prophylaxis; Prospective Studies; Thailand; Treatment Outcome; Zidovudine | 2019 |
Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV.
Topics: Adult; Cohort Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Logistic Models; Mycoplasma genitalium; Mycoplasma Infections; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2019 |
Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
Topics: Adolescent; Adult; Age Factors; Albuminuria; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Sex Factors; Tenofovir; Young Adult; Zidovudine | 2020 |
Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania.
Topics: Adolescent; Adult; Anti-HIV Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hematocrit; Hematologic Diseases; Hematologic Tests; Hemoglobins; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Tanzania; Young Adult; Zidovudine | 2013 |
Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Topics: Adult; Aged, 80 and over; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Interviews as Topic; Male; Metabolic Diseases; Middle Aged; Prevalence; Risk Factors; Stavudine; Surveys and Questionnaires; Zidovudine | 2012 |
Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Corneal Dystrophies, Hereditary; Didanosine; Electroretinography; HIV Infections; Humans; Male; Middle Aged; Retina; Visual Acuity; Zidovudine | 2013 |
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; India; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Program Evaluation; Prospective Studies; Socioeconomic Factors; Viral Load; Young Adult; Zidovudine | 2013 |
National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?
Topics: AIDS Serodiagnosis; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Data Collection; Delivery, Obstetric; Europe; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Surveys and Questionnaires; Zidovudine | 2013 |
High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships.
Topics: Anti-HIV Agents; Blood Chemical Analysis; Disease Transmission, Infectious; Female; Hemoglobins; HIV Infections; Humans; Infant, Newborn; Lactates; Male; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2013 |
Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
Topics: Adult; Anemia; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Retrospective Studies; Risk Factors; Stavudine; Zidovudine | 2013 |
Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination.
Topics: Adult; Anti-HIV Agents; Antigens, CD34; Cell Cycle; DNA Repair; Drug Combinations; Female; Fetal Blood; Gene Expression Profiling; Hematopoietic Stem Cells; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Karyotyping; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Stem Cells; Transcriptome; Young Adult; Zidovudine | 2013 |
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine | 2013 |
Talk of HIV cure goes viral.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Child, Preschool; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Nevirapine; Primary Prevention; Ritonavir; Secondary Prevention; Time Factors; Zidovudine | 2013 |
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
Topics: Adult; Africa, Southern; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections; Humans; International Cooperation; Male; Middle Aged; Treatment Outcome; Zidovudine | 2013 |
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine | 2013 |
Antiretroviral drugs in Africa: a public health versus a market approach.
Topics: Africa; Anti-HIV Agents; Drug Packaging; Health Resources; Health Services Accessibility; HIV Infections; Humans; Lamivudine; Nevirapine; Public Health; Zidovudine | 2013 |
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Thymidine; Treatment Failure; Viral Load; Zidovudine | 2013 |
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
Topics: Adenine; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Databases, Factual; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Mutation, Missense; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Tenofovir; Zidovudine | 2013 |
Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; Health Resources; HIV; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Residence Characteristics; RNA, Viral; Stavudine; Tenofovir; Young Adult; Zidovudine | 2013 |
Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematologic Tests; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Thailand; Treatment Outcome; Viral Load; Zidovudine | 2013 |
Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Organophosphonates; Prospective Studies; Tenofovir; Zidovudine | 2013 |
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Topics: Adult; Anti-HIV Agents; Antibiotic Prophylaxis; Chi-Square Distribution; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Viral Load; Zidovudine | 2013 |
Economic evaluation of 3-drug antiretroviral regimens for the prevention of mother-to-child HIV transmission in Thailand.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Health Services; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Models, Econometric; Mothers; Nevirapine; Pregnancy; Thailand; Zidovudine | 2015 |
Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asia, Southeastern; Child; Child, Preschool; Female; HIV Infections; Humans; Incidence; India; Kaplan-Meier Estimate; Male; Risk Factors; Treatment Outcome; Zidovudine | 2013 |
Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Caregivers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Medication Adherence; Middle Aged; Nevirapine; Odds Ratio; Stavudine; Surveys and Questionnaires; Tanzania; Young Adult; Zidovudine | 2013 |
Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine.
Topics: Adult; Anti-HIV Agents; Asian People; Body Mass Index; Bone Density; Bone Diseases, Metabolic; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Middle Aged; Odds Ratio; Osteoporosis; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors; Zidovudine | 2013 |
Predictors of 25-hydroxyvitamin D levels in HIV-infected patients in Hawai'i.
Topics: Anti-HIV Agents; Body Mass Index; Cross-Sectional Studies; Female; Hawaii; HIV Infections; Humans; Male; Middle Aged; Risk Factors; Seasons; Vitamin D; Vitamin D Deficiency; White People; Zidovudine | 2013 |
A conversation with Catherine M. Wilfert, MD by Stanford T. Shulman.
Topics: Anti-HIV Agents; Female; Global Health; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pediatrics; Pregnancy; United States; Zidovudine | 2012 |
Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Ukraine; Young Adult; Zidovudine | 2013 |
Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; HIV Infections; Humans; Infant; Male; United States; United States Food and Drug Administration; World Health Organization; Zidovudine | 2013 |
Clinical experience of raltegravir with abacavir/lamivudine or zidovudine/lamivudine in HIV-infected Korean adults.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lipids; Male; Middle Aged; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; Republic of Korea; Retrospective Studies; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2013 |
Robust joint modeling of longitudinal measurements and time to event data using normal/independent distributions: a Bayesian approach.
Topics: Bayes Theorem; Biometry; Clinical Trials as Topic; HIV Infections; Humans; Longitudinal Studies; Markov Chains; Models, Statistical; Monte Carlo Method; Multivariate Analysis; Survival Analysis; Time Factors; Zidovudine | 2013 |
[Ophthalmological alterations at the initial diagnosis of HIV infection].
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Cyclohexanes; Deoxycytidine; Drug Therapy, Combination; Early Diagnosis; Emtricitabine; Eye Infections, Viral; HIV Infections; Humans; Lopinavir; Male; Maraviroc; Organophosphonates; Retinal Diseases; Syndrome; Tenofovir; Treatment Outcome; Triazoles; Zidovudine | 2014 |
HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Resistance, Viral; Epidemiological Monitoring; Female; Ghana; HIV Infections; HIV Protease; HIV-1; Humans; Infant; Lamivudine; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Mutation, Missense; Nevirapine; Prevalence; Sequence Analysis, DNA; Stavudine; Zidovudine | 2013 |
Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
Topics: Adolescent; Adult; Anemia; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Longitudinal Studies; Male; Middle Aged; Nevirapine; Risk Factors; Social Class; Surveys and Questionnaires; Zidovudine | 2013 |
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.
Topics: Adenine; Adult; Anti-HIV Agents; Biomarkers; Blood Coagulation; Cardiovascular Diseases; Dideoxynucleosides; Endothelium, Vascular; Female; HIV Infections; Humans; Inflammation; Male; Middle Aged; Organophosphonates; Risk Factors; Tenofovir; Zidovudine | 2014 |
High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Topics: Adolescent; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nevirapine; Outcome Assessment, Health Care; Prevalence; South Africa; Stavudine; Young Adult; Zidovudine | 2013 |
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Viral Load; Zidovudine | 2014 |
Child cured of HIV: can this be repeated?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2013 |
Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Macrocytic; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cholesterol, HDL; Cholesterol, LDL; Erythrocyte Indices; Female; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2013 |
Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Topics: Africa, Western; Anemia; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; HIV Infections; Humans; Male; Retrospective Studies; Zidovudine | 2013 |
Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Linear Models; Male; Middle Aged; Nigeria; Retrospective Studies; Reverse Transcriptase Inhibitors; Rural Population; Socioeconomic Factors; Time Factors; Treatment Outcome; Zidovudine | 2014 |
[Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar].
Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Senegal; Zidovudine | 2013 |
Effects of combined zidovudine/lopinavir/ritonavir therapy during rat pregnancy: morphological aspects.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Fetus; HIV Infections; HIV Protease Inhibitors; Kidney; Liver; Lopinavir; Pancreas; Pregnancy; Pregnancy Complications, Infectious; Rats; Rats, Wistar; Ritonavir; Zidovudine | 2013 |
Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Retreatment; South Africa; Stavudine; Tenofovir; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cross-Sectional Studies; Female; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Zidovudine | 2014 |
An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Stavudine; Zidovudine | 2014 |
Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection.
Topics: Adult; Anti-HIV Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Coinfection; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria, Falciparum; Nevirapine; Parasite Load; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Quinidine; Quinine; Stavudine; Treatment Outcome; Young Adult; Zidovudine | 2014 |
Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
Topics: Adolescent; Adult; Amodiaquine; Anti-Retroviral Agents; Antimalarials; Antiretroviral Therapy, Highly Active; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Malaria; Male; Middle Aged; Nevirapine; Nigeria; Plasma; Young Adult; Zidovudine | 2014 |
Health literacy predicts pediatric dosing accuracy for liquid zidovudine.
Topics: Adolescent; Adult; Anti-HIV Agents; Caregivers; Cross-Sectional Studies; Female; Health Literacy; HIV Infections; Humans; Male; Middle Aged; Mozambique; Young Adult; Zidovudine | 2014 |
Clinical profile and response to first-line ARV in HIV patients from Eastern UP and Bihar: a retrospective study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Young Adult; Zidovudine | 2013 |
Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.
Topics: Adult; Alkynes; Area Under Curve; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Pharmacogenetics; Reverse Transcriptase Inhibitors; Treatment Outcome; Uganda; Zidovudine | 2014 |
Demographic and management trends among HIV-positive pregnant women over 10 years at one Canadian urban hospital.
Topics: Adolescent; Adult; Africa; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Canada; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Viral Load; Zidovudine | 2014 |
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prevalence; South Africa; Viral Load; Zidovudine | 2014 |
HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro.
Topics: Cell Line; Enfuvirtide; Hepacivirus; Hepatocytes; HIV Envelope Protein gp41; HIV Infections; Humans; Peptide Fragments; Pyrrolidinones; Raltegravir Potassium; Real-Time Polymerase Chain Reaction; Virus Replication; Zidovudine | 2014 |
Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; United Kingdom; Zidovudine | 2014 |
Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients.
Topics: Adenine; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation, Missense; Organophosphonates; Reverse Transcription; Tenofovir; Zidovudine | 2014 |
The financial and service implications of splitting fixed-dose antiretroviral drugs - a case study.
Topics: Adult; Aged; Anti-HIV Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Combinations; Drug Substitution; Female; Health Care Costs; HIV Infections; Humans; Lamivudine; Male; Treatment Outcome; Viral Load; Zidovudine | 2015 |
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2014 |
Clinical manifestations and treatment outcomes in HIV-1-infected children receiving antiretroviral therapy in Karachi, Pakistan.
Topics: Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Child, Preschool; Drug Resistance, Viral; Female; Genotype; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Pakistan; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abac
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatine Kinase; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Muscle Weakness; Myalgia; Pyrrolidinones; Raltegravir Potassium; Zidovudine | 2013 |
Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).
Topics: Alkynes; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Benzoxazines; Cell Line; Cognition Disorders; Cyclopropanes; Female; HIV Infections; Humans; Lamivudine; Mice; Oxidative Stress; Phagocytosis; Reverse Transcriptase Inhibitors; Zidovudine | 2014 |
Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV.
Topics: Adolescent; Anti-HIV Agents; Drug Combinations; Drug Hypersensitivity Syndrome; Female; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Lopinavir; Pleural Effusion; Postpartum Period; Pyrrolidinones; Radiography; Raltegravir Potassium; Respiratory Distress Syndrome; Ritonavir; Zidovudine | 2014 |
Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.
Topics: Anti-HIV Agents; Biodegradable Plastics; Cell Line; Drug Carriers; HIV Infections; HIV-1; Humans; Prodrugs; Zidovudine | 2015 |
Impact of Y181C and/or H221Y mutation patterns of HIV-1 reverse transcriptase on phenotypic resistance to available non-nucleoside and nucleoside inhibitors in China.
Topics: Alkynes; Benzoxazines; China; Cyclopropanes; Drug Resistance, Multiple, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2014 |
The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Birth Weight; Cesarean Section; Child; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Italy; Male; Pediatrics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Viral Load; Young Adult; Zidovudine | 2014 |
A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Retrospective Studies; Thailand; Young Adult; Zidovudine | 2014 |
A new antiviral: chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; In Vitro Techniques; Lamivudine; Palatine Tonsil; Thymine Nucleotides; Virus Replication; Zidovudine | 2014 |
Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin.
Topics: Adolescent; Adult; Anemia; Anti-Retroviral Agents; Chemoprevention; Cross-Sectional Studies; Erythrocyte Count; Erythropoiesis; Female; Hemoglobins; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Young Adult; Zidovudine | 2014 |
Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Fetus; HIV Infections; Humans; Labor, Obstetric; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2014 |
Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Post-Exposure Prophylaxis; Retrospective Studies; Ritonavir; Zidovudine | 2014 |
Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort.
Topics: Adult; Anti-HIV Agents; Cause of Death; CD4 Lymphocyte Count; Cesarean Section; Disease Progression; Emergencies; Female; HIV Infections; HIV-1; Humans; Kenya; Maternal Mortality; Parturition; Postpartum Period; Prospective Studies; RNA, Viral; Young Adult; Zidovudine | 2014 |
Pure red cell aplasia induced by lamivudine without the influence of zidovudine in a patient infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopsy, Needle; Bone Marrow; Diagnosis, Differential; HIV Infections; Humans; Lamivudine; Male; Platelet Count; Red-Cell Aplasia, Pure; Young Adult; Zidovudine | 2014 |
Anaemia in pregnancy is associated with advanced HIV disease.
Topics: Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Incidence; Multivariate Analysis; Pregnancy; Pregnancy Complications, Hematologic; Prevalence; Retrospective Studies; Risk Factors; South Africa; Urinary Tract Infections; Zidovudine | 2014 |
Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; Chemical and Drug Induced Liver Injury; Early Diagnosis; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Stavudine; Zidovudine | 2014 |
Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction.
Topics: Animals; Anti-HIV Agents; Antioxidants; Aorta, Thoracic; Female; HIV Infections; Humans; Lamivudine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Superoxide Dismutase; Zidovudine | 2014 |
Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations.
Topics: Administration, Oral; Adolescent; Age Factors; Antiretroviral Therapy, Highly Active; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; Computer Simulation; Dideoxynucleosides; Drug Combinations; Drug Dosage Calculations; Drug Monitoring; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Male; Models, Statistical; Ritonavir; Silybin; Silymarin; Viral Load; Zidovudine | 2015 |
[HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART].
Topics: AIDS Dementia Complex; Anti-Retroviral Agents; Central Nervous System; Cognition Disorders; Darunavir; Disease Progression; Drug Resistance, Viral; Drug Substitution; HIV; HIV Infections; Humans; Male; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Ritonavir; RNA, Viral; Sulfonamides; Time Factors; Viremia; Zidovudine | 2014 |
Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs.
Topics: Anti-HIV Agents; Cell Line; Disulfides; Dose-Response Relationship, Drug; HIV Infections; HIV-1; Humans; Macromolecular Substances; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Structure-Activity Relationship; Time Factors; Zidovudine | 2014 |
Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient.
Topics: Anti-HIV Agents; Base Sequence; Defective Viruses; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immune Evasion; Integrases; Lamivudine; Leukocytes, Mononuclear; Lopinavir; Molecular Sequence Data; Proviruses; Sequence Analysis, DNA; Sequence Deletion; Viral Load; Zidovudine | 2015 |
Zidovudine as modern day salvage therapy for HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Male; Middle Aged; North Carolina; Retrospective Studies; Salvage Therapy; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2014 |
Estimating HIV-1 fitness characteristics from cross-sectional genotype data.
Topics: Anti-HIV Agents; Cross-Sectional Studies; Drug Resistance, Viral; Genetic Fitness; Genotype; HIV Infections; HIV-1; Humans; Indinavir; Models, Biological; Mutation; Treatment Outcome; Zidovudine | 2014 |
[To evaluate the changes in body composition in male human immunodeficiency virus-related lipodystrophy after different treatment regimens by dual-energy X-ray absorptiometry].
Topics: Absorptiometry, Photon; Adenine; Anti-HIV Agents; Antiviral Agents; Body Composition; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Organophosphonates; Stavudine; Tenofovir; Zidovudine | 2014 |
Human immunodeficiency virus post-exposure prophylaxis: primum non nocere.
Topics: Adult; Antiviral Agents; Bipolar Disorder; Cytochrome P-450 CYP3A Inhibitors; Dihydroergotamine; Drug Synergism; Drug Therapy, Combination; Ergotism; Female; HIV Infections; Humans; Hypotension, Orthostatic; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Ritonavir; Vasoconstrictor Agents; Zidovudine | 2015 |
Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir.
Topics: Aneuploidy; Anti-HIV Agents; Female; Fetal Blood; Gene Expression; Hematopoietic Stem Cells; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2015 |
Is HIV post-exposure prophylaxis required following occupational exposure to a source patient who is virologically suppressed on antiretroviral therapy?
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Post-Exposure Prophylaxis; Practice Guidelines as Topic; Risk Assessment; United Kingdom; United States; Viral Load; Zidovudine | 2015 |
Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Stavudine; Zidovudine | 2015 |
Placebo orthodoxy and the double standard of care in multinational clinical research.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Developed Countries; Developing Countries; Female; Healthcare Disparities; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; International Cooperation; Placebos; Pregnancy; Pregnancy Complications, Infectious; Research Design; Social Justice; Standard of Care; Zidovudine | 2015 |
Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Cost-Benefit Analysis; Female; Health Care Costs; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Life Expectancy; Point-of-Care Systems; Pregnancy; South Africa; Young Adult; Zidovudine | 2015 |
Bayesian modeling of the covariance structure for irregular longitudinal data using the partial autocorrelation function.
Topics: Analysis of Variance; Anti-HIV Agents; Bayes Theorem; Bias; CD4 Lymphocyte Count; Child; Computer Simulation; Data Interpretation, Statistical; Dose-Response Relationship, Drug; HIV Infections; Humans; Likelihood Functions; Linear Models; Longitudinal Studies; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 2015 |
Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; India; Male; Middle Aged; Retrospective Studies; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load; Weight Gain; Zidovudine | 2015 |
Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; Health Resources; HIV; HIV Infections; Humans; Lamivudine; Lesotho; Logistic Models; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load; Zidovudine | 2015 |
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine | 2015 |
Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.
Topics: Adolescent; Age Distribution; Alkynes; Ambulatory Care Facilities; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Comorbidity; Cyclopropanes; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Male; Nevirapine; Severity of Illness Index; Tanzania; Tuberculosis; Zidovudine | 2015 |
Progress Toward Eliminating Mother to Child Transmission of HIV in Kenya: Review of Treatment Guideline Uptake and Pediatric Transmission at Four Government Hospitals Between 2010 and 2012.
Topics: Adult; Anti-HIV Agents; Child; Cohort Studies; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Early Diagnosis; Female; Gestational Age; Government; Guideline Adherence; HIV Infections; Hospitals, Public; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Lamivudine; Medication Adherence; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2016 |
Management and outcomes of pregnancies among women with HIV in Oxford, UK, in 2008-2012.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cesarean Section; Female; Gestational Age; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Stillbirth; United Kingdom; Viral Load; Zidovudine | 2015 |
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mothers; Mutation; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; South Africa; Tenofovir; Viral Load; Zidovudine | 2015 |
Very early virological failure and drug resistance mutations in a woman on antiretroviral therapy in Eastern Cape, South Africa: a case report.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Multiple, Viral; Female; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Mutation; South Africa; Treatment Failure; Viral Load; Zidovudine | 2015 |
[Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Democratic Republic of the Congo; Disease Progression; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Ritonavir; Zidovudine | 2014 |
Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Kenya; Male; Middle Aged; Poverty Areas; Proportional Hazards Models; Prospective Studies; Sex Factors; Survival Rate; Treatment Outcome; Young Adult; Zidovudine | 2015 |
Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Drug Combinations; Female; Ghana; HIV Infections; Hospitals, Teaching; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Middle Aged; Occupational Exposure; Post-Exposure Prophylaxis; Young Adult; Zidovudine | 2015 |
Nucleotide Sugar Pucker Preference Mitigates Excision by HIV-1 RT.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Nucleosides; Solid-Phase Synthesis Techniques; Zidovudine | 2015 |
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
Topics: Amino Acids, Branched-Chain; Anti-Retroviral Agents; Cameroon; Energy Metabolism; Female; HIV Infections; Humans; Infant; Insulin; Male; Nevirapine; Pregnancy; Prospective Studies; Zidovudine | 2015 |
Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Developing Countries; Female; HIV Infections; Home Childbirth; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Maternal Health Services; Nevirapine; Parity; Patient Dropouts; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Adolescence; Prenatal Care; Risk Factors; Socioeconomic Factors; South Africa; Zidovudine | 2015 |
Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.
Topics: Adult; Anti-HIV Agents; Biological Availability; Biological Transport; Blood Cells; Computer Simulation; Cytidine Triphosphate; Dideoxynucleotides; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Models, Statistical; Semen; Thymine Nucleotides; Time Factors; Zidovudine | 2015 |
Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Low Birth Weight; Live Birth; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Exposure Delayed Effects; Prevalence; Registries; Risk Factors; Stillbirth; Young Adult; Zidovudine | 2016 |
Prevalence of drug resistance mutations in HAART patients infected with HIV-1 CRF06_cpx in Estonia.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Resistance, Viral; Estonia; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Prevalence; Reverse Transcriptase Inhibitors; Zidovudine | 2016 |
Late ELISA Testing in Infants Born to HIV-Positive Mothers.
Topics: Anti-HIV Agents; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2016 |
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; Humans; India; Lamivudine; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2016 |
Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Medication Adherence; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Prospective Studies; Referral and Consultation; Risk Factors; Rural Health Services; Self Report; Time Factors; Young Adult; Zambia; Zidovudine | 2015 |
Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?
Topics: Adult; Anti-HIV Agents; Attitude of Health Personnel; Communication; Disclosure; Drug Combinations; Female; HIV Infections; Humans; Interviews as Topic; Lamivudine; Male; Medication Adherence; Middle Aged; Office Visits; Patient Care; Physician-Patient Relations; Zidovudine | 2016 |
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Coinfection; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin; Tenofovir; Zidovudine | 2015 |
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Quebec; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2015 |
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2016 |
Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.
Topics: Animals; Anti-HIV Agents; Dideoxynucleosides; Drug Therapy, Combination; Hep G2 Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mice; Nanogels; Polyethylene Glycols; Polyethyleneimine; Polylysine; Reverse Transcriptase Inhibitors; Zidovudine | 2015 |
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; Case-Control Studies; Cyclopropanes; DNA, Mitochondrial; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Lopinavir; Male; Middle Aged; Mitochondria; Nelfinavir; Predictive Value of Tests; Ritonavir; ROC Curve; Stavudine; Zidovudine | 2015 |
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; HIV-2; Humans; Kidney; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Salvage Therapy; Viral Load; Zidovudine | 2016 |
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.
Topics: Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine | 2015 |
Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Brazil; Case-Control Studies; Female; France; Gestational Age; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Live Birth; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Prenatal Exposure Delayed Effects; Prevalence; Prospective Studies; Registries; Risk Factors; South Africa; Uganda; United Kingdom; United States; Young Adult; Zidovudine | 2016 |
Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
Topics: Adult; Anti-Retroviral Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Maternal Exposure; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; United States; Young Adult; Zidovudine | 2016 |
Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.
Topics: 20-alpha-Hydroxysteroid Dehydrogenase; Animals; Anti-HIV Agents; Cells, Cultured; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Mice; Mice, Inbred C57BL; Placenta; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Prolactin; Ritonavir; Trophoblasts; Zidovudine | 2016 |
Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
Topics: Anti-HIV Agents; HeLa Cells; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Zidovudine | 2015 |
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Cloning, Molecular; Dideoxynucleotides; Drug Resistance, Multiple, Viral; Enzyme Inhibitors; Escherichia coli; Gene Expression; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Recombinant Proteins; Ribonuclease H, Human Immunodeficiency Virus; Thymine Nucleotides; Zidovudine | 2016 |
High Plasma Concentrations of Zidovudine (AZT) Do Not Parallel Intracellular Concentrations of AZT-Triphosphates in Infants During Prevention of Mother-to-Child HIV-1 Transmission.
Topics: Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Dideoxynucleotides; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Male; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Thymine Nucleotides; Treatment Outcome; Young Adult; Zidovudine | 2016 |
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; South Africa; Stavudine; Young Adult; Zidovudine | 2016 |
Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.
Topics: Adult; Anti-HIV Agents; Echocardiography; Female; HIV Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Ventricular Remodeling; Zidovudine | 2016 |
Prevention of perinatal transmission of zidovudine- and nevirapine-resistant HIV.
Topics: Adolescent; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Viral Load; Zidovudine | 2016 |
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.
Topics: Adult; Africa South of the Sahara; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Coinfection; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Rifampin; Tuberculosis; Viral Load; Zidovudine | 2016 |
The ethics of expanding access to cheaper, less effective treatments.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Developed Countries; Developing Countries; Drug Administration Schedule; Ethical Theory; Global Health; Health Services Accessibility; HIV Infections; Humans; South Africa; Stavudine; Tenofovir; Treatment Outcome; United States; United States Food and Drug Administration; World Health Organization; Zidovudine | 2016 |
Bayesian optimal response-adaptive design for binary responses using stopping rule.
Topics: Anti-HIV Agents; Bayes Theorem; Biostatistics; Clinical Trial Protocols as Topic; Clinical Trials, Phase III as Topic; Computer Simulation; Early Termination of Clinical Trials; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2018 |
[CLINICAL AND PHARMACOECONOMIC RESULTS OF THE USAGE OF VARIOUS HIV REVERSE TRANSCRIPTASE INHIBITORS IN THE SCHEMES OF ANTIRETROVIRAL THERAPY OF PATIENT RECEIVING THERAPY FOR THE CHRONIC HEPATITIS C VIRUS].
Topics: Adult; Alanine Transaminase; Biomarkers; Blood Platelets; CD4-Positive T-Lymphocytes; Cell Count; Coinfection; Dideoxynucleosides; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2016 |
Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Chi-Square Distribution; Female; Hematologic Diseases; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prospective Studies; Zidovudine | 2016 |
A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Algorithms; Antiretroviral Therapy, Highly Active; Blood Pressure; Cameroon; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; Humans; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Zidovudine | 2016 |
Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
Topics: Adult; Aged; Ambulatory Care Facilities; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Cross-Sectional Studies; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Tanzania; Young Adult; Zidovudine | 2016 |
Thailand eliminates mother-to-child transmission of HIV and syphilis.
Topics: Anti-HIV Agents; Disease Eradication; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Syphilis; Thailand; Zidovudine | 2016 |
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Zidovudine | 2016 |
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Coinfection; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Ethiopia; Female; Genetic Variation; Genome, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Immune Evasion; Lamivudine; Male; Mutation; Stavudine; Viral Load; Zidovudine | 2017 |
Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Dideoxynucleosides; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Indonesia; Lamivudine; Male; Prospective Studies; Ritonavir; Thailand; Treatment Outcome; Vietnam; Viral Load; Zidovudine | 2016 |
Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Autophagy; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondria; Mitochondrial Turnover; Oxidative Stress; T-Lymphocytes; Zidovudine | 2016 |
Early infant diagnosis of HIV infection using DNA-PCR at a referral center: an 8 years retrospective analysis.
Topics: Anti-HIV Agents; DNA, Viral; Early Diagnosis; Ethiopia; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Zidovudine | 2016 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine | 2016 |
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa.
Topics: Africa South of the Sahara; Alkynes; Anti-HIV Agents; Attitude to Health; Benzoxazines; Caregivers; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; Humans; Infant; Lamivudine; Linear Models; Logistic Models; Male; Medication Adherence; Multivariate Analysis; Nevirapine; Randomized Controlled Trials as Topic; Stavudine; Surveys and Questionnaires; Uganda; Zambia; Zidovudine | 2017 |
Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Nigeria; Retrospective Studies; Tenofovir; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2016 |
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
Topics: Adult; Africa South of the Sahara; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Drug Substitution; Drug Utilization; Female; Health Policy; HIV Infections; Humans; Male; Prospective Studies; Stavudine; Tenofovir; Zidovudine | 2017 |
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleotides; Female; HIV Infections; HIV Wasting Syndrome; Humans; Infant; Lamivudine; Malawi; Male; Proportional Hazards Models; Retrospective Studies; Rural Population; Stavudine; Survival Analysis; Tuberculosis, Pulmonary; Zidovudine | 2016 |
Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Topics: Animals; Cells, Cultured; DNA, Mitochondrial; HIV Infections; Mice, Inbred C57BL; Mitochondria; Neurocognitive Disorders; Neurons; Reverse Transcriptase Inhibitors; Zidovudine | 2017 |
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2).
Topics: Anti-HIV Agents; Drug Design; HIV Infections; HIV-1; Humans; Patents as Topic; Reverse Transcriptase Inhibitors; Triazines; Zidovudine | 2017 |
Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.
Topics: Alkynes; Animals; Anti-Retroviral Agents; Benzoxazines; Cell Line, Tumor; Cyclopropanes; Drug Combinations; Female; Half-Life; HIV Infections; HIV-1; Humans; Lactoferrin; Lamivudine; Male; Nanoparticles; Rats; Rats, Wistar; Tissue Distribution; Zidovudine | 2017 |
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lamivudine; Lopinavir; Male; Nevirapine; Phylogeny; Ritonavir; Zidovudine | 2016 |
Antiretrovirals causing severe pre-eclampsia.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delivery, Obstetric; Female; HIV Infections; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Lamivudine; Nevirapine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2016 |
Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.
Topics: Anti-HIV Agents; Child; Europe; HIV Infections; Humans; Lamivudine; Tablets; Thailand; Zidovudine | 2017 |
High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy.
Topics: Adult; Anti-Retroviral Agents; Botswana; Case-Control Studies; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Maternal Death; Medication Adherence; Mothers; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Survival Analysis; Zidovudine | 2017 |
Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.
Topics: Adult; Africa, Western; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Incidence; Male; Neutropenia; Retrospective Studies; Severity of Illness Index; Zidovudine | 2017 |
Role of inosine triphosphate pyrophosphatase gene variant on fever incidence during zidovudine antiretroviral therapy.
Topics: Antiviral Agents; Brazil; Fever; Genotype; HIV Infections; Humans; Incidence; Pyrophosphatases; Zidovudine | 2017 |
Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.
Topics: Adult; Age Factors; Anti-HIV Agents; Female; HIV Infections; Humans; Kenya; Male; Middle Aged; Polyneuropathies; Prevalence; Retrospective Studies; Risk Factors; Sex Workers; Stavudine; Tenofovir; Zidovudine | 2016 |
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Nevirapine; Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Thymidine; Treatment Failure; Viral Load; Zidovudine | 2017 |
First-line antiretroviral drug discontinuations in children.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Follow-Up Studies; HIV; HIV Infections; Humans; Infant; Kaplan-Meier Estimate; Lopinavir; Outcome Assessment, Health Care; Proportional Hazards Models; Ritonavir; South Africa; Stavudine; Withholding Treatment; Zidovudine | 2017 |
Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Case-Control Studies; Contraindications; Cross-Sectional Studies; DNA, Mitochondrial; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Infant, Small for Gestational Age; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Oxidative Stress; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Spain; Zidovudine | 2017 |
Triple-drug antiretroviral therapy results in lower HIV maternal-fetal transmission rates but increased adverse effects compared with zidovudine alone.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Zidovudine | 2017 |
A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity.
Topics: Computer Simulation; Coumarins; DNA; Dose-Response Relationship, Drug; HIV Infections; HIV Reverse Transcriptase; Ions; Kinetics; Magnesium; Molecular Dynamics Simulation; Mutation; Nucleotides; Protein Conformation; Reverse Transcriptase Inhibitors; Software; Substrate Specificity; Temperature; Thermodynamics; Thymine Nucleotides; Zidovudine | 2017 |
Breast-feeding, antiretroviral prophylaxis, and HIV.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Weaning; Zidovudine | 2008 |
[Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Congo; Cyclopropanes; Didanosine; Drug Evaluation; Drug Therapy, Combination; Female; Hematology; HIV Infections; Hospital Departments; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
FDA notifications. FDA approval for generic lamivudine/zidovudine.
Topics: Drug Approval; Drugs, Generic; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2008 |
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
Topics: Adult; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Models, Biological; Mutation; Nelfinavir; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Failure; Viral Load; Zidovudine | 2008 |
Rapid human immunodeficiency virus testing on labor and delivery.
Topics: Adolescent; Antiviral Agents; Blotting, Western; Contact Tracing; Female; Fetal Membranes, Premature Rupture; HIV Infections; Humans; Immunoenzyme Techniques; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Care; Reagent Kits, Diagnostic; Zidovudine | 2008 |
HIV and obstetric complications and fetal outcomes in Vellore, India.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; HIV Seronegativity; Humans; India; Infant; Infectious Disease Transmission, Vertical; Medical Audit; Nevirapine; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Zidovudine | 2008 |
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; HIV-1; Humans; Hypertension, Portal; Lamivudine; Male; Middle Aged; Risk Factors; Thrombophilia; Viral Load; Zidovudine | 2008 |
Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.
Topics: Amino Acid Sequence; Anti-HIV Agents; Codon; Crystallography, X-Ray; Deoxycytosine Nucleotides; DNA, Viral; Drug Resistance, Multiple, Viral; Foscarnet; HIV Infections; HIV Reverse Transcriptase; Humans; Lamivudine; Models, Molecular; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; Protein Conformation; Reverse Transcriptase Inhibitors; Sequence Alignment; Sequence Deletion; Zidovudine | 2008 |
Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a program setting in rural Cambodia.
Topics: Anemia; Antiretroviral Therapy, Highly Active; Body Mass Index; Cambodia; CD4 Lymphocyte Count; HIV Infections; Humans; Patient Compliance; Retrospective Studies; Risk Factors; Rural Population; Stavudine; Zidovudine | 2008 |
Variable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982-2005.
Topics: Adult; Anti-HIV Agents; Australia; Breast Feeding; Cesarean Section; Drug Utilization; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Patient Compliance; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2008 |
Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
Topics: Adolescent; Adult; Anti-HIV Agents; Birth Certificates; Cohort Studies; Female; Healthcare Disparities; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Logistic Models; New Jersey; Patient Acceptance of Health Care; Population Surveillance; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Premedication; Prenatal Care; Registries; Zidovudine | 2008 |
A review of the prevention of mother-to-child transmission programme of the Western Cape provincial government, 2003 - 2004.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Program Evaluation; Retrospective Studies; Rural Population; South Africa; Urban Population; Zidovudine | 2008 |
FDA notifications. Generic zidovudine oral solution approved.
Topics: Administration, Oral; Drug Approval; Drugs, Generic; HIV Infections; Reverse Transcriptase Inhibitors; Solutions; United States; United States Food and Drug Administration; Zidovudine | 2008 |
Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Nevirapine; Perinatal Mortality; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Zidovudine | 2008 |
A case of human bite by an 11-year old HIV positive girl in a paediatrics ward.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Bites, Human; Child; Cyclopropanes; Female; HIV Infections; Humans; Inpatients; Lamivudine; Male; Zidovudine | 2008 |
Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Salvage Therapy; Stavudine; Thymidine; Treatment Outcome; Zidovudine | 2008 |
Incidence of abacavir hypersensitivity reactions in euroSIDA.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Europe; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Middle Aged; Poisson Distribution; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2008 |
Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cohort Studies; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lamivudine; Lopinavir; Male; Multivariate Analysis; Pyrimidinones; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; South Africa; Stavudine; Treatment Outcome; Zidovudine | 2008 |
Cariogenic and erosive potential of the medication used by HIV-infected children: pH and sugar concentration.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Azithromycin; Cariogenic Agents; Chromatography, Thin Layer; Dental Caries; Dideoxynucleosides; Fructose; Glucose; HIV Infections; Humans; Hydrogen-Ion Concentration; Lactose; Sucrose; Tooth Erosion; Zidovudine | 2008 |
Zidovudine monotherapy in pregnancy: is it state of the art?
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2008 |
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
Topics: Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation; Postpartum Period; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Polymerase Chain Reaction; Viral Load; Zidovudine | 2008 |
Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Topics: Anti-Retroviral Agents; Breast Feeding; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine | 2008 |
HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
Topics: Adolescent; Animals; Anti-HIV Agents; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Macaca mulatta; Pyrimidinones; Sex Offenses; Zidovudine | 2008 |
HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Breast Feeding; Cesarean Section; Child; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pregnancy Trimester, Third; Risk Assessment; United States; Zidovudine | 2008 |
Tolerability of fosamprenavir/ritonavir associated with zidovudine-lamivudine used as postexposure prophylaxis for HIV infection.
Topics: Adult; Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Female; Furans; HIV Infections; Humans; Lamivudine; Male; Organophosphates; Prospective Studies; Ritonavir; Sulfonamides; Zidovudine | 2008 |
Recurrent Mycoplasma pneumoniae infection in a human immunodeficiency virus-positive child.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Child; Doxycycline; Fatal Outcome; Female; HIV Infections; Humans; Lymphoma, AIDS-Related; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Recurrence; Sepsis; Zidovudine | 2008 |
Nonparametric comparison of two survival functions with dependent censoring via nonparametric multiple imputation.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Dideoxynucleotides; HIV Infections; Humans; Placebos; Statistics, Nonparametric; Survival Analysis; Thymine Nucleotides; Zidovudine | 2009 |
[A case of acquired encephalopathy in a child. A cause that we thought had disappeared].
Topics: AIDS Dementia Complex; Anti-HIV Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Polymerase Chain Reaction; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2008 |
Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1.
Topics: Base Sequence; Case-Control Studies; DNA Primers; DNA, Mitochondrial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Mutation; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; RNA, Transfer; Umbilical Cord; Zidovudine | 2009 |
[Maternofetal transmission of HIV].
Topics: Abortion, Eugenic; AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Zidovudine | 2008 |
Retrovir efficacy supplement approved.
Topics: Administration, Oral; Adolescent; Anti-HIV Agents; Capsules; Child; Child, Preschool; Dosage Forms; Drug Approval; Drug Labeling; HIV Infections; Humans; Infant; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2008 |
FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
Topics: Child, Preschool; Drug Approval; HIV Infections; Humans; Infant; Pediatrics; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2008 |
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood; Breast Feeding; Clinical Trials, Phase II as Topic; Desiccation; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lactation; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Young Adult; Zidovudine | 2009 |
A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; India; Lamivudine; Male; Medication Adherence; Nevirapine; Prospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2009 |
Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India.
Topics: Adolescent; Adult; Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; India; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Young Adult; Zidovudine | 2009 |
[Analysis of pre-treatment screening on 160 HIV/AIDS patients receiving highly active antiretroviral therapy ( AZT +3TC + EFV) treatment].
Topics: Adult; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome; Zidovudine | 2008 |
Zidovudine monotherapy in pregnancy: is it state of the art?
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2009 |
Variable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982-2005. Comment.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; New South Wales; Patient Compliance; Pregnancy; Risk Factors; Western Australia; Zidovudine | 2009 |
Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; China; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epidemiologic Methods; Family Health; Female; HIV Infections; Humans; Male; Middle Aged; Taiwan; Young Adult; Zidovudine | 2009 |
Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat.
Topics: Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Lamivudine; Lipids; Lipodystrophy; Organophosphorus Compounds; Viral Load; Zidovudine | 2008 |
What is the best standard for the standard of care in clinical research?
Topics: Anti-HIV Agents; Control Groups; Developed Countries; Developing Countries; Drug Administration Schedule; Ethics, Research; Guidelines as Topic; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Internationality; Quality of Health Care; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 2009 |
Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Interleukin-10; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Young Adult; Zidovudine | 2009 |
Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.
Topics: Adult; Antiretroviral Therapy, Highly Active; Didanosine; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation, Missense; Nelfinavir; Phylogeny; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Selection, Genetic; Zidovudine | 2009 |
Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages.
Topics: Cell Membrane; Cell Movement; Chemotaxis; Endothelial Cells; HIV Infections; HIV-1; Humans; Macrophages; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Zidovudine | 2009 |
Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; India; Poverty; Stavudine; Treatment Outcome; Zidovudine | 2009 |
Resistance to antiretrovirals in HIV-infected pregnant women.
Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Viral Load; Zidovudine | 2009 |
Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Substance Abuse, Intravenous; Ukraine; Zidovudine | 2009 |
Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance.
Topics: Acquired Immunodeficiency Syndrome; Africa, Western; Amino Acid Substitution; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Viral; Genetic Predisposition to Disease; HIV Infections; HIV-1; HIV-2; Humans; Mutagenesis, Site-Directed; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 2009 |
The obstetric face and challenge of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Developing Countries; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal Mortality; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; World Health Organization; Zidovudine | 2009 |
Lamivudine/zidovudine: paediatric indication. For certain HIV-infected children.
Topics: Child; Drug Approval; Drug Therapy, Combination; Europe; HIV Infections; Humans; Lamivudine; Zidovudine | 2008 |
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Gambia; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Lamivudine; Longitudinal Studies; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Pyrimidinones; Ritonavir; Sequence Analysis, DNA; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation, Missense; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2009 |
Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leucine; Mutation; Polymorphism, Genetic; Virus Replication; Zidovudine | 2009 |
CCR2-64I polymorphism is associated with lower maternal HIV-1 viral load and reduced vertical HIV-1 transmission.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; Genetic Predisposition to Disease; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Polymorphism, Genetic; Pregnancy; Receptors, CCR2; Viral Load; Zidovudine | 2009 |
Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Topics: Adolescent; Adult; Anti-HIV Agents; Blood; Chemoprevention; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Mothers; Nevirapine; Thailand; Young Adult; Zidovudine | 2009 |
Virological and immunological stability in HIV infected patients undergoing partial-treatment interruption.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Combinations; Drug Resistance, Viral; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Peptide Fragments; Treatment Outcome; Viral Load; Withholding Treatment; Zidovudine | 2009 |
Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Emigrants and Immigrants; Ethiopia; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Israel; Middle Aged; National Health Programs; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Reverse Transcriptase Inhibitors; Viral Load; Young Adult; Zidovudine | 2009 |
[Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blepharoptosis; Female; HIV Infections; Humans; Hyperpigmentation; Mitochondria; Zidovudine | 2009 |
Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Jamaica; Lamivudine; Male; Medication Adherence; Nevirapine; Surveys and Questionnaires; Young Adult; Zidovudine | 2008 |
Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Child; Child Welfare; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Jamaica; Male; Prospective Studies; Surveys and Questionnaires; Young Adult; Zidovudine | 2008 |
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Stavudine; Young Adult; Zidovudine | 2009 |
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.
Topics: Adenine; Anti-HIV Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Mutation; Organophosphonates; Prospective Studies; Tenofovir; Viremia; Zidovudine | 2009 |
Evaluation of HIV/AIDS clinical care quality: the case of a referral hospital in North West Ethiopia.
Topics: Adolescent; Anti-HIV Agents; Antibiotic Prophylaxis; Child; Child, Preschool; Cross-Sectional Studies; Ethiopia; Female; Guideline Adherence; HIV Infections; Humans; Infant; Male; Outcome and Process Assessment, Health Care; Patient Satisfaction; Quality of Health Care; Stavudine; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult; Zidovudine | 2009 |
Feasibility of infant cord blood HIV testing for anti-retroviral post-exposure prophylaxis.
Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-Retroviral Agents; Breast Feeding; Feasibility Studies; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Male; Medication Adherence; Patient Acceptance of Health Care; Post-Exposure Prophylaxis; Pregnancy; Young Adult; Zidovudine | 2007 |
Response adaptive designs with a variance-penalized criterion.
Topics: Analysis of Variance; Anti-HIV Agents; Bias; Biometry; Clinical Trials as Topic; HIV Infections; Humans; Models, Statistical; Random Allocation; Randomized Controlled Trials as Topic; Zidovudine | 2009 |
Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Burkina Faso; CD4 Lymphocyte Count; DNA, Viral; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2009 |
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report.
Topics: Adult; Anti-HIV Agents; Antibodies, Viral; CD4 Lymphocyte Count; Female; Health Personnel; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Nurses; Occupational Exposure; Phylogeny; Pregnancy; Virus Replication; Zidovudine | 2009 |
Influence of development, HIV infection, and antiretroviral therapies on the gene expression profiles of ABC transporters in human lymphocytes.
Topics: Adolescent; Adult; Age Factors; Anti-HIV Agents; ATP-Binding Cassette Transporters; Child; Child, Preschool; Gene Expression Profiling; HIV Infections; Humans; Infant; Infant, Newborn; Lymphocytes; Zidovudine | 2010 |
High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; Humans; Lopinavir; Male; Pyrimidinones; Ritonavir; South Africa; Survival Analysis; Treatment Outcome; Viral Load; Zidovudine | 2010 |
Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis.
Topics: Anti-HIV Agents; Crime Victims; Disease Transmission, Infectious; Drug Combinations; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Pyrimidinones; Viral Load; Wounds, Stab; Zidovudine | 2010 |
Alternative dosage of zidovudine in infants exposed to maternal human immunodeficiency virus infection.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2009 |
Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Developing Countries; Female; Gastroenteritis; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Nevirapine; Randomized Controlled Trials as Topic; Risk Factors; Weaning; Zidovudine | 2010 |
Antiretroviral strategies to prevent mother-to-child transmission of HIV: striking a balance between efficacy, feasibility, and resistance.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2009 |
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.
Topics: Adult; Aged; Anti-Retroviral Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Intercellular Adhesion Molecule-1; Longitudinal Studies; Male; Matrix Metalloproteinase 9; Middle Aged; Peroxidase; Risk Factors; Vascular Cell Adhesion Molecule-1; Viral Load; Zidovudine | 2009 |
Treatment interruption after pregnancy: effects on disease progression and laboratory findings.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; RNA, Viral; Viral Load; Zidovudine | 2009 |
[News in the treatment of sexually transmitted diseases].
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Belgium; Ceftriaxone; Environmental Exposure; Female; Gonorrhea; HIV Infections; Humans; Male; Reimbursement Mechanisms; Sexually Transmitted Diseases; Zidovudine | 2009 |
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2010 |
FDA notifications. Zidovudine approved for pediatric use.
Topics: Child; Drug Approval; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2009 |
FDA notifications. Tentative approval given for combination of abacavir, lamivudine & zidovudine tablets.
Topics: Dideoxynucleosides; Drug Approval; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2009 |
Satisfactory cross-cultural validity of the ACTG symptom distress module in HIV-1-infected antiretroviral-naive patients.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cultural Competency; Cyclohexanes; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Language; Male; Maraviroc; Middle Aged; Multicenter Studies as Topic; Psychometrics; Randomized Controlled Trials as Topic; Reproducibility of Results; Stress, Psychological; Surveys and Questionnaires; Triazoles; Zidovudine | 2009 |
Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
Topics: Anti-HIV Agents; DNA, Mitochondrial; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Longitudinal Studies; Monocytes; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Exposure Delayed Effects; Reference Values; Reverse Transcriptase Inhibitors; Zidovudine | 2009 |
FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
Topics: Child; Drug Approval; Drug Combinations; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2009 |
Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy.
Topics: Acidosis, Lactic; Anti-HIV Agents; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infant, Newborn; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2009 |
Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.
Topics: Adult; Anemia; Anti-HIV Agents; Chemoprevention; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2010 |
Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1.
Topics: Alkynes; Alleles; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Polymerase Chain Reaction; Zidovudine | 2010 |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Pregnancy; Viral Load; Zidovudine | 2010 |
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Organophosphonates; RNA, Viral; Tenofovir; Treatment Failure; Viremia; Young Adult; Zidovudine | 2010 |
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.
Topics: Adenine; Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cost-Benefit Analysis; Female; HIV Infections; Humans; India; Male; Organophosphonates; Stavudine; Survival Analysis; Tenofovir; Treatment Outcome; Zidovudine | 2010 |
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cesarean Section; Delivery, Obstetric; Epidemiologic Methods; Europe; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Care; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Viral Load; Young Adult; Zidovudine | 2010 |
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Proportional Hazards Models; Prospective Studies; Pyridines; Pyrimidinones; Risk Factors; Switzerland; Tenofovir; Zidovudine | 2010 |
Response to Stegmann s, et Al. [J. Clin. Virol. 47 (1) (2010) 79-81].
Topics: Anti-HIV Agents; Foscarnet; HIV Infections; HIV-2; Humans; Salvage Therapy; Treatment Outcome; Viral Load; Zidovudine | 2010 |
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Models, Molecular; Mutation; Nevirapine; Protein Binding; Protein Structure, Tertiary; Zidovudine | 2010 |
Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing.
Topics: Adult; Anti-HIV Agents; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Peru; Retrospective Studies; Zidovudine | 2010 |
International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase.
Topics: Adenine; Amino Acid Substitution; Anti-HIV Agents; California; Cohort Studies; Drug Resistance, Viral; France; Genes, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Multivariate Analysis; Mutation, Missense; Organophosphonates; RNA, Viral; Tenofovir; Zidovudine | 2010 |
Thymidine kinase and deoxycytidine kinase in HIV-infected children.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Deoxycytidine Kinase; Female; HIV Infections; HIV-1; Humans; Infant; Leukocytes, Mononuclear; Male; Thymidine Kinase; Zidovudine | 2009 |
FDA notifications. Pediatric dosing recommendations revised.
Topics: HIV Infections; Humans; Infant, Newborn; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Mutation, Missense; Nevirapine; Pregnancy; Zidovudine | 2010 |
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Ligase Chain Reaction; Mutation, Missense; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Viral Load; Young Adult; Zidovudine | 2010 |
N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations.
Topics: Drug Resistance, Multiple, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Thymidine; Viral Load; Zidovudine | 2010 |
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.
Topics: Cell Line; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Ribonuclease H, Human Immunodeficiency Virus; Selection, Genetic; Statistics, Nonparametric; Zidovudine | 2010 |
Preventing perinatal transmission of HIV: your vigilance can pay off.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Disease Progression; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Care; Risk Assessment; Zidovudine | 2010 |
Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source.
Topics: Anti-HIV Agents; Child; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; HLA-A Antigens; HLA-B Antigens; HLA-DR Antigens; Host-Pathogen Interactions; Humans; Molecular Sequence Data; Polymorphism, Single Nucleotide; Viral Load; Zidovudine | 2010 |
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; India; Lamivudine; Molecular Sequence Data; Nevirapine; Polymorphism, Single Nucleotide; Stavudine; Treatment Failure; Zidovudine | 2010 |
Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Body Mass Index; CD4 Lymphocyte Count; Developing Countries; Drug Resistance, Viral; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; HIV Infections; HIV-1; Humans; Malawi; Male; Medication Adherence; Middle Aged; National Health Programs; Organophosphonates; Prospective Studies; RNA, Viral; Statistics as Topic; Tenofovir; Treatment Failure; Tuberculosis; Urban Population; Viral Load; Zidovudine | 2010 |
Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Evolution, Molecular; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation, Missense; Point Mutation; RNA, Viral; Selection, Genetic; Zidovudine | 2010 |
[Durability and tolerability of long-term nevirapine-based HAART].
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Comorbidity; Dideoxynucleosides; Female; Hepatitis, Viral, Human; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lipids; Liver Function Tests; Male; Middle Aged; Nevirapine; Retrospective Studies; Stavudine; Viral Load; Young Adult; Zidovudine | 2010 |
Exact inference for complex clustered data using within-cluster resampling.
Topics: Algorithms; Biometry; Biostatistics; CD4 Lymphocyte Count; Circadian Rhythm; Cluster Analysis; Computer Simulation; Heart; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Linear Models; Monte Carlo Method; Seizures; Viral Load; Zidovudine | 2010 |
Microparticulated anti-HIV vaginal gel: in vitro-in vivo drug release and vaginal irritation study.
Topics: Administration, Intravaginal; Administration, Oral; Animals; Area Under Curve; Cellulose; Delayed-Action Preparations; Diffusion; Female; HIV Infections; Humans; Rabbits; Rats; Rats, Wistar; Time Factors; Vaginal Creams, Foams, and Jellies; Zidovudine | 2011 |
Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; HIV Infections; HIV-1; Humans; Mitochondria; Prohibitins; Proteomics; Repressor Proteins; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stavudine; Zidovudine | 2010 |
Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia.
Topics: Antiretroviral Therapy, Highly Active; Breast Feeding; Child; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mother-Child Relations; Nevirapine; Odds Ratio; Polymerase Chain Reaction; Regression Analysis; Zambia; Zidovudine | 2010 |
CCR5, RANTES and SDF-1 polymorphisms and mother-to-child HIV-1 transmission.
Topics: Adolescent; Adult; Anti-HIV Agents; Body Fluids; Cervix Uteri; Chemokine CCL5; Chemokine CXCL12; Cohort Studies; Female; Genetic Predisposition to Disease; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Infectious; Receptors, CCR5; Viral Load; Viremia; Young Adult; Zidovudine | 2010 |
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Female; HIV Infections; Humans; Infant, Newborn; Male; Mitochondrial Diseases; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies; Regression Analysis; Stavudine; United States; Zidovudine | 2010 |
Recent FDA approvals and changes.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Capsules; Cyclopropanes; Dideoxynucleosides; Drug Approval; Drug Labeling; Drugs, Generic; HIV Infections; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R.
Topics: Adult; Amino Acid Substitution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Salvage Therapy; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2010 |
Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Topics: Adolescent; Adult; Age Distribution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Ethiopia; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; Male; Middle Aged; Neurologic Examination; Polyneuropathies; Prevalence; Risk Factors; Socioeconomic Factors; Stavudine; Young Adult; Zidovudine | 2010 |
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Body Weight; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethnicity; Female; Gestational Age; HIV Infections; Humans; Lopinavir; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimidinones; Racial Groups; Zidovudine | 2010 |
Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Burkina Faso; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Young Adult; Zidovudine | 2010 |
Efficacy and tolerability of zidovudine 200 mg twice a day as part of combination antiretroviral therapy for 96 weeks.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Male; Medication Adherence; Time Factors; Treatment Outcome; Zidovudine | 2010 |
Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.
Topics: Anti-HIV Agents; Blood Glucose; Clinical Laboratory Techniques; Cohort Studies; Cost-Benefit Analysis; Developing Countries; Haiti; Health Resources; HIV Infections; Humans; Hyperglycemia; Socioeconomic Factors; Zidovudine | 2010 |
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Malawi; Nevirapine; Plasma; Polymerase Chain Reaction; Postpartum Period; Pregnancy; RNA, Viral; Sequence Analysis, DNA; Young Adult; Zidovudine | 2010 |
Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Treatment Outcome; Zidovudine | 2010 |
Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Ireland; Monte Carlo Method; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Reverse Transcriptase Inhibitors; Risk Assessment; United Kingdom; Zidovudine | 2010 |
Recent FDA approvals and changes.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Approval; Drug Combinations; Drugs, Generic; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Nevirapine; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Tablets; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Genotypic and phenotypic cross-drug resistance of harboring drug-resistant HIV type 1 subtype B' strains from former blood donors in central Chinese provinces.
Topics: Adult; Anti-HIV Agents; Blood Donors; China; Didanosine; Drug Resistance, Multiple, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Phenotype; pol Gene Products, Human Immunodeficiency Virus; RNA, Viral; Sequence Analysis, RNA; Stavudine; Zidovudine | 2010 |
Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.
Topics: Cell Line; Cells, Cultured; Dideoxynucleosides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; Humans; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Stavudine; Virus Replication; Zidovudine | 2010 |
Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Eswatini; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Health Services; Neonatal Screening; Nevirapine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prevalence; Program Development; Program Evaluation; Rural Health; Zidovudine | 2010 |
Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
Topics: Animals; Anti-HIV Agents; Cardiomyopathies; Cardiotoxins; Dietary Supplements; DNA Copy Number Variations; DNA, Mitochondrial; Electron Transport Complex IV; Heart; HIV Infections; Mice; Mice, Inbred BALB C; Mitochondria, Heart; Mutation; Nucleosides; Pyrimidines; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Uridine; Zalcitabine; Zidovudine | 2010 |
HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Brazil; Cross-Sectional Studies; Feasibility Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Socioeconomic Factors; Young Adult; Zidovudine | 2010 |
Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.
Topics: Anti-HIV Agents; Blood; Colon; DNA, Viral; Drug Resistance, Viral; Duodenum; Esophagus; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lymph Nodes; Male; Mutation, Missense; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Stomach; Viral Load; Zidovudine | 2010 |
Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand.
Topics: Anemia; Confidence Intervals; Drug Monitoring; Female; Hematologic Tests; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Neutropenia; Neutrophils; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Thailand; Zidovudine | 2010 |
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Prospective Studies; Risk Factors; Sex Factors; Stavudine; Uganda; Zidovudine | 2011 |
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine | 2010 |
[Ultrastructural aspects of the HIV-1 infection in human placental villi with zidovudine treatment].
Topics: Adult; Anti-HIV Agents; Chorionic Villi; Cytopathogenic Effect, Viral; Female; HIV Infections; HIV-1; Humans; Microscopy, Electron; Organelles; Placental Insufficiency; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Zidovudine | 2010 |
Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
Topics: Administration, Oral; Animals; Anti-HIV Agents; HIV Infections; Mice; Polyethylene Glycols; Prodrugs; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Zidovudine | 2010 |
Management of pregnancy in an HIV elite controller.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Female; Genotype; HIV Infections; HIV Long-Term Survivors; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Proviruses; RNA, Viral; Viral Load; Zidovudine; Zimbabwe | 2010 |
[Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Chagas Disease; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Nitroimidazoles; Oligopeptides; Organophosphonates; Paraguay; Pyridines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Spain; Tenofovir; Trypanocidal Agents; Zidovudine | 2011 |
Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.
Topics: Adult; Anti-HIV Agents; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; HIV Infections; Humans; Peripartum Period; Pregnancy; RNA, Viral; Zidovudine | 2010 |
A turning point in the fight against HIV.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; Humans; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Male; Middle Aged; Nevirapine; Stavudine; Zidovudine | 2010 |
The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 20
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Confidence Intervals; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Nevirapine; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Uganda; Young Adult; Zidovudine | 2011 |
Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment.
Topics: Amino Acid Substitution; Anti-HIV Agents; Anti-Retroviral Agents; Drug Resistance; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Polymerase Chain Reaction; RNA, Viral; Taq Polymerase; Virus Replication; Zidovudine | 2010 |
Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.
Topics: Acetylcysteine; Adenosine Triphosphate; Antiretroviral Therapy, Highly Active; Apoptosis; Blood-Brain Barrier; Caspase 3; Cell Line, Transformed; Cytochromes c; Endothelial Cells; Glutathione; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Zidovudine | 2011 |
Aminotransferase serum levels decrease after initiating antiretroviral treatment in HIV infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Lopinavir; Male; Pyrimidinones; Ritonavir; Serum; Transaminases; Zidovudine | 2011 |
Statistical decisions and the interim analyses of clinical trials.
Topics: Anti-HIV Agents; Bayes Theorem; Clinical Trials as Topic; Data Interpretation, Statistical; Decision Making; HIV Infections; Humans; Mathematical Computing; Multicenter Studies as Topic; Research Design; Statistics as Topic; Zidovudine | 2011 |
HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.
Topics: Adenine; Anti-HIV Agents; HIV Infections; HIV-2; Humans; India; Organophosphonates; Prevalence; Tenofovir; Zidovudine | 2010 |
Perinatal tuberculosis: two unusual cases.
Topics: Anti-HIV Agents; Anti-Inflammatory Agents; Antimalarials; Drug Therapy, Combination; Endometritis; Female; HIV Infections; Humans; Immunocompromised Host; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Radiography; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Zidovudine | 2011 |
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Female; Hematologic Tests; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Treatment Outcome; Zidovudine | 2011 |
FDA notifications. FDA tentatively approves fixed-dose lamivudine/zidovudine.
Topics: Drug Approval; Drug Combinations; Drugs, Generic; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2010 |
Effectiveness of a PMTCT programme in rural Western Kenya.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Epidemiologic Methods; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Rural Health; Treatment Outcome; Young Adult; Zidovudine | 2011 |
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.
Topics: Amino Acid Substitution; Anti-HIV Agents; Brazil; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutant Proteins; Mutation, Missense; Nevirapine; Protein Structure, Tertiary; Thymidine; Zidovudine | 2011 |
Short communication: high prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004.
Topics: Anti-HIV Agents; Base Sequence; Belize; Cohort Studies; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Honduras; Humans; Infant; Infant, Newborn; Male; Molecular Sequence Data; Mutation; Nevirapine; Phylogeny; pol Gene Products, Human Immunodeficiency Virus; Pregnancy; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2011 |
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Malawi; Male; Nevirapine; Post-Exposure Prophylaxis; Viral Load; Zidovudine | 2011 |
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Europe; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Time Factors; Viral Load; Zidovudine | 2011 |
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Polyethylene Glycols; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors; Treatment Outcome; Zidovudine | 2011 |
Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.
Topics: Adult; Anti-HIV Agents; Delivery of Health Care; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mozambique; Nevirapine; Pregnancy; Retrospective Studies; Rural Population; Young Adult; Zidovudine | 2011 |
Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences'.
Topics: Africa; Biomedical Research; Clinical Trials as Topic; Ethics, Research; Female; Global Health; HIV Infections; Humans; Infectious Disease Transmission, Vertical; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Therapeutic Human Experimentation; United States; Zidovudine | 2010 |
Combination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine/didanosine prodrug.
Topics: Animals; Anti-HIV Agents; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Didanosine; HIV Infections; Humans; Mice; Prodrugs; Zidovudine | 2011 |
Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages.
Topics: Alkynes; Benzoxazines; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclopropanes; Drug Resistance, Viral; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Macrophages; Mutation; Pyrrolidinones; Raltegravir Potassium; Zidovudine | 2011 |
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
Topics: Anti-HIV Agents; Breast Feeding; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; National Health Programs; Nevirapine; Outcome Assessment, Health Care; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Survival Analysis; World Health Organization; Young Adult; Zidovudine; Zimbabwe | 2011 |
Ratiometric analysis of zidovudine (ZDV) incorporation by reverse transcriptases or polymerases via bio-orthogonal click chemistry.
Topics: Animals; Anti-HIV Agents; CHO Cells; Cricetinae; Cricetulus; DNA; DNA-Directed DNA Polymerase; Fluorescent Dyes; HIV Infections; Humans; Microscopy, Fluorescence; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 2011 |
Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Drug Monitoring; Feasibility Studies; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Rwanda; Saliva; Zidovudine | 2011 |
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2011 |
Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania.
Topics: Adolescent; Adult; Delivery, Obstetric; Drug Therapy, Combination; Female; HIV; HIV Infections; Hospitals; Humans; Infectious Disease Transmission, Vertical; Mothers; Patient Compliance; Pregnancy; Rural Population; Tanzania; Time Factors; Young Adult; Zidovudine | 2011 |
Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Case-Control Studies; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; France; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lopinavir; Male; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Retrospective Studies; Ritonavir; Zidovudine | 2011 |
Epigallocatechin gallate inhibits the HIV reverse transcription step.
Topics: Anti-HIV Agents; Catechin; Drug Evaluation, Preclinical; Drug Synergism; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Reverse Transcription; Uracil; Zidovudine | 2011 |
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
Topics: Adult; Anti-HIV Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Goals; Healthy People Programs; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Male; Nevirapine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Public Health; United Nations; Zidovudine | 2011 |
Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cost-Benefit Analysis; Developing Countries; Female; Health Care Costs; HIV Infections; Humans; Lesotho; Male; Middle Aged; Organophosphonates; Pregnancy; Rural Population; Stavudine; Tenofovir; Zidovudine | 2011 |
Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 2011 |
The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Viral Load; Young Adult; Zidovudine | 2011 |
Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Malawi; Morbidity; Nevirapine; Poisson Distribution; Post-Exposure Prophylaxis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Weaning; Zidovudine | 2011 |
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the Western Cape, South Africa.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Treatment Failure; Viral Load; Zidovudine | 2011 |
[Coinfection with HIV and HCV: abacavir and ribavirine, why not?].
Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Ribavirin; Zidovudine | 2012 |
Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.
Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tenofovir; Zambia; Zidovudine | 2011 |
Comprehensive analysis of the intracellular metabolism of antiretroviral nucleosides and nucleotides using liquid chromatography-tandem mass spectrometry and method improvement by using ultra performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; HIV Infections; Humans; Leukocytes, Mononuclear; Nucleosides; Nucleotides; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tandem Mass Spectrometry; Zidovudine | 2011 |
Zidovudine (AZT) overdose in a healthy newborn receiving postnatal prophylaxis.
Topics: Acidosis; Alanine Transaminase; Anti-HIV Agents; Drug Overdose; HIV Infections; Humans; Infant, Newborn; Lactic Acid; Male; Medication Errors; Neutropenia; Zidovudine | 2011 |
Hematological abnormalities in HIV-infected patients.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; Blood Cell Count; Brazil; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Hematologic Diseases; Hemoglobins; HIV Infections; HIV-1; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; RNA, Viral; Thrombocytopenia; Viral Load; Young Adult; Zidovudine | 2011 |
C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.
Topics: Adult; Arginine; CD4 Antigens; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Kenya; Polymorphism, Single Nucleotide; Postpartum Period; Pregnancy; Tryptophan; Viral Load; Zidovudine | 2012 |
Should sponsors and DSMBs share interim results across trials?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Confidentiality; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interinstitutional Relations; Nevirapine; Pregnancy; Zidovudine | 2011 |
Science and ethics of human immunodeficiency virus/acquired immunodeficiency syndrome controversies in Africa.
Topics: Africa; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Circumcision, Male; Confidentiality; Female; Guidelines as Topic; Health Care Rationing; Healthcare Disparities; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Infant, Newborn; Intensive Care Units; Male; Pregnancy; Randomized Controlled Trials as Topic; Standard of Care; Zidovudine | 2011 |
[Placental villous lesions in HIV-1 infection treated with zidovudine].
Topics: Adult; Anti-HIV Agents; Birth Weight; Calcinosis; Chorionic Villi; Edema; Female; Fibrosis; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Organ Size; Placenta; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Stromal Cells; Viral Load; Zidovudine | 2011 |
Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa.
Topics: Adult; Aged; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Databases, Factual; Electronic Health Records; Female; HIV Infections; Humans; Male; Medical Record Linkage; Middle Aged; Namibia; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Young Adult; Zidovudine | 2012 |
Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
Topics: Adult; Anemia; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Female; Hemoglobins; HIV Infections; Humans; Incidence; India; Male; Multivariate Analysis; Prospective Studies; Risk Factors; Severity of Illness Index; Stavudine; Zidovudine | 2011 |
Role of the pharmacist in perinatal management of HIV disease.
Topics: Alberta; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Medication Therapy Management; Perinatal Care; Pharmacists; Pregnancy; Prenatal Diagnosis; Professional Role; Workforce; Zidovudine | 2011 |
Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; HIV Infections; Humans; Lipodystrophy; Male; Retrospective Studies; Severity of Illness Index; Stavudine; Thailand; Treatment Outcome; Zidovudine | 2012 |
Mother-to-child transmission of human immunodeficiency virus in aten years period.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Birth Weight; CD4 Lymphocyte Count; Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Medication Adherence; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Retrospective Studies; Risk Factors; Viral Load; Young Adult; Zidovudine | 2011 |
Management of needlestick injuries: a house officer who has a needlestick.
Topics: Anti-HIV Agents; Blood-Borne Pathogens; Drug Combinations; Emergency Service, Hospital; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Internship and Residency; Lamivudine; Male; Needlestick Injuries; Occupational Exposure; Physicians; Post-Exposure Prophylaxis; Risk; United States; Zidovudine | 2012 |
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine | 2012 |
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
Topics: Administration, Oral; Antirheumatic Agents; Chemistry, Pharmaceutical; Child, Preschool; Dideoxynucleosides; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; Solutions; Tablets; Therapeutic Equivalency; Zidovudine | 2012 |
Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cost-Benefit Analysis; Cyclopropanes; Dominican Republic; Drug Administration Schedule; Drug Costs; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Zidovudine | 2012 |
Successful maternal-foetal outcome using nitric oxide and sildenafil in pulmonary hypertension with atrial septal defect and HIV infection.
Topics: Anti-HIV Agents; Anticoagulants; Enoxaparin; Female; Heart Septal Defects, Atrial; HIV Infections; Humans; Hypertension, Pulmonary; Nitric Oxide; Piperazines; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Infectious; Pregnancy Outcome; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents; Zidovudine | 2012 |
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Ritonavir; Tablets; Treatment Outcome; Young Adult; Zidovudine | 2012 |
HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.
Topics: Anti-HIV Agents; Base Sequence; Dideoxynucleotides; DNA, Viral; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutation; Nucleosides; pol Gene Products, Human Immunodeficiency Virus; Reverse Transcriptase Inhibitors; RNA, Viral; Thymine Nucleotides; Zidovudine | 2012 |
Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Black People; Case-Control Studies; Didanosine; DNA, Mitochondrial; Female; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Mitochondria; Mutation; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors; Sequence Deletion; Stavudine; White People; Zidovudine | 2012 |
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
Topics: Acyclovir; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Drug Synergism; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Nevirapine; Palatine Tonsil; Protease Inhibitors; Ribavirin; T-Lymphocytes; Tissue Culture Techniques; Zidovudine | 2012 |
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.
Topics: Adenine; Algorithms; Anti-HIV Agents; Dideoxynucleosides; Drug Resistance, Multiple, Viral; Genomics; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Least-Squares Analysis; Mutation; Nucleosides; Organophosphonates; Phenotype; Reverse Transcriptase Inhibitors; Tenofovir; Thymidine; Zidovudine | 2012 |
Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1.
Topics: Adult; Anti-HIV Agents; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Nevirapine; Plasma; Recombination, Genetic; RNA, Viral; Sequence Analysis, DNA; Zidovudine | 2012 |
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Organophosphonates; Pain; Retrospective Studies; Risk Factors; Stavudine; Tenofovir; Zidovudine | 2012 |
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
Topics: Adult; Alleles; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Oligonucleotides; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Tanzania; Zidovudine | 2012 |
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
Topics: Adult; Anti-HIV Agents; Black or African American; Cytidine Triphosphate; Dideoxynucleotides; Female; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Prospective Studies; Sex Factors; Thymine Nucleotides; Zidovudine | 2012 |
HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.
Topics: Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2012 |
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Female; France; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Zidovudine | 2012 |
Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; HIV Infections; Humans; Lamivudine; Limit of Detection; Lopinavir; Reference Standards; Reproducibility of Results; Ritonavir; Tandem Mass Spectrometry; Zidovudine | 2012 |
Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation, Missense; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Viral Proteins; Young Adult; Zidovudine | 2012 |
Commentary: the past, present and future of affordable antiretroviral therapy in Africa.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Male; Zidovudine | 2012 |
Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.
Topics: Adolescent; Adult; Anti-HIV Agents; Cohort Studies; Drugs, Generic; Female; HIV Infections; Humans; Male; Proportional Hazards Models; Treatment Outcome; Zambia; Zidovudine | 2012 |
Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Incidence; Kenya; Male; Peripheral Nervous System Diseases; Probability; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2012 |
Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.
Topics: Anti-HIV Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Viral; Antibody Specificity; Binding Sites; CD4 Antigens; Cell Death; Cell Line; Drug Synergism; Epithelium; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Interleukin-8; Lignin; Models, Molecular; Nevirapine; NF-kappa B; Protein Structure, Secondary; Receptors, CCR5; Receptors, CXCR4; Virus Internalization; Zidovudine | 2012 |
Effectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in Angola.
Topics: Adult; Angola; Anti-HIV Agents; Female; HIV Infections; Hospitals, Urban; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Mothers; Multivariate Analysis; Perinatal Care; Pregnancy; Pregnancy Outcome; Retrospective Studies; Survival Rate; Time Factors; Zidovudine | 2012 |
HIV: a growing concern in the elderly population.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antihypertensive Agents; Azithromycin; CD4 Lymphocyte Count; Depressive Disorder; Diltiazem; Drug Interactions; Drug Monitoring; HIV Infections; Humans; Hypertension; Lopinavir; Male; Patient Compliance; Pharmacists; Renal Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2012 |
K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data.
Topics: HIV Infections; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2012 |
Response to valacyclovir in an HIV-infected girl with Epstein Barr infection.
Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine | 2012 |
N348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Synergism; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutant Proteins; Mutation, Missense; Nevirapine; Selection, Genetic; Zidovudine | 2012 |
Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010.
Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Drug Prescriptions; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Organophosphonates; Prevalence; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Zidovudine | 2012 |
Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cords.
Topics: Adult; Anti-HIV Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Infant; Male; Placenta; Pregnancy; Tanzania; Umbilical Cord; Young Adult; Zidovudine | 2012 |
Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 2012 |
Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.
Topics: Adenine; Adult; Africa South of the Sahara; Anti-Retroviral Agents; Cost-Benefit Analysis; Drug Resistance, Viral; Epidemics; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Stochastic Processes; Tenofovir; Treatment Outcome; Zidovudine | 2012 |
Effects of daily intake of zidovudine-stavudine on rat pregnancy outcome: biological essay.
Topics: Animals; Anti-HIV Agents; Biological Assay; Disease Models, Animal; Drug Combinations; Female; HIV Infections; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rats; Stavudine; Weight Gain; Zidovudine | 2012 |
Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.
Topics: Anti-HIV Agents; Autophagy; Blotting, Western; Cells, Cultured; DNA, Mitochondrial; Fatty Liver; Female; Flow Cytometry; Hep G2 Cells; HIV Infections; Humans; Lipid Metabolism; Male; Microscopy, Electron; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Stavudine; Thymidine; Zidovudine | 2012 |
PharmGKB summary: zidovudine pathway.
Topics: Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; Humans; Zidovudine | 2012 |
Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.
Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thailand; Thymidine; Treatment Failure; Zidovudine | 2012 |
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance.
Topics: Amino Acid Sequence; Anti-HIV Agents; Brazil; Cell Line; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutation; Nitriles; Protein Structure, Tertiary; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Zidovudine | 2013 |
Design of HIV noninferiority trials: where are we going?
Topics: Anti-HIV Agents; Confidence Intervals; Drug Therapy, Combination; Endpoint Determination; Female; HIV Infections; Humans; Male; Randomized Controlled Trials as Topic; Research Design; Viral Load; Zidovudine | 2013 |
Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
Topics: Adult; Alcohol Drinking; Anti-HIV Agents; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Gingival Hemorrhage; HIV; HIV Infections; Humans; Male; Middle Aged; Mouth Mucosa; Oral Health; Periodontal Pocket; Saliva; Salivary Proteins and Peptides; Secretory Leukocyte Peptidase Inhibitor; Secretory Rate; Serine Proteinase Inhibitors; Smoking; Time Factors; Viral Load; Young Adult; Zidovudine | 2013 |
[Acute hemolytic anemia in an HIV patient after inhalation of amyl nitrite].
Topics: Administration, Inhalation; Adult; Amyl Nitrite; Anemia, Hemolytic; Anti-HIV Agents; Diagnosis, Differential; Dideoxynucleosides; HIV Infections; Humans; Illicit Drugs; Inhalant Abuse; Iraq; Lamivudine; Male; Travel; Zidovudine | 2012 |
Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Benzoxazines; Chemical and Drug Induced Liver Injury; Coinfection; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Nevirapine; Nigeria; Organophosphorus Compounds; RNA, Viral; Stavudine; Zidovudine | 2013 |
The pattern of attrition from an antiretroviral treatment program in Nigeria.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Child; Child, Preschool; Cohort Studies; Female; HIV Infections; Hospitals; Humans; Male; Medication Adherence; Middle Aged; Nigeria; Patient Compliance; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stavudine; Time Factors; Treatment Outcome; Zidovudine | 2012 |
Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line.
Topics: Anti-HIV Agents; Cell Line; Coculture Techniques; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Virus Integration; Virus Replication; Zidovudine | 2013 |
[The influence of long-term nucleotide reverse transcriptase inhibitors on lipids metabolism in HIV/AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cross-Sectional Studies; Female; HIV Infections; Humans; Lipid Metabolism; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2012 |
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
Topics: Adenine; Adult; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cells, Cultured; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Enzyme Activation; Female; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Regression Analysis; Reverse Transcriptase Inhibitors; Risk Factors; Telomerase; Telomere; Telomere Shortening; Tenofovir; Time Factors; Young Adult; Zidovudine | 2013 |
Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Treatment Outcome; Zidovudine | 2013 |
Drug-induced nanocarrier assembly as a strategy for the cellular delivery of nucleotides and nucleotide analogues.
Topics: Adenosine Triphosphate; Animals; Cell Survival; Chitosan; Dideoxynucleotides; Drug Carriers; Drug Delivery Systems; HIV Infections; Macrophages; Mice; Nanoparticles; Nucleotides; Zidovudine | 2013 |
Nevirapine inhibits the anti-HIV activity of CD8+ cells.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nevirapine; RNA, Viral; Zidovudine | 2013 |
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
Topics: Anti-HIV Agents; Causality; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Confounding Factors, Epidemiologic; HIV Infections; HIV-1; Humans; Male; Models, Statistical; Zidovudine | 2002 |
Anti-HIV agents. Trizivir--three drugs in one pill.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Zidovudine | 2000 |
Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Patient Compliance; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Zidovudine use during pregnancy among HIV-infected women on Medicaid.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Medicaid; New Jersey; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Time Factors; Zidovudine | 2002 |
[Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; Depression; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Mononucleosis; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Refusal; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Viremia; Zalcitabine; Zidovudine | 2002 |
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; beta 2-Microglobulin; Bone Marrow Cells; Case-Control Studies; Female; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; Humans; Immunoglobulin G; Immunophenotyping; Indinavir; Lamivudine; Leukocyte Count; Male; Middle Aged; Stavudine; T-Lymphocyte Subsets; Zidovudine | 2002 |
Antiretroviral rounds. Personal and public consequences.
Topics: Adult; Alcohol Drinking; Candidiasis, Oral; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Male; Pneumonia, Bacterial; Sexual Partners; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine | 2000 |
M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine.
Topics: Drug Resistance, Microbial; Genotype; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Viral Load; Zidovudine | 2002 |
Geotrichum proctitis after HIV postexposure prophylaxis.
Topics: Drug Therapy, Combination; Female; Geotrichosis; HIV Infections; Humans; Lamivudine; Middle Aged; Proctitis; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
New immune-based treatment approach: trial recruiting in San Francisco.
Topics: CD4 Lymphocyte Count; HIV Infections; Humans; Lipids; Mannans; Patient Selection; Placebos; Randomized Controlled Trials as Topic; San Francisco; Viral Load; Zidovudine | 2001 |
Nevirapine reduces perinatal HIV transmission.
Topics: Disease Transmission, Infectious; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Antiretroviral therapy in naïve patients.
Topics: Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Drug Administration Schedule; HIV Infections; Humans; Virus Activation; Zidovudine | 2000 |
HIV-1 infection in women.
Topics: CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Male; Sexual Behavior; Sexually Transmitted Diseases; Thailand; Viral Load; Zidovudine | 2000 |
Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Italy; Logistic Models; Male; Multivariate Analysis; Pregnancy; Prospective Studies; Risk Factors; Treatment Outcome; Zidovudine | 2002 |
Prevalence of G333D/E in naive and pretreated HIV-infected patients.
Topics: Amino Acid Sequence; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Multivariate Analysis; Patient Compliance; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Social Support; Zidovudine | 2002 |
Herpes virus infections, HIV, and disease progression. Recommended, not required.
Topics: Acyclovir; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Infections; HIV Infections; Humans; Zidovudine | 1995 |
A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Topics: Adenosine Monophosphate; Dideoxynucleotides; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Viral; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 2002 |
Guide addresses unique aspects of care for women with HIV.
Topics: Acyclovir; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Practice Guidelines as Topic; Pregnancy; United States; United States Dept. of Health and Human Services; Women; Women's Health; Women's Health Services; Zidovudine | 2001 |
[Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Didanosine; Ganciclovir; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Retinal Hemorrhage; Reverse Transcriptase Inhibitors; Risk; Saquinavir; Stavudine; Substance Abuse, Intravenous; Zidovudine | 2002 |
Highlights of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Topics: Adenine; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Drug Therapy; Epoetin Alfa; Erythropoietin; Hepatitis C; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Recombinant Proteins; Saquinavir; Tenofovir; Zidovudine | 2002 |
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Multiple, Viral; HIV Infections; HIV-1; Humans; Male; Mutagenesis, Insertional; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 2002 |
Antiretroviral treatment in developing countries.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Compliance; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Public Sector; Zidovudine | 2002 |
WHO takes major steps to make HIV treatment accessible.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Therapy, Combination; Health Services Accessibility; HIV Infections; Humans; Nevirapine; Practice Guidelines as Topic; World Health Organization; Zidovudine | 2002 |
Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cytidine Triphosphate; Dideoxynucleotides; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Models, Statistical; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Viral Load; Zidovudine | 2002 |
Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Lymphocytosis; Lymphoproliferative Disorders; Male; Nevirapine; Parotid Diseases; Parotid Gland; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.
Topics: HIV Infections; HIV-1; Humans; Macrophages; Ritonavir; RNA, Viral; Transcription, Genetic; Virus Replication; Zidovudine | 2002 |
Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Treatment Failure; Viral Proteins; Zidovudine | 2002 |
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Thymidine; Thymidine Monophosphate; Zidovudine | 2002 |
Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection.
Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Case-Control Studies; Chi-Square Distribution; Erythrocyte Indices; Female; HIV Infections; Humans; Incidence; Male; Patient Compliance; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2002 |
Prophylactic clarithromycin to treat mycobacterium avium in HIV patients receiving zidovudine may significantly increase mortality by suppressing lymphopoiesis and hematopoiesis.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Female; Hematopoiesis; HIV Infections; Humans; Lymphocyte Activation; Lymphopoiesis; Mice; Mice, Inbred BALB C; Mycobacterium avium-intracellulare Infection; Zidovudine | 2002 |
Two drugs reduce transmission.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Thailand; Zidovudine | 2002 |
[Factors predicting lack of adherence to highly active antiretroviral treatment].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Data Collection; Drug Combinations; Drug Utilization Review; HIV Infections; Humans; Lamivudine; Outpatient Clinics, Hospital; Patient Compliance; Patient Dropouts; Registries; Sensitivity and Specificity; Spain; Treatment Refusal; Zidovudine | 2002 |
Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Viral; Genotype; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Mutation; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine.
Topics: Clone Cells; Drug Resistance, Viral; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): a surrogate marker for adherence.
Topics: Biomarkers; Erythrocyte Indices; HIV Infections; Humans; Lamivudine; Patient Compliance; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 2002 |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
Topics: Cohort Studies; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Nevirapine; Phylogeny; Pregnancy; Pregnancy Complications, Infectious; Survival Rate; Uganda; Zidovudine | 2002 |
Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Burkina Faso; Cohort Studies; Cote d'Ivoire; Counseling; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Theoretical mechanistic basis of the toxic effects and efficacy of AZT in HIV: AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; Humans; Molecular Structure; Zidovudine | 2002 |
Ethnic disparity in HIV prevalence and zidovudine treatment among childbearing women and pediatric AIDS cases in California.
Topics: Adult; Anti-HIV Agents; Black or African American; California; Cross-Sectional Studies; Female; Hispanic or Latino; HIV Infections; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Zidovudine | 2002 |
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Phenotype; RNA, Viral; Stavudine; Zidovudine | 2002 |
Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients.
Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Patient Compliance; Reverse Transcriptase Inhibitors; Uganda; Viral Load; Zidovudine | 2002 |
Choosing cesarean? PCD may have no effect in blocking perinatal transmission of HIV.
Topics: Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Hope emerges for controlling perinatal HIV transmission.
Topics: Developing Countries; Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Prenatal HIV counseling, testing, and antiretroviral prophylaxis by obstetric and family medicine providers in Alabama.
Topics: AIDS Serodiagnosis; Alabama; Anti-HIV Agents; Directive Counseling; Family Practice; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Patient Education as Topic; Perinatal Care; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Preventive Health Services; United States; Zidovudine | 2002 |
Universality and its limits: when research ethics can reflect local circumstances.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Conflict of Interest; Developing Countries; Ethics, Medical; Ethics, Research; HIV Infections; Human Experimentation; Humans; Patient Selection; Research Personnel; Zidovudine | 2002 |
Fat wasting--AZT vs. d4T.
Topics: HIV Infections; HIV Wasting Syndrome; Humans; Male; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2002 |
Placebos in clinical trials: new forms of an old issue.
Topics: Control Groups; Fetal Tissue Transplantation; Government Regulation; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Placebos; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 2000 |
Indirect hyperbilirubinemia with indinavir.
Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; India; Indinavir; Lamivudine; Liver Function Tests; Needlestick Injuries; Prognosis; Risk Assessment; Severity of Illness Index; Zidovudine | 2002 |
Quantitative RNA testing for diagnosis of HIV-infected infants.
Topics: Anti-HIV Agents; Bottle Feeding; DNA, Viral; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Predictive Value of Tests; Proviruses; RNA, Viral; Viral Load; Zidovudine | 2003 |
Estimating the length of the first antiretroviral therapy regiment durability in São Paulo, Brazil.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; Cohort Studies; Drug Administration Schedule; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Retrospective Studies; Time Factors; Zidovudine | 2002 |
Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chromatography, High Pressure Liquid; HIV Infections; Humans; Intracellular Fluid; Leukocytes, Mononuclear; Mass Spectrometry; Stavudine; Zidovudine | 2003 |
HIV--a personal perspective.
Topics: Anti-HIV Agents; HIV Infections; Humans; Lamivudine; Needlestick Injuries; Zidovudine | 2000 |
Recommendations to reduce the risk of occupational HIV transmission.
Topics: Anti-HIV Agents; Health Occupations; HIV; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; New Jersey; Occupational Diseases; Practice Guidelines as Topic; Risk; Zidovudine | 2003 |
Zidovudine-related anemia with reticulocytosis.
Topics: Adult; Anemia; Erythrocyte Indices; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Reticulocyte Count; Time Factors; Zidovudine | 2003 |
Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.
Topics: Base Sequence; DNA Primers; DNA, Mitochondrial; Female; Fetal Blood; HIV Infections; HIV Seronegativity; Humans; Infectious Disease Transmission, Vertical; Mitochondria; Placenta; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Preventing HIV transmission.
Topics: Anti-HIV Agents; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Zidovudine | 2003 |
Can research subjects of clinical trials in developing countries sue physician-investigators for human rights violations?
Topics: Clinical Trials as Topic; Developing Countries; Female; Guidelines as Topic; Helsinki Declaration; HIV Infections; Human Experimentation; Human Rights; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Liability, Legal; Placebos; Pregnancy; Research Design; Research Subjects; Scientific Misconduct; United States; Zidovudine | 2000 |
New questions about an old combination--ddI + d4T.
Topics: Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.
Topics: Acidosis, Lactic; Acute Disease; Adult; Anti-HIV Agents; Biopsy; Critical Care; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Liver; Liver Failure; Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Zidovudine | 2003 |
Is mama a criminal? An analysis of potential criminal liability of HIV-infected pregnant women in the context of mandated drug therapy.
Topics: Child; Child Advocacy; Coercion; Criminal Law; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Liability, Legal; Mandatory Testing; Patient Compliance; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Privacy; Treatment Refusal; United States; Zidovudine | 2002 |
Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cognition Disorders; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Neuropsychological Tests; RNA, Viral; Time Factors; Viral Load; Viremia; Zidovudine | 2003 |
Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats.
Topics: Acute Kidney Injury; Animals; Anti-HIV Agents; Didanosine; Diet; Disease Models, Animal; HIV Infections; Hypokalemia; Magnesium; Male; Rats; Rats, Wistar; Risk Factors; Zidovudine | 2003 |
Negligence. Liver transplant patient too late to sue Viramune maker.
Topics: Drug Combinations; Drug Industry; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Liver Transplantation; Malpractice; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.
Topics: Anti-HIV Agents; Cells, Cultured; DNA, Viral; Euphorbiaceae; Ficus; HIV Infections; HIV-1; HIV-2; Humans; Ocimum; Plant Extracts; Plants, Medicinal; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Rutaceae; Virus Replication; Zidovudine | 2003 |
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Virus Cultivation; Zidovudine | 2003 |
A saga in international HIV policy modeling: preventing mother-to-child HIV transmission.
Topics: Africa; Antiretroviral Therapy, Highly Active; Female; Fetus; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Policy Making; Pregnancy; United Nations; Zidovudine | 2002 |
Abacavir arm stopped in clinical trial.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine | 2003 |
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV].
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Viremia; Zidovudine | 2003 |
Management of severely immunocompromised human immunodeficiency virus type 1-infected African orphans with structured treatment interruption: another kind of salvage therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Dideoxynucleosides; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Salvage Therapy; Zidovudine | 2003 |
Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
Topics: Adult; Barbados; Case-Control Studies; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Incidence; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Probability; Prospective Studies; Risk Factors; Survival Analysis; Zidovudine | 2003 |
Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homosexuality, Male; Humans; Male; Molecular Sequence Data; Mutation; Phenotype; Phylogeny; Reverse Transcriptase Inhibitors; RNA, Viral; Semen; Sequence Analysis, DNA; Zidovudine | 2003 |
Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments.
Topics: Cervix Uteri; Female; Half-Life; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; RNA, Viral; Vagina; Virus Replication; Zidovudine | 2003 |
Mother-to-child HIV transmission prevention in Thailand: physician zidovudine use and willingness to provide care.
Topics: Adult; Anti-HIV Agents; Attitude of Health Personnel; Drug Utilization; Family Practice; Female; Gynecology; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Male; Multivariate Analysis; Obstetrics; Physicians; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Surveys and Questionnaires; Thailand; Zidovudine | 2003 |
Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleotides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Reproducibility of Results; Stavudine; Thymine Nucleotides; Virion; Zidovudine | 2003 |
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Retrospective Studies; Zidovudine | 2003 |
[The issue of inhibitors of retroviral infections].
Topics: Anti-HIV Agents; Cell Line; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Trizivir trial halted.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Zidovudine | 2003 |
[Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Didanosine; Drug Evaluation; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2003 |
Nevirapine-based fixed-dose combination ARVs.
Topics: Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Patient Compliance; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis.
Topics: Adult; Drug Hypersensitivity; Female; Guideline Adherence; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Needlestick Injuries; Occupational Diseases; Occupational Exposure; Zidovudine | 2003 |
Study of the cardiac alterations in HIV-infected children consequent to the antiretroviral therapy. Prospective study of 47 cases.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Drug Therapy, Combination; Follow-Up Studies; Heart; Heart Diseases; HIV Infections; Humans; Infant; Prospective Studies; Zidovudine | 2003 |
Recurrence of post-traumatic stress disorder symptoms after initiation of antiretrovirals including efavirenz: a report of two cases.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Male; Middle Aged; Oxazines; Recurrence; Refugees; Reverse Transcriptase Inhibitors; Stress Disorders, Post-Traumatic; Zidovudine | 2003 |
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.
Topics: Anti-HIV Agents; Brain; Chi-Square Distribution; Female; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Magnetic Resonance Imaging; Microscopy, Electron; Mitochondria, Muscle; Mitochondrial Diseases; Muscle, Skeletal; Pregnancy; Prospective Studies; Risk Factors; Zidovudine | 2003 |
Vertical transmission of HIV in Rio de Janeiro, Brazil.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Brazil; Cohort Studies; Developing Countries; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2003 |
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
Topics: Adolescent; Adult; Africa, Western; Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Codon; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Genes, pol; Genetic Variation; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Nelfinavir; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Sequence Alignment; Sequence Homology, Amino Acid; Sweden; Treatment Failure; Viremia; Zidovudine | 2003 |
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Cesarean Section; Cost of Illness; Cost-Benefit Analysis; Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mexico; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Value of Life; Zidovudine | 2003 |
Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.
Topics: Adult; Anthropometry; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Exercise; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Semiparametric regression analysis of longitudinal data with informative drop-outs.
Topics: Child; Clinical Trials as Topic; Computer Simulation; Didanosine; HIV Infections; Humans; Longitudinal Studies; Models, Statistical; Numerical Analysis, Computer-Assisted; Patient Dropouts; Regression Analysis; Time Factors; Zidovudine | 2003 |
[Antiviral agents for reduction of mother-to-child transmission of HIV infection].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Evidence-Based Medicine; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 2003 |
[Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
Topics: Adult; Anti-HIV Agents; Chile; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2003 |
Targeted HIV treatment to sex workers to promote HIV prevention.
Topics: Anti-HIV Agents; Disease Outbreaks; HIV Infections; Humans; Risk-Taking; Sex Work; Sexual Behavior; Sexual Partners; Zidovudine | 2002 |
Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biological Transport; Cells, Cultured; Chemokine CCL5; HIV Infections; HIV-1; Humans; Lymphocytes; Macrophages; Polymerase Chain Reaction; Receptors, HIV; Reference Values; Virus Replication; Zidovudine | 2003 |
Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathy, Dilated; Female; HIV Infections; HIV-1; Humans; Zidovudine | 2003 |
Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematopoiesis; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Lymphocyte Subsets; Maternal-Fetal Exchange; Neutrophils; Platelet Count; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Zidovudine | 2003 |
Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV.
Topics: Anti-Retroviral Agents; Breast Feeding; Child, Preschool; Decision Support Techniques; Decision Trees; Female; HIV Infections; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Mathematics; Models, Theoretical; Nevirapine; Pregnancy; Weaning; Zidovudine | 2003 |
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Topics: Acidosis, Lactic; Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Confidence Intervals; Female; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Male; Monitoring, Physiologic; Odds Ratio; Perinatal Care; Pregnancy; Probability; Prognosis; Prospective Studies; Risk Assessment; Zidovudine | 2003 |
Replacement-fed infants born to HIV-infected mothers in India have a high early postpartum rate of hospitalization.
Topics: Animals; Breast Feeding; Female; Gastroenteritis; HIV Infections; Hospitalization; Humans; India; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; Jaundice, Neonatal; Male; Milk; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sepsis; Zidovudine | 2003 |
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.
Topics: Anti-HIV Agents; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; Humans; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Pregnancy-related changes in the longer-term management of HIV-infected women in Europe.
Topics: Abnormalities, Multiple; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Counseling; Delivery, Obstetric; Europe; Female; Health Care Surveys; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Postnatal Care; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Surveys and Questionnaires; Zidovudine | 2003 |
The ethics of mandatory HIV testing of all pregnant women.
Topics: AIDS Serodiagnosis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Pregnancy; Pregnant Women; Privacy; United States; Zidovudine | 2003 |
Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lactates; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Zidovudine | 2003 |
Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort.
Topics: Adult; Cohort Studies; DNA, Viral; Female; France; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission.
Topics: CD4-Positive T-Lymphocytes; Cervix Uteri; Coculture Techniques; DNA, Viral; Epithelial Cells; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Polymerase Chain Reaction; Sexually Transmitted Diseases, Viral; Viral Matrix Proteins; Virus Replication; Zidovudine | 2003 |
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
Topics: Anti-HIV Agents; Base Sequence; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Treatment Failure; Viral Load; Zidovudine | 2004 |
Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Integration Host Factors; Leptin; Male; Middle Aged; Retrospective Studies; Stavudine; Zidovudine | 2003 |
Integrating prevention of mother-to-child HIV transmission into antenatal care: learning from the experiences of women in South Africa.
Topics: Adult; Anti-HIV Agents; Attitude to Health; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; South Africa; Truth Disclosure; Urban Population; Women's Health Services; Zidovudine | 2004 |
Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost.
Topics: Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Space; Glutamic Acid; Glutaminase; Glutamine; HIV Infections; HIV-1; Humans; Macrophages; Mitochondria; Monocytes; RNA, Messenger; Zidovudine | 2004 |
Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.
Topics: Adult; Anti-HIV Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Lactic Acid; Male; Mitochondria; Pyruvic Acid; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Factors associated with vertical HIV transmission during two different time periods: the impact of zidovudine use on clinical practice at a Brazilian reference centre.
Topics: Adolescent; Adult; Anti-HIV Agents; Brazil; Breast Feeding; Cohort Studies; Female; Fetal Membranes, Premature Rupture; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Rh Isoimmunization; Rh-Hr Blood-Group System; Substance Abuse, Intravenous; Zidovudine | 2003 |
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cell Line; Didanosine; Disease Progression; Evolution, Molecular; Genetic Variation; HIV Infections; HIV-1; Humans; Male; Phenotype; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Recombinant Fusion Proteins; Virus Replication; Zidovudine | 2003 |
Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission.
Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2003 |
Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.
Topics: Adult; Aged; Anti-HIV Agents; Drug Resistance, Viral; Female; Genotype; Health Services Accessibility; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Korea; Male; Middle Aged; Molecular Sequence Data; Prevalence; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Time Factors; Zidovudine | 2003 |
AACTG A5095, Trizivir, and the role of all-nucleoside regimens: an editorial.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Abandon Trizivir when it's working well? A rebuttal.
Topics: Dideoxynucleosides; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Topics: Analysis of Variance; Anti-HIV Agents; Didanosine; DNA, Mitochondrial; Drug Combinations; HIV Infections; Humans; Mitochondrial Diseases; Reverse Transcriptase Inhibitors; Self-Sustained Sequence Replication; Sensitivity and Specificity; Zalcitabine; Zidovudine | 2004 |
Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4-CD8 Ratio; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Flow Cytometry; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2004 |
HIVNET 012 and Petra.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 2004 |
Comment: Reasons for early abacavir discontinuation in HIV-infected patients.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Treatment Refusal; Zidovudine | 2004 |
Conference report - antiretroviral therapy update from the 9th European AIDS Conference.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; HIV Infections; Humans; Lamivudine; Middle Aged; Pulse Therapy, Drug; Reverse Transcriptase Inhibitors; Salvage Therapy; Viral Load; Zidovudine | 2003 |
Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment.
Topics: Anti-HIV Agents; Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Time Factors; Zidovudine | 2004 |
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Ritonavir; Stavudine; Zidovudine | 2003 |
Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo.
Topics: Adult; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Drug Combinations; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Zidovudine | 2004 |
Management of infants born to HIV infected mothers.
Topics: AIDS Serodiagnosis; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Vaccines; Zidovudine | 2003 |
Preventing mother-to-child transmission: landmark decision by South African court.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 2002 |
In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
Topics: Cells, Cultured; Dideoxynucleotides; Drug Resistance, Viral; Genotype; HIV; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Neutrophils; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Thymidine Monophosphate; Viral Plaque Assay; Zidovudine | 2004 |
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Confidence Intervals; Confounding Factors, Epidemiologic; HIV Infections; Homosexuality, Male; Humans; Male; Models, Statistical; Monitoring, Physiologic; Sensitivity and Specificity; Time Factors; United States; Zidovudine | 2004 |
Modelling HIV-RNA viral load in vertically infected children.
Topics: Algorithms; Europe; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Models, Statistical; RNA, Viral; Viral Load; Zidovudine | 2004 |
Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?
Topics: Anti-HIV Agents; Biomarkers; Buffers; Culture Media; Dideoxynucleosides; Drug Resistance, Viral; HIV; HIV Infections; Humans; In Vitro Techniques; Leukocyte Count; Monocytes; Stavudine; Zidovudine | 2004 |
Severe anemia secondary to a probable drug interaction between zidovudine and valproic acid.
Topics: Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Interactions; Epilepsy, Complex Partial; HIV Infections; Humans; Lamivudine; Male; Valproic Acid; Zidovudine | 2004 |
Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
Topics: Africa; AIDS Vaccines; Biomedical Research; Developed Countries; Developing Countries; Drug Costs; Female; Health Services Accessibility; HIV Infections; HIV Seropositivity; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Moral Obligations; Pregnancy; Pregnant Women; Research Subjects; Social Justice; Zidovudine | 1997 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.
Topics: Adult; Anti-HIV Agents; Brazil; Chemoprevention; Cohort Studies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Lamivudine; Male; Patient Acceptance of Health Care; Sexual Behavior; Surveys and Questionnaires; Zidovudine | 2004 |
Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets.
Topics: Chromatography, High Pressure Liquid; Costs and Cost Analysis; Drug Combinations; Drugs, Generic; HIV Infections; Humans; Lamivudine; Tablets; Zidovudine | 2004 |
Drug-testing on seropositive pregnant women in the developing world: moral and legal implications.
Topics: AIDS Serodiagnosis; Breast Feeding; Clinical Trials as Topic; Compensation and Redress; Confidentiality; Consent Forms; Counseling; Developing Countries; Disclosure; Drugs, Investigational; Female; Guidelines as Topic; Health Services Accessibility; HIV Infections; HIV Seropositivity; Human Experimentation; Human Rights; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Mothers; Personal Autonomy; Pregnancy; Pregnant Women; Research Subjects; Social Justice; Zidovudine | 2000 |
Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.
Topics: Antiviral Agents; Drug Resistance, Viral; HIV; HIV Infections; Humans; Malonates; Phosphorylcholine; Zidovudine | 2004 |
Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
Topics: Adenoviridae; Adenoviridae Infections; Amides; Anti-HIV Agents; Antiviral Agents; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; In Vitro Techniques; Phosphoric Acids; Stavudine; Structure-Activity Relationship; Zidovudine | 2004 |
Interval-censored survival time data: confidence intervals for the non-parametric survivor function.
Topics: Antiviral Agents; Computer Simulation; Confidence Intervals; Data Interpretation, Statistical; Didanosine; HIV Infections; Humans; RNA, Viral; Survival Analysis; Zidovudine | 2004 |
Judge denies amicus brief in GlaxoSmithKline patent case.
Topics: California; Drug Industry; HIV Infections; Humans; Patents as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine.
Topics: Anti-HIV Agents; Drug Monitoring; HIV Infections; Humans; Stavudine; Zidovudine | 2004 |
Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; HIV Infections; Humans; Male; Regression Analysis; Risk Factors; Time Factors; Viral Load; Zidovudine | 2004 |
Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Infant, Newborn; Lamivudine; Maternal-Fetal Exchange; Microscopy, Electron; Mitochondria; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Umbilical Cord; Zidovudine | 2004 |
Mother-to-child transmission. How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues.
Topics: CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2004 |
Buffalo hump: what the experts suggest.
Topics: Adult; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Lamivudine 300 mg in HIV infection: dose change. Once-a-day dosing.
Topics: Adult; Child; Drug Therapy, Combination; France; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Protease Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
[Antiretroviral therapy of acute HIV-infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Count; Male; Nevirapine; Viral Load; Zidovudine | 2004 |
Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood-Borne Pathogens; Chemoprevention; Diagnostic Tests, Routine; Health Personnel; HIV Infections; Humans; Immunoenzyme Techniques; Infectious Disease Transmission, Patient-to-Professional; Italy; Lamivudine; Occupational Exposure; Pilot Projects; Zidovudine | 2004 |
Chemoenzymatic syntheses of homo- and heterodimers of AZT and d4T, and evaluation of their anti-HIV activity.
Topics: Anti-HIV Agents; Cell Line; Dimerization; Fungal Proteins; HIV Infections; HIV-1; HIV-2; Humans; Lipase; Stavudine; Virus Replication; Zidovudine | 2004 |
Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Evolution, Molecular; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Virus Replication; Zidovudine | 2004 |
AZT enhances osteoclastogenesis and bone loss.
Topics: Acid Phosphatase; Animals; Anti-HIV Agents; Bone and Bones; Bone Density; Carrier Proteins; Cell Differentiation; Cell Line; Cells, Cultured; Gene Expression Regulation; HIV Infections; Isoenzymes; Membrane Glycoproteins; Mice; NF-kappa B; Osteoclasts; Promoter Regions, Genetic; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Tartrate-Resistant Acid Phosphatase; Zidovudine | 2004 |
Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Developing Countries; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
Study of antiretroviral drug-resistant HIV-1 genotypes in northern Thailand: role of mutagenically separated polymerase chain reaction as a tool for monitoring zidovudine-resistant HIV-1 in resource-limited settings.
Topics: Drug Resistance, Viral; Genotype; HIV Infections; HIV-1; Humans; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Thailand; Time Factors; Zidovudine | 2004 |
Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Australia; Cohort Studies; Didanosine; Drug Administration Schedule; Europe; Female; HIV Infections; Humans; Lamivudine; Male; Proportional Hazards Models; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Viral Load; Zidovudine | 2004 |
Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.
Topics: Anti-HIV Agents; Cells, Cultured; Dideoxynucleosides; Drug Evaluation, Preclinical; HIV Core Protein p24; HIV Infections; Humans; Immunotoxins; Lamivudine; Phytohemagglutinins; Receptors, Interleukin-2; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance.
Topics: Adenine; Algorithms; Anti-HIV Agents; Databases, Genetic; Didanosine; Dideoxynucleosides; Drug Resistance, Multiple, Viral; HIV; HIV Infections; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zalcitabine; Zidovudine | 2004 |
Triple-nucleoside regimens versus efavirenz.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Oxazines; Research Design; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2004 |
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients.
Topics: Anti-HIV Agents; HIV Infections; Humans; Leukocytes, Mononuclear; Stavudine; Thymidine Kinase; Zidovudine | 2004 |
Triple-nucleoside regimens versus efavirenz.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Oxazines; Patient Compliance; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Evaluation of DNA adduction of AZT in peripheral blood leukocytes of HIV-infected individuals by (32)P-post-labeling thin-layer chromatography: a feasibility study.
Topics: Animals; Autoradiography; Cattle; Chromatography, Thin Layer; Densitometry; DNA Adducts; DNA Fingerprinting; DNA Repair; Feasibility Studies; HIV Infections; Humans; Isotope Labeling; Lasers; Leukocytes; Phosphorus Radioisotopes; Zidovudine | 2004 |
Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
Topics: Alanine; Antiretroviral Therapy, Highly Active; Didanosine; Female; HIV Infections; HIV Seronegativity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Logistic Models; Male; Mitochondria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Controlled Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 2004 |
Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis.
Topics: Animals; Animals, Newborn; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Drug Combinations; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Gap Junctions; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Indinavir; Mitochondria, Heart; Myocytes, Cardiac; Thiourea; Zidovudine | 2004 |
Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Nelfinavir; Oligopeptides; Organophosphonates; Oxazines; Pregnancy; Pyrimidinones; Ritonavir; Stavudine; Sulfonamides; Treatment Outcome; Viral Load; Zidovudine | 2004 |
[Prevention of vertical HIV transmission--a success story].
Topics: Administration, Oral; Adult; Anti-Retroviral Agents; Biomedical Research; Breast Feeding; Cesarean Section; Cohort Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Injections, Intravenous; Male; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Switzerland; Time Factors; Zidovudine | 2004 |
[Simplified treatments for HIV infection].
Topics: Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Switzerland; Time Factors; Treatment Outcome; Zidovudine | 2004 |
Meeting report from the XV International AIDS Conference. Perinatal transmission.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Genes, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Point Mutation; Retrospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2004 |
HIV infection and zidovudine use in childbearing women.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Seroprevalence; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; New Jersey; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2004 |
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Failure; Zidovudine | 2004 |
Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Population Surveillance; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Registries; United States; Zidovudine | 2001 |
Response to the comparison of generic zidovudine plus lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Drugs, Generic; HIV Infections; Humans; Lamivudine; Tablets; Zidovudine | 2004 |
Mixtures of varying coefficient models for longitudinal data with discrete or continuous nonignorable dropout.
Topics: Anti-HIV Agents; Biometry; CD4 Lymphocyte Count; Child; Data Interpretation, Statistical; HIV Infections; Humans; Linear Models; Longitudinal Studies; Models, Statistical; Randomized Controlled Trials as Topic; Zidovudine | 2004 |
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Hepatitis; HIV Infections; Humans; Indinavir; Liver Function Tests; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 2005 |
Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhib
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutation; Nucleotides; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2005 |
Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.
Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2005 |
Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine.
Topics: Adenine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Failure; Zidovudine | 2005 |
Effects of prenatal exposure to Zidovudine and Lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women.
Topics: Adult; Anti-HIV Agents; Apgar Score; Evoked Potentials, Auditory, Brain Stem; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; Zidovudine | 2004 |
[Simplification to lamivudine, zidovudine, and abacavir therapy: impact on adherence, clinical outcome, and economic issues].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Costs and Cost Analysis; Dideoxynucleosides; HIV Infections; Humans; Lamivudine; Patient Compliance; Retrospective Studies; Zidovudine | 2004 |
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Didanosine; Dideoxynucleosides; Drug Stability; HIV; HIV Infections; Humans; Lamivudine; Quality Control; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine | 2005 |
Prolonged treatment interruption in chronic HIV infection: a new strategy?
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Chronic Disease; Cohort Studies; Didanosine; Drug Administration Schedule; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2005 |
Inhibitory drug levels found in breast milk.
Topics: Anti-Retroviral Agents; Female; HIV Infections; Humans; Infant; Lamivudine; Milk, Human; Nevirapine; Zidovudine | 2004 |
AZT binding to Na,K-ATPase.
Topics: Antiviral Agents; Binding Sites; Deuterium Oxide; HIV Infections; Humans; Protein Structure, Secondary; Sodium-Potassium-Exchanging ATPase; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Water; Zidovudine | 2005 |
HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Program Evaluation; Zidovudine | 2004 |
Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica.
Topics: Antibiotic Prophylaxis; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Jamaica; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prospective Studies; Retrospective Studies; Treatment Outcome; Zidovudine | 2004 |
HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Chemoprevention; Child; Child Abuse, Sexual; Drug Therapy, Combination; Female; HIV Infections; Humans; Jamaica; Lamivudine; Male; Rape; Risk Factors; Zidovudine | 2004 |
Zidovudine monotherapy and the prevention of mother-to-child HIV-1 transmission.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
Recent advances in prevention of mother to child (PMTCT) of HIV.
Topics: Africa; Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Prenatal Care; Treatment Outcome; Zidovudine | 2004 |
Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda.
Topics: Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pilot Projects; Pregnancy; Risk Factors; Socioeconomic Factors; Treatment Outcome; Uganda; Zidovudine | 2004 |
The use of the triangular test with response-adaptive treatment allocation.
Topics: Clinical Trials as Topic; Endpoint Determination; HIV Infections; Humans; Likelihood Functions; Models, Statistical; Monte Carlo Method; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Topics: Adenine; CD4 Lymphocyte Count; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Zidovudine | 2005 |
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
Topics: Adult; Anti-HIV Agents; Cote d'Ivoire; Developing Countries; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2005 |
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.
Topics: Adult; Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Evolution, Molecular; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Recombination, Genetic; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Virus Replication; Zalcitabine; Zidovudine | 2005 |
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.
Topics: Adipocytes; Adipose Tissue; Adult; Anti-HIV Agents; Apoptosis; Biopsy; Dideoxynucleosides; DNA; DNA Fragmentation; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; In Situ Nick-End Labeling; Male; Middle Aged; Stavudine; Zidovudine | 2005 |
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Topics: Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Disease Progression; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Interferons; Interleukin-6; Male; Neopterin; Predictive Value of Tests; Risk Factors; Zidovudine | 2005 |
Prevention. Report: HIV transmission to U.S. newborns nears extinction.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Module four: standards of care and clinical trials.
Topics: Control Groups; Controlled Clinical Trials as Topic; Developed Countries; Developing Countries; Guidelines as Topic; Helsinki Declaration; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Placebos; Research Design; Research Subjects; South Africa; Zidovudine | 2005 |
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Deoxycytidine Kinase; Female; HIV; HIV Infections; Humans; Leukocytes, Mononuclear; Male; Middle Aged; RNA, Viral; Thymidine; Thymidine Kinase; Zidovudine | 2005 |
Postexposure prophylaxis after sexual assaults: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Brazil; Child; Child, Preschool; Cohort Studies; Drug Administration Schedule; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Prospective Studies; Rape; Sexually Transmitted Diseases; Zidovudine | 2005 |
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drugs, Generic; Female; HIV Infections; HIV-1; Humans; India; Lamivudine; Male; Middle Aged; Oxazines; Prospective Studies; Tablets; Treatment Outcome; Viral Load; Zidovudine | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.
Topics: Adolescent; Adult; Anti-HIV Agents; Cote d'Ivoire; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Socioeconomic Factors; Zidovudine | 2005 |
Copackaged drug regimen approved for PEPFAR.
Topics: Adult; Drug Combinations; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Clinical and immunologic characteristics and therapeutic interventions in children born to human immunodeficiency virus-infected mothers in southern Taiwan.
Topics: Anti-HIV Agents; Bottle Feeding; Cesarean Section; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Male; Pregnancy; Pregnancy Complications, Infectious; Taiwan; Zidovudine | 2005 |
Averting drug resistance while preventing MTCT.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
A drug is effective if better than a harmless control.
Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Zidovudine | 2005 |
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Zidovudine | 2005 |
The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chi-Square Distribution; HIV Infections; Humans; Lamivudine; Male; Nelfinavir; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Assessment; Risk-Taking; Stavudine; Tenofovir; Zidovudine | 2005 |
Recurrence of post-traumatic stress disorder and antiretrovirals.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lamivudine; Oxazines; Recurrence; RNA, Viral; Stress Disorders, Post-Traumatic; Viral Load; Zidovudine | 2005 |
KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
Topics: Animals; Anti-HIV Agents; Azacitidine; Cell Line; Cricetinae; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Zidovudine and red-cell distribution width.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Erythrocyte Indices; Erythrocytes; HIV Infections; Humans; Male; Patient Compliance; Zidovudine | 2005 |
The law and ACTG protocol 076: do the slings and arrows of mandatory HIV testing penetrate a woman's right to privacy.
Topics: AIDS Serodiagnosis; Civil Rights; Clinical Protocols; Counseling; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Mandatory Testing; Pregnancy; Pregnant Women; Privacy; United States; Zidovudine | 1999 |
Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection.
Topics: Cell Line; Deoxycytidine; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; In Vitro Techniques; Mutagens; Mutation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 2005 |
Prospective study on the prevention of vertical transmission of HIV in Campo Grande, Mato Grosso do Sul, Brazil, from 1996 to 2001.
Topics: Adolescent; Adult; Anti-HIV Agents; Brazil; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Viral Load; Zidovudine | 2005 |
Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates.
Topics: Adolescent; Adult; Anti-HIV Agents; Birth Weight; Case-Control Studies; CD4 Lymphocyte Count; Female; Fetal Development; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; RNA, Viral; Zidovudine | 2005 |
The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Topics: Adenosine Triphosphate; Anti-HIV Agents; Base Sequence; Didanosine; DNA Primers; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Thymidine; Zidovudine | 2005 |
Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmission.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2005 |
South Africa: Court upholds disciplinary measures against outspoken physician.
Topics: Female; HIV Infections; Humans; Physicians; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 2005 |
Mothers on the margins: implications for eradicating perinatal HIV.
Topics: Adult; Anti-HIV Agents; Communication; Female; HIV Infections; HIV Seroprevalence; Humans; Illinois; Infant, Newborn; Infectious Disease Transmission, Vertical; Interviews as Topic; Physician-Patient Relations; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, High-Risk; Self Disclosure; Vulnerable Populations; Zidovudine | 2006 |
Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Brazil; Cervix Uteri; Cross-Sectional Studies; Cyclopropanes; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Nelfinavir; Prevalence; Time Factors; Vagina; Viral Load; Zidovudine | 2006 |
Antiretroviral therapy--alternative uses.
Topics: Anti-Retroviral Agents; Breast; Cosmetic Techniques; Drug Combinations; Drug Resistance, Viral; Female; HIV Infections; Humans; Lamivudine; Zidovudine | 2005 |
Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Antigens; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Prevalence; Pseudomonas Infections; Sarcoma, Kaposi; Zidovudine | 2005 |
Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
Topics: Alkylation; Animals; Anti-HIV Agents; Anticoagulants; Dextran Sulfate; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lethal Dose 50; Lipids; Macaca fascicularis; Mice; Mice, Inbred NOD; Mice, SCID; Models, Animal; N-Acetylneuraminic Acid; Sialic Acids; T-Lymphocytes; U937 Cells; Virus Replication; Zidovudine | 2005 |
Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Child; Disease Outbreaks; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 2006 |
Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Topics: Anti-HIV Agents; Blotting, Western; Decision Support Techniques; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; Humans; Immunoassay; Labor, Obstetric; Mass Screening; Mexican Americans; Point-of-Care Systems; Pregnancy; Pregnancy Complications, Infectious; Sensitivity and Specificity; Texas; Zidovudine | 2005 |
Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Program Development; Program Evaluation; South Africa; Treatment Outcome; Zidovudine | 2005 |
The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy.
Topics: Acidosis, Lactic; Anti-HIV Agents; Blood Preservation; Blood Specimen Collection; Didanosine; HIV Infections; Humans; Lactates; Lamivudine; Multicenter Studies as Topic; Oxalates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sodium Fluoride; Specimen Handling; Stavudine; Time Factors; Zidovudine | 2005 |
Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Epidemiologic Methods; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Medicaid; Middle Aged; Patient Compliance; Zidovudine | 2005 |
Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
Topics: Africa; AIDS Vaccines; Clinical Trials as Topic; Developing Countries; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Risk Assessment; Social Justice; United States; Zidovudine | 2004 |
Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
Topics: Anti-HIV Agents; Chemoprevention; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mitochondrial Diseases; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
Homo and heterodimers of ddI, d4T and AZT: influence of (5'-5') thiolcabonate-carbamate linkage on anti-HIV activity.
Topics: Anti-HIV Agents; Antiviral Agents; Carbamates; Didanosine; Dimerization; HIV; HIV Infections; Models, Chemical; Molecular Conformation; Mutation; Stavudine; Sulfhydryl Compounds; Zidovudine | 2005 |
Prevention of mother-to-child transmission of HIV in São Paulo State, Brazil: an update.
Topics: Anti-HIV Agents; Brazil; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mortality; Outcome and Process Assessment, Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Program Evaluation; Zidovudine | 2005 |
Life-threatening maternal and fetal macrocytic anemia from antiretroviral therapy.
Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; Fetal Diseases; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pregnancy Outcome; Viral Load; Zidovudine | 2005 |
Physician, do no harm.
Topics: Controlled Clinical Trials as Topic; Developing Countries; Ethics, Research; Female; HIV Infections; Human Experimentation; Humans; Informed Consent; Placebos; Poverty; Research Subjects; Social Justice; Uterine Cervical Neoplasms; Women; Zidovudine | 1998 |
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2005 |
Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
Topics: Anti-HIV Agents; Chemoprevention; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Placenta; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Time Factors; Treatment Outcome; Zidovudine | 2005 |
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
Topics: Adiponectin; Adipose Tissue; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Drug Therapy, Combination; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Interleukin-6; Male; Middle Aged; Mitochondria; Reverse Transcriptase Inhibitors; Stavudine; Sterol Regulatory Element Binding Protein 1; Tumor Necrosis Factor-alpha; Zidovudine | 2005 |
Mass needle stick injury in children from the Western cape.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Communicable Disease Control; Environmental Exposure; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Medical Waste; Needlestick Injuries; South Africa; Treatment Outcome; Zidovudine | 2006 |
Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors.
Topics: Adolescent; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hypertriglyceridemia; Infant; Lamivudine; Male; Ritonavir; Saquinavir; Zidovudine | 2006 |
Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Drug Prescriptions; Health Care Costs; Health Services Accessibility; HIV Infections; HIV Protease Inhibitors; Humans; Mexico; Oxazines; Patient Compliance; Practice Guidelines as Topic; Saquinavir; Zidovudine | 2006 |
Less expensive ZDV on the way.
Topics: Africa; Anti-HIV Agents; China; Drug Compounding; Drug Industry; Drugs, Generic; HIV Infections; India; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
The role of zidovudine in development of lipoatrophy.
Topics: Adipose Tissue; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Mice; Randomized Controlled Trials as Topic; Rats; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |
[Detection of HIV infection in pregnant women by rapid testing: a successful strategy to reduce its vertical transmission].
Topics: Adolescent; Adult; Anti-HIV Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Middle Aged; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Uruguay; Zidovudine | 2005 |
Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Child; Child, Preschool; Drug Resistance, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; India; Infant; Lamivudine; Male; Middle Aged; Mutation; Zidovudine | 2005 |
Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Child; Clinical Trials as Topic; Cytokines; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Treatment Outcome; Zidovudine | 2005 |
Maternal HIV type 1 infection suppresses MMP-1 expression in endothelial cells of uninfected newborns: nonviral vertical transmission of HIV type 1-related effects.
Topics: Anti-HIV Agents; Blotting, Western; Cell Separation; Cells, Cultured; DNA; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Immunochemistry; Infant, Newborn; Matrix Metalloproteinase 1; Mutation; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Zidovudine | 2005 |
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hypersensitivity; Lamivudine; Male; Patient Compliance; Retrospective Studies; Spain; Treatment Failure; Zidovudine | 2006 |
A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
Topics: Adolescent; Anti-HIV Agents; Body Surface Area; Body Weight; Child; Child, Preschool; Didanosine; Dosage Forms; Female; HIV Infections; Humans; Infant; Male; Zidovudine | 2006 |
Goodness-of-fit methods for generalized linear mixed models.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Computer Simulation; Data Interpretation, Statistical; Female; HIV Infections; Humans; Indonesia; Linear Models; Male; Monte Carlo Method; Respiratory Tract Infections; Vitamin A; Zidovudine | 2005 |
Quantitation of zidovudine triphosphate concentrations from human peripheral blood mononuclear cells by anion exchange solid phase extraction and liquid chromatography-tandem mass spectroscopy; an indirect quantitation methodology.
Topics: Chemical Fractionation; Chromatography, Liquid; Dideoxynucleotides; Drug Stability; Enzyme-Linked Immunosorbent Assay; HIV Infections; Humans; Ion Exchange; Leukocytes, Mononuclear; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Thymine Nucleotides; Zidovudine | 2006 |
Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk Factors; Zidovudine | 2006 |
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
Topics: Cote d'Ivoire; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Mutation; Nevirapine; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2006 |
A rapid HIV testing program for labor and delivery in an inner-city teaching hospital.
Topics: Algorithms; Anti-HIV Agents; Delivery, Obstetric; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV-1; Hospitals, Teaching; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Time Factors; United States; Urban Population; Zidovudine | 2006 |
Perinatal HIV transmission: a children's human rights perspective.
Topics: AIDS Serodiagnosis; Female; HIV Infections; Human Rights; Humans; Infant; Infectious Disease Transmission, Vertical; Mandatory Testing; Pregnancy; Pregnant Women; Privacy; Public Policy; United States; Voluntary Programs; Zidovudine | 1998 |
Mandatory HIV testing and treating of child-bearing women: an unnatural, illegal, and unsound approach.
Topics: Female; Government Regulation; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Mandatory Testing; Pregnancy; Pregnant Women; Privacy; Reproductive Rights; Supreme Court Decisions; Treatment Refusal; United States; Voluntary Programs; Zidovudine | 1997 |
[HIV infection presenting with bilateral optic neuropathy].
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Progression; Drug Therapy, Combination; Evoked Potentials, Visual; Facial Nerve Diseases; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ischemia; Lamivudine; Lopinavir; Male; Meningitis, Viral; Methylprednisolone; Middle Aged; Optic Disk; Optic Nerve Diseases; Polyradiculopathy; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Visual Fields; Zidovudine | 2006 |
Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Topics: Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Female; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-7; Interleukin-7 Receptor alpha Subunit; Male; Middle Aged; Receptors, Interleukin-7; Reverse Transcriptase Inhibitors; Saquinavir; Zidovudine | 2005 |
Concerns regarding a randomized trial of two postexposure prophylaxis regimens.
Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine | 2006 |
[Severe anemia in the framework of zidovudine treatment in HIV disease].
Topics: Acute Disease; Adult; Anemia, Macrocytic; Anti-HIV Agents; Diagnosis, Differential; Female; Follow-Up Studies; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2006 |
Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients.
Topics: Anti-HIV Agents; Cell Line; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; HIV Infections; Humans; Kinetics; Leukocytes, Mononuclear; Mass Spectrometry; Microbial Sensitivity Tests; Stavudine; Time Factors; Zidovudine | 2006 |
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
Topics: Animals; DNA; DNA, Mitochondrial; Echocardiography; Genes, pol; HIV Infections; HIV-1; Humans; Immunoblotting; Lamivudine; Membrane Transport Proteins; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Models, Molecular; Myocardium; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Stavudine; Zidovudine | 2006 |
Determinants of HIV-1 mother-to-child transmission in Southern Brazil.
Topics: Adult; Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Epidemiologic Methods; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2006 |
Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort.
Topics: Adenine; Cohort Studies; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; France; HIV Infections; HIV Reverse Transcriptase; HIV-1; Hospitals, University; Humans; Lamivudine; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Species Specificity; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2006 |
[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Topics: Antiretroviral Therapy, Highly Active; Cesarean Section; Delivery, Obstetric; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Risk Factors; Viral Load; Zidovudine | 2006 |
Is elective caesarian section really essential for prevention of mother to child transmission of HIV in the era of antiretroviral therapy and abstinence of breast feeding?
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Delivery, Obstetric; Female; HIV Infections; Humans; India; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Perinatal Care; Pregnancy; Retrospective Studies; Zidovudine | 2006 |
Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Lactates; Lamivudine; Male; Mitochondria; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2007 |
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Down-Regulation; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Mimicry; Peptides; Receptors, CCR5; Receptors, CXCR4; RNA, Viral; Sequence Alignment; Virus Replication; Zidovudine | 2006 |
[Assessment of a programme of prevention of mother-to-child transmission of HIV in Abidjan, Ivory Coast (1999-20002)].
Topics: Breast Feeding; Cote d'Ivoire; Female; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2006 |
Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine | 2006 |
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Viremia; Zidovudine | 2006 |
Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Topics: Adenine; Anti-Retroviral Agents; Bias; Data Interpretation, Statistical; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Lamivudine; Organophosphonates; Research Design; Tenofovir; Zidovudine | 2006 |
Electronic chip fights counterfeiting.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Industry; Drug Labeling; Electronics; Fraud; HIV Infections; Humans; Lamivudine; United States; Zidovudine | 2006 |
Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Topics: Adenine; Bone Density; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; HIV; HIV Infections; Humans; Lamivudine; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2006 |
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-2; Humans; Lamivudine; Mutation; Viral Load; Zidovudine | 2006 |
Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; Area Under Curve; Drug Administration Schedule; Half-Life; HIV Infections; Humans; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2006 |
Human immunodeficiency virus-1 and preconception care.
Topics: Adolescent; Adult; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Maternal Welfare; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Time Factors; Zidovudine | 2006 |
Discussing the effectiveness of short-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2006 |
Is stavudine triphosphate a natural metabolite of zidovudine?
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; HIV Infections; Humans; Leukocytes, Mononuclear; Stavudine; Zidovudine | 2006 |
Proton Spectroscopy in a Cross-Section of HIV-Positive Asymptomatic Patients Receiving Immediate Compared with Deferred Zidovudine (Concorde Study).
Topics: HIV Infections; HIV Seropositivity; Humans; Magnetic Resonance Spectroscopy; Protons; Spectrum Analysis; Zidovudine | 1997 |
Rapid improvement of liver function in a patient with HIV and hepatitis B coinfection treated with lamivudine and tenofovir.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hepatitis; HIV Infections; Humans; Lamivudine; Liver Function Tests; Organophosphonates; Tenofovir; Zidovudine | 2006 |
Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Lamivudine; Mitochondrial Diseases; Nervous System Diseases; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine | 2006 |
Pregnant women with HIV infection can expect healthy survival: three-year follow-up.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Medical Audit; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; Zidovudine | 2006 |
Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Controlled Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Oxazines; Prospective Studies; Time Factors; Treatment Outcome; Zidovudine | 2006 |
Antiretroviral agents mimicking functional neonatal bowel obstruction: a case report.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Intestinal Obstruction; Male; Pregnancy; Zidovudine | 2006 |
HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women.
Topics: Anti-HIV Agents; Biomarkers; Cervix Mucus; Drug Resistance, Viral; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Plasma; Pregnancy; Pregnancy Complications, Infectious; RNA-Directed DNA Polymerase; Zidovudine | 2006 |
AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
Topics: Amides; Anti-HIV Agents; Cells, Cultured; Dideoxynucleotides; Drug Delivery Systems; Drug Evaluation; Drug Stability; Esters; HIV Infections; HIV Protease; HIV-1; Humans; Inhibitory Concentration 50; Models, Biological; Phosphoric Acids; Prodrugs; Protease Inhibitors; Thymidine Kinase; Thymine Nucleotides; Zidovudine | 2006 |
Functional impairment of CD4 T cells despite normalization of T cell number in HIV.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Proliferation; Female; HIV Infections; Humans; In Vitro Techniques; Lymphocyte Activation; Male; Zidovudine | 2006 |
Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Inhibitory Concentration 50; Lamivudine; Male; Microbial Sensitivity Tests; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Selection, Genetic; Thymidine; Virus Replication; Zidovudine | 2006 |
Disease progression among HIV-infected children who receive perinatal zidovudine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Zidovudine | 2007 |
[Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy].
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Phytotherapy; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2006 |
The ethics of placebo-controlled studies on perinatal HIV transmission and its treatment in the developing world.
Topics: Anti-HIV Agents; Breast Feeding; Control Groups; Controlled Clinical Trials as Topic; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Zidovudine | 2006 |
Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Weight; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Stavudine; Zidovudine | 2007 |
Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients.
Topics: Aged; Alkynes; Benzoxazines; Case-Control Studies; Cyclopropanes; Electrocardiography; Female; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; Risk Factors; Zidovudine | 2007 |
Medical morals: an exchange.
Topics: Biomedical Research; Control Groups; Controlled Clinical Trials as Topic; Developing Countries; Ethics, Research; Female; Guidelines as Topic; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Research Personnel; United States; World Health Organization; Zidovudine | 2001 |
Report from the XVI International AIDS Conference. Efavirenz for high viral load and low CD4--a secondary analysis of ACTG 5095.
Topics: Alkynes; Benzoxazines; CD4 Lymphocyte Count; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; HIV Infections; Humans; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2006 |
Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC-MS/MS.
Topics: Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV Infections; Humans; Lamivudine; Phosphates; Reference Standards; Reverse Transcriptase Inhibitors; Tandem Mass Spectrometry; Zidovudine | 2007 |
Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
Topics: Anti-HIV Agents; Drug Combinations; Granuloma, Pyogenic; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nail Diseases; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
Topics: Adenine; Adult; Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2006 |
Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivo.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Mutation; Retrospective Studies; RNA, Viral; T-Lymphocytes; Time Factors; Viral Load; Virus Replication; Zidovudine | 2007 |
Anti-HIV agents. Abacavir--as good as AZT?
Topics: Adult; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2003 |
Anti-HIV agents. Low rate of early virologic failure seen with a combination of Trizivir and tenofovir.
Topics: Adenine; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Organophosphonates; Tenofovir; Viral Load; Zidovudine | 2004 |
Justice and placebo controls.
Topics: Control Groups; Developing Countries; Drugs, Essential; Ethical Analysis; Ethics, Research; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Models, Theoretical; Moral Obligations; Placebos; Pregnancy; Pregnant Women; Professional Role; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Research Personnel; Research Subjects; Researcher-Subject Relations; Respiratory Distress Syndrome, Newborn; Social Justice; Stress, Psychological; Therapeutic Equivalency; Therapeutic Human Experimentation; Trust; Withholding Treatment; Zidovudine | 2006 |
AZT Availability in Illinois birthing hospitals: is the perinatal HIV prevention safety net in place?
Topics: Health Care Surveys; HIV Infections; Hospitals, Maternity; Humans; Illinois; Perinatal Care; Zidovudine | 2007 |
C34, a membrane fusion inhibitor, blocks HIV infection of langerhans cells and viral transmission to T cells.
Topics: Anti-HIV Agents; Antigens, CD34; Cells, Cultured; Chemokine CCL5; Coculture Techniques; Epidermal Cells; Epidermis; Gene Products, gag; HIV; HIV Envelope Protein gp41; HIV Infections; Humans; Langerhans Cells; Membrane Fusion; T-Lymphocytes; Virus Integration; Zidovudine | 2007 |
Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Black People; Cell Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Hemoglobins; Hepatitis C, Chronic; Hispanic or Latino; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Protease Inhibitors; Recombinant Proteins; Reticulocytes; Retrospective Studies; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors; Treatment Outcome; White People; Zidovudine | 2007 |
[Zidovudine-associated mitochondriopathy: three possible observations in Abidjan, Côte d'Ivoire].
Topics: Adult; Anemia, Hypochromic; Anti-HIV Agents; Cohort Studies; Comorbidity; Cote d'Ivoire; Epilepsy, Generalized; Failure to Thrive; Female; Fetus; Growth Disorders; HIV Infections; Humans; Infant; Male; Mitochondria; Muscle Hypotonia; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protein-Energy Malnutrition; Psychomotor Disorders; Randomized Controlled Trials as Topic; Zidovudine | 2004 |
Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimidinones; Ritonavir; Viral Load; Zidovudine | 2007 |
Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy.
Topics: Anti-HIV Agents; Drug Monitoring; HIV Infections; HIV-1; Immunoenzyme Techniques; Indinavir; Lamivudine; Sensitivity and Specificity; Time Factors; Virus Replication; Zidovudine | 2007 |
A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer.
Topics: DNA Primers; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydrolyzable Tannins; Nucleic Acid Synthesis Inhibitors; Plant Extracts; Reverse Transcriptase Inhibitors; Templates, Genetic; Terminalia; Zidovudine | 2007 |
Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
Topics: Anemia; Antiretroviral Therapy, Highly Active; Confidence Intervals; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Neutropenia; Odds Ratio; Perinatal Care; Pregnancy; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Zidovudine | 2007 |
[Changes in vertical HIV transmission: comparison between 1994 and 2004].
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cesarean Section; Cross-Sectional Studies; Delivery, Obstetric; Elective Surgical Procedures; Emigration and Immigration; Female; Hepatitis C; HIV Infections; Hospitals, University; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk; Sexual Behavior; Spain; Substance Abuse, Intravenous; Zidovudine | 2007 |
South Africa: Court overturns misconduct conviction of physician who denounced Minister inaction on HIV.
Topics: Female; Health Policy; HIV Infections; Humans; Physicians; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 2006 |
[Sustained spontaneous remission of chronic hepatitis C coinfection in HIV].
Topics: Adult; Anti-HIV Agents; Didanosine; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Remission, Spontaneous; Viremia; Zidovudine | 2007 |
[Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy].
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lamivudine; Nevirapine; Treatment Outcome; Vitiligo; Zidovudine | 2007 |
Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations.
Topics: Cell Line; DNA Primers; DNA, Single-Stranded; DNA, Viral; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Mutation; Phosphorylation; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Replication; Zidovudine | 2007 |
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
Topics: Adult; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Uganda; Zidovudine; Zimbabwe | 2007 |
Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.
Topics: Adenine; Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Erythrocytes; HIV Infections; Humans; Lamivudine; Nucleosides; Organophosphonates; Phosphorylation; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Zidovudine | 2007 |
New AZT analogues having 5'-alkylsulfonyl groups: synthesis and anti-HIV activity.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Design; Drug Industry; HIV Infections; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Phosphorylation; Temperature; Zidovudine | 2007 |
Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Humans; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cities; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zambia; Zidovudine | 2007 |
Increased haemoglobin A2 percentage in HIV infection: disease or treatment?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; Hemoglobin A2; HIV Infections; HIV Seropositivity; Humans; Prospective Studies; Zidovudine | 2007 |
Altered heterochromatin organization after perinatal exposure to zidovudine.
Topics: Adolescent; Anti-HIV Agents; Case-Control Studies; Cells, Cultured; Child; Child, Preschool; Chromatin Assembly and Disassembly; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 16; Cohort Studies; DNA Methylation; Female; Heterochromatin; HIV Infections; HIV-1; Humans; In Situ Hybridization, Fluorescence; Infant; Infant, Newborn; Leukocytes; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2007 |
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Follicle Stimulating Hormone; HIV Infections; HIV-1; Humans; Hypogonadism; Lamivudine; Luteinizing Hormone; Male; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Switzerland; Testosterone; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Dideoxynucleosides; DNA, Viral; Drug Combinations; Drug Monitoring; Drug Resistance, Viral; Follow-Up Studies; Genotype; Germany; HIV Infections; HIV-1; Humans; Lamivudine; Methionine; Mutation; Reverse Transcriptase Inhibitors; Thymidine; Time Factors; Treatment Failure; Valine; Viral Load; Virus Replication; Zidovudine | 2007 |
Ready or not--intrapartum prevention of perinatal HIV transmission in Illinois.
Topics: Anti-HIV Agents; Female; Health Care Surveys; HIV Infections; HIV-1; Hospitals, Maternity; Humans; Illinois; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
Topics: Adenine; Adult; Anti-HIV Agents; Chemoprevention; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Middle Aged; New York; Occupational Exposure; Occupational Health Services; Organophosphonates; Patient Compliance; Public Health Administration; Retrospective Studies; Risk Factors; Sex Factors; Student Health Services; Tenofovir; Universities; Zidovudine | 2007 |
Safety of HIV-1 Perinatal Transmission Prophylaxis With Zidovudine and Nevirapine in Rural South India.
Topics: Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Zidovudine | 2007 |
All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication.
Topics: Cell Line; Cells, Cultured; DNA, Viral; HIV Infections; HIV-1; Humans; Lymphocytes; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tretinoin; Virus Replication; Zidovudine | 2007 |
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Topics: Adult; Antiviral Agents; Area Under Curve; Drug Interactions; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Middle Aged; Phosphorylation; Reverse Transcriptase Inhibitors; Ribavirin; Zidovudine | 2007 |
The HBV drug entecavir - effects on HIV-1 replication and resistance.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA, Viral; Virus Replication; Zidovudine | 2007 |
Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Didanosine; Female; HIV Infections; HIV-1; Humans; Hyperplasia; Liver; Liver Diseases; Liver Regeneration; Middle Aged; Nevirapine; Zidovudine | 2007 |
Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1.
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Evolution, Molecular; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Inhibitors; Species Specificity; Thymidine; Time Factors; Zidovudine | 2007 |
HPV oral infection. Case report of an HIV-positive Nigerian sex worker.
Topics: Adenine; Adult; Alphapapillomavirus; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; HIV Infections; Humans; Italy; Lamivudine; Lopinavir; Mouth Mucosa; Nigeria; Organophosphonates; Papillomavirus Infections; Pyrimidinones; Ritonavir; Sex Work; Stomatitis; Tenofovir; Treatment Refusal; Zidovudine | 2007 |
Antiretroviral agents and acid-base balance at delivery of the neonate.
Topics: Acid-Base Equilibrium; Adult; Anti-HIV Agents; Case-Control Studies; Drug Therapy, Combination; Female; Fetal Blood; HIV Infections; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Outcome; Prospective Studies; Zidovudine | 2007 |
Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Clinical Protocols; Cohort Studies; Cyclopropanes; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Retrospective Studies; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.
Topics: Chromatography, High Pressure Liquid; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Postpartum Period; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine | 2007 |
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.
Topics: Africa, Southern; Antiretroviral Therapy, Highly Active; Didanosine; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymidine; Treatment Failure; Zidovudine | 2007 |
Effects of antiretroviral agents during pregnancy on liver enzymes and amylase in HIV-exposed, uninfected newborn infants.
Topics: Adolescent; Adult; Amylases; Anti-HIV Agents; Cohort Studies; Control Groups; Drug Therapy, Combination; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Liver; Male; Nelfinavir; Pregnancy; Prospective Studies; Transaminases; Zidovudine | 2007 |
[Update on HIV infection in Mayotte].
Topics: Adult; Anti-HIV Agents; Comoros; Dideoxynucleosides; Drug Combinations; Female; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Lamivudine; Male; Middle Aged; Transfusion Reaction; Viremia; Zidovudine | 2007 |
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings.
Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Benzoxazines; Chemokine CCL2; Cyclopropanes; Drug Resistance, Viral; Flow Cytometry; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interleukin-8; Lamivudine; Male; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Uveitis; Viral Load; Viremia; Zidovudine | 2007 |
Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; France; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kaplan-Meier Estimate; Medication Errors; Prospective Studies; Renal Dialysis; Stavudine; Zidovudine | 2007 |
Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Disease Progression; Follow-Up Studies; France; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Time Factors; Zidovudine | 2007 |
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Puerperal Disorders; Viral Load; Zidovudine | 2007 |
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
Topics: Adenine; Administration, Oral; Adult; Alkynes; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Genitalia, Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2007 |
Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.
Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Tuberculosis, Pulmonary; Zidovudine | 2007 |
Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
Topics: Adenine; Amino Acid Sequence; Deoxycytidine; Drug Resistance, Multiple, Viral; Genetic Variation; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Organophosphonates; Phenotype; Ribonuclease H; RNA-Directed DNA Polymerase; Sequence Homology, Amino Acid; Tenofovir; Zidovudine | 2007 |
Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anti-HIV Agents; Area Under Curve; Cohort Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Prior antiretroviral therapy experience protects against zidovudine-related anaemia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asia; Developing Countries; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Zidovudine | 2007 |
[Timely implementation of interventions to reduce vertical HIV transmission: a successful experience in Brazil].
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Brazil; Breast Feeding; Cesarean Section; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Odds Ratio; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2007 |
FDA notifications. FDA approves generic AZT.
Topics: Drug Approval; Drugs, Generic; HIV Infections; United States; United States Food and Drug Administration; Zidovudine | 2007 |
First use of tamoxifen in an HIV patient with encapsulating peritoneal sclerosis.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Estrogen Antagonists; Glucocorticoids; HIV Infections; Humans; Kidney Failure, Chronic; Lamivudine; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Diseases; Saquinavir; Sclerosis; Tamoxifen; Zidovudine | 2007 |
Human immunodeficiency virus infection in a child presenting as herpes zoster ophthalmicus.
Topics: Acyclovir; Child; Eye Diseases; Herpes Zoster Ophthalmicus; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Zidovudine | 2007 |
Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Treatment Outcome; United States; Zidovudine | 2007 |
Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Drugs, Generic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Kenya; Lamivudine; Male; Nevirapine; Prospective Studies; RNA, Viral; Viral Load; Zidovudine | 2007 |
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Topics: Anti-HIV Agents; Cytidine Triphosphate; Dideoxynucleotides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Reverse Transcriptase Inhibitors; Stavudine; Thymine Nucleotides; Zidovudine | 2007 |
[Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
Topics: Adult; alpha-Thalassemia; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Folic Acid; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Zidovudine | 2007 |
Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
Topics: Adult; Anemia, Hemolytic; Anti-HIV Agents; Anti-Retroviral Agents; Cohort Studies; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Male; Treatment Outcome; Zidovudine | 2007 |
Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention intervention.
Topics: Adult; Anti-HIV Agents; Attitude to Health; Drug Combinations; Feasibility Studies; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Risk-Taking; Treatment Outcome; Zidovudine | 2008 |
[Haematological parameters evolution during the antiretroviral therapy of HIV infected patients in Burkina-Faso].
Topics: Adolescent; Adult; Anemia; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Burkina Faso; Female; Follow-Up Studies; Hematologic Diseases; Hemoglobins; HIV Infections; Humans; Lymphopenia; Male; Middle Aged; Neutropenia; Retrospective Studies; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2007 |
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Aspartate Aminotransferases; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stavudine; Zidovudine | 2007 |
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; HIV; HIV Infections; Humans; Male; RNA, Viral; Stavudine; Viral Load; Viremia; Zidovudine | 2007 |
Clinical trials and SCID row: the ethics of phase 1 trials in the developing world.
Topics: Adenosine Deaminase; Africa; Anti-HIV Agents; Clinical Trials, Phase I as Topic; Developing Countries; Ethics, Research; Gene Transfer Techniques; Genetic Therapy; Hemophilia A; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Italy; Poverty; Severe Combined Immunodeficiency; Treatment Outcome; Zidovudine | 2007 |
Using causal models to show the effect of untestable assumptions on effect estimates in randomized controlled trials.
Topics: Data Interpretation, Statistical; HIV Infections; Humans; Models, Statistical; Placebos; Quebec; Randomized Controlled Trials as Topic; Survival Analysis; Zidovudine | 2007 |
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
Topics: Cell Line; Drug Resistance, Multiple, Viral; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Nevirapine; Phenotype; Protein Conformation; Protein Structure, Tertiary; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.
Topics: Drug Resistance, Multiple, Viral; Genetic Testing; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Nevirapine; Patient Selection; Phenotype; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Physical signs for the general dental practitioner. Case 49. Zidovudine (AZT or Retrovir) treatment.
Topics: Anti-HIV Agents; Diagnosis, Differential; HIV Infections; Humans; Male; Nail Diseases; Zidovudine | 2007 |
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Dideoxynucleosides; Drug Therapy, Combination; Female; Genes, MDR; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Prognosis; Proportional Hazards Models; Reverse Transcriptase Inhibitors; RNA, Viral; Switzerland; Treatment Failure; Viral Load; Zidovudine | 2007 |
Frequent detection of acute HIV infection in pregnant women.
Topics: Acute Disease; Algorithms; Anti-HIV Agents; Female; Follow-Up Studies; HIV; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; North Carolina; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Prenatal Care; Prevalence; RNA, Viral; Zidovudine | 2007 |
Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Case-Control Studies; Dideoxynucleosides; Femur Neck; HIV Infections; Humans; Lamivudine; Lopinavir; Lumbar Vertebrae; Male; Middle Aged; Prospective Studies; Pyrimidinones; Ritonavir; Zidovudine | 2008 |
Preventable zidovudine overdose during postnatal prophylaxis in healthy children born to HIV-1-positive mothers.
Topics: Anti-HIV Agents; Fatal Outcome; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Male; Medical Errors; Neutropenia; Pregnancy; Pregnancy Complications, Infectious; Staphylococcal Infections; Zidovudine | 2008 |
Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2007 |
Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cambodia; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
[Early intervention in HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Disease Progression; HIV Infections; Humans; Zidovudine | 1992 |
Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 2008 |
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Microbial Sensitivity Tests; Nevirapine; Pregnancy; RNA, Viral; Treatment Outcome; Treatment Refusal; Viral Load; Zidovudine | 2008 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
Topics: Adult; Anemia; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Spain; Thrombocytopenia; Zidovudine | 2007 |
[HIV mother to child transmission: report of nine Cuban fatal cases in ten years].
Topics: Anti-HIV Agents; Child, Preschool; Cuba; Fatal Outcome; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 2008 |
A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Topics: Amino Acid Substitution; Anti-HIV Agents; Cluster Analysis; DNA, Viral; Drug Resistance, Viral; Genetic Techniques; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infant, Newborn; Leukocytes, Mononuclear; Mothers; Mutation, Missense; Nevirapine; Phylogeny; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA; Uganda; Zidovudine | 2008 |
Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients.
Topics: Adolescent; Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Zidovudine | 2008 |
18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
Topics: Africa; Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Proportional Hazards Models; Survival Rate; Treatment Outcome; Zidovudine | 2008 |
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Cohort Studies; Drug Administration Schedule; Female; Hematologic Tests; HIV Infections; HIV-1; Humans; Male; Retrospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cost-Benefit Analysis; Cyclopropanes; Decision Trees; Deoxycytidine; Drug Costs; Emtricitabine; Health Care Costs; Health Resources; HIV Infections; HIV-1; Humans; Lamivudine; Models, Economic; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Zidovudine | 2008 |
Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Ontario; Pyrimidinones; Rape; Risk Factors; Zidovudine | 2008 |
Characteristics of pregnancy with human immuno-deficiency virus (HIV) and perinatal transmission in Nakornping Hospital.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Thailand; Zidovudine | 2008 |
Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Belgium; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Prevalence; Retrospective Studies; Zidovudine | 2009 |
High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
Topics: Anti-HIV Agents; Dideoxynucleotides; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Leukocytes, Mononuclear; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Thymine Nucleotides; Zidovudine | 2008 |
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; Follow-Up Studies; HIV; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Male; Nevirapine; Survival Analysis; Treatment Outcome; Zidovudine | 2008 |
Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; South Africa; Zidovudine | 2008 |
[Antiretroviral drug toxicity in human immunodeficiency virus infected children].
Topics: Acidosis, Lactic; Adolescent; Anti-Retroviral Agents; Bone Diseases, Metabolic; Child; Child, Preschool; Female; HIV Infections; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Lipodystrophy; Metabolic Syndrome; Radiography; Zidovudine | 2008 |
New formulations approved for children.
Topics: Anti-HIV Agents; Chemistry, Pharmaceutical; Child; Child, Preschool; Dideoxynucleosides; Drug Approval; Drug Combinations; European Union; HIV Infections; Humans; Infant; Infant, Newborn; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 2008 |
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cesarean Section; Delivery, Obstetric; Female; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Ireland; Male; Pregnancy; Pregnancy Complications, Infectious; United Kingdom; Viral Load; Zidovudine | 2008 |
25 years of HIV.
Topics: AIDS Vaccines; Anti-HIV Agents; Drug Resistance, Viral; History, 20th Century; History, 21st Century; HIV; HIV Infections; Humans; Time Factors; Zidovudine | 2008 |
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Thymidine; Viral Load; Zidovudine | 2008 |
[Antiretroviral treatment against HIV].
Topics: Antiviral Agents; Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1995 |
Is HIV the cause of AIDS?
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Viral; Female; Hemophilia A; HIV; HIV Infections; Humans; Male; Zidovudine | 1995 |
A quarter-century of antiviral therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
AZT trial in Thailand.
Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1995 |
Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
Topics: Animals; Cell Line; Disease Models, Animal; Female; HIV Core Protein p24; HIV Infections; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Spleen; Time Factors; Zidovudine | 1995 |
Change in zidovudine prescribing practices in Australia, 1991-1993.
Topics: Acquired Immunodeficiency Syndrome; Australia; Drug Utilization; HIV Infections; Humans; Practice Patterns, Physicians'; Zidovudine | 1995 |
[Apropos the prevention of the vertical transmission of HIV].
Topics: Cesarean Section; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1995 |
Early treatment of HIV infection.
Topics: Antiviral Agents; Costs and Cost Analysis; HIV Infections; HIV-1; Humans; RNA, Viral; Viremia; Zidovudine | 1995 |
Early treatment of HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV-1; Humans; Viremia; Zidovudine | 1995 |
Early treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Antiviral Agents; HIV Infections; Humans; Zidovudine | 1995 |
The management of pregnancy and delivery in HIV-infected women in Europe.
Topics: Blood Transfusion; Delivery, Obstetric; Europe; Female; HIV Infections; Hospitals; Humans; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Zidovudine | 1995 |
Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Topics: Adult; Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunocompromised Host; Treatment Outcome; Zalcitabine; Zidovudine | 1995 |
How much paediatric HIV infection could be prevented by antenatal HIV testing?
Topics: Bottle Feeding; Breast Feeding; Cesarean Section; Female; HIV Infections; HIV Seroprevalence; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; London; Mass Screening; Models, Statistical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Probability; Risk Factors; Zidovudine | 1995 |
Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Topics: Antimetabolites; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Erythroid Precursor Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-1; Recombinant Proteins; Zidovudine | 1995 |
Mathematical modelling of HIV infection therapy.
Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Lymphocyte Depletion; Models, Theoretical; Zidovudine | 1995 |
Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
Topics: Antiviral Agents; Cadaver; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; HIV Infections; HIV-1; Humans; Immunologic Memory; Skin; Virus Replication; Zidovudine | 1995 |
Unsuspected HIV infection presenting in first year of life.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mass Screening; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance.
Topics: Adult; Base Sequence; DNA Primers; Drug Resistance, Microbial; Female; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sexual Behavior; Time Factors; Zidovudine | 1994 |
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Topics: Antiviral Agents; Base Sequence; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Molecular Sequence Data; Mutagenesis; Nevirapine; Phenotype; Pyridines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Selection, Genetic; Time Factors; Zidovudine | 1994 |
A cost analysis of approved antiretroviral strategies in persons with advanced human immunodeficiency virus disease and zidovudine intolerance.
Topics: Acquired Immunodeficiency Syndrome; Agranulocytosis; Algorithms; Anemia; Costs and Cost Analysis; Decision Support Techniques; Didanosine; Erythrocyte Transfusion; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; HIV Infections; Humans; Pancreatitis; Quality of Life; Zidovudine | 1994 |
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
Topics: CD4-Positive T-Lymphocytes; Codon; DNA, Viral; Drug Resistance, Microbial; Genotype; Giant Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Leukocytes, Mononuclear; Mutation; Phenotype; Proviruses; Regression Analysis; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1994 |
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.
Topics: CD4-Positive T-Lymphocytes; Codon; Didanosine; Drug Resistance, Microbial; Genes, Viral; HIV; HIV Infections; Humans; Leukocyte Count; Mutation; Retrospective Studies; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1994 |
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment Program.
Topics: Adult; Amylases; Cause of Death; Cohort Studies; Didanosine; Drug Evaluation; Female; Follow-Up Studies; HIV Infections; Humans; Male; Pancreatitis; Peripheral Nervous System Diseases; Prospective Studies; Risk Factors; Safety; Survival Analysis; Treatment Failure; Zidovudine | 1994 |
[Anti-HIV-therapy. Monotherapy with drugs delaying the course of the disease has limited effect].
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; Humans; Palliative Care; Zalcitabine; Zidovudine | 1994 |
HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine.
Topics: Base Sequence; Child; Child, Preschool; DNA Probes; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Molecular Sequence Data; Mutation; Prospective Studies; RNA-Directed DNA Polymerase; Treatment Outcome; Zidovudine | 1994 |
Strategies to reduce vertical transmission of HIV-1.
Topics: Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Risk Factors; United Kingdom; Zidovudine | 1994 |
Transmission of zidovudine-resistant HIV-1 through heterosexual contacts.
Topics: Codon; Coitus; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Point Mutation; RNA-Directed DNA Polymerase; Sexual Behavior; Zidovudine | 1994 |
Rapid CD4+ cell decline after sexual transmission of a zidovudine-resistant syncytium-inducing isolate of HIV-1.
Topics: Adult; CD4 Lymphocyte Count; Codon; Cytopathogenic Effect, Viral; Disease Progression; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; RNA-Directed DNA Polymerase; Time Factors; Zidovudine | 1994 |
Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; beta 2-Microglobulin; CD4 Antigens; CD4-CD8 Ratio; CD8 Antigens; Female; HIV Infections; Humans; Interleukin-4; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Receptors, IgG; Reference Values; Zidovudine | 1994 |
Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection.
Topics: Adult; Aged; Biopterins; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Immunoglobulin G; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neopterin; Serotonin; Tryptophan; Zidovudine | 1994 |
Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients.
Topics: Amino Acid Sequence; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Proviruses; RNA-Directed DNA Polymerase; Time Factors; Zidovudine | 1994 |
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
Topics: Base Sequence; Biological Evolution; Didanosine; DNA Primers; DNA, Viral; Drug Resistance, Microbial; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Sequence Data; Mutation; Phenotype; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy.
Topics: Adult; Drug Resistance, Microbial; Genotype; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1995 |
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
Topics: AIDS Dementia Complex; Base Sequence; Brain; Codon; DNA Primers; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Time Factors; Viremia; Zidovudine | 1995 |
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Worki
Topics: Adult; Clinical Trials as Topic; Codon; Disease Progression; DNA, Viral; Drug Resistance, Microbial; Female; Genetic Markers; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Risk Factors; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations.
Topics: Base Sequence; Codon; Didanosine; DNA Primers; DNA Probes; DNA, Single-Stranded; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Nucleic Acid Hybridization; Point Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1995 |
In vitro proteolysis of the red cell membrane in patients with HIV infection.
Topics: Adult; Antiviral Agents; Blood Proteins; Erythrocyte Membrane; Erythrocytes; Female; Glycophorins; Hemoglobins; HIV Infections; Humans; Male; Membrane Proteins; Middle Aged; Spleen; Zidovudine | 1995 |
Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cell Cycle; Cells, Cultured; Flow Cytometry; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Kinetics; Lymphocytes; Reference Values; Thymidine Kinase; Zidovudine | 1995 |
Use of historical marker data for assessing treatment effects in phase I/II trials when subject selection is determined by baseline marker level.
Topics: Biometry; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; HIV Infections; Humans; Mathematics; Models, Statistical; Patient Selection; Placebos; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Simulation of the San Francisco HIV epidemic: AZT a possible epidemiological modulator.
Topics: Antiviral Agents; Computer Simulation; Disease Outbreaks; Epidemiologic Methods; HIV Infections; Humans; Incidence; Models, Biological; San Francisco; Zidovudine | 1995 |
Prospective study of antigenemia, plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs.
Topics: Adolescent; Adult; Biomarkers; Hemophilia A; HIV Antigens; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocytes; Prognosis; Prospective Studies; Viremia; Zidovudine | 1995 |
[Improved control of HIV transmission from mother to child].
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Risk Factors; Zidovudine | 1995 |
[Pregnancies in HIV infected women in Switzerland].
Topics: Abortion, Induced; Adult; CD4 Lymphocyte Count; Cesarean Section; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Risk Factors; Substance Abuse, Intravenous; Switzerland; Zidovudine | 1995 |
Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
Topics: Antiviral Agents; Base Sequence; Binding Sites; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; Deoxyribonucleotides; Dideoxynucleotides; DNA Primers; DNA, Viral; Drug Resistance, Multiple; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1995 |
Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group.
Topics: Adult; Base Sequence; Blotting, Western; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Male; Molecular Sequence Data; RNA, Viral; Statistics as Topic; Zidovudine | 1995 |
Loss of periodontal attachment in HIV-seropositive military personnel.
Topics: Adolescent; Adult; Age Factors; AIDS-Related Opportunistic Infections; Antiviral Agents; Candidiasis, Oral; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Forecasting; Gingival Diseases; HIV Infections; HIV Seropositivity; Humans; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Periodontal Attachment Loss; Sex Factors; Smoking; Zidovudine | 1995 |
Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys. Reframing the debate on prenatal HIV testing.
Topics: AIDS Serodiagnosis; Anonymous Testing; Antiviral Agents; Female; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Mandatory Testing; Patient Advocacy; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Assessment; United States; Voluntary Programs; Zidovudine | 1995 |
Combination superior to zidovudine in Delta trial.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1995 |
Study shows two drugs are best for HIV infection.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1995 |
Testing anti-HIV drugs in the FIV model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cats; Disease Models, Animal; DNA, Viral; Drug Evaluation, Preclinical; Feline Acquired Immunodeficiency Syndrome; HIV Infections; HIV-1; Humans; Immunodeficiency Virus, Feline; Mutation; Zidovudine | 1995 |
A.D.H. v. [Alabama] State Department of Human Resources.
Topics: Alabama; Child Welfare; Child, Preschool; Female; HIV Infections; Humans; Legal Guardians; Parental Consent; Public Health Administration; Treatment Refusal; Zidovudine | 1995 |
Recent advances in pediatric HIV.
Topics: Fatal Outcome; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Analysis of Variance; Bisexuality; CD4-CD8 Ratio; Disease Progression; Follow-Up Studies; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp41; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Time Factors; Zidovudine | 1995 |
Maternal-infant transmission of HIV infection: use of zidovudine.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach.
Topics: Decision Support Techniques; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1995 |
Perspectives in drug therapy of HIV infection.
Topics: Didanosine; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; Humans; Time Factors; Zidovudine | 1995 |
Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
Topics: Adenosine Triphosphate; HIV Infections; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Muscle, Skeletal; Phosphocreatine; Zidovudine | 1995 |
Time to hit HIV, early and hard.
Topics: HIV Infections; HIV-1; Humans; Time Factors; Viremia; Zidovudine | 1995 |
Perinatal transmission of HIV.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group.
Topics: Case-Control Studies; CD4-CD8 Ratio; Drug Resistance, Microbial; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Retrospective Studies; Zidovudine | 1995 |
Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assay.
Topics: Child; Child, Preschool; Disease Progression; Drug Resistance, Microbial; Follow-Up Studies; HIV; HIV Core Protein p24; HIV Infections; Humans; Infant; Lymphocytes; Microbial Sensitivity Tests; Zidovudine | 1995 |
Seizure associated with zidovudine.
Topics: Adult; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Medical Staff, Hospital; Needlestick Injuries; Seizures; Zidovudine | 1995 |
More HIV patients may benefit from zalcitabine now.
Topics: Drug Therapy, Combination; HIV Infections; Humans; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
AIDS battle update: zidovudine okayed for pregnant women.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Bringing AZT to poor countries.
Topics: Acquired Immunodeficiency Syndrome; Africa; Controlled Clinical Trials as Topic; Developing Countries; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1995 |
AZT reduces HIV transmission from infected moms to their newborns.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
Topics: Accidents, Occupational; Adult; Amino Acid Sequence; Blood Donors; Body Fluids; Female; Follow-Up Studies; Gene Products, env; Health Personnel; HIV Infections; HIV Seronegativity; HIV-1; Humans; Male; Medical Waste; Molecular Sequence Data; Needlestick Injuries; Occupational Exposure; Prospective Studies; Proviruses; T-Lymphocytes, Cytotoxic; Zidovudine | 1995 |
Reporting of occupational exposures to blood-borne pathogens in Australian teaching hospitals.
Topics: Accidents, Occupational; Australia; Blood-Borne Pathogens; Body Fluids; Feasibility Studies; HIV Infections; Hospitals, Teaching; Humans; Infectious Disease Transmission, Patient-to-Professional; National Health Programs; Occupational Exposure; Risk Management; Surveys and Questionnaires; Zidovudine | 1995 |
Serum 27E10 antigen: a new potential marker for staging HIV disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Antigens, Differentiation; Biomarkers; Biopterins; Calcium-Binding Proteins; Calgranulin A; Calgranulin B; Cell Adhesion Molecules, Neuronal; Female; HIV Antigens; HIV Infections; Humans; Leukocyte L1 Antigen Complex; Male; Middle Aged; Neopterin; Reference Values; Zidovudine | 1995 |
Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infectious Disease Transmission, Vertical; Male; Mothers; Prospective Studies; Survival Analysis; Zidovudine | 1995 |
Comparative study of various biological markers in infection by HIV1.
Topics: Adult; Antibodies, Anticardiolipin; beta 2-Microglobulin; Biomarkers; Blood Cell Count; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lipoproteins, HDL; Male; Middle Aged; Prospective Studies; Time Factors; Zidovudine | 1994 |
Zidovudine and prevention of perinatal HIV transmission.
Topics: CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 1995 |
Is zidovudine a prophylactic treatment for health care workers?
Topics: Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Needlestick Injuries; Nurses; Zidovudine | 1995 |
Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
Topics: Animals; Calcium Phosphates; Ceramics; Drug Delivery Systems; Durapatite; HIV Infections; Humans; In Vitro Techniques; Materials Testing; Rats; Rats, Sprague-Dawley; Zidovudine | 1995 |
Virologic characterization of primary human immunodeficiency virus type 1 infection in a health care worker following needlestick injury.
Topics: Acquired Immunodeficiency Syndrome; Catheterization, Central Venous; Follow-Up Studies; Health Personnel; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Phenotype; RNA, Viral; Time Factors; Zidovudine | 1995 |
Chemotherapeutic options in HIV infection.
Topics: Analysis of Variance; Antiviral Agents; Biotransformation; Cell Line; Cells, Cultured; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lymphocytes; Microbial Sensitivity Tests; Tumor Cells, Cultured; Zidovudine | 1994 |
Early intervention for human immunodeficiency virus disease.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; HIV Infections; Humans; Population Surveillance; Time Factors; Zidovudine | 1995 |
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.
Topics: CD4-Positive T-Lymphocytes; Codon; DNA, Viral; Drug Resistance; Genes, pol; HIV; HIV Infections; Humans; Leukocyte Count; Longitudinal Studies; Point Mutation; Polymerase Chain Reaction; Proviruses; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1993 |
[Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
Topics: Adult; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Neutropenia; Recombinant Proteins; Tongue Diseases; Ulcer; Zidovudine | 1993 |
Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.
Topics: Antigens, CD; CD4-Positive T-Lymphocytes; CD8 Antigens; Cytotoxicity, Immunologic; Female; HIV Infections; HLA-DR Antigens; Humans; Immunophenotyping; Infectious Mononucleosis; Integrin beta1; Leukocyte Common Antigens; Leukocyte Count; Lymphocyte Function-Associated Antigen-1; Male; T-Lymphocytes, Cytotoxic; Zidovudine | 1993 |
[Mutations of HIV-1 RT gene isolated from patients treated with AZT].
Topics: Amino Acid Sequence; Base Sequence; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Zidovudine | 1993 |
Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
Topics: Antiviral Agents; Cells, Cultured; Didanosine; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Piperazines; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
Effect of resistance on combination chemotherapy for human immunodeficiency virus infection.
Topics: Antiviral Agents; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1993 |
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.
Topics: Amino Acid Sequence; Didanosine; DNA, Viral; Female; Genes, pol; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Mutagenesis; RNA, Viral; Sequence Analysis, DNA; Transcription, Genetic; Viremia; Zidovudine | 1995 |
Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.
Topics: Acyclovir; Adolescent; Adult; Bisexuality; CD4 Lymphocyte Count; Cohort Studies; HIV Infections; HIV-1; Homosexuality, Male; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Rate; Zidovudine | 1995 |
Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
Topics: Antiviral Agents; Base Sequence; Didanosine; DNA Primers; DNA, Viral; Efficiency; Evaluation Studies as Topic; Genes, pol; Genotype; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Proviruses; Reproducibility of Results; RNA, Viral; Sensitivity and Specificity; Templates, Genetic; Virion; Zalcitabine; Zidovudine | 1994 |
New optimism for pregnant HIV positive women.
Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Zidovudine | 1994 |
Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
Topics: Base Sequence; Didanosine; DNA Ligases; DNA Primers; DNA Probes; DNA, Viral; Drug Resistance, Microbial; Evaluation Studies as Topic; Genes, pol; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors; Virology; Zidovudine | 1995 |
Treatment of children with HIV infection. PENTA (Paediatric European Network for Treatment of AIDS)
Topics: Child; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zidovudine | 1995 |
HIV infection and drug use: influence on cognitive function.
Topics: Cognition; Female; HIV Infections; HIV Seropositivity; Humans; Male; Neurologic Examination; Prospective Studies; Substance-Related Disorders; Zidovudine | 1995 |
Zidovudine to decrease mother-to-child transmission of HIV-1: is it good for developing countries?
Topics: Developing Countries; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1995 |
Maternal-infant transmission of HIV-1.
Topics: Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
[Tuberculosis and AIDS in Paraguay].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Female; HIV Infections; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Paraguay; Sex Factors; Tuberculosis; Zidovudine | 1995 |
[Evaluation of serum adenosine deaminase as a prognostic marker in the treatment of human immunodeficiency virus infection with zidovudine].
Topics: Adenosine Deaminase; Adolescent; Adult; Biomarkers; Case-Control Studies; CD4-CD8 Ratio; Female; HIV Infections; Humans; Male; Middle Aged; Prognosis; Zidovudine | 1995 |
Sarcoid myopathy in a patient with human immunodeficiency virus infection.
Topics: Adult; CD4 Antigens; HIV Infections; Homosexuality, Male; Humans; Male; Muscular Diseases; Prednisone; Sarcoidosis; Zidovudine | 1995 |
Study finds AZT reduces HIV transmission rate from mother to infant.
Topics: Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; Biomarkers; Biopterins; CD4 Lymphocyte Count; Decision Making; Follow-Up Studies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Neopterin; Prognosis; Zidovudine | 1995 |
Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.
Topics: Base Sequence; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; Humans; Molecular Sequence Data; RNA, Viral; Zidovudine | 1995 |
HIV results in the frame. Results confirmed.
Topics: Cohort Studies; HIV Infections; Humans; Male; Viremia; Zidovudine | 1995 |
Presence of HIV-1 proviral sequences in saliva of infected individuals in relation with clinical stage and CD4+ lymphocyte count.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; CD4 Lymphocyte Count; DNA, Viral; Female; HIV Infections; HIV-1; Humans; Male; Polymerase Chain Reaction; Proviruses; Risk Factors; Saliva; Zidovudine | 1994 |
Zidovudine use in pregnancy.
Topics: Abnormalities, Drug-Induced; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Zidovudine in pregnancy: is it dangerous for the fetus?
Topics: Abnormalities, Drug-Induced; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 1995 |
Study of AZT effectiveness in treating HIV-infected children halted.
Topics: Adolescent; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Treatment Outcome; Zidovudine | 1995 |
Mandatory screening of pregnant women for human immunodeficiency virus.
Topics: Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Female; Fetal Diseases; HIV Infections; Humans; Injections, Intravenous; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1995 |
[Use of an apoptosis test in the biological follow up of patients infected with HIV].
Topics: Apoptosis; CD4 Lymphocyte Count; Cells, Cultured; Didanosine; HIV Infections; Humans; Lymphocytes; Zidovudine | 1993 |
Serum HIV-1 RNA and routine patient monitoring.
Topics: Drug Resistance; HIV; HIV Infections; Humans; Zidovudine | 1995 |
MAB labelled liposomes as selective vehicles for drugs in H.I.V. infected cells.
Topics: Antibodies, Monoclonal; Biotechnology; Cells, Cultured; Drug Carriers; HIV Infections; Humans; Liposomes; Zidovudine | 1993 |
Synergistic effect of recombinant CD4-immunoglobulin in combination with azidothymidine, dideoxyinosine and 0.5 beta-monoclonal antibody on human immunodeficiency virus infection in vitro.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; CD4 Immunoadhesins; Cells, Cultured; Didanosine; Drug Synergism; Drug Therapy, Combination; HIV Infections; Humans; Lymphocytes; Zidovudine | 1994 |
Community treatment of HIV-1: initial stage and asymptotic dynamics.
Topics: Community Health Services; Didanosine; HIV Infections; HIV-1; Humans; Male; Mathematics; Models, Biological; Zidovudine | 1995 |
Publication of clinical trial results: a clinician's view.
Topics: Attitude of Health Personnel; Clinical Trials as Topic; Conflict of Interest; HIV Infections; Humans; Publishing; Zidovudine | 1995 |
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; DNA; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Reproducibility of Results; RNA, Viral; Time Factors; Zidovudine | 1995 |
The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Prognosis; Prospective Studies; Viremia; Virus Replication; Zidovudine | 1995 |
Patients' attitudes to zidovudine: the influence of the Concorde trial and the media.
Topics: Attitude; Clinical Trials as Topic; HIV Infections; Humans; Mass Media; Surveys and Questionnaires; Zidovudine | 1994 |
Mathematical modelling of chemotherapy in HIV infection.
Topics: CD4 Lymphocyte Count; HIV; HIV Infections; Humans; Models, Biological; Survival Analysis; Virus Replication; Zidovudine | 1994 |
Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
Topics: Adult; Cell Nucleus; Cytochrome-c Oxidase Deficiency; DNA, Mitochondrial; Electron Transport Complex IV; Enzyme Induction; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondria, Muscle; Mitochondrial Myopathies; Muscle Proteins; Muscles; Proton-Translocating ATPases; Zidovudine | 1994 |
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
Topics: Anticoagulants; Blood Specimen Collection; CD4 Lymphocyte Count; Culture Media; Didanosine; DNA, Viral; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; False Negative Reactions; Gels; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Polyesters; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Viral; Severity of Illness Index; Specimen Handling; Viremia; Virus Cultivation; Zidovudine | 1994 |
Maternal-fetal transmission of HIV-1.
Topics: Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Disease Progression; Factor VIII; Fluconazole; Hemophilia A; HIV Infections; Humans; Male; Middle Aged; Pentamidine; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1994 |
Provider assessments of compliance with zidovudine.
Topics: HIV Infections; Humans; Patient Compliance; Substance Abuse, Intravenous; Zidovudine | 1995 |
Generalists' prudence may lead to better outcomes.
Topics: Acquired Immunodeficiency Syndrome; Family Practice; HIV Infections; Humans; Practice Patterns, Physicians'; Treatment Outcome; Zidovudine | 1995 |
Perinatal human immunodeficiency virus testing. Provisional Committee on Pediatric AIDS, American Academy of Pediatrics.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Parental Consent; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Assessment; Voluntary Programs; Zidovudine | 1995 |
Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells.
Topics: Animals; Dose-Response Relationship, Drug; HIV Infections; Humans; Leukocytes, Mononuclear; Macaca nemestrina; Phosphorylation; Simian Acquired Immunodeficiency Syndrome; Zidovudine | 1994 |
Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy.
Topics: AIDS Dementia Complex; Antibodies, Viral; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Infant; Interleukin-1; Interleukin-6; Male; Tumor Necrosis Factor-alpha; Zidovudine | 1994 |
HIV drug mislabelled.
Topics: HIV Infections; Humans; Zidovudine | 1994 |
[Clinical effectiveness of zidovudine].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4 Lymphocyte Count; Drug Resistance; HIV Infections; HIV-1; Humans; Randomized Controlled Trials as Topic; Virus Replication; Zidovudine | 1995 |
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Biopterins; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Male; Middle Aged; Monitoring, Immunologic; Neopterin; Zidovudine | 1994 |
Federal task force advises on zidovudine use during pregnancy.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; United States; United States Public Health Service; Zidovudine | 1994 |
Zidovudine-associated myopathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; HIV Infections; Humans; Mitochondrial Myopathies; Muscular Diseases; Zidovudine | 1994 |
Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells: a model of maternal --> fetal transmission.
Topics: Antibodies, Monoclonal; CD3 Complex; CD4 Antigens; Cell Adhesion; Cells, Cultured; Complement System Proteins; HeLa Cells; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lymphocyte Function-Associated Antigen-1; Lymphocytes; Phenotype; Phytohemagglutinins; Placenta; Proviruses; Zidovudine | 1995 |
[Thrombotic thrombopenic purpura and HIV infection. Apropos of a case].
Topics: Adult; Blood Coagulation Tests; Blood Transfusion; HIV Infections; Humans; Male; Methylprednisolone; Prognosis; Purpura, Thrombotic Thrombocytopenic; Zidovudine | 1994 |
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Topics: Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Topics: Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Topics: Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Successful monochemotherapy of extensive gastrointestinal Kaposi's sarcoma with bowel obstruction in acquired immunodeficiency syndrome.
Topics: Adult; Duodenal Obstruction; Endoscopy, Gastrointestinal; Gastrointestinal Neoplasms; HIV Infections; Humans; Male; Sarcoma, Kaposi; Tomography, X-Ray Computed; Vincristine; Zidovudine | 1994 |
Interrelations among patterns of change in neurocognitive, CT brain imaging and CD4 measures associated with anti-retroviral therapy in children with symptomatic HIV infection.
Topics: AIDS Dementia Complex; Atrophy; Brain; Calcinosis; CD4 Lymphocyte Count; Child; Child, Preschool; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Male; Neuropsychological Tests; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine | 1994 |
[Substitution treatments in Geneva].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Family; Female; HIV Infections; Humans; Male; Methadone; Pregnancy; Psychotherapy; Substance-Related Disorders; Switzerland; Zidovudine | 1994 |
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Didanosine; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Polymerase Chain Reaction; Proviruses; RNA, Viral; Viremia; Virion; Zidovudine | 1995 |
[Genetically controlled pharmacomodulation: application to the treatment of HIV infection].
Topics: Cell Line, Transformed; Genetic Therapy; Herpesvirus 1, Human; HIV Infections; HIV-1; In Vitro Techniques; Lymphocytes; Thymidine Kinase; Zidovudine | 1994 |
Point/counterpoint: II. The case against mandatory prenatal HIV testing.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prenatal Diagnosis; Risk Assessment; Voluntary Programs; Zidovudine | 1995 |
In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine.
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Giant Cells; HIV Infections; HIV-1; Humans; Phenotype; Prospective Studies; Zidovudine | 1995 |
Preliminary study findings fuel debate over timing of zidovudine therapy.
Topics: CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Time Factors; Zidovudine | 1993 |
Antiviral and immunological effects of escalating low doses of zidovudine in HIV-positive patients.
Topics: CD4-Positive T-Lymphocytes; Cell Count; Drug Administration Schedule; Erythrocyte Indices; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Prospective Studies; Zidovudine | 1993 |
CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Prognosis; Proportional Hazards Models; Prospective Studies; Time Factors; Zidovudine | 1993 |
Zidovudine in asymptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Zidovudine | 1993 |
Zidovudine in asymptomatic HIV infection.
Topics: CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Zidovudine | 1993 |
[Cerebral changes and HIV infection. Diagnostic methods are continuously improved].
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Austria; Brain; Brain Diseases; Cognition Disorders; HIV Infections; Humans; Magnetic Resonance Imaging; Zidovudine | 1993 |
Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients.
Topics: Adolescent; Adult; Aged; Animals; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Survival Rate; Zidovudine | 1993 |
Antiretroviral therapy in HIV-infected adults. Which regimens are recommended?
Topics: Adult; CD4-Positive T-Lymphocytes; Didanosine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; HIV Infections; Humans; Leukocyte Count; Zalcitabine; Zidovudine | 1994 |
Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.
Topics: Acquired Immunodeficiency Syndrome; British Columbia; Case-Control Studies; CD4-Positive T-Lymphocytes; Cohort Studies; Educational Status; Follow-Up Studies; Health Services Accessibility; HIV Infections; Humans; Income; Leukocyte Count; Male; Occupations; Odds Ratio; Pneumonia, Pneumocystis; Prospective Studies; Regression Analysis; Risk Factors; Sarcoma, Kaposi; Social Class; Zidovudine | 1994 |
Features of children perinatally infected with HIV-1 surviving longer than 5 years. Italian Register for HIV Infection in Children.
Topics: CD4-Positive T-Lymphocytes; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Italy; Leukocyte Count; Linear Models; Male; Population Surveillance; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Survival Rate; Time Factors; Zidovudine | 1994 |
Care of pregnant women infected with HIV.
Topics: CD4-Positive T-Lymphocytes; Female; Guidelines as Topic; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts.
Topics: Adult; CD4-Positive T-Lymphocytes; Hematocrit; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Proportional Hazards Models; Survival Rate; Zidovudine | 1994 |
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes.
Topics: CD4-Positive T-Lymphocytes; HIV Infections; HIV-1; Humans; Leukocyte Count; Leukocytes, Mononuclear; Polymerase Chain Reaction; Prospective Studies; RNA, Messenger; RNA, Viral; Time Factors; Virus Replication; Zidovudine | 1994 |
Marker paths. MAP Workshop (Multi-cohort Analysis Project).
Topics: Acquired Immunodeficiency Syndrome; Adult; Analysis of Variance; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections; HIV Seroprevalence; Humans; Immunoglobulin A; Leukocyte Count; Male; Middle Aged; Models, Statistical; Population Surveillance; Zidovudine | 1993 |
Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudine.
Topics: Adult; CD4-Positive T-Lymphocytes; Didanosine; DNA, Viral; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Middle Aged; Polymerase Chain Reaction; Proviruses; RNA, Viral; Time Factors; Zidovudine | 1994 |
Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection.
Topics: Adult; CD28 Antigens; CD4-Positive T-Lymphocytes; Down-Regulation; Female; Flow Cytometry; Fluorescent Antibody Technique; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Male; Middle Aged; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Zidovudine | 1994 |
Size and power of two-sample tests of repeated measures data.
Topics: Analysis of Variance; Biometry; CD4-Positive T-Lymphocytes; Data Interpretation, Statistical; HIV Infections; Humans; Linear Models; Randomized Controlled Trials as Topic; Reproducibility of Results; Zidovudine | 1993 |
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Didanosine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Polymerase Chain Reaction; Proviruses; RNA, Viral; Time Factors; Transcription, Genetic; Zidovudine | 1994 |
Concorde lands.
Topics: Clinical Protocols; Drug Administration Schedule; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
Topics: CD4-Positive T-Lymphocytes; Cell Line; Child; Child, Preschool; Female; Follow-Up Studies; Giant Cells; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Microbial Sensitivity Tests; Phenotype; Species Specificity; Zidovudine | 1994 |
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
Topics: Biomarkers; CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Time Factors; Viremia; Zidovudine | 1993 |
Concorde trial of immediate versus deferred zidovudine.
Topics: Drug Administration Schedule; HIV Infections; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Concorde trial of immediate versus deferred zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; Randomized Controlled Trials as Topic; T-Lymphocytes; Zidovudine | 1994 |
Concorde trial of immediate versus deferred zidovudine.
Topics: Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; Survival Analysis; T-Lymphocytes; Zidovudine | 1994 |
Concorde trial of immediate versus deferred zidovudine.
Topics: Double-Blind Method; Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; Randomized Controlled Trials as Topic; T-Lymphocytes; Zidovudine | 1994 |
Concorde trial of immediate versus deferred zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; T-Lymphocytes; Zidovudine | 1994 |
Concorde trial of immediate versus deferred zidovudine.
Topics: HIV Infections; Humans; Penicillins; Pneumonia; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Protecting babies from HIV.
Topics: Female; HIV Infections; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Topics: Adult; Biomarkers; CD4-Positive T-Lymphocytes; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Prospective Studies; Viremia; Zidovudine | 1994 |
Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children.
Topics: Antigen-Antibody Complex; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Leukocyte Count; Male; Neutralization Tests; Prognosis; Prospective Studies; Retrospective Studies; Zidovudine | 1994 |
Zidovudine for mother, fetus, and child: hope or poison?
Topics: Adult; Child; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.
Topics: CD4-Positive T-Lymphocytes; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, pol; HIV; HIV Infections; Humans; Leukocyte Count; Models, Biological; Mutation; Population Dynamics; Species Specificity; Virus Replication; Zidovudine | 1994 |
Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
Topics: Adult; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Female; Fetal Monitoring; Gestational Age; Hematologic Tests; HIV Infections; Humans; Infant; Infant, Newborn; Leukocyte Count; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events.
Topics: AIDS-Related Opportunistic Infections; Antigens, Surface; beta 2-Microglobulin; Biopterins; Calcium-Binding Proteins; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules, Neuronal; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Leukocyte L1 Antigen Complex; Male; Neopterin; Prognosis; Survival Analysis; T-Lymphocytes, Regulatory; Time Factors; Zidovudine | 1994 |
Zidovudine for mother, fetus, and child.
Topics: Counseling; Female; Fetal Diseases; Foundations; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Zidovudine | 1994 |
HIV infection in recipients of blood products from donors with known duration of infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Blood Component Transfusion; Blood Donors; Blood-Borne Pathogens; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Survival Analysis; Time Factors; Zidovudine | 1994 |
Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
Topics: Adult; beta 2-Microglobulin; Biopterins; CD4-Positive T-Lymphocytes; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Immunoglobulin A; Leukocyte Count; Male; Middle Aged; Neopterin; Prognosis; Proportional Hazards Models; T-Lymphocytes, Regulatory; Thymidine Kinase; Viremia; Zidovudine | 1994 |
In vivo eradication of Friend virus as an experimental HIV-model, by combination of zidovudine, acriflavine and an ellipticine analogue. Possible application to the treatment of human pre-AIDS?
Topics: Acquired Immunodeficiency Syndrome; Acriflavine; AIDS-Related Complex; Animals; Drug Therapy, Combination; Ellipticines; Friend murine leukemia virus; HIV Infections; Humans; Male; Mice; Mice, Inbred DBA; Zidovudine | 1994 |
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cell Division; Cell-Free System; Dextran Sulfate; HIV; HIV Infections; Immunity, Cellular; Immunologic Factors; In Vitro Techniques; Leucine; Virus Replication; Zidovudine | 1994 |
Mixed connective tissue disease complicated by infection with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Diagnosis, Differential; Fatal Outcome; Female; HIV Infections; Humans; Japan; Kenya; Mixed Connective Tissue Disease; Zidovudine | 1994 |
[Zidovudine for asymptomatic HIV patients?].
Topics: Disease Progression; HIV Infections; Humans; Zidovudine | 1994 |
Lower socioeconomic status and shorter survival following HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; British Columbia; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Health Services; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Income; Male; Pneumonia, Pneumocystis; Regression Analysis; Socioeconomic Factors; Survival Rate; Zalcitabine; Zidovudine | 1994 |
Reducing the risk of maternal-infant transmission of HIV: a door is opened.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk; Zidovudine | 1994 |
Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV.
Topics: Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Neonatal Screening; Pregnancy; Zidovudine | 1994 |
[Porphyria cutanea tarda and human immunodeficiency virus infection. Apropos of 2 further cases].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; HIV Infections; Humans; Male; Porphyria Cutanea Tarda; Pyrimethamine; Substance-Related Disorders; Zidovudine | 1994 |
[HIV infection--current possibilities in antiviral therapy].
Topics: Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Pancreatitis; Zalcitabine; Zidovudine | 1994 |
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
Topics: Adult; Age Factors; Antiviral Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Cohort Studies; Comorbidity; Databases, Factual; Disease Progression; District of Columbia; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Immunoglobulin A; Italy; Life Tables; London; Male; Middle Aged; New York City; Ontario; Prognosis; Regression Analysis; Risk; Risk Factors; Scotland; Sex Factors; Sexual Behavior; Substance Abuse, Intravenous; Survival Analysis; Time Factors; Zidovudine | 1994 |
[Accidental needle injuries of medical personnel].
Topics: Accidents, Occupational; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Medical Staff; Needles; Risk Factors; Wounds and Injuries; Zidovudine | 1994 |
Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Topics: Adolescent; Adult; Anemia; Blood Coagulation Disorders; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hemophilia A; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Pancytopenia; Thrombocytopenia; Treatment Outcome; Zidovudine | 1994 |
Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor.
Topics: Adult; Autoradiography; DNA, Viral; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HIV; HIV Infections; Humans; Lymphocytes; Male; Monocytes; Pilot Projects; Polymerase Chain Reaction; Zidovudine | 1994 |
B and T cell function parameters during zidovudine treatment of human immunodeficiency virus-infected patients.
Topics: Antigen-Antibody Complex; B-Lymphocytes; CD4-Positive T-Lymphocytes; Herpesvirus 4, Human; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; Humans; T-Lymphocytes; Zidovudine | 1994 |
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
Topics: Antiviral Agents; Asparagine; Aspartic Acid; Cell Survival; Cells, Cultured; Didanosine; Drug Synergism; HIV Infections; Humans; Hydroxyurea; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Virus Replication; Zalcitabine; Zidovudine | 1994 |
Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
Topics: HIV Infections; Humans; Immunohistochemistry; Interleukin-1; MERRF Syndrome; Microscopy, Immunoelectron; Mitochondrial Myopathies; Muscles; Zidovudine | 1994 |
Could drugs, rather than a virus, be the cause of AIDS?
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Female; HIV Infections; Humans; Illicit Drugs; Male; Zidovudine | 1994 |
AIDS in Italy and proposals for a new therapeutic strategy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Fibronectins; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Italy; Male; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnancy Outcome; Uterine Diseases; Zidovudine | 1994 |
MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.
Topics: Adult; Biomarkers; CD4 Lymphocyte Count; Cell Line; Didanosine; Disease Progression; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Male; Prognosis; Virus Replication; Zidovudine | 1994 |
Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.
Topics: Adult; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Male; Middle Aged; Prospective Studies; Zidovudine | 1994 |
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clinical Trials as Topic; Data Interpretation, Statistical; HIV Infections; Humans; Prognosis; Zidovudine | 1994 |
Working towards a European strategy for interventions to reduce vertical transmission of HIV.
Topics: Clinical Trials as Topic; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Zidovudine | 1994 |
Birth outcomes following zidovudine therapy in pregnant women.
Topics: Abnormalities, Drug-Induced; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Registries; Zidovudine | 1994 |
From the Centers for Disease Control and Prevention. Birth outcomes following zidovudine therapy in pregnant women.
Topics: Abnormalities, Drug-Induced; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Registries; Zidovudine | 1994 |
AZT reduced rate of maternal transmission of HIV.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
[Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
Topics: AIDS-Related Opportunistic Infections; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Foscarnet; Herpesviridae Infections; HIV Infections; Humans; Zidovudine | 1994 |
Zidovudine and the quality of life.
Topics: HIV Infections; Humans; Quality of Life; Zidovudine | 1994 |
Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
Topics: Cytopathogenic Effect, Viral; Dehydroepiandrosterone; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; In Vitro Techniques; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1994 |
Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine.
Topics: Adult; Blood Glucose; Didanosine; Female; HIV Infections; HIV Seropositivity; Humans; Hyperglycemia; Hyperglycemic Hyperosmolar Nonketotic Coma; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Diabetics; Zidovudine | 1994 |
AIDS update.
Topics: AIDS Serodiagnosis; Female; HIV Infections; Humans; Infant, Newborn; New Jersey; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcome.
Topics: Adult; Female; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Thrombocytopenia; Zidovudine | 1994 |
Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
Topics: Antiviral Agents; Dideoxynucleotides; HeLa Cells; HIV; HIV Infections; Humans; Phosphatidic Acids; Zidovudine | 1994 |
AZT reduces maternal transmission of HIV.
Topics: Female; Fetal Diseases; HIV Infections; Humans; Maternal-Fetal Exchange; Pregnancy; Zidovudine | 1994 |
Transmission of zidovudine-resistant HIV during a bloody fight.
Topics: Adult; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Male; Violence; Zidovudine | 1994 |
Zidovudine reduces transmission of HIV from mother to infant, study shows.
Topics: Adult; Female; HIV Infections; HIV Seronegativity; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse.
Topics: Adolescent; Adult; Central African Republic; Coitus; Enzyme-Linked Immunosorbent Assay; Female; HIV Antibodies; HIV Infections; HIV-1; HIV-2; Humans; Immunoglobulin G; Male; Nonoxynol; Rape; Semen; Vagina; Zidovudine | 1994 |
Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?
Topics: Acidosis, Lactic; Adult; DNA Polymerase III; DNA Replication; DNA, Mitochondrial; Fatty Liver; Hemophilia A; Hepatomegaly; HIV Infections; Humans; Male; Mitochondrial Myopathies; Zidovudine | 1994 |
The in vivo effect of ellipticine analogues on the blood concentration of Friend virus: a murine model for studying anti-HIV drugs.
Topics: Acquired Immunodeficiency Syndrome; Animals; Blood; Disease Models, Animal; Ellipticines; Friend murine leukemia virus; HIV Infections; HIV-1; Male; Mice; Mice, Inbred DBA; Zidovudine | 1993 |
[Obstetrical management of a patient with HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Infections; Humans; Maternal-Fetal Exchange; Mexico; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Zidovudine | 1994 |
Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Adult; Aged; Dapsone; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Phenotype; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis, Cerebral; Zidovudine | 1994 |
Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.
Topics: Antibodies, Monoclonal; Base Sequence; CD8 Antigens; Cells, Cultured; Didanosine; DNA Probes; DNA, Viral; Flow Cytometry; HIV Infections; HIV-1; Humans; Lymphocytes; Molecular Sequence Data; Zidovudine | 1994 |
Reduction of HIV transmission from mother to infant.
Topics: Adolescent; Adult; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 1994 |
[Lactic acidosis in HIV infected patients].
Topics: Acidosis, Lactic; Aged; Fatal Outcome; Female; HIV Infections; Humans; Zidovudine | 1994 |
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
Topics: Antiviral Agents; Base Sequence; Cell Line; Gene Products, gag; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Molecular Sequence Data; Pyridines; RNA, Viral; Valine; Virion; Zidovudine | 1994 |
Neopterin and HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Biopterins; HIV Infections; Humans; Lymphocyte Activation; Neopterin; Zidovudine | 1994 |
Increased spontaneous secretion of interleukin 6 and tumor necrosis factor alpha by peripheral blood lymphocytes of human immunodeficiency virus-infected children.
Topics: Child; Child, Preschool; Female; HIV Antibodies; HIV Infections; Humans; Infant; Interleukin-6; Leukocytes, Mononuclear; Male; Pilot Projects; Tumor Necrosis Factor-alpha; Zidovudine | 1994 |
Zidovudine use in pregnancy: a report on 104 cases and the occurrence of birth defects.
Topics: Abnormalities, Drug-Induced; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Zidovudine | 1994 |
Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood.
Topics: Adult; Female; Health Personnel; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Neutropenia; Occupational Exposure; Prospective Studies; Zidovudine | 1994 |
[Diffuse CD8 lymphocytic infiltration syndrome resistant to corticoids and zidovudine in human immunodeficiency virus infection].
Topics: Adrenal Cortex Hormones; Adult; CD8 Antigens; Drug Resistance; Female; HIV Infections; Humans; Lymphocytosis; Syndrome; Zidovudine | 1994 |
Combination chemoprophylaxis after needlestick injury.
Topics: Health Personnel; HIV Infections; Humans; Nausea; Needlestick Injuries; Zidovudine | 1993 |
Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment.
Topics: Adult; CD4-Positive T-Lymphocytes; Cognition Disorders; Erythrocyte Count; HIV Infections; Homosexuality; Humans; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Proportional Hazards Models; Serologic Tests; Survival Analysis; Zidovudine | 1993 |
Use of didanosine in zidovudine-intolerant patients infected with human immunodeficiency virus.
Topics: CD4-Positive T-Lymphocytes; Didanosine; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Zidovudine | 1993 |
Didanosine and ACTG 116A.
Topics: Didanosine; HIV Infections; Humans; Zidovudine | 1993 |
Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.
Topics: CD4-Positive T-Lymphocytes; Codon; Didanosine; Drug Therapy, Combination; Gene Amplification; Genes, Viral; HIV; HIV Infections; Humans; Leukocyte Count; RNA, Viral; Zidovudine | 1993 |
Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.
Topics: Adult; Antiviral Agents; Biomarkers; CD4-Positive T-Lymphocytes; Didanosine; DNA, Viral; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Zidovudine | 1993 |
Immediate versus deferred zidovudine.
Topics: AIDS-Related Complex; HIV Infections; Humans; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Zidovudine | 1993 |
Immediate versus deferred zidovudine.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1993 |
Detection of zidovudine-resistant variants of HIV-1 in genital fluids.
Topics: Adult; Blood; Body Fluids; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Semen; Vagina; Zidovudine | 1993 |
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
Topics: Base Sequence; CD4-Positive T-Lymphocytes; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Genes, pol; Genes, Viral; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reproducibility of Results; Serial Passage; Zidovudine | 1993 |
Erratic zidovudine bioavailability in HIV seropositive patients.
Topics: Adult; Biological Availability; CD4-Positive T-Lymphocytes; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Zidovudine | 1993 |
Early markers of HIV infection and subclinical disease progression.
Topics: Aerospace Medicine; Analysis of Variance; beta 2-Microglobulin; Biomarkers; Biopterins; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Military Personnel; Neopterin; T-Lymphocytes, Helper-Inducer; United States; Zidovudine | 1993 |
After Concorde.
Topics: CD4-Positive T-Lymphocytes; Clinical Trials as Topic; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1993 |
The Concorde trial.
Topics: Bias; CD4-Positive T-Lymphocytes; Clinical Protocols; HIV Infections; Humans; Leukocyte Count; Zidovudine | 1993 |
The Concorde trial.
Topics: Didanosine; HIV Infections; Humans; Time Factors; Zidovudine | 1993 |
The Concorde trial.
Topics: Female; HIV Infections; HIV Seropositivity; Humans; Male; Patient Satisfaction; Scotland; Zidovudine | 1993 |
The Concorde trial.
Topics: Antigen-Presenting Cells; HIV Infections; Humans; Zidovudine | 1993 |
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.
Topics: CD4-Positive T-Lymphocytes; Didanosine; HIV Infections; Humans; Interleukin-6; Leukocyte Count; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Risk Factors; Zidovudine | 1993 |
Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Female; Fluconazole; HIV Infections; Humans; Leukocyte Count; Logistic Models; Male; Pneumonia, Pneumocystis; Proportional Hazards Models; Survival Rate; Texas; Time Factors; Zidovudine | 1993 |
The epidemiology of HIV-1 infection of the lung in AIDS patients.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; Humans; Leukocyte Count; London; Male; Middle Aged; Pneumonia, Viral; Polymerase Chain Reaction; Prospective Studies; Smoking; Zidovudine | 1993 |
Progressive CD4 cell depletion and death in zidovudine-treated patients.
Topics: Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Prognosis; Zidovudine | 1993 |
Zidovudine now or later?
Topics: CD4-Positive T-Lymphocytes; Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; Zidovudine | 1993 |
Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Cohort Studies; HIV Infections; Humans; Likelihood Functions; Lymphocyte Subsets; Male; Pentamidine; Pneumonia, Pneumocystis; Zidovudine | 1993 |
NIH panel loosens zidovudine guidelines.
Topics: CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; National Institutes of Health (U.S.); Practice Guidelines as Topic; United States; Zidovudine | 1993 |
[Results of zidovudine treatment of 9 vertically HIV infected children].
Topics: AIDS-Related Opportunistic Infections; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Combined Modality Therapy; Female; HIV Infections; Humans; Immunoglobulins; Infant; Leukocyte Count; Lymphocyte Activation; Male; Zidovudine | 1993 |
Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; HIV Infections; Humans; Research Design; T-Lymphocyte Subsets; Time Factors; Zidovudine | 1993 |
Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; beta 2-Microglobulin; Blood Sedimentation; CD4-Positive T-Lymphocytes; Cohort Studies; Germany; HIV Infections; Homosexuality; Humans; Immunoglobulin A; Incidence; Leukocyte Count; Life Tables; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Time Factors; Zidovudine | 1993 |
Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.
Topics: CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cytomegalovirus; Drug Therapy, Combination; HIV Infections; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Infant; Pentamidine; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1993 |
HIV infection in Romanian children: a call for antiretroviral therapy.
Topics: CD4-Positive T-Lymphocytes; Child; Child, Preschool; HIV Infections; Humans; Infant; International Cooperation; Leukocyte Count; Romania; Zidovudine | 1993 |
Early announcements.
Topics: Clinical Trials as Topic; Communication; Diffusion of Innovation; Drug Costs; Drug Industry; Ethics; HIV Infections; Humans; Publishing; Zidovudine | 1993 |
What to do when zidovudine fails.
Topics: Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1994 |
Zidovudine dosage.
Topics: HIV Infections; Humans; Infant; Zidovudine | 1993 |
Cardiac involvement in human immunodeficiency virus infection.
Topics: Cardiomyopathies; Cytomegalovirus Infections; Heart Diseases; HIV Infections; Humans; Myocarditis; Zidovudine | 1993 |
Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
Topics: HIV Infections; Humans; Muscular Diseases; Zidovudine | 1994 |
Trial halted after drug cuts maternal HIV transmission rate by two thirds.
Topics: Control Groups; Female; HIV Infections; Humans; Infant; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Randomized Controlled Trials as Topic; Risk Assessment; Therapeutic Human Experimentation; United States; Zidovudine | 1994 |
[Progression of HIV infection halved: early AZT therapy--advantage confirmed in a large European-Australian study].
Topics: HIV Infections; Humans; Zidovudine | 1993 |
Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Female; HIV Infections; Humans; Logistic Models; Male; Proportional Hazards Models; Prospective Studies; Risk Factors; Sarcoma, Kaposi; Zidovudine | 1994 |
Prophylactic zalcitabine and interferon-alpha for a large-bore needlestick exposure to human immunodeficiency virus.
Topics: Adult; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Needlestick Injuries; Recombinant Proteins; Zalcitabine; Zidovudine | 1994 |
Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.
Topics: Antiviral Agents; Base Sequence; CD4 Antigens; Cell Line; DNA, Viral; Genotype; HeLa Cells; HIV Infections; HIV-1; Humans; Lymphocytes; Microbial Sensitivity Tests; Molecular Sequence Data; Phenotype; Polymerase Chain Reaction; Recombination, Genetic; Viral Plaque Assay; Virus Replication; Zidovudine | 1994 |
Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.
Topics: Antigen-Antibody Complex; Didanosine; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Prognosis; Viremia; Zidovudine | 1993 |
Study confirms AZT's lack of prophylactic effect [new].
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Multicenter Studies as Topic; Zidovudine | 1994 |
[What is the future of antiviral therapy of HIV-infected patients? Reports of results of antiretroviral therapy studies at the IX. World Congress on AIDS in Berlin].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Berlin; HIV; HIV Infections; Humans; Zidovudine | 1993 |
Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.
Topics: Adult; Aged; Female; HIV Infections; Humans; Lactates; Male; Middle Aged; Mitochondrial Myopathies; Prospective Studies; Pyruvates; Sensitivity and Specificity; Zidovudine | 1994 |
Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
Topics: Administration, Oral; Adult; Animals; Bone Marrow Diseases; Chromatography, High Pressure Liquid; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1994 |
The development of a Q-sort behavioral rating procedure for pediatric HIV patients.
Topics: AIDS Dementia Complex; Child; Child, Preschool; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Male; Motivation; Q-Sort; Sick Role; Social Behavior; Zidovudine | 1994 |
Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy.
Topics: Activities of Daily Living; AIDS Dementia Complex; Child; Child, Preschool; Communication; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Male; Motivation; Q-Sort; Quality of Life; Social Behavior; Socialization; Zidovudine | 1994 |
Effectiveness of zidovudine in treatment of advanced HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1994 |
Apparent selection against transmission of zidovudine-resistant human immunodeficiency virus type 1 variants.
Topics: Adult; Base Sequence; DNA Primers; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Male; Molecular Sequence Data; Phylogeny; Selection, Genetic; Zidovudine | 1994 |
Intermittent therapy.
Topics: Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1994 |
Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
Topics: Adult; CD4 Antigens; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Male; Pharmaceutical Services; Zalcitabine; Zidovudine | 1994 |
Zidovudine cuts rate of maternal transmission.
Topics: Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
HIV testing, counseling, and prophylaxis after sexual assault.
Topics: AIDS Serodiagnosis; Counseling; Criminal Law; Disclosure; Federal Government; HIV Infections; Humans; Mandatory Programs; Policy Making; Rape; Risk Assessment; United States; Zidovudine | 1994 |
3'-Azido-3'-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity.
Topics: Animals; CHO Cells; Cricetinae; Cytidine Monophosphate N-Acetylneuraminic Acid; Dideoxynucleotides; Glycosylation; Golgi Apparatus; HIV; HIV Infections; Humans; Intracellular Membranes; Kinetics; Membrane Proteins; Nucleoside Diphosphate Sugars; Protein Processing, Post-Translational; Thymine Nucleotides; Uridine Diphosphate Galactose; Uridine Diphosphate N-Acetylglucosamine; Zidovudine | 1994 |
Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Topics: Cell Line; Culture Media; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Microscopy, Electron; Time Factors; Zalcitabine; Zidovudine | 1993 |
A cohort study of drug users' compliance with zidovudine treatment.
Topics: Adult; Aged; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Patient Compliance; Risk Factors; Substance Abuse, Intravenous; Time Factors; Zidovudine | 1994 |
More on zidovudine in asymptomatic HIV infection.
Topics: HIV Infections; Humans; Research Design; Zidovudine | 1994 |
Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.
Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Regression Analysis; Time Factors; Zidovudine | 1994 |
Zidovudine reduces HIV transmission from mother to infant.
Topics: Adult; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cause of Death; Combined Modality Therapy; Female; HIV Infections; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Severity of Illness Index; Treatment Outcome; Zidovudine | 1994 |
Intravascular distribution of zidovudine: role of plasma proteins and whole blood components.
Topics: Adult; Blood Proteins; Female; HIV Infections; Humans; Male; Protein Binding; Zidovudine | 1993 |
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Cohort Studies; Female; Herpes Zoster; HIV Infections; Humans; Male; Middle Aged; Survival Analysis; Zidovudine | 1993 |
White lichenoid lesions of the buccal mucosa in patients with HIV infection.
Topics: Adult; Female; HIV Infections; Humans; Ketoconazole; Lichen Planus, Oral; Male; Mouth Mucosa; Zidovudine | 1993 |
Treatment trials for primary human immunodeficiency virus type 1 infection.
Topics: Clinical Trials as Topic; HIV Infections; Humans; Zidovudine | 1993 |
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation.
Topics: Base Sequence; Child, Preschool; DNA, Viral; Drug Resistance; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Zidovudine | 1993 |
Zidovudine in asymptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Time Factors; Zidovudine | 1993 |
Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Topics: Adolescent; Adult; Antiviral Agents; Cell Division; Child; Child, Preschool; Clone Cells; Dideoxynucleotides; DNA, Neoplasm; Drug Resistance; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Infant; Leukemia, T-Cell; T-Lymphocytes; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured; Zidovudine | 1993 |
Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA.
Topics: Amino Acid Sequence; Consensus Sequence; DNA, Complementary; DNA, Viral; Genetic Variation; Glycosylation; HIV; HIV Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Protein Processing, Post-Translational; Proviruses; RNA, Viral; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Time Factors; Virion; Zidovudine | 1994 |
Role of the general pediatrician in the management of human immunodeficiency virus infection in children.
Topics: Child; HIV Infections; Humans; Pediatrics; Physician's Role; Zidovudine | 1993 |
Smoothed nonparametric back-projection of AIDS incidence data with adjustment for therapy.
Topics: Acquired Immunodeficiency Syndrome; Australia; HIV; HIV Infections; Humans; Incidence; Mathematics; Models, Statistical; Zidovudine | 1993 |
The use of health services by women with HIV infection.
Topics: Adolescent; Adult; Ambulatory Care; Data Collection; Drug Utilization; Female; Health Care Costs; Health Services; Health Services Accessibility; Health Services Research; Health Status; HIV Infections; Hospitalization; Humans; Insurance, Health; Male; Multivariate Analysis; Prevalence; Sampling Studies; Sex Factors; United States; Urban Population; Women's Health; Zidovudine | 1993 |
[Treatment--medical management of HIV carrier].
Topics: Accidents, Occupational; Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Animals; Carrier State; Didanosine; Female; HIV Infections; Humans; Immunologic Factors; Male; Needles; Pneumonia, Pneumocystis; Zidovudine | 1993 |
[Interferon therapy of HIV carriers].
Topics: Acquired Immunodeficiency Syndrome; Carrier State; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; Humans; Interferon-alpha; Sarcoma, Kaposi; Zidovudine | 1993 |
[BRM and drug combination therapy of HIV carriers].
Topics: Carrier State; Cytokines; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunologic Factors; Male; Zidovudine | 1993 |
[Early treatment in HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Carrier State; CD4 Antigens; Didanosine; HIV Infections; Humans; Zidovudine | 1993 |
[Treatment by antiviral drugs of HIV-infected patients].
Topics: Acyclovir; Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Interferon-alpha; Zalcitabine; Zidovudine | 1993 |
Zidovudine dosage.
Topics: Drug Administration Schedule; HIV Infections; Humans; Zidovudine | 1993 |
Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
Topics: Adult; Biopsy; HIV Infections; Humans; Inclusion Bodies; Middle Aged; Mitochondria, Muscle; Mitochondrial Myopathies; Muscles; Muscular Diseases; Myositis; Necrosis; Zidovudine | 1993 |
Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV.
Topics: Adult; Blood-Brain Barrier; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Proteins; Spinal Puncture; Zidovudine | 1993 |
Transmission of zidovudine-resistant HIV-1.
Topics: Codon; Drug Resistance, Microbial; Female; Gene Products, pol; HIV Infections; HIV-1; Humans; Male; Mutation; Risk Factors; Sexual Behavior; Substance Abuse, Intravenous; Zidovudine | 1993 |
Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses.
Topics: Female; Fetal Diseases; HIV Infections; HIV-1; Humans; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
Acute diffuse leukoencephalitis in HIV-1 infection.
Topics: Adult; AIDS Dementia Complex; Brain; Cerebrospinal Fluid; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Magnetic Resonance Imaging; Radiography; Zidovudine | 1994 |
Use of antiretroviral drugs in HIV disease declines following preliminary results from Concorde trial.
Topics: Clinical Trials as Topic; Drug Utilization; HIV Infections; Humans; Zidovudine | 1994 |
Treatment of early or asymptomatic HIV infection. Where are we and where do we go from here?
Topics: HIV Infections; Humans; Zidovudine | 1993 |
HIV or zidovudine myopathy?
Topics: Animals; HIV Infections; Humans; Incidence; Mitochondria, Liver; Mitochondria, Muscle; Mitochondrial Myopathies; Muscular Diseases; Prospective Studies; Rats; Zidovudine | 1994 |
HIV or zidovudine myopathy?
Topics: DNA Polymerase III; DNA Replication; DNA, Mitochondrial; HIV Infections; Humans; Mitochondria, Muscle; Mitochondrial Myopathies; Zidovudine | 1994 |
HIV or zidovudine myopathy?
Topics: Biomarkers; Creatine Kinase; Electromyography; HIV Infections; Humans; Muscular Diseases; Retrospective Studies; Zidovudine | 1994 |
HIV or zidovudine myopathy?
Topics: Cytochrome-c Oxidase Deficiency; Electron Transport Complex IV; HIV Infections; Humans; Mitochondria, Muscle; Mitochondrial Myopathies; Muscular Diseases; Zidovudine | 1994 |
Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
Topics: Adult; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; Hepatitis, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Pilot Projects; Recombinant Proteins; Zidovudine | 1993 |
[Investigation of AZT sensitivity of HIV-1 isolates from patients treated with AZT].
Topics: Adolescent; Adult; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Middle Aged; Zidovudine | 1993 |
HIV/AIDS early treatment controversy cues new advice but questions remain.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; HIV Infections; Humans; Zidovudine | 1993 |
Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
Topics: Adult; AIDS Dementia Complex; Cerebrospinal Fluid; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Netherlands; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Zidovudine | 1993 |
Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Color Vision Defects; Contrast Sensitivity; Female; HIV Infections; Humans; Male; Zidovudine | 1993 |
Physicians not fazed by AZT guidelines.
Topics: HIV Infections; Humans; National Institutes of Health (U.S.); Practice Guidelines as Topic; United States; Zidovudine | 1993 |
Treating HIV infection: what pharmacists need to know.
Topics: Adult; AIDS-Related Opportunistic Infections; Didanosine; Education, Pharmacy, Continuing; Female; HIV Infections; Humans; Male; Middle Aged; Pharmacists; Risk Factors; Zidovudine | 1993 |
Zidovudine in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1993 |
Conditioning a diffusion at first-passage and last-exit times, and a mirage arising in drug therapy for HIV.
Topics: Acquired Immunodeficiency Syndrome; Antigens, CD; Antiviral Agents; Biomarkers; CD4 Antigens; HIV Infections; Humans; Mathematics; Models, Theoretical; T-Lymphocyte Subsets; Zidovudine | 1993 |
HIV-related thrombocytopenia.
Topics: Didanosine; HIV Infections; Humans; Recurrence; Thrombocytopenia; Zidovudine | 1993 |
Azidothymidine (AZT)-induced siderosis.
Topics: Animals; Disease Models, Animal; Heme; HIV Infections; Iron; Liver; Macrophages; Mice; Mice, Inbred Strains; Siderosis; Zidovudine | 1993 |
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children.
Topics: Child; Child, Preschool; Erythropoiesis; Female; Growth Disorders; Growth Hormone; HIV Infections; HIV-1; Humans; In Vitro Techniques; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Zidovudine | 1993 |
Update on drug therapy for HIV and related infections in adults.
Topics: Adult; HIV Infections; Humans; Zidovudine | 1993 |
Development of AIDS in people with transfusion-acquired HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Demography; Female; HIV Infections; Humans; Male; Middle Aged; New South Wales; Time Factors; Transfusion Reaction; Zidovudine | 1993 |
Effects of human immunodeficiency virus sera and macrophage supernatants on mesangial cell proliferation and matrix synthesis.
Topics: Cell Division; Cells, Cultured; Extracellular Matrix Proteins; Glomerular Mesangium; HIV Infections; Humans; Lipopolysaccharides; Macrophages; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1993 |
[The treatment of 12 HIV-infected children with zidovudine].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anemia; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Infant; Leukopenia; Male; Zidovudine | 1993 |
[Nephropathies and HIV virus infection. Anatamo-clinical study].
Topics: Adult; Black People; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; HIV Infections; Humans; Kidney Diseases; Male; Nephrotic Syndrome; Renal Insufficiency; White People; Zidovudine | 1993 |
Primary infection with zidovudine-resistant HIV.
Topics: Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Male; Mutation; Prospective Studies; Zidovudine | 1993 |
Primary infection with zidovudine-resistant HIV.
Topics: Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1993 |
Zidovudine for early HIV infection: yes, no, maybe.
Topics: Decision Making; HIV Infections; Humans; Zidovudine | 1993 |
Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Anti-Inflammatory Agents, Non-Steroidal; Depression; HIV Infections; HIV Seropositivity; Humans; Longitudinal Studies; Male; Outpatients; Pain; Psychiatric Status Rating Scales; Zidovudine | 1993 |
Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiviral Agents; Cohort Studies; Dapsone; Didanosine; Drug Combinations; Follow-Up Studies; HIV Infections; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; San Francisco; Sulfamethizole; Trimethoprim; Zalcitabine; Zidovudine | 1993 |
Antiretroviral therapy.
Topics: Didanosine; Dideoxynucleosides; HIV Infections; Humans; Zalcitabine; Zidovudine | 1993 |
Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
Topics: Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Occupational Diseases; Population Surveillance; Prospective Studies; Risk Factors; Treatment Failure; United States; Zidovudine | 1993 |
In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent.
Topics: Antiviral Agents; B-Lymphocytes; CD3 Complex; Cytokines; Female; HIV Infections; HIV-1; Humans; Immunoglobulins; Lamivudine; Lymphocyte Activation; Male; Phytohemagglutinins; T-Lymphocytes; Zalcitabine; Zidovudine | 1993 |
Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Didanosine; HIV Infections; Humans; Immunoglobulins, Intravenous; Infant; Zalcitabine; Zidovudine | 1993 |
Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients.
Topics: Administration, Oral; Adult; Half-Life; HIV Infections; Homosexuality; Humans; Male; Middle Aged; Radioimmunoassay; Zidovudine | 1993 |
Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient.
Topics: Adult; Drug Therapy, Combination; HIV Infections; Humans; Male; Oxazepam; Zidovudine | 1993 |
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women.
Topics: Adolescent; Adult; Cervix Uteri; Cross-Sectional Studies; Female; HIV Infections; HIV-1; Humans; Middle Aged; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Vagina; Zidovudine | 1993 |
Benefits of early diagnosis of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Counseling; HIV Infections; Humans; Patient Education as Topic; Survival Rate; Time Factors; Zidovudine | 1993 |
Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy.
Topics: DNA, Viral; Gene Products, tat; HIV Infections; HIV-1; Humans; Proviruses; RNA, Messenger; tat Gene Products, Human Immunodeficiency Virus; Zidovudine | 1993 |
Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection.
Topics: Adult; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Injections, Intradermal; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocyte Count; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Zidovudine | 1993 |
Cell-to-cell transmission of human immunodeficiency virus infection induces two distinct phases of viral RNA expression under separate regulatory control.
Topics: Cell Line; Gene Expression Regulation, Viral; HIV; HIV Infections; Humans; RNA, Viral; Time Factors; Transcription, Genetic; Zidovudine | 1993 |
Lack of effect of clinical research protocol participation on morbidity measures in human immunodeficiency virus-infected children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Clinical Protocols; Clinical Trials as Topic; HIV Infections; Humans; Infant; Morbidity; Retrospective Studies; Zidovudine | 1993 |
Human immunodeficiency virus-associated autonomic neuropathy, drug addiction, and zidovudine treatment.
Topics: Autonomic Nervous System Diseases; HIV Infections; Humans; Substance Abuse, Intravenous; Zidovudine | 1993 |
Defective IL-6 secretion in HIV-infected haemophilia patients.
Topics: B-Lymphocytes; Hemophilia A; HIV Infections; Humans; Immunoglobulin G; Interleukin-6; Lymphocyte Activation; Mitogens; Monocytes; Zidovudine | 1993 |
Outpatient compliance with zidovudine therapy in French Polynesia.
Topics: Drug Prescriptions; HIV Infections; Humans; Outpatients; Patient Compliance; Polynesia; Records; Zidovudine | 1993 |
Does zidovudine reduce tumour necrosis factor-alpha in HIV-positive patients?
Topics: HIV; HIV Infections; Humans; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1993 |
Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response.
Topics: CD8 Antigens; HIV Infections; HIV-1; Humans; Immune System; Male; T-Lymphocyte Subsets; Zidovudine | 1993 |
Alert! Don't abbreviate zidovudine as AZT.
Topics: Azathioprine; HIV Infections; Humans; Medication Errors; Terminology as Topic; Zidovudine | 1993 |
A disappointing decade of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Africa; Antiviral Agents; Child; Forecasting; HIV; HIV Infections; Humans; Zidovudine | 1993 |
[Antiretroviral therapy].
Topics: Clinical Trials as Topic; Didanosine; HIV Infections; Humans; Zidovudine | 1993 |
Managing the HIV positive patient in general practice.
Topics: Clinical Competence; Family Practice; HIV Infections; Humans; Zidovudine | 1993 |
Cholestatic giant cell hepatitis associated with ultrastructural evidence of intrahepatic retroviral infection in a human immunodeficiency virus-seropositive infant.
Topics: AIDS-Related Opportunistic Infections; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Cholestasis; Giant Cells; Hepatitis, Viral, Human; Hepatomegaly; HIV Infections; HIV Seropositivity; Humans; Infant; Liver; Pentamidine; Pneumonia, Pneumocystis; Splenomegaly; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1993 |
Zidovudine therapy of HIV-associated thrombocytopenia: from MAIDS to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; HIV Infections; Humans; Mice; Murine Acquired Immunodeficiency Syndrome; Thrombocytopenia; Zidovudine | 1993 |
Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns.
Topics: Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1993 |
Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.
Topics: Adult; Base Sequence; DNA, Viral; Drug Resistance; HIV Infections; HIV-1; Humans; Male; Molecular Sequence Data; Zidovudine | 1993 |
A tale of two mutants.
Topics: Antitubercular Agents; Drug Resistance; HIV; HIV Infections; Humans; Mutation; Mycobacterium tuberculosis; Tuberculosis, Pulmonary; Zidovudine | 1993 |
AIDS Q&A.
Topics: Antiviral Agents; HIV Infections; Humans; Zidovudine | 1993 |
[Infection by HIV].
Topics: Acquired Immunodeficiency Syndrome; Adult; Child, Preschool; HIV Infections; HIV-1; HIV-2; Humans; Infant; Polymerase Chain Reaction; Risk Factors; Zidovudine | 1993 |
AIDS administrators plan crisis meeting over future of AZT.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; France; HIV Infections; Humans; United Kingdom; Zidovudine | 1993 |
Zidovudine-responsive pure red cell aplasia as initial manifestation of HIV infection.
Topics: Adult; HIV Infections; Humans; Male; Red-Cell Aplasia, Pure; Zidovudine | 1993 |
Hepatomegaly with severe steatosis in HIV-seropositive patients.
Topics: Adult; Aspartate Aminotransferases; Fatty Liver; Female; Hepatomegaly; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Zidovudine | 1993 |
p24 antigenaemia and clinical response to zidovudine therapy.
Topics: Adult; Blood; Cohort Studies; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Viremia; Virus Replication; Zidovudine | 1993 |
Case study of zidovudine overdose.
Topics: Adult; Amitriptyline; Attitude to Health; Drug Overdose; HIV Infections; Humans; Male; Suicide, Attempted; Zidovudine | 1993 |
Using convergent combination therapy, researchers stopped the human immunodeficiency virus (HIV) from reproducing in test tubes.
Topics: Didanosine; Drug Therapy, Combination; HIV Infections; Humans; In Vitro Techniques; Pyridones; Zidovudine | 1993 |
Syringe attack by AIDS patient may be first documented.
Topics: Acquired Immunodeficiency Syndrome; Female; HIV; HIV Infections; Humans; Needlestick Injuries; Nursing Staff, Hospital; Occupational Exposure; Violence; Zidovudine | 1993 |
Exposure to human immunodeficiency virus in the endoscopy setting: a personal experience.
Topics: Adult; AIDS Serodiagnosis; Endoscopy, Gastrointestinal; Female; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Zidovudine | 1993 |
[The use of erythropoietin in HIV myelodysplasias. Preliminary study].
Topics: Adult; Anemia; Erythropoietin; HIV Infections; Humans; Recombinant Proteins; Zidovudine | 1993 |
[Cell-specific therapy of HIV infection].
Topics: HIV Infections; Humans; Virus Replication; Zidovudine | 1993 |
Continuous infusion of zidovudine in HIV related thrombocytopenia.
Topics: HIV Infections; Humans; Infant; Infusions, Intravenous; Thrombocytopenia; Zidovudine | 1993 |
Polycythemia as a complication of human immunodeficiency virus infection.
Topics: Adult; HIV Infections; Humans; Male; Polycythemia Vera; Zidovudine | 1993 |
Drug interactions with zidovudine.
Topics: Adjuvants, Immunologic; Analgesics; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; HIV Infections; Humans; In Vitro Techniques; Zidovudine | 1993 |
Further observations on zidovudine transfer and metabolism by human placenta.
Topics: Female; HIV Infections; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1993 |
Zidovudine treatment and virus excretion in the cervicovaginal secretions of HIV-infected women.
Topics: Cervix Uteri; Female; HIV Infections; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Vagina; Virus Shedding; Zidovudine | 1993 |
Use of backcalculation for estimation of the probability of progression from HIV infection to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Canada; Child; Female; HIV Infections; HIV Seroprevalence; Humans; Male; Middle Aged; Models, Statistical; Population Surveillance; Probability; Zidovudine | 1993 |
Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Didanosine; Erythema Infectiosum; HIV Infections; Humans; Incidence; Male; Middle Aged; Parvovirus B19, Human; Zidovudine | 1993 |
Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.
Topics: Adult; Base Sequence; Biomarkers; Cell-Free System; Cells, Cultured; DNA, Viral; HIV Infections; HIV-1; Humans; Longitudinal Studies; Molecular Sequence Data; Monte Carlo Method; Polymerase Chain Reaction; Regression Analysis; RNA, Viral; Zidovudine | 1993 |
[Nutrition and human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Diarrhea; Enteral Nutrition; HIV Infections; Humans; Male; Metabolic Diseases; Nutrition Disorders; Parenteral Nutrition, Total; Weight Loss; Zidovudine | 1995 |
Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
Topics: Adult; Drug Resistance, Microbial; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Mutation; Polymerase Chain Reaction; Time Factors; Zidovudine | 1995 |
Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994.
Topics: Antiviral Agents; Blood-Borne Pathogens; Case-Control Studies; France; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; Risk Factors; United Kingdom; United States; Zidovudine | 1995 |
The European Collaborative Study: clinical and immunological characteristics of HIV 1-infected pregnant women.
Topics: Antiviral Agents; Breast Feeding; CD4 Lymphocyte Count; Disease Progression; Europe; Female; HIV Infections; Humans; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Zidovudine | 1995 |
Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.
Topics: Antiviral Agents; Demography; Didanosine; HIV Infections; Humans; Zidovudine | 1996 |
[Zidovudine therapy alone is not enough].
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Treatment Outcome; Zidovudine | 1995 |
Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
Topics: Adult; Antiviral Agents; Creatine Kinase; Female; HIV Infections; Humans; Male; Microscopy, Electron; Middle Aged; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle Weakness; Muscles; Muscular Diseases; Pain; Zidovudine | 1995 |
Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies.
Topics: AIDS Dementia Complex; Antiviral Agents; Brain; HIV Infections; Humans; Neurons; Zidovudine | 1996 |
Zidovudine adherence among individuals with HIV infection.
Topics: Adult; Antiviral Agents; Attitude to Health; Black or African American; Cross-Sectional Studies; Culture; Factor Analysis, Statistical; Female; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Models, Psychological; Patient Compliance; Reverse Transcriptase Inhibitors; Texas; Zidovudine | 1995 |
Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Topics: Antiviral Agents; Base Sequence; Blotting, Southern; Cell Line; Cells, Cultured; Child; DNA; DNA Primers; Down-Regulation; Drug Resistance; Gene Expression Regulation, Enzymologic; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Methylation; Molecular Sequence Data; Phosphorylation; Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Thymidine Kinase; Transcription, Genetic; Zidovudine | 1995 |
Health insurance and use of medical services by men infected with HIV.
Topics: Adult; Ambulatory Care; Antiviral Agents; Cohort Studies; Emergency Service, Hospital; HIV Infections; HIV-1; Humans; Insurance, Health; Male; Pneumonia, Pneumocystis; Prospective Studies; San Francisco; Zidovudine | 1995 |
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.
Topics: Body Height; Body Weight; Female; Growth; Head; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 1996 |
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
Topics: Animals; Antiviral Agents; Base Sequence; Cell Line; Didanosine; DNA Primers; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1996 |
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV-1; Humans; Life Tables; Outcome Assessment, Health Care; Regression Analysis; Retrospective Studies; Risk; RNA, Viral; Zidovudine | 1996 |
Zidovudine in patients with HIV infection.
Topics: Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Zidovudine in patients with HIV infection.
Topics: Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Development of a human thymic organ culture model for the study of HIV pathogenesis.
Topics: Animals; Antiviral Agents; Apoptosis; Cats; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Didanosine; Drug Evaluation, Preclinical; Fetus; HIV Infections; HIV-1; Humans; Mice; Models, Biological; Organ Culture Techniques; Thymus Gland; Time Factors; Virus Replication; Zidovudine | 1995 |
Efficacy of ultraviolet B phototherapy for psoriasis in patients infected with human immunodeficiency virus.
Topics: Administration, Cutaneous; Adult; Antiviral Agents; Body Surface Area; Case-Control Studies; CD4 Lymphocyte Count; Dermatitis, Exfoliative; Erythema; HIV Infections; HIV Seronegativity; Humans; Immunocompromised Host; Keratolytic Agents; Male; Psoriasis; Salicylates; Salicylic Acid; Ultraviolet Rays; Ultraviolet Therapy; Zidovudine | 1995 |
Pityriasis rubra pilaris and HIV infection: a part of the spectrum of HIV-associated follicular syndrome.
Topics: Adult; Antiviral Agents; HIV Infections; Humans; Male; Pityriasis Rubra Pilaris; Zidovudine | 1995 |
[Attempted suicide using massive doses of zidovudine].
Topics: Adult; Antiviral Agents; HIV Infections; Humans; Suicide, Attempted; Zidovudine | 1995 |
Using HIV/AIDS surveillance to monitor public health efforts to reduce perinatal transmission of HIV.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Environmental Monitoring; Epidemiological Monitoring; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Public Health; United States; Zidovudine | 1996 |
[Frequency and mode of use of testing for HIV infection in women hospitalized for childbirth].
Topics: Adult; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Hospitals, Maternity; Humans; Pregnancy; Pregnancy Complications, Infectious; Rome; Zidovudine | 1995 |
Treatment during primary HIV infection shows promise.
Topics: Antiviral Agents; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1995 |
AIDS in Africans living in London.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Antiviral Agents; Female; HIV Infections; Humans; London; Male; Middle Aged; Pneumonia, Pneumocystis; Retrospective Studies; Tuberculosis; Zidovudine | 1995 |
Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.
Topics: Antiviral Agents; Drug Resistance, Microbial; Genotype; HIV Infections; HIV-1; Humans; Luminescent Measurements; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Zidovudine | 1995 |
Acyclovir in human immunodeficiency virus patients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Herpesviridae Infections; HIV Infections; Humans; Survival Rate; Zidovudine | 1996 |
Vertical transmission of HIV-1 infection. Diagnosis and prevention.
Topics: Adolescent; Adult; Antiviral Agents; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Risk Factors; Vaccination; Zidovudine | 1995 |
From pseudocholinesterase to human immunodeficiency virus.
Topics: Animals; Antibodies; Apolipoproteins E; Biochemistry; Butyrylcholinesterase; Chloroquine; Drug Carriers; Endocytosis; Enzyme Activation; HIV; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV Reverse Transcriptase; Humans; Immunoconjugates; Immunotherapy; Liposomes; Liver; Low Density Lipoprotein Receptor-Related Protein-1; Lysosomes; Mammals; Receptors, Lipoprotein; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
Plasma viral load, CD4+ cell counts, and HIV-1 production by cells.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cells, Cultured; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymphocyte Count; T-Lymphocytes; Tumor Cells, Cultured; Viremia; Virus Replication; Zidovudine | 1996 |
The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Proviruses; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1995 |
A new HIV/AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Zalcitabine; Zidovudine | 1996 |
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
Topics: AIDS Serodiagnosis; Antiviral Agents; Cohort Studies; Delivery, Obstetric; DNA, Viral; Drug Resistance, Microbial; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk; RNA, Viral; Zidovudine | 1996 |
Managing HIV disease after Delta.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Combinations; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1996 |
Redox potential status in children with perinatal HIV-1 infection treated with zidovudine.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Hydroxybutyrates; Infant; Infectious Disease Transmission, Vertical; Lactates; Lactic Acid; Male; Mitochondria; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Zidovudine | 1995 |
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
Topics: Adult; Antiviral Agents; Consensus Sequence; DNA, Viral; Female; Giant Cells; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Kinetics; Leukocytes, Mononuclear; Male; Middle Aged; Neutralization Tests; Peptide Fragments; Proviruses; RNA, Viral; Viremia; Zidovudine | 1996 |
Hepatotoxicity and rash associated with zidovudine and zalcitabine chemoprophylaxis.
Topics: Chemical and Drug Induced Liver Injury; Erythema; Female; HIV Infections; Humans; Middle Aged; Zalcitabine; Zidovudine | 1996 |
Pediatric AIDS.
Topics: Child; Female; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Transfusion Reaction; Zidovudine | 1995 |
Mother-infant HIV transmission: making the most of what we know.
Topics: AIDS Vaccines; Antiviral Agents; Disease Susceptibility; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Zidovudine | 1996 |
Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
Topics: AIDS Serodiagnosis; Antiviral Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; North Carolina; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Rural Population; Seroepidemiologic Studies; Urban Population; Zidovudine | 1996 |
Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
Topics: Adolescent; Adult; Antiviral Agents; Counseling; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Medical Indigency; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Urban Population; Zidovudine | 1996 |
Preventing perinatal HIV infection. How far have we come?
Topics: Antiviral Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.
Topics: Antiviral Agents; Blood-Borne Pathogens; Chemoprevention; HIV; HIV Infections; Humans; Occupational Exposure; United States; United States Public Health Service; Zidovudine | 1996 |
The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
Topics: Cost-Benefit Analysis; Drug Costs; Female; HIV Infections; HIV Seropositivity; Humans; Mass Screening; Models, Statistical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; CD4 Lymphocyte Count; DNA Primers; Drug Resistance, Microbial; Evolution, Molecular; Genes, pol; Genome, Viral; Genotype; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Proviruses; RNA-Directed DNA Polymerase; RNA, Viral; Virus Replication; Zidovudine | 1996 |
CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression.
Topics: Adult; Antiviral Agents; Biomarkers; CD4 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Membrane; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; T-Lymphocytes; Zidovudine | 1996 |
In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Genetic Variation; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Molecular Sequence Data; Substrate Specificity; Zidovudine | 1996 |
Viral load and response to treatment of HIV.
Topics: Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Data Interpretation, Statistical; HIV Infections; HIV-1; Humans; Outcome Assessment, Health Care; RNA, Viral; Zidovudine | 1996 |
Consumer campaign is directed at women with HIV or AIDS.
Topics: Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; United States; United States Dept. of Health and Human Services; Zidovudine | 1996 |
Lamivudine as adjunct therapy in HIV.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1996 |
Monoblastic leukemia in an HIV-infected patient: absence of viral expression in RNA blasts.
Topics: Adult; Bone Marrow; DNA, Viral; Fatal Outcome; Foot Diseases; Gene Expression; HIV Infections; HIV-1; Humans; Immunophenotyping; Leukemia, Monocytic, Acute; Male; Neoplastic Stem Cells; RNA, Viral; Sarcoma, Kaposi; Zalcitabine; Zidovudine | 1996 |
Duration of the survival benefit of zidovudine therapy in HIV infection.
Topics: Adult; Antiviral Agents; Female; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Survival Rate; Time Factors; Treatment Outcome; Zidovudine | 1996 |
The deoxyuridine suppression test in HIV-1 positive patients: the role of azydothymidine (AZT).
Topics: Anemia, Megaloblastic; Bone Marrow; Cells, Cultured; Deoxyuridine; Folic Acid; HIV Infections; HIV-1; Humans; Intestinal Absorption; Methotrexate; Vitamin B 12; Vitamin B 12 Deficiency; Zidovudine | 1996 |
Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Drug Therapy, Combination; Drug Utilization; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Multicenter Studies as Topic; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1995 |
Vertical transmission of HIV--a rediscussion of testing.
Topics: AIDS Serodiagnosis; Ethics, Medical; Female; Health Services Accessibility; HIV Infections; Humans; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Prejudice; Prenatal Care; Prognosis; Risk Factors; Zidovudine | 1995 |
New nucleoside analogue, lamivudine, released for HIV therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; Lamivudine; Zalcitabine; Zidovudine | 1996 |
Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Topics: Abortion, Induced; AIDS Serodiagnosis; Antiviral Agents; Cost of Illness; Cost Savings; Counseling; Drug Costs; Female; Health Care Costs; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Sensitivity and Specificity; United States; Voluntary Programs; Zidovudine | 1996 |
Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Topics: Africa South of the Sahara; Antiviral Agents; Cost-Benefit Analysis; Decision Support Techniques; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Program Development; Zidovudine | 1996 |
From the Centers for Disease Control and Prevention. Update: provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV.
Topics: Antiviral Agents; Blood-Borne Pathogens; Chemoprevention; HIV; HIV Infections; Humans; Occupational Exposure; United States; United States Public Health Service; Zidovudine | 1996 |
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; HIV-1; Humans; Immune Tolerance; Incidence; Male; Pneumonia, Pneumocystis; Prevalence; Survival Rate; Zidovudine | 1996 |
[Pancreatic disease in patients with HIV treated with didanosine (DDI)].
Topics: Acute Disease; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Pancreatic Diseases; Pancreatitis; Zidovudine | 1996 |
Use of zidovudine to prevent maternal transmission of HIV.
Topics: Antiviral Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1995 |
No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; HIV Infections; HIV-1; Humans; Male; Platelet Count; Prognosis; Risk Factors; Thrombocytopenia; Zidovudine | 1996 |
Analysis of an HIV-infected cohort followed for as long as 15 years after seroconversion.
Topics: Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Hemophilia A; Hemophilia B; HIV Infections; Humans; Lymphocyte Count; Male; von Willebrand Diseases; Zidovudine | 1996 |
[Zidovudine-resistant HIV strains in intravenous drug users and homosexual men in Amsterdam].
Topics: Cohort Studies; Drug Resistance; HIV; HIV Infections; Homosexuality; Humans; Male; Point Mutation; Substance Abuse, Intravenous; Zidovudine | 1996 |
Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains.
Topics: Antiviral Agents; Cell Line, Transformed; Cytotoxicity, Immunologic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Microbial Sensitivity Tests; Nevirapine; Pyridines; Stavudine; T-Lymphocytes; Zidovudine | 1996 |
[Present and future of the antiretroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Zidovudine | 1996 |
Adverse events from drug therapy for human immunodeficiency virus disease.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Dapsone; Didanosine; Female; HIV Infections; Humans; Male; Pneumonia, Pneumocystis; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urban Health; Zalcitabine; Zidovudine | 1996 |
Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV)
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Didanosine; HIV Infections; Humans; Infant; Zidovudine | 1996 |
New guidelines set for occupational HIV exposure.
Topics: Accidents, Occupational; Antiviral Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Practice Guidelines as Topic; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
[Anti-retroviral monotherapy with nucleoside analogues].
Topics: Antiviral Agents; Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1995 |
[Resistance and combined use of anti-HIV drugs].
Topics: Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Mutation; Zalcitabine; Zidovudine | 1995 |
Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cervix Uteri; Female; HIV Infections; HIV-1; Humans; RNA, Viral; Vagina; Viremia; Zidovudine | 1996 |
Risk factors for occupational HIV.
Topics: Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Risk Factors; Zidovudine | 1996 |
Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma.
Topics: Antiviral Agents; Biopsy; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lymph Nodes; RNA, Viral; Viremia; Zalcitabine; Zidovudine | 1996 |
Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.
Topics: Didanosine; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis; Zidovudine | 1996 |
Antiretroviral drug treatment for HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Disease Progression; HIV Infections; Humans; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Perinatal HIV infection.
Topics: Antiviral Agents; HIV Infections; Humans; Infant, Newborn; North Carolina; Rural Population; Urban Population; Zidovudine | 1996 |
Delta in the real world.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Physician's Role; Pregnancy; Zidovudine | 1996 |
A model for treatment strategy in the chemotherapy of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; HIV Infections; Humans; Mathematics; Models, Immunological; Models, Theoretical; Zidovudine | 1996 |
Teleconference on HIV and pregnancy set for June 18.
Topics: Antiviral Agents; Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pennsylvania; Pregnancy; Pregnancy Complications, Infectious; Telecommunications; Zidovudine | 1996 |
Vertical transmission of HIV-1 in mid-trimester gestation.
Topics: Adolescent; Adult; Antiviral Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Zidovudine | 1995 |
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.
Topics: Advisory Committees; Anti-Infective Agents; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Confidentiality; Conflict of Interest; Didanosine; Drug Evaluation; Federal Government; HIV Infections; Humans; National Institutes of Health (U.S.); Organizational Objectives; Professional Staff Committees; Pyrimethamine; Reverse Transcriptase Inhibitors; Risk Assessment; Toxoplasmosis, Cerebral; Treatment Outcome; United States; Zalcitabine; Zidovudine | 1995 |
Consensus symposium on combined antiviral therapy; overview of interferon and IL-2 combinations for the treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Interferon-alpha; Interleukin-2; Sarcoma, Kaposi; Zidovudine | 1996 |
Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Middle Aged; Sexual Behavior; Substance Abuse, Intravenous; Virus Replication; Zidovudine | 1996 |
MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Didanosine; DNA, Viral; Guanine; HIV Infections; HIV-1; HIV-2; Humans; Male; Mice; Mice, SCID; Monocytes; Organophosphonates; Spleen; T-Lymphocytes; Zidovudine | 1996 |
Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.
Topics: Antiviral Agents; Cell Line; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Models, Biological; Monte Carlo Method; Pyridines; Valine; Zidovudine | 1996 |
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985.
Topics: Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Follow-Up Studies; Histocompatibility Testing; HIV Infections; HIV Seropositivity; Humans; Male; Statistics as Topic; Substance Abuse, Intravenous; United Kingdom; Zidovudine | 1996 |
Combination antiretroviral chemotherapy: a potential strategy in AIDS-related malignancy.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell Division; Didanosine; HIV Infections; HL-60 Cells; Humans; Zalcitabine; Zidovudine | 1996 |
Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
Topics: Adult; Aged; Antiviral Agents; Atrophy; Biomarkers; Capillaries; Cytochrome-c Oxidase Deficiency; Electron Transport Complex IV; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondrial Myopathies; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscle, Smooth, Vascular; Succinate Dehydrogenase; Zidovudine | 1995 |
Combination drug treatment benefits patients with HIV.
Topics: Antiviral Agents; Didanosine; Drug Combinations; HIV Infections; Humans; Zalcitabine; Zidovudine | 1996 |
Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.
Topics: HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patients.
Topics: Adolescent; Adult; Female; HIV Infections; Humans; Leukocytes, Mononuclear; Lymphocyte Count; Male; Models, Biological; Phosphorylation; Zidovudine | 1996 |
Intracellular metabolism of zidovudine and stavudine in combination.
Topics: Antiviral Agents; Cells, Cultured; Drug Combinations; Genetic Variation; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Phosphorylation; Stavudine; Zidovudine | 1996 |
Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection.
Topics: Female; Fetal Death; HIV Infections; HIV-1; Humans; Infant, Newborn; Obesity; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
HIV screening and treatment in pregnancy.
Topics: AIDS Serodiagnosis; Antiviral Agents; Female; HIV Infections; Humans; Infant, Newborn; Mass Screening; Mississippi; Neonatal Screening; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1996 |
Guidelines for management of the HIV infected pregnant woman. Mississippi State Medical Association.
Topics: Antiviral Agents; Combined Modality Therapy; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1996 |
Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; Giant Cells; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Phenotype; Prospective Studies; Zidovudine | 1996 |
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.
Topics: Antiviral Agents; Base Sequence; Codon; DNA Ligases; DNA Primers; DNA, Viral; Drug Resistance, Microbial; Evaluation Studies as Topic; Genotype; HIV Infections; HIV-1; Humans; Laboratories; Leukocytes, Mononuclear; Mutation; Plasma; Polymerase Chain Reaction; Sensitivity and Specificity; Zidovudine | 1996 |
[Prescription of antiretroviral and prophylactic drugs in HIV diseases: reality of medical practices].
Topics: Anti-Infective Agents; Antiviral Agents; CD4 Lymphocyte Count; Dapsone; Didanosine; Drug Utilization; France; HIV Infections; Hospital Information Systems; Hospital Records; Humans; Pentamidine; Trimethoprim, Sulfamethoxazole Drug Combination; Zalcitabine; Zidovudine | 1995 |
Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine.
Topics: Didanosine; Encephalitis, Viral; HIV Infections; Humans; Retrospective Studies; Zidovudine | 1996 |
Occupational transmission of HIV to health care workers.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Risk Factors; Zidovudine | 1996 |
Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
Topics: Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; In Situ Hybridization; Infant; Lymph Nodes; Male; Nevirapine; Pyridines; Viremia; Zidovudine | 1996 |
Therapy of HIV infections: problems and prospects.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Stavudine; Urban Health; Zalcitabine; Zidovudine | 1996 |
Different properties of wild type and drug-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase in vitro.
Topics: Antiviral Agents; Cells, Cultured; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Proviruses; RNA-Directed DNA Polymerase; Uracil; Virus Replication; Zidovudine | 1996 |
Development of zidovudine-resistant HIV genotypes following postnatal prophylaxis in a perinatally infected infant.
Topics: Administration, Oral; Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; HIV Core Protein p24; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Leukocytes, Mononuclear; Mutation; Perinatal Care; Polymerase Chain Reaction; Pregnancy; Zidovudine | 1996 |
Kinetics of viral clearance in plasma, peripheral blood mononuclear cells and lymph nodes.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymph Nodes; Male; Plasma; RNA, Viral; Time Factors; Zidovudine | 1996 |
Transmission of HIV infection from mother to child.
Topics: Antiviral Agents; Female; Fetus; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1996 |
AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.
Topics: Base Sequence; Didanosine; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
New combinations of drug therapies for the treatment of the human immunodeficiency virus (HIV)
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Protease Inhibitors; Time Factors; Zidovudine | 1996 |
Therapy for human immunodeficiency virus infection -- what have we learned?
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1996 |
Rate of development of mutation at codon 215 of HIV-1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy.
Topics: Adolescent; Adult; Biomarkers; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Time Factors; Zidovudine | 1996 |
Zidovudine phosphorylation after short-term and long-term therapy with zidovudine in patients infected with the human immunodeficiency virus.
Topics: Administration, Oral; Anti-HIV Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Separation; Chromatography, High Pressure Liquid; Flow Cytometry; Gene Expression Regulation, Viral; HIV Infections; Humans; Leukocytes, Mononuclear; Nucleotides; Phosphates; Phosphorylation; Radioimmunoassay; Time Factors; Zidovudine | 1996 |
Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
Topics: Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Male; RNA, Viral; Treatment Outcome; Viremia; Virus Integration; Zidovudine | 1996 |
The chemical pathology of AIDS.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lymphoma, AIDS-Related; Pneumonia, Pneumocystis; Thiamine Deficiency; Zidovudine | 1995 |
Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.
Topics: Cell Line; HIV Infections; HIV-1; Humans; Kinetics; Leukocytes, Mononuclear; Phosphorylation; T-Lymphocytes; Thymidine; Thymidine Kinase; Time Factors; Tritium; Zidovudine | 1996 |
Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients.
Topics: Adult; Dideoxynucleosides; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Zidovudine | 1996 |
Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-HIV Agents; Candidiasis, Oral; Cohort Studies; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Leukoplakia, Hairy; Linear Models; Lymphocyte Count; Male; Mexico; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Zidovudine | 1996 |
Biological testing versus sequence analysis for determination of drug resistance of human immunodeficiency virus.
Topics: DNA, Viral; Drug Resistance, Microbial; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Sequence Analysis, DNA; Zidovudine | 1996 |
First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands.
Topics: Antiviral Agents; Drug Resistance, Microbial; HIV Infections; HIV-1; Homosexuality, Male; Humans; Incidence; Male; Netherlands; Prospective Studies; Substance Abuse, Intravenous; Zidovudine | 1996 |
Detection of Mycoplasma genitalium from urethral swabs of human immunodeficiency virus-infected patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents, Urinary; DNA, Bacterial; HIV Infections; HIV Seronegativity; Humans; Male; Mucous Membrane; Mycoplasma; Mycoplasma Infections; Polymerase Chain Reaction; Trimethoprim, Sulfamethoxazole Drug Combination; Urethra; Urethritis; Zidovudine | 1996 |
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry.
Topics: Animals; Antiviral Agents; Benzylamines; CD4-CD8 Ratio; Chromatography, High Pressure Liquid; Cyclams; Didanosine; Drug Implants; Heterocyclic Compounds; HIV Infections; HIV-1; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, SCID; Rats; Spectrophotometry, Ultraviolet; Virus Replication; Zidovudine | 1996 |
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
Topics: Animals; Antiviral Agents; Didanosine; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Fetal Tissue Transplantation; Flow Cytometry; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Liver Transplantation; Lymphocyte Count; Mice; Mice, SCID; Neutrophils; Nevirapine; Polymerase Chain Reaction; Pyridines; Rats; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Zidovudine | 1996 |
[What should be done after needlestick injuries with possible HIV exposure?].
Topics: Antiviral Agents; Drug Therapy, Combination; First Aid; HIV Infections; Humans; Needlestick Injuries; Risk Factors; Zalcitabine; Zidovudine | 1996 |
An update on HIV/AIDS.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; United States; Viremia; Zidovudine | 1996 |
Reverse transcriptase mutations in HIV-1-infected children treated with zidovudine.
Topics: Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Codon; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Male; Mutagenesis; Zidovudine | 1996 |
Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy.
Topics: Amino Acid Sequence; Anti-HIV Agents; Codon; Drug Resistance, Microbial; Genes, env; Genes, pol; Genetic Variation; HIV Infections; HIV-1; Humans; Likelihood Functions; Molecular Sequence Data; Mutagenesis; Phylogeny; Polymerase Chain Reaction; Proviruses; Recombination, Genetic; Sequence Analysis, DNA; Time Factors; Zidovudine | 1996 |
Preventing HIV infection in infants and children by reducing perinatal HIV transmission: review of efficacy and preliminary cost evaluation. South Carolina Pediatric AIDS Advisory Committee.
Topics: Cost-Benefit Analysis; Female; Health Care Costs; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; South Carolina; United States; Zidovudine | 1996 |
Combined therapy with zidovudine and L-697,661 in primary HIV infection.
Topics: Adult; Anti-HIV Agents; Benzoxazoles; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; HIV Infections; Humans; Pyridones; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia; Zidovudine | 1996 |
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
Topics: Base Sequence; Cell Line; Cell Line, Transformed; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Point Mutation; Reverse Transcriptase Inhibitors; Tryptophan; Zidovudine | 1996 |
The Delta trial.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Zidovudine | 1996 |
The Delta trial.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Patient Dropouts; Treatment Outcome; Zidovudine | 1996 |
The Delta trial.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Quality of Life; Zidovudine | 1996 |
Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.
Topics: Anti-HIV Agents; Biopterins; Chromatography, High Pressure Liquid; HIV Infections; HIV Seropositivity; Humans; Kynurenine; Neopterin; Quinolinic Acid; Radioimmunoassay; Time Factors; Tryptophan; Zidovudine | 1996 |
Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with Rauscher murine leukemia virus.
Topics: Animals; HIV Infections; Leukemia, Experimental; Mice; Rauscher Virus; Retroviridae Infections; RNA-Directed DNA Polymerase; Tumor Virus Infections; Viral Load; Zidovudine | 1996 |
Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease.
Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Diagnosis, Dual (Psychiatry); Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Compliance; Pilot Projects; Retrospective Studies; San Francisco; Substance Abuse Detection; Substance Abuse, Intravenous; Zidovudine | 1996 |
Preventing perinatal transmission of HIV: the effect of breast-feeding.
Topics: Antiviral Agents; Breast Feeding; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1996 |
Lamivudine-zidovudine treatment and clinical end points.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zidovudine | 1996 |
[Lamivudine-zidovudine combination treatment].
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zidovudine | 1996 |
Beginning to make progress against HIV.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 1996 |
Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy.
Topics: AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Drug Resistance, Microbial; Follow-Up Studies; Genes, pol; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Point Mutation; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1996 |
Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.
Topics: Adult; Anti-HIV Agents; Antibodies, Bacterial; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Progression; DNA, Viral; HIV Infections; HIV-1; Humans; Immunoglobulin G; Influenza Vaccines; Lymphocyte Activation; Middle Aged; Pneumococcal Infections; Polysaccharides, Bacterial; Proviruses; Receptors, Interleukin-2; RNA, Viral; Time Factors; Vaccination; Vaccines; Viral Load; Zidovudine | 1996 |
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmissi
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cesarean Section; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Gestational Age; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Substance-Related Disorders; Time Factors; Zidovudine | 1996 |
Recommendations for HIV occupational exposure.
Topics: Anti-HIV Agents; Chemoprevention; Health Personnel; HIV Infections; Humans; New Jersey; Occupational Exposure; Practice Guidelines as Topic; United States; Zidovudine | 1996 |
Porphyrin abnormalities in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Case-Control Studies; Feces; Female; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV Seropositivity; Humans; Immunocompromised Host; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Prospective Studies; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Zidovudine | 1996 |
Occurrence of lymphomas during ddC or ddC/zidovudine combination therapy in persons infected with HIV type 1.
Topics: Antiviral Agents; HIV Infections; HIV-1; Humans; Lymphoma; Zalcitabine; Zidovudine | 1996 |
Long-term zidovudine responders: is there still rationale for HIV monotherapy?
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Time Factors; Zidovudine | 1996 |
Efficacy of a combined zidovudine plus didanosine therapy in one case of HIV-related thrombocytopenia non-responder to zidovudine alone or to anti-Rho immunoglobulin administration.
Topics: Acute-Phase Proteins; Adult; Anti-HIV Agents; Didanosine; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Male; Thrombocytopenia; Zidovudine | 1996 |
Priming of neutrophil and monocyte activation in human immunodeficiency virus infection. Comparison of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interferon-gamma.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; Humans; Interferon-gamma; Luminescent Measurements; Male; Matched-Pair Analysis; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Respiratory Burst; Tetradecanoylphorbol Acetate; Zidovudine | 1996 |
Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
Topics: Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; HIV Infections; Humans; Longitudinal Studies; Tumor Necrosis Factor-alpha; Zidovudine | 1996 |
Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients.
Topics: Anti-HIV Agents; Cells, Cultured; Coculture Techniques; Codon; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Mutagenesis; Polymerase Chain Reaction; Proviruses; Sequence Analysis, DNA; Zidovudine | 1997 |
Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells.
Topics: Cells, Cultured; Dideoxynucleosides; Endocytosis; HIV Infections; HIV Reverse Transcriptase; Humans; Leukocytes, Mononuclear; Lipoproteins, LDL; Receptors, LDL; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1996 |
Testicular abscess due to Streptococcus pneumoniae in an infant with human immunodeficiency virus infection.
Topics: Abscess; Anti-HIV Agents; Female; HIV Infections; Humans; Immunocompromised Host; Infant; Infectious Disease Transmission, Vertical; Male; Penicillin G; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Streptococcal Infections; Streptococcus pneumoniae; Testicular Diseases; Zidovudine | 1997 |
Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Adult; HIV Infections; Humans; Peripheral Nervous System Diseases; Retrospective Studies; Zidovudine | 1997 |
[HIV: less resistance due to combined treatment].
Topics: Adult; Anti-HIV Agents; Computer Graphics; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine | 1996 |
[Nevirapine: a new principle of action against HIV].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant, Newborn; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1996 |
Reverse transcriptase fidelity and HIV-1 variation.
Topics: Anti-HIV Agents; Cells, Cultured; Drug Resistance, Microbial; Drug Therapy, Combination; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH].
Topics: Adolescent; Adult; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance; Female; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Retrospective Studies; Zidovudine | 1996 |
[HIV prevention after needlestick injury: preventive possibilities not proven, but likely. Official recommendations are still unavailable].
Topics: Anti-HIV Agents; HIV Infections; Humans; Needlestick Injuries; Treatment Outcome; Zidovudine | 1996 |
HIV postexposure prophylaxis: new recommendations.
Topics: Anti-HIV Agents; Blood-Borne Pathogens; Chemoprevention; Drug Combinations; Guidelines as Topic; Health Personnel; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Zidovudine | 1997 |
The Delta trial.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1997 |
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 1997 |
Renal involvement in the diffuse infiltrative CD8 lymphocytosis syndrome.
Topics: Adult; Anti-HIV Agents; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Kidney Diseases; Lymphocytosis; Male; Prednisone; Zalcitabine; Zidovudine | 1997 |
Focusing on the second phase of plasma HIV-1 RNA clearance.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Replication; Zidovudine | 1997 |
Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
Topics: Adult; Anti-HIV Agents; Cytochrome P-450 Enzyme System; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Hypnotics and Sedatives; Lamivudine; Liver; Male; Midazolam; Saquinavir; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1997 |
The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Treatment of late-state HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Combinations; HIV Infections; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Reverse Transcriptase Inhibitors; Treatment Outcome; Zalcitabine; Zidovudine | 1997 |
Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.
Topics: Adolescent; Adult; Anti-HIV Agents; CD8-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; Humans; Immunity, Cellular; Immunophenotyping; Infant, Newborn; Infant, Newborn, Diseases; Lymphocyte Count; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 1997 |
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrations.
Topics: Anti-HIV Agents; Cells, Cultured; Cost-Benefit Analysis; Drug Resistance, Microbial; Evaluation Studies as Topic; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Phenotype; Virus Replication; Zidovudine | 1997 |
Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; RNA, Viral; Time Factors; Viral Load; Viremia; Zidovudine | 1997 |
Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; CD28 Antigens; CD3 Complex; Exons; Gene Products, tat; HIV Infections; HIV-1; Humans; Interleukin-2; Jurkat Cells; Leukocytes, Mononuclear; Lymphocyte Activation; Promoter Regions, Genetic; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus; Transcription Factors; Transcription, Genetic; Transfection; Zidovudine | 1997 |
Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
Topics: Academic Medical Centers; Anti-HIV Agents; Chemoprevention; Dental Care for Chronically Ill; Dentistry; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Organizational Policy; Surveys and Questionnaires; Zidovudine | 1995 |
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine.
Topics: Adult; Anti-HIV Agents; Delavirdine; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Male; Mutation; Phenotype; Piperazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1997 |
Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone.
Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Delivery, Obstetric; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Retrospective Studies; Risk Factors; Zidovudine | 1997 |
HIV voluntary testing of all pregnant women.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Tennessee; Zidovudine | 1997 |
Resolution of HIV-associated cystic benign lymphoepithelial lesion of the parotid gland in a patient undergoing chemotherapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cysts; Didanosine; Doxorubicin; Fatal Outcome; HIV Infections; Humans; Hyperplasia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Parotid Diseases; Prednisone; Vincristine; Zidovudine | 1996 |
Human immunodeficiency virus drug therapy and virus load.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1997 |
[Antiretroviral drugs in the primary and secondary prevention of HIV infection].
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zidovudine | 1997 |
Viral load and combination therapy for human immunodeficiency virus.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; Humans; Time Factors; Zidovudine | 1997 |
Threshold of HIV-1 copy numbers for vertical transmission.
Topics: Anti-HIV Agents; Female; Follow-Up Studies; Gene Dosage; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; RNA, Viral; Zidovudine | 1997 |
Shedding of HIV-1 in semen during primary infection.
Topics: Anti-HIV Agents; Didanosine; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; RNA, Viral; Semen; Virus Shedding; Zidovudine | 1997 |
Analysis of repeated virological measurements based on cell dilution assays.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Models, Statistical; Survival Analysis; Treatment Outcome; Viral Load; Zidovudine | 1997 |
Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.
Topics: Anti-HIV Agents; Disease Transmission, Infectious; Female; Health Policy; HIV Infections; Humans; Male; Primary Prevention; Sexual Behavior; Substance Abuse, Intravenous; United States; Zidovudine | 1997 |
HIV update.
Topics: Anti-HIV Agents; Antiviral Agents; HIV Infections; Humans; Virginia; Zidovudine | 1997 |
Hearing loss and antiretroviral therapy in patients infected with HIV-1.
Topics: Adult; Anti-HIV Agents; Didanosine; Female; Hearing Disorders; HIV Infections; HIV-1; Humans; Male; Middle Aged; Stavudine; Zidovudine | 1997 |
Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons.
Topics: Anti-HIV Agents; Antiviral Agents; Area Under Curve; Biological Availability; Clinical Trials as Topic; Didanosine; Drug Interactions; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Zidovudine | 1996 |
Antiretroviral effect of zidovudine-didanosine combination on blood and lymph nodes.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymph Nodes; Male; Viral Load; Zidovudine | 1997 |
HIV trial stopped early after good results.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Zidovudine | 1997 |
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
Topics: Adult; Anti-HIV Agents; Antibodies, Anticardiolipin; Case-Control Studies; Didanosine; Echocardiography, Doppler; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; Humans; Hypertension, Pulmonary; Immunoglobulin M; Male; Prospective Studies; Survival Rate; Zidovudine | 1997 |
Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women.
Topics: Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; RNA, Viral; Viral Load; Virus Cultivation; Washington; Zidovudine | 1997 |
Treatment options for human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Child; Didanosine; Drug Approval; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Lamivudine; Male; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
[Therapeutic strategies against HIV: status in 1994 and future prospectives].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Forecasting; HIV Infections; Humans; Male; Zalcitabine; Zidovudine | 1994 |
[Individualization of HIV-therapy].
Topics: Antiviral Agents; Female; HIV Infections; Humans; Male; Protease Inhibitors; Zidovudine | 1995 |
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression.
Topics: Cross-Sectional Studies; Disease Progression; DNA, Circular; DNA, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Leukocytes, Mononuclear; Longitudinal Studies; Molecular Sequence Data; Polymerase Chain Reaction; Risk Factors; Virus Integration; Zidovudine | 1997 |
Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV-1 infection. HIV/GI Research Study Group.
Topics: Biopsy; Didanosine; Digestive System; Female; Giant Cells; HIV; HIV Enteropathy; HIV Infections; Humans; Male; Mutation; Phenotype; Prospective Studies; Stavudine; Viral Load; Zidovudine | 1997 |
The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
Topics: Anti-HIV Agents; Blotting, Northern; Cells, Cultured; DNA Replication; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Oligodeoxyribonucleotides, Antisense; Oligonucleotides, Antisense; RNA, Messenger; RNA, Viral; Thionucleotides; Transcription, Genetic; Virus Assembly; Virus Replication; Zidovudine | 1997 |
Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; DNA, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Twins; Viral Load; Zidovudine | 1997 |
Low infant infection rate halts study of perinatal HIV transmission.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV; HIV Infections; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1997 |
Decay characteristics of HIV-1-infected compartments during combination therapy.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Lamivudine; Leukocytes, Mononuclear; Macrophages; Mathematics; Models, Biological; Nelfinavir; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Sulfonic Acids; Viral Load; Viremia; Virus Latency; Zidovudine | 1997 |
Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients.
Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Aged; Area Under Curve; Chromatography, High Pressure Liquid; Half-Life; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1997 |
Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Male; Saquinavir; Thrombocytopenia; Zalcitabine; Zidovudine | 1997 |
[Therapy of HIV infection: combination drug therapy effective, immunotherapy still experimental].
Topics: Animals; Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; Humans; Immunotherapy; Interleukin-2; Stavudine; Zidovudine | 1997 |
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.
Topics: Base Sequence; Codon; Drug Resistance; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Retrospective Studies; Time Factors; Virus Replication; Zidovudine | 1997 |
Pregnancy and childbirth. Vancouver Conference Review.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cesarean Section; Choice Behavior; Counseling; Decision Making; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Labor, Obstetric; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Pregnancy; Pregnancy Complications, Infectious; Research; Spermatozoa; Zidovudine | 1997 |
New drugs--reports of new drugs recently approved by the FDA. Lamivudine.
Topics: Administration, Oral; Anti-HIV Agents; Area Under Curve; Biological Availability; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 1997 |
Thiadiazole derivatives: highly potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replications in vitro.
Topics: Anti-HIV Agents; Cells, Cultured; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Oligopeptides; Protein Binding; Reverse Transcriptase Inhibitors; Thiadiazoles; Zidovudine | 1997 |
Paediatric HIV infection.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antifungal Agents; Clotrimazole; HIV Infections; Humans; Infant, Newborn; Opportunistic Infections; Social Problems; Zidovudine | 1997 |
Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
Topics: Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; RNA, Viral; Stavudine; Viral Load; Viremia; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Ethics of AZT studies in poorer countries attacked.
Topics: Africa; Anti-HIV Agents; Bioethics; Caribbean Region; Control Groups; Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Thailand; Therapeutic Human Experimentation; Withholding Treatment; Zidovudine | 1997 |
Difference of virus populations in HIV carriers in relation to AZT treatment.
Topics: Anti-HIV Agents; Carrier State; DNA, Viral; Drug Resistance, Microbial; Follow-Up Studies; HIV Infections; HIV-1; Humans; RNA, Viral; Zidovudine | 1997 |
Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group.
Topics: Adolescent; Adult; Anti-HIV Agents; Base Sequence; Codon; DNA Mutational Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homosexuality, Male; Humans; Male; Molecular Sequence Data; Nevirapine; Pyridines; RNA, Viral; Sexual Partners; Zidovudine | 1997 |
[New therapeutic strategies in HIV infection].
Topics: Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Male; Pregnancy; Time Factors; Zidovudine | 1997 |
Obstetrics and gynecology.
Topics: Anti-HIV Agents; Calcium; Female; Fetal Blood; Genital Diseases, Female; Gynecology; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Obstetrics; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Zidovudine | 1997 |
Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland.
Topics: Abortion, Induced; Anti-HIV Agents; Breast Feeding; Cesarean Section; Delivery, Obstetric; Drug Utilization; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Ireland; Maternal Health Services; Pregnancy; Pregnancy Complications, Infectious; United Kingdom; Zidovudine | 1997 |
Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymph Nodes; Male; Polymerase Chain Reaction; RNA, Viral; Saquinavir; Viral Load; Viremia; Zidovudine | 1997 |
AZT blocks down-regulation of IL-2 and IFN-gamma gene expression in HIV acutely infected cells.
Topics: CD4-Positive T-Lymphocytes; Down-Regulation; HIV Infections; Humans; Interferon-gamma; Interleukin-2; RNA, Messenger; Zidovudine | 1997 |
[Revision of the brochure "Hygiene, Accident Prevention and First Aid" and "Recommendations for HIV-Post-Exposure Preventive Management].
Topics: Accidents, Occupational; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Pamphlets; Risk Factors; Zidovudine | 1997 |
Stable neurological function in subjects treated with 2'3'-dideoxyinosine.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Follow-Up Studies; HIV Infections; Humans; Neuropsychological Tests; Zidovudine | 1997 |
HIV-infected women: barriers to AZT use.
Topics: Adult; Anti-HIV Agents; Black or African American; Female; Health Knowledge, Attitudes, Practice; Hispanic or Latino; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Middle Aged; New York City; Patient Satisfaction; Pregnancy; Puerto Rico; Sampling Studies; Treatment Refusal; White People; Women's Health; Zidovudine | 1997 |
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.
Topics: Adult; Aged; Anti-HIV Agents; beta 2-Microglobulin; Biopterins; Didanosine; HIV Infections; HIV-1; Humans; Middle Aged; Neopterin; RNA, Viral; Viral Load; Zidovudine | 1997 |
Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; HIV; HIV Infections; HTLV-I Infections; Humans; Polymerase Chain Reaction; RNA, Viral; Viral Load; Zidovudine | 1997 |
Successful treatment of HIV-1-related, zidovudine resistant, thrombocytopenia with didanosine.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; HIV Infections; Humans; Male; Platelet Count; Thrombocytopenia; Zidovudine | 1997 |
Increased fidelity of drug-selected M184V mutated HIV-1 reverse transcriptase as the basis for the effectiveness of 3TC in HIV clinical trials.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Resistance, Microbial; Female; Genes, env; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1997 |
AIDS among children--United States, 1996. Division of HIV/AIDS Prevention, CDC.
Topics: Acquired Immunodeficiency Syndrome; Child; Child, Preschool; Female; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1997 |
A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.
Topics: Adenosine; Anti-HIV Agents; Cytidine; DNA; DNA, Viral; Drug Therapy, Combination; Guanosine; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Nelfinavir; Nucleic Acid Hybridization; RNA, Viral; Sulfonic Acids; Zidovudine | 1997 |
Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Therapy, Combination; Fas Ligand Protein; fas Receptor; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Lamivudine; Membrane Glycoproteins; Reverse Transcriptase Inhibitors; RNA, Messenger; T-Lymphocytes; Time Factors; Transcription, Genetic; Zalcitabine; Zidovudine | 1997 |
Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.
Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Female; Fetal Diseases; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk; Risk Assessment; Risk Factors; Therapeutic Human Experimentation; Women's Health; Zidovudine | 1997 |
Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996.
Topics: Anti-HIV Agents; Codon; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Time Factors; Zidovudine | 1997 |
Transmission of the human immunodeficiency virus and the hepatitis C virus.
Topics: Adult; Hepatitis C; HIV Infections; Humans; Male; Suicide, Attempted; Time Factors; Zidovudine | 1997 |
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.
Topics: Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; RNA, Viral; Zidovudine | 1997 |
Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study.
Topics: Adult; Anti-HIV Agents; Female; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; RNA, Viral; Zidovudine | 1997 |
Epidemiology of HIV/AIDS in women and children in the USA.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1997 |
Antiretroviral resistance and HIV vertical transmission.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Female; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry.
Topics: Abnormalities, Drug-Induced; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Registries; Teratogens; Zidovudine | 1997 |
Progress in prevention of perinatal HIV-1.
Topics: Anti-HIV Agents; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1997 |
Effects of HIV-1 on the surface expression of LFA-1 on cultured monocytes.
Topics: CD4 Antigens; Cells, Cultured; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Lymphocyte Function-Associated Antigen-1; Monocytes; Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA, Messenger; Up-Regulation; Zidovudine | 1997 |
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Anti-Infective Agents; Antidotes; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Leucovorin; Male; Middle Aged; Pyrimethamine; Spinal Puncture; Sulfadiazine; Time Factors; Toxoplasmosis, Cerebral; Zidovudine | 1997 |
CD8 T-cell response to antiretroviral therapy.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lymphocyte Count; T-Lymphocytes, Cytotoxic; Zidovudine | 1997 |
[Kidney colic under Indinavir [correction of indiavir] therapy in HIV infection].
Topics: Adult; Anti-HIV Agents; Colic; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Kidney Diseases; Zidovudine | 1997 |
Cure or control of HIV/AIDS?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1997 |
Time for action and education: women, HIV and babies.
Topics: Anti-HIV Agents; Female; Health Education; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; New Zealand; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
HIV case study.
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Male; Socioeconomic Factors; Zidovudine | 1997 |
Postexposure treatment of HIV.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Decision Support Techniques; HIV Infections; Humans; Needlestick Injuries; Zidovudine | 1997 |
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance, Microbial; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Male; Phenotype; RNA, Viral; Saquinavir; Time Factors; Zidovudine | 1997 |
Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.
Topics: Absorption; Adult; Anti-HIV Agents; Blood-Brain Barrier; Chromatography, High Pressure Liquid; HIV Infections; HIV-1; Humans; Infusions, Intravenous; Longitudinal Studies; Male; Middle Aged; Zidovudine | 1997 |
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.
Topics: Adult; Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Drug Interactions; HIV Infections; Humans; Male; Middle Aged; Time Factors; Zidovudine | 1997 |
Postexposure chemoprophylaxis for occupational exposure to HIV in the dental office.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Child; Dental Auxiliaries; Dentists; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; United States; United States Public Health Service; Universal Precautions; Zidovudine | 1997 |
Viral kinetics in HIV-1 perinatal infection.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Virus Replication; Zidovudine | 1997 |
Effect of subspecialty training and experience on agreement with HIV guidelines.
Topics: Anti-HIV Agents; Clinical Competence; HIV Infections; Humans; Medicine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Specialization; Surveys and Questionnaires; Zidovudine | 1997 |
Monitoring antiretroviral activity using ICDp24 and CD4 counts in HIV infection.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Zidovudine | 1997 |
Infection of human thymic dendritic cells with HIV-1 induces the release of a cytotoxic factor(s).
Topics: Anti-HIV Agents; Apoptosis; CD4-Positive T-Lymphocytes; Child; Cytotoxins; Dendritic Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Phytohemagglutinins; Thymus Gland; Zidovudine | 1997 |
Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity.
Topics: Animals; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Cell Differentiation; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Mice; Mice, SCID; Organ Culture Techniques; Thymus Gland; Zidovudine | 1997 |
Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymphoid Tissue; Male; RNA, Viral; Zidovudine | 1997 |
CD80 expression on monocytes in HIV-infected patients.
Topics: B7-1 Antigen; Female; HIV Infections; Humans; Male; Monocytes; Zidovudine | 1997 |
Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Control Groups; Developing Countries; Ethical Relativism; Ethics, Medical; Federal Government; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Therapeutic Human Experimentation; United States; United States Public Health Service; Zidovudine | 1997 |
[Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; RNA, Viral; Zidovudine | 1997 |
Breaking the mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Models, Biological; Nevirapine; Pyridines; Risk Factors; RNA, Viral; Substance Withdrawal Syndrome; Viral Load; Viremia; Zidovudine | 1997 |
Dynamics of HIV-1 viral load in pregnancy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Leukocytes, Mononuclear; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Proviruses; RNA, Viral; Viral Load; Zidovudine | 1997 |
[The management of the occupational exposures of health workers to HIV].
Topics: Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Health Personnel; HIV Infections; HIV-1; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Saquinavir; Zidovudine | 1997 |
Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.
Topics: Adult; Anti-HIV Agents; Case Management; Cohort Studies; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Neonatal Nursing; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Primary Health Care; Retrospective Studies; Risk Factors; Wisconsin; Zidovudine | 1997 |
Ethical complexities of conducting research in developing countries.
Topics: Beneficence; Clinical Trials as Topic; Control Groups; Developing Countries; Ethical Review; Ethics, Medical; Federal Government; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Internationality; Personal Autonomy; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Assessment; Therapeutic Human Experimentation; Zidovudine | 1997 |
Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
Topics: Anti-HIV Agents; Cell Line; Drug Interactions; Drug Synergism; Female; Gene Expression; Gene Products, tat; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Infectious Disease Transmission, Vertical; Macrophages; Monocytes; Placenta; Pregnancy; Progesterone; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1997 |
Mother to child transmission of HIV infection: the reality and the promise.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Delivery, Obstetric; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Zidovudine | 1997 |
Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
Topics: AIDS Serodiagnosis; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Treatment Outcome; Zidovudine | 1997 |
[New options in the management of HIV-infection].
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Saquinavir; Zidovudine | 1997 |
Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.
Topics: Animals; Antigens, CD; Antigens, CD34; Antiviral Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Flow Cytometry; Hematopoietic Stem Cells; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lymphocyte Depletion; Methylurea Compounds; Mice; Mice, SCID; Polymerase Chain Reaction; Proviruses; Pyridines; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Valine; Zidovudine | 1997 |
[AIDS; new developments. II. Treatment of HIV infection].
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Protease inhibitor therapy in children with perinatally acquired HIV infection.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Protease Inhibitors; Retrospective Studies; Ritonavir; Saquinavir; Stavudine; Zidovudine | 1997 |
Drug resistance mutations as predictors of phenotypic zidovudine resistance in HIV-1 infection.
Topics: Anti-HIV Agents; DNA, Viral; Drug Resistance; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Polymerase Chain Reaction; Viral Load; Zidovudine | 1997 |
Prophylaxis after HIV exposure.
Topics: Feces; HIV Infections; Humans; Occupational Exposure; Polymerase Chain Reaction; Predictive Value of Tests; Sputum; Zidovudine | 1997 |
Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1997 |
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Coculture Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Mutation; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Viremia; Virus Activation; Virus Latency; Virus Replication; Zidovudine | 1997 |
Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis.
Topics: Animals; Anti-HIV Agents; Carcinogens; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mice; National Institutes of Health (U.S.); Placenta; Pregnancy; Pregnancy Complications, Infectious; Risk; United States; Zidovudine | 1997 |
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
Topics: Analysis of Variance; Anti-HIV Agents; Blood-Borne Pathogens; Case-Control Studies; Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Logistic Models; Male; Needlestick Injuries; Occupational Diseases; Population Surveillance; Risk Factors; Wounds, Stab; Zidovudine | 1997 |
Postexposure treatment of HIV--taking some risks for safety's sake.
Topics: Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Retrospective Studies; Wounds, Stab; Zidovudine | 1997 |
Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: a potential model for autologous transplantations in HIV-infected newborns.
Topics: Antiviral Agents; Bone Marrow Cells; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Cytarabine; Drug Resistance; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; HIV Infections; Humans; Infant, Newborn; Interferon-alpha; Models, Biological; Phenanthrolines; Transplantation, Autologous; Zidovudine | 1997 |
[HIV-therapy: as early and as intensive as possible].
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome; Zidovudine | 1997 |
[Initial administration of a protease inhibitor delays the progression of AIDS by half time].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Disease Progression; HIV Infections; HIV Protease Inhibitors; Humans; Time Factors; Zalcitabine; Zidovudine | 1997 |
Viral phenotype, antiretroviral resistance and clinical evolution in human immunodeficiency virus-infected children.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Drug Resistance; Female; HIV; HIV Infections; Humans; Infant; Male; Mutation; Phenotype; Prospective Studies; Zidovudine | 1997 |
Update: perinatally acquired HIV/AIDS--United States, 1997.
Topics: Adult; Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1997 |
Ethics of HIV trials.
Topics: Controlled Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Zidovudine | 1997 |
Trial to reduce vertical transmission of HIV-1 on schedule in Uganda.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Uganda; Zidovudine | 1997 |
Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection.
Topics: Adult; Age Factors; Anti-HIV Agents; Antigens, CD; Female; HIV Infections; HIV-1; Humans; Immunophenotyping; Infant; Infant, Newborn; Infant, Newborn, Diseases; Lymphocyte Count; Lymphocyte Subsets; Pregnancy; Prospective Studies; Zidovudine | 1997 |
First combination drug for patients with HIV.
Topics: Anti-HIV Agents; Drug Combinations; HIV Infections; Humans; Lamivudine; Zidovudine | 1997 |
Drugs for HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Prevention of vertical HIV transmission with zidovudine: projected impact of HIV testing and prenatal care.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Zidovudine | 1997 |
[Frequency and characteristics of patients treated with zidovudine and absence of progression of HIV infection].
Topics: Adult; Anti-HIV Agents; Disease Progression; Female; HIV Infections; Humans; Male; Zidovudine | 1997 |
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
Topics: Animals; Anti-HIV Agents; CD4 Lymphocyte Count; Cell Fusion; Didanosine; Giant Cells; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mice; Ritonavir; RNA, Viral; Zidovudine | 1997 |
Bangkok study adds fuel to AIDS ethics debate.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Ethics, Medical; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Thailand; Zidovudine | 1997 |
Advanced HIV infection treated with zidovudine monotherapy: lifetime values of absolute cost-effectiveness as a pharmacoeconomic reference for future studies evaluating antiretroviral combination treatments. The Osservatorio SIFO sui Farmaci.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; HIV Infections; Humans; Research Design; Saquinavir; Survival Analysis; Zalcitabine; Zidovudine | 1997 |
Ethical considerations of clinical trials to prevent vertical transmission of HIV in developing countries.
Topics: Anti-HIV Agents; Bioethics; Clinical Trials as Topic; Developing Countries; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Personal Autonomy; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Research Subjects; Zidovudine | 1998 |
[Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
Topics: Adult; Anti-HIV Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; HIV Infections; Humans; Muscular Diseases; Zidovudine | 1997 |
A controlled trial of double versus triple therapy for HIV.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Stavudine; Zidovudine | 1998 |
U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies.
Topics: Animals; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Mice; Mice, SCID; Models, Biological; Transplantation, Heterologous; Tumor Cells, Cultured; Zidovudine | 1997 |
Indinavir urinary stones as origin of upper urinary tract obstruction.
Topics: Aged; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Ureteral Calculi; Ureteral Obstruction; Zidovudine | 1997 |
Bioethics and local circumstances.
Topics: Africa; AIDS Vaccines; Anti-HIV Agents; Bioethics; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; Guidelines as Topic; HIV Infections; Humans; Internationality; Pregnant Women; Research; Social Control, Formal; Zidovudine | 1998 |
Relationship between CD4 count and CD4% in HIV-infected people.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Risk Factors; Sex Factors; United Kingdom; Zidovudine | 1997 |
Ethics of HIV trials.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Developing Countries; Ethical Relativism; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Internationality; Pregnancy; Pregnant Women; Research Design; Zidovudine | 1998 |
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Monitoring; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1998 |
Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C.
Topics: Adult; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon Type I; Male; Middle Aged; Virus Replication; Zidovudine | 1997 |
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
Topics: Anti-HIV Agents; Cell Line, Transformed; Cells, Cultured; Didanosine; Foscarnet; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Zidovudine | 1998 |
thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
Topics: Animals; Anti-HIV Agents; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Fetal Tissue Transplantation; Flow Cytometry; HIV Infections; HIV-1; Lamivudine; Leukocytes, Mononuclear; Liver Transplantation; Mice; Mice, SCID; Recurrence; Ritonavir; RNA, Viral; Saquinavir; Thymus Gland; Viremia; Zidovudine | 1998 |
Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.
Topics: Anti-HIV Agents; Codon; Didanosine; Drug Resistance, Microbial; Genes, pol; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Oligonucleotide Probes; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, DNA; Zidovudine | 1998 |
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.
Topics: Abortion, Induced; Abortion, Spontaneous; Anti-HIV Agents; Cesarean Section; Child, Preschool; Delivery, Obstetric; Female; Fetal Monitoring; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Obstetrical Forceps; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Switzerland; Vacuum Extraction, Obstetrical; Zidovudine | 1998 |
Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Polymerase Chain Reaction; Treatment Outcome; Zidovudine | 1998 |
Occupational HIV transmission by an internal fixation wire of the patella.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Internal Fixators; Nurses; Occupational Diseases; Patella; Zidovudine | 1998 |
Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Health Behavior; Health Care Costs; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Paediatric AIDS--is now not the right time to act?
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status.
Topics: Africa; Anti-HIV Agents; Awareness; Cohort Studies; Female; Health Care Surveys; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; London; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Retrospective Studies; Zidovudine | 1998 |
Radioimmunoassay for monitoring zidovudine in dried blood spot specimens.
Topics: Adult; Female; HIV Infections; Humans; Iodine Radioisotopes; Male; Radioimmunoassay; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; United States; United States Public Health Service; Zidovudine | 1998 |
Human immunodeficiency virus (HIV) infection in older people: a case report.
Topics: Aged; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Sexual Behavior; Substance Abuse, Intravenous; Zidovudine | 1998 |
[Antiviral therapy of HIV infection. A practice-based presentation 1997/1998].
Topics: Antiviral Agents; HIV Infections; Humans; Patient Compliance; Prognosis; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons.
Topics: Adult; Age Factors; AIDS Dementia Complex; Anti-HIV Agents; Blood Transfusion; Ethnicity; Female; Heterosexuality; HIV Infections; Homosexuality, Male; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Probability; Racial Groups; Risk Assessment; Risk Factors; Sex Factors; Substance Abuse, Intravenous; Survival Analysis; Time Factors; United States; Zidovudine | 1998 |
Complement-mediated cytolysis and azidothymidine are synergistic in HIV-1 suppression.
Topics: Anti-HIV Agents; Complement Hemolytic Activity Assay; Complement System Proteins; Cytotoxicity, Immunologic; Drug Synergism; HIV Infections; HIV-1; Humans; Immunoglobulin M; Virion; Zidovudine | 1998 |
Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
Topics: Anti-HIV Agents; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; DNA, Viral; HIV Infections; HIV-1; Humans; Interferon-alpha; Interleukin-8; Macrophage Inflammatory Proteins; Macrophages; Polymerase Chain Reaction; Proviruses; Species Specificity; Virus Replication; Zidovudine | 1998 |
HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Codon; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Male; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1998 |
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Dideoxynucleosides; Disease Progression; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Stavudine; Survival Analysis; Zalcitabine; Zidovudine | 1998 |
Ethical issues in studies in Thailand of the vertical transmission of HIV.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Control Groups; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Internationality; Nontherapeutic Human Experimentation; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Resource Allocation; Thailand; Therapeutic Human Experimentation; Withholding Treatment; Zidovudine | 1998 |
Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients.
Topics: Anti-HIV Agents; Cohort Studies; Cost Savings; Costs and Cost Analysis; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Prospective Studies; Zalcitabine; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Cote d'Ivoire; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Control Groups; Developing Countries; Ethical Relativism; Ethics Committees, Research; Ethics, Medical; Federal Government; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Internationality; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Assessment; Therapeutic Human Experimentation; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Uganda; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developed Countries; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
Studies in Thailand of the vertical transmission of HIV.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nontherapeutic Human Experimentation; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Thailand; Therapeutic Human Experimentation; Zidovudine | 1998 |
Studies in Thailand of the vertical transmission of HIV.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
Controversial trial offers hopeful result.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Costs and Cost Analysis; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Internationality; Placebos; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Thailand; Therapeutic Human Experimentation; Zidovudine | 1998 |
HIV vaccine trials.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Placebos; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Zidovudine | 1998 |
Uveitis associated with human immunodeficiency virus infection.
Topics: Adult; Anti-HIV Agents; Aqueous Humor; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Eye Infections, Viral; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Practice Guidelines as Topic; Uveitis, Anterior; Uveitis, Posterior; Vitreous Body; Zidovudine | 1998 |
Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus.
Topics: Acyclovir; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chronic Disease; Fundus Oculi; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Retinal Diseases; Syndrome; Uveitis; Visual Acuity; Zidovudine | 1998 |
Glaxo cuts HIV drug cost for developing world.
Topics: Anti-HIV Agents; Costs and Cost Analysis; Developing Countries; Drug Industry; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Prevalence; Risk; Risk Factors; Zidovudine | 1998 |
Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
Topics: Anti-HIV Agents; Delivery, Obstetric; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Treatment Outcome; Zidovudine | 1998 |
Ethics and international research. Comparison of short and long zidovudine regimens is appropriate.
Topics: Anti-HIV Agents; Controlled Clinical Trials as Topic; Female; HIV Infections; Humans; Pregnancy; Thailand; Zidovudine | 1998 |
Ethics and international research. Zidovudine is too expensive for developing countries.
Topics: Anti-HIV Agents; Developing Countries; Drug Costs; Ethics, Medical; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Zidovudine | 1998 |
HIV testing of pregnant women: a policy analysis.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Counseling; Female; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious; Privacy; Social Justice; United States; Women's Rights; Zidovudine | 1997 |
Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Codon; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Mutation; Polymerase Chain Reaction; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Zidovudine | 1998 |
Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Zidovudine | 1998 |
Short course of zidovudine cuts transmission of HIV.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Drug Costs; Female; HIV Infections; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; DNA, Circular; DNA, Viral; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; RNA, Viral; Viremia; Zidovudine | 1998 |
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Male; Military Personnel; Proportional Hazards Models; Time Factors; United States; Zidovudine | 1998 |
[HIV therapy: concepts for today and tomorrow].
Topics: Anti-HIV Agents; Drug Therapy, Combination; Forecasting; HIV Infections; Humans; Protease Inhibitors; Zidovudine | 1996 |
Antiretrovirals during pregnancy in HIV-1-positive women in New York City.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; New York City; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
[Zidovudine-resistant HIV strains in untreated intravenous drug users and homosexual men in Amsterdam infected in 1996].
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV; HIV Infections; Homosexuality, Male; Humans; Male; Substance Abuse, Intravenous; Zidovudine | 1997 |
[Death and HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Attitude to Death; Attitude to Health; Family Health; Family Relations; HIV Infections; HIV Protease Inhibitors; Humans; Patient Care Planning; Patient Care Team; Suicide, Assisted; Zidovudine | 1998 |
A decision analysis of mandatory compared with voluntary HIV testing in pregnant women.
Topics: Anti-HIV Agents; Decision Trees; Female; Health Policy; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mandatory Testing; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prenatal Care; Prevalence; Risk Assessment; Sensitivity and Specificity; United States; Voluntary Programs; Zidovudine | 1998 |
Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies.
Topics: Abortion, Spontaneous; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Female; Follow-Up Studies; Gestational Age; HIV Infections; Humans; Infant, Premature; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Survival Rate; Switzerland; Time Factors; Zidovudine | 1998 |
[Combined antiretroviral therapy for prevention of vertical HIV-1 transmission].
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Drug shows potency against HIV.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Zidovudine | 1996 |
[Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; HIV Infections; HIV-1; Humans; Pneumonia, Pneumocystis; Zidovudine | 1998 |
[Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; HIV Infections; Humans; Male; Mitochondria, Liver; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Middle Aged; Prospective Studies; Receptors, Antigen, T-Cell, alpha-beta; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Zidovudine | 1998 |
Intestinal malabsorption and zidovudine bioavailability.
Topics: Administration, Oral; Anti-HIV Agents; Biological Availability; Child; Child, Preschool; HIV Infections; Humans; Intestinal Absorption; Malabsorption Syndromes; Zidovudine | 1998 |
HIV-2 in pregnancy: to treat or not to treat?
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-2; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion.
Topics: Adult; Anti-HIV Agents; CD4-CD8 Ratio; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Zidovudine | 1998 |
[Glaxo reduces the price for Retrovir in developing countries. Program to stem further spread of HIV].
Topics: Developing Countries; Drug Costs; Drug Industry; HIV Infections; Humans; Zidovudine | 1998 |
Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.
Topics: Adenoids; Adult; Anti-HIV Agents; CD4-CD8 Ratio; Dendritic Cells; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lymph Nodes; Male; Middle Aged; Palatine Tonsil; Proviruses; Reverse Transcriptase Inhibitors; Viral Load; Virus Replication; Zidovudine | 1998 |
Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Didanosine; Dideoxynucleosides; Disease Progression; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1998 |
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure.
Topics: Anti-HIV Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Failure; Zidovudine | 1998 |
Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
Topics: Adult; Anti-HIV Agents; Codon; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymph Nodes; Male; Point Mutation; Proviruses; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Profound anemia in a newborn infant of a mother receiving antiretroviral therapy.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Leukocyte Count; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zalcitabine; Zidovudine | 1998 |
Altered bleeding time associated with ibuprofen and zidovudine use.
Topics: Adult; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Coagulation Disorders; Heroin Dependence; HIV Infections; Humans; Ibuprofen; Male; Varicose Ulcer; Zidovudine | 1998 |
Induction-maintenance antiretroviral therapy: proof of concept.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
Topics: Anti-HIV Agents; Cohort Studies; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Methionine; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Valine; Zalcitabine; Zidovudine | 1998 |
Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease.
Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 1998 |
Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy.
Topics: Adult; Anti-HIV Agents; Codon; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Virus Latency; Zidovudine | 1998 |
HIV, maternal anemia and perinatal intervention using zidovudine. DITRAME Study Group (ANRS 049 Clinical Trial).
Topics: Adult; Anemia; Anti-HIV Agents; Burkina Faso; Cross-Sectional Studies; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prevalence; Zidovudine | 1998 |
The case for rapid HIV testing during labor.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Zidovudine | 1998 |
Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
PHS report addresses antiretroviral drug use during pregnancy.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; United States; United States Public Health Service; Zidovudine | 1998 |
Nonparametric estimation of covariance structure in longitudinal data.
Topics: Anti-HIV Agents; Bisexuality; Blood Pressure; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Infant, Newborn; Infant, Premature; Longitudinal Studies; Male; Models, Statistical; Multicenter Studies as Topic; Reproducibility of Results; Statistics, Nonparametric; Zidovudine | 1998 |
A mixed model for repeated dilution assays.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Models, Statistical; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reproducibility of Results; Viral Load; Zalcitabine; Zidovudine | 1998 |
[Resistance of human immunodeficiency virus (HIV) to zidovudine. Genotypic analysis in strains isolated from Chilean patients].
Topics: Anti-HIV Agents; Chile; Codon; Drug Resistance; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Mutation; Prospective Studies; Zidovudine | 1998 |
Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa.
Topics: Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; HIV Infections; HIV Seroprevalence; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 1998 |
Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.
Topics: Anti-HIV Agents; Follow-Up Studies; HIV; HIV Infections; Humans; Proviruses; RNA, Viral; Virus Replication; Zidovudine | 1998 |
[HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viremia; Zidovudine | 1998 |
Comment: cost-effective pharmaceutical care for HIV disease.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Therapy, Combination; HIV Infections; Humans; Zidovudine | 1998 |
Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viral Load; Zidovudine | 1998 |
Cost-effectiveness of zidovudine to prevent mother-to-child transmission of HIV in sub-Saharan Africa.
Topics: Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; Cost-Benefit Analysis; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
Topics: Anti-HIV Agents; Cesarean Section; Delivery, Obstetric; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Zidovudine | 1998 |
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Prevalence; Reverse Transcriptase Inhibitors; Spain; Zalcitabine; Zidovudine | 1998 |
Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Retrospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; HIV Infections; Humans; Indinavir; Lamivudine; Occupational Exposure; United States; Zidovudine | 1998 |
Trends in zidovudine prescription for pregnant women infected with HIV.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Utilization; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1998 |
Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Oligonucleotides; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, DNA; Zidovudine | 1998 |
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Virus Integration; Virus Latency; Virus Replication; Zidovudine | 1998 |
Parkinsonism with HIV infection.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antipsychotic Agents; Benztropine; Drug Therapy, Combination; HIV Infections; Homosexuality, Male; Humans; Male; Neurologic Examination; Parkinson Disease, Secondary; Risk Factors; Zidovudine | 1998 |
Transient dissociation between infectious HIV-1 titer and viral RNA during the early phase of AZT treatment.
Topics: Adult; Anti-HIV Agents; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Prospective Studies; RNA, Viral; Time Factors; Viremia; Zidovudine | 1998 |
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.
Topics: Adult; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cesarean Section; Cohort Studies; Didanosine; Europe; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prospective Studies; Risk Factors; Zidovudine | 1998 |
A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity.
Topics: Anti-HIV Agents; CD4-CD8 Ratio; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Models, Theoretical; Nelfinavir; Zidovudine | 1997 |
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.
Topics: Acquired Immunodeficiency Syndrome; Age of Onset; Anti-HIV Agents; Child; Child, Preschool; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Longitudinal Studies; Prognosis; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1998 |
Preventing perinatal HIV transmission--does the end justify the means?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; South Africa; Zidovudine | 1998 |
Preventing perinatal HIV transmission--does the end justify the means?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Placebos; South Africa; Zidovudine | 1998 |
Do nucleoside analogues directly influence T-lymphocyte subset counts? The pediatric model.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Infant, Newborn; Lymphocyte Count; T-Lymphocyte Subsets; Zidovudine | 1998 |
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.
Topics: Anti-HIV Agents; Codon; Didanosine; DNA Probes; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Zalcitabine; Zidovudine | 1998 |
Perinatal transmission of HIV in women receiving zidovudine: abstract and commentary.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Zidovudine | 1998 |
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Virus Replication; Zidovudine | 1998 |
Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunophenotyping; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1998 |
Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Delavirdine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine | 1998 |
Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness.
Topics: Anti-HIV Agents; Cesarean Section; Cost-Benefit Analysis; Female; Health Care Costs; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Public Health; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Rebound of plasma HIV viral load following prolonged suppression with combination therapy.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Male; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Viral Load; Zidovudine | 1998 |
Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
Topics: Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Proportional Hazards Models; Time Factors; Treatment Outcome; Zidovudine | 1998 |
Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
Topics: Anti-HIV Agents; Blood-Borne Pathogens; Dental Staff; Dentistry; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Mandatory Reporting; Occupational Exposure; Risk Factors; Risk Management; Surveys and Questionnaires; Zidovudine | 1998 |
Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Forensic Medicine; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Occupational Exposure; Zidovudine | 1998 |
Visceral leishmaniasis: a lingual presentation in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimony; Antiprotozoal Agents; Didanosine; HIV Infections; Humans; Laryngitis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Tongue Diseases; Zidovudine | 1998 |
Anemia and survival in HIV infection.
Topics: Adult; Anemia; Anti-HIV Agents; Anti-Infective Agents; Blood Transfusion; Erythropoietin; Female; Ganciclovir; Hemoglobins; HIV Infections; Humans; Incidence; Longitudinal Studies; Male; Prognosis; Proportional Hazards Models; Risk Factors; Survival Analysis; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1998 |
[Antiproteases in every shape].
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Zidovudine | 1997 |
Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV--Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Female; Guideline Adherence; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Louisiana; Michigan; New Jersey; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; South Carolina; Zidovudine | 1998 |
Experts plan strategy to tackle mother-to-child HIV-1 transmission.
Topics: Adult; Anti-HIV Agents; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary.
Topics: Anti-HIV Agents; Blood-Brain Barrier; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Zidovudine | 1998 |
Decrease in thymidylate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals.
Topics: Cell Cycle; Deoxycytidine Kinase; Enzyme Stability; HIV Infections; Humans; Leukocytes, Mononuclear; Nucleoside-Phosphate Kinase; Phosphorylation; Zidovudine | 1998 |
Deconstructing equity, autonomy, and ethical analysis.
Topics: Anti-HIV Agents; Control Groups; Cultural Diversity; Developing Countries; Dose-Response Relationship, Drug; Ethical Analysis; Ethics, Clinical; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Mentally Ill Persons; Paternalism; Personal Autonomy; Persons; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Randomized Controlled Trials as Topic; Resource Allocation; Siblings; Social Values; Treatment Outcome; Vulnerable Populations; Zidovudine | 1998 |
The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries.
Topics: Anti-HIV Agents; Beneficence; Comprehension; Control Groups; Developing Countries; Dose-Response Relationship, Drug; Ethical Analysis; Ethical Relativism; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Internationality; Personal Autonomy; Persons; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Randomized Controlled Trials as Topic; Research Subjects; Risk Assessment; Social Justice; Treatment Outcome; Vulnerable Populations; Zidovudine | 1998 |
The "best proven therapeutic method" standard in clinical trials in technologically developing countries.
Topics: Anti-HIV Agents; Developing Countries; Dose-Response Relationship, Drug; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 1998 |
Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions?
Topics: Anti-HIV Agents; Developing Countries; Drug Costs; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; United Nations; World Health Organization; Zidovudine | 1998 |
Clozapine treatment of HIV-associated psychosis--too much bone marrow toxicity?
Topics: Adult; Anti-HIV Agents; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Male; Neutropenia; Psychotic Disorders; Zidovudine | 1998 |
The sequential occurrence of pol 215 and pol 41 zidovudine resistance mutations is associated in an additive fashion with low CD4 cell counts and high plasma and cellular HIV viral load.
Topics: Adult; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Cross-Sectional Studies; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Longitudinal Studies; Male; Mutation; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 1998 |
Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
Topics: Animals; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Rabbits; Radioimmunoassay; Zidovudine | 1998 |
Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.
Topics: Adult; Anti-HIV Agents; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Taste and smell complaints in HIV-infected patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Clarithromycin; Didanosine; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Quality of Life; Ritonavir; Smell; Surveys and Questionnaires; Taste; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1998 |
Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; HIV Seroprevalence; Humans; Pregnancy; Pregnancy Complications, Infectious; Public Health Practice; Rural Health; South Africa; Zidovudine | 1998 |
Comparison of zidovudine phosphorylation in lymph nodes and peripheral blood mononuclear cells in HIV-infected patients. DATRI 012 Study Group.
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Lymph Nodes; Middle Aged; Monocytes; Phosphorylation; Zidovudine | 1998 |
[AIDS drug in the correct form].
Topics: Anti-HIV Agents; HIV; HIV Infections; Humans; Molecular Conformation; National Institutes of Health (U.S.); Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; United States; Zidovudine | 1998 |
[Failure of anti-pneumococcal vaccination in a splenectomized patient with HIV infection].
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Humans; Immunosuppression Therapy; Pneumococcal Infections; Splenectomy; Treatment Failure; Vaccination; Zidovudine | 1998 |
Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices.
Topics: Anti-HIV Agents; Attitude to Health; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Reverse Transcriptase Inhibitors; Risk Factors; Sexual Behavior; Sexual Partners; Sexually Transmitted Diseases, Viral; Surveys and Questionnaires; Viral Load; Zidovudine | 1998 |
Resting energy expenditure and body composition in children with HIV infection.
Topics: Adipose Tissue; Anthropometry; Anti-HIV Agents; Arm; Body Composition; Body Water; Child; Child Development; Child, Preschool; Didanosine; Energy Intake; Energy Metabolism; Female; Growth Disorders; HIV Infections; Humans; Male; Muscle Development; Muscle, Skeletal; Skinfold Thickness; Zidovudine | 1998 |
Zidovudine and confusion in urinary metabolic screening.
Topics: Anti-HIV Agents; Diagnosis, Differential; Gas Chromatography-Mass Spectrometry; HIV Infections; Humans; Infant, Newborn; Metabolism, Inborn Errors; Neonatal Screening; Predictive Value of Tests; Zidovudine | 1998 |
Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients.
Topics: Adult; Anti-HIV Agents; Antigens, CD34; CD4 Lymphocyte Count; Hematopoietic Stem Cells; HIV Infections; Humans; Leukocyte Common Antigens; Leukocyte Count; Middle Aged; T-Lymphocytes; Viral Load; Zidovudine | 1998 |
[New trends in HIV].
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lipodystrophy; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
[Vertical transmission: healthy children--a new UNAIDS initiative].
Topics: Anti-HIV Agents; Developing Countries; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Switzerland; United Nations; Zidovudine | 1998 |
Cost of preventing HIV infection after sexual exposure.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Indinavir; Lamivudine; Male; Models, Theoretical; Reproducibility of Results; Sexual Behavior; Zidovudine | 1998 |
Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected children.
Topics: Anemia; Anti-HIV Agents; Bahamas; Canada; Child; Child, Preschool; Cross-Sectional Studies; Erythropoietin; Female; Hemoglobins; HIV Infections; Humans; Infant; Male; Renal Insufficiency; Zidovudine | 1998 |
Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.
Topics: Adult; Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Acute generalized exanthematous pustulosis: a cutaneous adverse effect due to prophylactic antiviral therapy with protease inhibitor.
Topics: Acute Disease; Adult; Anti-HIV Agents; Diagnosis, Differential; Drug Eruptions; Exanthema; HIV Infections; Humans; Lamivudine; Male; Protease Inhibitors; Skin Diseases, Vesiculobullous; Zidovudine | 1998 |
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine.
Topics: Anti-HIV Agents; Child; Child, Preschool; Codon; Cohort Studies; Disease Progression; Female; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Male; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 1998 |
[Perinatal HIV transmission prophylaxis in the Liege region].
Topics: Anti-HIV Agents; Belgium; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Pregnancy; Retrospective Studies; Urban Health; Zidovudine | 1998 |
Carbamazepine and psoriasis.
Topics: Adjuvants, Immunologic; Anti-HIV Agents; Carbamazepine; Dermatitis, Exfoliative; Dermatologic Agents; HIV Infections; Humans; Psoriasis; Zidovudine | 1998 |
Short (and shorter) courses of zidovudine.
Topics: Anti-HIV Agents; Clinical Protocols; Drug Administration Schedule; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Internationality; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Therapeutic Human Experimentation; Zidovudine | 1998 |
High incidence of nevirapine-associated rash in HIV-infected Chinese.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; China; Didanosine; Drug Eruptions; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1998 |
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.
Topics: Amino Acid Sequence; Anti-HIV Agents; Base Sequence; Cells, Cultured; Didanosine; Drug Resistance, Multiple; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis, Site-Directed; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1998 |
A Markov mixed effect regression model for drug compliance.
Topics: Anti-HIV Agents; Drug Therapy; HIV Infections; Humans; Markov Chains; Models, Statistical; Patient Compliance; Zidovudine | 1998 |
Prevention of perinatal transmission of HIV in Arkansas.
Topics: Anti-HIV Agents; Arkansas; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Medication adherence strategies for drug abusers with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Patient Compliance; Pharmaceutical Services; Professional-Patient Relations; San Francisco; Social Support; Zidovudine | 1998 |
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; Biomarkers; Female; HIV Infections; HLA-DR Antigens; Humans; Lamivudine; Leukocyte Common Antigens; Lymphocyte Activation; Lymphocyte Count; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Prospective Studies; Ritonavir; RNA, Viral; T-Lymphocytes; Viral Load; Zidovudine | 1998 |
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
Topics: Analysis of Variance; Anti-HIV Agents; Data Interpretation, Statistical; Didanosine; HIV Infections; HIV-1; Humans; Nevirapine; RNA, Viral; Statistics, Nonparametric; Time Factors; Viral Load; Zidovudine | 1998 |
Phase III results of second-generation HIV protease inhibitor reported.
Topics: Anti-HIV Agents; Carbamates; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Sulfonamides; Viral Load; Zidovudine | 1998 |
[Current treatment of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Zidovudine | 1998 |
Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prognosis; Risk Factors; Time Factors; Zidovudine | 1999 |
Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Health Personnel; HIV Infections; Humans; Italy; Occupational Exposure; Registries; Retrospective Studies; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1997 |
Zidovudine treatment prevents vertical transmission of human immunodeficiency virus-1 independently of viral load.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Zidovudine | 1998 |
The inter-relation of maternal immune competence, HIV-1 viral load, and nutritional status in preventing vertical transmission: an alternative to chemoprophylaxis?
Topics: Anti-HIV Agents; Antioxidants; Female; HIV Infections; HIV-1; Humans; Immunocompetence; Infectious Disease Transmission, Vertical; Nutritional Status; Pregnancy; Pregnancy Complications, Infectious; Vagina; Viral Load; Zidovudine | 1998 |
[Observing in HIV infections].
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Patient Compliance; Physician-Patient Relations; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1998 |
Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
Topics: Administration, Oral; Amniotic Fluid; Animals; Anti-HIV Agents; Area Under Curve; Disease Models, Animal; Female; Fetal Blood; Fetus; Half-Life; HIV Infections; Infectious Disease Transmission, Vertical; Papio; Pregnancy; Pregnancy, Animal; Zidovudine | 1998 |
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cohort Studies; Cytomegalovirus; Female; Gestational Age; Herpesviridae Infections; Herpesvirus 4, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Oropharynx; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Urine; Uterine Hemorrhage; Virus Shedding; Zidovudine | 1998 |
Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.
Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; Base Sequence; CD4 Lymphocyte Count; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; Genotype; Half-Life; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Longitudinal Studies; Male; Molecular Sequence Data; Mutation; Retrospective Studies; RNA, Viral; Zidovudine | 1998 |
US scientists may boycott AIDS congress.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Congresses as Topic; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Public Policy; Research Personnel; Reverse Transcriptase Inhibitors; South Africa; United States; Zidovudine | 1998 |
Should research ethics change at the border?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethical Relativism; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Research Design; Zidovudine | 1998 |
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine | 1998 |
Selective vertical transmission of HIV-1 antiretroviral resistance mutations.
Topics: Anti-HIV Agents; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Report updates recommendations for health workers exposed to HIV.
Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; Health Personnel; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Occupational Exposure; Practice Guidelines as Topic; United States; United States Public Health Service; Zidovudine | 1998 |
Perinatal transmission--successful interventions. Where do we go from here?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Thailand; Zidovudine | 1998 |
On World AIDS Day, a shadow looms over southern Africa.
Topics: Acquired Immunodeficiency Syndrome; Africa South of the Sahara; Anti-HIV Agents; Cost-Benefit Analysis; Disease Outbreaks; Female; Global Health; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Zidovudine | 1998 |
Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-2; Humans; Indinavir; Lamivudine; Male; Proviruses; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
[Benign symmetrical lipomatosis ("peripheral lipodystrophy") during antiretroviral therapy of HIV infection].
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Hemophilia A; HIV Infections; Humans; Indinavir; Lipomatosis, Multiple Symmetrical; Male; Zalcitabine; Zidovudine | 1998 |
A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Analysis of Variance; Anti-HIV Agents; Biometry; Breast Neoplasms; Computer Simulation; Drug Resistance, Microbial; Female; Hemophilia A; HIV Infections; Humans; Likelihood Functions; Markov Chains; Monte Carlo Method; Proportional Hazards Models; Transfusion Reaction; Zidovudine | 1998 |
South Africa: setting the wrong example.
Topics: Anti-HIV Agents; Female; Health Policy; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 1999 |
Sexually transmitted diseases and HIV. A female perspective.
Topics: Anti-HIV Agents; Epidemiologic Factors; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Infertility, Female; Male; Pelvic Pain; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Ectopic; Sexually Transmitted Diseases, Viral; Uterine Cervical Neoplasms; Women's Health; Zidovudine | 1998 |
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Zidovudine | 1999 |
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Randomized Controlled Trials as Topic; Viral Load; Zidovudine | 1999 |
Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Didanosine; Drug Therapy, Combination; Enzyme Induction; HIV Infections; HIV-1; Humans; Lymphoid Tissue; Reverse Transcriptase Inhibitors; Telomerase; Telomere; Up-Regulation; Zalcitabine; Zidovudine | 1999 |
Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS.
Topics: Acute Disease; Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hypertriglyceridemia; Male; Pancreatitis; Reverse Transcriptase Inhibitors; Ritonavir; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1998 |
Huge percentage of women volunteer for zidovudine project.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; South Africa; Voluntary Programs; Zidovudine | 1999 |
[Clinical case of the month. Apropos of pancytopenia in a seropositive patient].
Topics: Adult; Anemia, Aplastic; Anti-HIV Agents; Bone Marrow; HIV Infections; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Male; Pancytopenia; Stavudine; Zidovudine | 1998 |
Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; Humans; Injections, Subcutaneous; Interleukin-2; Leukocyte Common Antigens; Male; Pilot Projects; Receptors, Interleukin-2; Zidovudine | 1999 |
Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Erythrocyte Transfusion; HIV Infections; Humans; Immunoglobulins, Intravenous; Lamivudine; Male; Parvoviridae Infections; Parvovirus B19, Human; Red-Cell Aplasia, Pure; Remission Induction; Ritonavir; Saquinavir; Zidovudine | 1999 |
A model of primary HIV-1 infection.
Topics: Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Progression; Flow Cytometry; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunologic Memory; Middle Aged; Models, Immunological; RNA, Viral; Viral Load; Zidovudine | 1998 |
Recommendations for occupational exposures to HIV.
Topics: Anti-HIV Agents; Chemoprevention; Drug Monitoring; Follow-Up Studies; Health Personnel; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; Viral Load; Zidovudine | 1999 |
Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children.
Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Resistance; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; Phenotype; Zidovudine | 1999 |
[Jaundice with free bilirubin following preventive anti-retroviral therapy after sexual aggression].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Bilirubin; Female; HIV Infections; Humans; Indinavir; Jaundice; Rape; Retroviridae Infections; Zidovudine | 1999 |
Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study.
Topics: Amino Acid Substitution; Anti-HIV Agents; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Switzerland; Zidovudine | 1999 |
Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type-1 infection.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Syphilis; Zidovudine | 1998 |
Estimating the proportion of treatment effect explained by a surrogate marker.
Topics: Biomarkers; CD4 Lymphocyte Count; HIV Infections; Humans; Treatment Outcome; Zidovudine | 1999 |
Short course antiretroviral regimens to reduce maternal transmission of HIV.
Topics: Africa; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
An asymptomatic 41-year-old man with HIV infection.
Topics: Adaptation, Psychological; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Decision Making; Disease Progression; HIV Infections; Humans; Male; Viral Load; Zidovudine | 1999 |
Oral manifestations of HIV infection in a group of predominantly ethnic Chinese.
Topics: Adult; Age Factors; Asian People; Candidiasis, Oral; CD4 Lymphocyte Count; China; HIV Infections; Homosexuality, Male; Hong Kong; Humans; Leukoplakia, Hairy; Linear Models; Logistic Models; Male; Middle Aged; Mouth Diseases; Oral Ulcer; Risk Factors; Stomatitis, Herpetic; Xerostomia; Zidovudine | 1999 |
The costing of HIV/AIDS--without a clue?
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Female; Health Care Costs; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 1999 |
Cheap treatment cuts HIV transmission.
Topics: Africa; Anti-HIV Agents; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Lamivudine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
South Africa stands firm on AIDS drug...
Topics: Female; Financing, Government; Health Care Costs; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
Synthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents.
Topics: Anti-HIV Agents; Contraceptive Devices, Female; Dideoxynucleotides; Female; HIV; HIV Infections; Humans; Male; Nonoxynol; Organophosphorus Compounds; Spermatocidal Agents; Spermatozoa; Virus Replication; Zidovudine | 1999 |
Pharmacokinetics of azidothymidine and its major metabolite glucuronylazidothymidine in hemophiliacs coinfected with human immunodeficiency virus and chronic hepatitis C.
Topics: Adult; Anti-HIV Agents; Glucuronates; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Middle Aged; Zidovudine | 1998 |
To AZT or not to AZT.
Topics: Emergency Medical Technicians; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; United States; United States Occupational Safety and Health Administration; Zidovudine | 1993 |
The pharmacoeconomics of HIV disease.
Topics: Cost-Benefit Analysis; Developing Countries; Economics, Pharmaceutical; Europe; Female; Financing, Government; Health Expenditures; HIV Infections; Humans; Male; Pneumonia, Pneumocystis; United States; Zidovudine | 1992 |
Total costs of HIV disease higher with zidovudine?
Topics: HIV Infections; Humans; Models, Econometric; Zidovudine | 1992 |
Antiretroviral drugs: new agents, new combinations line up against HIV.
Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
PHS recommends preventive drugs for HIV exposures.
Topics: Antiviral Agents; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Pyridines; United States; United States Public Health Service; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Patient classification and cost analysis of AIDS and HIV: the case of Belgium.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Belgium; Cost of Illness; Drug Costs; Episode of Care; Female; Health Care Costs; HIV Infections; HIV Seropositivity; Hospital Costs; Hospitals, University; Humans; Male; Middle Aged; Zidovudine | 1997 |
CDC's new needlestick guidelines get to the point.
Topics: Centers for Disease Control and Prevention, U.S.; Emergency Service, Hospital; Guidelines as Topic; HIV Infections; Humans; Needlestick Injuries; Occupational Health; Personnel, Hospital; United States; Zidovudine | 1997 |
Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.
Topics: Adult; Cost-Benefit Analysis; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Models, Economic; Zidovudine | 1997 |
Hospital security: 'stay current' on HIV exposure treatment guidelines.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Chicago; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Personnel, Hospital; Practice Guidelines as Topic; United States; Zidovudine | 1997 |
The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.
Topics: Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; HIV Infections; Humans; Lamivudine; Markov Chains; Models, Econometric; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1998 |
Scientific world belatedly recognizes HIV risks to laboratorians.
Topics: Centers for Disease Control and Prevention, U.S.; HIV Infections; Humans; Laboratory Infection; Medical Laboratory Personnel; Needlestick Injuries; Occupational Exposure; Protective Devices; Risk Factors; Tuberculosis; United States; United States Occupational Safety and Health Administration; Zidovudine | 1992 |
Now, a scary strain of drug-resistant HIV.
Topics: Drug Resistance, Microbial; Global Health; HIV Infections; Humans; Protease Inhibitors; United States; Zidovudine | 1998 |
Risks and recommendations for HIV occupational exposures.
Topics: Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Premedication; Risk Factors; Safety; United States; Workplace; Zidovudine | 1998 |
Short courses of zidovudine and perinatal transmission of HIV.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Short courses of zidovudine and perinatal transmission of HIV.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Short courses of zidovudine and perinatal transmission of HIV.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Risk; Selection Bias; Zidovudine | 1999 |
Short courses of zidovudine and perinatal transmission of HIV.
Topics: Anti-HIV Agents; Cesarean Section; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
[HIV post-exposure prophylaxis after sexual risk contact].
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Risk; Sexual Behavior; Zidovudine | 1999 |
[Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].
Topics: Adult; Anti-HIV Agents; Contact Tracing; Female; HIV Infections; Humans; Male; Practice Guidelines as Topic; Risk Factors; Sexual Behavior; Switzerland; Treatment Outcome; Zidovudine | 1999 |
The mother-to-child HIV transmission debate.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
The mother-to-child HIV transmission debate.
Topics: Abortion, Therapeutic; Anti-HIV Agents; Costs and Cost Analysis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Early lipodystrophy occurring during post-exposure prophylaxis.
Topics: Adult; Anti-HIV Agents; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Lipodystrophy; Male; Rape; Zidovudine | 1998 |
Patients with HIV-1 RNA below 1000 copies/ml after 48 weeks on dual nucleoside combination therapy. Delta Coordinating Committee.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1999 |
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cytokines; Female; Gene Expression; HIV Infections; HIV Protease Inhibitors; Humans; Interferon-gamma; Interleukin-10; Interleukin-13; Interleukin-2; Interleukin-4; Lamivudine; Longitudinal Studies; Male; Receptors, CCR3; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Receptors, Interleukin; Receptors, Interleukin-12; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Messenger; Saquinavir; Zidovudine | 1999 |
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
Topics: Adult; Aging; Anti-HIV Agents; Didanosine; Follow-Up Studies; HIV Infections; HIV-1; Humans; Immunologic Memory; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1999 |
Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1999 |
Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Psoriasis; Reverse Transcriptase Inhibitors; Viral Load; Zalcitabine; Zidovudine | 1999 |
Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Zidovudine | 1999 |
Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?
Topics: Anti-HIV Agents; Birth Weight; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Highly active antiretroviral therapy used to treat concurrent hepatitis B and human immunodeficiency virus infections.
Topics: Adult; Anti-HIV Agents; Biopsy, Needle; Drug Therapy, Combination; Gene Products, pol; Hepatitis B Antibodies; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Liver; Male; Zidovudine | 1999 |
Tackling mother-to-child HIV in Côte d'Ivoire.
Topics: Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1997 |
Medical student electives and infectious diseases. Zidovudine alone is not recommended prophylaxis.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Students, Medical; Travel; Zidovudine | 1999 |
Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Fatal Outcome; Fatty Liver; Female; Hepatomegaly; HIV Infections; Humans; Multiple Organ Failure; Respiratory Insufficiency; Zidovudine | 1999 |
Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5.
Topics: CD4 Antigens; Cell Survival; Cells, Cultured; Endopeptidases; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Intestinal Mucosa; Macrophages; Polymerase Chain Reaction; Proviruses; Receptors, CCR5; RNA, Viral; Time Factors; Virus Replication; Zidovudine | 1999 |
[AZT and 3TC treatment in a pregnant woman with HIV infection].
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Models, Biological; Models, Economic; Outcome and Process Assessment, Health Care; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 1999 |
Zidovudine to prevent mother-to-infant HIV transmission in developing countries: a view from Thailand.
Topics: Anti-HIV Agents; Drug Costs; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1999 |
Zidovudine against mother-to-child HIV transmission.
Topics: Anti-HIV Agents; Budgets; Developing Countries; Female; Health Policy; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.
Topics: Anti-HIV Agents; Antimetabolites, Antineoplastic; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neoplasms; Perinatal Care; Pregnancy; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
[Infectious diseases in 1998].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-HIV Agents; Antiviral Agents; Bacterial Vaccines; Blood Donors; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Interferons; Lamivudine; Middle Aged; Multicenter Studies as Topic; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Ribavirin; Streptococcus pneumoniae; Transfusion Reaction; Zidovudine | 1999 |
Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Didanosine; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; Humans; Liver Failure, Acute; Male; Middle Aged; Zidovudine | 1999 |
AZT helps with birth weight.
Topics: Anti-HIV Agents; Birth Weight; Female; HIV Infections; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1999 |
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Counseling; Drug Resistance, Microbial; Drug Therapy; Female; HIV Infections; HIV Seropositivity; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; North Carolina; Patient Compliance; Pregnancy; Zidovudine | 1999 |
Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine.
Topics: Adult; Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; Salvage Therapy; Saquinavir; Sulfonamides; Zidovudine | 1999 |
A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors.
Topics: Adenoviridae; Anti-HIV Agents; Biological Assay; Cell Line; Gene Products, tat; Genes, Reporter; Genetic Vectors; HeLa Cells; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Luciferases; Luminescent Measurements; tat Gene Products, Human Immunodeficiency Virus; Zidovudine | 1999 |
The mother-to-child HIV transmission debate.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
Topics: Anti-HIV Agents; Child; Child, Preschool; Disease Progression; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Retrospective Studies; Zidovudine | 1999 |
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
Topics: Adult; Anti-HIV Agents; Cohort Studies; DNA; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Infant, Newborn; Leukocytes, Mononuclear; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 1999 |
Universal HIV screening of pregnant women in England: cost effectiveness analysis.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cost of Illness; Cost-Benefit Analysis; England; Female; Health Care Costs; HIV Infections; Humans; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Sensitivity and Specificity; Zidovudine | 1999 |
When the unthinkable happens: post-exposure prophylaxis of HIV-contaminated percutaneous injuries.
Topics: Anti-HIV Agents; Canada; Centers for Disease Control and Prevention, U.S.; Dental Staff; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; United States; Zidovudine | 1999 |
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, pol; HIV Infections; HIV-1; Humans; Predictive Value of Tests; Proviruses; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 1999 |
Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Models, Economic; Pregnancy; Sensitivity and Specificity; Time Factors; Zidovudine | 1999 |
Prevention of vertical HIV-1 transmission.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Prevention of vertical HIV-1 transmission.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
Topics: Anti-HIV Agents; Gene Products, env; Health Personnel; HIV Antibodies; HIV Infections; HIV-1; Humans; Infection Control; Occupational Diseases; Occupational Exposure; Premedication; T-Lymphocytes, Cytotoxic; Virus Replication; Zidovudine | 1999 |
Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
Topics: Anti-HIV Agents; Dacryocystorhinostomy; Drug Therapy, Combination; HIV Infections; HIV Seropositivity; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Middle Aged; Needlestick Injuries; Occupational Exposure; Ophthalmology; Primary Prevention; Risk Factors; Zidovudine | 1999 |
Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
Topics: Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Models, Animal; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Kinetics; Lymphocyte Depletion; Mice; Mice, SCID; Reverse Transcriptase Inhibitors; Thymus Gland; Zidovudine | 1999 |
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cytotoxicity, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes, Cytotoxic; Viral Load; Viremia; Zidovudine | 1999 |
Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Computer Simulation; Disease Progression; HIV Infections; Humans; Likelihood Functions; Models, Biological; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Sampling Studies; Zidovudine | 1999 |
Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Pediatric AIDS Clinical Trials Group 076 Study Group.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load.
Topics: Anti-HIV Agents; Cross-Cultural Comparison; Developing Countries; Female; Health Policy; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Philosophy, Medical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load.
Topics: Anti-HIV Agents; Bottle Feeding; Breast Feeding; Developing Countries; Female; Health Policy; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Costs; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Hospital Costs; Humans; Nevirapine; RNA-Directed DNA Polymerase; United Kingdom; Zalcitabine; Zidovudine | 1999 |
Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine.
Topics: Animals; Cattle; Cells, Cultured; Drug Synergism; Female; HIV Infections; HIV-1; Humans; Lactoferrin; Leukocytes, Mononuclear; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1999 |
Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Multiple; Drug Therapy, Combination; Genes, MDR; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nucleosides; Point Mutation; Zidovudine | 1999 |
CCR5 genotype and resistance to vertical transmission of HIV-1.
Topics: Alleles; Anti-HIV Agents; Child; Female; Genotype; HIV Infections; HIV-1; Humans; Immunity, Innate; Infectious Disease Transmission, Vertical; Prospective Studies; Receptors, CCR5; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Prevention of mother-to-child transmission of HIV in Thailand: physicians' attitudes on zidovudine use, pregnancy termination, and willingness to provide care.
Topics: Abortion, Induced; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Mass Screening; Perinatal Care; Physician's Role; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 1999 |
Adequacy of prenatal care and prescription of zidovudine to prevent perinatal HIV transmission.
Topics: Adult; Anti-HIV Agents; Drug Prescriptions; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Neonatal Nursing; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
[In old age ... AIDS. Is it worth to initiate antiretroviral treatment? Review of 37 patients more than 60 years of age].
Topics: Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Data Interpretation, Statistical; Female; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Software; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1999 |
Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Stavudine; Viremia; Zidovudine | 1999 |
Tuskegee as a metaphor.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Ethics, Medical; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Metaphor; Needle-Exchange Programs; Syphilis; United States; United States Public Health Service; Zidovudine | 1999 |
Pharmacokinetics of zidovudine in infants: a population analysis across studies.
Topics: Anti-HIV Agents; Biological Availability; Clinical Trials as Topic; Female; Gestational Age; HIV Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Population Surveillance; Zidovudine | 1999 |
Innocents abroad? The ethics of international research.
Topics: Clinical Trials as Topic; Control Groups; Developing Countries; Drug Administration Schedule; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Internationality; Persons; Pregnancy; Pregnant Women; Research Subjects; Risk Assessment; Therapeutic Human Experimentation; Treatment Outcome; Vulnerable Populations; Withholding Treatment; Zidovudine | 1999 |
Drug could slash rate of perinatal HIV.
Topics: Anti-HIV Agents; Drug Costs; Drug Therapy, Combination; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Reverse Transcriptase Inhibitors; Uganda; United States; Zidovudine | 1999 |
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1999 |
Opening the AIDS door.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Thailand; Zidovudine | 1998 |
From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
Topics: Anti-HIV Agents; Drug Administration Schedule; Feasibility Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prevalence; Preventive Health Services; Thailand; Zidovudine | 1998 |
The need to revise the Declaration of Helsinki.
Topics: Anti-HIV Agents; Control Groups; Editorial Policies; Ethics; Ethics, Medical; Ethics, Research; Federal Government; Government Regulation; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Internationality; Nontherapeutic Human Experimentation; Placebos; Pregnant Women; Randomized Controlled Trials as Topic; Risk Assessment; Therapeutic Human Experimentation; Therapeutics; Zidovudine | 1999 |
SAMA Committee wants free AZT for rape survivors.
Topics: Adult; Anti-HIV Agents; Female; Health Services Needs and Demand; HIV Infections; Humans; Rape; South Africa; Zidovudine | 1999 |
Influenza myositis and rhabdomyolysis in an HIV positive man: was zidovudine a co-factor?
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Influenza, Human; Male; Myositis; Rhabdomyolysis; Zidovudine | 1999 |
IAS position paper on prevention of HIV 1 mother-to-child transmission. International Aids Society.
Topics: Anti-HIV Agents; Child, Preschool; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Program Development; Reverse Transcriptase Inhibitors; Societies, Medical; Zidovudine | 1999 |
Infant growth after in utero exposure to zidovudine.
Topics: Anti-HIV Agents; Female; Growth; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Trends in perinatal transmission of HIV/AIDS in the United States.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pneumonia, Pneumocystis; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1999 |
JAMA Patient Page. HIV/AIDS.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Sequence analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands.
Topics: Adolescent; Adult; Amino Acid Sequence; Anti-HIV Agents; Base Sequence; Child; DNA Primers; DNA-Directed DNA Polymerase; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine | 1999 |
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Sickness Impact Profile; Zidovudine | 1999 |
Changing attitudes towards antiretroviral treatment of HIV infection: a prospective study in a sample of Dutch general practitioners.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Family Practice; Female; Health Care Surveys; HIV Infections; Humans; Male; Middle Aged; Netherlands; Practice Patterns, Physicians'; Prospective Studies; Zidovudine | 1999 |
Should research ethics change at the border?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Research Design; Sample Size; Time Factors; Zidovudine | 1999 |
Transmission of antiretroviral-drug-resistant HIV-1 variants.
Topics: Adolescent; Adult; Anti-HIV Agents; DNA Mutational Analysis; Drug Resistance, Multiple; Female; Genetic Variation; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Phenotype; Switzerland; Zidovudine | 1999 |
Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy.
Topics: Adult; Anti-HIV Agents; B-Lymphocytes; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lymphocyte Activation; Male; Paraproteinemias; Ritonavir; Viral Load; Zidovudine | 1999 |
The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination.
Topics: Adult; Antiviral Agents; Female; HIV Infections; HIV Seropositivity; Humans; Indinavir; Insemination, Artificial, Heterologous; Lamivudine; Male; Pregnancy; Tissue Donors; Zidovudine | 1999 |
Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Brain; CD4 Lymphocyte Count; Child; Hemophilia B; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Papillomavirus Infections; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; Zidovudine | 1999 |
Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers.
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Health Care Costs; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Middle Aged; Models, Econometric; New Jersey; Quality-Adjusted Life Years; Zidovudine | 1999 |
Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
Topics: Anti-HIV Agents; Data Interpretation, Statistical; Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 1999 |
Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; RNA-Directed DNA Polymerase; Viral Load; Zidovudine | 1999 |
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.
Topics: Acidosis, Lactic; Anti-HIV Agents; Child, Preschool; DNA, Mitochondrial; Female; France; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Maternal-Fetal Exchange; Mitochondrial Encephalomyopathies; Pregnancy; Prenatal Exposure Delayed Effects; Reference Values; Retrospective Studies; Zidovudine | 1999 |
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Cross-Sectional Studies; Energy Intake; Female; Glucose Tolerance Test; HIV Infections; HIV Wasting Syndrome; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Syndrome; Zidovudine | 1999 |
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; Humans; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 1999 |
Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiency.
Topics: Anti-HIV Agents; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Renal Insufficiency; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cardiomyopathies; Chi-Square Distribution; Chicago; Female; Heart Failure; HIV Infections; Hospitals, Urban; Humans; Hypertension; Male; Zidovudine | 1999 |
3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT.
Topics: Anti-HIV Agents; DNA; Female; HIV Infections; HIV-1; Humans; In Vitro Techniques; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Perfusion; Placenta; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Platelet Count; Thrombocytopenia; Zidovudine | 1999 |
AIDS drug trials in Thailand and Uganda.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Uganda; Zidovudine | 1999 |
Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; False Negative Reactions; False Positive Reactions; Female; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Male; Occupational Exposure; Practice Guidelines as Topic; Public Health; United States; Zidovudine | 1999 |
Recommendations for antiretroviral therapy during pregnancy: prevention for the child; treatment for the mother.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Evaluation; Female; France; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1999 |
HIV infection in adults: a therapeutic update.
Topics: Adult; Anti-HIV Agents; Drug Costs; Drug Interactions; Education, Pharmacy, Continuing; Female; Health Personnel; HIV Infections; Humans; Managed Care Programs; Pregnancy; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1999 |
Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
Topics: Adolescent; Adult; Anti-HIV Agents; Dideoxynucleotides; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Phosphorylation; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine | 1999 |
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Semen; Viral Load; Zidovudine | 1999 |
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
Topics: 5' Untranslated Regions; Adult; Alleles; Anti-HIV Agents; Black or African American; Cohort Studies; Female; Gene Frequency; Genotype; Hispanic or Latino; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Linkage Disequilibrium; Perinatal Care; Polymorphism, Genetic; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Receptors, Cytokine; Regulatory Sequences, Nucleic Acid; White People; Zidovudine | 1999 |
The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Topics: Analysis of Variance; Anti-HIV Agents; Cost Savings; Cost-Benefit Analysis; Decision Trees; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Labor, Obstetric; Mass Screening; Models, Econometric; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Sensitivity and Specificity; Time Factors; Zidovudine | 1999 |
Maternal and umbilical cord serum vitamin A, E levels and mother-to-child transmission in the non-supplemented vitamin A, E HIV-1 infected parturients with short-course zidovudine therapy.
Topics: Adult; Anti-HIV Agents; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Vitamin A; Vitamin E; Zidovudine | 1999 |
[Vertical transmission of HIV treated with zidovudine in county hospitals in Catalonia].
Topics: Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Hospitals, County; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Severe anemia as a newly recognized side-effect caused by lamivudine.
Topics: Anemia; Anti-HIV Agents; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; CD4-CD8 Ratio; Choice Behavior; Cognition; Cross-Sectional Studies; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time; Statistics, Nonparametric; Zalcitabine; Zidovudine | 1999 |
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Controlled Clinical Trials as Topic; Denmark; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Multicenter Studies as Topic; Retrospective Studies; Ritonavir; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 1999 |
HIVNET nevirapine trials.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
[Pregnancy and HIV].
Topics: Anti-HIV Agents; Cesarean Section; Chemoprevention; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Mitochondrial Myopathies; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Risk Assessment; Zidovudine | 1999 |
ACOG committee opinion. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Number 219, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients.
Topics: Adult; Aged; Anti-HIV Agents; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1999 |
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Palatine Tonsil; Proviruses; T-Lymphocyte Subsets; Time Factors; Viremia; Virus Replication; Zidovudine | 1999 |
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Disease Progression; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; RNA, Viral; Salvage Therapy; Saquinavir; Stavudine; Switzerland; Treatment Failure; Viral Load; Zalcitabine; Zidovudine | 1999 |
Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.
Topics: Acute Disease; Adult; Anti-HIV Agents; Candida; CD4 Lymphocyte Count; Chronic Disease; Cytokines; Cytotoxicity, Immunologic; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; T-Lymphocytes; Tetanus Toxoid; Viral Load; Zidovudine | 2000 |
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.
Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocytes; Male; Middle Aged; Ritonavir; T-Lymphocyte Subsets; Thymus Gland; Tomography; Zidovudine | 2000 |
Maternal viral load and the risk of perinatal transmission of HIV-1.
Topics: Anti-HIV Agents; Bias; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; RNA, Viral; Viral Load; Zidovudine | 1999 |
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lymph Nodes; Models, Theoretical; Reverse Transcriptase Inhibitors; RNA, Viral; Tetanus Toxoid; Zidovudine | 1999 |
Current laboratory assays and in vitro intracellular Th1 and Th2 cytokine synthesis in monitoring antiretroviral therapy of pediatric HIV infection.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Saquinavir; Th1 Cells; Th2 Cells; Viral Load; Zalcitabine; Zidovudine | 2000 |
High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Gene Deletion; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
AZT in Africa.
Topics: Africa; Anti-HIV Agents; Developing Countries; Drug Industry; Ethics, Medical; HIV Infections; Humans; Research; Zidovudine | 1999 |
Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Martinique; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Sequence Analysis, DNA; Zidovudine | 1999 |
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Phenotype; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2000 |
Late onset of Leber's hereditary optic neuropathy in HIV infection.
Topics: Age of Onset; Anti-HIV Agents; HIV Infections; Humans; Male; Middle Aged; Optic Atrophies, Hereditary; Zidovudine | 1999 |
Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Treatment Outcome; United States; Zidovudine | 2000 |
Re: Emergency Department management of occupational exposures to HIV-infected fluids.
Topics: Anti-HIV Agents; Emergency Service, Hospital; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Zidovudine | 2000 |
Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; HIV Infections; HIV-1; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Leukocytes, Mononuclear; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Viremia; Zidovudine | 2000 |
Risk of HIV transmission from patients to surgeons in the era of post-exposure prophylaxis.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; General Surgery; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Needlestick Injuries; Prevalence; Probability; Scotland; Zidovudine | 2000 |
Effortless unintentional smoking cessation after lamivudine-zidovudine-indinavir post-exposure anti-HIV chemoprophylaxis.
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Indinavir; Lamivudine; Male; Smoking; Smoking Cessation; Zidovudine | 1999 |
The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; British Columbia; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Female; HIV Infections; Humans; Male; Zidovudine | 2000 |
Perceived compliance with AZT dosing among a sample of African-American drug users.
Topics: Adolescent; Adult; Anti-HIV Agents; Attitude to Health; Black or African American; Black People; Drug Administration Schedule; Educational Status; Female; HIV Infections; Humans; Male; Marital Status; Patient Compliance; Pilot Projects; Socioeconomic Factors; Substance Abuse, Intravenous; Viral Load; Zidovudine | 2000 |
AZT--the saga continues.
Topics: Adolescent; Adult; Child; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Zidovudine | 1999 |
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutagenesis, Site-Directed; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Zidovudine | 2000 |
Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Interleukin-2; Kinetics; Lymphoid Tissue; Male; Middle Aged; RNA, Viral; Saquinavir; Viremia; Zalcitabine; Zidovudine | 1998 |
Drugs for HIV infection.
Topics: Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Costs; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 2000 |
Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Models, Animal; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Mice; Mice, SCID; Receptors, Antigen, T-Cell, alpha-beta; Reverse Transcriptase Inhibitors; Thymus Gland; Zidovudine | 2000 |
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
Topics: Acute Disease; Anti-HIV Agents; Clone Cells; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Saquinavir; T-Lymphocytes, Cytotoxic; Viremia; Zidovudine | 2000 |
A model of HIV-1 pathogenesis that includes an intracellular delay.
Topics: Anti-HIV Agents; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Models, Biological; Numerical Analysis, Computer-Assisted; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Tolerability and side-effects of post-exposure prophylaxis for HIV infection.
Topics: Anti-HIV Agents; Drug Combinations; Drug Tolerance; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; London; Needlestick Injuries; Patient Compliance; Personnel, Hospital; Retrospective Studies; Zidovudine | 2000 |
Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy.
Topics: Amino Acid Sequence; Anti-HIV Agents; Codon; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Zidovudine | 2000 |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2000 |
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Male; Palatine Tonsil; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Time Factors; Viremia; Zidovudine | 2000 |
The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mississippi; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Adherence to antiretroviral therapy in HIV-infected children in Italy.
Topics: Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Italy; Male; Parents; Patient Compliance; Radioimmunoassay; Zidovudine | 1999 |
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Cohort Studies; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Organ Size; Reverse Transcriptase Inhibitors; Stavudine; Thymus Gland; Viral Load; Zidovudine | 2000 |
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2000 |
[First HIV triple therapy with one tablet].
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Tablets; Zidovudine | 2000 |
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Dideoxynucleosides; Furans; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Lymph Nodes; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Stavudine; Sulfonamides; Time Factors; Viral Load; Viremia; Zidovudine | 2000 |
The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Chicago; Family Planning Services; Female; Health Services Needs and Demand; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Child Health Centers; Patient Education as Topic; Perinatal Care; Pregnancy; Preventive Health Services; Referral and Consultation; Zidovudine | 1998 |
Knowledge of treatment to reduce perinatal human immunodeficiency virus (HIV) transmission and likelihood of testing for HIV: results from two surveys of women of childbearing age.
Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents; California; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Multivariate Analysis; Odds Ratio; Poverty Areas; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis.
Topics: Adenosine Triphosphate; Anti-HIV Agents; Base Sequence; Diphosphates; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Templates, Genetic; Zidovudine | 2000 |
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice. The Ghent International Working Group on Mother-To-Child Transmission of HIV.
Topics: Anti-HIV Agents; Breast Feeding; Counseling; Developing Countries; Female; HIV Infections; Humans; Infant; Infant Care; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Randomized Controlled Trials as Topic; Zidovudine | 2000 |
Antiretroviral therapy for pregnant HIV-infected women.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; United States; Zidovudine | 2000 |
Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
Topics: Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Drug Therapy, Combination; Glycine; Glycyrrhetinic Acid; Hemophilia A; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1999 |
[A two-year follow-up of zidovudine plus lamivudine combined with indinavir in antivival naive HIV-infected patients].
Topics: Anti-HIV Agents; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Contraceptive use and pregnancy decision making among women with HIV.
Topics: Abortion, Therapeutic; Adolescent; Adult; Anti-HIV Agents; Condoms; Contraception Behavior; Decision Making; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Insurance, Health; Missouri; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Surveys and Questionnaires; Women; Zidovudine | 1999 |
Amprenavir study results released.
Topics: Anti-HIV Agents; Carbamates; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Sulfonamides; Viral Load; Zidovudine | 1999 |
Drug combination treats brain cancer.
Topics: Anti-HIV Agents; Brain Neoplasms; CD4 Lymphocyte Count; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; HIV Infections; Humans; Interleukin-2; Lymphoma, AIDS-Related; Radiotherapy, Adjuvant; Treatment Outcome; Zidovudine | 1999 |
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Topics: Adolescent; Anti-HIV Agents; Base Sequence; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, pol; HIV Infections; HIV-1; Humans; Infant; Molecular Sequence Data; Mutagenesis; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Latency; Virus Replication; Zidovudine | 2000 |
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cell Lineage; Drug Therapy, Combination; Gene Products, gag; Gene Products, pol; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Interferon-gamma; Lamivudine; Longitudinal Studies; Lymphocyte Activation; Peptides; Phenotype; Phosphoproteins; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Viral Load; Viral Matrix Proteins; Zidovudine | 2000 |
Parvovirus B19 infection in a human immunodeficiency virus-infected patient with anemia.
Topics: Adult; Anemia; Anti-HIV Agents; Erythema Infectiosum; HIV Infections; Humans; Male; Zidovudine | 2000 |
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome; Zidovudine | 2000 |
Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Immunologic Memory; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Nelfinavir; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2000 |
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.
Topics: CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 2000 |
Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.
Topics: Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Jurkat Cells; Nelfinavir; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; T-Lymphocytes; Viral Load; Zidovudine | 2000 |
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Heterosexuality; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; London; Male; Population Surveillance; Retrospective Studies; Risk Factors; Sex Factors; Substance Abuse, Intravenous; Survival Analysis; Zidovudine | 2000 |
Efavirenz in HIV infection.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Oxazines; Research Design; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Base Sequence; Didanosine; DNA, Viral; Drug Resistance, Microbial; Evolution, Molecular; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Protein Structure, Secondary; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Clinical trials of antiretroviral therapy in developing countries.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; HIV Infections; Humans; Zidovudine | 2000 |
Politicisation of debate on HIV care in South Africa.
Topics: Anti-HIV Agents; Congresses as Topic; Health Policy; HIV Infections; Humans; Politics; South Africa; Zidovudine | 2000 |
Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Cesarean Section; Cost-Benefit Analysis; Decision Support Techniques; Delivery, Obstetric; Elective Surgical Procedures; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Models, Economic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects.
Topics: Adult; Anti-HIV Agents; Child; Cytokines; Drug Therapy, Combination; HIV Infections; HIV Seronegativity; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
HIV infection prevention in specific situations.
Topics: Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Vertical; Resuscitation; Risk Factors; Zidovudine | 2000 |
Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production.
Topics: Adult; Anti-HIV Agents; Cells, Cultured; Child, Preschool; Cytokines; Female; Fetal Blood; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Interleukin-10; Interleukin-12; Lymphocytes; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Regression Analysis; Tumor Necrosis Factor-alpha; Zidovudine | 2000 |
Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Blood Component Transfusion; CD4 Lymphocyte Count; Cohort Studies; Cytomegalovirus Infections; Disease Progression; Follow-Up Studies; Hemophilia A; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; RNA, Viral; Time Factors; Zidovudine | 2000 |
Vertical transmission of HIV-1 in Poland.
Topics: Anti-HIV Agents; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Longitudinal Studies; Poland; Pregnancy; RNA, Viral; Zidovudine | 2000 |
Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Budgets; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Fees, Pharmaceutical; Government Programs; HIV Infections; HIV Protease Inhibitors; Humans; Models, Economic; New York; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2000 |
Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; HIV Infections; Humans; Lipodystrophy; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Zidovudine | 2000 |
Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Stavudine; Zidovudine | 2000 |
Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; Drug Therapy, Combination; Erythrocyte Indices; Female; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2000 |
Cutaneous side effects induced by indinavir.
Topics: Adult; Alopecia; Didanosine; Drug Eruptions; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Middle Aged; Pruritus; Pyoderma Gangrenosum; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Scalp Dermatoses; Skin; Stavudine; Zalcitabine; Zidovudine | 2000 |
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Gene Products, pol; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Mutation; Phenotype; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Outcome; Zidovudine | 2000 |
Zidovudine + lamivudine: new preparation. Fewer tablets required.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Combinations; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Health care providers' influence on HIV-infected women's beliefs and intentions related to AZT therapy.
Topics: Adult; Anti-HIV Agents; Attitude to Health; Black or African American; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Middle Aged; Nursing Methodology Research; Patient Education as Topic; Pregnancy; Primary Health Care; Professional-Patient Relations; Surveys and Questionnaires; Women; Zidovudine | 1999 |
Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
Topics: Anti-HIV Agents; Codon; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Lymphocytes; Nucleic Acid Hybridization; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
[HIV infection in childhood].
Topics: Adult; Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Risk Factors; Zidovudine | 2000 |
The changing HIV epidemic in Italian pregnant women.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cesarean Section; Female; Gestational Age; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Italy; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
A mixture model for longitudinal data with application to assessment of noncompliance.
Topics: Anti-HIV Agents; Biometry; Clinical Trials as Topic; HIV Infections; Humans; Longitudinal Studies; Markov Chains; Models, Statistical; Monte Carlo Method; Motivation; Patient Compliance; Treatment Refusal; Zidovudine | 2000 |
GEE with Gaussian estimation of the correlations when data are incomplete.
Topics: Anti-HIV Agents; Biometry; Computer Simulation; Controlled Clinical Trials as Topic; Didanosine; HIV Infections; Humans; Longitudinal Studies; Models, Statistical; Normal Distribution; Zidovudine | 2000 |
Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 2000 |
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
Topics: Adolescent; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Transfusion Reaction; Zidovudine | 2000 |
Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Male; Mass Spectrometry; Reference Standards; Reverse Transcriptase Inhibitors; Semen; Zidovudine | 2000 |
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child.
Topics: Anti-HIV Agents; Antibody Formation; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Viremia; Zidovudine | 2000 |
The mother of all HIV challenges.
Topics: Africa South of the Sahara; AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Social Conditions; Zidovudine | 2000 |
[Human immunodeficiency virus: current pregnancy aspects].
Topics: Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; HIV Infections; HIV-1; HIV-2; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
[Antiretroviral drugs and pregnancy: apropos of an alert regarding mitochondrial pathology and nucleoside analogs].
Topics: Abnormalities, Drug-Induced; Animals; Anti-HIV Agents; Female; HIV Infections; Humans; Lamivudine; Mitochondrial Myopathies; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk; Zidovudine | 2000 |
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Mutation; Nelfinavir; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 2000 |
The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
The "best proven therapeutic method" standard in clinical trials in technologically developing countries.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cohort Studies; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors; Zidovudine | 2000 |
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples.
Topics: Age Factors; Anti-HIV Agents; Cesarean Section; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 2000 |
Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Factors; Zidovudine | 2000 |
[Guidelines for the management of patients with HIV infection. II. Pregnant women and children. Liege Working Group on HIV Infection].
Topics: Adult; Age Factors; Anti-HIV Agents; Cesarean Section; Child; Child Welfare; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Life Expectancy; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Topics: Anti-HIV Agents; Cells, Cultured; Deoxycytidine; Didanosine; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Molecular Structure; Mutation; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; T-Lymphocytes; Thionucleosides; Zidovudine | 2000 |
Human immunodeficiency virus type 1 infection modulates the interleukin (IL)-1beta and IL-6 responses of human macrophages to CD40 ligand stimulation.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; CD40 Ligand; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Interleukin-1; Interleukin-6; Macrophages; Oligopeptides; Polymerase Chain Reaction; RNA, Messenger; Virus Replication; Zidovudine | 2000 |
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.
Topics: Anti-HIV Agents; Carbamates; Dideoxynucleosides; Furans; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Lamivudine; Neutralization Tests; Ritonavir; Sulfonamides; Zidovudine | 2000 |
Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
Topics: Animals; Anti-HIV Agents; Cats; Disease Models, Animal; Feline Acquired Immunodeficiency Syndrome; HIV Infections; Immunodeficiency Virus, Feline; Lymphocyte Count; Lymphocytes; Phenotype; Plasma; Thymus Gland; Viral Load; Zidovudine | 2000 |
[Perinatal co-infection with hepatitis B and HIV viruses--reciprocal effect of the disease and the treatment].
Topics: Anti-HIV Agents; Didanosine; Female; Hepatitis B; HIV Infections; Humans; Infant; Ritonavir; Zidovudine | 1999 |
Marginal structural models and causal inference in epidemiology.
Topics: Anti-HIV Agents; Causality; Confounding Factors, Epidemiologic; Epidemiologic Methods; HIV Infections; Humans; Models, Statistical; Risk Factors; Time Factors; Zidovudine | 2000 |
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.
Topics: Anti-HIV Agents; Causality; CD4 Lymphocyte Count; Confounding Factors, Epidemiologic; Epidemiologic Methods; HIV Infections; Humans; Male; Models, Statistical; Proportional Hazards Models; Survival Analysis; Time Factors; Treatment Outcome; United States; Zidovudine | 2000 |
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amino Acid Sequence; Cohort Studies; Consensus Sequence; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Italy; Male; Middle Aged; Molecular Sequence Data; Multicenter Studies as Topic; Mutagenesis, Insertional; Mutation; Prevalence; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Prenatal zidovudine use and congenital anomalies in a medicaid population.
Topics: Abnormalities, Drug-Induced; Adult; Anti-HIV Agents; Cardiovascular Abnormalities; Central Nervous System; Digestive System Abnormalities; Female; HIV Infections; Humans; Infant, Newborn; Male; Medicaid; Musculoskeletal Abnormalities; New York; New York City; Parity; Pregnancy; Prenatal Exposure Delayed Effects; Prevalence; Registries; Retrospective Studies; United States; Zidovudine | 2000 |
Intensification of background antiretroviral therapy with abacavir during low-level failure may restore optimal suppression.
Topics: Adult; Aged; Anti-HIV Agents; Dideoxynucleosides; Drug Resistance; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2000 |
Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Models, Biological; Predictive Value of Tests; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Virus Replication; Zidovudine | 2000 |
Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Health Plan Implementation; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Male; Middle Aged; National Health Programs; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; Thailand; Zidovudine | 2000 |
Mitochondrial and peroxisomal dysfunction following perinatal exposure to antiretroviral drugs.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lamivudine; Male; Mitochondria; Perinatal Care; Peroxisomes; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 2000 |
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
Topics: Anti-HIV Agents; Child, Preschool; Female; Heart Ventricles; HIV Infections; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Mitochondria, Heart; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prenatal Exposure Delayed Effects; Ventricular Function; Ventricular Function, Left; Zidovudine | 2000 |
Perinatal exposure to zidovudine--benefits and risks.
Topics: Anti-HIV Agents; Female; Heart Ventricles; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Mitochondria, Heart; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prenatal Care; Prenatal Exposure Delayed Effects; Risk Assessment; Ventricular Function, Left; Zidovudine | 2000 |
AZT blues.
Topics: Anti-HIV Agents; Counseling; Female; Foster Home Care; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; South Africa; Zidovudine | 2000 |
[Mother-to-child transmission of HIV infections. Antiviral agents and Cesarean section reduce the risk of transmission].
Topics: Anti-HIV Agents; Cesarean Section; Developed Countries; Developing Countries; Drug Resistance, Microbial; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2000 |
[Reduced mother-to-child transmission of HIV-1 infection. Exclusive breast feeding and weaning--a possible model in developing countries?].
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Weaning; Zidovudine | 2000 |
Acute hepatitis and bleeding possibly induced by zidovudine and ritonavir in an infant with HIV infection.
Topics: Acute Disease; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Fatal Outcome; Hemorrhage; HIV Infections; Humans; Infant; Male; Ritonavir; Zidovudine | 2000 |
Postexposure prophylaxis for HIV after sexual assault.
Topics: Adult; Anti-HIV Agents; Chemoprevention; Female; HIV Infections; Humans; Lamivudine; Male; Retrospective Studies; San Francisco; Sex Offenses; Zidovudine | 2000 |
Abacavir: new preparation. Risks limit the value.
Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; France; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Risk Assessment; Treatment Outcome; Zidovudine | 2000 |
Prevention of mother-child HIV transmission: progress and problems.
Topics: Africa; Antiviral Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Cohort Studies; Developing Countries; Drug Therapy, Combination; Europe; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mitochondrial Myopathies; Nervous System Diseases; Nevirapine; Pregnancy; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Thailand; United States; Zidovudine | 2000 |
Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Arteriosclerosis; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Oxazines; Risk Factors; Stavudine; Thymidine; Triglycerides; Zidovudine | 2000 |
Preventing vertical transmission of HIV infection.
Topics: Anti-HIV Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine.
Topics: Amino Acid Sequence; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Integrase; HIV-1; Humans; Molecular Sequence Data; Mutation; Proviruses; Reverse Transcriptase Inhibitors; Sequence Alignment; Sequence Analysis, DNA; Time Factors; Zidovudine | 2000 |
Prevention of vertical transmission of HIV--a constitutional catch-22 situation.
Topics: Abortion, Legal; Anti-HIV Agents; Health Policy; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Politics; South Africa; Zidovudine | 2000 |
National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cost-Benefit Analysis; Disabled Persons; Female; Forecasting; Health Services Research; HIV Infections; HIV Seroprevalence; Humans; Infant Food; Infectious Disease Transmission, Vertical; Maternal Health Services; Models, Econometric; National Health Programs; Program Evaluation; Quality-Adjusted Life Years; Sensitivity and Specificity; South Africa; Zidovudine | 2000 |
Exposure to HIV: medical management and legal implications.
Topics: Allied Health Personnel; Counseling; Emergency Service, Hospital; HIV Infections; Humans; Mandatory Testing; Occupational Exposure; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Risk Assessment; Zidovudine | 2000 |
Brief report: effect of antiretroviral agents on T-lymphocyte subset counts in healthy HIV-negative individuals. The Italian Registry on Antiretroviral Postexposure Prophylaxis.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Health Personnel; HIV Infections; HIV Seronegativity; Humans; Lamivudine; Longitudinal Studies; Lymphocyte Count; Male; Occupational Diseases; Retrospective Studies; T-Lymphocyte Subsets; Zidovudine | 2000 |
Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
Topics: Anti-HIV Agents; Chromatography, Ion Exchange; Cytidine Triphosphate; Dideoxynucleotides; HIV Infections; Humans; Lamivudine; Reference Standards; Thymine Nucleotides; Zidovudine | 2000 |
Increased fetal hemoglobin levels in patients infected with human immunodeficiency virus (HIV1/2).
Topics: Anti-HIV Agents; Case-Control Studies; Chi-Square Distribution; Erythroid Precursor Cells; Fetal Hemoglobin; HIV Infections; HIV Protease Inhibitors; Humans; Statistics, Nonparametric; Zidovudine | 2000 |
Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy.
Topics: Adult; Amino Acid Sequence; Consensus Sequence; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, Viral; Genotype; HIV Infections; HIV-2; Humans; Lamivudine; Male; Molecular Sequence Data; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zidovudine | 2000 |
Monotherapy in an era of combination therapy: is there a benefit? Experience in HIV-1-infected symptomatic South African children.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; Health Care Rationing; HIV Infections; HIV-1; Hospitalization; Humans; Infant; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; South Africa; Treatment Outcome; Zidovudine | 2000 |
[Risk management. Accidental exposure to blood].
Topics: Health Personnel; HIV Infections; Humans; Occupational Exposure; Occupational Health; Risk Management; Zidovudine | 2000 |
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs.
Topics: Anti-HIV Agents; Chemokine CXCL12; Chemokines, CXC; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Methionine; Nelfinavir; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
AZT for rape victims.
Topics: Anti-HIV Agents; Health Policy; HIV Infections; Humans; Rape; South Africa; Zidovudine | 2000 |
Molecular evidence for drug-induced compartmentalization of HIV-1 quasispecies in a patient with periodic changes to HAART.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coculture Techniques; Drug Resistance, Microbial; Evolution, Molecular; Follow-Up Studies; Genes, env; Genes, pol; HIV Infections; HIV Protease; HIV-1; Humans; Leukocytes, Mononuclear; Longitudinal Studies; Male; Mutation; Zidovudine | 2000 |
Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Evolution, Molecular; Genes, env; Genes, pol; Genetic Variation; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Lymph Nodes; Male; Mutation; Peptide Fragments; Time Factors; Zidovudine | 2000 |
Acute lymphoblastic leukaemia in an infant exposed to zidovudine in utero and early infancy.
Topics: Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Prenatal Exposure Delayed Effects; Zidovudine | 2000 |
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
Topics: Anti-HIV Agents; Codon; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Nucleic Acid Hybridization; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zalcitabine; Zidovudine | 2000 |
[Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; Endopeptidases; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Mutation; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Zidovudine | 2000 |
[Prevalence of primary mutations in human immunodeficiency virus with resistance to nucleoside analogues in previously untreated patients from Andalusia. Andalusian Group for the Study of Infectious diseases (GAEI)].
Topics: Adult; Anti-HIV Agents; CD4 Antigens; Codon; Data Interpretation, Statistical; DNA, Viral; Drug Resistance, Microbial; Female; Genotype; HIV; HIV Infections; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Viral Load; Zidovudine | 2000 |
[Resistance to antiretroviral drugs: a clinical, public health and health policy debate].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Child; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Genotype; Health Policy; HIV; HIV Infections; Humans; Male; Pregnancy; Public Health; Research; Reverse Transcriptase Inhibitors; Spain; Viral Load; Zidovudine | 2000 |
Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2000 |
Suppression of maternal virus load with zidovudine, didanosine, and indinavir combination therapy prevents mother-to-fetus HIV transmission in macaques.
Topics: Animals; Didanosine; Drug Therapy, Combination; Female; Fetus; HIV Antibodies; HIV Infections; HIV Protease Inhibitors; HIV-2; Indinavir; Infectious Disease Transmission, Vertical; Macaca nemestrina; Pregnancy; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Viral Load; Zidovudine | 2000 |
Multicenter review of protease inhibitors in 89 pregnancies.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Apgar Score; CD4-Positive T-Lymphocytes; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Linear Models; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Puerto Rico; Regression Analysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; United States; Viral Load; Zidovudine | 2000 |
Sustained responses to dual nucleoside therapy in women.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 2000 |
Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Body Composition; Female; HIV Infections; Humans; Lipodystrophy; Male; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2000 |
Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Cytidine Triphosphate; Dideoxynucleotides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Mass Spectrometry; Monocytes; Reference Standards; Sensitivity and Specificity; Stavudine; Thymine Nucleotides; Zidovudine | 2000 |
Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Case-Control Studies; CD4 Lymphocyte Count; Female; Gingivitis; Herpes Labialis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Leukoplakia, Hairy; Male; Middle Aged; Mouth Diseases; Periodontitis; Prevalence; Viral Load; Xerostomia; Zidovudine | 2000 |
Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Didanosine; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Middle Aged; Pilot Projects; Treatment Outcome; Zidovudine | 2000 |
Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Drug Resistance, Microbial; Genetic Variation; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Oligonucleotide Array Sequence Analysis; Phenotype; Reverse Transcriptase Inhibitors; Selection, Genetic; Zidovudine | 2000 |
Some recent developments in the international guidelines on the ethics of research involving human subjects.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bioethics; Developing Countries; Ethics, Medical; Female; Guidelines as Topic; HIV Infections; Human Experimentation; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Organizational approaches to the HIV/AIDS crisis.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Postnatal Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; United States; Zidovudine | 2000 |
Future directions for NIH-supported pediatric AIDS research.
Topics: Acquired Immunodeficiency Syndrome; Africa South of the Sahara; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Incidence; Infectious Disease Transmission, Vertical; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; Prevalence; Research Support as Topic; United States; Zidovudine | 2000 |
Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cause of Death; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Los Angeles; Mitochondrial Myopathies; New York City; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; United States; Zidovudine | 2000 |
A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Does fetal nucleoside toxicity underlie reports of mitochondrial disease in infants born to women treated for HIV infection?
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mitochondria; Mitochondrial Myopathies; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Zidovudine | 2000 |
Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
Topics: Adult; Animals; Anti-HIV Agents; DNA; Female; Fetal Blood; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Leukocytes; Maternal-Fetal Exchange; Mice; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2000 |
Antiretroviral pharmacology in pregnant women and their newborns.
Topics: Administration, Oral; Anti-HIV Agents; Delivery, Obstetric; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Maternal-Fetal Exchange; Nevirapine; Placenta; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.
Topics: Drug Resistance, Microbial; Evolution, Molecular; Genes, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Self-Sustained Sequence Replication; Virus Cultivation; Virus Replication; Zidovudine | 2001 |
Clinical trials in developing countries: a review of the moral issues.
Topics: Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placebos; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Zidovudine | 2001 |
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine | 2001 |
Using focus groups to develop a culturally sensitive videotape intervention for HIV-positive women.
Topics: Adolescent; Adult; Anti-HIV Agents; Culture; Female; Focus Groups; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Patient Education as Topic; Pregnancy; Pregnancy Complications; Prenatal Care; Videotape Recording; Zidovudine | 2000 |
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 2000 |
Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen.
Topics: Adult; Anti-HIV Agents; Chemoprevention; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Red Cross; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 2000 |
Protease inhibitor therapy in HIV-infected children.
Topics: Adolescent; Age Factors; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lamivudine; Male; Nelfinavir; Patient Compliance; Retrospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2000 |
Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1).
Topics: Cesarean Section; Cost-Benefit Analysis; Decision Trees; Elective Surgical Procedures; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 2001 |
Detection of resistant mutations in the reverse transcriptase of HIV-1-infected children.
Topics: CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Male; Mutation; Reverse Transcriptase Inhibitors; Ritonavir; Viremia; Zidovudine | 2000 |
Immune restoration disease in HIV-infected patients after antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Immunity; Zidovudine | 2001 |
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2001 |
Indinavir, zidovudine, lamivudine: 3-year follow-up.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Kidney Calculi; Lamivudine; Risk Factors; Zidovudine | 2001 |
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Contact Tracing; Counseling; Didanosine; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Patient Compliance; Reverse Transcriptase Inhibitors; Risk Factors; Risk-Taking; Sexually Transmitted Diseases, Viral; Substance Abuse, Intravenous; Time Factors; Zidovudine | 2001 |
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Epstein-Barr Virus Infections; Flow Cytometry; Furans; Genotype; HIV Infections; HIV-1; Humans; Immunoglobulin M; Lamivudine; Longitudinal Studies; Male; Proto-Oncogene Proteins c-bcl-2; Receptors, CCR5; Sulfonamides; Time Factors; Zidovudine | 2001 |
Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents.
Topics: Adult; Anti-HIV Agents; Dideoxynucleotides; Female; HIV; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Phosphorylation; Thymine Nucleotides; Zidovudine | 2001 |
Association between high serum prolactin levels and concomitant infections in HIV-infected patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; CD4-CD8 Ratio; Female; HIV Infections; Humans; Immunoglobulins; Indinavir; Lamivudine; Male; Prolactin; Sex Factors; T-Lymphocyte Subsets; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Zidovudine | 2001 |
FDA approves Trizivir for HIV infection.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Approval; Drug Combinations; HIV Infections; Humans; Lamivudine; United States; United States Food and Drug Administration; Zidovudine | 2000 |
Shortened zidovudine regimens to prevent mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Clinical Protocols; Data Interpretation, Statistical; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 2001 |
Triple-drug tablet approved for HIV infection.
Topics: Anti-HIV Agents; Chemistry, Pharmaceutical; Dideoxynucleosides; Drug Combinations; Drug Labeling; HIV Infections; Humans; Lamivudine; Tablets; Zidovudine | 2001 |
Prevention of vertical transmission of human immunodeficiency type 1 virus in a managed care setting.
Topics: Administration, Oral; Anti-HIV Agents; Bottle Feeding; Cesarean Section; Chemoprevention; Female; HIV Infections; HIV-1; Humans; Infant; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Managed Care Programs; Pregnancy; Zidovudine | 2000 |
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Nevirapine; Occupational Exposure; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Zidovudine | 2001 |
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Time Factors; Viral Load; Zidovudine | 2001 |
Absence of cardiac toxicity of zidovudine in infants.
Topics: Adult; Animals; Anti-HIV Agents; Cardiomyopathies; Child; Female; Heart Ventricles; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prenatal Exposure Delayed Effects; Zidovudine | 2001 |
Strategy for preventing vertical transmisssion of HIV : Bombay experience.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; India; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Zidovudine | 2001 |
Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Topics: Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Therapy, Combination; Fatal Outcome; Granulocyte Colony-Stimulating Factor; HIV Infections; HIV-1; Humans; Leukopenia; Male; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Further views by the Erice working group on mother-to-child transmission of HIV type 1.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2001 |
Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Stavudine; Virus Replication; Zalcitabine; Zidovudine | 2000 |
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Evolution, Molecular; Gene Products, gag; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viremia; Zidovudine | 2000 |
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Protease Inhibitors; Reverse Transcriptase Inhibitors; Spain; Viral Load; Zidovudine | 2001 |
Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374.
Topics: Anti-HIV Agents; Cell Line; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Reverse Transcriptase Inhibitors; Thiazoles; Virus Replication; Zidovudine | 2001 |
[Bilateral hip necrosis, corticoids, and human immunodeficiency virus protease inhibitors].
Topics: Aged; Antiretroviral Therapy, Highly Active; Dexamethasone; Didanosine; Femur Head Necrosis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Prednisone; Zidovudine | 2001 |
Failure of postexposure prophylaxis after sexual exposure to HIV.
Topics: Adult; Antiretroviral Therapy, Highly Active; Copulation; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Treatment Failure; Viral Load; Zidovudine | 2001 |
No adverse effects in infants following short-course zidovudine.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Time Factors; Zidovudine | 2001 |
Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
Topics: Clone Cells; Dideoxynucleosides; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 2001 |
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals.
Topics: Adult; Anti-HIV Agents; DNA; DNA-Binding Proteins; Female; HIV Infections; Humans; Interleukin-2; Male; Middle Aged; Milk Proteins; Protein Isoforms; STAT5 Transcription Factor; Trans-Activators; Zidovudine | 2001 |
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
Topics: Cohort Studies; DNA, Viral; Female; Genitalia; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymph Nodes; Male; Molecular Sequence Data; Randomized Controlled Trials as Topic; RNA, Viral; Time Factors; Viral Load; Viremia; Virus Replication; Zidovudine | 2001 |
Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.
Topics: Amino Acid Sequence; Anti-HIV Agents; Clinical Trials as Topic; Female; Fetal Blood; Gene Products, env; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Molecular Sequence Data; Peptide Fragments; South Africa; T-Lymphocytes, Helper-Inducer; Zidovudine | 2001 |
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies].
Topics: Africa South of the Sahara; Antiviral Agents; Cesarean Section; Female; France; Hepatitis B; Hepatitis C; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Papillomaviridae; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sexually Transmitted Diseases; Zidovudine | 2001 |
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Statistics, Nonparametric; Viral Load; Viremia; Virus Shedding; Zidovudine | 2001 |
Combination prophylaxis for prevention of maternal-infant HIV transmission: beyond 076.
Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2001 |
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
Topics: Adult; Amylases; Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Incidence; Lipase; Longitudinal Studies; Male; Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States; Zidovudine | 2001 |
Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Nelfinavir; Prospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Codon; Didanosine; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mutation; Retrospective Studies; Survival Rate; Zidovudine | 1996 |
Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Lamivudine; RNA, Viral; Viremia; Zidovudine | 1996 |
A bend in the road--implications of ACTG 175 and Delta trials.
Topics: Anti-HIV Agents; Australia; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Europe; HIV Infections; HIV-1; Humans; Survival Analysis; United States; Zalcitabine; Zidovudine | 1996 |
Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
Topics: Acyclovir; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Proportional Hazards Models; Zidovudine | 1997 |
Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Zidovudine | 1997 |
A review and update on HIV infection and the AIDS epidemic in the adolescent and adult.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Dental Care for Disabled; Global Health; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Exposure; Tennessee; United States; Viral Load; Zidovudine | 2000 |
Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Evolution, Molecular; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Mutation; Phenotype; Protein Conformation; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 2001 |
Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Indinavir; Lamivudine; Nelfinavir; Occupational Exposure; Reverse Transcriptase Inhibitors; Thyroxine; Zidovudine | 2001 |
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Microbial Sensitivity Tests; Mutagenesis; Mutation; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Proviruses; Retrospective Studies; Ritonavir; Zidovudine | 2001 |
Where is the M in MTCT? The broader issues in mother-to-child transmission of HIV.
Topics: Africa South of the Sahara; Anti-HIV Agents; Breast Feeding; Child, Preschool; Female; Foster Home Care; Health Planning; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Health Services; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Women's Health; Zidovudine | 2001 |
The relationship of pregnancy to the use of highly active antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 2001 |
Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Forecasting; HIV Infections; Humans; Interviews as Topic; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Substance-Related Disorders; Zidovudine | 2001 |
Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia.
Topics: Acute Disease; Aged; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Didanosine; Fatal Outcome; Fatty Liver; HIV Infections; HIV-1; Humans; Hypertension, Portal; Male; Mitochondria, Liver; Stavudine; Zidovudine | 2001 |
Self-medication with zidovudine that was not.
Topics: Adult; Anti-HIV Agents; Fraud; HIV Infections; Humans; Male; Self Care; Zidovudine | 2001 |
Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
Topics: Administration, Sublingual; Anti-HIV Agents; Dideoxynucleotides; HIV; HIV Infections; HIV Seropositivity; Humans; Models, Biological; Thymidine Kinase; Thymine Nucleotides; Virus Replication; Zidovudine | 2001 |
HIV-infected women's experiences and beliefs related to AZT therapy during pregnancy.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Georgia; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Longitudinal Studies; Middle Aged; North Carolina; Pregnancy; Pregnancy Complications, Infectious; South Carolina; Surveys and Questionnaires; Women's Health; Zidovudine | 2001 |
Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Survival Rate; Zalcitabine; Zidovudine | 1995 |
U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women.
Topics: AIDS Serodiagnosis; Counseling; Female; Follow-Up Studies; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1995 |
Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor alpha in the serum of children vertically infected with HIV-1.
Topics: Adolescent; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Intercellular Adhesion Molecule-1; Male; Severity of Illness Index; Tumor Necrosis Factor-alpha; Zidovudine | 1996 |
Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.
Topics: Anemia; Anti-HIV Agents; Blood Transfusion; Child; Cost-Benefit Analysis; Decision Trees; Erythropoietin; Health Care Costs; HIV Infections; Humans; Outcome Assessment, Health Care; Sensitivity and Specificity; Zidovudine | 1997 |
Triple therapy in previously untreated patients reduces viral load below limit of detection.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Pyridines; Viral Load; Zidovudine | 1996 |
Evidence of decline in perinatal HIV transmission.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; HIV Infections; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; United States; Zidovudine | 1996 |
AIDS treatments seek to eradicate virus, restore immunity.
Topics: Adjuvants, Immunologic; Anti-HIV Agents; Combined Modality Therapy; HIV Infections; Humans; Lamivudine; Ritonavir; Thymus Gland; Viral Load; Zidovudine | 1996 |
UCLA researcher demonstrates new ways to assess drug treatment in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Evaluation; HIV Infections; HIV-1; Humans; Prognosis; Random Allocation; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zidovudine | 1996 |
Crixivan reduces viral load.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Viral Load; Zalcitabine; Zidovudine | 1996 |
Ethical issues for perinatal HIV trials in developing countries.
Topics: Anti-HIV Agents; Control Groups; Developing Countries; Ethical Relativism; Ethics, Medical; Female; Gestational Age; Health Care Rationing; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Therapeutic Human Experimentation; Treatment Outcome; Zidovudine | 1996 |
ACTH and cortisol secretions in children with perinatal HIV-1 infection.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Hydrocortisone; Infant; Male; Zidovudine | 1996 |
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Research Design; Risk Factors; Zidovudine | 1995 |
Phosphorylated zidovudine concentrations in mononuclear cells in pediatric patients with human immunodeficiency virus infections.
Topics: Adolescent; Anti-HIV Agents; Biological Availability; Child; Child, Preschool; Dideoxynucleotides; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Monocytes; Phosphorylation; Thymine Nucleotides; Treatment Outcome; Zidovudine | 1997 |
ACTG 315 drug cocktail restores immune function.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Ritonavir; RNA, Viral; Viral Load; Zidovudine | 1997 |
Two studies suggest nevirapine benefit for children.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1997 |
Delaviridine and AZT combination tested in women.
Topics: Anti-HIV Agents; Delavirdine; Drug Therapy, Combination; Female; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Anti-HIV effects of nelfinavir reported after ten months of combination therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphoid Tissue; Nelfinavir; Zidovudine | 1997 |
Viramune triple therapy shows suppression of HIV after 1 year, 7 months.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Zidovudine | 1997 |
Head-to-head study of protease inhibitors.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Zidovudine | 1998 |
Data in from first head-to-head protease inhibitor.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Viral Load; Zidovudine | 1998 |
Double protease inhibitor regimens with amprenavir show promise.
Topics: Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Sulfonamides; Viral Load; Zidovudine | 1998 |
AZT program announced.
Topics: Anti-HIV Agents; Communicable Disease Control; Developing Countries; Drug Costs; Drug Industry; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; United Nations; Zidovudine | 1998 |
Prenatal care and HIV infection.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Patient Acceptance of Health Care; Philadelphia; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1999 |
ZDV reduces maternal transmission.
Topics: Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1994 |
AZT studies reinforce benefits of combination.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Synergism; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Lymphocyte Count; Zalcitabine; Zidovudine | 1995 |
Combination 3TC/AZT therapy shows promise.
Topics: CD4 Lymphocyte Count; Codon; Drug Resistance; Drug Therapy, Combination; Drug Tolerance; HIV Infections; Humans; Lamivudine; Mutation; Zalcitabine; Zidovudine | 1995 |
Finding suggests AZT therapy may help prevent occupational HIV infection.
Topics: Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Occupational Exposure; Risk Factors; United States; Zidovudine | 1995 |
Clinical progress and transmission perils stressed at second human retroviruses conference.
Topics: Acyclovir; AIDS Vaccines; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Herpesviridae; HIV Infections; Humans; Interleukin-2; Lamivudine; Lymphoma, Non-Hodgkin; Retroviridae; Sarcoma, Kaposi; Zalcitabine; Zidovudine | 1995 |
Acyclovir improves survival time.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Retrospective Studies; Survival Analysis; Zidovudine | 1995 |
Nevirapine triple combo results released.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Erythema; HIV Infections; HIV-1; Humans; Nevirapine; Pyridines; Virus Replication; Zidovudine | 1995 |
Treatment briefs.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Industry; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Nerve Growth Factors; Nervous System Diseases; Pyridines; Recombinant Proteins; Stavudine; Zalcitabine; Zidovudine | 1995 |
New combo trial/same old style.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Protocols; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1995 |
Interleukin-2.
Topics: AIDS-Related Opportunistic Infections; Antibody Formation; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Infections; Humans; Interleukin-2; Th1 Cells; Virus Replication; Zidovudine | 1995 |
Results of pediatric study present new questions.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious; Quality of Health Care; Zidovudine | 1995 |
3TC: the good news and the bad news.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; Europe; HIV Infections; Humans; Lamivudine; United States; Zalcitabine; Zidovudine | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Mycoses; Pneumonia, Pneumocystis; Valacyclovir; Valine; Zidovudine | 1995 |
Management of HIV infection during pregnancy: new options, new questions.
Topics: AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Delivery, Obstetric; Drug Resistance, Microbial; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Labor, Obstetric; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Recurrence; Zidovudine | 1995 |
First women's HIV conference hears go-for-broke antiretroviral strategy.
Topics: Antifungal Agents; Antiviral Agents; CD4 Lymphocyte Count; Counseling; Female; Fluconazole; Health Education; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mycoses; Pain; Practice Patterns, Physicians'; Pregnancy; Zidovudine | 1995 |
Pregnancy laws becoming a hot topic in state legislatures.
Topics: Counseling; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Informed Consent; Mandatory Testing; Mass Screening; Maternal-Fetal Exchange; Pregnancy; Public Policy; Truth Disclosure; United States; Zidovudine | 1995 |
CDC suspends testing of newborns. Centers for Disease Control and Prevention.
Topics: Centers for Disease Control and Prevention, U.S.; Cost-Benefit Analysis; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Population Surveillance; Pregnancy Complications, Infectious; Truth Disclosure; United States; Zidovudine | 1995 |
HIV disease and reproductive counseling.
Topics: Adolescent; Adult; Counseling; Female; Fetal Diseases; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Adolescence; Zidovudine | 1995 |
Nevirapine: ethical dilemmas and care for HIV-infected mothers.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Counseling; Ethics, Medical; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyridines; RNA-Directed DNA Polymerase; United States; Zidovudine | 1995 |
What we know about anti-HIV drugs.
Topics: Antiviral Agents; Didanosine; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Zalcitabine; Zidovudine | 1995 |
Lamivudine useful against hepatitis B-HIV co-infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Combination antiretroviral treatment: new views, evolving practices.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Cells, Cultured; Clinical Trials as Topic; Drug Administration Schedule; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Lamivudine; Stavudine; Zalcitabine; Zidovudine | 1995 |
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Peripheral Nervous System Diseases; Protease Inhibitors; Quinolines; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1995 |
Studies say doctors are lax in assisting pregnant women.
Topics: Adolescent Health Services; Continuity of Patient Care; Costs and Cost Analysis; Counseling; Female; HIV Infections; Humans; Mass Screening; Medicaid; Physician-Patient Relations; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Adolescence; United States; Zidovudine | 1995 |
Study says 90 percent of women will agree to voluntary testing.
Topics: Attitude to Health; Counseling; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mass Screening; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; United States; Zidovudine | 1995 |
A closer look at 3TC. Interview by Mark Mascolini.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
Antiretroviral drug resistance.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Viremia; Zalcitabine; Zidovudine | 1995 |
A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV; HIV Infections; Humans; Hydroxyurea; Indinavir; Interleukin-2; Lamivudine; Mutation; Pyridines; RNA, Viral; Zalcitabine; Zidovudine | 1995 |
Roche submits NDA for Invirase.
Topics: Clinical Trials as Topic; Drug Approval; HIV Infections; HIV Protease Inhibitors; Humans; Investigational New Drug Application; Isoquinolines; Quinolines; Saquinavir; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
Update on clinical trials of combination therapies for HIV infection.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; RNA-Directed DNA Polymerase; Stavudine; Zalcitabine; Zidovudine | 1995 |
Researchers are rethinking role of AZT in drug therapy.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; HIV Infections; Humans; United States; Zidovudine | 1995 |
Update on HIV protease inhibitors.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Design; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Phosphorylation; Pyridines; Quinolines; Ritonavir; Saquinavir; Substrate Specificity; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Study: AIDS cases among newborns peaked in 1991.
Topics: Adult; Child; Child, Preschool; Female; Health Surveys; HIV Infections; Humans; Infant; Infant, Newborn; Pregnancy; United States; Zidovudine | 1995 |
ICAAC 1995: new perspectives on treatment.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Antiviral Agents; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; Humans; Treatment Failure; Zidovudine | 1995 |
Protease inhibitors and prevention of cross resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbamates; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nelfinavir; Pyridines; Quinolines; Saquinavir; Sulfonamides; Zalcitabine; Zidovudine | 1995 |
Nutrition and HIV: a new model for treatment. Vitamins, minerals and trace elements.
Topics: Antioxidants; Drug Interactions; HIV Infections; Humans; Minerals; Nutritional Physiological Phenomena; Vitamins; Zidovudine | 1995 |
3TC and saquinavir: we need them now.
Topics: Antiviral Agents; Drug Approval; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
Sleep disturbance in early HIV infection.
Topics: Antiviral Agents; HIV Infections; Humans; Interleukin-1; Sleep Wake Disorders; Stress, Psychological; Tumor Necrosis Factor-alpha; Zidovudine | 1995 |
Roaches of inner space.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Lamivudine; Mutation; T-Lymphocytes, Cytotoxic; Virulence; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |
Mothers shown to transmit resistant strains to babies.
Topics: Antiviral Agents; HIV; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Viremia; Zidovudine | 1995 |
Closing the circle on HIV--or not.
Topics: Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-2; Nelfinavir; Prognosis; RNA, Viral; Zalcitabine; Zidovudine | 1995 |
An interview with Charles A.B. Boucher, MD, PhD. Interview by Mark Mascolini.
Topics: Antiviral Agents; Drug Resistance, Microbial; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Mutation; RNA, Viral; Zalcitabine; Zidovudine | 1995 |
Protease inhibitors.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-2; Zidovudine | 1995 |
Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Mutation; RNA, Viral; Zidovudine | 1995 |
3TC/AZT: just another combination.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
Conference news highlights.
Topics: CD4 Lymphocyte Count; Cervix Uteri; Cytokines; Female; Genital Diseases, Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Vagina; Zidovudine | 1995 |
Combination therapy increases survival.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Stavudine; Zalcitabine; Zidovudine | 1995 |
Lamivudine (3TC) approved for combination use with AZT.
Topics: Adult; Antiviral Agents; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
CDC study supports AZT use after occupational injury. Centers for Disease Control and Prevention.
Topics: Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV Infections; Humans; Needlestick Injuries; Occupational Exposure; United States; Zidovudine | 1996 |
Noninfectious skin disorders.
Topics: Diagnosis, Differential; Drug Therapy; Hair Diseases; HIV Infections; Humans; Light; Skin Diseases; Vasculitis; Zidovudine | 1995 |
3TC approved: now for the tough questions.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Zalcitabine; Zidovudine | 1995 |
Benefits of combination therapy confirmed.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Treatment Failure; Zalcitabine; Zidovudine | 1995 |
Merck protease inhibitor: more news from Retroviruses Conference.
Topics: CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Zalcitabine; Zidovudine | 1996 |
Potent new AIDS drugs underscore promise of combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Approval; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
CDC to revisit AZT, post-exposure guidelines. Centers for Disease Control and Prevention.
Topics: Adenine; Antiviral Agents; Blood-Borne Pathogens; Centers for Disease Control and Prevention, U.S.; Guidelines as Topic; Health Personnel; HIV Infections; Humans; Macaca; Needlestick Injuries; Occupational Exposure; Organophosphonates; Zidovudine | 1996 |
CDC wants more input before updating post-exposure guidelines. Centers for Disease Control and Prevention.
Topics: Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Guidelines as Topic; Health Personnel; HIV Infections; HIV Seropositivity; Infectious Disease Transmission, Patient-to-Professional; Insurance Benefits; Needlestick Injuries; Occupational Exposure; United States; Zidovudine | 1996 |
Clinicians experiment with post-exposure drug pairs.
Topics: Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Needlestick Injuries; Occupational Exposure; Zalcitabine; Zidovudine | 1996 |
Viral load linked to risk of transmission.
Topics: Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; RNA, Viral; Zidovudine | 1996 |
A more practical therapy for low platelets.
Topics: Adrenal Cortex Hormones; Antibodies; Blood Platelets; HIV Infections; Humans; Immunoglobulins; Immunotherapy; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Zidovudine | 1996 |
A surprisingly potent nucleoside analogue.
Topics: Adult; Antiviral Agents; HIV Infections; HIV-1; Humans; Lamivudine; Nucleosides; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Three days that shook the world.
Topics: Antiviral Agents; Drug Approval; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine; Zidovudine | 1996 |
Pediatric treatment update.
Topics: Adolescent; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Zidovudine | 1996 |
AZT and 3TC.
Topics: CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1996 |
Update on other antivirals.
Topics: Adenine; Antiviral Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Organophosphonates; Stavudine; Zalcitabine; Zidovudine | 1996 |
Ritonavir: first to prolong survival.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
New "ThetaSwitch" drug may increase long-term survival in HIV disease.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Interferons; Interleukin-12; Interleukin-2; Poly I-C; Poly U; RNA, Double-Stranded; Zidovudine | 1996 |
CDC takes aggressive stance on postexposure prophylaxis. Centers for Disease Control and Prevention.
Topics: Antiviral Agents; Blood-Borne Pathogens; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Exposure; Pyridines; Risk Factors; United States; Zalcitabine; Zidovudine | 1996 |
The (viral) burden of motherhood.
Topics: Antiviral Agents; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Zidovudine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Antiviral roundup.
Topics: CD4 Lymphocyte Count; Cohort Studies; Delavirdine; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Mutation; Piperazines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stavudine; Zidovudine | 1996 |
Top AIDS researchers' strategy for antiretroviral treatment.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Patient Compliance; Practice Guidelines as Topic; RNA, Viral; Stavudine; Zalcitabine; Zidovudine | 1996 |
Nevirapine: new drug, new class, new questions.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Approval; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 1996 |
3TC: combination trial stopped early as clinical benefit shown.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Placebos; Treatment Failure; Zalcitabine; Zidovudine | 1996 |
ACTG 152: new insights into pediatric antiretroviral therapy.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Infant; Zidovudine | 1996 |
Blacks, Hispanics not at increased risk for AZT side effects.
Topics: Black People; Hispanic or Latino; HIV Infections; Humans; Risk Factors; Zidovudine | 1996 |
Eradication of HIV: the cutting edge of clinical trial design.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Pyridines; Zalcitabine; Zidovudine | 1996 |
Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Decision Making; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Zalcitabine; Zidovudine | 1996 |
New findings bring hope to Vancouver AIDS conference.
Topics: Adult; AIDS Vaccines; Antiviral Agents; Clinical Trials as Topic; Developing Countries; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 1996 |
Nevirapine approved by FDA. Food and Drug Administration.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Approval; Drug Therapy, Combination; Female; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pyridines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Viral Load; Zidovudine | 1996 |
Weight loss update.
Topics: AIDS-Related Opportunistic Infections; Appetite Stimulants; Female; Growth Hormone; HIV Infections; HIV Wasting Syndrome; Humans; Male; Recombinant Proteins; Testosterone; Thalidomide; Weight Loss; Zidovudine | 1996 |
A patient's guide to protease inhibitors.
Topics: Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Eating; Guidelines as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Ritonavir; Saquinavir; Stavudine; Zidovudine | 1996 |
AZT twice-daily tablets approved: dosing concerns.
Topics: Dosage Forms; Dose-Response Relationship, Drug; Drug Approval; HIV Infections; Patient Compliance; Zidovudine | 1996 |
ddI and d4T plus protease inhibitors.
Topics: Anti-HIV Agents; Didanosine; HIV Infections; Humans; Lamivudine; Stavudine; Zalcitabine; Zidovudine | 1996 |
FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Delavirdine; Didanosine; Disease Progression; Drug Approval; Drug Industry; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indoles; Piperazines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Viral Load; Zidovudine | 1996 |
Supreme Court won't review invasion-of-privacy case.
Topics: Anti-HIV Agents; Civil Rights; Drug Prescriptions; Employment; HIV Infections; Humans; Male; Pennsylvania; Privacy; United States; Zidovudine | 1996 |
Dethroning AZT.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; Oxazines; Stavudine; Viral Load; Zidovudine | 1997 |
Study shows three drugs better than two.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Stavudine; United States; Zidovudine | 1997 |
Study confirms that protease inhibitor cocktail can delay HIV disease progression and death.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1997 |
Panel affirms importance of prenatal AZT use.
Topics: Adult; Animals; Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Mice; Pregnancy; Zidovudine | 1997 |
NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chemokines; Clinical Trials as Topic; Clone Cells; Dendritic Cells; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-10; Killer Cells, Natural; Lamivudine; Male; Nevirapine; Pyridines; Receptors, Cytokine; Reverse Transcriptase Inhibitors; Ritonavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
AZT, d4T ok'd for infants.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Child; Child, Preschool; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mice; Pregnancy; Stavudine; Vaginal Neoplasms; Zidovudine | 1997 |
AZT during pregnancy.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1997 |
Nelfinavir at six months.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Nelfinavir; Sulfonic Acids; Viral Load; Zidovudine | 1997 |
ACTG 320: last of the body count trials?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethics, Medical; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
Nelfinavir - major trial results at retroviruses conference.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Nelfinavir; Stavudine; Sulfonic Acids; Viral Load; Zidovudine | 1997 |
Delavirdine (Rescriptor) approved.
Topics: Anti-HIV Agents; Delavirdine; Didanosine; Drug Approval; Drug Costs; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indoles; Piperazines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 1997 |
New recommendations on health care worker exposure to HIV.
Topics: Anti-HIV Agents; Disease Transmission, Infectious; Drug Therapy, Combination; Guidelines as Topic; Health Personnel; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Risk Factors; Viral Load; Zidovudine | 1996 |
Immune modulation with IL-2 and IL-12.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cytokines; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Interleukin-12; Interleukin-2; Zidovudine | 1997 |
Spring cleaning in trial land.
Topics: Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Stavudine; United States; Viral Load; Zidovudine | 1997 |
Doctor withheld prenatal care to woman with HIV, suit says.
Topics: Disabled Persons; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Massachusetts; Pregnancy; Prejudice; Prenatal Care; Refusal to Treat; Zidovudine | 1997 |
Newly approved PI provides treatment options.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Nelfinavir; Sulfonic Acids; Viral Load; Zidovudine | 1997 |
Court says inmate not harmed by suspension of HIV drug.
Topics: Anti-HIV Agents; Civil Rights; Health Services Accessibility; HIV Infections; Humans; Male; Michigan; Prisoners; Refusal to Treat; Zidovudine | 1997 |
CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Risk-Taking; Sexual Behavior; United States; Zidovudine | 1997 |
Postexposure prophylaxis for HIV.
Topics: Anti-HIV Agents; HIV Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; Zidovudine | 1997 |
New studies of methods for preventing perinatal HIV transmission.
Topics: Administration, Oral; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
NIH reaffirms support for perinatal AZT despite cancer findings. National Institutes of Health.
Topics: Animals; Anti-HIV Agents; Female; Health Policy; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mice; Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Zidovudine | 1997 |
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1997 |
Nelfinavir (Viracept).
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Lamivudine; Nelfinavir; Reverse Transcriptase Inhibitors; Sulfonic Acids; United States; United States Food and Drug Administration; Viral Load; Virus Replication; Zidovudine | 1997 |
141 (Vertex-478).
Topics: Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Sulfonamides; Viral Load; Zidovudine | 1997 |
New developments in women and AIDS research.
Topics: AIDS-Related Opportunistic Infections; Delavirdine; Drug Therapy, Combination; Estrogens; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Indoles; Infant; Infectious Disease Transmission, Vertical; Isoquinolines; Nelfinavir; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Sulfonic Acids; Zidovudine | 1997 |
Scientific basis for PEP rests in animal trials.
Topics: Adenine; Animals; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Health Personnel; HIV; HIV Infections; Humans; Macaca; Nevirapine; Occupational Diseases; Organophosphonates; Organophosphorus Compounds; Pan troglodytes; Pyridines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Tenofovir; United States; Zidovudine | 1997 |
Experience with PEP finds most patients stop early.
Topics: Anti-HIV Agents; British Columbia; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Male; Occupational Diseases; Patient Compliance; Sexually Transmitted Diseases; Time Factors; United States; Zidovudine | 1997 |
CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; Female; Health Personnel; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Occupational Diseases; Practice Guidelines as Topic; Pregnancy; Public Health; Sexually Transmitted Diseases; Substance Abuse, Intravenous; United States; Zidovudine | 1997 |
Preventive therapy isn't a magic pill for exposures.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; Female; Health Personnel; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Occupational Diseases; Pregnancy; United States; Zidovudine | 1997 |
Guidelines for post-exposure treatment not likely soon.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; HIV Infections; Humans; Occupational Diseases; Practice Guidelines as Topic; Time Factors; United States; Zidovudine | 1997 |
Combo therapy for children and adolescents.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Infant; Lamivudine; Zidovudine | 1997 |
USPHS recommendations for HIV treatment during pregnancy. United States Public Health Service.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; United States; United States Public Health Service; Zidovudine | 1997 |
Update on nevirapine: quest for a niche.
Topics: Adult; Anti-HIV Agents; Child; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Nevirapine; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1997 |
Two drugs better than one for children.
Topics: Anti-HIV Agents; Child; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zidovudine | 1997 |
What you need to know about Combivir.
Topics: Anti-HIV Agents; Drug Combinations; Guidelines as Topic; HIV Infections; Humans; Lamivudine; Patient Compliance; Zidovudine | 1998 |
Preventing HIV infection in infants in developing countries: NIAID's role. National Institute of Allergy and Infectious Diseases.
Topics: Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Ethiopia; Female; Health Planning; HIV Infections; Humans; Immunization, Passive; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Male; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Uganda; Zidovudine | 1997 |
Pediatric HIV clinical trials in the United States.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nevirapine; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1997 |
Global strategies for the prevention of vertical HIV transmission.
Topics: Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Developed Countries; Developing Countries; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Time Factors; Vitamin A; Zidovudine | 1997 |
Highlights from the Conference on Global Strategies on the Prevention of Mother-to-Child HIV Transmission.
Topics: Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
AZT trials in developing countries: what's next?
Topics: Anti-HIV Agents; Clinical Trials as Topic; Cote d'Ivoire; Developing Countries; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Spouses; Thailand; Zidovudine | 1998 |
AZT trials pose difficult breast-feeding dilemma.
Topics: Africa; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1998 |
HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Blood-Brain Barrier; Brain; Drug Therapy, Combination; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 1998 |
ACTG 343: three drugs better than two for maintaining HIV suppression.
Topics: AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Viral Load; Zidovudine | 1998 |
Medical advances with international impact.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Isoniazid; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Reagent Kits, Diagnostic; Rifampin; RNA, Viral; Tuberculosis; Viral Load; Zidovudine | 1998 |
Post-exposure prophylaxis revisited: new CDC guidelines. Centers for Disease Control and Prevention.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; Guidelines as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Patient-to-Professional; Needlestick Injuries; Occupational Exposure; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1998 |
Summary of the 5th Conference on Retroviruses and Opportunistic Infections.
Topics: AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Phosphorylation; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Salvage Therapy; Thailand; Viral Load; Zidovudine | 1998 |
Revised CDC guidelines underscore mother's health. Centers for Disease Control and Prevention.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Clinical Trials as Topic; Drug Therapy, Combination; Female; Guidelines as Topic; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Care Planning; Pregnancy; Pregnancy Complications, Infectious; Prevalence; United States; Zidovudine | 1998 |
Drug research shows easier dosing, new combinations are making gains.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Salvage Therapy; Stavudine; United States; Zidovudine | 1998 |
Thai study success affects ongoing placebo trials.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 1998 |
Studies look at approaches other than antiretovirals.
Topics: Anti-HIV Agents; Anti-Infective Agents; Breast Feeding; Cesarean Section; Chlorhexidine; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunoglobulins, Intravenous; Infectious Disease Transmission, Vertical; Suppositories; Vagina; Vitamin A; Zidovudine | 1998 |
Positive results from AZT trial are still just a start.
Topics: Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
Abbreviated AZT regimen is effective in curbing HIV in infants.
Topics: Administration, Oral; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 1998 |
New ways to take old drugs.
Topics: Anti-HIV Agents; Biological Availability; Drug Combinations; Drug Storage; HIV Infections; Humans; Lamivudine; Saquinavir; Zidovudine | 1998 |
Reevaluating initial therapy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Polymerase Chain Reaction; Stavudine; Viral Load; Zidovudine | 1998 |
Anemia in HIV disease.
Topics: Anemia; Anti-HIV Agents; Bone Marrow; Erythropoiesis; Erythropoietin; HIV Infections; Humans; Kidney; Recombinant Proteins; Zidovudine | 1998 |
2, 4, 6, 8, who's afraid to phosphorylate?
Topics: Anti-HIV Agents; Biotransformation; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Mutation; Phosphorylation; Prodrugs; Treatment Failure; Virus Replication; Zidovudine | 1998 |
San Francisco group demonstrates the ability of combination anti-HIV therapy to lower PHT.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia, Pneumocystis; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
Short-course AZT reduces HIV transmission to infants; Glaxo cuts AZT price for developing countries.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Developing Countries; Drug Costs; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Thailand; United States; Zidovudine | 1998 |
Vertical transmission research at the Retrovirus Conference.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Resistance, Microbial; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zidovudine | 1998 |
Preventing mother-infant transmission worldwide: what is needed? Interview with Joseph Saba, M.D. Interview by John S. James.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; Global Health; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
New drugs: amprenavir and abacavir.
Topics: Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Administration Schedule; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Sulfonamides; Viral Load; Zidovudine | 1998 |
New guidelines issued for occupational exposures.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Occupational Exposure; Practice Guidelines as Topic; United States; United States Public Health Service; Zidovudine | 1998 |
Maternal AZT programs at the starting gate.
Topics: Anti-HIV Agents; Developing Countries; Drug Costs; Female; Health Services Accessibility; HIV Infections; Humans; Infant; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; Pregnancy; Pregnancy Complications, Infectious; United Nations; Zidovudine | 1998 |
Giving improper dose of HIV drug is not proof of indifference.
Topics: Anti-HIV Agents; Disabled Persons; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Prisoners; Reverse Transcriptase Inhibitors; Texas; Zidovudine | 1998 |
The triple whammy & pregnancy.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Viral Load; Zidovudine | 1998 |
Epoietin alfa (EPO) for anemia.
Topics: Anemia; Anti-HIV Agents; Clinical Trials as Topic; Erythropoietin; Female; HIV Infections; Humans; Male; Pregnancy; Recombinant Proteins; Zidovudine | 1998 |
Updated postexposure guidelines stress need for expert advice.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Combination; Female; Guidelines as Topic; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Occupational Diseases; Occupational Exposure; Pregnancy; Registries; United States; Zidovudine | 1998 |
Registry finds 3 drugs most favored PEP regimen.
Topics: Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Combinations; Drug Therapy, Combination; Guidelines as Topic; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Registries; United States; Zidovudine | 1998 |
New drugs on the horizon.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides; United States; Zidovudine | 1998 |
Lower dose maintenance therapy?
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine | 1998 |
U.N. drug initiative hits the ground.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Clinical Trials as Topic; Developing Countries; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; International Cooperation; National Health Programs; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; United Nations; Zidovudine | 1998 |
Sending HIV drugs to developing countries.
Topics: Anti-HIV Agents; Developing Countries; Female; Health Services Accessibility; Health Services Needs and Demand; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy Complications, Infectious; Zidovudine | 1998 |
Pregnancy & perinatal transmission update.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Developing Countries; Drug Costs; Female; Health Promotion; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Vitamins; Zidovudine | 1998 |
Report from Geneva: women and HIV.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Papillomaviridae; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Tumor Virus Infections; Uterine Cervical Dysplasia; Viral Load; Zidovudine | 1998 |
Bridging the gap?
Topics: AIDS Vaccines; AIDS-Related Opportunistic Infections; Animals; Anti-HIV Agents; Clinical Trials as Topic; Congresses as Topic; Drug Resistance, Microbial; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Needle-Exchange Programs; Pregnancy; Pregnancy Complications, Infectious; Switzerland; Zidovudine | 1998 |
Prevention of mother-to-child HIV transmission.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Cesarean Section; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 1998 |
First once-daily drug simplifies dosing, offers new options in HIV-1 treatment.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Patient Compliance; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
New report calls for universal testing of pregnant women. Institute of Medicine.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Female; Guidelines as Topic; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; United States; Zidovudine | 1998 |
Highlights on women and pregnancy from the 12th World AIDS Conference.
Topics: Anti-HIV Agents; Anti-Infective Agents; Cesarean Section; Clinical Trials as Topic; Condoms, Female; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Sexually Transmitted Diseases; Uterine Cervical Dysplasia; Weight Gain; Zidovudine | 1998 |
A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
Topics: Alkynes; Anti-HIV Agents; Antineoplastic Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Lamivudine; Lipodystrophy; Oxazines; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 1998 |
Viral load--how low is best?
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 1998 |
IOM: Make prenatal HIV testing part of routine care. Institute of Medicine.
Topics: Anti-HIV Agents; Female; Health Services Accessibility; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Organizations, Nonprofit; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Prenatal Diagnosis; Risk Factors; United States; Zidovudine | 1998 |
South African government abandons AZT pilot project.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Female; Health Policy; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; South Africa; Zidovudine | 1998 |
Triple-drug therapy may mean lifelong commitment.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; France; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Patient Compliance; United States; Zidovudine | 1999 |
Unequal care sustains vertical transmission rate.
Topics: Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
State of emergency: HIV/AIDS among African Americans.
Topics: Adult; Anti-HIV Agents; Black or African American; Child; Female; Financing, Government; Health Policy; HIV Infections; Homosexuality, Male; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Substance-Related Disorders; United States; Zidovudine | 1999 |
Judge orders mother to give baby AZT, stop breast-feeding.
Topics: Anti-HIV Agents; Breast Feeding; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maine; Male; Oregon; Pregnancy Complications, Infectious; Treatment Refusal; Zidovudine | 1999 |
A new HAART on the horizon says the proof is in the potency.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Oxazines; Patient Compliance; Pregnancy; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
New study shows efavirenz effective with d4T and 3TC.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cerebrospinal Fluid; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Vagina; Viral Load; Zidovudine | 1999 |
Protease inhibitors work against HIV-1 subtype C.
Topics: Africa; Anti-HIV Agents; Cesarean Section; Drug Therapy, Combination; Female; Health Services Accessibility; Heterosexuality; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; India; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Zidovudine | 1999 |
Pregnancy.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Zidovudine | 1999 |
Promising findings from the PETRA study of perinatal transmission.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Randomized Controlled Trials as Topic; South Africa; Tanzania; Uganda; Zidovudine | 1999 |
Viral load and perinatal transmission.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunoglobulins; Immunotherapy; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Time Factors; Viral Load; Zidovudine | 1999 |
Single-dose Nevirapine during pregnancy.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Prevention of perinatal HIV infection: cause for optimism.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Cesarean Section; Clinical Trials as Topic; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Load; Zidovudine | 1999 |
Nukes alone.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Administration Schedule; Drug Therapy, Combination; France; HIV Infections; Humans; Lamivudine; Zidovudine | 1999 |
Viral load affects risk for perinatal HIV transmission.
Topics: Clinical Trials as Topic; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 1999 |
Despite epidemic, South Africa cuts AZT project.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 1999 |
South Africa HIV dispute: time to stop and think.
Topics: Anti-HIV Agents; Female; Government; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Internet; Pregnancy; Pregnancy Complications, Infectious; South Africa; Zidovudine | 2000 |
HIV prophylaxis is deemed pertinent evidence in rape trial.
Topics: Anti-HIV Agents; Georgia; HIV Infections; Humans; Sex Offenses; Zidovudine | 2000 |
Strategies for preventing late-term vertical HIV transmission.
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Female; Health Promotion; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Global strategies for the prevention of HIV transmission from mothers to infants: the second conference.
Topics: Anti-HIV Agents; Breast Feeding; Cesarean Section; Clinical Trials as Topic; Congresses as Topic; Developing Countries; Drug Therapy, Combination; Female; Global Health; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Mother-to-child HIV prevention: is elective C-section necessary?
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cesarean Section; Drug Administration Schedule; Elective Surgical Procedures; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mycoses; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
Simpler regimens for preventing mother-to-child HIV transmission.
Topics: Delivery, Obstetric; Developing Countries; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Progress in reducing mother-to-infant HIV transmission.
Topics: Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Female; HIV Infections; Humans; Immunoglobulins, Intravenous; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Cesarean section and perinatal transmission.
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postoperative Complications; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Protease inhibitors: where are they now?
Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine | 1995 |
Hydroxyurea, a potential new anti-HIV agent.
Topics: Didanosine; DNA Replication; Drug Therapy, Combination; HIV; HIV Infections; Humans; Hydroxyurea; Leukocytes, Mononuclear; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Antiretroviral therapy for adults and children.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Didanosine; Female; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Primary Health Care; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1995 |
ACTG 076 and reduction of perinatal transmission.
Topics: Adolescent; Adult; Animals; Anti-HIV Agents; Black or African American; CD4 Lymphocyte Count; Disease Progression; Hispanic or Latino; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Mice; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; United States; United States Public Health Service; Zidovudine | 1997 |
[Compact therapy with 2 tablets daily. Initial triple combination tablet simplifies HIV therapy].
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; HIV Infections; Humans; Lamivudine; Patient Compliance; Zidovudine | 2001 |
[Results of the TRIZAL Study. Therapy change with positive concomitant effect].
Topics: Anti-HIV Agents; Cholesterol; Clinical Trials as Topic; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Treatment Outcome; Triglycerides; Zidovudine | 2001 |
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymphoid Tissue; Phenotype; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine | 2001 |
CT appearances of HIV-related lipodystrophy syndrome.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Mass Index; HIV Infections; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine | 2001 |
Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Microbial; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; New York; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2001 |
R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
Choosing which nuke to use first.
Topics: Didanosine; Dideoxynucleosides; Drug Administration Schedule; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2001 |
Risk of perinatal transmission with treatment combinations of intrapartum and newborn zidovudine monotherapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Connecticut; Drug Administration Schedule; Female; Florida; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Medical Records; New York City; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Texas; Zidovudine | 2001 |
[Pharmacology of antiretroviral agents in children].
Topics: Anti-HIV Agents; Child; HIV Infections; Humans; Zidovudine | 2001 |
Combination antiretroviral therapy and duration of pregnancy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Delivery, Obstetric; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; HIV-1; Humans; Infant, Newborn; Infant, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Viral Load; Zidovudine | 2000 |
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.
Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Microbial; Female; France; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Molecular Sequence Data; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2001 |
Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants.
Topics: Anti-HIV Agents; Codon; Cohort Studies; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2001 |
Mother-to-child transmission of the human immunodeficiency virus in Texas.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; Texas; Zidovudine | 2001 |
Specific IgA detection can be used for perinatal diagnosis of HIV in children under protocol ACTG 076.
Topics: Antibodies, Viral; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; HIV Infections; HIV-1; Humans; Immunoglobulin A; Infant; Infectious Disease Transmission, Vertical; Reproducibility of Results; Zidovudine | 2001 |
The inference of stepwise changes in substitution rates using serial sequence samples.
Topics: Anti-HIV Agents; Evolution, Molecular; Genes, env; Genetic Techniques; HIV Infections; HIV-1; Humans; Least-Squares Analysis; Likelihood Functions; Models, Genetic; Time Factors; Zidovudine | 2001 |
[Risk of materno-fetal transmission of the HIV infection with antiretroviral therapy and cesarean section: experience of the Parma group].
Topics: Anti-HIV Agents; Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Italy; Pregnancy; Retrospective Studies; Risk Factors; Zidovudine | 2000 |
Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
Topics: Amino Acid Sequence; Anti-HIV Agents; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Evolution, Molecular; Genetic Heterogeneity; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Sequence Data; Mutagenesis, Insertional; Phylogeny; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Time Factors; Zidovudine | 2001 |
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life.
Topics: Age Distribution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disease Progression; Europe; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Life Tables; Male; Severity of Illness Index; Survival Analysis; Zidovudine | 2001 |
Human immunodeficiency virus infection in pregnant women, transmission and zidovudine therapy.
Topics: Adult; Birth Weight; CD4 Lymphocyte Count; Cesarean Section; Delivery, Obstetric; Female; Fetal Monitoring; Gestational Age; Heart Rate, Fetal; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Sexual Partners; Substance Abuse, Intravenous; Zidovudine | 2001 |
The cost effectiveness of antiretroviral therapy for HIV disease.
Topics: Anti-HIV Agents; Cost-Benefit Analysis; Drug Therapy, Combination; HIV Infections; Humans; Life Expectancy; Quality-Adjusted Life Years; Zidovudine | 2001 |
[Symptomatic hyperlactemia in patients infected with the human immunodeficiency virus treated with nucleoside analogs].
Topics: Adult; Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Lactic Acid; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Surveillance shows success of perinatal HIV prevention guidelines.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Population Surveillance; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Prevalence and predictive value of intermittent viremia with combination hiv therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Predictive Value of Tests; Prevalence; Proportional Hazards Models; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine | 2001 |
[Vertical transmission of HIV infection: risk factors and prevention strategies].
Topics: Anti-HIV Agents; Cesarean Section; Female; Follow-Up Studies; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Zidovudine | 2000 |
Association between zalcitabine therapy for human immunodeficiency virus and granuloma annulare?
Topics: Adult; Female; Granuloma Annulare; HIV Infections; Humans; Pain; Remission, Spontaneous; Zalcitabine; Zidovudine | 2001 |
Factors associated with HIV-infected women's use or intention to use AZT during pregnancy.
Topics: Adult; Antiviral Agents; Attitude; Female; HIV Infections; Humans; Infant, Newborn; Interviews as Topic; Physician-Patient Relations; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Sampling Studies; Zidovudine | 2001 |
Stavudine versus zidovudine and the development of lipodystrophy.
Topics: Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Lipodystrophy; Male; Odds Ratio; Prevalence; Regression Analysis; Risk Factors; Stavudine; Viral Load; White People; Zidovudine | 2001 |
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.
Topics: Anti-HIV Agents; Case-Control Studies; Female; HIV Infections; HLA-DR Antigens; Humans; Lamivudine; Leukocyte Common Antigens; Longitudinal Studies; Lymphocyte Count; Male; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Ritonavir; T-Lymphocyte Subsets; Viral Load; Zidovudine | 2001 |
Experience during the first fifteen months of New York State expedited human immunodeficiency virus testing.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Mass Screening; New York; Perinatal Care; Pregnancy; Risk Factors; Zidovudine | 2001 |
[Recommendations on the use of antiretroviral agents in pregnant women infected with HIV-1].
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Zidovudine | 2001 |
Evaluation of a regional pilot program to prevent mother-infant HIV transmission--Thailand, 1998-2000.
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Female; HIV Infections; Humans; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2001 |
Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Cote d'Ivoire; Counseling; Female; HIV Infections; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Reverse Transcriptase Inhibitors; Truth Disclosure; Zidovudine | 2001 |
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Hypergammaglobulinemia; Immunoglobulin G; Lamivudine; Male; Middle Aged; Retrospective Studies; Ritonavir; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2001 |
Lipid abnormalities in a healthcare worker receiving HIV prophylaxis.
Topics: Adult; Allied Health Personnel; Anti-HIV Agents; Cholesterol; Cholesterol, LDL; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Lamivudine; Needlestick Injuries; Nelfinavir; Practice Guidelines as Topic; Renal Dialysis; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
A retrospective analysis of oral hairy leukoplakia in South Australia.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Chi-Square Distribution; Female; HIV Infections; Humans; Leukoplakia, Hairy; Male; Middle Aged; Prevalence; Retrospective Studies; South Australia; Time Factors; Zidovudine | 2001 |
Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Topics: Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Mutagenesis, Site-Directed; Mutation; Peptide Chain Termination, Translational; Recombinant Proteins; Viral Load; Virus Replication; Zidovudine | 2001 |
Successful prevention of hiv transmission from mother to infant in Brazil using a multidisciplinary team approach.
Topics: Adolescent; Adult; Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Cohort Studies; Female; HIV Infections; Humans; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Care Team; Patient Compliance; Patient Education as Topic; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Safety; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Trends in HIV testing among pregnant women: United States, 1994-1999.
Topics: Adolescent; Adult; AIDS Serodiagnosis; Anti-HIV Agents; Female; Guideline Adherence; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Population Surveillance; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Risk Factors; United States; United States Public Health Service; Zidovudine | 2001 |
Neurological disorders after zidovudine exposure in utero.
Topics: Female; France; HIV Infections; Humans; Infant, Newborn; Lamivudine; Mitochondria; Neurotoxicity Syndromes; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; United States; Zidovudine | 1999 |
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; Salvage Therapy; Treatment Failure; Viral Load; Zidovudine | 2001 |
From the Centers for Disease Control and Prevention. Evaluation of a regional pilot program to prevent mother-infant HIV transmission--Thailand, 1998-2000.
Topics: Anti-HIV Agents; Breast Feeding; Developing Countries; Female; HIV Infections; Humans; Infant Food; Infant, Newborn; Infectious Disease Transmission, Vertical; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Thailand; Zidovudine | 2001 |
High prevalence of genotypic zidovudine resistance among HIV-infected Canadian children.
Topics: Adolescent; Anti-HIV Agents; Canada; Child; Cohort Studies; Drug Resistance; Genotype; HIV Infections; Humans; Prevalence; Zidovudine | 2001 |
Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Viremia; Zidovudine | 2001 |
Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.
Topics: Adenine; Anti-HIV Agents; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine | 2001 |
Postnatal zidovudine in prevention of vertical HIV-1 transmission in a service setting.
Topics: Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Factors; South Africa; Zidovudine | 2001 |
Prevention of mother-infant HIV transmission. Thailand, 1998-2000. Part I.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Program Evaluation; Reverse Transcriptase Inhibitors; Thailand; Zidovudine | 2001 |
Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayelitsha.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Counseling; Female; Health Plan Implementation; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Outcome Assessment, Health Care; Pilot Projects; Pregnancy; Prenatal Care; South Africa; Zidovudine | 2001 |
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Platelet Count; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia; Time Factors; Treatment Outcome; Zidovudine | 2001 |
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Didanosine; DNA, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunologic Memory; Interleukin-2; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine | 2001 |
Discrimination. Pregnant woman with HIV loses lawsuit against doctor.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Massachusetts; Obstetrics; Patient Advocacy; Patient Transfer; Physicians; Pregnancy; Pregnancy Complications, Infectious; Prejudice; Reverse Transcriptase Inhibitors; Workforce; Zidovudine | 2001 |
Antiretroviral rounds. When success is a pain.
Topics: Abdominal Pain; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Oxazines; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2001 |
New procedure under study may replace Pap smear.
Topics: Cancer Vaccines; Complementary Therapies; Female; Growth Inhibitors; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mental Health Services; Papanicolaou Test; Papillomaviridae; Placenta; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervical Neoplasms; Vaginal Smears; Zidovudine | 2001 |
Discrimination. Supreme Court decision limits N.J. agency's ADS liability.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Disabled Persons; Female; Government Agencies; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Liability, Legal; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; State Government; Zidovudine | 2001 |
Taking HIV to court.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Jurisprudence; Male; Nevirapine; Politics; Pregnancy; Pregnant Women; South Africa; Zidovudine | 2001 |
Correlation coefficient estimation involving a left censored laboratory assay variable.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Laboratory Techniques; Female; HIV Infections; HIV-1; Humans; Likelihood Functions; Pregnancy; Statistics as Topic; Thailand; Viral Load; Zidovudine | 2001 |
An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Brain; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Magnetic Resonance Imaging; Motor Neuron Disease; Nelfinavir; Neurologic Examination; Treatment Outcome; Zidovudine | 2001 |
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.
Topics: Antiviral Agents; Biomarkers; Biotechnology; Clinical Trials as Topic; Consensus Development Conferences as Topic; Female; Genomics; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Meta-Analysis as Topic; National Institutes of Health (U.S.); Predictive Value of Tests; Pregnancy; Research Design; RNA, Viral; United States; Viral Load; Zidovudine | 2001 |
Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US cities, 1994-1998.
Topics: Adult; Cohort Studies; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Reverse Transcriptase Inhibitors; United States; Zidovudine | 2001 |
[Acceptance of antiretroviral therapy. HIV-infected patients assess convenient triple combination].
Topics: Anti-HIV Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Patient Acceptance of Health Care; Patient Compliance; Zidovudine | 2001 |
Editorial comment: Perinatal trials and prophylaxis decision making in 2001.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2001 |
[Pregnant HIV infected patient].
Topics: Cesarean Section; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk; Zidovudine | 2001 |
Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates.
Topics: Anti-HIV Agents; Cytidine Triphosphate; Dideoxynucleotides; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; HIV Infections; HIV-1; Lamivudine; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Stavudine; Thymine Nucleotides; Transfection; Zidovudine | 2001 |
So you want to have a baby?
Topics: Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Insemination, Artificial; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Viral Load; Zidovudine | 2001 |
Is peripartum zidovudine 'safe and highly beneficial to African children?'.
Topics: Africa; Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Cohort Studies; Didanosine; Female; HIV Infections; Humans; Male; Prevalence; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Switzerland; Zidovudine | 2001 |
[Anemia, neutropenia and thrombocytopenia: hematological findings and HIV].
Topics: Adult; Anemia, Macrocytic; Anti-HIV Agents; Biopsy; Bone Marrow; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Neutropenia; Thrombocytopenia; Zidovudine | 2001 |
Development and application of a genotypic AZT resistance assay: quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Drug Resistance, Microbial; Genotype; HIV Infections; HIV-1; Humans; Mutation; Prospective Studies; Reproducibility of Results; Viral Load; Zidovudine | 2001 |
Randomised placebo-controlled trials and HIV-infected pregnant women in developing countries. Ethical imperialism or unethical exploitation?
Topics: Developing Countries; Ethical Analysis; Ethics, Research; Female; Helsinki Declaration; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Placebos; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Research Design; Social Justice; Zidovudine | 2001 |
Equipoise and international human-subjects research.
Topics: Clinical Trials as Topic; Developed Countries; Developing Countries; Ethical Analysis; Ethical Relativism; Female; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Internationality; Placebos; Pregnancy; Pregnant Women; Research Design; Research Subjects; Uganda; Uncertainty; United States; Zidovudine | 2001 |
Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.
Topics: Anti-HIV Agents; Base Sequence; Didanosine; Dideoxynucleosides; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutagenesis; Recombination, Genetic; Reverse Transcriptase Inhibitors; Stavudine; Virus Replication; Zalcitabine; Zidovudine | 2001 |
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carrier State; Cohort Studies; Drug Resistance, Viral; Genetic Variation; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Homosexuality, Male; Humans; Incidence; Male; Models, Genetic; Models, Statistical; Netherlands; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Failure; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Transmission of zidovudine resistant strains of HIV-1: the first wave.
Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Male; Models, Genetic; Models, Statistical; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |
Zidovudine (Retrovir).
Topics: Drug Resistance, Microbial; HIV; HIV Infections; Humans; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral therapy.
Topics: Adolescent; Adult; Analysis of Variance; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Lymphocyte Count; Male; Middle Aged; Sensitivity and Specificity; Time Factors; Zidovudine | 2001 |
Drugs for HIV infection.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dose-Response Relationship, Drug; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Zidovudine | 2001 |
Experience with routine voluntary perinatal human immunodeficiency virus testing in an inner city hospital.
Topics: Anti-HIV Agents; Decision Making; Female; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Mass Screening; Pregnancy; Prenatal Care; Risk Factors; Zidovudine | 2001 |
A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.
Topics: Abdomen; Adipose Tissue; Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Lipodystrophy; Male; Oxazines; Reverse Transcriptase Inhibitors; Tomography, X-Ray Computed; Zidovudine | 2000 |
Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Microbial Sensitivity Tests; Mutation; Patient Selection; Phenotype; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Time Factors; Treatment Failure; Viral Load; Zidovudine | 2001 |
Germ cell tumors in patients infected by the human immunodeficiency virus.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; Germinoma; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Immune Tolerance; Leukocyte Count; Male; Middle Aged; Neutrophils; Pneumonia, Pneumocystis; Retrospective Studies; Seminoma; Zidovudine | 2001 |
Summaries for patients. Predictors of outcomes in patients with HIV infection treated with indinavir, zidovudine, and lamivudine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine | 2001 |
Mandatory HIV testing of new-borns in the United States.
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Female; HIV Infections; Humans; Infant, Newborn; Informed Consent; Legislation as Topic; Mandatory Testing; Maternal-Fetal Relations; Neonatal Screening; Pregnancy; United States; Women's Rights; Zidovudine | 1999 |
Estimation of the timing of perinatal transmission of HIV.
Topics: Anti-HIV Agents; Biometry; Clinical Trials as Topic; Female; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Models, Statistical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Sensitivity and Specificity; Time Factors; Zidovudine | 2001 |
Effect of opioid dependence pharmacotherapies on zidovudine disposition.
Topics: Anti-HIV Agents; Buprenorphine; Drug Interactions; Female; HIV Infections; Humans; Male; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Radioimmunoassay; Substance Abuse Detection; Time Factors; Zidovudine | 2001 |
Prevention of HIV transmission from mother-to-child in Srinagarind Hospital.
Topics: Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Thailand; Treatment Outcome; Zidovudine | 2001 |
Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients.
Topics: Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Genetic Heterogeneity; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Mutagenesis; Prevalence; Reverse Transcriptase Inhibitors; Spain; Zidovudine | 2001 |
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; B-Lymphocytes; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cell Division; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunotherapy; Interleukin-2; Lymph Nodes; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; T-Lymphocytes; Zidovudine | 2002 |
Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy.
Topics: Adult; Attitude; Decision Making; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Compliance; Physician-Patient Relations; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2001 |
Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Italy; Male; Morbidity; Prevalence; Reverse Transcriptase Inhibitors; Skin Diseases; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Fetal Death; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors.
Topics: Acanthosis Nigricans; Adult; Diabetes Mellitus; Didanosine; HIV Infections; HIV Protease Inhibitors; Humans; Insulin Resistance; Male; Ritonavir; Zidovudine | 2002 |
Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.
Topics: Anti-HIV Agents; Developing Countries; Didanosine; Drug Resistance, Viral; Gabon; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Population Surveillance; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2002 |
Codes of medical ethics and the exportation of less-than-standard care.
Topics: Codes of Ethics; Developed Countries; Developing Countries; Double Effect Principle; Ethical Analysis; Ethics, Research; Female; Guidelines as Topic; HIV Infections; Human Experimentation; Humans; Infectious Disease Transmission, Vertical; Informed Consent; Internationality; Placebos; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 1999 |
Effect of target cell availability on HIV-1 production in vitro.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Genotype; HIV Infections; HIV-1; Humans; In Vitro Techniques; Virus Replication; Zidovudine | 2002 |
Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Anticoagulants; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; HIV Infections; Humans; Hypertension, Pulmonary; Lamivudine; Male; Nelfinavir; Severity of Illness Index; Stavudine; Treatment Outcome; Zidovudine | 2001 |
Canadian court upholds Glaxo's patent on AZT.
Topics: Canada; Drug Industry; Drugs, Generic; HIV Infections; Humans; Patents as Topic; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV Infections; Humans; Zidovudine | 2001 |
Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
Topics: Anti-HIV Agents; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Organophosphates; Prodrugs; Zidovudine | 2001 |
Recurrent hypersensitivity to Combivir.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; HIV-1; Humans; Lamivudine; Recurrence; Zidovudine | 2002 |
[25-year-old medical assistant, post-exposure HIV prevention after accidental needlestick injury].
Topics: Adult; Female; HIV Infections; Humans; Needlestick Injuries; Occupational Diseases; Physician Assistants; Risk Factors; Zidovudine | 2002 |
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.
Topics: Anti-HIV Agents; Cohort Studies; Decision Support Techniques; Female; Fetal Death; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Perinatal Care; Pregnancy; Quality-Adjusted Life Years; Reproducibility of Results; Zidovudine | 2002 |
From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Child, Preschool; Counseling; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Michigan; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
Topics: Adult; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; Carbamates; CD48 Antigen; CD8-Positive T-Lymphocytes; Dideoxynucleosides; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Sulfonamides; T-Lymphocyte Subsets; Treatment Outcome; Viral Load; Viremia; Zidovudine | 2002 |
From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
Topics: Adult; AIDS Serodiagnosis; Anti-HIV Agents; Child, Preschool; Counseling; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Michigan; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Stage of the epidemic and viral phenotype should influence recommendations regarding mother-to-child transmission of HIV-1.
Topics: Anti-HIV Agents; Breast Feeding; Disease Outbreaks; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Phenotype; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Virulence; Zidovudine | 2002 |
Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys.
Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA; DNA Damage; Erythrocebus patas; Female; Fetus; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal-Fetal Exchange; Placenta; Pregnancy; Reverse Transcriptase Inhibitors; Telomere; Zidovudine | 2002 |
Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study.
Topics: AIDS Serodiagnosis; Cambodia; Counseling; Feasibility Studies; Female; HIV Infections; HIV Seroprevalence; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
HIV and pregnancy: treatment guidelines updated.
Topics: Breast Feeding; Delivery, Obstetric; Female; Hepatitis C; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; United States; United States Food and Drug Administration; Viral Load; Zidovudine | 2002 |
[Prevention of vertical transmission of HIV-1 in Mallorca, Spain. Impact of antiretroviral therapy from 1995 to 2000].
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Spain; Time Factors; Zidovudine | 2002 |
The dangers of inferring treatment effects from observational data: a case study in HIV infection.
Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Observation; Randomized Controlled Trials as Topic; Selection Bias; Zalcitabine; Zidovudine | 2002 |
Antiretroviral therapy in pregnant women of Florence.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Italy; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine | 2001 |
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Dideoxynucleosides; Drug Evaluation; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; London; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Viremia; Zidovudine | 2002 |
Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy.
Topics: Adipose Tissue; Adult; Anti-HIV Agents; Cytokines; Female; HIV Infections; HIV-1; Humans; Insulin Resistance; Lipodystrophy; Obesity; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
[Post-exposure prophylaxis in Zambia; the experiences of a tropical disease specialist following a cut accidentally incurred while operating on an HIV positive patient].
Topics: Adult; Anti-HIV Agents; Health Personnel; HIV Infections; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Male; Reverse Transcriptase Inhibitors; Zambia; Zidovudine | 2002 |
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.
Topics: Animals; Anti-HIV Agents; Cytidine; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Macaca mulatta; Nucleosides; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 2002 |
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Follow-Up Studies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load; Virus Replication; Zidovudine | 2002 |
Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cohort Studies; Drug Resistance, Viral; Female; France; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Ritonavir; RNA, Viral; Viral Load; Zidovudine | 2002 |
[Drug combination therapy for children infected with HIV/AIDS--own experience].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lamivudine; Male; Nelfinavir; Poland; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Needlestick transmission of hepatitis C.
Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine | 2002 |
Delayed recovery of effector memory CD4+ T cells by highly active antiretroviral therapy in a patient with HIV-1 infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; HIV Infections; HIV-1; Humans; Immunologic Memory; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Time Factors; Zidovudine | 2002 |
Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
Topics: Adult; Anti-HIV Agents; Child Welfare; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Female; Health Care Costs; Health Policy; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; South Africa; Zidovudine | 2002 |
Information from your family doctor. Preventing HIV infection in your baby.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Information from your family doctor. HIV and pregnancy.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2002 |
Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; Cell Line; Female; Giant Cells; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Multivariate Analysis; Phenotype; Pregnancy; Pregnancy Complications, Infectious; Regression Analysis; Zidovudine | 2002 |
Drug-resistant virus tracked through 3 men.
Topics: Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; Sexual Partners; United Kingdom; Zidovudine | 2002 |
Low prevalence of antiretroviral drug resistance among HIV-1 seroconverters in London, 1984-1991.
Topics: Anti-HIV Agents; Drug Resistance, Multiple, Viral; Europe; Genetic Variation; Genotype; HIV Infections; HIV-1; Humans; London; North America; Prevalence; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Zidovudine | 2002 |
Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents.
Topics: Anti-HIV Agents; HIV Infections; HIV-1; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Ritonavir; Virus Replication; Zidovudine | 2002 |
Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
Topics: Adult; Anti-HIV Agents; Health Personnel; HIV; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Needlestick Injuries; Occupational Exposure; Treatment Failure; Zidovudine | 2002 |
Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
Topics: Base Sequence; Codon; Czech Republic; Didanosine; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Molecular Probe Techniques; Molecular Sequence Data; Mutation; Phylogeny; Prevalence; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Zalcitabine; Zidovudine | 2001 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Ganciclovir; HIV Infections; Humans; Indinavir; Lamivudine; Male; Organophosphonates; Organophosphorus Compounds; Zidovudine | 2001 |
Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Infant; Leukocyte Count; Male; Neutrophils; Pilot Projects; Platelet Count; Zidovudine | 1992 |
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in children.
Topics: CD4-Positive T-Lymphocytes; Chickenpox; Child; Child, Preschool; Developmental Disabilities; Female; HIV Infections; Humans; Longitudinal Studies; Male; Retrospective Studies; Zidovudine | 1992 |
[Granulocyte colony stimulating factor (G-CSF) in treatment of patients with HIV-associated mucocutaneous Kaposi sarcoma. Successful use in virus and drug-induced leukopenia].
Topics: Adult; Combined Modality Therapy; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Injections, Subcutaneous; Leukocyte Count; Leukopenia; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Sarcoma, Kaposi; Skin; Skin Neoplasms; Zidovudine | 1992 |
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
Topics: Cytopathogenic Effect, Viral; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Male; Mutation; Phenotype; RNA-Directed DNA Polymerase; Time Factors; Zidovudine | 1992 |
Occupational exposure to HIV and use of zidovudine.
Topics: England; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Risk Factors; Zidovudine | 1992 |
[Vesiculo-pustular cutaneous eruption disclosing primary infection by HIV virus].
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Humans; Skin Diseases, Vesiculobullous; Zidovudine | 1992 |
Risks to surgeons and patients from HIV and hepatitis: guidelines on precautions and management of exposure to blood or body fluids. Joint Working Party of the Hospital Infection Society and the Surgical Infection Study Group.
Topics: General Surgery; Hepatitis B; HIV Infections; Humans; Needlestick Injuries; Occupational Exposure; Occupational Health; Operating Rooms; Patients; Personnel, Hospital; Protective Clothing; Protective Devices; Risk Factors; Surgical Procedures, Operative; Zidovudine | 1992 |
Combination therapy for HIV infection: getting closer.
Topics: Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1992 |
A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation.
Topics: CD4 Antigens; Cell Fusion; Cells, Cultured; HIV Core Protein p24; HIV Infections; HIV-1; Humans; In Vitro Techniques; Neurons; Recombinant Proteins; RNA, Viral; Transfection; Virus Replication; Zalcitabine; Zidovudine | 1992 |
Trial of three drugs for HIV-infected patients.
Topics: Clinical Trials as Topic; Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1992 |
From the Food and Drug Administration.
Topics: Astemizole; Contraindications; Drug Therapy, Combination; HIV Infections; Humans; Terfenadine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1992 |
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Benzodiazepines; CD4 Antigens; Cytokines; Didanosine; Doxorubicin; Drug Interactions; HIV; HIV Infections; Humans; Imidazoles; Leukocytes, Mononuclear; Lymphocytes; Macrophages; Monocytes; Organ Specificity; Organophosphonates; Zalcitabine; Zidovudine | 1992 |
Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Evaluation; HIV Infections; HIV-1; Humans; Nucleosides; Zalcitabine; Zidovudine | 1992 |
Herpes simplex virus type 1 and human immunodeficiency virus type 1 antigens in platelets from a hemophilia B patient with human immunodeficiency virus type 1-related thrombocytopenia.
Topics: Acyclovir; Adult; Antigens, Human Platelet; Antigens, Viral; Blood Platelets; Hemophilia A; Herpes Simplex; HIV Antigens; HIV Infections; HIV-1; Humans; Immune Complex Diseases; Immunoglobulin G; Male; Molecular Weight; Simplexvirus; Thrombocytopenia; Zidovudine | 1992 |
Zalcitabine approved under accelerated drug review policy.
Topics: Drug Therapy, Combination; Drugs, Investigational; HIV Infections; Humans; Time Factors; Zalcitabine; Zidovudine | 1992 |
Myocardial dysfunction in patients infected with HIV: prevalence and risk factors.
Topics: Adult; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Toxoplasmosis; United Kingdom; Ventricular Function, Left; Zidovudine | 1992 |
The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Didanosine; Female; HIV Infections; Humans; Maternal-Fetal Exchange; Osmolar Concentration; Placenta; Pregnancy; Zalcitabine; Zidovudine | 1992 |
Zidovudine (AZT).
Topics: HIV Infections; Humans; Photomicrography; Zidovudine | 1992 |
Criteria for use of didanosine in adult and pediatric patients.
Topics: Adult; Child, Preschool; Didanosine; HIV Infections; Humans; Infant; Leukocyte Count; Zidovudine | 1992 |
Publicity and unpublished results.
Topics: Acyclovir; HIV Infections; Humans; Publishing; Zidovudine | 1992 |
HIV-1 sensitivity to zidovudine and clinical outcome.
Topics: Adult; Cells, Cultured; Child; Drug Resistance, Microbial; HIV Infections; HIV Seropositivity; Humans; T-Lymphocytes; Zidovudine | 1992 |
Testing an anti-HIV trio.
Topics: Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1992 |
When should asymptomatic patients with HIV infection be treated with zidovudine?
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Predictive Value of Tests; Time Factors; Zidovudine | 1992 |
Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
Topics: Animals; Antibodies, Monoclonal; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Fusion; Cell Line; DNA, Viral; Gene Amplification; Giant Cells; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Mice; Protein Synthesis Inhibitors; Transcription, Genetic; Virus Cultivation; Virus Replication; Zidovudine | 1992 |
Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen.
Topics: CD4-Positive T-Lymphocytes; Cross-Sectional Studies; HIV Infections; HIV Seropositivity; HIV-1; Leukocyte Count; Leukocytosis; Longitudinal Studies; Prevalence; Risk Factors; Semen; Zidovudine | 1992 |
Time to finish with "AIDS"?
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Terminology as Topic; Time Factors; Zidovudine | 1992 |
The relationship of HIV-1 viral sequences detected by the polymerase chain reaction in haemophilic patients to clinical and other markers of infection.
Topics: Adult; Aged; Base Sequence; beta 2-Microglobulin; Biomarkers; CD4-Positive T-Lymphocytes; Child; Enzyme-Linked Immunosorbent Assay; Hemophilia A; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Predictive Value of Tests; Zidovudine | 1992 |
CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment.
Topics: Adult; CD4-Positive T-Lymphocytes; Female; Health Behavior; HIV Infections; HIV Seropositivity; Humans; Insurance, Health; Leukocyte Count; Male; Pneumonia, Pneumocystis; Retrospective Studies; Zidovudine | 1992 |
HIV and AIDS.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Female; HIV; HIV Infections; Humans; Male; Research; Viral Vaccines; Zidovudine | 1992 |
CD4+ cells and CD4+ percent as risk markers for Pneumocystis carinii pneumonia (PCP): implications for primary PCP prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; CD4-Positive T-Lymphocytes; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Retrospective Studies; Risk Factors; T-Lymphocyte Subsets; Zidovudine | 1992 |
Prognostic value of serum beta 2-microglobulin in HIV infection.
Topics: beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; HIV Infections; HIV-1; Humans; Prognosis; Zidovudine | 1992 |
Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infection.
Topics: CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; Humans; Interleukin-2; Leukocyte Count; Lymphoma, AIDS-Related; Recombinant Proteins; Remission Induction; Zidovudine | 1992 |
3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.
Topics: CD4-Positive T-Lymphocytes; Cell Fusion; Cells, Cultured; HIV Infections; Humans; In Vitro Techniques; Time Factors; Zidovudine | 1992 |
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Topics: AIDS-Related Opportunistic Infections; Case-Control Studies; CD4-Positive T-Lymphocytes; Cohort Studies; Colitis; Cytomegalovirus Infections; Esophagitis; Female; Follow-Up Studies; HIV Infections; Homosexuality; Humans; Incidence; Male; Probability; Proportional Hazards Models; Prospective Studies; Retinitis; Risk Factors; Zidovudine | 1992 |
Immunodeficiency and the risk of death in HIV infection.
Topics: Cause of Death; CD4-Positive T-Lymphocytes; Cohort Studies; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Risk; Time Factors; Zidovudine | 1992 |
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Bacterial Infections; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; HIV Infections; Humans; Leukocyte Count; Male; Multivariate Analysis; New York City; Proportional Hazards Models; Prospective Studies; Racial Groups; Substance Abuse, Intravenous; Zidovudine | 1992 |
Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; HIV Antibodies; HIV Infections; HIV Seropositivity; Humans; Neutralization Tests; Prospective Studies; Zidovudine | 1992 |
Resolution of HIV retinitis with zidovudine therapy.
Topics: Adult; CD4-Positive T-Lymphocytes; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Male; Retinitis; Zidovudine | 1992 |
Detection of circulating p24 antigen-positive CD4+ cells during HIV infection by flow cytometry.
Topics: Blood Circulation; CD4-Positive T-Lymphocytes; Flow Cytometry; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Time Factors; Treatment Outcome; Zidovudine | 1992 |
Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
Topics: CD4-Positive T-Lymphocytes; Evaluation Studies as Topic; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Time Factors; Viremia; Zidovudine | 1992 |
[HIV-1 proviral DNA sequences in the saliva of patients with HIV infection].
Topics: Base Sequence; CD4-Positive T-Lymphocytes; Didanosine; DNA, Viral; Genes, env; HIV Infections; HIV-1; Humans; Leukocyte Count; Molecular Sequence Data; Polymerase Chain Reaction; Proviruses; Saliva; Zidovudine | 1992 |
[AIDS. 3rd European conference on the clinical aspects and treatment of HIV infection. Paris, 12-13 March 1992. 4th German AIDS congress. Wiesbaden, 25-28 March 1992. 8th International AIDS Conference. Amsterdam, 19-24 July 1992].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Zidovudine | 1992 |
HPLC-monitoring of AZT in HIV-infected patient's plasma: a critical study.
Topics: Calibration; Chromatography, High Pressure Liquid; HIV Infections; Humans; Reference Standards; Reproducibility of Results; Zidovudine | 1992 |
[HIV infection in the child after materno-fetal transmission: early treatment with azidothymidine and prevention of secondary infectious complications].
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Infant; Infant, Newborn; Leukocyte Count; Male; Maternal-Fetal Exchange; Pneumonia, Pneumocystis; Pregnancy; Zidovudine | 1992 |
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
Topics: Acquired Immunodeficiency Syndrome; Codon; Cohort Studies; Drug Resistance, Microbial; Genotype; HeLa Cells; HIV; HIV Infections; Homosexuality; Humans; Male; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Time Factors; Viral Plaque Assay; Zidovudine | 1992 |
Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
Topics: Amino Acid Sequence; Base Sequence; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Male; Molecular Sequence Data; RNA-Directed DNA Polymerase; Zidovudine | 1992 |
Characterization of HIV isolates arising after prolonged zidovudine therapy.
Topics: Amino Acid Sequence; Base Sequence; Cells, Cultured; DNA, Viral; Drug Resistance, Microbial; Genetic Variation; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monocytes; Phenotype; RNA-Directed DNA Polymerase; Sequence Homology, Nucleic Acid; Zidovudine | 1992 |
A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine.
Topics: Base Sequence; Cross-Sectional Studies; DNA Mutational Analysis; DNA, Viral; Drug Resistance; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Point Mutation; RNA-Directed DNA Polymerase; Zidovudine | 1992 |
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes].
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocyte Count; Male; Middle Aged; Risk Factors; RNA-Directed DNA Polymerase; Tears; Zidovudine | 1992 |
Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. The University of Calgary Gastrointestinal/HIV Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Bisexuality; Digestive System; Duodenum; Esophagus; HIV; HIV Infections; Homosexuality; Humans; Male; Rectum; Stomach; Zidovudine | 1992 |
Identification of HIV-1 in semen following primary HIV-1 infection.
Topics: Adult; DNA, Viral; HIV Infections; HIV-1; Humans; Male; Polymerase Chain Reaction; Proviruses; Semen; Virus Cultivation; Zidovudine | 1992 |
Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. The Italian Study Group on Occupational Risk of HIV Infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Female; Follow-Up Studies; Health Personnel; Hematologic Tests; HIV Infections; Humans; Italy; Male; Middle Aged; Neutropenia; Occupational Diseases; Prospective Studies; Retrospective Studies; Zidovudine | 1992 |
Zidovudine's impact on resource use by patients with symptomatic HIV illness: a large sample analysis.
Topics: Adult; Cost Savings; Cross-Sectional Studies; Drug Costs; Female; Health Expenditures; Health Resources; Health Services Research; HIV Infections; HIV-1; Humans; Insurance Claim Reporting; Length of Stay; Longitudinal Studies; Male; Medicaid; New York; Regression Analysis; Retrospective Studies; Substance Abuse, Intravenous; Time Factors; United States; Zidovudine | 1992 |
Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy.
Topics: CD4 Antigens; Drug Resistance, Microbial; Female; Hemophilia A; HIV; HIV Antigens; HIV Infections; Homosexuality; Humans; Male; Substance Abuse, Intravenous; T-Lymphocyte Subsets; Virus Replication; Zidovudine | 1992 |
Acidification modified p24 antigen capture assay in HIV seropositives.
Topics: Analysis of Variance; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Prognosis; Zidovudine | 1992 |
Exposure to blood borne infections in health care workers.
Topics: Blood; Body Fluids; Hepatitis B; HIV Infections; HIV Seropositivity; Housekeeping, Hospital; Humans; Immunization, Passive; Immunoglobulins; Infection Control; Medical Staff, Hospital; Needlestick Injuries; Nursing Staff, Hospital; Occupational Diseases; Occupational Exposure; Personnel, Hospital; Universal Precautions; Western Australia; Zidovudine | 1992 |
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Cardiomegaly; Child; Child, Preschool; Dilatation, Pathologic; Echocardiography; Female; Follow-Up Studies; Heart; Heart Ventricles; HIV Infections; Humans; Infant; Male; Myocardium; Zidovudine | 1992 |
Early thrombocytopenia in HIV infection.
Topics: Child, Preschool; HIV Infections; Humans; Infant; Male; Thrombocytopenia; Zidovudine | 1992 |
Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis.
Topics: HIV Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Zidovudine | 1992 |
Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.
Topics: Antiviral Agents; Cell Line; Exotoxins; HIV Infections; HIV-1; Humans; Immunotoxins; Microbial Sensitivity Tests; Recombinant Proteins; Zidovudine | 1992 |
Starting therapy for an HIV-infected patient.
Topics: Didanosine; HIV Infections; Humans; Zidovudine | 1992 |
Psoriasis and human immunodeficiency virus infection.
Topics: Adolescent; Adult; Age Factors; Child; Cohort Studies; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Psoriasis; Severity of Illness Index; Survival Rate; Zidovudine | 1992 |
Continued zidovudine or didanosine for human immunodeficiency virus infection.
Topics: Didanosine; HIV Infections; Humans; Zidovudine | 1992 |
Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.
Topics: Blood Platelets; Cell Survival; HIV Infections; Humans; Kinetics; Liver; Male; Platelet Count; Spleen; Thrombocytopenia; Zidovudine | 1992 |
[HIV infection. Natural history, classification, treatment and occupational risk].
Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Risk Factors; Zidovudine | 1992 |
Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
Topics: Administration, Oral; Adult; Blood Coagulation; Chromatography, High Pressure Liquid; Half-Life; Hemophilia A; HIV Infections; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Zidovudine | 1992 |
Cerebral artery aneurysms in children infected with human immunodeficiency virus.
Topics: Brain; Cerebral Angiography; Child; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Zidovudine | 1992 |
Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetal medicine fellowship training programs.
Topics: Clinical Trials as Topic; Fellowships and Scholarships; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Obstetrics; Perinatology; Pregnancy; Pregnancy Complications, Infectious; Specialty Boards; United States; Zidovudine | 1992 |
[Fever of unknown origin in a cohort of HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Diagnosis, Differential; Female; Fever of Unknown Origin; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Zidovudine | 1992 |
Human immunodeficiency virus infection during pregnancy.
Topics: Abnormalities, Drug-Induced; AIDS Serodiagnosis; Ethics, Medical; Female; HIV Infections; Humans; Infant, Newborn; Informed Consent; Morals; Pentamidine; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Risk Factors; Zidovudine | 1992 |
Approval for broader use of DDI.
Topics: Didanosine; Drug Approval; HIV Infections; HIV-1; Humans; United States; United States Food and Drug Administration; Zidovudine | 1992 |
[Ocular pathology in HIV infection].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Cranial Nerve Diseases; Eye Diseases; Eye Infections; Eye Neoplasms; HIV Infections; Humans; Zidovudine | 1992 |
Summary of the Working Group on Perinatal Intervention.
Topics: Animals; Clinical Trials as Topic; Female; Fetal Diseases; HIV; HIV Infections; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Zidovudine | 1992 |
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antigens, Bacterial; HIV Infections; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculin; Zidovudine | 1992 |
Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
Topics: Cells, Cultured; DNA, Viral; Genes, gag; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; RNA, Viral; Virus Replication; Zidovudine | 1992 |
[Role of passive immunoprophylaxis in the prevention of HIV infection].
Topics: CD4 Immunoadhesins; HIV Infections; Humans; Immunization, Passive; Zidovudine | 1992 |
A modeled time-varying density function for the incubation period of AIDS.
Topics: Acquired Immunodeficiency Syndrome; HIV; HIV Infections; Humans; Mathematics; Proportional Hazards Models; Time Factors; Zidovudine | 1992 |
Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Dideoxynucleotides; Drug Stability; HIV Infections; Humans; Intracellular Fluid; Leukocytes, Mononuclear; Phosphorylation; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Thymine Nucleotides; Tritium; Zidovudine | 1992 |
DDI more effective than AZT.
Topics: Didanosine; HIV Infections; Zidovudine | 1992 |
[Monitoring of several hematological parameters of the erythroid series in patients with HIV infection treated with zidovudine].
Topics: Adult; Anemia, Macrocytic; Bone Marrow; Drug Monitoring; Female; HIV Infections; Humans; Male; Reticulocytes; Time Factors; Zidovudine | 1992 |
Pharmacokinetics of zidovudine plus probenecid.
Topics: Drug Therapy, Combination; HIV Infections; Humans; Male; Probenecid; Zidovudine | 1992 |
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Interferon-alpha; Leukocytes, Mononuclear; Zidovudine | 1992 |
Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine.
Topics: Adult; Didanosine; Drug Tolerance; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1992 |
An improved method for monitoring efficacy of anti-retroviral therapy in HIV-infected individuals: a highly sensitive HIV p24 antigen assay.
Topics: Biomarkers; Didanosine; Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; HIV Core Protein p24; HIV Infections; Humans; Sensitivity and Specificity; Zidovudine | 1992 |
[AIDS from the CIA?].
Topics: Didanosine; Government Agencies; HIV Infections; HIV-1; HIV-2; Humans; Mass Media; Zidovudine | 1992 |
[Administer zidovudine early or late?].
Topics: Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Survival Rate; Zidovudine | 1992 |
Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.
Topics: Extracellular Space; Female; HIV Infections; Humans; Intracellular Fluid; Male; Phosphorylation; Radioimmunoassay; Zidovudine | 1992 |
Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Analysis of Variance; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lung; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Prospective Studies; Pulmonary Diffusing Capacity; Smoking; Time Factors; Zidovudine | 1992 |
Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
Topics: Cells, Cultured; Female; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocytes, Mononuclear; Male; Viremia; Zidovudine | 1992 |
Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.
Topics: Antibodies, Monoclonal; Blotting, Southern; CD4 Antigens; Cells, Cultured; Cytopathogenic Effect, Viral; DNA, Viral; Flow Cytometry; Giant Cells; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Lymphocytes; Superinfection; Zidovudine | 1992 |
[Correction of Von Willebrand disease in HIV infection].
Topics: Blood Coagulation Tests; Female; HIV Infections; Humans; Middle Aged; von Willebrand Diseases; von Willebrand Factor; Zidovudine | 1992 |
Bilateral optic neuropathies with remission in two HIV-positive men.
Topics: Adult; HIV Infections; HIV Seropositivity; Humans; Male; Optic Nerve Diseases; Prednisone; Prognosis; Remission Induction; Zidovudine | 1992 |
[Non-typhic Salmonella bacteremias in HIV infections. Clinical and therapeutic data, and course in 68 patients].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Cephalosporins; Drug Therapy, Combination; Female; HIV Infections; Humans; In Vitro Techniques; Male; Opportunistic Infections; Penicillins; Retrospective Studies; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Zidovudine | 1992 |
Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne.
Topics: Acne Vulgaris; Adult; Etretinate; HIV Infections; Humans; Male; Pityriasis Rubra Pilaris; Zidovudine | 1992 |
Early predictors of survival in symptomatic HIV-infected persons treated with high-dose zidovudine.
Topics: Drug Administration Schedule; HIV Infections; Humans; Leukocyte Count; Regression Analysis; Survival Analysis; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Zidovudine | 1992 |
A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.
Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Female; Fetal Growth Retardation; HIV Infections; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Zidovudine | 1992 |
Wasted drugs in HIV infections and AIDS.
Topics: HIV Infections; HIV Seropositivity; Humans; Patient Compliance; Zidovudine | 1992 |
31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
Topics: Adult; Exercise; HIV Infections; Humans; Male; Mitochondria, Muscle; Muscular Diseases; Phosphocreatine; Zidovudine | 1992 |
Early changes of neopterin concentrations during treatment of human immunodeficiency virus infection with zidovudine.
Topics: Adult; Biopterins; Female; HIV Infections; Humans; Male; Neopterin; Zidovudine | 1992 |
Zidovudine-induced hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; HIV Infections; Humans; Male; Zidovudine | 1992 |
HIV-1 isolation from small amounts of whole blood: a technical evaluation.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cells, Cultured; Cryopreservation; Edetic Acid; Evaluation Studies as Topic; Heparin; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Kinetics; Leukocytes, Mononuclear; Sensitivity and Specificity; Time Factors; Viremia; Virus Replication; Zidovudine | 1992 |
Characteristics and outcome variables of HIV cases at a university-based medical practice.
Topics: Adult; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Opportunistic Infections; Pentamidine; West Virginia; Zidovudine | 1992 |
Zidovudine-induced leukocytoclastic vasculitis.
Topics: Adult; Drug Hypersensitivity; HIV Infections; Humans; Leukocytes; Male; Skin; Vasculitis, Leukocytoclastic, Cutaneous; Zidovudine | 1992 |
Zidovudine reverses the defect in dendritic cells in HIV infection.
Topics: Dendritic Cells; HIV Infections; Humans; Zidovudine | 1992 |
Understanding the AIDS pandemic.
Topics: Acquired Immunodeficiency Syndrome; Africa; Disease Outbreaks; Female; HIV Infections; Homosexuality; Humans; Male; Models, Theoretical; Risk; United States; Zidovudine | 1992 |
p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection.
Topics: Female; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Male; Predictive Value of Tests; Retrospective Studies; Zidovudine | 1992 |
Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus.
Topics: Adult; beta-Galactosidase; beta-Glucosidase; Female; HIV Infections; Humans; Intestinal Mucosa; Intestine, Small; Lactase; Male; Microvilli; Middle Aged; Zidovudine | 1992 |
Listeria meningitis and HIV infection.
Topics: Amoxicillin; HIV Infections; Humans; Male; Meningitis, Listeria; Middle Aged; Zidovudine | 1992 |
Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation.
Topics: Cost-Benefit Analysis; HIV Infections; Humans; Occupational Diseases; Personnel, Hospital; Zidovudine | 1992 |
Cognitive dysfunction in an HIV-infected patient.
Topics: Adult; AIDS Dementia Complex; Cognition Disorders; Diagnosis, Differential; HIV Infections; Humans; Male; Mental Processes; Neuropsychological Tests; Zidovudine | 1992 |
Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
Topics: Adult; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Substance Abuse, Intravenous; Zidovudine | 1992 |
Effects of zidovudine on EEG sleep in HIV-infected men.
Topics: Electroencephalography; HIV Infections; Humans; Male; Sleep; Zidovudine | 1992 |
Rage and confusion hide role of HIV.
Topics: Acquired Immunodeficiency Syndrome; Complementary Therapies; HIV; HIV Infections; Humans; Zidovudine | 1992 |
Synergistic antiviral effect in vitro of azidothymidine and amphotericin B methyl ester in combination on HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; HIV; HIV Infections; Humans; Zidovudine | 1992 |
Pharmaceutical care for patients with HIV infection.
Topics: Health Services Needs and Demand; HIV Infections; Hospitals, Teaching; Humans; Male; Pharmacy Service, Hospital; Risk Factors; Zidovudine | 1992 |
Intestinal permeability in HIV infection: proper controls are necessary.
Topics: California; Congresses as Topic; Didanosine; HIV Infections; Humans; Intestinal Absorption; Research Design; Zidovudine | 1992 |
Semen analysis in human immunodeficiency virus infection.
Topics: CD4 Antigens; Hemophilia A; HIV Infections; Humans; Immune System; Semen; Zidovudine | 1992 |
Doctors, patients, and HIV.
Topics: Health Personnel; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1992 |
Susceptibility of Treponema pallidum and other selected spirochaetes to zidovudine.
Topics: Administration, Cutaneous; Animals; HIV Infections; Male; Microbial Sensitivity Tests; Rabbits; Spirochaetaceae; Treponema pallidum; Zidovudine | 1992 |
[Contamination by the HIV virus. Care of at risk nursing personnel].
Topics: HIV Infections; Humans; Nurses; Occupational Diseases; Zidovudine | 1992 |
Early versus late treatment with zidovudine.
Topics: HIV Infections; Humans; Quality of Life; Time Factors; Zidovudine | 1992 |
Early versus late treatment with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Quality of Life; Time Factors; Zidovudine | 1992 |
Zidovudine pharmacokinetics during pregnancy.
Topics: Adult; Amniotic Fluid; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1992 |
Pregnancy and HIV.
Topics: Female; Fetus; HIV Infections; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1992 |
Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
Topics: Adult; Chemical and Drug Induced Liver Injury; HIV Infections; Humans; Male; Muscular Diseases; Zidovudine | 1992 |
Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT.
Topics: Antiviral Agents; Cells, Cultured; Dideoxynucleotides; Drug Resistance; HIV Infections; HIV-1; Humans; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1992 |
Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents.
Topics: Adolescent; Antiviral Agents; Bacterial Infections; Catheterization, Central Venous; Child; Child, Preschool; Didanosine; Female; HIV Infections; HIV-1; Humans; Male; Retrospective Studies; Zalcitabine; Zidovudine | 1991 |
Visceral leishmaniasis in an adult with HIV infection.
Topics: Adult; Antimony Sodium Gluconate; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Zidovudine | 1991 |
Neuromuscular complications of HIV infection and its treatment.
Topics: Adrenal Cortex Hormones; Demyelinating Diseases; HIV Infections; Humans; Myositis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Zidovudine | 1991 |
Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection.
Topics: Animals; Bone Marrow; Didanosine; Dideoxyadenosine; Female; HIV Infections; Immune System; Immunoglobulin M; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Zalcitabine; Zidovudine | 1991 |
Race joins host of unanswered questions on early HIV therapy.
Topics: Black People; CD4-Positive T-Lymphocytes; Child; Female; HIV Infections; Humans; Leukocyte Count; Male; Zidovudine | 1991 |
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cognition; Drug Evaluation; Drug Tolerance; Follow-Up Studies; Gene Products, gag; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Multicenter Studies as Topic; Opportunistic Infections; Viral Core Proteins; Weight Gain; Zidovudine | 1991 |
Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Female; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interferon Type I; Leukocyte Count; Male; Middle Aged; Viral Core Proteins; Viremia; Zidovudine | 1991 |
Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Cost-Benefit Analysis; HIV Infections; Humans; Leukocyte Count; Life Expectancy; Models, Statistical; Probability; Survival Analysis; Zidovudine | 1991 |
Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigen.
Topics: beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cells, Cultured; Cholesterol, HDL; Drug Resistance, Microbial; Evaluation Studies as Topic; HIV; HIV Antigens; HIV Infections; Humans; Leukocyte Count; Macrophages; Monocytes; Time Factors; Zidovudine | 1991 |
AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Disease Outbreaks; HIV Infections; Humans; Leukocyte Count; Scotland; Substance-Related Disorders; Time Factors; Zidovudine | 1991 |
Feedback from the Sixth International AIDS Conference, San Francisco 1990.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Equipment Contamination; Female; Health Workforce; HIV Infections; Humans; Male; Occupational Diseases; Pregnancy; Pregnancy Complications, Infectious; Substance Abuse, Intravenous; Transfusion Reaction; Zidovudine | 1991 |
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
Topics: Adult; CD4-Positive T-Lymphocytes; Child; Gene Products, gag; HIV Antibodies; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocyte Count; Reproducibility of Results; Viral Core Proteins; Viremia; Zidovudine | 1991 |
Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Cell Count; Follow-Up Studies; HIV Infections; Humans; Male; Prospective Studies; T-Lymphocyte Subsets; T-Lymphocytes; Zidovudine | 1991 |
Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy.
Topics: Acquired Immunodeficiency Syndrome; Calcium; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Interferon-gamma; Leukocyte Count; Lymphocyte Activation; Lymphocytes; Phosphatidylinositols; T-Lymphocytes, Regulatory; Zidovudine | 1991 |
Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.
Topics: Adult; Aged; Australia; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections; Humans; Leukocyte Count; Lymphoma; Male; Middle Aged; Opportunistic Infections; Predictive Value of Tests; Retrospective Studies; Sarcoma, Kaposi; Zidovudine | 1991 |
Primary care intervention and management for adults with early HIV infection.
Topics: CD4-Positive T-Lymphocytes; Clinical Protocols; HIV Infections; HIV-1; Humans; Pneumonia, Pneumocystis; Primary Health Care; Zidovudine | 1991 |
Population dynamics of HIV within an individual after treatment with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; CD4-Positive T-Lymphocytes; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Leukocyte Count; Models, Theoretical; Time Factors; Viremia; Zidovudine | 1991 |
HIV transmission by stabbing despite zidovudine prophylaxis.
Topics: Adult; AIDS Serodiagnosis; HIV Antigens; HIV Infections; Humans; Male; Needlestick Injuries; Zidovudine | 1991 |
Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine.
Topics: CD4-Positive T-Lymphocytes; Female; HIV Core Protein p24; HIV Infections; HIV-1; Homosexuality; Humans; Male; Plasma; Prospective Studies; Receptors, Interleukin-2; Solubility; Substance-Related Disorders; Time Factors; Treatment Outcome; Zidovudine | 1991 |
Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
Topics: ADP Ribose Transferases; Bacterial Toxins; CD4 Antigens; Cells, Cultured; Didanosine; Drug Synergism; Exotoxins; HIV; HIV Infections; Humans; Immunotoxins; In Vitro Techniques; Pseudomonas aeruginosa Exotoxin A; Reverse Transcriptase Inhibitors; T-Lymphocytes; Virulence Factors; Virus Replication; Zidovudine | 1990 |
Zidovudine (AZT) therapy in children with HIV infection: the Australian experience.
Topics: Adolescent; Child; Child, Preschool; Developmental Disabilities; Failure to Thrive; Female; HIV Infections; Humans; Infant; Male; Opportunistic Infections; Respiratory Tract Infections; Retrospective Studies; Zidovudine | 1990 |
Current status of HIV therapy: I. Antiretroviral agents.
Topics: Adult; Antiviral Agents; Child; Drug Therapy, Combination; HIV Infections; Humans; Immunity; Palliative Care; Virus Replication; Zidovudine | 1991 |
The treatment of HIV associated thrombocytopenia in haemophiliacs.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Child; Hemophilia A; HIV Infections; Humans; Immunoglobulin G; Infusions, Intravenous; Interferons; Prednisolone; Retrospective Studies; Splenectomy; Thrombocytopenia; Zidovudine | 1990 |
Effects of long-term zidovudine treatment on cell-mediated immune response and lymphokine production.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Infections; Humans; Interferon Type I; Interferon-gamma; Interferons; Interleukin-2; Lymphocyte Activation; Male; Opportunistic Infections; Time Factors; Zidovudine | 1991 |
[Retinitis in an infant infected with HIV].
Topics: Cytomegalovirus Infections; gamma-Globulins; HIV Infections; HIV-1; Humans; Infant, Newborn; Infusions, Intravenous; Male; Retinal Diseases; Zidovudine | 1990 |
Prognosis in AZT myopathy.
Topics: Adult; Biopsy; Creatine Kinase; Electromyography; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondria, Muscle; Muscles; Muscular Diseases; Necrosis; Prognosis; Staining and Labeling; Zidovudine | 1991 |
AIDS: the ultimate occupational accident.
Topics: Dental Staff; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1991 |
Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
Topics: Acquired Immunodeficiency Syndrome; Base Sequence; Codon; DNA, Viral; Drug Resistance, Microbial; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Oligonucleotide Probes; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Probability; Regression Analysis; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine | 1991 |
Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Anemia; Colony-Forming Units Assay; Erythroid Precursor Cells; Erythropoietin; Granulocytes; Hematopoietic Cell Growth Factors; HIV; HIV Infections; Humans; Lymphocytes; Macrophages; Monocytes; Neutropenia; Recombinant Proteins; Stem Cell Factor; Thrombocytopenia; Virus Replication; Zidovudine | 1991 |
[Combination therapies with anti-retroviral agents in HIV and AIDS infections].
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Interferons; Zalcitabine; Zidovudine | 1991 |
[Therapy of HIV-associated Kaposi's sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; HIV Infections; Humans; Interferons; Sarcoma, Kaposi; Zidovudine | 1991 |
Rationale for a combined use of antiretroviral and immunomodulatory therapies in HIV infection.
Topics: Cells, Cultured; Ditiocarb; Drug Therapy, Combination; HIV Infections; Humans; Inosine Pranobex; Male; RNA-Directed DNA Polymerase; Zidovudine | 1991 |
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment.
Topics: AIDS-Related Complex; Chi-Square Distribution; HIV; HIV Core Protein p24; HIV Infections; Humans; Regression Analysis; Sensitivity and Specificity; Viremia; Virus Cultivation; Zidovudine | 1992 |
The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Hemophilia A; HIV Infections; Humans; Middle Aged; Survival; Time Factors; Zidovudine | 1992 |
Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases.
Topics: Adult; Antiviral Agents; Female; Heart Diseases; Heart Failure; HIV Infections; Humans; Male; Middle Aged; Myocarditis; Zidovudine | 1992 |
Combined toxicity of zidovudine and antituberculosis chemotherapy.
Topics: Adult; Antitubercular Agents; CD4 Antigens; Drug Interactions; Female; HIV Infections; Humans; Male; T-Lymphocyte Subsets; Tuberculosis; Zidovudine | 1992 |
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
Topics: DNA, Viral; Follow-Up Studies; HIV; HIV Infections; HIV Seropositivity; Humans; Interleukin-2; Leukocytes, Mononuclear; Polymerase Chain Reaction; Proviruses; Recombinant Proteins; Zidovudine | 1992 |
From the National Institutes of Health.
Topics: Acquired Immunodeficiency Syndrome; Child; Didanosine; HIV Infections; Humans; National Institutes of Health (U.S.); United States; Zidovudine | 1992 |
Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells.
Topics: Adult; Dideoxynucleotides; Female; Half-Life; HIV Infections; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Male; Middle Aged; Phosphorylation; Phytohemagglutinins; Thymine Nucleotides; Zidovudine | 1991 |
Breaking the chain of HIV transmission.
Topics: AIDS Serodiagnosis; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Zidovudine | 1991 |
Prophylaxis with zidovudine (AZT) after exposure to human immunodeficiency virus: a brief discussion of the issues for emergency physicians.
Topics: Animals; Cats; Cost-Benefit Analysis; Health Personnel; HIV Infections; HIV Seropositivity; Humans; Mice; Occupational Exposure; Time Factors; Zidovudine | 1991 |
Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
Topics: Adult; DNA, Mitochondrial; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondria, Muscle; Muscular Diseases; Zidovudine | 1991 |
Zidovudine therapy in thrombocytopenic human immunodeficiency virus-infected children.
Topics: Child; Child, Preschool; Female; HIV Infections; Humans; Male; Thrombocytopenia; Zidovudine | 1991 |
HIV-related autoimmune hemolytic anemia: good response to zidovudine.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Female; HIV Infections; Humans; Zidovudine | 1991 |
HIV-1 transmission by a heterosexual man treated with zidovudine.
Topics: Adult; Female; HIV Infections; Humans; Male; Sexual Behavior; Zidovudine | 1991 |
Papular pruritic eruption with human immunodeficiency virus infection.
Topics: Adult; Dermatitis; Female; HIV Infections; Humans; Metronidazole; Pruritus; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Physicians; Uganda; Zidovudine | 1991 |
[Several aspects of HIV infections].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS Vaccines; Anti-Bacterial Agents; Antiviral Agents; Clinical Trials as Topic; HIV Infections; Humans; Randomized Controlled Trials as Topic; Zidovudine | 1991 |
The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV.
Topics: Adult; Drug Tolerance; HIV Infections; Humans; Male; Middle Aged; Platelet Count; Prognosis; Thrombocytopenia; Time Factors; Zidovudine | 1991 |
Zidovudine-associated hypertrichosis and nail pigmentation in an HIV-infected patient.
Topics: Adult; HIV Infections; Humans; Hypertrichosis; Male; Nails; Pigmentation Disorders; Zidovudine | 1991 |
[Chemotherapy of HIV].
Topics: HIV Infections; HIV-1; Humans; Interferon-alpha; Zidovudine | 1991 |
Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.
Topics: Administration, Oral; Adult; Half-Life; HIV Infections; Humans; Leukocytes; Male; Middle Aged; Phosphorylation; Radioimmunoassay; Zidovudine | 1991 |
Zidovudine removal during plasma exchange.
Topics: Adult; HIV Infections; Humans; Male; Plasma Exchange; Vasculitis; Zidovudine | 1991 |
[Managing HIV infected patients in general practice].
Topics: Adult; Ambulatory Care; Catheters, Indwelling; Combined Modality Therapy; Erythropoietin; Female; HIV Infections; Humans; Male; Opportunistic Infections; Physician's Role; Terminal Care; Zidovudine | 1991 |
Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease.
Topics: Acute Disease; Adult; AIDS Dementia Complex; beta 2-Microglobulin; Biopterins; Female; HIV Infections; Humans; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neopterin; Zidovudine | 1991 |
[AIDS and perinatal aspects].
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1991 |
Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
Topics: AIDS Dementia Complex; Convulsants; HIV Infections; HIV-1; Humans; Neurotoxins; Quinolinic Acid; Quinolinic Acids; Regression Analysis; Zidovudine | 1991 |
In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
Topics: Administration, Oral; Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Infusions, Intravenous; Phosphonoacetic Acid; Viral Core Proteins; Zidovudine | 1991 |
HIV: risks to health care workers and risk reduction.
Topics: Clinical Protocols; Health Occupations; HIV Infections; HIV-1; Humans; Infection Control; Occupational Diseases; Population Surveillance; Risk Factors; Universal Precautions; Zidovudine | 1991 |
[Some aspects of the treatment of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Dapsone; HIV Infections; Humans; Primaquine; Trimethoprim; Trimetrexate; Zidovudine | 1991 |
Ethical dilemma in continuing a zidovudine-placebo trial in symptomatic human immunodeficiency virus infection.
Topics: Black People; Clinical Protocols; Ethics, Medical; HIV Infections; Humans; Randomized Controlled Trials as Topic; Research Subjects; Therapeutic Human Experimentation; White People; Zidovudine | 1991 |
Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Therapy, Combination; Female; HIV Infections; Mice; Mice, Inbred C57BL; Zalcitabine; Zidovudine | 1991 |
[Early treatment of human immunodeficiency virus infection].
Topics: HIV Infections; Humans; Managed Care Programs; Opportunistic Infections; Pneumonia, Pneumocystis; Zidovudine | 1991 |
Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis.
Topics: Adolescent; Adult; Antigens, CD; Child; Child, Preschool; HIV Antigens; HIV Infections; HIV Seropositivity; Humans; Immunoenzyme Techniques; Macrophages; Middle Aged; Myositis; T-Lymphocyte Subsets; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Health Workforce; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1991 |
Zidovudine therapy is associated with an increased capacity of phytohemagglutinin-stimulated cells to express interleukin-2 receptors. Pittsburgh AIDS Clinical Trial Unit.
Topics: Acquired Immunodeficiency Syndrome; Colony-Forming Units Assay; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Male; Phytohemagglutinins; Receptors, Interleukin-2; T-Lymphocyte Subsets; Zidovudine | 1991 |
Zidovudine treatment increases erythrocyte adenosine deaminase activity.
Topics: Acquired Immunodeficiency Syndrome; Adenosine Deaminase; Child; Child, Preschool; Erythrocytes; HIV Infections; HIV-1; Humans; Time Factors; Zidovudine | 1991 |
Fertility parameters in men infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Fertility; HIV; HIV Infections; HIV Seropositivity; Humans; Male; Semen; Sperm Count; Spermatozoa; Zidovudine | 1991 |
Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Time Factors; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Animals; Disease Models, Animal; HIV Infections; Humans; Mice; Occupational Diseases; Occupational Exposure; Zidovudine | 1991 |
From the Centers for Disease Control. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Algorithms; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Personnel, Hospital; Zidovudine | 1991 |
Self-reported sleep quality in HIV infection: correlation to the stage of infection and zidovudine therapy.
Topics: Adult; Aged; Female; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Self Disclosure; Sleep Wake Disorders; Zidovudine | 1991 |
Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
Topics: Adult; DNA Polymerase III; DNA Replication; DNA, Mitochondrial; HIV Infections; Humans; Male; Microscopy, Electron; Middle Aged; Mitochondria; Muscles; Muscular Diseases; Oxidative Phosphorylation; Zidovudine | 1991 |
Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV-infected patients.
Topics: Adult; Evaluation Studies as Topic; HIV Infections; Humans; Male; Regression Analysis; Saliva; Zidovudine | 1991 |
A simple scoring system to assess risk of hematological side effects in zidovudine recipients.
Topics: Anemia; Female; HIV Infections; Humans; Male; Methods; Neutropenia; Risk Factors; Zidovudine | 1991 |
Fed-state effects on zidovudine absorption.
Topics: Absorption; Fasting; HIV Infections; Humans; Zidovudine | 1991 |
Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
Topics: Animals; Antibodies; Cell Division; Disease Models, Animal; Female; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Immunosuppression Therapy; Interferon Type I; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Core Proteins; Virus Replication; Zidovudine | 1991 |
HIV infection and haemophilia.
Topics: Adolescent; Adolescent Behavior; Child; Factor VIII; Growth; Hemophilia A; HIV Infections; HIV-1; Humans; Immunotherapy; Public Assistance; Schools; Zidovudine | 1991 |
Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
Topics: Animals; Antiviral Agents; Didanosine; DNA, Viral; HIV; HIV Infections; Humans; Immunohistochemistry; Immunologic Deficiency Syndromes; Lymph Nodes; Macrophages; Mice; Nucleic Acid Hybridization; Polymerase Chain Reaction; T-Lymphocytes; Transplantation, Heterologous; Zidovudine | 1991 |
[Anti-retroviral therapy of HIV-infection. With preliminary results of the Swiss postmarketing surveillance of zidovudine].
Topics: Didanosine; Hematologic Diseases; HIV Infections; Humans; Opportunistic Infections; Product Surveillance, Postmarketing; Switzerland; Zidovudine | 1991 |
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
Topics: Gene Products, gag; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Viral Core Proteins; Zidovudine | 1991 |
Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; beta 2-Microglobulin; Biomarkers; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Time Factors; Viral Core Proteins; Zidovudine | 1991 |
Availability of dideoxyinosine.
Topics: Clinical Protocols; Didanosine; Drugs, Investigational; HIV Infections; Humans; Zidovudine | 1991 |
Zidovudine in the management of primary HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Blood Cell Count; Drug Administration Schedule; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; T-Lymphocyte Subsets; Viral Core Proteins; Zidovudine | 1991 |
Zidovudine therapy associated with remission of chronic active hepatitis C in HIV-1 carriers.
Topics: Adult; AIDS-Related Complex; Hepatitis C; Hepatitis, Chronic; HIV Infections; HIV-1; Humans; Prospective Studies; Zidovudine | 1991 |
Cost effectiveness of treating asymptomatic HIV infection.
Topics: Cost-Benefit Analysis; HIV Infections; Humans; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Health Personnel; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Health Personnel; HIV Infections; Humans; Occupational Diseases; Zidovudine | 1991 |
Clinical significance of neutropenia in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Bacterial Infections; Hematologic Diseases; HIV Infections; Hospitals, Teaching; Humans; Incidence; Neutropenia; New York; Opportunistic Infections; Prospective Studies; Risk Factors; Zidovudine | 1991 |
[Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance; HIV Infections; HIV-1; Humans; Time Factors; Zidovudine | 1991 |
Stochastic methods for short term projections of symptomatic HIV disease.
Topics: Confidence Intervals; Forecasting; HIV Infections; HIV Seroprevalence; Humans; Monte Carlo Method; Philadelphia; Stochastic Processes; Zidovudine | 1991 |
Percutaneous injuries among health care workers. The real value of human immunodeficiency virus testing of 'donor' blood.
Topics: Allied Health Personnel; Blood Donors; Blotting, Western; Decision Trees; Enzyme-Linked Immunosorbent Assay; HIV Infections; HIV Seropositivity; Humans; Mass Screening; Occupational Diseases; Prevalence; Probability; Sensitivity and Specificity; Zidovudine | 1991 |
Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma.
Topics: HIV Infections; Homosexuality; Humans; Interleukin-2; Lymphoma, B-Cell; Male; Pleural Effusion; Recombinant Proteins; Zidovudine | 1991 |
Zidovudine after exposure to HIV.
Topics: HIV Infections; Humans; Sexual Partners; Sexually Transmitted Diseases; Zidovudine | 1991 |
Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
Topics: Base Sequence; DNA, Viral; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; RNA, Viral; Viremia; Zidovudine | 1991 |
Production of a tac inhibitory activity by adherent cells of HIV-infected subjects at different clinical stages.
Topics: Acquired Immunodeficiency Syndrome; Cell Membrane; HIV Infections; Humans; Macrophages; Monocytes; Receptors, Interleukin-2; Tumor Cells, Cultured; Zidovudine | 1991 |
Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infected homosexual males.
Topics: Adult; Blood Cell Count; Blood Proteins; Body Height; Body Weight; CD4-CD8 Ratio; Energy Intake; HIV Infections; HIV-1; Homosexuality; Humans; Longitudinal Studies; Lymphocyte Activation; Male; Middle Aged; Nutritional Status; Trace Elements; Vitamins; Zidovudine | 1991 |
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Black People; Female; Follow-Up Studies; Hispanic or Latino; HIV Infections; Humans; Male; Multivariate Analysis; Opportunistic Infections; Prospective Studies; Risk Factors; Treatment Outcome; Zidovudine | 1991 |
Zidovudine. Does it work for everyone?
Topics: Acquired Immunodeficiency Syndrome; Black People; Female; Hispanic or Latino; HIV Infections; Humans; Male; Zidovudine | 1991 |
Management of health-care workers exposed to blood and body fluids.
Topics: Blood; Body Fluids; Health Personnel; Hepatitis B; Hepatitis C; HIV Infections; Humans; Occupational Exposure; Risk Factors; Universal Precautions; Zidovudine | 1991 |
Zidovudine for prophylaxis of human immunodeficiency virus infection after accidental exposure.
Topics: Accidents, Occupational; Health Personnel; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Zidovudine | 1991 |
Immunological and virological status of a hemophiliac infected with human T cell lymphotropic virus type 1 and human immunodeficiency virus type 1, and results of therapy.
Topics: Adolescent; Adult; Hemophilia A; Hemophilia B; HIV Infections; HTLV-I Infections; Humans; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: HIV; HIV Infections; Humans; Occupational Diseases; Occupational Exposure; Zidovudine | 1991 |
Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus.
Topics: Amino Acid Sequence; Base Sequence; Blotting, Southern; DNA Replication; Drug Resistance, Microbial; Genetic Vectors; Genotype; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Oligonucleotide Probes; Plasmids; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Viral; Transcription, Genetic; Zidovudine | 1991 |
Patients' views on the least acceptable increase in survival with zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1991 |
FDA approves Epoetin Alfa use for AZT patients.
Topics: Anemia; Erythropoietin; HIV Infections; HIV-1; Humans; United States; United States Food and Drug Administration; Zidovudine | 1991 |
Early treatment for HIV: the time has come.
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leukocyte Count; Zidovudine | 1990 |
A.I.D.S. Zidovudine update.
Topics: Adult; CD4-Positive T-Lymphocytes; Child; HIV Infections; Humans; United States; United States Food and Drug Administration; Zidovudine | 1990 |
Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
Topics: CD4-Positive T-Lymphocytes; Flow Cytometry; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Homosexuality; Humans; Leukocyte Count; Lymphocytes; Male; Viral Core Proteins; Zidovudine | 1990 |
Zidovudine-related myopathy.
Topics: Adult; Clinical Enzyme Tests; Creatine Kinase; HIV Infections; Humans; Male; Muscular Diseases; Zidovudine | 1990 |
Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Dideoxynucleotides; Drug Carriers; Glycoproteins; HIV Infections; Humans; In Vitro Techniques; Lysine; Serum Albumin; Thymine Nucleotides; Zidovudine | 1990 |
Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Factors; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Hemophilia A; HIV Infections; HIV-1; Humans; Immunophenotyping; Liver; Male; Middle Aged; Patient Compliance; Survival Rate; Transfusion Reaction; Zidovudine | 1990 |
Sequential autonomic function tests in HIV infection.
Topics: Adult; Autonomic Nervous System; Blood Pressure; CD4-Positive T-Lymphocytes; Heart Function Tests; Heart Rate; Hemodynamics; HIV Infections; Humans; Leukocyte Count; Male; Middle Aged; Zidovudine | 1990 |
Natural history of HIV and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; HIV Infections; Humans; Risk Factors; Zidovudine | 1990 |
[Management and early treatment of patients infected with HIV. Synthesis of recommendations of an expert group convened by the french minister of Solidarité, Santé et Protection sociale].
Topics: Aerosols; CD4-Positive T-Lymphocytes; Clinical Protocols; Delivery of Health Care; France; HIV Infections; Humans; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccination; Zidovudine | 1990 |
Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; beta 2-Microglobulin; Biopterins; CD4-Positive T-Lymphocytes; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Male; Neopterin; Treatment Outcome; Zidovudine | 1990 |
Zidovudine after occupational exposure to the human immunodeficiency virus.
Topics: HIV Infections; Humans; Informed Consent; Occupational Exposure; Zidovudine | 1991 |
Zidovudine-induced macular edema.
Topics: Adult; HIV Infections; Humans; Macular Edema; Male; Uveitis, Anterior; Vision Disorders; Zidovudine | 1991 |
Pharmacokinetic disposition of zidovudine during pregnancy.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Fetal Blood; Half-Life; HIV Infections; Humans; Infant, Newborn; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1991 |
Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy.
Topics: HIV Infections; HIV Seropositivity; HIV-1; Humans; Leukocyte Count; Lymphocytes; Male; Risk Factors; Semen; Zidovudine | 1991 |
Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.
Topics: Animals; Chimera; Disease Models, Animal; HIV Infections; HIV-1; Mice; Mice, Inbred Strains; Time Factors; Zidovudine | 1991 |
Behçet's disease in a patient with immunodeficiency virus infection.
Topics: Adult; Behcet Syndrome; Colchicine; Female; HIV Infections; Humans; Zidovudine | 1991 |
Failure of prophylactic zidovudine after suicidal self-inoculation of HIV-infected blood.
Topics: Adult; Female; HIV Infections; Humans; Self Administration; Suicide, Attempted; Time Factors; Zidovudine | 1991 |
Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; HIV-1; Humans; Immunotherapy; Male; Models, Statistical; Sexual Behavior; Time Factors; Zidovudine | 1991 |
Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Case-Control Studies; Female; Follow-Up Studies; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Multicenter Studies as Topic; Opportunistic Infections; Proportional Hazards Models; Prospective Studies; Risk Factors; Zidovudine | 1991 |
Use of zidovudine in HIV infection.
Topics: HIV Infections; HIV-1; Humans; United States; United States Food and Drug Administration; Zidovudine | 1991 |
Zidovudine in the treatment of human immunodeficiency virus disease.
Topics: Adult; HIV Infections; Humans; Zidovudine | 1991 |
No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection.
Topics: Adult; Chronic Disease; DNA-Directed DNA Polymerase; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Homosexuality; Humans; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Virus Replication; Zidovudine | 1991 |
[Preventive use of AZT in occupational HIV exposure].
Topics: Adult; Health Workforce; HIV Infections; Humans; Male; Middle Aged; Occupational Diseases; Risk Factors; Zidovudine | 1991 |
Zidovudine.
Topics: Drug Administration Schedule; Drug Interactions; HIV Infections; Humans; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1991 |
Guidelines for hemophilia care.
Topics: AIDS Serodiagnosis; Blood Coagulation Factors; Child; Female; Hemophilia A; HIV Infections; HIV Seropositivity; Humans; Male; Sexual Partners; Zidovudine | 1991 |
How much zidovudine is safe for children with advanced HIV?
Topics: Administration, Oral; Child; Child, Preschool; Clinical Trials as Topic; HIV Infections; HIV-1; Humans; Infant; Zidovudine | 1991 |
Delayed-type hypersensitivity skin testing in patients with HIV infection.
Topics: HIV Infections; Humans; Hypersensitivity, Delayed; Leukocyte Count; Skin Tests; T-Lymphocyte Subsets; Zidovudine | 1991 |
Effect of zidovudine in HIV-infected children with lymphocytic interstitial pneumonitis.
Topics: Child, Preschool; Female; HIV Infections; Humans; Infant; Lymphocytes; Pulmonary Fibrosis; Radiography; Respiratory Mechanics; Zidovudine | 1991 |
Zidovudine after occupational exposure to HIV.
Topics: Animals; Drug Administration Schedule; Health Workforce; HIV Infections; Humans; Macaca; Mice; Occupational Diseases; Occupational Exposure; Zidovudine | 1991 |
[AIDS therapy--new perspectives for the 90s].
Topics: HIV Infections; Humans; Zidovudine | 1991 |
Guidelines for the care of children and adolescents with HIV infection. Medical management in HIV-infected adolescents.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Female; HIV Infections; HIV Seropositivity; Humans; Male; Medical History Taking; Social Support; Zidovudine | 1991 |
Guidelines for the care of children and adolescents with HIV infection. Management of the HIV-positive child with fever.
Topics: Acetaminophen; Acquired Immunodeficiency Syndrome; Child; Fever; HIV Infections; HIV Seropositivity; Humans; Recurrence; Zidovudine | 1991 |
Guidelines for the care of children and adolescents with HIV infection. Retroviral therapy and clinical trials for HIV-infected children.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; CD4 Antigens; Child; Clinical Trials as Topic; HIV Infections; Humans; Immunoglobulins; Infant, Newborn; Zidovudine | 1991 |
[How can we organize the fight against H.I.V.?].
Topics: CD4 Antigens; HIV Infections; Humans; Peptide T; Vaccination; Zidovudine | 1990 |
Accommodating change due to treatment in the method of back projection for estimating HIV infection incidence.
Topics: Acquired Immunodeficiency Syndrome; Australia; HIV Infections; Humans; Incidence; Mathematics; Models, Statistical; New South Wales; Victoria; Zidovudine | 1990 |
Synthesis and anti-HIV evaluation of some phosphoramidate derivatives of AZT: studies on the effect of chain elongation on biological activity.
Topics: Cells, Cultured; Deoxyribonucleotides; DNA; Dose-Response Relationship, Drug; HIV; HIV Infections; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Prodrugs; Structure-Activity Relationship; Thymine Nucleotides; Zidovudine | 1990 |
Serum beta 2-M in asymptomatic HIV-infected patients treated with zidovudine.
Topics: Administration, Oral; beta 2-Microglobulin; HIV Infections; Humans; Zidovudine | 1990 |
Estimates of HIV prevalence and projected AIDS cases: summary of a workshop, October 31-November 1, 1989.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Female; HIV Infections; Humans; Incidence; Infant, Newborn; Male; Models, Statistical; Prevalence; United States; Zidovudine | 1990 |
Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
Topics: Acute Disease; Adult; HIV Infections; Homosexuality; Humans; Male; Platelet Count; Purpura, Thrombocytopenic; Remission Induction; Substance-Related Disorders; Thrombocytopenia; Zidovudine | 1990 |
From the National Institutes of Health.
Topics: Anorexia; Cachexia; Feeding and Eating Disorders; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; GTP-Binding Proteins; HIV Infections; Humans; Macrophages; Megestrol; National Institutes of Health (U.S.); Neoplasms; United States; Zidovudine | 1990 |
Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
Topics: Acquired Immunodeficiency Syndrome; Adult; Follow-Up Studies; Gene Products, gag; HIV Core Protein p24; HIV Infections; HIV-1; Homosexuality; Humans; Male; Viral Core Proteins; Zidovudine | 1990 |
[Virological monitoring in subjects with HIV infection under treatment with zidovudine (AZT)].
Topics: Gene Products, gag; HIV; HIV Core Protein p24; HIV Infections; Humans; Viral Core Proteins; Viremia; Virus Replication; Zidovudine | 1990 |
Zidovudine treatment of an infant with congenital human immunodeficiency virus infection.
Topics: Female; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Infant, Newborn; Viral Core Proteins; Zidovudine | 1990 |
Dental management of HIV-infected individuals.
Topics: Adult; Candidiasis, Oral; Dental Care for Disabled; HIV Infections; Humans; Oral Hygiene; Sarcoma, Kaposi; Virus Diseases; Zidovudine | 1990 |
Drugs for HIV infection.
Topics: Didanosine; HIV Infections; Humans; Zalcitabine; Zidovudine | 1990 |
From the Centers for Disease Control. HIV prevalence, projected AIDS case estimates: workshop, October 31-November 1, 1989.
Topics: Acquired Immunodeficiency Syndrome; Adult; Centers for Disease Control and Prevention, U.S.; HIV Infections; Humans; Incidence; Infant, Newborn; Models, Statistical; Prevalence; United States; Zidovudine | 1990 |
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Topics: Animals; Antibodies, Viral; Disease Models, Animal; Friend murine leukemia virus; Genotype; HIV Infections; Killer Cells, Natural; Leukocyte Count; Macrophages; Male; Mice; Mice, Inbred Strains; Retroviridae Infections; Spleen; T-Lymphocytes; Zidovudine | 1990 |
Clinical trials of combination therapies for HIV infection. Discussion.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Zalcitabine; Zidovudine | 1990 |
Strategies for the combination therapy of HIV infection.
Topics: Acyclovir; Antiviral Agents; Drug Therapy, Combination; HIV; HIV Infections; Humans; Virus Replication; Zalcitabine; Zidovudine | 1990 |
Oral melanotic macules in patients infected with human immunodeficiency virus.
Topics: Adult; Chi-Square Distribution; DNA, Viral; Female; Herpesvirus 4, Human; HIV; HIV Infections; Humans; Lip Diseases; Male; Melanosis; Middle Aged; Mouth Diseases; Mouth Mucosa; Nucleic Acid Hybridization; Zidovudine | 1990 |
Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection.
Topics: Adult; HIV Infections; HIV-1; Humans; Male; Methylprednisolone; Middle Aged; Prognosis; Purpura, Thrombocytopenic; Zidovudine | 1990 |
Oral temperature rhythmometry and substantial within-day variation in zidovudine levels following steady-state dosing in human immunodeficiency virus (HIV) infection.
Topics: Adult; Body Temperature; Circadian Rhythm; Female; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1990 |
[Antiviral substances: against what? For whom?].
Topics: Acyclovir; Antiviral Agents; Herpes Simplex; Herpes Zoster; HIV Infections; Humans; Zidovudine | 1990 |
Treatment of symptomatic children infected with human immunodeficiency virus.
Topics: Child; Clinical Trials as Topic; HIV Infections; Humans; Immunization, Passive; Zidovudine | 1990 |
Pseudofailure of zidovudine prophylaxis after a human immunodeficiency virus-positive needlestick.
Topics: Health Workforce; HIV Infections; Humans; Needles; Occupational Diseases; Zidovudine | 1990 |
AZT demonstrates anti-HIV-1 activity in persistently infected cell lines: implications for combination chemotherapy and immunotherapy.
Topics: Cell Line; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunotherapy; Immunotoxins; Interferon Type I; Ricin; Zidovudine | 1990 |
Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; HIV Infections; Humans; Zidovudine | 1990 |
HIV-associated nephropathy--beneficial effect of zidovudine therapy.
Topics: HIV Infections; Humans; Male; Middle Aged; Nephrotic Syndrome; Zidovudine | 1990 |
Zidovudine and HIV-2 disease.
Topics: Adult; Female; HIV Infections; HIV-2; Humans; Zidovudine | 1990 |
Neutrophilic eccrine hidradenitis in HIV-infected patients. Armed Forces Retrovirus Research Group.
Topics: Adult; Eccrine Glands; HIV Infections; Humans; Male; Necrosis; Skin; Sweat Gland Diseases; Zidovudine | 1990 |
[Utilization of zidovudine in the early stage of HIV infection. Lower dosages lessen toxicity].
Topics: HIV Infections; Humans; Zidovudine | 1990 |
Eosinophils, HIV infection and zidovudine.
Topics: Blood Cell Count; Eosinophils; HIV Infections; Humans; Zidovudine | 1990 |
For HIV patients survival increases the risk of lymphoma.
Topics: HIV Infections; HIV-1; Humans; Lymphoma, Non-Hodgkin; Zidovudine | 1990 |
[HIV-infection in children].
Topics: Child; Female; HIV Infections; Humans; Immunization, Passive; Infant, Newborn; Maternal-Fetal Exchange; Opportunistic Infections; Pregnancy; Quality of Life; Transfusion Reaction; Zidovudine | 1990 |
Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
Topics: Acyclovir; Adult; Diseases in Twins; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1990 |
[Initial therapeutic experiences in AIDS in childhood].
Topics: Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; Humans; Immunization, Passive; Male; Prednisolone; Pulmonary Fibrosis; Zidovudine | 1990 |
Guidelines for counselling persons who have had an occupational exposure to human immunodeficiency virus.
Topics: Canada; Counseling; Health Workforce; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Zidovudine | 1990 |
Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
Topics: Canada; Health Workforce; HIV Infections; HIV Seropositivity; Humans; Occupational Diseases; Occupational Exposure; Public Health Administration; Risk Factors; Zidovudine | 1990 |
Esophageal ulceration induced by zidovudine.
Topics: Adult; Esophageal Diseases; HIV Infections; Humans; Male; Posture; Ulcer; Zidovudine | 1990 |
Suppression of HIV infection in AZT-treated SCID-hu mice.
Topics: Animals; DNA, Viral; HIV; HIV Infections; Humans; Mice; Mice, Mutant Strains; Nucleic Acid Hybridization; Polymerase Chain Reaction; Spleen; Thymus Gland; Transplantation, Heterologous; Zidovudine | 1990 |
[Commentary on the press announcement "The first German preparation against HIV"].
Topics: Antiviral Agents; HIV Infections; Humans; Pentosan Sulfuric Polyester; Polysaccharides; Zidovudine | 1990 |
Therapy may explain recent deficits in AIDS incidence.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Male; United States; Zidovudine | 1990 |
Human immunodeficiency virus wasting syndrome may represent a treatable myopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; HIV Infections; HIV Seropositivity; Humans; Middle Aged; Muscular Diseases; Prednisone; Time Factors; Weight Loss; Zidovudine | 1990 |
Should the dosage of zidovudine be adjusted in HIV-infected patients with impaired renal function?
Topics: Half-Life; HIV Infections; Humans; Kidney Diseases; Zidovudine | 1990 |
Suicidal attempts with zidovudine.
Topics: Adult; Drug Overdose; HIV Infections; Humans; Male; Suicide, Attempted; Zidovudine | 1990 |
Successful chemotherapy for acute myeloid leucaemia in HIV-infected patients.
Topics: CD4 Antigens; Cytarabine; HIV Antibodies; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Zidovudine | 1990 |
[Preliminary study on the transport of AZT (Retrovir-zidovudine) through the placenta].
Topics: Abortion, Therapeutic; Adult; Amniotic Fluid; Female; Fetal Blood; HIV Infections; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1990 |
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
Topics: HIV Infections; Humans; Iatrogenic Disease; Male; Middle Aged; Time Factors; Transfusion Reaction; Zidovudine | 1990 |
Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia.
Topics: Aerosols; Biopsy; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Gallium Radioisotopes; HIV Infections; Humans; Lung; Pentamidine; Pneumonia, Pneumocystis; Radiography; Recurrence; Severity of Illness Index; Zidovudine | 1990 |
NIAID releases statement on early zidovudine use.
Topics: CD4 Antigens; HIV Infections; Humans; Zidovudine | 1990 |
Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.
Topics: Administration, Oral; Adult; Drug Administration Schedule; Hemophilia A; HIV Infections; Humans; Zidovudine | 1990 |
[The progression of HIV infection slowed down. Studies with zidovudine--the blood picture changes].
Topics: AIDS-Related Complex; HIV Infections; HIV-1; Humans; Zidovudine | 1990 |
The effect of acetaminophen on zidovudine metabolism in HIV-infected patients.
Topics: Acetaminophen; Adult; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; HIV Infections; Humans; Male; Zidovudine | 1990 |
[Varied behavior of Kaposi sarcomas].
Topics: Adult; Combined Modality Therapy; HIV Infections; Humans; Interferon Type I; Male; Neoplasms, Multiple Primary; Prognosis; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1990 |
[Myopathy associated with human immunodeficiency virus].
Topics: Adult; Electromyography; HIV Infections; Humans; Male; Myositis; Polyneuropathies; Zidovudine | 1990 |
[HIV infection in adults and children. Approaches to therapy. Position of the scientific consultant of the federal medical council].
Topics: Adult; Child; Germany, West; HIV; HIV Infections; Humans; Zidovudine | 1990 |
Longitudinal melanonychia induced by 3'-azidodeoxythymidine. Report of 9 cases.
Topics: Adult; Female; HIV Infections; Humans; Male; Nail Diseases; Pigmentation Disorders; Zidovudine | 1990 |
[The HIV-AIDS situation in Norway].
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Infections; HIV Seropositivity; Humans; Male; Norway; Zidovudine | 1990 |
Postexposure use of zidovudine by health-care workers examined in Public Health Service statement.
Topics: Health Occupations; HIV Infections; Humans; Occupational Diseases; United States; United States Public Health Service; Zidovudine | 1990 |
[Current developments in the anti-retroviral treatment of HIV-infected patients].
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1990 |
Zidovudine for HIV-related myelopathy.
Topics: Adult; HIV Infections; Humans; Nervous System Diseases; Zidovudine | 1990 |
Compliance with zidovudine therapy.
Topics: HIV Infections; Humans; Patient Compliance; Zidovudine | 1990 |
[Beginnings of therapy of manifest HIV infection in adults and in children. Position of the Scientific Advisory Committee of the General Medical Council].
Topics: Adult; Child; Germany, West; HIV Infections; Humans; Immunization; Immunoglobulins; Zidovudine | 1990 |
Zidovudine in asymptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1990 |
Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Topics: Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Colony-Forming Units Assay; Drug Stability; Erythroid Precursor Cells; Granulocytes; HIV Infections; HIV-1; Humans; Macrophages; Pyrimidine Dimers; T-Lymphocytes; Zidovudine | 1990 |
Should you take zidovudine after a needle stick?
Topics: Decision Making; Environmental Exposure; Health Occupations; HIV Infections; Humans; Needles; Wounds, Stab; Zidovudine | 1990 |
Early diagnosis of HIV infection.
Topics: HIV Infections; Humans; Zidovudine | 1990 |
Treatment of mildly symptomatic human immunodeficiency virus (HIV) infection.
Topics: CD4 Antigens; HIV Infections; Humans; Zidovudine | 1990 |
Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.
Topics: Adult; Blotting, Western; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Lymphoma, Non-Hodgkin; Male; Polymerase Chain Reaction; Viral Core Proteins; Whole-Body Irradiation; Zidovudine | 1989 |
Insurance company to pay for AZT.
Topics: HIV Infections; Humans; Insurance, Health, Reimbursement; United States; Zidovudine | 1989 |
Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus infection with a combination of interferon alpha and azidothymidine: a pilot study.
Topics: Adult; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Antigens; HIV Infections; Humans; Interferon Type I; Leukocyte Count; Male; Middle Aged; Pilot Projects; Zidovudine | 1989 |
Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals.
Topics: Acyclovir; Adult; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Drug Synergism; Erythrocyte Count; HIV Infections; HIV Seropositivity; Humans; Leukocyte Count; Male; Metabolic Clearance Rate; Middle Aged; Monocytes; Zidovudine | 1989 |
AIDS therapy and the detection of adverse drug effects in dental practice.
Topics: Acquired Immunodeficiency Syndrome; Drug and Narcotic Control; HIV Infections; Humans; Mouth Diseases; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Food and Drug Administration; Zidovudine | 1989 |
Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection.
Topics: Adult; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Virus Replication; Zidovudine | 1989 |
AZT to cost less.
Topics: Costs and Cost Analysis; HIV Infections; Humans; Zidovudine | 1989 |
AZT and asymptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Zidovudine | 1989 |
The potential value of hyperthermia in the management of human immunodeficiency virus infection.
Topics: HIV Infections; Humans; Hyperthermia, Induced; Zidovudine | 1989 |
[Psoriasis and HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Infections; Humans; Male; Middle Aged; Psoriasis; Zidovudine | 1989 |
AZT benefits HIV-positive asymptomatic people: new hope, new challenges.
Topics: HIV Infections; Humans; Zidovudine | 1989 |
Wider use of zidovudine for HIV-infected patients.
Topics: HIV Infections; Humans; Zidovudine | 1989 |
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Female; HIV Infections; Humans; Male; Methadone; New York City; Pentamidine; Pneumonia, Pneumocystis; Primary Health Care; Substance Abuse, Intravenous; Tuberculosis; Zidovudine | 1989 |